Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6607034655504634,-2.2529458231491204,0.0,0.01714894225139796,0.014,15/30,7.61%,TJP1;CDH5;GJB6;OCLN;PECAM1;DMD;CLDN5;LAMA2;ESAM;SLC12A2;F11R;LSR;TJP2;ACTB;GJA1
prerank,dopaminergic neuron differentiation (GO:0071542),0.8363451451828041,1.9367802895056605,0.0,0.05141129388781734,0.05,5/19,3.91%,LMX1A;LRP6;WNT2;VEGFA;LMX1B
prerank,collagen fibril organization (GO:0030199),0.6827677332112764,1.9189042727888694,0.0,0.04462112299697354,0.081,35/88,10.87%,COL14A1;PLOD2;COL3A1;P4HA3;COL5A2;COL6A3;COL1A2;DDR2;COL1A1;LOXL2;COL17A1;COL5A1;BMP1;COL8A1;COL11A1;COL5A3;ADAMTS2;COL6A2;TGFB2;COL8A2;P4HA1;ADAMTS3;DPT;DST;COL12A1;COL6A1;P4HA2;TLL1;COL15A1;PLOD3;COL9A3;LOXL1;COL2A1;COLGALT1;SERPINH1
prerank,protein localization to cell-cell junction (GO:0150105),-0.6658187655603198,-1.9104009784520144,0.0,0.7888513435643062,0.696,7/15,5.82%,TJP1;CGNL1;CDH5;F11R;LSR;TJP2;ACTB
prerank,superoxide anion generation (GO:0042554),0.897165926406875,1.9077557451092886,0.0,0.0423577327000256,0.11,3/13,0.87%,NOX4;DUOX1;NCF4
prerank,ethanol metabolic process (GO:0006067),-0.7133606220123819,-1.8875649933203975,0.0035335689045936395,0.6710952734380402,0.767,5/12,15.32%,ALDH1A1;ACSS1;ACSS2;ADH1A;SULT1A1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6190334670003336,-1.8684873147084062,0.0,0.6099307127413874,0.824,6/19,3.99%,TJP1;PRKCH;OCLN;CLDN5;F11R;NPHP1
prerank,protein homotrimerization (GO:0070207),0.8357464569243868,1.8327780032443712,0.001314060446780552,0.18158857010942273,0.523,5/14,4.28%,SCARA5;SLC1A5;DISP1;MIF;P2RX3
prerank,protein trimerization (GO:0070206),0.8357464569243868,1.8327780032443712,0.001314060446780552,0.18158857010942273,0.523,5/14,4.28%,SCARA5;SLC1A5;DISP1;MIF;P2RX3
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.6922177891148096,-1.831974387761084,0.006557377049180328,0.6848144272391585,0.899,4/11,4.27%,TJP1;RAPGEF2;F11R;TJP2
prerank,regulation of cell junction assembly (GO:1901888),-0.5559684831870343,-1.8264731981927398,0.0,0.6002129787989287,0.91,8/27,3.21%,TJP1;RAPGEF2;PRKCH;OCLN;PDLIM5;CLDN5;MEF2C;F11R
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.8366245964968309,1.8171165078937943,0.0013605442176870747,0.20726188290623215,0.626,5/13,6.59%,GFPT2;UAP1;GFPT1;GNPNAT1;NAGK
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.7939170460946811,1.814663450470182,0.0,0.18513608796259828,0.641,9/19,11.47%,GFPT2;UAP1;UGDH;UGP2;GFPT1;GNPNAT1;NAGK;GMPPB;SLC35D1
prerank,regulation of multicellular organismal development (GO:2000026),-0.5532528923457909,-1.77758700512749,0.015706806282722512,0.7947309809076426,0.972,10/25,18.82%,PTN;INSR;TRIP12;MYSM1;SOX17;OAS2;SPAAR;TDG;DUSP6;RACGAP1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.8689448864988233,1.7708061481197357,0.0,0.38255337786807475,0.9,3/11,1.22%,LMX1A;LRP6;WNT2
prerank,amino sugar biosynthetic process (GO:0046349),0.8426865718860059,1.7688437194336186,0.0028328611898017,0.3523344228915615,0.905,5/12,6.59%,GFPT2;UAP1;GFPT1;GNPNAT1;NAGK
prerank,amino acid import (GO:0043090),-0.5618821749535465,-1.7687738286419126,0.00558659217877095,0.7541247355052254,0.979,6/21,4.70%,SLC6A13;SLC1A3;SLC16A2;SLC6A1;SLC7A5;SLC22A4
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6774733902524595,-1.7667711601943008,0.0036231884057971015,0.6811305803851545,0.98,9/12,21.82%,ATP1B3;DMD;WNK4;FXYD1;NOS1;ATP1B1;GLRX;ANK3;ATP1B2
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7843974559784216,1.7595968563771007,0.0013550135501355014,0.3721983672595379,0.931,2/15,0.49%,SYK;CD55
prerank,bicellular tight junction assembly (GO:0070830),-0.4612039582142205,-1.7594349800352629,0.0,0.6488016485112229,0.982,10/46,3.96%,CDH5;PARD6G;OCLN;PECAM1;CLDN5;PATJ;ESAM;F11R;DLG1;STRN
prerank,regulation of transmembrane transport (GO:0034762),-0.5124714665745477,-1.7555285372425675,0.007246376811594203,0.6100866122164001,0.99,8/31,5.82%,NEDD4L;OCLN;SLC2A1;BCL2;CTTNBP2NL;SNCA;WWP2;ACTB
prerank,macrophage activation involved in immune response (GO:0002281),0.8193788802452622,1.7533974774604577,0.00546448087431694,0.37619310416025514,0.953,2/13,0.28%,SYK;LBP
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.8505275958490112,1.752809108161034,0.0014204545454545455,0.3479962581557447,0.954,5/11,6.59%,GFPT2;UAP1;GFPT1;GNPNAT1;NAGK
prerank,tight junction assembly (GO:0120192),-0.44740354634529594,-1.7494853137407849,0.0,0.5888756225327267,0.993,11/49,3.96%,CDH5;PARD6G;OCLN;PECAM1;CLDN5;PATJ;ESAM;F11R;DLG1;LSR;STRN
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.8002367993075359,1.7488274599839184,0.006702412868632708,0.34510483923244584,0.962,4/14,8.08%,SYK;CD55;TGFBR2;CD81
prerank,positive regulation of protein processing (GO:0010954),0.7738882154886465,1.7483663790787887,0.005115089514066497,0.32274097968929,0.963,6/19,7.11%,GSN;CCBE1;HPN;CLEC3B;KLKB1;MELTF
prerank,actin filament bundle organization (GO:0061572),-0.4836596237735281,-1.7474060841520969,0.007633587786259542,0.5528994868437896,0.994,5/33,2.04%,PAWR;MYO1B;SHROOM2;CALD1;EPS8
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.4958798349011103,-1.7444902070064352,0.0,0.5256559108202318,0.994,12/35,13.23%,TJP1;RAPGEF3;ESAM;F11R;IQGAP2;NRP1;NTRK3;MDK;TEK;CDK5;ABL1;ABI3
prerank,heart process (GO:0003015),0.8101457996945755,1.7382034081688305,0.004054054054054054,0.3567749790931927,0.979,3/14,3.15%,NOX4;FYN;TNNI3
prerank,skin development (GO:0043588),0.6517215392428215,1.731321151436094,0.0,0.37230749500599797,0.987,13/65,4.91%,COL3A1;COL5A2;COL1A2;COL1A1;LORICRIN;COL5A1;ANXA1;COL5A3;SCEL;ADAM9;PKD1;KRT10;DACT2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.49491523267543824,-1.7302641467061441,0.0,0.5502142849459639,0.995,13/35,7.48%,PDE7B;IRAG1;RAPGEF2;ADCY1;RAPGEF3;PDE3A;ADGRG6;APOE;NUDT4;KSR1;GUCY1B1;AHR;CAP2
prerank,vascular transport (GO:0010232),-0.40601952333594,-1.7296441181231745,0.0,0.5180409638443133,0.995,22/81,5.74%,ATP1A2;SLC24A3;SLC7A2;SLC6A13;SLC1A3;SLC16A12;ABCC4;SLC13A3;SLC22A8;SLC16A2;INSR;ABCG2;SLCO2B1;SLC2A1;SLCO1C1;SLC12A2;SLC6A1;SLC5A3;SLC7A5;ABCC9;SLC6A9;SLC5A5
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.8572903970150384,1.7272815249729614,0.0,0.3746006041881474,0.991,3/10,3.12%,GFPT2;PFKP;GFPT1
prerank,superoxide metabolic process (GO:0006801),0.7080078180511056,1.7265658103319816,0.003579952267303103,0.3584779108404202,0.992,3/29,0.87%,NOX4;DUOX1;NCF4
prerank,positive regulation of vascular permeability (GO:0043117),-0.6624340851982242,-1.7263008479046982,0.011538461538461539,0.49960585092406057,0.995,8/12,12.49%,TJP1;BMP6;OCLN;PDE3A;TJP2;PDE2A;TGFB1;TRPV4
prerank,muscle tissue morphogenesis (GO:0060415),-0.5994701485259936,-1.7246136510099228,0.007692307692307693,0.47864603261679645,0.995,5/16,10.57%,MYLK;NOTCH1;TGFBR3;TBX1;BMP2
prerank,cation transmembrane transport (GO:0098655),-0.4649219241063217,-1.7236085482942782,0.0,0.4568839246135604,0.995,10/44,9.21%,ATP1A2;TRPM3;SLC7A2;TRPM6;SLC7A5;ABCC9;SLC6A9;SLC3A2;SLC25A20;SLC38A5
prerank,C21-steroid hormone metabolic process (GO:0008207),0.7460255099630982,1.722531780415317,0.0012330456226880395,0.36176805212420426,0.994,2/20,0.74%,AKR1B1;DHRS9
prerank,transport across blood-brain barrier (GO:0150104),-0.40014812787423404,-1.7150426404303027,0.0,0.46462200873120874,0.996,22/83,5.74%,ATP1A2;SLC24A3;SLC7A2;SLC6A13;SLC1A3;SLC16A12;ABCC4;SLC13A3;SLC22A8;SLC16A2;INSR;ABCG2;SLCO2B1;SLC2A1;SLCO1C1;SLC12A2;SLC6A1;SLC5A3;SLC7A5;ABCC9;SLC6A9;SLC5A5
prerank,actin filament bundle assembly (GO:0051017),-0.4899187121191033,-1.7150146632711072,0.01652892561983471,0.4425515922590922,0.996,5/33,2.04%,PAWR;MYO1B;SHROOM2;CALD1;EPS8
prerank,cGMP-mediated signaling (GO:0019934),-0.6384207507063043,-1.7124392808294813,0.01937984496124031,0.4317376128018614,0.996,5/13,9.63%,IRAG1;PDE3A;APOE;GUCY1B1;PDE2A
prerank,extracellular matrix organization (GO:0030198),0.5905441086533738,1.7112001048444878,0.0,0.40532470096272594,0.997,75/276,10.15%,COL14A1;PLOD2;MFAP5;COMP;COL3A1;P4HA3;DCN;ADAMTS5;COL5A2;COL6A3;COL1A2;TIMP2;DDR2;FBN1;HAS2;GSN;COL1A1;HAS1;LOXL2;COL17A1;COL5A1;BMP1;COL8A1;FLRT2;COL11A1;POSTN;VIT;COL5A3;ITGA11;ADAMTS2;SPARC;COL6A2;CD44;ITGB3;CAPN2;MMP2;FGF2;TGFB2;COL8A2;P4HA1;KLKB1;ELN;SMOC2;ADAMTS3;ACAN;SCUBE3;ITGA2;ADAMTSL1;ADAM19;ITGA5;ITGB5;DPT;DST;VCAN;ADAMTSL4;COL12A1;CREB3L1;JAM3;COL6A1;TGFBI;P4HA2;TLL1;GAS6;MMP11;CAPN1;COL15A1;PLOD3;ADAMTSL5;ADAMTSL3;ADAMTS18;ITGAV;COL9A3;LOXL1;COL2A1;CD47
prerank,eye morphogenesis (GO:0048592),0.7484594191702441,1.7083683100297853,0.0012285012285012285,0.40320681432772465,0.998,7/19,5.31%,MFAP5;COL5A2;FBN1;COL5A1;VEGFA;SKI;TENM3
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.7556211775747944,1.704747771614248,0.00788436268068331,0.40644022903765026,0.999,6/17,8.76%,SYK;LIF;TGFB2;ADAM9;RET;FOXC2
prerank,response to iron ion (GO:0010039),-0.643922525741859,-1.7028672737460477,0.014652014652014652,0.44249241716505694,0.999,5/12,6.86%,BMP6;BCL2;SNCA;ACO1;B2M
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.765693433326104,1.7014327732287355,0.005277044854881266,0.40842245283808293,0.999,5/17,7.26%,SFRP4;FSTL1;PCSK6;SLIT2;SULF1
prerank,extracellular matrix disassembly (GO:0022617),0.6443438933616538,1.6995511719158714,0.0,0.4027218021212358,0.999,13/53,8.22%,ADAMTS5;TIMP2;GSN;BMP1;HPN;CD44;CAPN2;MMP2;KLKB1;SCUBE3;TLL1;MMP11;CAPN1
prerank,regulation of interleukin-2 production (GO:0032663),0.6637714142934446,1.6989904008803245,0.0011402508551881414,0.3901050179231061,0.999,7/43,3.72%,CD34;CD80;IRF4;ANXA1;GLMN;RUNX1;HDAC7
prerank,transition metal ion transport (GO:0000041),-0.4802554618216307,-1.698754208345273,0.0,0.43767911501623463,0.999,15/35,14.72%,CP;IREB2;ATP2C1;SLC30A10;SLC39A8;FTH1;TRPC5;SLC30A1;TRPC6;TRPC4;CUTC;TFRC;TRPC7;TRPC3;COX17
prerank,response to interleukin-4 (GO:0070670),-0.6630075311874202,-1.6896260862036918,0.032679738562091505,0.449576670062649,0.999,2/10,4.63%,LEF1;TCF7
prerank,response to glucagon (GO:0033762),-0.5473029896078621,-1.6890223693624618,0.02336448598130841,0.43422001213475614,0.999,9/19,15.91%,ADCY5;ADCY1;PRKAR1B;CRY1;ADCY4;ADCY9;PRKAR2B;CYSLTR2;PRKACB
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.6258841120624102,-1.688192061847603,0.022304832713754646,0.4208477457694922,0.999,6/13,8.63%,PLXNA2;NRP2;PLXNA4;PLXND1;NRP1;PLXNB1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.7493053915851136,1.6866546161385236,0.007702182284980745,0.4483378219520326,1.0,2/18,0.28%,SYK;LBP
prerank,smooth muscle tissue development (GO:0048745),-0.6707134330457953,-1.6830379514591403,0.02903225806451613,0.4223539491630012,0.999,4/10,8.05%,MYLK;ENG;PTCH1;STRA6
prerank,embryonic eye morphogenesis (GO:0048048),0.8195601388394602,1.6830354953203797,0.008379888268156424,0.45328881550146144,1.0,3/11,0.47%,MFAP5;FBN1;LRP6
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.7661331634281567,1.6806829533527337,0.0103359173126615,0.4516502954282174,1.0,3/17,2.88%,SFRP4;TMEM100;FGF2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.7280205554400632,1.6755294394899964,0.0049813200498132005,0.46718382676066667,1.0,6/21,8.56%,DCN;UGDH;CSGALNACT2;VCAN;CHST12;CHSY3
prerank,smooth muscle cell differentiation (GO:0051145),-0.6516441285860554,-1.6740420435604746,0.02120141342756184,0.43428217894574705,0.999,9/12,23.49%,MEF2C;TBX18;MRTFB;TMEM204;EDNRB;MYOCD;APLNR;HEY1;HEY2
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.6759025927012656,-1.6710858582740724,0.006920415224913495,0.4293332964538877,0.999,4/10,6.08%,ENG;ENPP1;ERRFI1;CAV1
prerank,regulation of mast cell activation (GO:0033003),-0.649738516993994,-1.6621327897684814,0.03169014084507042,0.4440285262512505,1.0,4/10,12.01%,LYN;PLSCR1;NECTIN2;CD84
prerank,B cell homeostasis (GO:0001782),-0.6760370881835144,-1.6563369143694033,0.023026315789473683,0.44815902416986664,1.0,2/10,2.00%,LYN;MEF2C
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7704469560613201,1.6561625224241652,0.0026666666666666666,0.5804302745787479,1.0,6/15,8.69%,DCN;CSGALNACT2;VCAN;CHST12;CHST14;B3GAT3
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5426631966346542,-1.6513224362505043,0.04326923076923077,0.4498565962311162,1.0,10/18,30.06%,SLC39A8;ITGA4;VCAM1;GCNT1;ROCK1;JAM2;SELPLG;PODXL2;SELP;ITGB7
prerank,renal water homeostasis (GO:0003091),-0.5020713340167059,-1.6476668049442664,0.020100502512562814,0.4471838882379245,1.0,9/23,15.91%,ADCY5;ADCY1;PRKAR1B;ADCY4;ADCY9;RAB11A;MYO5B;PRKAR2B;PRKACB
prerank,smooth muscle contraction (GO:0006939),-0.5933669303512265,-1.6458437383359559,0.019762845849802372,0.43969887932584373,1.0,5/14,11.49%,MYLK;EDNRA;MYH11;SMTN;ACTA2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.6904432345280062,1.6454114398995696,0.0024242424242424242,0.6476633967681334,1.0,8/27,9.11%,DCN;UGDH;CSGALNACT2;VCAN;CHST12;CHSY3;B3GAT3;XYLT1
prerank,cellular component disassembly (GO:0022411),0.6253689245857866,1.644300945530309,0.001081081081081081,0.6359419424955897,1.0,12/53,8.22%,ADAMTS5;TIMP2;GSN;BMP1;CD44;CAPN2;MMP2;KLKB1;SCUBE3;TLL1;MMP11;CAPN1
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5723576604210323,-1.638512477774555,0.00851063829787234,0.4489847139819711,1.0,5/16,8.38%,PRKAG2;LONP2;PPARA;ACADL;APPL2
prerank,positive regulation of protein depolymerization (GO:1901881),-0.6383872138057907,-1.6374040785492547,0.025925925925925925,0.43993989148721474,1.0,5/11,19.05%,SEMA5A;NES;TRPV4;WDR1;KATNB1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.7036876646652149,1.6358559521309506,0.014943960149439602,0.6826914239820226,1.0,7/20,7.85%,NPTN;SULF2;FGF2;SMOC2;CREB3L1;SULF1;PRKD2
prerank,myoblast fusion (GO:0007520),0.7879504521464755,1.6341761342079857,0.006666666666666667,0.6763923171433814,1.0,4/12,8.08%,ADAMTS5;CD9;PTGFRN;CD81
prerank,apical junction assembly (GO:0043297),-0.4100008372089009,-1.6322382149962869,0.0,0.44415760431120715,1.0,10/53,3.96%,CDH5;PARD6G;OCLN;PECAM1;CLDN5;PATJ;ESAM;F11R;DLG1;STRN
prerank,carbohydrate catabolic process (GO:0016052),-0.4571492429363735,-1.6318752333628386,0.014925373134328358,0.43370700958877406,1.0,18/38,20.36%,ENO1;HK2;PGAM1;PGAM4;DERA;MAN2B1;PGK1;PFKM;ALDOC;GAPDH;PFKL;MANBA;TPI1;MAN2B2;GAPDHS;NEU3;ENO3;GPI
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.642484910175948,-1.6311448041813819,0.04,0.42497937056006047,1.0,5/11,9.37%,MLLT3;WNT5B;RSPO3;NKD1;SFRP1
prerank,homocysteine metabolic process (GO:0050667),0.7792314532323891,1.6289493478399335,0.009790209790209791,0.6998033265053304,1.0,1/11,0.01%,NOX4
prerank,establishment of endothelial barrier (GO:0061028),-0.4788335782017692,-1.6265924954644524,0.0,0.42696683537139124,1.0,10/29,10.95%,TJP1;RAPGEF2;RAPGEF3;PECAM1;PPP1R16B;F11R;TJP2;PDE2A;ROBO4;ICAM1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.6671160907273341,1.624322182344965,0.004784688995215311,0.718222242442228,1.0,3/30,1.14%,CD34;SYK;IRF4
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.7148141886653281,1.6238770648549496,0.013054830287206266,0.7026909281362408,1.0,5/17,4.94%,MID1;STK25;TGFB2;TAOK3;KLHDC10
prerank,presynaptic endocytosis (GO:0140238),0.6778477562972259,1.6233630534656711,0.012180267965895249,0.6884875905900304,1.0,5/24,3.29%,STON2;SNCB;SYT2;CEL;STX1A
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.6270872766929108,1.6196220190909005,0.005688282138794084,0.7013027781620212,1.0,12/41,17.16%,CD34;LBP;IRAK3;SYT11;GAS6;TLR4;SIRPA;ZC3H12A;IL4;SELENOS;ILRUN;CHRNA7
prerank,negative regulation of hormone secretion (GO:0046888),0.7991258435124575,1.617326008274308,0.014388489208633094,0.7028554390333065,1.0,2/10,1.02%,LIF;RAB11FIP5
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.6659865957337063,-1.6168478479888861,0.03308823529411765,0.44521920549819854,1.0,3/10,13.41%,ACTN2;SEMA5A;WDR1
prerank,sulfur amino acid metabolic process (GO:0000096),0.6712326986427262,1.6162076565553027,0.01488833746898263,0.6956967771611914,1.0,2/24,0.79%,NOX4;GCLC
prerank,bone morphogenesis (GO:0060349),0.7403946101736925,1.6135579306274523,0.02356020942408377,0.7004962010860287,1.0,3/14,4.06%,SFRP4;LRP6;SKI
prerank,external encapsulating structure organization (GO:0045229),0.5615582357885714,1.6094113033014712,0.0,0.7178406243107658,1.0,52/205,10.15%,COL14A1;MFAP5;COMP;COL3A1;DCN;ADAMTS5;COL5A2;COL6A3;COL1A2;DDR2;FBN1;COL1A1;COL17A1;COL5A1;COL8A1;COL11A1;POSTN;VIT;COL5A3;ITGA11;ADAMTS2;SPARC;COL6A2;CD44;ITGB3;MMP2;FGF2;COL8A2;ELN;SMOC2;ADAMTS3;ACAN;ITGA2;ADAMTSL1;ADAM19;ITGA5;ITGB5;VCAN;ADAMTSL4;JAM3;COL6A1;TGFBI;MMP11;COL15A1;ADAMTSL5;ADAMTSL3;ADAMTS18;ITGAV;COL9A3;LOXL1;COL2A1;CD47
prerank,endothelial cell proliferation (GO:0001935),0.7093935674215344,1.6091467997905833,0.020833333333333332,0.7033558834463655,1.0,3/17,1.55%,CD34;LOXL2;ANGPT4
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.6195799914542778,-1.6087108450727354,0.055762081784386616,0.4597511773816645,1.0,6/11,15.14%,EFNB2;SOX6;MEF2C;BMP2;TGFB1;MYOCD
prerank,extracellular structure organization (GO:0043062),0.5601478082302657,1.6054467068920169,0.0,0.7169989338769729,1.0,52/204,10.15%,COL14A1;MFAP5;COMP;COL3A1;DCN;ADAMTS5;COL5A2;COL6A3;COL1A2;DDR2;FBN1;COL1A1;COL17A1;COL5A1;COL8A1;COL11A1;POSTN;VIT;COL5A3;ITGA11;ADAMTS2;SPARC;COL6A2;CD44;ITGB3;MMP2;FGF2;COL8A2;ELN;SMOC2;ADAMTS3;ACAN;ITGA2;ADAMTSL1;ADAM19;ITGA5;ITGB5;VCAN;ADAMTSL4;JAM3;COL6A1;TGFBI;MMP11;COL15A1;ADAMTSL5;ADAMTSL3;ADAMTS18;ITGAV;COL9A3;LOXL1;COL2A1;CD47
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.47877876830495336,-1.6045247743611042,0.006024096385542169,0.4609167978750734,1.0,8/29,12.16%,TPM1;ENG;NOTCH1;TGFBR3;S1PR1;FGFR2;BMP2;TGFB1
prerank,peptide cross-linking (GO:0018149),0.6814989218939462,1.6041197975138322,0.013157894736842105,0.7122720564597236,1.0,4/25,4.62%,COL3A1;LORICRIN;ANXA1;KRT10
prerank,positive regulation of interleukin-2 production (GO:0032743),0.6708049633328829,1.6029413932379113,0.014319809069212411,0.7065286325418109,1.0,7/25,11.84%,CD80;IRF4;ANXA1;GLMN;RUNX1;PRKD2;PDE4D
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.61996792865935,1.6029346713351986,0.0034207525655644243,0.6918497037143971,1.0,12/43,17.16%,CD34;LBP;IRAK3;SYT11;GAS6;TLR4;SIRPA;ZC3H12A;IL4;SELENOS;ILRUN;CHRNA7
prerank,synaptic vesicle membrane organization (GO:0048499),0.7193832500638094,1.6020225222719735,0.01699346405228758,0.6845402893133753,1.0,11/17,17.97%,STX2;STX1A;STX11;AP3D1;STX1B;TOR1A;STX4;SNAP23;SNAP25;SNAP47;STX3
prerank,diol biosynthetic process (GO:0034312),-0.5744517869383471,-1.601455318045852,0.021551724137931036,0.46032842170826616,1.0,8/15,22.80%,ACER2;GCH1;QDPR;SPR;SPHK1;SPTLC2;SPHK2;ABCA2
prerank,cellular response to interleukin-4 (GO:0071353),-0.6414111013434713,-1.600081296401236,0.05067567567567568,0.45432270196457203,1.0,2/10,4.63%,LEF1;TCF7
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.7502099314544901,1.5968563301452074,0.026917900403768506,0.7125023318203696,1.0,4/13,8.08%,SYK;CD9;ABCA1;CD81
prerank,positive regulation of cell adhesion (GO:0045785),0.581550992553707,1.595430113459279,0.0021164021164021165,0.7095633480499126,1.0,19/74,10.15%,SYK;LIF;FBLN2;PRKCA;VIT;VEGFA;TGFB2;ADAM9;PTPRJ;ZFHX3;C1QBP;RET;FLCN;PRKD2;TNFRSF18;FOXC2;STX4;ITGAV;CD47
prerank,cell junction maintenance (GO:0034331),0.735937015461172,1.594895868528675,0.0291005291005291,0.7001151200666444,1.0,5/14,8.24%,DCTN1;CD177;F2R;MYADM;PARD6A
prerank,vasoconstriction (GO:0042310),-0.636785569286346,-1.5936029244679282,0.04693140794223827,0.4628511676022701,1.0,5/11,15.58%,EDNRA;ACTA2;EDNRB;EDN1;EDN3
prerank,heart trabecula morphogenesis (GO:0061384),-0.5408300640569829,-1.5909419026061835,0.031746031746031744,0.46092545895701853,1.0,8/18,6.54%,BMP5;ENG;ADGRG6;BMP7;RBP4;NOTCH1;TGFBR3;S1PR1
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.7646388492338417,1.5904788859722143,0.02077562326869806,0.7208745576217377,1.0,4/12,7.68%,DCN;VCAN;CHST12;CHST14
prerank,regulation of interleukin-1 production (GO:0032652),0.7394180521143233,1.58756824815479,0.00909090909090909,0.7308954317636309,1.0,6/15,10.19%,ANXA1;FOXP1;F2R;GAS6;TLR4;SIRPA
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6450083946527133,-1.586724061142767,0.04318936877076412,0.46411803981606564,1.0,5/10,25.34%,LYN;KIT;CD40;BTLA;FGR
prerank,regulation of sensory perception of pain (GO:0051930),0.7671954445111294,1.5863628280649122,0.02545968882602546,0.7267070165878646,1.0,4/11,8.27%,MGLL;TMEM100;F2R;SPX
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5460203175795965,-1.5857276772899582,0.03319502074688797,0.45751091401096244,1.0,11/17,12.04%,MAML3;CREBBP;NOTCH3;NOTCH1;PLXND1;WWC1;HEYL;MAML2;NOTCH4;STAT1;EP300
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5701808268497579,1.5849966877416883,0.0021008403361344537,0.724261799203982,1.0,20/86,8.08%,GHR;LIF;CD80;FGF7;EGFR;EFNA5;ANGPT4;CD44;FYN;ITGB3;DGKQ;VEGFA;MIF;ACVR1;ITGA5;PTPRJ;THBS4;SRC;BANK1;CD81
prerank,positive regulation of bone mineralization (GO:0030501),-0.4608450351973986,-1.5844141336589184,0.03937007874015748,0.45241823858524666,1.0,14/35,12.16%,PTN;BMP6;WNT4;ADGRV1;BMP7;MEF2C;OSR1;KL;NELL1;ATRAID;BMPR2;BMP2;PKDCC;TGFB1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.6591535344541268,1.5818485747693263,0.019536019536019536,0.7376440031669786,1.0,6/24,11.91%,GFPT2;GFPT1;COQ10B;PID1;ACADVL;NDUFS1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.4853067773744523,-1.5800752889927305,0.03355704697986577,0.4548427144832321,1.0,8/27,3.53%,TJP1;CGNL1;PHLDB2;ARHGAP28;ARHGAP6;F11R;SHANK3;RHPN2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.6919281224028807,1.5794276201113102,0.022900763358778626,0.7433230178412625,1.0,7/19,14.82%,SYK;AXL;ZMIZ1;GAS6;ZBTB1;CD27;IL4
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.6706727841961487,1.5783411810054302,0.012330456226880395,0.7396025121661217,1.0,8/25,10.58%,HAS2;HAS1;B3GALNT1;CSGALNACT2;EXT1;HS2ST1;FUT9;B3GNT8
prerank,response to glucocorticoid (GO:0051384),0.6515331689930767,1.5754112190611718,0.015625,0.7507988956447287,1.0,10/26,20.58%,ANXA1;SLIT3;SLIT2;ADAM9;ZFP36L1;ZFP36L2;ZFP36;IL6;PDCD7;GOT1
prerank,modified amino acid transport (GO:0072337),-0.577384800158365,-1.5753939751004904,0.046153846153846156,0.4591170904135273,1.0,5/15,10.49%,SLC6A13;SLC16A12;PDPN;CTNS;MGST1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.7167218038099671,1.5753251676198585,0.022941970310391364,0.7393176230845665,1.0,3/15,2.91%,TGFB3;IRAK3;TGFB2
prerank,regulation of protein neddylation (GO:2000434),-0.6323666442073206,-1.5745709205386125,0.05338078291814947,0.45304964844156165,1.0,7/10,25.13%,EPAS1;DCUN1D4;RPL5;DCUN1D3;DCUN1D5;HIF1A;DCUN1D2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.4101072452806535,-1.5739182112673646,0.0,0.4466416026130763,1.0,14/46,17.58%,ATP1A2;MEF2C;GRM3;SHANK3;DGKZ;CACNG4;OPHN1;GRM7;CACNG8;CDK5;UNC13A;GRM8;CDH2;CLN3
prerank,amino sugar metabolic process (GO:0006040),0.7625915999465596,1.5724764223245062,0.024890190336749635,0.7488588468187733,1.0,2/10,3.12%,GFPT2;GFPT1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.5353124738338435,-1.569951737295458,0.04888888888888889,0.4496289335057008,1.0,8/17,15.91%,ADCY5;ADCY1;PRKAR1B;ADCY4;ADCY9;PRKAR2B;CYSLTR2;PRKACB
prerank,cellular defense response (GO:0006968),0.6078076558188442,1.5695111509319213,0.01710376282782212,0.7598524568325205,1.0,4/40,4.69%,LBP;LSP1;KIR3DL2;RAB23
prerank,angiogenesis involved in wound healing (GO:0060055),0.7699647736118121,1.5692788417582728,0.022988505747126436,0.7494499554454316,1.0,4/11,6.10%,CD34;ITGB3;VEGFA;PRCP
prerank,spinal cord development (GO:0021510),0.7468226351761276,1.568716273042947,0.020718232044198894,0.7424417622406132,1.0,5/12,7.85%,VIT;ZPR1;PKD1;GLI2;PKD2
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.7521607234161057,1.5660287321473216,0.023709902370990237,0.7511516317949023,1.0,9/12,17.97%,STX2;STX1A;STX11;STX1B;STX4;SNAP23;SNAP25;SNAP47;STX3
prerank,renal absorption (GO:0070293),0.7899951966388148,1.5638447051483695,0.020114942528735632,0.75753115463032,1.0,2/10,0.45%,HAS2;GSN
prerank,regulation of protein localization to membrane (GO:1905475),0.6471174781383244,1.5625422942478053,0.015439429928741092,0.7572467049780509,1.0,6/28,5.39%,AR;GSN;GPC6;GPC3;FYN;ZDHHC7
prerank,regulation of interleukin-12 production (GO:0032655),0.5958991144749509,1.5617446842586635,0.009793253536452665,0.7522328447769565,1.0,11/47,11.89%,SYK;IL16;IRAK3;FOXP1;MAPK14;C1QBP;TIRAP;TLR4;MAPK11;CD47;PIBF1
prerank,positive regulation of actin nucleation (GO:0051127),0.743359357934728,1.5585350740649124,0.031988873435326845,0.7661945688278459,1.0,3/11,5.88%,GSN;SCIN;WASF1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.7167250634458946,1.5582421667370454,0.02490170380078637,0.7578349882177359,1.0,7/16,14.08%,ZFP36L1;TRIM71;TARDBP;RC3H1;ZFP36L2;ZFP36;ZC3H12A
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.5031122397207033,-1.5569324304545125,0.03614457831325301,0.477603056012033,1.0,5/22,7.77%,LYN;EPHA4;SP1;ABCG1;CASP3
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.7086486385139932,1.556738837201638,0.024327784891165175,0.7586938165614636,1.0,6/15,7.85%,FGF18;FGFR1;VEGFA;FGF2;SMOC2;PRKD2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.5415155390178389,-1.5560990513107515,0.0311284046692607,0.47147764334619285,1.0,6/15,18.72%,SORT1;ZFYVE27;CASP3;NTRK2;BDNF;GRB2
prerank,regulation of B cell differentiation (GO:0045577),0.6925718188757745,1.5560626719821076,0.02594033722438392,0.753323616719602,1.0,5/17,12.21%,SYK;ZFP36L1;INHA;ZFP36L2;CD27
prerank,gliogenesis (GO:0042063),0.7140028647271353,1.5543869994819135,0.030183727034120734,0.7549411620569035,1.0,4/15,5.94%,CD9;ANXA1;TGFB2;NFIB
prerank,positive regulation of immune system process (GO:0002684),0.7079385548930548,1.554242685492375,0.02423469387755102,0.7460393091917182,1.0,5/16,8.13%,ANXA1;VEGFA;TGFB2;MIA3;TNFRSF18
prerank,regulation of coagulation (GO:0050818),0.7612261663874322,1.5530684999910236,0.03248587570621469,0.7452978361448157,1.0,4/11,11.66%,EPHB2;F2R;PROCR;HS3ST5
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.5490696512230366,1.5508429570513709,0.0,0.7528271285082275,1.0,25/121,8.88%,NOX4;GHR;LIF;CD80;FGF7;EFNA5;ANGPT4;CTF1;CD44;ITGB3;DGKQ;VEGFA;MIF;DLG4;ACVR1;ITGA5;CLCF1;PTPRJ;THBS4;SRC;BANK1;GAS6;CD81;TNFRSF18;SRCIN1
prerank,early endosome to Golgi transport (GO:0034498),0.7395440205033945,1.5502095779422327,0.03651685393258427,0.7474535550409979,1.0,5/11,8.78%,RAB6A;STX5;SNX1;SURF4;LMAN1
prerank,positive regulation of dendrite development (GO:1900006),-0.6223511654201008,-1.5489793804672805,0.06993006993006994,0.48321262477187676,1.0,4/10,3.59%,PTN;BMP5;BMP7;DAB2IP
prerank,negative regulation of actin filament polymerization (GO:0030837),0.6635192515107774,1.5486143693853949,0.024752475247524754,0.7503445804133341,1.0,8/22,10.99%,GSN;SCIN;SLIT2;MYADM;PFN2;TWF1;KANK1;SSH1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.42847244777776505,-1.5477252027626578,0.023076923076923078,0.4781696731098132,1.0,10/39,9.90%,TJP1;RAPGEF2;SNCAIP;APOE;NOTCH1;DAB2IP;TIE1;PINK1;GFAP;PARP10
prerank,extracellular matrix assembly (GO:0085029),0.6504141893739326,1.5471648136979215,0.01987577639751553,0.751696168226733,1.0,5/23,7.57%,HAS2;TNXB;HAS1;NTN4;GAS6
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.50188960281189,-1.544803226388312,0.015789473684210527,0.4790271202223831,1.0,5/20,12.04%,WNT4;CRY1;C1QTNF3;SIK1;EP300
prerank,response to laminar fluid shear stress (GO:0034616),0.7594718273906614,1.5439902491921105,0.041726618705035974,0.7653851886695042,1.0,6/10,14.32%,MAPK7;NFE2L2;KLF2;ABCA1;SMAD6;KLF4
prerank,gas transport (GO:0015669),0.770647818442198,1.5437989582156388,0.028328611898016998,0.7575180891395009,1.0,1/10,0.41%,CYGB
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.7024142909544914,1.5431817867234943,0.0274869109947644,0.7529376241697276,1.0,8/16,17.22%,AR;ESR1;TRIP4;EGLN2;RBFOX2;DDX17;DDX5;PADI2
prerank,regulation of epithelial cell migration (GO:0010632),-0.4050042032149927,-1.5430161635794648,0.010638297872340425,0.47650087819180076,1.0,18/51,14.14%,PTN;PTPRG;SASH1;DOCK5;GLUL;PLCG1;DAB2IP;DUSP10;PRKCE;BMPR2;EMP2;RAB11A;MACF1;EVL;CEACAM1;PPM1F;PTK2;PFN1
prerank,iron ion transmembrane transport (GO:0034755),0.7567622712504817,1.5417389516603084,0.022598870056497175,0.7540438582643326,1.0,4/10,12.18%,SCARA5;SLC39A14;SLC11A2;SLC25A28
prerank,regulation of synapse organization (GO:0050807),-0.46086000243529,-1.5411478080643881,0.027777777777777776,0.4739278051190573,1.0,8/26,12.11%,EPHA4;PDLIM5;MEF2C;CDKL5;WNT5A;ABHD17C;CAMK2B;ABL1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.5529508386751513,1.539661646224462,0.004119464469618949,0.7606703205532663,1.0,26/95,12.53%,DCN;HAS2;HAS1;ST3GAL2;GPC6;UGDH;B4GALT3;GPC3;B4GALT1;OGN;CHST1;CSGALNACT2;EXT1;ACAN;VCAN;CHST12;CHST14;CHSY3;B3GAT3;XYLT1;HS2ST1;HS3ST6;HS3ST5;ST3GAL4;HSPG2;GLCE
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5421620888882073,-1.539626150543476,0.055793991416309016,0.4709528265790165,1.0,10/16,21.84%,APOE;SCARB1;PIK3CB;NPR3;GCH1;TERT;S100A1;HIF1A;NOS1AP;TERF2
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.551027171224639,-1.537591240124368,0.04149377593360996,0.4689664074348962,1.0,4/15,5.80%,PLTP;APOE;SCARB1;ABCG1
prerank,regulation of immune response (GO:0050776),0.5427293502425321,1.536116533011053,0.0010245901639344263,0.7769782754414868,1.0,19/135,11.15%,CD34;COL3A1;SYK;COL1A2;COL1A1;COL17A1;IRF4;KIR3DL2;NPDC1;TGFB2;FOXP1;CD160;CSK;CD81;TIRAP;SAMHD1;COL2A1;SPPL2B;BCL6
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.6001692020693156,1.5357212707139707,0.018327605956471937,0.7707791686108897,1.0,8/41,8.88%,NOX4;AREG;BTC;FYN;DLG4;SRC;GAS6;SRCIN1
prerank,regulation of actin nucleation (GO:0051125),0.7403700836065724,1.535630115094912,0.039492242595204514,0.7628690857834851,1.0,3/12,9.95%,GSN;SCIN;ARF1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.7055349376588625,1.5344640494887427,0.028225806451612902,0.7620795166271096,1.0,6/15,7.11%,DDR2;DPP4;LRP1;FAP;FSCN1;MELTF
prerank,regulation of leukocyte migration (GO:0002685),0.6834737379618947,1.533402240713783,0.037467700258397935,0.7609733739319613,1.0,6/16,14.42%,ANXA1;VEGFA;MIA3;CD81;TNFRSF18;HOXA7
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6463535498270644,1.533168238150242,0.03106332138590203,0.7542206301124852,1.0,6/24,9.77%,CDON;MAPK12;MAPK14;RBM4;BOC;MAPK11
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.5001198749173549,-1.5325597468516663,0.04716981132075472,0.4758398420665677,1.0,8/18,12.75%,ACSL1;ELOVL7;ACSL4;HACD1;ACSL3;HACD2;ACSL6;ELOVL1
prerank,synaptic vesicle endocytosis (GO:0048488),0.6055974546578841,1.5312928302459767,0.023228803716608595,0.7598981463882041,1.0,6/33,3.29%,STON2;SNCB;SYT2;DNM1;CEL;STX1A
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5523135812663612,-1.530605960180464,0.042735042735042736,0.4744199417070821,1.0,6/14,17.74%,OSR1;CAV1;NOTCH4;SPRED3;SPRED2;SPRY1
prerank,cardiac muscle cell contraction (GO:0086003),0.6784863596207219,1.5295611374694078,0.03756476683937824,0.7644000981664802,1.0,5/19,8.49%,GSN;ATP1A1;KCNJ2;CAMK2D;PIK3CA
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.47375171540656946,-1.5294561850382067,0.04046242774566474,0.47045264909668405,1.0,7/24,3.53%,TJP1;CGNL1;PHLDB2;ARHGAP28;ARHGAP6;F11R;RHPN2
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.4359102983425443,-1.5283014962537342,0.044642857142857144,0.4667163336593022,1.0,15/40,12.16%,PTN;BMP6;WNT4;ADGRV1;BMP7;MEF2C;WNT6;OSR1;KL;NELL1;ATRAID;BMPR2;BMP2;PKDCC;TGFB1
prerank,embryonic skeletal system development (GO:0048706),0.6070999820689218,1.5277862556863047,0.018369690011481057,0.7690023325010333,1.0,14/35,14.58%,HOXA3;COL1A1;PCSK5;SULF2;WNT9A;HOXA4;UCMA;SULF1;XYLT1;SLC2A10;SIX1;PDGFRA;HOXC4;HOXA9
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7527932412158054,1.527621499245243,0.04360056258790436,0.7621226543183314,1.0,3/10,8.08%,CD55;TGFBR2;CD81
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.6505347978426119,1.5276023495906248,0.029832935560859187,0.7543051297208042,1.0,8/23,11.70%,DPP4;SLIT2;JAM3;THBS4;C1QBP;MCU;TIRAP;MPP1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.5681484991502984,-1.5263991916907906,0.026022304832713755,0.46516097548768126,1.0,7/12,21.62%,INSR;IGF1R;UVRAG;JMJD4;ADRB2;IRGM;BNIP3
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.5516959911000461,1.5248108304681907,0.0041797283176593526,0.7659792776952454,1.0,24/90,17.74%,EBF2;IL4R;SYK;UCP1;GNAS;IRF4;GADD45G;GRB10;VEGFA;PRKAB2;ADCYAP1;ALMS1;HDAC3;CEBPB;TSHR;HCRT;CNOT3;IL4;DYNC1H1;DIO2;OGT;CXCR4;FABP5;IL18
prerank,dermatan sulfate metabolic process (GO:0030205),0.7202971063243218,1.523264118240696,0.04377564979480164,0.7694471200738099,1.0,4/13,7.68%,DCN;VCAN;CHST12;CHST14
prerank,secretion (GO:0046903),-0.5520303314962965,-1.5228613400108313,0.06374501992031872,0.4687538571647381,1.0,5/14,16.66%,SLC22A6;SLC22A4;FBLN5;NPR1;SLC22A2
prerank,actin filament capping (GO:0051693),0.6609331343189797,1.5217828724312497,0.043202033036848796,0.7647284462150882,1.0,7/18,14.36%,GSN;SCIN;SVIL;ADD3;TWF1;AVIL;TRIOBP
prerank,barbed-end actin filament capping (GO:0051016),0.6609331343189797,1.5217828724312497,0.043202033036848796,0.7647284462150882,1.0,7/18,14.36%,GSN;SCIN;SVIL;ADD3;TWF1;AVIL;TRIOBP
prerank,embryonic appendage morphogenesis (GO:0035113),0.7344168693709775,1.5206643535515851,0.034482758620689655,0.7655893668921112,1.0,5/12,9.48%,LRP6;MBNL1;TGFB2;SKI;FBXW4
prerank,leukocyte tethering or rolling (GO:0050901),-0.5110639848087026,-1.5205703092222296,0.05855855855855856,0.4684836964678199,1.0,9/17,30.06%,ITGA4;VCAM1;GCNT1;ROCK1;JAM2;SELPLG;PODXL2;SELP;ITGB7
prerank,phosphate ion homeostasis (GO:0055062),0.7518586478076226,1.519993092709745,0.04741379310344827,0.7626103693792217,1.0,1/10,0.14%,SFRP4
prerank,bone development (GO:0060348),0.5987614241194847,1.5199308316200602,0.015855039637599093,0.755752612549838,1.0,9/39,7.35%,SFRP4;MYOC;LRP6;GNAS;AKAP13;SULF2;SKI;SULF1;LRRC17
prerank,synaptic vesicle recycling (GO:0036465),0.617776588636987,1.5185833380560922,0.022592152199762187,0.7577942640075485,1.0,5/31,3.29%,STON2;SNCB;SYT2;CEL;STX1A
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.5965949867376107,-1.5171286907817143,0.07608695652173914,0.47124353638773026,1.0,4/11,12.04%,CRY1;C1QTNF3;SIK1;EP300
prerank,regulation of spindle organization (GO:0090224),0.6854899540410945,1.517023450434247,0.0258732212160414,0.7613398275990862,1.0,6/18,7.42%,PARP3;GPSM2;DCTN1;PSRC1;FSD1;CLTC
prerank,regulation of protein processing (GO:0070613),0.6470979947635613,1.5156312265257001,0.04192355117139334,0.7643609350790016,1.0,3/21,3.49%,CCBE1;GAS1;RUNX1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.6112898269319316,1.5149835407984547,0.031137724550898204,0.7617592649465046,1.0,5/30,4.05%,SFRP4;FSTL1;PCSK6;SMAD4;SMURF2
prerank,negative regulation of interleukin-2 production (GO:0032703),0.6702749839142756,1.5134089780256512,0.030534351145038167,0.7656456581878037,1.0,2/18,3.72%,CD34;HDAC7
prerank,nucleotide-sugar metabolic process (GO:0009225),0.7145833800705862,1.5113909843140154,0.05146036161335188,0.7729314710123938,1.0,3/12,3.12%,GFPT2;UGP2;GFPT1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.6037158863307692,1.5098983867183469,0.03360370799536501,0.776107714419692,1.0,20/33,24.80%,AR;ESR1;RUNX1;AXIN1;PRMT2;HDAC6;RNF14;TRIM68;DDX5;UFL1;GPAM;UFM1;KCTD6;CARM1;RNF6;NCOA2;KDM4C;LATS1;UFSP2;CALR
prerank,central nervous system neuron differentiation (GO:0021953),0.6152452639983685,1.509794713980365,0.024793388429752067,0.769954693061369,1.0,3/33,1.22%,LMX1A;LRP6;WNT2
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.5196524014105086,-1.5089015411014244,0.05829596412556054,0.4871690054174162,1.0,3/18,1.84%,PRKAG2;OCLN;SLC2A1
prerank,hippo signaling (GO:0035329),-0.45823829155644674,-1.508777777524967,0.03296703296703297,0.48102401927565697,1.0,14/26,17.82%,TJP1;FAT4;TEAD4;TEAD1;TJP2;AMOT;WWC1;TEAD2;CASP3;YAP1;AMOTL1;TEAD3;SAV1;NPHP4
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.6099196325435121,1.5071582445652838,0.023255813953488372,0.7812940381277147,1.0,9/33,8.76%,SYK;LIF;DPP4;TGFB2;ADAM9;JAM3;MUC1;RET;FOXC2
prerank,positive regulation of bone resorption (GO:0045780),0.728982224289162,1.5052498444017783,0.031506849315068496,0.7878229247878503,1.0,2/11,1.26%,SYK;PRKCA
prerank,regulation of epidermal cell differentiation (GO:0045604),0.6517814365666923,1.5051258967417283,0.03333333333333333,0.7819077487486447,1.0,6/21,12.63%,SFRP4;RUNX1;ZFP36L1;MAFF;SFN;ZFP36
prerank,urogenital system development (GO:0001655),0.7311264978433858,1.5036331661937803,0.030344827586206897,0.7857535144915071,1.0,3/11,1.34%,EPHB2;AMH;ANXA1
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5119364011430814,-1.503363081746212,0.07264957264957266,0.4888802405510371,1.0,6/16,12.97%,APOE;NOS3;GUCY1B1;NDNF;NOS1;GUCY1A1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.740012525292966,1.503252024901541,0.03142857142857143,0.7816138953156145,1.0,3/10,6.81%,DCN;MYOC;SRC
prerank,positive regulation of ossification (GO:0045778),-0.4230320002039653,-1.502617681863918,0.05982905982905983,0.48444648292520576,1.0,15/39,12.16%,PTN;BMP6;WNT4;ADGRV1;BMP7;MEF2C;OSR1;KL;WNT5A;NELL1;ATRAID;BMPR2;BMP2;PKDCC;TGFB1
prerank,skeletal system development (GO:0001501),0.5246059905216783,1.501935782631203,0.0,0.7845093166974404,1.0,30/148,9.27%,COMP;COL1A2;FBN1;MYOC;COL1A1;TRPS1;GNAS;BMP1;AKAP13;FGFR1;PAPSS2;PCSK5;EIF2AK3;CD44;SULF2;TGFB2;EXT1;PKD1;PAX1;ACAN;VCAN;TNFRSF11B;INHA;TLL1;UCMA;SULF1;GLI2;BPNT2;XYLT1;SOX5
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.5795910636570737,-1.5012271445611538,0.058394160583941604,0.48206116385147657,1.0,4/12,13.27%,LYN;IL34;MAPK3;PTK2
prerank,chondroitin sulfate metabolic process (GO:0030204),0.6178496395323213,1.5010501639134362,0.028402366863905324,0.7843140611676949,1.0,6/30,8.56%,DCN;UGDH;CSGALNACT2;VCAN;CHST12;CHSY3
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5519829352846749,1.5001690644122663,0.010787486515641856,0.7841220872434915,1.0,16/65,13.17%,ASPN;FBN1;HTRA3;LDLRAD4;SKIL;TGFBR2;PMEPA1;SMURF2;SKI;STUB1;SMAD6;PEG10;SLC2A10;VASN;UBA52;PIN1
prerank,ganglioside metabolic process (GO:0001573),-0.4984865460865652,-1.499508171970621,0.06190476190476191,0.4809373821440578,1.0,12/20,31.87%,ST8SIA4;ST6GALNAC3;ST6GALNAC5;ST8SIA2;ST8SIA6;NEU3;ST6GALNAC6;ABCA2;ST3GAL5;GM2A;NEU2;B4GALNT1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.44610013708292046,-1.498831431507265,0.018867924528301886,0.47659768673676833,1.0,8/30,12.56%,FLT1;MLLT3;KDR;KIT;SFRP1;INHBA;TGFB1;FLT4
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6913525518995001,1.4980255841468406,0.040522875816993466,0.7927847856531127,1.0,5/14,8.22%,SEC24D;SEC31A;MIA3;SEC24A;SEC23A
prerank,negative regulation of cell communication (GO:0010648),0.6426831684164399,1.4978933428953043,0.034782608695652174,0.7871868362274206,1.0,3/21,4.40%,LIF;SRMS;ACVR1
prerank,limb morphogenesis (GO:0035108),0.6558350196975222,1.4969216813192527,0.05150753768844221,0.7872861254082908,1.0,7/20,11.60%,LRP6;MBNL1;PCSK5;TGFB2;SKI;FBXW4;GLI3
prerank,toxin transport (GO:1901998),0.7419854008170621,1.495470995810449,0.03824362606232295,0.7908459197837585,1.0,2/10,1.15%,ANTXR1;ANTXR2
prerank,cyclooxygenase pathway (GO:0019371),-0.6075357434574571,-1.4953036102226716,0.07213114754098361,0.48008569690456815,1.0,7/10,23.96%,PTGDS;PTGS2;PTGIS;PTGES3;TBXAS1;CBR1;PTGS1
prerank,Notch signaling pathway (GO:0007219),-0.3698621555458517,-1.4951203004206826,0.015384615384615385,0.47478868246268796,1.0,19/59,12.04%,SORBS2;ADAM10;GMDS;MAML3;CREBBP;NOTCH3;NOTCH1;PLXND1;WWC1;HEYL;DTX3L;JAG2;MAML2;NOTCH4;STAT1;BMP2;MDK;GALNT11;EP300
prerank,positive regulation of interleukin-12 production (GO:0032735),0.6065192828832972,1.495001515714415,0.02833530106257379,0.7875737727851165,1.0,6/31,9.77%,SYK;IL16;MAPK14;TIRAP;TLR4;MAPK11
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.7064572398028854,1.4933515916005622,0.040376850605652756,0.7927427512618838,1.0,3/13,10.05%,GNAI3;RAB23;RHOQ
prerank,regulation of Wnt signaling pathway (GO:0030111),0.5259243626110546,1.4930395901619211,0.007157464212678937,0.788652943570215,1.0,26/108,10.38%,RSPO2;SFRP4;ESR1;LRP1;GPC3;GRB10;SULF2;DACT3;CDK14;AMER3;RUNX1;SKI;KREMEN1;AXIN1;DACT1;ZRANB1;NFATC1;DAAM2;SULF1;FOXL1;MDFIC;FZD7;PSEN1;GSKIP;TSKU;KANK1
prerank,response to fatty acid (GO:0070542),0.6737922749323845,1.4905834428269202,0.036,0.7998347754188762,1.0,5/17,8.42%,UCP1;IRS1;FOXO1;PID1;PPP5C
prerank,glycine transport (GO:0015816),-0.5924360458709441,-1.4904517107813045,0.08843537414965986,0.4810932578430334,1.0,3/10,10.88%,SLC6A9;SLC38A5;SLC6A17
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.699586068169781,1.489258014893346,0.05006765899864682,0.8028543463692891,1.0,3/12,7.42%,AR;TMEFF2;CLTC
prerank,renal filtration (GO:0097205),0.7431076788145319,1.488204813530666,0.04291845493562232,0.8040600035293872,1.0,4/10,10.06%,CD34;SULF2;SULF1;XPNPEP3
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5888476192478879,1.4869824250471926,0.03784403669724771,0.8060977489107103,1.0,9/35,10.38%,MYOC;EPHB2;ARHGAP44;HEG1;TGFB2;ABL2;FLCN;CUL3;KANK1
prerank,granulocyte chemotaxis (GO:0071621),0.5565090698889815,1.4867161108149527,0.026680896478121666,0.8015659748460645,1.0,8/55,9.02%,SYK;CCL8;ANXA1;TGFB2;S100A8;S100A9;CXCL10;CCL25
prerank,limb development (GO:0060173),0.6186453154431846,1.485875182060066,0.038238702201622246,0.8014679738832221,1.0,7/28,11.93%,RSPO2;COMP;PCSK5;KREMEN1;KAT2B;GLI3;LNPK
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.5194259686033809,1.485463405376095,0.0020161290322580645,0.7980967025481895,1.0,56/173,18.09%,AREG;CD55;SEC16B;DCTN1;COPA;SEC24D;BET1L;ANK2;CNIH3;DYNC1LI2;TMED1;STX5;SPTAN1;SEC31A;SPTA1;ZW10;PREB;MIA3;KDELR3;SEC24A;KDELR1;SEC22B;ARF4;GAS6;COPB1;TFG;SEC23A;USO1;DYNC1LI1;DYNC1I1;ARFGAP3;ARFGAP1;LMAN1;CUL3;NRBP2;SCFD1;RAB2A;COPB2;NAPA;MPPE1;STX17;GOSR1;CNIH1;TRAPPC2L;KDELR2;COG6;DYNC1H1;NSF;ANK1;SPTBN1;COPZ2;GOPC;SEC24B;RAB1B;BCAP31;ARCN1
prerank,osteoclast differentiation (GO:0030316),0.6406420215637513,1.4822948428968086,0.043586550435865505,0.8136622687962078,1.0,6/22,7.43%,ANXA2;FOXP1;MAPK14;FARP2;SRC;OSTM1
prerank,DNA dealkylation (GO:0035510),0.7299187533357442,1.4818841142703054,0.047075606276747506,0.8044212745915391,1.0,1/10,0.11%,MPG
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.7299187533357442,1.4818841142703054,0.047075606276747506,0.8044212745915391,1.0,1/10,0.11%,MPG
prerank,B cell proliferation (GO:0042100),-0.5145622097415582,-1.4814585585996964,0.05063291139240506,0.5006402315677958,1.0,3/17,2.75%,MEF2C;BCL2;CTPS1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.7126831769490514,1.4801574198606438,0.05329593267882188,0.8102040403519023,1.0,4/11,7.08%,P4HA3;P4HA1;EGLN2;P4HA2
prerank,potassium ion export across plasma membrane (GO:0097623),0.6957609245871441,1.4791903401018456,0.052269601100412656,0.8109052634372808,1.0,2/13,1.19%,KCNK5;KCNT2
prerank,regulation of muscle cell differentiation (GO:0051147),0.6005487250130238,1.4786965026892727,0.04050925925925926,0.8083862442482672,1.0,8/31,9.77%,CDON;MAPK12;HDAC9;MAPK14;RBM4;BOC;CDK9;MAPK11
prerank,skeletal system morphogenesis (GO:0048705),0.5714187346707323,1.4779734147354764,0.0314192849404117,0.8079264048233074,1.0,14/42,19.25%,SFRP4;LRP6;HOXA3;FGFR1;SKI;HOXA4;SIX1;PDGFRA;HOXC4;HOXA9;RAB33B;DYNC2I1;TGFBR1;RFLNA
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5233643380951565,1.4768907437447654,0.006179196704428424,0.809536969673122,1.0,26/112,17.16%,CD34;SYK;LBP;EPHB2;IRAK3;FOXP1;MIF;TMEM106A;SYT11;PTPRJ;IL33;GAS6;PSEN1;TIRAP;TLR4;CD47;SIRPA;ZFP36;TWIST1;ZC3H12A;IL4;CD14;SELENOS;ILRUN;IL6;CHRNA7
prerank,androgen receptor signaling pathway (GO:0030521),0.7338650936043212,1.4763798118468197,0.05040871934604905,0.807408700647166,1.0,7/11,16.59%,AR;ZMIZ1;PMEPA1;PLPP1;DDX17;RNF14;DDX5
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.4839530087942685,-1.475853864321587,0.05106382978723404,0.5097069141639037,1.0,9/18,10.66%,FLT1;COL4A3;MEF2C;PLCG1;SP1;HMGB1;ITGA4;IGF2;MDK
prerank,vesicle coating (GO:0006901),0.5518519882871364,1.4755841926739157,0.022629310344827586,0.7959752739953376,1.0,22/61,17.28%,AREG;SEC16B;SEC24D;CNIH3;STX5;SEC31A;PREB;SEC24A;SEC22B;TFG;SEC23A;USO1;LMAN1;CUL3;SCFD1;SEC23IP;NAPA;CNIH1;TRAPPC2L;NSF;SEC24B;RAB1B
prerank,COPII vesicle coating (GO:0048208),0.5518519882871364,1.4755841926739157,0.022629310344827586,0.7959752739953376,1.0,22/61,17.28%,AREG;SEC16B;SEC24D;CNIH3;STX5;SEC31A;PREB;SEC24A;SEC22B;TFG;SEC23A;USO1;LMAN1;CUL3;SCFD1;SEC23IP;NAPA;CNIH1;TRAPPC2L;NSF;SEC24B;RAB1B
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.5518519882871364,1.4755841926739157,0.022629310344827586,0.7959752739953376,1.0,22/61,17.28%,AREG;SEC16B;SEC24D;CNIH3;STX5;SEC31A;PREB;SEC24A;SEC22B;TFG;SEC23A;USO1;LMAN1;CUL3;SCFD1;SEC23IP;NAPA;CNIH1;TRAPPC2L;NSF;SEC24B;RAB1B
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.749191349214391,1.475352038527575,0.05233380480905234,0.7921378812443667,1.0,2/10,1.22%,LRP6;WNT2
prerank,regulation of interleukin-10 production (GO:0032653),0.5721407194779156,1.4751932311547904,0.03712035995500562,0.7878973803369773,1.0,3/44,1.14%,CD34;SYK;IRF4
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.6589347974867746,1.4749097742692066,0.047182175622542594,0.7845727861857693,1.0,8/18,16.59%,ESR1;EGFR;NCOR2;NCOR1;ZC3H12A;MAP2K2;IL6;DDX5
prerank,regulation of blood coagulation (GO:0030193),0.609844190208143,1.4734385173805304,0.05174488567990373,0.7888967672202013,1.0,4/27,3.19%,CD34;EPHB2;FAP;F2R
prerank,hyaluronan metabolic process (GO:0030212),0.6188843845921307,1.4718302688660219,0.05392156862745098,0.794728067893778,1.0,4/23,2.88%,HAS2;HAS1;CD44;FGF2
prerank,ribosomal small subunit assembly (GO:0000028),0.6576063549345795,1.4691827138373204,0.0651890482398957,0.8073558157232422,1.0,8/16,17.34%,RPSA;MRPS11;ABT1;XRCC5;RPS27L;RPS5;RRP7A;PWP2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.5436601628851849,-1.4686299170446477,0.08480565371024736,0.5237207201054838,1.0,6/13,17.35%,NAMPT;PTGS2;PTGIS;PARP10;NUDT12;PARP9
prerank,positive regulation of T cell proliferation (GO:0042102),0.5484173703144279,1.4686291079270934,0.021436227224008574,0.8057456732482673,1.0,4/55,1.34%,TNFSF9;SYK;CD80;ANXA1
prerank,regulation of cell communication (GO:0010646),0.5925982264474168,1.4678248363262623,0.031578947368421054,0.8061790475882586,1.0,9/35,6.99%,MGLL;ANXA1;ANK2;SRI;MTCH1;SOCS2;CAMK2D;SCG5;YWHAG
prerank,glycolytic process (GO:0006096),-0.43872886537803835,-1.4677336016238898,0.05202312138728324,0.5198166349720683,1.0,13/28,20.36%,ENO1;HK2;PGAM1;PGAM4;PGK1;PFKM;ALDOC;GAPDH;PFKL;TPI1;GAPDHS;ENO3;GPI
prerank,endoplasmic reticulum organization (GO:0007029),0.5400646386660636,1.4668136435826422,0.015940488841657812,0.8075831169628704,1.0,31/72,24.68%,SEC16B;TLE6;MOSPD3;EIF2AK3;STX1A;STX5;UBE2J2;SEC31A;GET4;REEP3;TOR1AIP2;MIA3;ALDH3A2;WDR83OS;LMAN1;TRAM2;LNPK;SGTA;RTN3;TRAM1;SEC61A1;REEP5;SHTN1;VAMP2;RAB10;TMEM33;BNIP1;EMD;RAB18;RTN4;SEC61B
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6605983477825225,1.4660719294780278,0.04287515762925599,0.8074733542507023,1.0,7/17,13.39%,EGFR;PKD1;PSRC1;MAPRE3;PKD2;AKT1;CCND1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.7070680610655393,1.4655268662326864,0.05379310344827586,0.8057607276082528,1.0,5/11,21.60%,ANXA1;RC3H1;ZC3H12A;IL4;RC3H2
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.7272374602979804,1.4648199331481957,0.050724637681159424,0.8001534922012324,1.0,4/10,18.61%,MAPK7;MYADM;KLF4;MBP
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.7272374602979804,1.4648199331481957,0.050724637681159424,0.8001534922012324,1.0,4/10,18.61%,MAPK7;MYADM;KLF4;MBP
prerank,protein heterooligomerization (GO:0051291),0.6506110181312699,1.4643487742541057,0.06257982120051085,0.7984826114424242,1.0,8/17,15.11%,PKD1;KRT10;PKD2;CPSF6;MAT2A;TMEM120A;KCNC2;HSD17B8
prerank,histone H4 deacetylation (GO:0070933),0.7088736302501965,1.464256141034588,0.06371191135734072,0.7941286736419256,1.0,4/10,13.86%,HDAC9;SIRT2;HDAC3;HDAC4
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.6841021506193263,1.4641213199400673,0.06359945872801083,0.7900396968976707,1.0,2/13,0.36%,FSTL1;FBN1
prerank,transition metal ion homeostasis (GO:0055076),-0.4351371790437518,-1.463817374546374,0.03529411764705882,0.524406859073999,1.0,10/28,19.01%,CP;IREB2;XIAP;SLC40A1;B2M;CUTC;HFE;FTL;MT3;CYBRD1
prerank,ERBB2 signaling pathway (GO:0038128),0.5935807906358068,1.4636891081061267,0.040840140023337225,0.7880310672490203,1.0,10/31,16.30%,MYOC;PRKCA;EGFR;BTC;SRC;STUB1;PIK3CA;EGF;HSP90AA1;SOS1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.4014083662557649,-1.462597956839978,0.03937007874015748,0.5218159791283056,1.0,11/35,10.42%,FLT1;NR2F2;COL4A3;MEF2C;APOE;THBS1;PTPRM;CAV1;RGCC;CAV2;STAT1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5388227299517954,1.462475260564793,0.028938906752411574,0.7905044348066128,1.0,10/68,9.07%,SYK;LBP;IL16;RAB7B;F2R;TMEM106A;IL33;IL17RA;TIRAP;TLR4
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.6443233693455753,1.4624329627082324,0.040293040293040296,0.7859563658321638,1.0,5/20,11.62%,PLOD2;GCLC;HAGH;CNDP2;GAMT
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.5591049977006681,1.462360695907983,0.042222222222222223,0.7816456719774191,1.0,15/47,18.12%,MID1;EGFR;STK25;TGFB2;TAOK3;COPS5;KLHDC10;FOXO1;TAOK2;MAP2K2;PER1;NBR1;PPIA;QARS1;EPHB1
prerank,gastrulation (GO:0007369),0.6674054703594867,1.4592905336613318,0.06275033377837116,0.796781558932207,1.0,2/15,2.21%,UGDH;GPC3
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6927456808884316,1.4590093148265588,0.06377204884667571,0.7940724398164877,1.0,2/13,5.07%,DCN;VCAN
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.6810327928899982,1.45755716260293,0.060927152317880796,0.7986245635774321,1.0,2/14,1.34%,CD80;ANXA1
prerank,regulation of hormone secretion (GO:0046883),0.6726753304912082,1.4574317191147015,0.06349206349206349,0.7946681062269088,1.0,3/15,6.70%,LIF;ANXA1;SCG5
prerank,positive regulation of metabolic process (GO:0009893),0.5222884680755914,1.4562490295008899,0.010384215991692628,0.7980219664788659,1.0,25/103,17.74%,EBF2;IL4R;SYK;UCP1;GNAS;IRF4;GADD45G;GRB10;VEGFA;ACLY;PRKAB2;ADCYAP1;ALMS1;HDAC3;CEBPB;TSHR;HCRT;CNOT3;IL4;DYNC1H1;DIO2;OGT;CXCR4;FABP5;IL18
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.6252386911206522,1.455192311575836,0.06546854942233633,0.8000035258094564,1.0,9/21,12.53%,UGDH;SULF2;EXT1;SULF1;B3GAT3;XYLT1;HS2ST1;HS3ST5;GLCE
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.6314970653995133,1.455029186970142,0.06527415143603134,0.7964013224083191,1.0,8/19,18.66%,HNRNPA1;CTC1;GNL3L;SRC;ACD;TERF1;TENT4B;TINF2
prerank,COPII-coated vesicle budding (GO:0090114),0.5384449370969691,1.4542902883079831,0.0308839190628328,0.7964965775277815,1.0,23/68,17.28%,AREG;SEC16B;SEC24D;CNIH3;STX5;SEC31A;PREB;MIA3;SEC24A;SEC22B;TFG;SEC23A;USO1;LMAN1;CUL3;SCFD1;SEC23IP;NAPA;CNIH1;TRAPPC2L;NSF;SEC24B;RAB1B
prerank,positive regulation of superoxide anion generation (GO:0032930),0.6910674184597735,1.4528052244003682,0.060941828254847646,0.8012011411489313,1.0,2/13,2.49%,SYK;CD177
prerank,actin filament-based transport (GO:0099515),-0.473846703184101,-1.452642013332249,0.06310679611650485,0.543138758402239,1.0,5/21,5.81%,SYNE2;MYO1B;FNBP1L;SUN2;MYO1D
prerank,atrioventricular valve morphogenesis (GO:0003181),0.6293615381785719,1.4519833050738782,0.07224334600760456,0.8019441256935579,1.0,7/19,10.09%,TGFB2;SLIT3;TGFBR2;SMAD4;ACVR1;MDM4;SMAD6
prerank,anion transport (GO:0006820),-0.41714004772159935,-1.4510731103814096,0.027972027972027972,0.5415045486591611,1.0,7/33,7.49%,SLC13A4;SLC13A3;ABCG2;SLCO2B1;SLC26A7;SLC22A6;LRRC8B
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.6026123456352833,-1.4508967594406985,0.07368421052631578,0.5360411398234076,1.0,4/10,4.65%,ATP1A2;NEDD4L;OSR1;PRKCE
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.7131490609998495,1.4508717359781798,0.06559766763848396,0.8044754169969427,1.0,5/10,16.37%,DGKQ;USP7;ZNF692;SELENOS;OGT
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.43973304753698583,-1.4504989549632792,0.054878048780487805,0.5312975879305868,1.0,7/32,3.17%,NEDD4L;RAPGEF2;TNIK;CUX1;PTPRD;CDKL5;YWHAH
prerank,mesonephros development (GO:0001823),-0.5694538988285287,-1.450037432909039,0.11029411764705882,0.5271171327486437,1.0,4/11,13.55%,BMP7;OSR1;FGF1;PAX8
prerank,chordate embryonic development (GO:0043009),0.5453936144369509,1.4483994141947152,0.03278688524590164,0.8157302473111672,1.0,18/55,9.11%,COL1A1;TGFB3;FGFR1;MBNL1;PCSK5;SIX4;SULF2;VEGFA;LMX1B;PKD1;DACT1;TRIM71;UCMA;SULF1;FLCN;PKD2;SOX8;XYLT1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.4572471300368928,-1.4483821302211575,0.05045871559633028,0.5258527583277792,1.0,7/20,16.42%,IGF1;NIBAN2;FOXC1;LAMTOR5;EP300;TGFB1;GTF2B
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.6726606518502914,1.4482752351208246,0.0723055934515689,0.8119322319637381,1.0,6/13,17.66%,SEC16B;EDEM1;CD81;EDEM2;TMEM30A;BCAP31
prerank,regulation of superoxide anion generation (GO:0032928),0.6704798892068391,1.4470886277923285,0.06224627875507442,0.8152973904115466,1.0,2/14,2.49%,SYK;CD177
prerank,positive regulation of interleukin-4 production (GO:0032753),0.6498686437177416,1.4464084812848454,0.06464379947229551,0.8151330703232154,1.0,2/17,1.14%,SYK;IRF4
prerank,regulation of hemopoiesis (GO:1903706),-0.596882040194033,-1.4459419550477692,0.05862068965517241,0.5273895191688602,1.0,4/10,5.36%,PTN;CREBBP;PURB;MYSM1
prerank,cytoplasmic sequestering of protein (GO:0051220),0.6857323056623457,1.4451293557542126,0.06914893617021277,0.818705963804067,1.0,9/13,24.04%,DBN1;PKD1;GET4;PKD2;KEAP1;GOPC;FLNA;YWHAB;LATS1
prerank,embryonic digit morphogenesis (GO:0042733),-0.5013369604183878,-1.4450841464289208,0.07476635514018691,0.5243569015961814,1.0,7/18,9.70%,MAP3K20;CREBBP;OSR1;TBX3;SALL1;TBX2;INTU
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5058315513868766,-1.4441709200815407,0.088,0.5215144995962547,1.0,4/15,2.85%,ATP1A2;NEDD4L;ATP1B3;SLC12A2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.5268580358949514,1.4440312721047872,0.016597510373443983,0.8212322616749491,1.0,37/80,23.55%,COPA;RAB6A;KLC1;PLPP3;RAB6B;ZW10;KDELR3;ATP9A;RINT1;KDELR1;SEC22B;ARF4;COPB1;SURF4;ARFGAP3;ARFGAP1;KIF2A;RER1;ATP9B;SCFD1;COPB2;NAPA;KIF3A;SCYL1;KIF3B;KDELR2;NSF;COPZ2;RAB1B;ARCN1;CENPE;TMED2;COPG1;USE1;GOLPH3L;BNIP1;PICK1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5043107678866677,-1.4433602423697915,0.05504587155963303,0.5184292690181876,1.0,11/17,26.62%,NRP1;NTRK3;TEK;CDK5;ABL1;BAIAP2L1;FES;HRAS;NTF3;HCK;HCLS1
prerank,neurogenesis (GO:0022008),0.5568793972408912,1.4428548437102766,0.054748603351955305,0.8242133115995971,1.0,16/43,19.88%,WNT2;ANXA1;SIX4;TGFB2;LPAR1;TRAK2;DAGLA;MAPT;SIX1;THOC2;DAGLB;CDK5RAP2;CXCR4;EPHB1;CIT;WDR62
prerank,positive regulation of embryonic development (GO:0040019),-0.469663663621275,-1.442056437727218,0.06796116504854369,0.5168348215726317,1.0,5/19,4.84%,WNT4;TENM4;NIBAN2;OSR1;PLCB1
prerank,protein import into peroxisome membrane (GO:0045046),0.6117593245657795,1.4418584998722503,0.06180469715698393,0.8262341093691726,1.0,13/22,24.14%,PXMP2;PEX16;GDAP1;ALDH3A2;PXMP4;PEX12;SLC25A17;PEX3;PEX5;ATAD1;ABCD3;PEX2;FIS1
prerank,cAMP-mediated signaling (GO:0019933),-0.44103407168640985,-1.4417721693780345,0.06896551724137931,0.5124647277541517,1.0,10/24,9.63%,PDE7B;RAPGEF2;ADCY1;RAPGEF3;PDE3A;ADGRG6;KSR1;AHR;CAP2;PDE2A
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.7221315604973509,1.4411266952789359,0.07262569832402235,0.8262353347231608,1.0,3/10,6.71%,ESR1;PSMC4;PSMC6
prerank,atrial septum development (GO:0003283),0.6696688748787768,1.439869490906021,0.0697986577181208,0.8296889993818977,1.0,3/13,6.76%,ANK2;TGFB2;MDM4
prerank,neutrophil activation (GO:0042119),0.6864104404585366,1.4395349605393362,0.07320441988950276,0.8274515734552701,1.0,1/12,0.24%,SYK
prerank,cellular response to fatty acid (GO:0071398),0.6811825516941594,1.439331922282592,0.0702247191011236,0.8243865987185997,1.0,4/12,14.08%,UCP1;IRS1;PID1;ZC3H12A
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.6915279231231144,1.4374995786386167,0.06948228882833787,0.8319319428423544,1.0,2/11,1.26%,SYK;PRKCA
prerank,PERK-mediated unfolded protein response (GO:0036499),0.706330231890242,1.4359836945193736,0.0847953216374269,0.8375854482563481,1.0,5/10,13.68%,EIF2AK3;NFE2L2;HERPUD1;QRICH1;EIF2S1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6161285153986003,1.435344426743132,0.06109725685785536,0.8372783495933361,1.0,3/20,3.89%,SFRP4;GSN;CD160
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.6128769972237085,1.4343342965872055,0.059178743961352656,0.8394651896434703,1.0,5/22,13.19%,ESR1;PSMC4;PSMC6;MED24;MED13
prerank,regulation of cholesterol storage (GO:0010885),-0.500904882501404,-1.4340419150364534,0.10408921933085502,0.5281089621301424,1.0,5/15,5.80%,SCARB1;TTC39B;PPARA;NR1H3;ABCG1
prerank,natural killer cell activation (GO:0030101),0.594419523979189,1.4323422226996128,0.07151515151515152,0.848510007627626,1.0,3/23,2.92%,AXL;ELF4;PBX1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.5989254176204037,1.4322427072465413,0.0759493670886076,0.8448812634518839,1.0,9/24,18.66%,HNRNPA1;CTC1;GNL3L;SRC;ACD;ERCC4;TERF1;TENT4B;TINF2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.6603756898323146,1.4317368328180857,0.07294429708222812,0.843772004765513,1.0,3/14,5.38%,DDX18;URB1;ZNHIT6
prerank,organelle transport along microtubule (GO:0072384),0.5850050129174279,1.431663896671519,0.05052878965922444,0.8398877194100925,1.0,15/31,25.67%,ARHGAP21;RAB6A;NDEL1;TRAK2;BICD1;DYNC1I1;MAPT;UXT;PAFAH1B1;COPG1;TMEM201;FBXW11;MAP1S;RHOT2;RAB1A
prerank,focal adhesion assembly (GO:0048041),-0.46412410257310305,-1.4313669506828577,0.07692307692307693,0.5304406480595839,1.0,5/21,5.86%,PTPRK;SORBS1;ACTN2;THSD1;PIP5K1A
prerank,positive regulation of viral life cycle (GO:1903902),0.6094094386028398,1.431356458203254,0.0724269377382465,0.8376185425971274,1.0,7/22,20.75%,AXL;KPNA2;LGALS1;TRIM11;DDB1;VPS37B;TYRO3
prerank,regulation of translational initiation (GO:0006446),0.5375221551808855,1.4311789506701058,0.030139935414424113,0.8344953454998335,1.0,31/63,26.92%,EIF3B;EIF2AK3;DAZL;RBM4;PAIP2B;CTIF;AGO2;EIF1;NPM1;CEBPB;LARP1;POLR2D;POLR2G;CDC123;EIF3E;NCK1;YTHDF1;YTHDF2;PAIP2;MTIF2;ATF4;YTHDF3;TPR;EIF4G3;NCK2;EIF4H;DNAJC3;EIF2B2;EIF4EBP2;EIF4G1;DDX1
prerank,regulation of vasculogenesis (GO:2001212),0.6648833935768386,1.430642861933902,0.06719367588932806,0.8337725416633526,1.0,2/14,0.95%,CD34;TMEM100
prerank,regulation of mitotic spindle organization (GO:0060236),0.5731179799822894,1.4301603541436494,0.05767012687427912,0.8324215998747361,1.0,10/35,15.34%,PARP3;GPSM2;DCTN1;PSRC1;VPS4B;FSD1;CLTC;CCSAP;CEP97;DYNC1H1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6247908441429985,1.429608477207046,0.08025477707006369,0.8316004814481385,1.0,6/18,10.38%,MYOC;HEG1;ABL2;FLCN;CUL3;KANK1
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.6689718406410938,1.4286009036450689,0.06732117812061711,0.8339856922091468,1.0,8/13,25.23%,DESI1;DESI2;UBA6;UBA2;SENP6;SAE1;ATG10;UBA7
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.5593087094226955,1.4267479913485446,0.061155152887882216,0.8417422681954249,1.0,12/38,14.60%,CD34;KLF2;ATP2B4;PKD2;TLR4;CD47;SIRPA;AKT1;GLA;ZC3H12A;KLF4;HSP90AA1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.6328722611008466,1.4266191169593891,0.07783641160949868,0.8383483539375971,1.0,5/19,7.90%,AR;ZC3H8;MTOR;MAF1;BRF2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.6947438444236608,1.4258664072741398,0.07510431154381085,0.8392509266290792,1.0,3/11,1.94%,GHR;IRS1;EIF2AK3
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.5104280853271994,-1.425772226584117,0.08856088560885608,0.5402356525658344,1.0,8/14,24.03%,WNT5A;SEMA7A;KIT;MAVS;SIRT1;CD74;NR4A3;GPRC5B
prerank,DNA modification (GO:0006304),0.6066035208967291,1.4253271867866169,0.0792838874680307,0.8385955227319566,1.0,2/22,0.89%,MPG;PARP3
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.6609686960800409,1.425309959355653,0.0781456953642384,0.8346474310138579,1.0,6/13,21.13%,SYK;CD177;STX4;IL4;ITGAM;GAB2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.5415980777408355,1.4238556576181312,0.04405286343612335,0.8395234843798269,1.0,8/51,6.84%,FSTL1;FBN1;HTRA3;SKIL;SMAD4;SMURF2;SKI;SMAD5
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.6835161654621315,1.4232967858503272,0.08298755186721991,0.8389922157184223,1.0,4/11,6.33%,TRIAP1;CD44;MIF;MUC1
prerank,aggrephagy (GO:0035973),0.5796748386076347,1.422746623682971,0.062424969987995196,0.8387477757547055,1.0,9/27,15.34%,DYNC1LI2;HDAC6;UBE2N;ARL13B;DYNC1LI1;DYNC1I1;SQSTM1;UBA52;DYNC1H1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.34619104201424467,-1.4216418739025178,0.014925373134328358,0.5465776203669372,1.0,23/66,12.16%,PTPRK;NR2F2;ROBO1;MTSS1;APOE;THBS1;DAB2IP;CDK6;DUSP10;PTPRM;TGFBR3;CAV1;RGCC;FGFR2;B2M;BRCA2;AQP11;SFRP1;CAV2;STAT1;CEACAM1;CDKN1C;TGFB1
prerank,regulation of cell killing (GO:0031341),0.6345422712409277,1.4214401678144566,0.07490144546649145,0.8429512148776088,1.0,4/16,8.19%,CD55;CFH;TGFB2;FZD7
prerank,supramolecular fiber organization (GO:0097435),0.4853340985666503,1.4207493509022509,0.0,0.8431708430465849,1.0,75/334,13.66%,COL14A1;PLOD2;COL3A1;P4HA3;COL5A2;COL6A3;COL1A2;DDR2;DBN1;TNXB;GSN;KRT20;COL1A1;LOXL2;COL17A1;COL5A1;BMP1;COL8A1;TLE6;DCTN1;COL11A1;COL5A3;ADAMTS2;CCDC88C;COL6A2;FGF13;TGFB2;CDC42EP2;COL8A2;P4HA1;HOOK2;CLIP1;ADAMTS3;SPTA1;DPT;DST;MARCKS;VPS4B;COL12A1;FSD1;MYO1A;NEFL;COL6A1;TGFBI;P4HA2;TLL1;MYO5A;SLK;CLIP2;COL15A1;PLOD3;SIAH1;KIF2A;GGA1;COL9A3;LOXL1;COL2A1;CALCA;COLGALT1;SERPINH1;CLIP4;CAMSAP1;AVIL;MAPT;COL20A1;TPPP3;NAT8;UBA52;HSPG2;PIN1;SLAIN2;P3H1;CRIPT;RHOA;WDR73
prerank,sphingoid biosynthetic process (GO:0046520),-0.5515931488494059,-1.4207300009225738,0.08214285714285714,0.5391285533464413,1.0,5/11,22.80%,ACER2;SPHK1;SPTLC2;SPHK2;ABCA2
prerank,sphingosine biosynthetic process (GO:0046512),-0.5515931488494059,-1.4207300009225738,0.08214285714285714,0.5391285533464413,1.0,5/11,22.80%,ACER2;SPHK1;SPTLC2;SPHK2;ABCA2
prerank,response to hydrogen peroxide (GO:0042542),0.542634535510386,1.4203874376442955,0.052106430155210645,0.8415895374152598,1.0,14/45,16.30%,ANXA1;STK25;FYN;MAPK7;ADAM9;NFE2L2;HDAC6;ANKZF1;SIRPA;GPX1;PLEKHA1;OSER1;STK24;IL6
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.5835563507653874,1.4201849428135545,0.06425233644859812,0.839025788982101,1.0,12/26,23.83%,FYN;MAPK7;PDE8A;NFE2L2;AKT1;GPR37L1;GPR37;HTRA2;PPIA;PYCR1;ATF4;BAG5
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.65761337361414,1.4201558112395642,0.08311345646437995,0.8352947896272686,1.0,6/13,19.80%,PDE8A;NFE2L2;GPR37L1;GPR37;HGF;PYCR1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.6851293332577649,1.4194441405974676,0.06830601092896176,0.8357927939781346,1.0,3/12,5.50%,UMPS;TK1;TK2
prerank,RNA catabolic process (GO:0006401),0.5497780580550471,1.4191903519512195,0.05672969966629588,0.8335638818487925,1.0,17/46,19.45%,DIS3L2;ZPR1;ZFP36L2;HNRNPD;NUDT16L1;EXOSC7;SIDT2;ERN1;NUDT16;RNASE6;ZFP36;DNA2;CNOT10;AGO4;YTHDF2;SUPV3L1;AGO3
prerank,negative regulation of translational initiation (GO:0045947),0.6773408236240599,1.418318622346895,0.0743801652892562,0.8350842278952942,1.0,8/13,26.07%,RBM4;PAIP2B;AGO2;LARP1;EIF3E;PAIP2;TPR;EIF4EBP2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5415894554368099,1.418149461872518,0.044372294372294376,0.8323385276927022,1.0,17/48,11.30%,FGF18;PRKCA;ANXA1;FGFR1;ANGPT4;VEGFA;FGF2;HDAC9;HDAC7;MAPK14;MAP2K3;PRKD2;STAT5A;FOXC2;AKT3;RHOJ;AKT1
prerank,regulation of cellular pH (GO:0030641),0.570325756492668,1.4179779992304762,0.06257242178447277,0.8295604687766396,1.0,12/29,15.88%,SLC4A10;SLC4A8;ATP1A4;SLC4A3;SLC9A9;SLC4A4;SLC26A6;SLC9A1;ATP6AP1;CHP1;SLC9A7;SLC9A6
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.604732889306318,1.41683384459202,0.05970149253731343,0.8330227297094843,1.0,8/23,13.71%,LIF;SIX4;VEGFA;FGF2;SOX8;EGF;GDNF;SIX1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.492369184337878,-1.4162062808955103,0.11693548387096774,0.5461514676397377,1.0,6/14,12.02%,KMT5B;SHLD1;KMT5C;NECTIN2;TFRC;RIF1
prerank,miRNA metabolic process (GO:0010586),0.6164236279942316,1.4161081310705665,0.08198757763975155,0.8337010271196188,1.0,6/20,13.11%,DIS3L2;TARBP2;TRIM71;DGCR8;AGO2;DDX17
prerank,cellular response to estradiol stimulus (GO:0071392),0.6294412050998331,1.416031343270271,0.082687338501292,0.8304191954435787,1.0,3/18,6.23%,ESR1;EGFR;NCOA3
prerank,glutathione biosynthetic process (GO:0006750),0.6877964458090184,1.4159838940321716,0.06403269754768393,0.8270064385892881,1.0,3/11,9.77%,GCLC;HAGH;CNDP2
prerank,protein insertion into membrane (GO:0051205),0.562974833024851,1.4152485904765844,0.08051341890315053,0.8278188340351569,1.0,10/32,14.22%,EGFR;STX1A;STX5;UBE2J2;GET4;ALDH3A2;WDR83OS;TRAM2;SGTA;TRAM1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5792335472177553,1.4143783706779525,0.07237635705669482,0.8295897724103541,1.0,8/27,14.13%,DDR2;WNT2;MIF;CDK4;GAS6;S100A6;CDKN1A;PDGFRA
prerank,vasculogenesis (GO:0001570),0.5667891448213218,1.4141239591950538,0.05957943925233645,0.827571841034848,1.0,6/32,3.19%,HAS2;WT1;GLMN;VEGFA;TNNI3;TGFBR2
prerank,negative regulation of signaling (GO:0023057),0.5893284546884288,1.4140363783837944,0.06690997566909976,0.8243846072537727,1.0,3/25,4.40%,LIF;SRMS;ACVR1
prerank,regulation of plasminogen activation (GO:0010755),0.6744138156927091,1.4116308038835845,0.08423913043478261,0.8358136990004584,1.0,4/12,7.11%,HPN;CLEC3B;RUNX1;MELTF
prerank,actin filament polymerization (GO:0030041),0.582670589178333,1.410578724339023,0.06946107784431138,0.8387041949477456,1.0,7/29,5.88%,GSN;PSTPIP1;ANG;DIAPH3;COBL;MSRB1;WASF1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6513171829308841,1.410146008972053,0.08755129958960328,0.8378869315786864,1.0,4/14,7.26%,SULF2;FGF2;CREB3L1;SULF1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.6527925509746362,1.410133259365843,0.10054347826086957,0.8343589727712761,1.0,3/13,11.60%,TGFBR2;RUNX1;GLI3
prerank,negative regulation of T cell activation (GO:0050868),0.5591870755253868,1.4096150510765209,0.07407407407407407,0.8339420611021422,1.0,3/35,1.78%,CD80;LAX1;GLMN
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5888737161091623,1.4092920528041986,0.06235294117647059,0.8324757802981446,1.0,11/26,16.59%,EGFR;PDE8A;ZPR1;ZFP36L1;ZFP36L2;SYAP1;IQGAP1;INPP5K;ZFP36;STAT5B;SNAI2
prerank,GTP metabolic process (GO:0046039),0.6449950981207322,1.4089661205587638,0.07891332470892626,0.8308279735971175,1.0,3/15,10.05%,GNAI3;RAB23;RHOQ
prerank,regulation of glucose import (GO:0046324),-0.41434823387974334,-1.4087654112368542,0.050314465408805034,0.561048360837632,1.0,7/30,3.34%,PRKAG2;SORBS1;OCLN;INSR;IGF1;ENPP1;OSBPL8
prerank,mammary gland development (GO:0030879),0.6070048805008816,1.4081293782824327,0.0930817610062893,0.8322151819678726,1.0,5/21,7.49%,WNT2;TGFB3;GPAT4;VEGFA;GLI2
prerank,regulation of cholesterol esterification (GO:0010872),-0.559504507311077,-1.4079304206903414,0.06430868167202572,0.5586501787605405,1.0,3/10,6.35%,APOE;ABCG1;AGTR1
prerank,positive regulation of vasculogenesis (GO:2001214),0.7130934700180822,1.407784779262361,0.07902298850574713,0.8307420046501302,1.0,2/10,0.95%,CD34;TMEM100
prerank,positive regulation of vasoconstriction (GO:0045907),0.6633610032061368,1.4073638897330252,0.07983761840324763,0.8299373999589629,1.0,2/13,3.19%,AVPR1A;F2R
prerank,cAMP biosynthetic process (GO:0006171),-0.5756792972271174,-1.4072023833286336,0.12786885245901639,0.5556463282753257,1.0,4/10,9.13%,ADCY5;ADCY1;ADCY4;ADCY9
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.6702090016737309,1.4062744078946232,0.09239130434782608,0.8332428533887275,1.0,6/12,25.21%,TIPIN;NBN;GMNN;BLM;WDR18;KAT7
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6304694488519099,1.4057002818322948,0.08157894736842106,0.8332186366007327,1.0,7/17,23.23%,ANXA1;OTUD7B;BCL3;KLF4;ANXA4;ARRB1;SSC5D
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6322005285296168,1.4050861690224843,0.09043250327653997,0.8337540954433598,1.0,4/15,6.67%,SFRP4;GPC3;DACT1;DAAM2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5900780859500435,1.4043448464067836,0.09046454767726161,0.8348463001542994,1.0,5/24,6.33%,ACKR3;TRIAP1;CD44;MIF;MUC1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6163417055996461,1.4039664294196772,0.08448928121059268,0.8336701170991185,1.0,8/18,9.72%,ANXA1;VEGFA;FGF2;HDAC9;HDAC7;FOXC2;AKT3;RHOJ
prerank,telomere maintenance via recombination (GO:0000722),0.6755252707382796,1.4029434866645423,0.0993006993006993,0.8364830602877945,1.0,9/11,26.42%,XRCC3;SMC5;ERCC4;SMC6;RAD50;TEP1;ERCC1;NSMCE2;RAD51D
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.6034372813131758,1.4028106948058068,0.066167290886392,0.833939886045212,1.0,18/23,31.45%,SYVN1;PREB;SURF4;LMAN1;HERPUD1;SELENOS;AUP1;DERL1;SEL1L;TECPR2;SEC61B;HSP90B1;UFD1;NPLOC4;RANGRF;SEC13;TMEM129;DERL2
prerank,peroxisomal membrane transport (GO:0015919),0.5770614531003233,1.4022429420563098,0.0803357314148681,0.833941028765194,1.0,13/27,21.44%,PXMP2;PEX16;GDAP1;ALDH3A2;PXMP4;PEX12;PEX1;SLC25A17;PEX3;PEX5;ATAD1;ABCD3;PEX2
prerank,neutrophil chemotaxis (GO:0030593),0.5257708401618293,1.4020953898132584,0.06531049250535331,0.831468010895638,1.0,7/53,9.02%,SYK;CCL8;TGFB2;S100A8;S100A9;CXCL10;CCL25
prerank,regulation of BMP signaling pathway (GO:0030510),0.5172330455256148,1.4018361655591198,0.034334763948497854,0.8297111639182158,1.0,10/73,7.26%,SFRP4;FSTL1;HTRA3;PCSK6;SKIL;SMAD4;SMURF2;SKI;SMAD5;SULF1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.670934899302551,1.401666390717668,0.0817174515235457,0.8274191372288456,1.0,3/12,17.74%,CD80;PAEP;IL18
prerank,integrated stress response signaling (GO:0140467),0.6462706474057558,1.4011348256013088,0.08762169680111266,0.827198018410851,1.0,5/14,13.68%,EIF2AK3;NFE2L2;HERPUD1;QRICH1;EIF2S1
prerank,cellular response to hormone stimulus (GO:0032870),0.5147547558373887,1.4003199710994265,0.03208556149732621,0.8287254783669679,1.0,14/69,7.15%,GHR;AR;UCP1;WT1;SLIT3;SLIT2;SFR1;ATP1A3;ATP1A1;ZFP36L1;SOCS2;NCOA3;SRC;GAS2L1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.4740324271783316,-1.3995681774459137,0.09502262443438914,0.5723051168255227,1.0,8/17,12.16%,PTN;IL34;TENM4;NOTCH1;PTPRZ1;BMP2;MDK;TGFB1
prerank,neutrophil migration (GO:1990266),0.5228755094920386,1.3991939254872405,0.06216505894962487,0.8320384402316099,1.0,10/58,12.90%,SYK;CCL8;CD177;TGFB2;S100A8;S100A9;CXCL10;CCL25;IRAK4;CCL13
prerank,nuclear membrane disassembly (GO:0051081),0.6471473785847348,1.399120414797832,0.11235955056179775,0.8291638323121235,1.0,2/14,1.73%,PRKCA;DCTN1
prerank,regulation of platelet aggregation (GO:0090330),0.6203708478077615,1.3982701923768026,0.10646387832699619,0.8310244973904855,1.0,4/17,1.27%,SYK;C1QTNF1;PRKCA;CD9
prerank,response to cAMP (GO:0051591),0.5518650613732593,1.3979917455806001,0.08083140877598152,0.8293594610440038,1.0,10/37,11.33%,IGFBP5;DUOX1;WT1;DGKQ;ZFP36L1;RAP1B;PKD2;INPP5K;HCN4;SLC26A6
prerank,circulatory system development (GO:0072359),0.4948940442820481,1.3978254551818352,0.01842374616171955,0.8269950711156985,1.0,32/118,13.16%,COL3A1;FBN1;WT1;AKAP13;PCSK5;PLCE1;ZDHHC16;HEG1;TGFB2;TNNI3;TGFBR2;BORCS8;HDAC9;CRIP1;PKD1;ACVR1;TCF25;PDLIM7;GLI2;ZFPM2;FOXL1;PKD2;PIK3CA;FOXC2;ECE1;KAT2B;EEF1AKMT4-ECE2;MICAL2;PDLIM1;FLRT3;HSPG2;CDKN1A
prerank,regulation of T cell activation (GO:0050863),0.5381069036015165,1.3976001258289352,0.05630630630630631,0.8250718154835414,1.0,9/42,20.96%,TNFSF9;LAX1;CD47;SIRPA;GPNMB;TNFRSF1B;VTCN1;PRELID1;PYCARD
prerank,proteoglycan metabolic process (GO:0006029),0.5870476170755021,1.3954361122288559,0.07720588235294118,0.8347699237045877,1.0,9/26,9.11%,SULF2;CSGALNACT2;CHST10;GAL3ST3;SULF1;CHST12;CHST14;FOXL1;XYLT1
prerank,positive regulation of heart rate (GO:0010460),-0.4740302197038534,-1.395310139485909,0.0821256038647343,0.5795330743966528,1.0,7/17,15.58%,TPM1;ADRA1B;KCNQ1;RYR2;EDN1;ADM;EDN3
prerank,receptor internalization (GO:0031623),0.5376702137163398,1.3949903024738912,0.07021517553793885,0.834048712832636,1.0,8/44,8.08%,ACKR3;SYK;CD9;LRP1;DNM1;CLTC;SNX1;CD81
prerank,regulation of T cell proliferation (GO:0042129),0.5161600454784101,1.3943624507544166,0.04461371055495103,0.8347171999566789,1.0,11/61,18.08%,TNFSF9;CD80;ANXA1;GLMN;CEBPB;GPNMB;TNFRSF1B;IL4;IL6;NCK1;VTCN1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.528341694450557,1.393568279185461,0.05683060109289618,0.8360978623200193,1.0,18/52,17.06%,DCTN1;GFPT1;LMNA;CXXC1;SEC31A;SYVN1;PREB;EDEM1;KDELR3;TPP1;ARFGAP1;CTDSP2;ACADVL;ERN1;DDX11;DNAJB11;KLHDC3;PPP2R5B
prerank,melanocyte differentiation (GO:0030318),-0.5598603668192843,-1.3933649722882593,0.13793103448275862,0.5801356791572335,1.0,6/11,13.98%,LRMDA;ENPP1;MEF2C;KIT;SLC24A5;MREG
prerank,hematopoietic stem cell proliferation (GO:0071425),0.6683333811468659,1.3928557609298937,0.10743801652892562,0.8371014493336975,1.0,3/11,3.49%,CD34;WNT10B;RUNX1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6064934767949718,1.3925452928297741,0.0829145728643216,0.835718447296433,1.0,4/19,4.22%,DCN;CCBE1;SMOC2;ADAMTS3
prerank,regulation of lymphocyte activation (GO:0051249),-0.5345515995796412,-1.392432825485509,0.11372549019607843,0.5774570780375083,1.0,8/12,38.31%,PAG1;DCAF15;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,activation of protein kinase A activity (GO:0034199),-0.4865209489018198,-1.3923356846678654,0.09053497942386832,0.5727056811991288,1.0,7/16,15.91%,ADCY5;ADCY1;PRKAR1B;ADCY4;ADCY9;PRKAR2B;PRKACB
prerank,adipose tissue development (GO:0060612),-0.5429286182837254,-1.3916711817823924,0.11636363636363636,0.5699898002327897,1.0,6/11,17.20%,ARID5B;NAMPT;SH3PXD2B;SPTLC2;DYRK1B;PGRMC2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.43021671808490825,-1.3912558243664266,0.09340659340659341,0.5664479710327581,1.0,11/25,19.64%,EPHA4;RPS7;PSMF1;OPHN1;PDCL3;PSME3IP1;RPL5;HIPK2;HFE;CSNK2A1;TAF1
prerank,regulation of cholesterol efflux (GO:0010874),-0.41307761568004,-1.3911601317803,0.08074534161490683,0.5618992635616318,1.0,11/30,16.89%,PLTP;PTCH1;APOE;TTC39B;NR1H3;CAV1;SIRT1;ABCA3;NFKBIA;EEPD1;ABCA5
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.6651122344575264,1.3906391744361741,0.08276797829036635,0.8436750588524444,1.0,1/12,0.38%,AKR1B1
prerank,cellular glucan metabolic process (GO:0006073),-0.5263740648214046,-1.390634417770482,0.12186379928315412,0.5585886850787299,1.0,4/11,5.31%,PRKAG2;PHKB;PYGM;GBE1
prerank,heart development (GO:0007507),0.48638076122188156,1.389987464956209,0.011144883485309016,0.844170151215426,1.0,37/150,13.16%,COL3A1;FBN1;WT1;AKAP13;FLRT2;PCSK5;PLCE1;GPC3;ZDHHC16;HEG1;VEGFA;TGFB2;TNNI3;TGFBR2;BORCS8;HDAC9;CRIP1;MEF2D;PKD1;ACVR1;TCF25;PDLIM7;GLI2;ZFPM2;FOXL1;PKD2;NDRG4;FOXC2;ECE1;KAT2B;EEF1AKMT4-ECE2;ALPK2;MICAL2;PDLIM1;FLRT3;SGCZ;CDKN1A
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6863812194078632,1.3883349578451367,0.0953058321479374,0.8508171647226948,1.0,3/10,14.32%,MAPK7;IRAK3;KLF4
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.5568491818482089,-1.3882746294912054,0.09859154929577464,0.5602838162896131,1.0,7/11,32.92%,ALG10B;LRRC38;AKAP6;NOS1AP;LRRC55;TREM2;RNF207
prerank,positive regulation of protein maturation (GO:1903319),0.6760504770407084,1.3867079875445496,0.09431345353675451,0.8573126624600086,1.0,1/11,0.71%,CCBE1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.6560886528386926,1.386337446273303,0.09917355371900827,0.856289050556052,1.0,4/12,6.33%,TRIAP1;CD44;MIF;MUC1
prerank,cardiac ventricle development (GO:0003231),-0.4452631798990916,-1.3862246103352314,0.05238095238095238,0.5613045590023142,1.0,7/20,9.63%,ENG;NOTCH1;SALL1;HEYL;STRA6;HECTD1;PDE2A
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5466733599076645,-1.3862087193511794,0.11428571428571428,0.5567782865817024,1.0,6/11,10.53%,LYN;RAPGEF2;MEF2C;PIK3CB;PIK3CD;SIRT1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.6681542035341074,1.386154609955688,0.10650069156293222,0.8542381160397654,1.0,1/10,0.19%,DCN
prerank,plasma membrane repair (GO:0001778),0.6447879466448992,1.3859823895606471,0.09375,0.8520478882615329,1.0,2/13,4.28%,AHNAK2;SYT11
prerank,regulation of transforming growth factor beta production (GO:0071634),0.6205479907200144,1.3858300168729043,0.09806451612903226,0.8498917216553347,1.0,3/18,3.68%,CD34;TGFB2;SMAD4
prerank,keratinocyte differentiation (GO:0030216),0.5675719831022851,1.3857954690691832,0.09090909090909091,0.8469703969122626,1.0,6/29,8.92%,LORICRIN;ANXA1;SCEL;ADAM9;KRT10;JAG1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.5320809264845124,-1.3853928703819032,0.12237762237762238,0.5544824661285341,1.0,6/11,31.89%,AHR;CEACAM1;HFE;PTPRC;LILRB1;IL4I1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5549765673195816,1.3850934319928898,0.07373271889400922,0.8479718906854383,1.0,20/35,26.82%,AR;ESR1;ZMIZ1;PMEPA1;TRIP4;SRC;EGLN2;PLPP1;RBFOX2;DDX17;RNF14;DDX5;PADI2;TMF1;UBE3A;NCOA4;NR3C1;KDM3A;SAFB;ARID1A
prerank,axonal transport (GO:0098930),0.5480987188025223,1.38427100931506,0.07390300230946882,0.8497059834176138,1.0,15/36,22.51%,DCTN1;DST;DTNBP1;NEFL;AP3D1;SYBU;MAPT;KIF3A;KIF3B;BLOC1S2;DYNC1H1;SNAPIN;PAFAH1B1;AP3B2;FBXW11
prerank,regulation of interleukin-6 production (GO:0032675),0.497246724148887,1.3835194250663192,0.035751840168243953,0.8509124697870293,1.0,20/96,16.30%,SYK;LBP;IL16;RAB7B;IRAK3;F2R;TMEM106A;SYT11;IL33;IL17RA;GAS6;TIRAP;TLR4;CD47;SIRPA;TWIST1;CD200R1;ZC3H12A;SELENOS;IL6
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.5675854955258116,1.382687812261799,0.0927710843373494,0.8525952257080825,1.0,11/27,17.31%,ANK2;FGF13;SRI;DSC2;CAMK2D;HCN4;PDE4D;JUP;ATP2A2;STC1;AKAP9
prerank,regulation of osteoblast differentiation (GO:0045667),-0.31402017451841957,-1.3824341146948196,0.0,0.5577201864255981,1.0,24/82,10.57%,BMP6;RANBP3L;SMOC1;WNT4;TMEM64;PTCH1;IGF1;BMP7;MEF2C;PRKD1;NOTCH1;CDK6;ZHX3;IL6R;NELL1;ATRAID;FGFR2;NOCT;BMPR2;YAP1;NPNT;RUNX2;LRP3;BMP2
prerank,protein insertion into ER membrane (GO:0045048),0.5458357601795781,1.381889600356365,0.07816091954022988,0.8541222541461966,1.0,18/37,24.68%,STX1A;STX5;UBE2J2;GET4;ALDH3A2;WDR83OS;EMC1;TRAM2;EMC10;EMC8;SGTA;TRAM1;EMC3;VAMP2;EMC2;EMD;EMC6;SEC61B
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.5033486240554838,1.381711524293951,0.04468085106382979,0.8521769146902454,1.0,16/72,15.09%,FGF18;FGF7;POLR2H;FGFR1;FLRT2;HNRNPA1;FGF2;TRIM71;HNRNPH1;RBFOX2;FLRT3;SHOC2;POLR2D;POLR2G;CBL;GTF2F1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.6148461484630219,1.3815857648968966,0.08723135271807839,0.8499360860090501,1.0,7/18,14.97%,NXF1;DDX19B;NUP93;MCM3AP;POLDIP3;THOC2;ZC3H11A
prerank,positive regulation of multicellular organismal process (GO:0051240),0.4765185353769052,1.3805709463692484,0.002002002002002002,0.8529944319248314,1.0,59/308,14.01%,EBF2;IL4R;GHR;SYK;LBP;AVPR1A;UCP1;COL1A1;LOXL2;GNAS;IRF4;BMP1;LRP1;TGFB3;TLE6;TMEM119;GLMN;GADD45G;SIX4;GRB10;VEGFA;FGF2;TGFB2;F2R;TGFBR2;MIF;SMAD4;WWTR1;SMURF2;ACVR1;MTOR;PRKAB2;IL33;NCOA3;C1QBP;ABCA1;SCAMP5;ADCYAP1;GAS6;HMCES;SOX8;CYP27B1;VDR;AGO2;SOX5;ALMS1;INPP5K;TSKU;HDAC3;CEBPB;FBXO5;TSHR;HCRT;EGF;GDNF;CNOT3;TWIST1;SIX1;NME2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6529624125700063,1.3804739994209785,0.1062937062937063,0.8505319038843667,1.0,6/12,13.76%,GPAA1;KDELR3;KDELR1;INSIG2;RER1;KDELR2
prerank,regulation of cardiac muscle contraction (GO:0055117),0.5526812342733418,1.3797444424750693,0.07925407925407925,0.851853424738553,1.0,11/34,15.37%,ANK2;TNNI3;SRI;TNNI3K;HCN4;PDE4D;SLC9A1;CALM2;ATP2A2;ZC3H12A;STC1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.6246478382449007,1.3796793054982108,0.11024643320363164,0.8491655408872503,1.0,3/15,2.91%,FGFR1;SCEL;TGFB2
prerank,negative regulation of neurogenesis (GO:0050768),-0.40051887026638,-1.3791592552257725,0.051094890510948905,0.5620860712114291,1.0,7/34,10.51%,PTN;RAPGEF2;YWHAH;NOTCH1;B2M;APPL2;SORL1
prerank,regulation of extracellular matrix organization (GO:1903053),0.6183239431702598,1.3790647043980604,0.09171974522292993,0.8495979314538574,1.0,4/15,3.49%,DDR2;LRP1;FAP;RUNX1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6044882833324168,1.3782680099277844,0.09001233045622688,0.8512525816960388,1.0,7/20,13.39%,EGFR;PKD1;PSRC1;MAPRE3;PKD2;AKT1;CCND1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5793353095238607,1.3779264146385177,0.09741060419235512,0.8503111903187331,1.0,9/24,18.39%,LOXL2;TRPS1;SCIN;WNT9A;CHADL;SOX5;SNAI2;EFEMP1;TGFBR1
prerank,aminoglycan biosynthetic process (GO:0006023),0.519089073076254,1.3777305857498594,0.07760532150776053,0.8484840718951853,1.0,13/49,12.32%,HAS1;GPC6;UGDH;GPC3;B3GALNT1;EXT1;B3GAT3;XYLT1;HS2ST1;B3GNT8;HS3ST6;HS3ST5;HSPG2
prerank,camera-type eye morphogenesis (GO:0048593),0.6805727108720944,1.3776500204380655,0.0954356846473029,0.8459960137294553,1.0,4/10,5.31%,LRP6;VEGFA;SKI;TENM3
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.6775689845758832,1.3763653977918728,0.1056338028169014,0.8506744888369916,1.0,6/10,20.09%,PDE8A;NFE2L2;GPR37L1;GPR37;PYCR1;STK26
prerank,positive regulation of translational initiation (GO:0045948),0.6102217840586911,1.3762416963308992,0.10285006195786865,0.8484736642080437,1.0,9/18,22.31%,DAZL;MTOR;LARP1;POLR2D;POLR2G;CDC123;YTHDF1;YTHDF2;YTHDF3
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.6248448413534978,1.3753698219629629,0.12026143790849673,0.8506247413335354,1.0,4/16,5.66%,TGFB3;F2R;RUNX1;CREB3L1
prerank,pentose-phosphate shunt (GO:0006098),-0.5191815589828801,-1.3752586013589008,0.1289198606271777,0.5682826385544623,1.0,7/11,29.43%,DERA;PGLS;TALDO1;RBKS;RPE;RPIA;H6PD
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.5731202201874807,1.3750043089753723,0.09615384615384616,0.849757995775524,1.0,10/25,12.37%,AR;EGFR;GLMN;ANG;MIF;SRC;FZD7;PSEN1;DSCAM;EGF
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6424614364661261,1.3746137430590188,0.1044776119402985,0.8494169407429515,1.0,3/13,8.30%,AXL;GAS6;ZBTB1
prerank,protein ADP-ribosylation (GO:0006471),0.5654075064696328,1.373560389874352,0.1045673076923077,0.8526349619935595,1.0,8/28,11.05%,PARP3;ART4;PARP11;ARF4;PARP6;SIRT2;ZC3HAV1;PARP14
prerank,regulation of lymphocyte proliferation (GO:0050670),0.6325432299285181,1.3733049986712815,0.10053619302949061,0.8513723420695947,1.0,1/16,0.18%,TNFSF9
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.5499801375608241,1.3732123782230838,0.08644859813084112,0.8490499156632556,1.0,11/33,14.32%,CDK2AP2;FHL1;CDK4;DACT1;PRMT2;PKD2;BRD7;GPNMB;CDKN1A;NACC2;KLF4
prerank,aminoglycan metabolic process (GO:0006022),0.6715986316922408,1.3731432986699041,0.11494252873563218,0.8465406318131726,1.0,5/10,21.54%,GAL3ST3;B3GAT3;XYLT1;XYLT2;B3GAT2
prerank,secretory granule organization (GO:0033363),0.6788237208660886,1.3729803104700231,0.11598302687411598,0.8446699158509384,1.0,6/10,21.09%,F2R;DTNBP1;ABCA1;BLOC1S2;VPS33B;LYST
prerank,atrioventricular valve development (GO:0003171),0.6217310521192858,1.3726682741295402,0.11288180610889774,0.8435513972067087,1.0,5/14,6.76%,TGFB2;SLIT3;TGFBR2;ACVR1;MDM4
prerank,"base-excision repair, AP site formation (GO:0006285)",0.6056410856075718,1.372538002791476,0.10821382007822686,0.8414961782581423,1.0,7/17,22.09%,MPG;ACD;TERF1;ERCC5;TINF2;OGG1;TERF2IP
prerank,muscle cell differentiation (GO:0042692),-0.4005600438987421,-1.371880179877606,0.07042253521126761,0.5735070739386786,1.0,9/32,11.66%,NEBL;DMD;WNT5B;MEF2C;SPEG;TBX18;TBX1;MRTFB;TMEM204
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.6056988164525562,1.3717349070319695,0.125,0.8407606299449902,1.0,6/17,16.39%,IRS1;SOCS2;STAT5A;IRS2;SMARCA4;STAT5B
prerank,cellular response to interleukin-7 (GO:0098761),0.6056988164525562,1.3717349070319695,0.125,0.8407606299449902,1.0,6/17,16.39%,IRS1;SOCS2;STAT5A;IRS2;SMARCA4;STAT5B
prerank,positive regulation of collagen metabolic process (GO:0010714),0.6174186602519285,1.371724066046534,0.12109375,0.8380658774049885,1.0,4/17,5.66%,TGFB3;F2R;RUNX1;CREB3L1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6654006103308598,1.3714162293191756,0.11218836565096953,0.8342337167924553,1.0,2/11,8.10%,SYK;STAT5A
prerank,cellular response to interleukin-2 (GO:0071352),0.6654006103308598,1.3714162293191756,0.11218836565096953,0.8342337167924553,1.0,2/11,8.10%,SYK;STAT5A
prerank,carbohydrate transport (GO:0008643),0.6584445041267536,1.371061397557941,0.10955056179775281,0.8335584621467169,1.0,4/11,13.02%,SLC50A1;SLC26A6;SLC23A1;SLC23A2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.4914890223897053,1.3705042298426775,0.04343329886246122,0.8340187750877459,1.0,20/87,15.09%,FGF18;FGF7;POLR2H;FGFR1;FLRT2;HNRNPA1;CD44;FGF2;ZFP36L1;TRIM71;ZFP36L2;HNRNPH1;RBFOX2;FLRT3;SHOC2;ZFP36;POLR2D;POLR2G;CBL;GTF2F1
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.6003401709796775,1.3704032196989275,0.11420982735723771,0.8318242789975758,1.0,8/18,18.62%,RAB23;FLCN;MDFIC;OTUD7B;CABP1;CHP1;ILRUN;UFM1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6530550951836414,1.3701443566926728,0.11281337047353761,0.8305418087141757,1.0,6/12,22.26%,EPHB2;MYCBP2;HSP90AA1;EPHB1;PTEN;SPTBN4
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.45679000085515487,-1.3699444603036057,0.10747663551401869,0.5742547091067609,1.0,9/21,15.06%,PLTP;PTCH1;APOE;NR1H3;CAV1;SIRT1;ABCA3;NFKBIA;EEPD1
prerank,positive regulation of cell projection organization (GO:0031346),-0.30253888834989656,-1.368615071109678,0.0,0.5733814799225107,1.0,32/115,12.46%,PLXNA2;PTN;ROBO1;LYN;RAPGEF2;PTK7;CUX1;ITGA6;SCARB2;APOE;PLXNA4;PTPRD;CDKL5;PRKD1;WNT5A;DAB2IP;PLXND1;SNX3;ROBO2;NDNF;PLPPR5;DVL3;NTRK3;MAP3K13;PLXNB1;CX3CL1;CAMK2B;MDK;EP300;SS18L1;NTRK2;BDNF
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.5609885473630569,1.3682932671458872,0.09541062801932366,0.8383952292476232,1.0,4/29,3.66%,DBN1;EPHB2;SLC4A10;DLG4
prerank,negative regulation of macroautophagy (GO:0016242),0.5759059761028426,1.367699661992501,0.0783132530120482,0.8390368076805446,1.0,19/26,31.64%,USP36;MTOR;SEC22B;PIK3CA;NRBP2;SCFD1;AKT1;SMCR8;NUPR1;QSOX1;UBQLN4;TSC2;MTM1;TMEM39A;TSC1;LZTS1;RUBCN;CHMP4A;CHMP4B
prerank,lipid translocation (GO:0034204),0.5846014437901456,1.367487305908465,0.10532994923857868,0.837426428397284,1.0,7/21,12.70%,ATP8B1;ATP9A;ABCA1;ATP11A;ATP9B;TMEM30A;ABCC1
prerank,regulation of wound healing (GO:0061041),0.5270361937544266,1.3672534648669985,0.08437856328392246,0.8360866651180383,1.0,6/42,3.19%,EPHB2;DUOX1;ANXA1;SRSF6;FGF2;F2R
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.6491875243245563,1.3672147812015567,0.11080332409972299,0.833621680714575,1.0,2/11,4.28%,NEUROD2;P2RX3
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6912123556467528,1.365903789759967,0.11033519553072625,0.8385168175611394,1.0,3/10,11.34%,LBP;TIRAP;WDFY1
prerank,peptidyl-amino acid modification (GO:0018193),0.6802145366315318,1.3656520071572509,0.09455587392550144,0.8373919926880435,1.0,5/10,21.79%,FKBP10;METAP2;METAP1;FKBP7;METAP1D
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.6741914744489312,1.3653791041304761,0.1071932299012694,0.8362559044183179,1.0,1/11,0.11%,CD34
prerank,actin polymerization or depolymerization (GO:0008154),0.5202010871820699,1.365321884014114,0.06465997770345597,0.8339434095583537,1.0,13/50,11.23%,GSN;PSTPIP1;SCIN;ANG;DIAPH3;COBL;SVIL;MSRB1;WASF1;ABI1;TWF1;AVIL;MICAL2
prerank,positive regulation of glucose import (GO:0046326),-0.4347183246933298,-1.365159454008883,0.09569377990430622,0.5784735308863422,1.0,5/21,3.34%,SORBS1;OCLN;INSR;IGF1;OSBPL8
prerank,positive regulation of macrophage differentiation (GO:0045651),0.658013243971064,1.3646349803820284,0.11527777777777778,0.8349690390654884,1.0,2/11,1.26%,LIF;PRKCA
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.563668036448426,1.3644372655327144,0.11363636363636363,0.8334540696092991,1.0,9/29,16.39%,GHR;PKD1;CLCF1;SOCS2;PKD2;STAT5A;FER;SOCS6;STAT5B
prerank,ion homeostasis (GO:0050801),0.5536913096213485,1.364392741507957,0.09597156398104266,0.8310812588209847,1.0,9/30,12.92%,SLC4A10;FHL1;SLC4A8;SLC4A3;CAMK2D;AP3D1;HCN4;SLC4A4;SLC12A5
prerank,integrin-mediated signaling pathway (GO:0007229),0.49749099106447814,1.3639564665543513,0.04842105263157895,0.8309102596643424,1.0,19/73,14.01%,COL3A1;SYK;ITGA11;PRAM1;ITGBL1;ITGB3;ADAM9;PLPP3;ITGA2;ITGA5;ITGB5;DST;SRC;CUL3;ITGAV;CD47;FYB2;ADAM15;NME2
prerank,protein targeting to membrane (GO:0006612),0.4890035456794388,1.3639184393225388,0.046826222684703434,0.828523978716789,1.0,48/83,33.06%,PXMP2;PEX16;GDAP1;ZDHHC7;ALDH3A2;VPS37D;SRP19;PXMP4;TAOK2;ZDHHC2;VPS37C;SGTA;PEX12;TRAM1;SEC63;SLC25A17;SEC61A1;ZDHHC4;PEX3;ZDHHC24;VPS37B;ZDHHC21;ZDHHC20;NACA;PEX5;ATAD1;ABCD3;ZDHHC18;ICMT;PEX2;ATG3;SDCBP;FIS1;MICALL1;SSR1;RAB8B;PRKCI;ZDHHC15;PARD3;MYO1C;GOLGA7B;PIKFYVE;CHMP4A;CHMP4B;ARL6;CHM;PEX19;ZDHHC3
prerank,positive regulation of macrophage activation (GO:0043032),0.5926342079583898,1.3637137346695036,0.11719745222929936,0.8271553852391204,1.0,3/17,9.07%,LBP;IL33;TLR4
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6274634361162686,1.3632121820966068,0.11241830065359477,0.8273472529359247,1.0,6/15,14.01%,SFRP4;NCOA3;CYP27B1;VDR;SFN;NME2
prerank,regulation of Rho protein signal transduction (GO:0035023),0.5027642645812144,1.363126217981901,0.053022269353128315,0.8254074604637548,1.0,16/72,10.38%,COL3A1;MYOC;ARHGEF28;AKAP13;HEG1;F2R;LPAR1;RIT2;ABCA1;ARHGEF3;ABL2;MYO9B;FLCN;CUL3;GPR20;KANK1
prerank,vasculature development (GO:0001944),-0.4700813502529528,-1.362578565514493,0.13658536585365855,0.5809160882251333,1.0,8/16,16.13%,CDH5;ERRFI1;BMPR2;STRA6;PDGFRB;NOTCH4;FLT4;SOX18
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5950177857016975,1.362571258791411,0.10997442455242967,0.8256242650421266,1.0,4/18,12.63%,ANXA1;ZFP36L1;ZFP36L2;ZFP36
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.4501829073320399,-1.3624853711284874,0.10945273631840796,0.5767546011527808,1.0,7/19,14.84%,TJP1;BMP6;NOTCH1;RGCC;NOTCH4;PPM1F;AFDN
prerank,positive regulation of cell killing (GO:0031343),0.6320960997303696,1.3621571980766467,0.11420612813370473,0.8253222041283406,1.0,2/13,8.19%,SYK;FZD7
prerank,stress granule assembly (GO:0034063),0.5855496825910967,1.3617846028740008,0.11479591836734694,0.8248332816929648,1.0,12/20,24.44%,UBAP2L;BICD1;ATXN2;MAPT;EIF2S1;ATXN2L;DYNC1H1;YTHDF1;YTHDF2;YTHDF3;OGFOD1;G3BP1
prerank,wound healing (GO:0042060),0.5009707601825152,1.3616794409332644,0.06357758620689655,0.8230128039890402,1.0,13/62,10.18%,COL3A1;AHNAK2;DCBLD2;ITGB3;FGF2;TGFB2;SYT11;DST;MIA3;PPL;PRCP;FZD7;TSKU
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.6290994489037829,1.3605785693742545,0.09759358288770054,0.8262087693448549,1.0,12/15,31.45%,SYVN1;HERPUD1;SELENOS;AUP1;DERL1;SEL1L;SEC61B;HSP90B1;UFD1;NPLOC4;TMEM129;DERL2
prerank,regulation of axonogenesis (GO:0050770),-0.3477710858610378,-1.3598819501510764,0.053763440860215055,0.5793868255473553,1.0,8/51,5.19%,PLXNA2;ROBO1;EPHA4;PLXNA4;CHN1;PLXND1;SIPA1L1;ROBO2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5026718663839619,1.3592338877712262,0.05603448275862069,0.8310129023733112,1.0,10/69,9.07%,SYK;LBP;EPHB2;MIF;TMEM106A;PTPRJ;IL33;PSEN1;TIRAP;TLR4
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6316010364080684,1.3590394849181309,0.12149532710280374,0.8295456522694307,1.0,4/15,5.33%,PIEZO2;HPN;COL11A1;PDZD7
prerank,renal system development (GO:0072001),0.5130714509906227,1.3571443312236182,0.07330415754923414,0.8374447289883702,1.0,10/52,7.49%,HAS2;WT1;PCSK5;SULF2;VEGFA;TGFB2;C1GALT1;PKD1;SULF1;GLI2
prerank,regulation of fibroblast migration (GO:0010762),0.5787506275837904,1.3565934509281317,0.1054590570719603,0.8378404892390846,1.0,3/20,2.88%,DDR2;HAS1;FGF2
prerank,regulation of muscle contraction (GO:0006937),-0.406662535173615,-1.3563320198131261,0.09782608695652174,0.5851134410042409,1.0,7/26,10.28%,ATP1A2;TPM1;KCNB2;CAV1;ENO1;MYL9;KCNA1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5397653081872865,1.3560005170860085,0.09133489461358314,0.8384475301030695,1.0,4/33,4.40%,LIF;PRKCA;RUNX1;ZFP36L1
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.45831334644658206,-1.355775470100118,0.08866995073891626,0.5823410909428149,1.0,3/18,4.61%,PTN;LYN;IL6R
prerank,regulation of integrin activation (GO:0033623),0.6171664696756243,1.3554685895203862,0.13866666666666666,0.8388437227787389,1.0,4/15,6.81%,RAP1B;JAM3;FARP2;SRC
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.6566672859217216,1.3554210683241084,0.12962962962962962,0.8317046377130264,1.0,7/10,22.85%,XRCC3;TERF1;DNA2;NBN;BLM;SMARCAL1;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.6566672859217216,1.3554210683241084,0.12962962962962962,0.8317046377130264,1.0,7/10,22.85%,XRCC3;TERF1;DNA2;NBN;BLM;SMARCAL1;ERCC1
prerank,t-circle formation (GO:0090656),0.6566672859217216,1.3554210683241084,0.12962962962962962,0.8317046377130264,1.0,7/10,22.85%,XRCC3;TERF1;DNA2;NBN;BLM;SMARCAL1;ERCC1
prerank,negative regulation of peptidase activity (GO:0010466),0.519510084954058,1.3547592765252243,0.08552631578947369,0.8329352150004989,1.0,10/47,12.89%,TIMP2;LRP1;SERPINB8;ECM1;SERPINE3;SERPINF1;CSTB;SERPINH1;AKT1;SERPING1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.6679103042642269,1.3547549967483277,0.11781206171107994,0.8305252588739385,1.0,4/10,12.42%,GAP43;F2R;PLPP1;PRKD3
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.5523698705522734,1.354586374953314,0.0880952380952381,0.8290032253592242,1.0,10/31,14.32%,CDK2AP2;FHL1;CDK4;DACT1;PRMT2;PKD2;BRD7;GPNMB;CDKN1A;KLF4
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.47614636961094703,1.3542279065908724,0.01717171717171717,0.828657453978237,1.0,23/150,8.49%,AREG;MYOC;CD80;ESR1;FGF18;AXL;FGF7;EGFR;IRS1;FGFR1;BTC;FYN;FGF2;MST1R;PIK3R2;TCF7L2;PTPRJ;C1QBP;RET;SRC;GAS6;FLT3LG;PIK3CA
prerank,negative regulation of calcium ion transport (GO:0051926),-0.48303922628984175,-1.3537509082429486,0.1124031007751938,0.5835230106710474,1.0,4/15,11.92%,ATP1A2;SLC30A1;ADRA2A;NOS1
prerank,negative regulation of defense response to virus (GO:0050687),0.6569134768530345,1.3536841958331616,0.12086330935251799,0.829185303208221,1.0,5/10,20.73%,TARBP2;ITCH;C1QBP;ILRUN;TSPAN6
prerank,membrane repolarization (GO:0086009),-0.49034648683372867,-1.3528773555315123,0.12121212121212122,0.5815479706383492,1.0,3/15,2.68%,ATP1A2;ATP1B3;KCND3
prerank,embryonic organ morphogenesis (GO:0048562),0.5280285205389587,1.3527753239322327,0.08240534521158129,0.8319164862952961,1.0,13/42,18.94%,MFAP5;FBN1;HOXA3;ACVR1;HOXA4;ALDH1A3;SIX1;PDGFRA;HOXC4;HOXA9;EFEMP1;DYNC2I1;NIPBL
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.4525823319641257,-1.3526353605282067,0.107981220657277,0.5779399161529883,1.0,4/18,7.77%,EPHA4;SP1;ABCG1;CASP3
prerank,receptor signaling pathway via STAT (GO:0097696),0.5743037066916095,1.3525031095665985,0.11887254901960784,0.8311348079794628,1.0,10/25,19.87%,GHR;PKD1;CLCF1;SOCS2;PKD2;STAT5A;SOCS6;STAT5B;THPO;IL31RA
prerank,negative regulation of cation channel activity (GO:2001258),0.5552925550928229,1.3523787137289187,0.1162227602905569,0.8294349839048248,1.0,6/26,12.62%,EPHB2;SRI;PKD2;CRHR1;GSTM2;CALM2
prerank,response to organophosphorus (GO:0046683),0.5985007122261374,1.3517452072948144,0.12032085561497326,0.8304548545316268,1.0,2/16,2.74%,DUOX1;DGKQ
prerank,RNA transport (GO:0050658),0.49625949144221526,1.3516873640839293,0.06533192834562697,0.8283786766963611,1.0,24/71,19.21%,SRSF2;HNRNPA1;SRSF6;NXF1;TGFBR2;RFTN1;ZFP36L1;RTRAF;U2AF1;SRSF3;ATXN2;SIDT2;SRSF11;THOC7;ZFP36;POLDIP3;THOC2;THOC1;ZC3H11A;DDX39A;CKAP5;SRRM1;SLBP;U2AF2
prerank,nucleosome organization (GO:0034728),0.5039202325856623,1.3516339484821551,0.07799145299145299,0.8263419649573925,1.0,25/55,22.50%,CHAF1B;SMARCD2;MCM3AP;SMARCD1;SPTY2D1;POLE3;NPM1;SMARCC2;SETD2;ANP32B;DMAP1;INO80;SMARCA4;SRCAP;GRWD1;NAP1L2;SET;CTCF;PRDM9;ZNHIT1;PAF1;BRD2;KAT6B;VPS72;NAP1L3
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.4734652223887351,-1.3506831437341742,0.12083333333333333,0.5750855215709938,1.0,4/16,3.43%,PHLDB2;ARHGAP6;THBS1;APOD
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.4734652223887351,-1.3506831437341742,0.12083333333333333,0.5750855215709938,1.0,4/16,3.43%,PHLDB2;ARHGAP6;THBS1;APOD
prerank,acylglycerol catabolic process (GO:0046464),0.5538288116497728,1.3501409889501352,0.10093896713615023,0.83167192532557,1.0,6/30,18.64%,MGLL;FABP12;DAGLA;FABP5;LIPC;LIPH
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.6193383055213558,1.3498587635622241,0.10182767624020887,0.8308767466888723,1.0,5/15,13.71%,SIX4;VEGFA;SOX8;GDNF;SIX1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.5427658588587797,1.348950750585823,0.10381861575178998,0.8334345629389888,1.0,6/31,7.33%,SYT2;STX1A;SYT12;SYT11;SYT13;SCAMP5
prerank,skeletal muscle organ development (GO:0060538),0.5604029877793183,1.3486263538242582,0.11547619047619048,0.8327809870885863,1.0,7/26,13.71%,WT1;DISP1;SIX4;SVIL;MYH14;LARGE1;SIX1
prerank,negative regulation of T cell proliferation (GO:0042130),0.5501085121280039,1.3484255126719675,0.10771113831089352,0.8315370792990595,1.0,5/28,11.78%,CD80;GLMN;RC3H1;CEBPB;GPNMB
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.5577176087100193,1.3483872333346152,0.10463733650416171,0.8293980446481055,1.0,12/29,17.05%,COPA;RAB6A;RAB6B;COPB1;COPB2;NAPA;GOSR1;COG6;RAB33B;NSF;COPZ2;NAPG
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6101473551776354,1.3481673040330533,0.12548512289780078,0.8282328556281819,1.0,6/17,17.74%,CD55;JAG1;TLR4;BACH2;BTN3A3;IL18
prerank,membrane raft organization (GO:0031579),0.614330500052268,1.347172642277918,0.12583668005354753,0.8313703663148724,1.0,6/15,16.98%,ANXA2;S100A10;RFTN1;MYADM;FA2H;FLOT2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.5665143973868167,1.3461537173213503,0.11644657863145258,0.8343503317492067,1.0,13/26,26.46%,CUL3;HECW2;CDC23;ANAPC5;FBXO5;CDC27;CDK5RAP2;ANAPC4;CENPE;RIOK2;ANAPC15;NSMCE2;DUSP1
prerank,amino acid import across plasma membrane (GO:0089718),-0.42557623779044956,-1.345672469499267,0.07947019867549669,0.5848513910920425,1.0,8/24,6.69%,SLC7A2;SLC6A13;SLC1A3;SLC16A2;SLC7A5;SLC22A4;SLC6A9;SLC3A2
prerank,calcium-ion regulated exocytosis (GO:0017156),0.561620335282294,1.3456030394363745,0.0988095238095238,0.8350244225831928,1.0,10/27,21.37%,SCIN;SYT2;SYT12;SYT11;SYT13;SYT1;VAMP2;RIMS2;PPP3CB;ARHGAP17
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4921998648073442,1.3454012898151035,0.050156739811912224,0.8337922550887753,1.0,22/79,17.19%,DCTN1;SEC24D;DYNC1LI2;ACTR1B;KLC1;SEC31A;AP1M1;SEC24A;AP2A2;CLTC;SEC23A;DYNC1LI1;DYNC1I1;KIF2A;ARF1;AP1S2;KIF3A;KIF3B;DYNC1H1;MFSD6;SEC24B;CTSD
prerank,negative regulation of interleukin-6 production (GO:0032715),0.5630787609258606,1.3453509597146962,0.10850801479654747,0.8317625310838413,1.0,8/27,15.83%,IRAK3;SYT11;GAS6;TLR4;SIRPA;CD200R1;ZC3H12A;SELENOS
prerank,regulation of cartilage development (GO:0061035),0.5922857369576026,1.3450793563703365,0.13248407643312102,0.830839234226555,1.0,3/18,1.35%,TRPS1;SCIN;BMP1
prerank,lipoprotein transport (GO:0042953),0.6570713012562011,1.3442448230651256,0.13402061855670103,0.8329666074267672,1.0,2/10,5.30%,LRP1;MIA3
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.6066850021008408,1.3441686398838892,0.12827225130890052,0.8310988947277831,1.0,4/15,12.63%,ANXA1;ZFP36L1;ZFP36L2;ZFP36
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.49517653497533115,-1.3441138832165893,0.14049586776859505,0.5851426962143668,1.0,10/14,38.74%,WDR48;ARID2;MRNIP;FANCB;TIMELESS;WRAP53;RAD51AP1;ERCC6;WAS;PARP1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.5150560040591147,1.3440134735219165,0.08661417322834646,0.8296695454628598,1.0,12/49,17.74%,GHR;LIF;CTF1;VEGFA;CLCF1;TNFRSF18;PARP14;PIBF1;FLT3;IL4;IL6;IL18
prerank,membrane assembly (GO:0071709),0.5325081980074791,1.3439271526515209,0.11662817551963048,0.8278762974378822,1.0,8/34,9.18%,CEL;STX2;ANXA2;S100A10;RFTN1;CHMP7;TLCD2;STX4
prerank,sulfur compound transport (GO:0072348),-0.3981513241356517,-1.3435803376368052,0.08982035928143713,0.5825082837893836,1.0,9/27,12.50%,SLC6A13;SLC13A4;ABCG2;SLC26A7;SLC25A26;SLC35F3;SLC25A11;MGST1;SLC6A6
prerank,regulation of lipase activity (GO:0060191),0.629442116574462,1.3433245735638102,0.1408839779005525,0.8287320765312773,1.0,5/13,18.77%,PCSK6;PCSK5;RHOA;LIPC;ANGPTL3
prerank,cytoplasmic microtubule organization (GO:0031122),0.5043353443046115,1.3432288965513903,0.08807134894091416,0.827011354253543,1.0,27/54,26.59%,DCTN1;CCDC88C;HOOK2;CLIP1;DST;VPS4B;FSD1;SLK;CLIP2;CLIP4;CAMSAP1;MAPT;SLAIN2;CRIPT;RHOA;WDR73;CHP1;DYNC1H1;CLIP3;NUMA1;TUBGCP5;PCM1;CCDC88A;KATNA1;CEP126;CCDC88B;KPNB1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.6357505952255695,1.342593116420231,0.12301587301587301,0.8279929677977023,1.0,5/12,13.71%,SIX4;VEGFA;SOX8;GDNF;SIX1
prerank,response to UV-A (GO:0070141),0.6318105654734747,1.342541236999524,0.12774193548387097,0.8260409774631994,1.0,4/14,13.39%,EGFR;MMP2;AKT1;CCND1
prerank,response to peptide hormone (GO:0043434),0.5230105323375572,1.3415915681173542,0.08361204013377926,0.8288507527672468,1.0,12/43,16.39%,IGFBP5;ANXA1;IRS1;ZFP36L1;MEAK7;SRC;STAT5A;EPM2AIP1;AKT1;EIF6;OGT;STAT5B
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.6384645033711707,1.3401685534132022,0.10554803788903924,0.8340887191044944,1.0,4/12,16.56%,GCLC;HAGH;CNDP2;BDH2
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6257480191769617,1.339681747245629,0.14630872483221477,0.8322138701786377,1.0,7/12,24.32%,EFNA5;MELTF;KANK1;RCC2;CORO1C;FBLN1;DMTN
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6257480191769617,1.339681747245629,0.14630872483221477,0.8322138701786377,1.0,7/12,24.32%,EFNA5;MELTF;KANK1;RCC2;CORO1C;FBLN1;DMTN
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5464764465372162,1.3390224374539765,0.12071005917159763,0.8337115393683174,1.0,6/30,8.98%,COL3A1;AKAP13;F2R;LPAR1;ARHGEF3;GPR20
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.4402388783832937,-1.338918795321267,0.10714285714285714,0.5914532202512031,1.0,3/21,3.34%,OSBPL10;PLA1A;OSBPL8
prerank,protein polymerization (GO:0051258),0.5017437788672138,1.3387381664651505,0.09344790547798067,0.8329866519263063,1.0,17/56,17.82%,GSN;PSTPIP1;ANG;DIAPH3;FGF13;COBL;MSRB1;WASF1;MAPT;TPPP3;PIN1;CASQ1;DIAPH1;WASHC3;CORO7;MAP7D3;CKAP5
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6426762967170184,1.3387275532892677,0.13073713490959665,0.8308323082933097,1.0,4/11,16.31%,HPN;MST1R;SIRT2;HGF
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.6082569439125977,1.338715766093473,0.12516644474034622,0.8287071721817786,1.0,4/15,6.33%,TRIAP1;CD44;MIF;MUC1
prerank,eye development (GO:0001654),0.5081163416867662,1.3386137233800388,0.07692307692307693,0.8270565628822816,1.0,9/54,5.70%,COL5A2;FBN1;COL5A1;WT1;ZDHHC16;TGFB2;PBX1;SKI;MEIS2
prerank,sulfur compound biosynthetic process (GO:0044272),0.48610239940891437,1.3385792589064716,0.048254620123203286,0.8250667071796982,1.0,28/104,18.15%,DCN;GCLC;ST3GAL2;UGDH;B4GALT3;PAPSS2;B4GALT1;OGN;CHST1;CSGALNACT2;ACAN;VCAN;CHST12;CHST14;CHSY3;HAGH;CNDP2;GSTM2;ST3GAL4;MAT2A;MAT2B;GLCE;GGT7;SLC26A1;MPST;GSTO2;ST3GAL1;ST3GAL3
prerank,regulation of RNA metabolic process (GO:0051252),0.5037573404221057,1.3385275420764344,0.08205689277899343,0.8231530925897588,1.0,19/59,21.97%,AHNAK2;AHNAK;AFF2;MBNL1;USP36;CLK1;RC3H1;MBNL2;SON;HNRNPH1;MITF;IGF2BP1;TNFRSF1B;YTHDF2;NOVA1;PTBP1;RASA1;RC3H2;PTBP2
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4588260003148172,-1.3384869465831464,0.14,0.5885689253159019,1.0,4/16,14.37%,SNCAIP;MEF2C;MCTP1;KCNMB4
prerank,odontogenesis (GO:0042476),0.5267275632518393,1.3384214074653038,0.11316397228637413,0.8214944769509618,1.0,5/35,7.49%,COL1A2;LRP6;TGFB3;TGFB2;GLI2
prerank,response to ketone (GO:1901654),0.5700806942198167,1.3382629477942298,0.12591687041564792,0.820184615927826,1.0,5/24,3.64%,TGFB3;TGFB2;SLIT3;SLIT2;CATSPERB
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.5226360258267287,-1.3380932841805981,0.13309352517985612,0.5855449946328803,1.0,6/10,13.63%,EPHA4;DAB2IP;NELL1;ATRAID;RGP1;RIC1
prerank,polyamine metabolic process (GO:0006595),0.6193433667785001,1.3372008776461275,0.11843876177658143,0.823701507614891,1.0,6/13,22.17%,SRM;HDAC6;ODC1;SMS;SAT1;AMD1
prerank,import into cell (GO:0098657),-0.36506351500889705,-1.337063722421981,0.059322033898305086,0.5842304736105762,1.0,9/41,4.70%,ATP1A2;SLC6A13;SLC1A3;SLC16A2;SLC12A7;GLUL;SLC5A3;SLC7A5;SLC22A4
prerank,intracellular lipid transport (GO:0032365),-0.4390096496635287,-1.3366118060882852,0.11666666666666667,0.5815678201094893,1.0,6/21,11.31%,PRKAG2;PLEKHA8;CERT1;PRKAA2;SLC25A20;ACACB
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.6109126115965191,1.3364407267933665,0.13689700130378096,0.8254356319373295,1.0,3/16,5.30%,SEC16B;ANK2;MIA3
prerank,negative regulation of immune effector process (GO:0002698),0.6257681678458537,1.3360557724047673,0.14150943396226415,0.8252732699699664,1.0,4/13,14.21%,CD55;RC3H1;CD47;FER
prerank,engulfment of apoptotic cell (GO:0043652),-0.4659956994931701,-1.3353238845151103,0.1198501872659176,0.5810823809984803,1.0,5/15,16.68%,RHOBTB1;THBS1;XKR6;RHOH;MEGF10
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.4219202824972528,-1.3349830447549624,0.1016949152542373,0.5782789895263901,1.0,9/23,16.37%,EFNB2;IGF1;MEF2C;NIBAN2;TGFB1;AKAP6;EDN1;MYOCD;MAML1
prerank,protein import (GO:0017038),0.48514296990403455,1.3349692785267484,0.055323590814196244,0.828732502274013,1.0,39/84,27.68%,SYK;PXMP2;PEX16;SPRN;NUP93;GDAP1;ALDH3A2;NUP107;PXMP4;AKT1;IPO9;TNPO2;PEX12;HSP90AA1;SLC25A17;E2F3;PEX3;IPO5;PEX5;NUP50;NXT2;ATAD1;ABCD3;PEX2;RANBP6;TPR;IPO11;FIS1;IPO13;TSC2;NUP133;NUP85;TNPO1;FAM53C;NUP188;KPNB1;SNX33;NUP88;RAB8B
prerank,chemokine-mediated signaling pathway (GO:0070098),0.5170738636548483,1.3344412827152508,0.09364548494983277,0.8294305669059505,1.0,6/42,12.90%,ACKR3;CCL8;CXCL10;CCL25;STK39;CCL13
prerank,response to interleukin-1 (GO:0070555),0.4903914427822377,1.3340542241080575,0.08898305084745763,0.8292641952193021,1.0,17/73,14.08%,HAS2;CCL8;PRKCA;ANXA1;IRAK3;USP10;NR1D1;SRC;RC3H1;CCL25;MAPK11;CD47;SIRPA;IRAK1;CCL13;HDAC4;ZC3H12A
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.659723867374622,1.334024253368088,0.13564213564213565,0.8273120457704175,1.0,4/10,7.85%,GRB10;ITGB3;ITGA5;PRKD2
prerank,regulation of intracellular pH (GO:0051453),0.5235365602222177,1.3339969792484183,0.1096045197740113,0.8253476166247923,1.0,12/34,16.48%,SLC4A10;SLC4A8;SLC4A3;SLC9A9;VPS33A;SLC4A4;SLC26A6;SLC9A1;CHP1;SLC9A7;SLC9A6;TMEM165
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.48822703962340697,1.3338651990424406,0.06616862326574173,0.8239003293252705,1.0,10/73,9.07%,SYK;LBP;EPHB2;MIF;TMEM106A;PTPRJ;IL33;PSEN1;TIRAP;TLR4
prerank,long-term synaptic potentiation (GO:0060291),0.5720397076120761,1.3334970990180433,0.13871374527112232,0.8236612357283943,1.0,8/21,18.56%,NPTN;NFATC4;MPP2;GRIN2D;STX4;SLC8A2;GRIN2A;VAMP2
prerank,snRNA metabolic process (GO:0016073),0.586820513031577,1.3329937958647515,0.14545454545454545,0.8240161423717565,1.0,7/17,18.59%,INTS3;MEPCE;INTS10;INTS6;ZCCHC8;INTS2;INTS12
prerank,activation of phospholipase C activity (GO:0007202),0.5453221834180975,1.3327513438980891,0.12514484356894554,0.8231891054263154,1.0,4/29,3.92%,AVPR1A;EGFR;ANG;LPAR1
prerank,cellular response to pH (GO:0071467),0.5888228970331104,1.3321696791179407,0.15335051546391754,0.8241917226497464,1.0,6/17,20.32%,RAB11FIP5;SLC9A1;GPR68;CHP1;GPLD1;ASIC1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6447346331947233,1.33177418123038,0.13728323699421965,0.8241463556435676,1.0,4/11,5.77%,SMAD4;LMNA;ATP2B4;FOXO1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.6371674980806379,1.3310457526944743,0.13692946058091288,0.8258957606364287,1.0,3/12,7.35%,PARP3;PARP11;PARP6
prerank,atrial septum morphogenesis (GO:0060413),0.6567501029850877,1.3304623537458709,0.1267605633802817,0.8267849476658136,1.0,2/10,4.40%,TGFB2;ACVR1
prerank,catecholamine metabolic process (GO:0006584),-0.48583410280467265,-1.3303955014557616,0.1444866920152091,0.5869375914858946,1.0,3/14,11.47%,SNCAIP;DDC;RNF180
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5003604452958094,1.3296891365358567,0.09436008676789588,0.8285456284460744,1.0,14/55,16.73%,DCN;GPC6;GPC3;CD44;OGN;FGF2;ACAN;VCAN;SLC9A1;HSPG2;CHP1;NAGLU;IDUA;SDC2
prerank,endodermal cell differentiation (GO:0035987),0.5473380877697684,1.329637550316531,0.10613207547169812,0.8267664899325419,1.0,9/31,11.81%,COL8A1;COL11A1;MMP2;ITGA5;ITGB5;COL12A1;COL6A1;ITGAV;SETD2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.5285770017159763,1.3294644243461355,0.10250569476082004,0.8256708542335484,1.0,7/40,3.92%,AVPR1A;ESR1;EGFR;FGFR1;ANG;FGF2;LPAR1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.48665014647282245,1.3294203961410493,0.05747126436781609,0.8218280970570775,1.0,21/78,17.19%,DCTN1;SEC24D;DYNC1LI2;ACTR1B;KLC1;SEC31A;AP1M1;SEC24A;AP2A2;CLTC;SEC23A;DYNC1LI1;DYNC1I1;KIF2A;ARF1;AP1S2;KIF3A;KIF3B;DYNC1H1;SEC24B;CTSD
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.48665014647282245,1.3294203961410493,0.05747126436781609,0.8218280970570775,1.0,21/78,17.19%,DCTN1;SEC24D;DYNC1LI2;ACTR1B;KLC1;SEC31A;AP1M1;SEC24A;AP2A2;CLTC;SEC23A;DYNC1LI1;DYNC1I1;KIF2A;ARF1;AP1S2;KIF3A;KIF3B;DYNC1H1;SEC24B;CTSD
prerank,JNK cascade (GO:0007254),-0.36439187121307814,-1.328654939145236,0.06956521739130435,0.5879060908302783,1.0,21/40,26.54%,MAP4K3;TNFRSF19;CRKL;IRAK2;MAP3K13;IKBKG;MAPK8;MAPK10;NOD1;MAPK9;TAB1;UBE2V1;MAP3K5;MINK1;MAP2K7;MAP3K10;NOD2;TAB3;RIPK2;ARHGEF6;SH2D3C
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5721385882991513,1.3285656062213476,0.14412136536030343,0.8242013818139836,1.0,4/19,5.35%,MYOC;VEGFA;S100A10;PTPRJ
prerank,regulation of vesicle-mediated transport (GO:0060627),0.4798907996412684,1.3285224637121467,0.059375,0.8224214089803973,1.0,34/91,24.55%,SYK;STON2;BET1L;CD177;GAS1;ATP9A;RINT1;SRC;RIT2;ABL2;INPP5F;ARFGAP1;STX4;SCFD1;ITGAV;RAB3D;RUFY1;USP7;MAP2K2;RAB33B;NSF;SYT1;RAB5B;RAB5C;VAMP2;RIMS2;RALA;RAB10;MAPK1;PACSIN2;PACSIN3;STXBP5L;RAB12;TSC2
prerank,regulation of tissue remodeling (GO:0034103),0.57622698893457,1.3279030690844273,0.1421383647798742,0.823451115309143,1.0,4/18,11.78%,DDR2;RUNX1;THBS4;GPNMB
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.5052634650982345,-1.327145151743215,0.14726027397260275,0.5878746489193514,1.0,3/11,12.87%,ENPP3;CTPS2;SLC19A3
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.4896491944606338,1.3269573598268414,0.07173447537473233,0.8262904541064163,1.0,18/67,14.82%,GHR;SYK;DDR2;EPHB2;SRMS;EGFR;FGFR1;EPHA3;FYN;SRC;ABL2;ABI1;PIBF1;FLT3;PDGFRA;FER;DDR1;IL4
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.38405756287075055,-1.3268721624623927,0.0847457627118644,0.584789994606381,1.0,13/35,25.09%,CDH5;ATP2C1;CDH6;CDH7;CDH13;PCDHB14;PCDHGC3;CDH11;DCHS1;CDH19;CDH24;CDH20;PCDHGB4
prerank,cellular response to fluid shear stress (GO:0071498),0.642984618901269,1.3261823044726668,0.14204545454545456,0.8284740135413433,1.0,7/12,14.32%,HAS2;MAPK7;NFE2L2;KLF2;PKD2;HDAC3;KLF4
prerank,pyroptosis (GO:0070269),-0.4798873150298136,-1.3259981950264823,0.13076923076923078,0.5834744385843162,1.0,7/15,30.71%,CASP4;AIM2;GSDMD;ZBP1;CASP1;TREM2;NLRC4
prerank,regulation of receptor internalization (GO:0002090),0.5350067290704305,1.3256205367483926,0.12064965197215777,0.8292931769657556,1.0,15/35,24.50%,SFRP4;VEGFA;DLG4;ATXN2;ARF1;MAGI2;EGF;AHI1;ATAD1;MKLN1;ARRB1;SDCBP;FLOT1;PICK1;RSPO1
prerank,monosaccharide transmembrane transport (GO:0015749),0.5996733548201303,1.325430059296768,0.14720812182741116,0.8283092483146478,1.0,5/16,13.02%,SLC5A9;SLC50A1;SLC2A10;SLC23A1;SLC23A2
prerank,negative regulation of response to stimulus (GO:0048585),0.494834699582815,1.324797605580903,0.08648648648648649,0.8293615008793708,1.0,6/60,4.40%,CD34;COL3A1;SRMS;MAPK7;SLIT2;ACVR1
prerank,lipoprotein localization (GO:0044872),0.6344801396674636,1.3242515784833595,0.15482954545454544,0.8302146774648005,1.0,2/11,5.30%,LRP1;MIA3
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.37747971438974015,-1.3240541116271356,0.07751937984496124,0.5847315982356709,1.0,9/33,4.17%,NR2F2;PTPRG;SP100;ADAMTS9;APOE;THBS1;DAB2IP;DUSP10;PTPRM
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5352563680799496,1.323851183346986,0.11516533637400228,0.8303152478249018,1.0,5/36,7.10%,AREG;EPHB2;BTC;NCOA3;HDAC6
prerank,T cell activation involved in immune response (GO:0002286),-0.494913191459159,-1.32338228348138,0.16967509025270758,0.5827167161981353,1.0,6/12,31.71%,MDK;ICAM1;CD74;LCP1;SLC11A1;LILRB1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5959383934741338,1.3230293687853778,0.12810457516339868,0.832615918794012,1.0,13/17,31.45%,SYVN1;HERPUD1;SELENOS;AUP1;DERL1;SEL1L;SEC61B;HSP90B1;UFD1;NPLOC4;HM13;TMEM129;DERL2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5083263800930979,1.3221574356446524,0.10201793721973094,0.8350564228849052,1.0,15/49,18.04%,LDLRAD4;PMEPA1;DACT1;AIDA;JAM3;SRC;HDAC6;TFIP11;SMAD6;ULK1;NOP53;NLRP2B;ANKRD27;PEX5;IAPP
prerank,regulation of catecholamine secretion (GO:0050433),0.5390098960641941,1.3211764777088606,0.11913357400722022,0.8382006418574889,1.0,7/29,10.51%,SYT2;STX1A;SYT12;SYT11;SYT13;DTNBP1;KCNA2
prerank,protein targeting to peroxisome (GO:0006625),0.5383143255406406,1.3211364672841084,0.12033694344163658,0.8363943117622668,1.0,13/29,21.44%,PXMP2;PEX16;GDAP1;ALDH3A2;PXMP4;PEX12;PEX1;SLC25A17;PEX3;PEX5;ATAD1;ABCD3;PEX2
prerank,response to molecule of bacterial origin (GO:0002237),0.48739672150340735,1.3207743718622575,0.09148936170212765,0.8362117340986069,1.0,18/69,16.30%,LBP;IRAK3;FOXP1;F2R;S100A8;S100A9;CYP27B1;TIRAP;SIRT2;TLR4;SMAD6;C4B;SLPI;IRAK1;FER;GGT7;CD14;IL6
prerank,long-chain fatty acid transport (GO:0015909),-0.3895700748983508,-1.3194016947821343,0.11515151515151516,0.589197389897821,1.0,7/30,11.31%,PRKAG2;ACSL1;APOE;PRKAA2;ACSL3;SLC25A20;ACACB
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.5155927325776706,1.3193214488602718,0.13211845102505695,0.8417651186759584,1.0,16/41,22.29%,MGLL;DAGLA;SCP2;PTGR1;GPX1;GSTM2;PNPLA8;ELOVL5;FADS1;DAGLB;ACOX1;EPHX1;FADS3;SCD5;HSD17B4;CYP1B1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.642222177861839,1.3188380199125431,0.14326647564469913,0.8422494950894972,1.0,3/10,13.75%,CNGB1;SAG;GNB1
prerank,signal peptide processing (GO:0006465),0.6486693746778364,1.3187627310237848,0.17086834733893558,0.840587924267689,1.0,3/11,9.03%,PCSK5;SPCS1;SEC11C
prerank,macrophage activation (GO:0042116),0.5250814547063295,1.3185902167555825,0.10907003444316878,0.8394933631466414,1.0,6/34,11.37%,SYK;LBP;FOXP1;TMEM106A;TLR4;MAPT
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.47917734622210856,1.3183806006608487,0.07845188284518828,0.8385428410195693,1.0,46/80,32.02%,SGSM2;DCTN1;RAB7B;BET1L;RAB6A;STX5;HEATR5A;RAB6B;VPS52;CLTC;SNX1;SURF4;MAGEL2;LMAN1;TBC1D17;GGA1;TBC1D10A;TBC1D23;GOSR1;ARFRP1;TMEM87A;EVI5;PHETA2;PREPL;SNX6;DENND2A;STX16;ANKFY1;VTI1A;BAIAP3;RAB29;RNF126;GOSR2;GBF1;RBSN;VAMP3;YKT6;RHOBTB3;TBC1D5;SPAG9;RAB9B;PIKFYVE;TRAPPC10;TMEM87B;SNX5;ARL1
prerank,blood vessel morphogenesis (GO:0048514),0.4944782023692948,1.3182985824239655,0.09466811751904244,0.8369584176845521,1.0,8/54,3.19%,SYK;HAS2;CCBE1;WT1;GLMN;VEGFA;TNNI3;TGFBR2
prerank,positive regulation of behavior (GO:0048520),-0.5424769090703332,-1.3180668798351691,0.16785714285714284,0.5891304748689628,1.0,5/10,21.72%,MEF2C;STRA6;SGIP1;CFAP20;NR4A3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.552279161601864,1.3179745930494444,0.14547677261613692,0.8366324577201747,1.0,15/24,29.97%,MAPK7;VEGFA;NFE2L2;KLF2;CREB3L1;MUC1;CEBPB;ATF6;SESN2;ATF4;CHD6;DDIT3;RBPJ;TP53;HSF1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.46934176769014646,1.317936779138372,0.0607621009268795,0.8348722003611302,1.0,36/104,23.82%,ASPN;HTRA3;LDLRAD4;SKIL;TGFBR2;PMEPA1;SMAD4;SMURF2;SKI;ACVR1;IGSF1;SMAD5;STUB1;SMAD6;PEG10;SLC2A10;MAGI2;VASN;UBA52;PIN1;SNX6;HTRA4;TGFBR1;STRAP;NBL1;UBE2D3;BMPER;PPM1A;ACVR2A;BMPR1A;SMURF1;CILP;CD109;FKBP1A;SKOR2;CCN3
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.6123488677184827,1.3177510751576755,0.14285714285714285,0.833808170817612,1.0,3/14,17.74%,CD80;PAEP;IL18
prerank,establishment of spindle orientation (GO:0051294),0.5443309468977572,1.3169070236390548,0.13701923076923078,0.8361205325263622,1.0,5/28,4.97%,GPSM2;DCTN1;LLGL1;NDEL1;ZW10
prerank,miRNA mediated inhibition of translation (GO:0035278),0.6421265599853089,1.316656939295859,0.1491108071135431,0.8335354813724234,1.0,9/11,27.66%,RBM4;TRIM71;AGO2;EIF6;ZFP36;AGO4;AGO3;TNRC6A;AGO1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.6421265599853089,1.316656939295859,0.1491108071135431,0.8335354813724234,1.0,9/11,27.66%,RBM4;TRIM71;AGO2;EIF6;ZFP36;AGO4;AGO3;TNRC6A;AGO1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.5390351349692728,1.3163919396447201,0.13365155131264916,0.83297158583626,1.0,12/28,20.64%,DCTN1;CLIP1;PSRC1;TOGARAM1;MAPRE1;MAPT;SLAIN2;CDK5RAP2;AKAP9;CKAP5;NAV3;NUMA1
prerank,positive regulation of cell cycle (GO:0045787),0.4895968156783999,1.3163519471049252,0.10649627263045794,0.8312752428630084,1.0,17/62,17.07%,LRP6;PRKCA;EGFR;TGFB2;SMOC2;PKD1;CDK4;PSRC1;MEIS2;MAPRE3;PKD2;AKT1;NUDT16;CCND1;NUPR1;USP22;TTL
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5078453181265477,1.3162336281009992,0.11469933184855234,0.8299426535411855,1.0,13/45,16.67%,AREG;EGFR;PLCE1;BTC;SRC;PIK3CA;IQGAP1;AKT1;EGF;AAMP;CBL;SOS1;EFEMP1
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.47311396149295615,1.3157178349047223,0.06101344364012409,0.8306560999497291,1.0,21/95,16.30%,LBP;CD80;AXL;ADAM9;MAPK14;NR1D1;CXCL10;CARD16;TIRAP;SIRT2;TLR4;SIRPA;IRAK1;ZFP36;RHOA;TNFRSF1B;ZC3H12A;CD14;SELENOS;PDCD4;IL6
prerank,protein hydroxylation (GO:0018126),0.5950579181881724,1.3153564423354351,0.14947089947089948,0.8306221602953101,1.0,7/15,22.69%,PLOD2;PLOD3;P3H1;VPS33B;PLOD1;OGFOD1;JMJD7
prerank,positive regulation of DNA recombination (GO:0045911),-0.4053183829540445,-1.3149511664512108,0.09554140127388536,0.5937581595415702,1.0,11/27,19.43%,WDR48;KMT5B;SHLD1;KMT5C;ARID2;MRNIP;TFRC;RIF1;FANCB;TIMELESS;MAD2L2
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.654485576507361,1.3148109995886688,0.15021459227467812,0.8314633858956704,1.0,4/10,13.72%,DPP4;FAP;CHADL;TNFRSF1B
prerank,phospholipid translocation (GO:0045332),0.5410463248200486,1.314756863494778,0.14424242424242426,0.8298426576967786,1.0,8/28,12.70%,ATP8B1;PLSCR4;ATP9A;ABCA1;ATP11A;ATP9B;TMEM30A;ABCC1
prerank,long-chain fatty acid import into cell (GO:0044539),-0.5097274646693003,-1.31448790729849,0.1644295302013423,0.5913844492695053,1.0,3/10,5.96%,ACSL1;SLC2A1;ACSL3
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.6422877155503313,1.3144857439587068,0.1440329218106996,0.829483052789939,1.0,3/11,8.92%,TGFB2;ZFPM2;JAG1
prerank,visual perception (GO:0007601),0.4797016407367093,1.3144706380761146,0.07747933884297521,0.8276854008127383,1.0,20/84,20.29%,COL1A1;SLC4A10;ROM1;RABGGTA;COL11A1;ABLIM1;MYO9A;CNGB1;COL2A1;CRYBB1;RPGR;CABP1;CRYZ;OPA3;EFEMP1;TYR;RP2;SFRP5;KIFC3;ATF6
prerank,receptor metabolic process (GO:0043112),0.49571927775774766,1.3138314630650898,0.1005586592178771,0.8289811115936413,1.0,9/53,8.08%,ACKR3;SYK;CD9;LRP1;DNM1;MVB12A;CLTC;SNX1;CD81
prerank,negative chemotaxis (GO:0050919),0.528850676199505,1.3135637102390587,0.12485549132947976,0.8284401739969831,1.0,10/33,13.49%,SEMA3C;ITGB3;SLIT3;SLIT2;SLIT1;NTN1;SEMA3A;ITGAV;SEMA3D;RHOA
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.476499430420512,-1.313296716559041,0.15079365079365079,0.5908915292070644,1.0,7/14,17.69%,RAPGEF2;PKIG;PRKAR1B;SIRT1;HTT;PRKAR2B;ADRB2
prerank,female gamete generation (GO:0007292),-0.3955120536712616,-1.3132655325507414,0.09774436090225563,0.5873373298809076,1.0,4/29,3.89%,PTN;MCM9;DIAPH2;TOB2
prerank,import into nucleus (GO:0051170),0.4857177820111308,1.313216138926128,0.07650862068965517,0.8282744185347353,1.0,31/73,27.02%,SYK;GEMIN6;HNRNPA1;SPRN;NUP93;NUP107;AKT1;BACH2;IPO9;TNPO2;DDX20;E2F3;SNRPG;SNRPD3;IPO5;NUP50;NXT2;RANBP6;TPR;HTATIP2;SMN1;IPO11;IPO13;TSC2;NUP133;NUP85;TNPO1;FAM53C;NUP188;KPNB1;NUP88
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.5221209276214379,1.3127732237209506,0.1145124716553288,0.8286574919132829,1.0,9/39,7.85%,LRP6;WT1;VEGFA;FGF2;SLIT2;TGFBR2;PKD1;GLI2;PKD2
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.536227786857989,-1.3126879663896163,0.17525773195876287,0.5852258426010403,1.0,2/11,1.20%,NEDD4L;ACTN2
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5863282261249451,1.3126143879446999,0.15567282321899736,0.8275631989661439,1.0,3/17,3.71%,PCSK6;PCSK5;HDAC9
prerank,nuclear membrane organization (GO:0071763),0.5720602100221764,1.3123190151802955,0.15063291139240506,0.8271709963022039,1.0,5/19,9.04%,DCTN1;TMEM43;CHMP7;TARDBP;TOR1A
prerank,cell projection assembly (GO:0030031),0.5593631959782781,1.31224765981295,0.1396508728179551,0.8256441646050826,1.0,4/22,10.05%,GSN;SCIN;RHOJ;RHOQ
prerank,response to estradiol (GO:0032355),0.5388883219618722,1.312167506370285,0.12366230677764566,0.8241758534619739,1.0,5/31,6.23%,ESR1;EGFR;ANXA1;SOCS2;NCOA3
prerank,epithelial cell morphogenesis (GO:0003382),0.5818861861699238,1.3121333742890802,0.15708812260536398,0.8225075739788219,1.0,4/17,8.29%,TNMD;CCDC88C;DACT2;COL15A1
prerank,alpha-amino acid metabolic process (GO:1901605),0.5032170810370795,1.3120730775295588,0.12292358803986711,0.8209840248527424,1.0,2/45,2.65%,NOX4;ALDH18A1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.4524710961191347,-1.3120366675128758,0.14224137931034483,0.5832981988112044,1.0,13/16,45.25%,TRIB2;TNFRSF21;JAK3;FCGR2B;DLL1;AGER;LILRB1;TYROBP;PDCD1LG2;IL23A;FOXP3;IL23R;IL12B
prerank,plasma membrane organization (GO:0007009),0.49072623310849783,1.3120052741444725,0.10857763300760044,0.8195078875635255,1.0,12/61,11.28%,AHNAK2;COL5A1;STX2;ANK2;PLSCR4;BIN1;SYT11;TLCD2;OSBPL2;STX4;EHD2;FA2H
prerank,regulation of platelet activation (GO:0010543),0.5642642314614249,1.311376451611199,0.13720642768850433,0.8205615985260819,1.0,3/21,1.26%,SYK;C1QTNF1;PRKCA
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.48584720364804057,1.3112962027278476,0.09533898305084745,0.8191504400501739,1.0,27/69,25.51%,UBE2J2;SYVN1;EDEM1;RNF121;PSMC6;STUB1;ANKZF1;FBXO2;EDEM2;FBXO17;ECPAS;UBE2G2;HERPUD1;DNAJB2;TMUB2;SGTA;AMFR;SELENOS;AUP1;JKAMP;DERL1;SEL1L;USP19;RHBDD2;SEC61B;HSP90B1;UFD1
prerank,muscle tissue development (GO:0060537),-0.5089354994545291,-1.311177329872898,0.13494809688581316,0.5820713832036374,1.0,4/13,8.05%,PGM5;ENG;PTCH1;STRA6
prerank,calcium-mediated signaling (GO:0019722),0.47447713763609145,1.3109924820120333,0.07974816369359916,0.8188367483304267,1.0,21/93,17.66%,ACKR3;EGFR;EIF2AK3;PLCE1;ANK2;TNNI3;PTPRJ;RCAN3;STIMATE;MCU;ACKR4;RCAN1;PPP3CC;CAMKK2;SLC9A1;ATP2A2;PPP3CA;CXCR4;PPP1R9B;CXCR2;BCAP31
prerank,dendritic spine morphogenesis (GO:0060997),0.5970154061865872,1.3103165759543494,0.15074024226110364,0.8204453749414985,1.0,7/15,21.11%,EPHB2;DLG4;EPHB3;CTNND2;DIP2A;EPHB1;PTEN
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.47524154593797796,1.3102184334085005,0.07773109243697479,0.8192067963319912,1.0,13/79,7.26%,HTRA3;TNMD;SULF2;SKIL;FGF2;SLIT2;SMAD4;SMURF2;SKI;ATP2B4;CREB3L1;SMAD5;SULF1
prerank,regulation of defense response to virus (GO:0050688),0.5982656948196735,1.3099812890553337,0.15945945945945947,0.8186076174634694,1.0,5/14,16.05%,ITCH;C1QBP;RNF216;ILRUN;TRAF3
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.46527559133656227,-1.3098823370943093,0.12444444444444444,0.5821317329410063,1.0,5/15,9.07%,GGACT;GGT5;PRODH;ALDH4A1;SARDH
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5265856645098472,-1.3095895501113968,0.18439716312056736,0.5793501236102457,1.0,5/10,12.23%,BMP6;NOTCH1;RGCC;NOTCH4;PPM1F
prerank,phosphatidylserine metabolic process (GO:0006658),-0.3743545967701969,-1.3093770504353939,0.11805555555555555,0.5764532874365016,1.0,6/32,13.10%,OSBPL10;PLA1A;OSBPL8;PLSCR1;PLAAT3;PLA2G15
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6080434597530741,1.3090804786782602,0.1510204081632653,0.8213386492067211,1.0,2/12,5.24%,DCN;ATP2B4
prerank,intestinal lipid absorption (GO:0098856),0.6262493276343548,1.3088500495961983,0.17379310344827587,0.8205796323206049,1.0,1/11,1.78%,CEL
prerank,reticulophagy (GO:0061709),0.6258298494779271,1.308844522628004,0.16133518776077885,0.8188265817496574,1.0,7/12,18.62%,ATG2B;ULK2;ATG2A;ULK1;UFC1;UFL1;UFM1
prerank,epidermal cell differentiation (GO:0009913),0.5152690053352824,1.308724370099861,0.12026726057906459,0.8176677275864322,1.0,7/41,11.87%,LORICRIN;ANXA1;SCEL;ADAM9;KRT10;JAG1;ERCC3
prerank,positive regulation of DNA replication (GO:0045740),0.5830374513217881,1.308701150780946,0.13568521031207598,0.8160288562777668,1.0,5/16,13.51%,EGFR;CTC1;GLI2;EGF;DNA2
prerank,insulin secretion (GO:0030073),0.574001404086434,1.308224193291098,0.14824120603015076,0.8165686369186221,1.0,3/19,7.34%,RAB11FIP5;ANXA1;ADCYAP1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6382391840018785,1.3074445107361594,0.14425770308123248,0.8185757087060022,1.0,3/11,5.60%,SESTD1;BIN1;CAMK2D
prerank,protein localization to nucleus (GO:0034504),0.4669721327429815,1.3072748507226777,0.07267144319344933,0.8176246459965875,1.0,42/102,27.02%,SYK;COL1A1;SIX4;SPRN;LMNA;TOR1AIP2;TAF8;NUP93;NUP107;YWHAE;TOR1A;TAF3;AKT1;BCL3;IPO9;SIX1;TNPO2;BBS4;NOP53;E2F3;PML;IPO5;RPF2;TBRG1;NUP50;NXT2;PAF1;RANBP6;TPR;IPO11;IPO13;DVL1;TSC2;NUP133;MDM2;CALR;NUP85;TNPO1;FAM53C;NUP188;KPNB1;NUP88
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.5172157975090464,1.306935462217681,0.13205417607223477,0.8175606185977442,1.0,10/37,13.14%,PHLDB1;CDK2AP2;EFNA5;EPHA3;MAPRE3;BICD1;GAS2L1;MAPRE1;MAPT;MAP6
prerank,lysosome organization (GO:0007040),0.5181226598031171,1.3068959781850271,0.13073394495412843,0.8160407934762172,1.0,13/36,20.11%,HOOK2;ACP2;MTOR;ABCA1;TPP1;CLVS2;HPS4;VPS33A;GAA;SNAPIN;TMEM165;CLVS1;ACP3
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5248128928566345,1.3066304615468944,0.1283236994219653,0.8156006541950975,1.0,6/32,12.90%,ANG;S100A9;CXCL14;CXCL10;RNASE6;CCL13
prerank,axonal transport of mitochondrion (GO:0019896),0.6356261589808497,1.306092904740698,0.1466854724964739,0.8165710817442092,1.0,4/11,11.37%,NEFL;TRAK2;SYBU;MAPT
prerank,cell proliferation in forebrain (GO:0021846),0.6542672001275961,1.3060839678443006,0.1458625525946704,0.8148965469505782,1.0,3/10,5.71%,NUMBL;AKNA;DOCK7
prerank,selective autophagy (GO:0061912),0.48505493972469005,1.3060677917831045,0.10184182015167931,0.8132660068906067,1.0,20/56,18.78%,DYNC1LI2;HDAC6;UBE2N;ATG2B;ARL13B;DYNC1LI1;DYNC1I1;SQSTM1;UBA52;ULK2;ATG2A;ULK1;UFC1;DYNC1H1;NBR1;UFL1;PEX5;AUP1;UFM1;ATG13
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6228117537535085,1.3060641983005423,0.1634078212290503,0.8115645810762611,1.0,5/12,16.30%,ESR1;NCOR2;NCOR1;ZC3H12A;IL6
prerank,cellular response to virus (GO:0098586),0.5345249858388222,1.305957782331013,0.14849187935034802,0.8103747318548298,1.0,15/30,30.22%,MAPK14;CXCL10;CHUK;MAPK11;ARF1;ZC3H12A;HSP90AA1;VWCE;IL6;RRP1B;LGALS8;RIOK3;GBF1;BAX;LGALS9
prerank,positive regulation of leukocyte activation (GO:0002696),0.5678746764916763,1.3051278285574452,0.1444866920152091,0.8126522170369529,1.0,3/18,9.07%,LBP;IL33;TLR4
prerank,coenzyme A metabolic process (GO:0015936),0.6040491061058034,1.3046354903847577,0.14794520547945206,0.8134091925561688,1.0,9/14,26.30%,ACLY;NUDT7;SLC25A16;PANK1;PANK3;DCAKD;ACAT1;CROT;ACOT7
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.6108541912174844,1.3045824023006047,0.16285329744279947,0.8119307270600837,1.0,3/13,7.04%,AR;ESR1;PLPP1
prerank,polyol metabolic process (GO:0019751),-0.3557041464954538,-1.3043680785075669,0.0967741935483871,0.5853639336759834,1.0,14/46,11.72%,ITPKB;INPP4B;PLCG1;ISYNA1;SLC5A3;NUDT4;PLCB1;INPPL1;ITPK1;INPP5D;MINPP1;NUDT3;ITPKC;PLCD3
prerank,ribosome assembly (GO:0042255),0.5017477543878107,1.3040200765324799,0.109375,0.812947286479535,1.0,20/47,26.66%,RPSA;MRPS11;C1QBP;NPM1;EIF6;SBDS;RPS27L;RPS5;RRP7A;RPL6;NOP53;PWP2;RPF2;MPV17L2;EIF2A;NOP2;RSL24D1;BRIX1;ERAL1;DHX29
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5652481398401059,1.3040124667140243,0.14547677261613692,0.8112900222148558,1.0,4/21,4.00%,IGFBP5;MMP2;FGF2;MEF2D
prerank,fatty acid transmembrane transport (GO:1902001),-0.4419725724901289,-1.3039894835948815,0.1201923076923077,0.5829510396412231,1.0,5/19,11.31%,PRKAG2;SLC2A1;PRKAA2;SLC25A20;ACACB
prerank,mitochondrion distribution (GO:0048311),0.6050778521487928,1.3023709715782692,0.1524966261808367,0.8173897607518456,1.0,4/12,14.51%,CLUH;TRAK2;MAPT;ATCAY
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.6021459451348359,1.30206381024719,0.16194331983805668,0.8171791554738905,1.0,3/15,3.63%,FANCD2;EME1;TIPIN
prerank,positive regulation of receptor internalization (GO:0002092),0.553157108124771,1.302032861095396,0.1477832512315271,0.8156198230842064,1.0,8/22,23.55%,SFRP4;VEGFA;MAGI2;EGF;AHI1;ATAD1;ARRB1;PICK1
prerank,regulation of vasculature development (GO:1901342),-0.3964681210731982,-1.3018287212306014,0.12422360248447205,0.5849342294789934,1.0,11/26,15.57%,ETS1;SP100;PLXND1;EMP2;ERBB2;TSPAN12;SFRP1;EGLN1;CTNNB1;ADGRA2;EPHA2
prerank,negative regulation of proteolysis (GO:0045861),0.5180853092402784,1.3017372633734166,0.14022988505747128,0.8153576278572022,1.0,7/34,11.30%,TIMP2;GAS1;ECM1;CAMK2N1;HDAC6;CSTB;AKT1
prerank,regulation of dopamine secretion (GO:0014059),0.5443425818301707,1.301690459210475,0.13763702801461633,0.8139404847533998,1.0,8/25,17.26%,SYT2;SYT12;SYT11;SYT13;DTNBP1;KCNA2;GDNF;SYT1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.5476882201208348,1.3014003034227464,0.14321608040201006,0.8137187507778738,1.0,4/24,7.26%,CCBE1;EIF2AK3;SULF2;SULF1
prerank,regulation of dendrite development (GO:0050773),-0.3700215821645388,-1.3013115339328754,0.09395973154362416,0.5829589089321965,1.0,8/37,3.59%,PTN;NEDD4L;BMP5;MARK1;TNIK;BMP7;CDKL5;DAB2IP
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.4452861075117003,-1.3010877052538419,0.13274336283185842,0.5802156789012033,1.0,8/18,11.90%,PTN;IL34;TENM4;NOTCH1;PTPRZ1;TNFRSF21;MDK;SLC45A3
prerank,ncRNA metabolic process (GO:0034660),0.519180121692067,1.3008690105273242,0.12457142857142857,0.8146452252824838,1.0,10/37,18.36%,TARBP2;TRIM71;DGCR8;MEPCE;AGO2;MAPT;DDX17;DDX4;ZCCHC8;TENT4B
prerank,endoderm formation (GO:0001706),0.5224974422807425,1.300649003076631,0.1380897583429229,0.8140134783937375,1.0,9/35,11.81%,COL8A1;COL11A1;MMP2;ITGA5;ITGB5;COL12A1;COL6A1;ITGAV;SETD2
prerank,regulation of macrophage differentiation (GO:0045649),0.5877991537860724,1.3003078077123722,0.15746971736204576,0.8140508351788932,1.0,3/15,6.74%,LIF;PRKCA;INHA
prerank,regulation of establishment of cell polarity (GO:2000114),0.5827921375341906,1.300057528356979,0.15850515463917525,0.8136386608307504,1.0,7/16,19.86%,GSN;RAP1B;KANK1;KIF20B;BCAS3;SHTN1;ARFGEF1
prerank,carnitine shuttle (GO:0006853),-0.5064538049890124,-1.299769293229467,0.1750841750841751,0.5802643418087607,1.0,4/11,11.31%,PRKAG2;PRKAA2;SLC25A20;ACACB
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.621527928343251,1.2996813184362503,0.1648793565683646,0.8138129459020326,1.0,7/12,21.33%,DCTN1;BICD1;KIF3A;BBS4;NIN;CCDC120;PCM1
prerank,cell junction assembly (GO:0034329),-0.30601867580926206,-1.2995673112568646,0.038461538461538464,0.5773670997996085,1.0,25/100,13.24%,TJP1;PKP4;CDH5;ITGA6;CLDN5;SPOCK2;CDH1;SHANK3;PLXND1;DNM3;CDH6;ACTB;TLN2;RYK;CDH7;OPHN1;SDK2;LIMS1;SDK1;CDK5;FBLIM1;BDNF;TRPV4;PCDHB14;SLITRK1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5955953305737962,1.2993823934862907,0.1727891156462585,0.8135823456586745,1.0,8/15,24.70%,SKI;ACVR1;DACT1;IGSF1;MAGI2;ACVR2A;FKBP1A;ACVR1B
prerank,keratan sulfate biosynthetic process (GO:0018146),0.5407544624833867,1.299361624366835,0.14166666666666666,0.8120206189911803,1.0,6/26,4.27%,ST3GAL2;B4GALT3;B4GALT1;OGN;CHST1;ACAN
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6378995060337759,1.2990708482988906,0.17597765363128492,0.8117769080346255,1.0,7/10,29.58%,CSGALNACT2;B3GAT3;XYLT1;XYLT2;B3GAT2;DSEL;CSGALNACT1
prerank,icosanoid metabolic process (GO:0006690),0.5042234022337193,1.2989819159127793,0.12960893854748604,0.8106033502614015,1.0,12/40,17.77%,MGLL;CYP2S1;DPEP1;DAGLA;PON3;PTGR1;GPX1;PNPLA8;ABCC1;FADS1;DAGLB;EPHX1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.485227461169343,1.2986248023460332,0.08723404255319149,0.8107174600899109,1.0,27/69,22.79%,IRS1;FGFR1;PLCE1;PIK3C2B;PIK3R2;CD160;ZFP36L1;PLCB4;C1QBP;INPP5F;PIK3CA;SIRT2;AKT1;IRS2;PLEKHA1;RHOA;PI4KB;PDGFRA;PI4KA;OGT;PLCD4;TYRO3;PTEN;GAB2;PIK3CG;NF1;HTR2A
prerank,positive regulation of B cell activation (GO:0050871),0.4905868355069757,1.298474861778724,0.12292358803986711,0.809864989829726,1.0,12/50,16.30%,SYK;EPHB2;MIF;CLCF1;HMCES;CD81;TIRAP;TNFSF13B;IRS2;CD27;IL4;IL6
prerank,oogenesis (GO:0048477),-0.45841091236110143,-1.2979177713703354,0.1646090534979424,0.5783689516090393,1.0,1/15,0.09%,PTN
prerank,regulation of cilium movement (GO:0003352),-0.5208298477251961,-1.2977730801541107,0.1791530944625407,0.5755529914497116,1.0,8/10,35.93%,DNAH11;CFAP43;CFAP298;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,membrane depolarization during action potential (GO:0086010),-0.4056504882429011,-1.2977407973878963,0.1569767441860465,0.5724062865112914,1.0,4/26,4.94%,ATP1A2;YWHAH;CACNA1D;SCN3A
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.6245318445435211,1.2972435567775362,0.16897506925207756,0.8139283960957464,1.0,3/11,4.40%,TGFB2;TGFBR2;ACVR1
prerank,catecholamine biosynthetic process (GO:0042423),-0.48865678986644234,-1.2970166897646562,0.17333333333333334,0.571151364324276,1.0,4/11,10.24%,MOXD1;SNCA;GCH1;DDC
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.4783766758636793,1.2969269840950242,0.10256410256410256,0.8137941083239969,1.0,29/71,27.80%,FAP;CAPN2;ZRANB1;VPS4B;NR1D1;HDAC6;STUB1;UBE2W;CLPX;OTUD7B;UBA52;RSPRY1;DDB1;CLPP;NGLY1;SOCS6;ZER1;IDE;NEDD8;RNF41;PDCD6IP;RNF123;ZYG11B;CTSK;MDM2;PRPF19;CTSB;CTSL;CASP8
prerank,muscle cell migration (GO:0014812),0.6384419478426091,1.2963111358112742,0.16643356643356644,0.8150242120279811,1.0,5/10,14.52%,ITGB3;THBS4;SIX1;AAMP;DDR1
prerank,intracellular protein transport (GO:0006886),0.4479868367190977,1.295677234983081,0.005,0.8164468951385838,1.0,123/304,25.81%,SYK;SGSM2;COPA;DESI1;STX2;RAB32;RABGAP1L;RAB6A;AP4B1;STX1A;TMED1;SPRN;STX5;STX11;PKD1;SEC31A;RAB23;RAB19;RAB6B;NUP93;PREB;SCFD2;ARF4;TRAK2;SCG5;TBCK;AP3D1;HDAC6;NUP107;STX1B;CLTC;SNX1;STRADA;ACD;SURF4;USO1;HPS4;TBC1D2B;ARFGAP3;LMAN1;STX4;TBC1D17;GGA1;SCFD1;ARF1;STX12;AP4E1;NPM1;SEC23IP;COPB2;VPS33A;AKT1;TBC1D10A;NAPA;STX17;RAB43;RPGR;IPO9;TNPO2;ARFRP1;SYNDIG1;ARF6;GGA2;GIPC1;CHP1;E2F3;NSF;EVI5;SGSM1;COPZ2;EVI5L;AP4M1;NAPG;TBC1D13;RAB1B;RAB5B;RAB5C;IPO5;BCS1L;STX3;SNX6;ARCN1;ADPRH;NUP50;NXT2;TBC1D22B;TBC1D15;CLIP3;RAB24;TMED2;VPS33B;VPS36;AP1S3;COX18;RUNDC1;CTTN;SMURF1;RANBP6;NAPB;STX16;BAG3;TPR;TBC1D8B;IPO11;TBC1D12;FUT10;TECPR2;XPO7;PICK1;RABL3;STAM;IPO13;RAB18;TSC2;NUP133;CALR;NUP85;STX7;TNPO1;RAB29;KIF13B;RAB1A;FAM53C
prerank,regulation of trophoblast cell migration (GO:1901163),0.5983484646069432,1.2951374758241332,0.14986737400530503,0.8175257542681259,1.0,4/14,8.90%,VEGFA;SMURF2;C1QBP;AGO2
prerank,mRNA metabolic process (GO:0016071),0.46805120383645155,1.2944007118527245,0.08212058212058213,0.8194584963907415,1.0,32/90,21.68%,SRSF2;DIS3L2;RNASE4;U2AF1;ZFP36L2;PRPF3;AURKAIP1;CPSF6;USP39;NUDT16L1;ERN1;SON;TCERG1;NUDT16;SRSF11;ZFP36;CNOT10;SF3B4;SF3A1;DDX5;SNRPG;SNRPD3;AGO4;YTHDF2;SLBP;U2AF2;AGO3;PTBP1;HIPK3;SF3B2;AKAP8L;KIN
prerank,lymphocyte mediated immunity (GO:0002449),0.6196766733726567,1.2936448257521427,0.17687074829931973,0.8214855754372514,1.0,3/12,15.16%,CD55;JAG1;BTN3A3
prerank,protein mono-ADP-ribosylation (GO:0140289),0.625830343803894,1.2935503560112114,0.18016759776536312,0.8203045063053177,1.0,4/11,11.05%,PARP3;PARP11;PARP6;PARP14
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.5408381592907,1.2932938791055812,0.1376720901126408,0.8198795867942363,1.0,6/23,14.76%,CCDC88C;HOOK2;MYO10;DYNC1I1;MAP6;CCDC186
prerank,positive regulation of B cell proliferation (GO:0030890),0.5204329144785537,1.2931391222448174,0.14183551847437426,0.8189837674981779,1.0,8/29,14.82%,EPHB2;MIF;CLCF1;CD81;TIRAP;TNFSF13B;IRS2;IL4
prerank,regulation of osteoblast proliferation (GO:0033688),0.5814505795052279,1.2930334678643083,0.15721649484536082,0.8178642449215048,1.0,4/17,8.12%,MN1;TMEM119;TNN;SOX8
prerank,energy reserve metabolic process (GO:0006112),0.5685575946135174,1.2930211569707695,0.15269086357947434,0.8163222342832333,1.0,4/19,7.25%,GFPT2;UGP2;GFPT1;PID1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.6102427733708262,1.2927775118850098,0.16120218579234974,0.8159217699112835,1.0,8/12,22.26%,EPHB2;NFIB;GLI2;MYCBP2;TSKU;EPHB1;PAFAH1B1;SPTBN4
prerank,regulation of hydrolase activity (GO:0051336),-0.31806940639919296,-1.292652908424601,0.057971014492753624,0.5793515732249753,1.0,14/71,6.08%,PLXNA2;PRKG1;EPHA4;CHN2;SCARB2;PLXNA4;FGD4;CHN1;FGD5;DAB2IP;PLXND1;SIPA1L1;RASIP1;CAV1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.49766422564931617,1.2924988613551998,0.12780269058295965,0.8155570420719708,1.0,10/47,14.08%,SYK;CD177;TGFBR2;MAPK14;PID1;DHRS4;TLR4;MAPT;CDKN1A;ZC3H12A
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5692910389242766,1.291420031946711,0.1662303664921466,0.8189203757092319,1.0,7/17,15.11%,MLXIPL;PID1;FLCN;TIGAR;NCOR1;HDAC4;NUPR1
prerank,iron ion transport (GO:0006826),0.4911666792309857,1.2911631626356306,0.1256890848952591,0.8185871514054499,1.0,13/47,16.13%,SCARA5;STEAP3;ATP6V0A2;SLC39A14;MELTF;SLC11A2;CLTC;ATP6V1E1;ATP6AP1;REP15;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,N-glycan processing (GO:0006491),-0.4420528875044156,-1.2910946033324449,0.14222222222222222,0.5799216256358901,1.0,8/18,21.59%,FUT8;ST8SIA4;MAN2A1;MGAT4A;ST8SIA2;ST8SIA6;MAN2A2;MAN1A2
prerank,"wound healing, spreading of cells (GO:0044319)",0.5408227323788554,1.2910218919135108,0.1423487544483986,0.8177192568980141,1.0,7/24,14.52%,COL5A1;TMEFF2;CD44;ITGA5;TOR1A;RHOA;DDR1
prerank,positive regulation of vacuole organization (GO:0044090),0.648033474116559,1.290862397191116,0.1683453237410072,0.8168302468015418,1.0,4/10,20.46%,ANXA2;PIP4K2C;LRSAM1;PIP4K2B
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.46222183512730075,1.2907266346437447,0.059063136456211814,0.8158638471128888,1.0,30/113,17.52%,SYK;ESR1;PSMC4;GTF2H3;VEGFA;CDC42EP2;MPP7;RAP1B;GNL3L;PSMC6;SRC;FSCN1;ABCA1;STUB1;DHX33;TIRAP;TLR4;BMF;USP50;TPPP3;ERCC3;BAK1;ERCC4;DDB1;TERF1;IL5;HSP90AA1;HRK;SPIDR;ERCC5
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.48328846772759615,1.2904682149558107,0.11894273127753303,0.8155053403843059,1.0,13/57,17.74%,GHR;LIF;CTF1;VEGFA;CLCF1;TNFRSF18;INPP5F;PARP14;PIBF1;FLT3;IL4;IL6;IL18
prerank,neuron differentiation (GO:0030182),0.45576204052249003,1.2903645238391421,0.04919678714859438,0.8143972916168294,1.0,16/165,5.31%,LMX1A;LRP6;LHX8;WNT10B;WNT2;UGDH;CTF1;NEUROD2;VEGFA;WNT9A;TGFB2;PBX1;RUNX1;LMX1B;IRX5;TENM3
prerank,water transport (GO:0006833),-0.4922134379779698,-1.28972592814592,0.14814814814814814,0.580491695209821,1.0,2/12,8.86%,PDPN;AQP11
prerank,regulation of RNA splicing (GO:0043484),0.47347909139836025,1.2895075599134997,0.10993657505285412,0.8169082087688784,1.0,12/69,10.62%,AHNAK2;AHNAK;AFF2;MBNL1;ZPR1;CLK1;SRSF3;RBM22;ERN1;MBNL2;SON;HNRNPH1
prerank,B cell activation involved in immune response (GO:0002312),-0.48047139068390565,-1.288911448547003,0.18110236220472442,0.5792943591517279,1.0,7/13,25.78%,MSH2;BATF;RNF8;CD180;GPR183;LIG4;FCGR2B
prerank,myotube differentiation (GO:0014902),0.5802656592587672,1.2886867849575332,0.15734720416124837,0.8191706933071481,1.0,3/17,4.06%,ADAMTS5;SIX4;SKI
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.6177225757873295,1.28842732888192,0.1717877094972067,0.8188718948525793,1.0,4/12,12.62%,SRI;CAMK2D;PDE4D;CALM2
prerank,cardiac muscle cell differentiation (GO:0055007),0.5531798095308258,1.287046917385829,0.1670886075949367,0.8238146029909341,1.0,4/21,4.40%,WT1;AKAP13;VEGFA;ACVR1
prerank,positive regulation of organelle organization (GO:0010638),0.5234791941169722,1.2866799935753628,0.15930232558139534,0.8239550580177285,1.0,8/32,16.64%,ANXA1;ANXA2;SORBS3;SURF4;LMAN1;LNPK;SMCR8;HTRA2
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.44109134859633115,-1.2862608278491592,0.1799163179916318,0.5828058804276172,1.0,8/16,25.96%,ST8SIA4;ST6GALNAC3;ST6GALNAC5;ST8SIA2;ST8SIA6;ST6GALNAC6;ST3GAL5;A4GALT
prerank,cartilage development (GO:0051216),0.493750969339347,1.2857279856313795,0.1188118811881188,0.8268106750746461,1.0,11/49,10.13%,WNT10B;CD44;SULF2;FGF2;RUNX1;PKD1;SLC39A14;NFIB;SULF1;SOX5;COL2A1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5253009377943862,1.2848822087812073,0.1595238095238095,0.8292267551831358,1.0,12/28,22.56%,MAP1B;MAPRE3;GAS2L1;MAPRE1;CAMSAP1;MAPT;GBA2;FKBP4;STMN4;CLASP2;MAP1A;MAP1S
prerank,keratan sulfate metabolic process (GO:0042339),0.5201226938484214,1.2847315687917786,0.15832363213038417,0.8284045369886962,1.0,6/31,4.27%,ST3GAL2;B4GALT3;B4GALT1;OGN;CHST1;ACAN
prerank,regulation of collagen biosynthetic process (GO:0032965),0.5712299116074012,1.2846587009445467,0.1641025641025641,0.8271307977437508,1.0,4/19,5.66%,TGFB3;F2R;RUNX1;CREB3L1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.5708902725865792,1.284524568556075,0.14901960784313725,0.8262017592467042,1.0,4/16,12.39%,PRKCA;SLC39A14;GRP;KLK6
prerank,response to chemokine (GO:1990868),-0.4693957594289632,-1.2844037206650156,0.17712177121771217,0.584665827231975,1.0,5/13,5.61%,SLC12A2;FOXC1;DOCK8;CXCL12;LRCH1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.5186147838928542,1.2843432304914966,0.15876777251184834,0.8255329504184877,1.0,12/31,18.39%,HOXA3;TGFBR2;IRX5;HOXA4;COL2A1;TWIST1;SIX1;PDGFRA;HOXC4;HOXA9;DYNC2I1;TGFBR1
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.476353926958801,-1.28433708172052,0.15384615384615385,0.5817200946193183,1.0,3/13,4.21%,DDO;GLUL;MTHFS
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.39996676789979757,-1.284305197980839,0.16477272727272727,0.5787147986361533,1.0,9/23,20.40%,SASH1;DAB2IP;DVL3;TNFRSF11A;EDN1;MAP3K5;ARHGEF5;DUSP19;MAP3K10
prerank,regulation of interleukin-4 production (GO:0032673),0.5551053802401507,1.2838590646434274,0.1717557251908397,0.8263454950682757,1.0,2/21,1.14%,SYK;IRF4
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5546898918329581,1.2836250460522647,0.1480552070263488,0.8259292045572206,1.0,8/21,17.29%,CDK4;RAD51B;VPS4B;DTL;NPM1;FBXO5;CCND1;RCC2
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.4450516401234575,-1.282849924248,0.15810276679841898,0.5794898359519761,1.0,3/16,3.59%,PTN;SOX6;FOXC1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.47289625683488007,1.2822949934887757,0.10609243697478991,0.8306016371537407,1.0,12/74,5.16%,COL1A1;PHLDB1;LOXL2;TGFB3;HPN;LDLRAD4;EPHA3;TGFB2;TGFBR2;SMAD4;WWTR1;MTOR
prerank,regulation of immune effector process (GO:0002697),0.4992441374254981,1.2820287948770814,0.133630289532294,0.8303008589777815,1.0,9/41,13.58%,CD55;IRF4;CFH;C7;C1QBP;CD81;C4B;SERPING1;CR2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5966312922429584,1.2819338697118867,0.1891891891891892,0.8291456239812971,1.0,6/14,22.15%,EHHADH;CRAT;SCP2;ACOX1;HSD17B4;CROT
prerank,positive regulation of histone acetylation (GO:0035066),0.5393367274781894,1.2818294583059895,0.15632754342431762,0.8280853641075079,1.0,4/23,10.14%,LIF;SMAD4;MUC1;BRD7
prerank,basement membrane organization (GO:0071711),0.589225420435574,1.2809980126769611,0.17765814266487215,0.8304440530901296,1.0,3/14,3.04%,HPN;FLRT2;NTN4
prerank,establishment of protein localization to extracellular region (GO:0035592),0.5082718790841514,1.2801994501309428,0.13516609392898052,0.8326259643290419,1.0,19/39,30.69%,NECAB3;STEAP3;PREB;MIA3;RCN3;ABCA1;ARFGAP3;RAB3D;MON1A;RAB10;COPG1;SEL1L;RAB12;AFM;RAB3C;RAB8B;PDIA4;COPG2;TMEM167A
prerank,peripheral nervous system development (GO:0007422),0.5410012809569217,1.2801826004854029,0.17026378896882494,0.8311576652767034,1.0,7/23,14.31%,PMP22;SOX10;ALDH3A2;SOX8;GDNF;ASIC2;ARTN
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6335579531563074,1.2795140970527759,0.18181818181818182,0.8313953499726358,1.0,3/10,8.76%,AP2A2;CLTC;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6335579531563074,1.2795140970527759,0.18181818181818182,0.8313953499726358,1.0,3/10,8.76%,AP2A2;CLTC;MYLIP
prerank,myelination in peripheral nervous system (GO:0022011),0.6007107148704934,1.2792567754557882,0.1686746987951807,0.8310222455254082,1.0,4/13,9.54%,MYOC;SKI;SIRT2;ARHGEF10
prerank,ERAD pathway (GO:0036503),0.46605371988219674,1.2787844934856782,0.11502590673575129,0.8315346360392607,1.0,32/83,25.51%,UBE2J2;GET4;SYVN1;EDEM1;RNF121;RCN3;PSMC6;STUB1;ANKZF1;FBXO2;FBXO17;TOR1A;ECPAS;UBE2G2;HERPUD1;DNAJB2;TMUB2;SGTA;AMFR;SELENOS;AUP1;UGGT1;JKAMP;USP13;DERL1;SEL1L;USP19;UBXN6;RHBDD2;SEC61B;HSP90B1;UFD1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.4509648173061946,1.2784004456742877,0.05156723963599596,0.8317718174993135,1.0,28/152,12.37%,RSPO2;SFRP4;COL1A1;DKK2;EGFR;SCEL;GPC3;PSMC4;SULF2;UBE2B;SMURF2;SKI;AXIN1;DACT1;ZRANB1;DAAM2;PSMC6;SULF1;PSMD8;GSKIP;PLEKHA4;KANK1;TMEM9;CSNK1G1;CSNK1G3;PRDM15;JUP;EGF
prerank,positive regulation of lipid transport (GO:0032370),0.6012098149271523,1.2783390688059666,0.18636995827538247,0.8305762710796949,1.0,2/12,1.66%,LRP1;TRIAP1
prerank,lytic vacuole organization (GO:0080171),0.5162773416824579,1.2779681748294578,0.14402810304449648,0.8307787433907199,1.0,11/32,20.11%,HOOK2;ACP2;MTOR;ABCA1;TPP1;CLVS2;HPS4;GAA;SNAPIN;CLVS1;ACP3
prerank,proteolysis (GO:0006508),0.4416862037684676,1.2779194302824333,0.025025025025025027,0.8294454903584579,1.0,60/252,19.06%,CAPN5;HTRA3;PCSK6;PRSS48;DPP4;BMP1;HPN;FAP;PCSK5;DESI1;DESI2;PSMC4;ANPEP;CAPN2;MMP2;KLKB1;ADAMTS3;ACAN;ADAM19;ADAM33;PCSK4;SPCS1;PRCP;RET;LNPEP;TPP1;FBXO2;CAPN1;CLPX;PSEN1;ECE1;FBXL2;CNDP2;XPNPEP3;EEF1AKMT4-ECE2;ECE2;CAPN11;SPPL2B;NAPSA;THOP1;RSPRY1;NPEPPS;TASP1;FAM111A;CLPP;HGF;OGT;HTRA2;SENP6;IDE;SPG7;LAP3;CTSD;PGPEP1;HTRA4;MMP16;METAP2;CAPN10;NEDD8;PCSK7
prerank,regulation of biosynthetic process (GO:0009889),0.608170650891804,1.2776967730574857,0.19176136363636365,0.8289186679308219,1.0,1/11,0.56%,UCP1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.546851730905609,1.2772273126765172,0.1814814814814815,0.8295655860255334,1.0,4/23,4.97%,GPSM2;DCTN1;NDEL1;ZW10
prerank,sensory perception of light stimulus (GO:0050953),0.4664393640212371,1.2771644846343257,0.11534500514933059,0.8283478418844201,1.0,20/87,20.29%,COL1A1;SLC4A10;ROM1;RABGGTA;COL11A1;ABLIM1;MYO9A;CNGB1;COL2A1;CRYBB1;RPGR;CABP1;CRYZ;OPA3;EFEMP1;TYR;RP2;SFRP5;KIFC3;ATF6
prerank,protein heterotetramerization (GO:0051290),0.5919930902505766,1.2764123528859692,0.1955085865257596,0.8303708800816636,1.0,5/13,15.11%,PKD1;KRT10;PKD2;CPSF6;HSD17B8
prerank,establishment of protein localization to membrane (GO:0090150),0.4666761381677998,1.2756353901806612,0.11099252934898612,0.8324059404062181,1.0,35/66,33.06%,EGFR;RFTN1;NECTIN3;ZDHHC7;VPS37D;TAOK2;ZDHHC2;VPS37C;SEC63;FRMPD1;ZDHHC4;ZDHHC24;VPS37B;ZDHHC21;ZDHHC20;NACA;RAB10;COX18;ZDHHC18;ICMT;ATG3;SDCBP;SYNE3;MICALL1;GORASP1;PRKCI;ZDHHC15;PARD3;MYO1C;GOLGA7B;PIKFYVE;ARL6;CHM;RAB3GAP1;ZDHHC3
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6330358587828331,1.275246600496367,0.19337016574585636,0.8327343273104851,1.0,2/10,2.27%,AREG;BTC
prerank,ESCRT III complex disassembly (GO:1904903),0.6414469049399187,1.275210904005451,0.19154929577464788,0.8299031608604432,1.0,2/10,5.32%,CHMP7;VPS4B
prerank,ESCRT complex disassembly (GO:1904896),0.6414469049399187,1.275210904005451,0.19154929577464788,0.8299031608604432,1.0,2/10,5.32%,CHMP7;VPS4B
prerank,regulation of interleukin-8 production (GO:0032677),0.46944358296272504,1.274493980823115,0.1231578947368421,0.8317513654391204,1.0,14/69,16.44%,SYK;LBP;ANXA1;F2R;TLR5;PRKD2;TIRAP;TLR4;OTUD7B;BCL3;KLF4;CD14;IL6;ANXA4
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.5347906804305553,1.2744913448730428,0.15555555555555556,0.8302676222834581,1.0,10/24,17.66%,SEC24D;SEC31A;SEC24A;SEC23A;PDIA3;MFSD6;IDE;SEC24B;ABCB9;BCAP31
prerank,microtubule bundle formation (GO:0001578),0.4978144915545091,1.2742470968696527,0.1511758118701008,0.8298811372844355,1.0,14/42,22.56%,NAV1;CLIP1;PSRC1;GAS2L1;TOGARAM1;RSPH1;TPPP3;TTLL3;CHP1;CDK5RAP2;SPAG16;NUMA1;DCX;MAP1S
prerank,positive regulation of immune effector process (GO:0002699),0.5236527172707326,1.2731514929307737,0.17661388550548113,0.8335378059237124,1.0,3/27,8.08%,LBP;PTPRJ;CD81
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6201915725315231,1.2730683162904008,0.20056497175141244,0.830954091512817,1.0,1/10,1.06%,SMPD3
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6201915725315231,1.2730683162904008,0.20056497175141244,0.830954091512817,1.0,1/10,1.06%,SMPD3
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.38318647045560944,-1.2730129384043782,0.13636363636363635,0.6013322989388977,1.0,8/23,12.75%,ACSL1;ELOVL7;ACSL4;HACD1;ACSL3;HACD2;ACSL6;ELOVL1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.6102242610273942,1.2729739598639205,0.18758620689655173,0.829939746593015,1.0,5/11,17.51%,TIMM10B;TIMM9;AGK;TIMM22;TIMM8B
prerank,intestinal absorption (GO:0050892),-0.484874015786971,-1.272794806584347,0.17857142857142858,0.5988136727471653,1.0,4/13,10.38%,F11R;TJP2;ADRA2A;KCNQ1
prerank,response to estrogen (GO:0043627),0.5151264744655812,1.2727061416801486,0.15995260663507108,0.8296746529832593,1.0,4/31,8.43%,AR;ESR1;SFR1;CYP27B1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.5012031431646824,1.2722011795705401,0.16666666666666666,0.8304477208012694,1.0,4/38,8.88%,NOX4;DLG4;GAS6;SRCIN1
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5065477466015539,1.271922387648348,0.17257142857142857,0.8302910203670968,1.0,9/33,16.30%,ANXA1;MAPK7;NFE2L2;HDAC6;ANKZF1;SIRPA;PLEKHA1;OSER1;IL6
prerank,regulation of regulated secretory pathway (GO:1903305),0.5069775784329067,1.2713608527951317,0.17103762827822122,0.8312748679171464,1.0,10/34,18.84%,SYT2;SYT12;SYT11;SYT13;DTNBP1;RAB3D;SNAPIN;SYT1;PREPL;RIMS2
prerank,establishment of spindle localization (GO:0051293),0.5888493263678134,1.2713480744419785,0.18716577540106952,0.8298661682467172,1.0,7/14,26.59%,TLE6;LLGL1;DYNC1H1;MAP4;CLASP2;NLRP5;KPNB1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.5531917990931201,1.2713310950513637,0.16182048040455121,0.8284590159316934,1.0,4/21,11.89%,LAX1;BANK1;GPNMB;PIBF1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.5266409736045441,1.2709092213162922,0.17772215269086358,0.8288943998367297,1.0,9/23,21.11%,MTMR11;OCRL;INPP5F;INPP5K;MTMR6;MTMR1;PIP4P1;INPP5B;PTEN
prerank,peptidyl-tyrosine modification (GO:0018212),0.47857478632088896,1.2704713826377325,0.13785557986870897,0.8294049688573615,1.0,11/56,8.00%,SYK;DDR2;EPHB2;SRMS;EGFR;FGFR1;EPHA3;FYN;SRC;ABL2;ABI1
prerank,cellular response to oxygen levels (GO:0071453),0.6312771377527436,1.2702652553248026,0.1688125894134478,0.8289062824560213,1.0,5/10,23.55%,ATP6V0A2;ATP6AP1;CCDC115;TMEM199;PICK1
prerank,acylglycerol biosynthetic process (GO:0046463),0.5423891980130457,1.2700336151493299,0.1769041769041769,0.8284840907078751,1.0,8/23,20.27%,PLCE1;GPAT4;ANG;MOGAT1;MOGAT2;GPAT3;GPAM;LPIN3
prerank,negative regulation of immune system process (GO:0002683),0.5732360930824845,1.269862846933296,0.18393782383419688,0.8278530901420488,1.0,1/16,0.16%,COL3A1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.5266670378406249,1.2698584014224112,0.18237454100367198,0.8264269421113345,1.0,4/26,7.26%,CCBE1;EIF2AK3;SULF2;SULF1
prerank,negative regulation of hemostasis (GO:1900047),0.6123935208072637,1.269757088494533,0.19363762102351315,0.8254214879859406,1.0,1/12,0.11%,CD34
prerank,cellular response to estrogen stimulus (GO:0071391),0.5874525298910108,1.2692584324710432,0.1855807743658211,0.8263055959509117,1.0,2/14,3.41%,AR;SFR1
prerank,regulation of protein kinase activity (GO:0045859),0.4504951529296602,1.2692200116476178,0.09259259259259259,0.8250394446407499,1.0,25/106,13.16%,DDR2;LRP6;PLCE1;TARBP2;CAMKK1;CAMK2N1;WWTR1;MAP2K3;DTNBP1;RTRAF;MAPRE3;RASSF2;YWHAG;ADCYAP1;GAS6;IQGAP1;GSKIP;INPP5K;CAMKK2;AKT1;XRCC5;SFN;DEPTOR;SMCR8;CDKN1A
prerank,positive regulation of protein secretion (GO:0050714),-0.300382115580749,-1.2691572246029323,0.05660377358490566,0.6050822121428489,1.0,10/69,3.64%,BMP6;WLS;UNC13B;FRMD4A;MYRIP;IGF1;RBP4;CD2AP;MYO18A;ACSL4
prerank,neurotransmitter uptake (GO:0001504),-0.4881428732096317,-1.2690664746655853,0.19272727272727272,0.6021518111015782,1.0,3/12,1.65%,ATP1A2;SLC1A3;GLUL
prerank,cellular response to chemokine (GO:1990869),0.48424896998034844,1.2687850760392616,0.1600441501103753,0.8255866010792613,1.0,8/46,14.08%,ACKR3;CCL8;CXCL10;CCL25;STK39;CCL13;RHOA;ZC3H12A
prerank,ribosomal subunit export from nucleus (GO:0000054),0.6037088648622235,1.2676562320492524,0.19327731092436976,0.8293708730959212,1.0,5/13,12.35%,SDAD1;ABCE1;NOP9;NPM1;EIF6
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.5260044099433125,1.2673775070584183,0.17064439140811455,0.8292267934767222,1.0,11/26,20.64%,DCTN1;CLIP1;PSRC1;TOGARAM1;MAPRE1;MAPT;SLAIN2;CDK5RAP2;AKAP9;NAV3;NUMA1
prerank,proteoglycan biosynthetic process (GO:0030166),0.5119058364119902,1.2661731232880267,0.16430260047281323,0.8331221916447297,1.0,10/31,12.53%,UGDH;CSGALNACT2;CHST10;EXT1;GAL3ST3;CHST12;FOXL1;B3GAT3;XYLT1;GLCE
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3818931116270342,-1.2661466988787038,0.13125,0.6066445650039829,1.0,6/28,3.46%,PTN;EPHA4;ADCY1;APP;APOE;SHANK3
prerank,neuron apoptotic process (GO:0051402),-0.4188864419596388,-1.2659119457648191,0.16417910447761194,0.6041094051336001,1.0,8/19,13.10%,APP;BCL2;TRPC5;FAM162A;TNFRSF21;FAS;CDK5;GAPDH
prerank,arachidonic acid secretion (GO:0050482),0.6258923288280361,1.2650266958621497,0.18688981868898186,0.8354943605414195,1.0,2/10,11.43%,ANXA1;PNPLA8
prerank,arachidonate transport (GO:1903963),0.6258923288280361,1.2650266958621497,0.18688981868898186,0.8354943605414195,1.0,2/10,11.43%,ANXA1;PNPLA8
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.5771623789381242,1.2650204782346965,0.20592193808882908,0.8341011979777317,1.0,7/15,26.92%,TSEN54;RTRAF;ERN1;CPSF4;TRPT1;CPSF1;DDX1
prerank,peptidyl-proline modification (GO:0018208),0.5347884285668699,1.2649478700639563,0.18863361547763,0.8329785666318587,1.0,14/25,25.76%,FKBP10;PPIL6;NTMT1;NKTR;PPIC;PIN1;PPIA;FKBP4;FKBP7;OGFOD1;FKBP1A;PPIG;CWC27;PPIH
prerank,negative regulation of interferon-gamma production (GO:0032689),0.5297426529197988,1.2649345161493595,0.1922110552763819,0.8316160236175825,1.0,6/23,14.08%,AXL;C1QBP;INHA;GAS6;TLR4;ZC3H12A
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.3861522555692302,-1.2643242528218457,0.13450292397660818,0.605064591564468,1.0,5/26,3.34%,SORBS1;OCLN;INSR;IGF1;OSBPL8
prerank,dopamine metabolic process (GO:0042417),-0.4196873600292952,-1.2639254955652859,0.18725099601593626,0.6028921401472953,1.0,4/18,8.05%,SNCAIP;MOXD1;SNCA;GCH1
prerank,positive regulation of T cell migration (GO:2000406),-0.4117473505052244,-1.2638184917766424,0.1651376146788991,0.6001153131311653,1.0,5/20,4.18%,ADAM10;APP;WNT5A;DOCK8;CXCL12
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5905313629143633,1.2635789561832147,0.19917582417582416,0.8364325183958577,1.0,3/13,12.18%,SEC16B;CD81;TMEM30A
prerank,detection of mechanical stimulus (GO:0050982),0.5579599036479694,1.2633345165589973,0.17789072426937738,0.8361081636099076,1.0,4/19,12.08%,PIEZO2;PKD1;PKD2;JUP
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.6049830889006194,1.2632438778119663,0.2152777777777778,0.8351002859977436,1.0,5/11,16.99%,MTOR;DDX11;SMARCA4;NOP53;IPPK
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.5668676635199593,1.2630669845571862,0.2020460358056266,0.8344565019367957,1.0,8/17,24.13%,GET4;EMC1;EMC10;EMC8;SGTA;EMC3;EMC2;EMC6
prerank,glycosaminoglycan metabolic process (GO:0030203),0.46799983466428513,1.2627929940738603,0.19001085776330076,0.8342752507635693,1.0,15/54,17.63%,HAS1;GPC6;UGDH;GPC3;EXT1;B3GAT3;XYLT1;HS2ST1;HS3ST6;HS3ST5;HSPG2;NAGLU;IDUA;SDC2;NDST2
prerank,sulfur compound catabolic process (GO:0044273),0.4966462870620117,1.262279712634841,0.16555555555555557,0.8350662787017292,1.0,6/38,7.87%,DCN;OGN;ACAN;VCAN;NUDT7;DPEP1
prerank,regulation of urine volume (GO:0035809),0.6272342687684709,1.2619530823761211,0.20523415977961432,0.8351008990624464,1.0,2/10,9.96%,HAS2;INPP5K
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5459116794014276,1.2619336058032864,0.1601423487544484,0.8337531587660175,1.0,2/21,4.35%,LRP6;AXIN1
prerank,cardiocyte differentiation (GO:0035051),0.6158295964317924,1.2618494554174444,0.21075581395348839,0.8327447290508234,1.0,3/10,10.65%,AKAP13;TGFB2;EEF1AKMT4-ECE2
prerank,positive regulation of interleukin-8 production (GO:0032757),0.4818268120260652,1.2617299028598965,0.1461038961038961,0.8318407671894693,1.0,7/49,9.07%,SYK;LBP;F2R;TLR5;PRKD2;TIRAP;TLR4
prerank,regulation of microtubule-based process (GO:0032886),0.5059376901664455,1.2614627327410823,0.1697674418604651,0.8316087649882774,1.0,10/36,15.01%,PHLDB1;CDK2AP2;EFNA5;EPHA3;ATF5;BICD1;HDAC6;MAPT;MAP6;DIAPH1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6385825785179429,1.261317509660777,0.2016925246826516,0.8308657180874446,1.0,3/10,5.16%,FGF7;ADAM9;MTOR
prerank,ERBB signaling pathway (GO:0038127),0.4703376228851314,1.2613101614150095,0.1440677966101695,0.8295184855065916,1.0,16/64,16.67%,AREG;PRKCA;EGFR;PLCE1;BTC;SRC;STUB1;PIK3CA;IQGAP1;AKT1;EGF;AAMP;CBL;HSP90AA1;SOS1;EFEMP1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.44305070977731914,1.260413615604734,0.09683995922528033,0.8320396547863841,1.0,53/132,27.22%,RPSA;GEMIN6;TARBP2;MRPS11;SRSF6;ABT1;LSM4;WDR77;CPSF6;USP39;KHDC4;CELF2;EIF6;EIF3A;XRCC5;TGS1;POLR2D;RPS27L;RPS5;RRP7A;HSP90AA1;DDX20;RPL6;NOP53;SNRPG;SNRPD3;PWP2;LUC7L3;RPF2;EIF2S2;PUF60;GCFC2;STRAP;LUC7L2;SF3B1;SRPK1;NOP2;RSL24D1;RBM5;SMN1;COIL;BRIX1;EIF4H;CPSF7;CELF3;RAMAC;ERAL1;PRPF19;CRNKL1;PRPF6;DHX29;DDX1;PRKDC
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.4726431237793432,1.260252354374109,0.1349036402569593,0.8313545730204605,1.0,15/54,12.08%,FGF18;PRKCA;FGFR1;ANGPT4;VEGFA;FGF2;MAPK14;MAP2K3;ATP2B4;PRCP;PRKD2;STAT5A;AKT3;AKT1;JUP
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4948371109813603,1.2602013897255908,0.16059225512528474,0.8302085480881598,1.0,9/40,5.16%,COL1A1;LOXL2;TGFB3;TGFB2;TGFBR2;SMAD4;WWTR1;TCF7L2;MTOR
prerank,recombinational repair (GO:0000725),0.46615163641416474,1.2593876505076709,0.12195121951219512,0.8324034078886521,1.0,25/77,18.42%,REV3L;XRCC3;SFR1;RAD51B;RFWD3;UBE2N;RHNO1;HELQ;AP5S1;SAMHD1;SMC5;RMI1;ERCC4;FAN1;SEM1;SMC6;NBN;INO80;RECQL;SPIDR;RNF138;RAD50;ERCC5;BLM;MORF4L1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.38251127501867316,-1.258777152021759,0.15384615384615385,0.6102736915864154,1.0,10/26,22.93%,ACER2;NOS3;GCH1;NOS1;SPR;SPHK1;SPTLC2;SPHK2;ABCA2;NQO1
prerank,regulation of actomyosin structure organization (GO:0110020),0.5942842281125106,1.2586735624886747,0.19865771812080538,0.8343416449634188,1.0,5/13,15.98%,AKAP13;ASAP3;ALMS1;SLC9A1;ACTG1
prerank,negative regulation of T cell differentiation (GO:0045581),0.6192594404051245,1.2585100554056214,0.20768136557610242,0.8336331989105614,1.0,2/10,11.60%,ZC3H8;GLI3
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.4461234751612612,1.2582803349206642,0.08486707566462168,0.8332349372864604,1.0,38/122,17.46%,AR;NIBAN1;EGFR;IRS1;CTC1;FGF2;TGFB2;SMOC2;TMEM106A;MTOR;IL33;GLI2;PRKD2;LARP4;EPM2AIP1;TLR4;HNRNPD;DYRK2;NPM1;AKT1;PASK;IRS2;EIF6;EGF;RPS27L;BCL3;ZCCHC4;DNA2;POLDIP3;RBM3;KLF4;EIF3E;IL4;IL6;HGF;EIF3D;FXR2;YTHDF1
prerank,cellular response to reactive oxygen species (GO:0034614),0.47341158961673563,1.2580030222797498,0.1423982869379015,0.8331101091169044,1.0,17/59,14.21%,UCP1;EGFR;ANXA1;MAPK7;NFE2L2;HDAC6;PKD2;ANKZF1;CHUK;SIRPA;CAMKK2;AKT1;MAPT;PLEKHA1;OSER1;PDGFRA;FER
prerank,cell differentiation in spinal cord (GO:0021515),-0.5045145006516005,-1.2577066956980938,0.2210144927536232,0.6102122625395449,1.0,2/10,2.51%,SOX6;SOX13
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5379571506239313,1.2570272125843835,0.21085858585858586,0.8361738284930315,1.0,3/21,7.57%,ASPN;ECM1;GAS6
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.3908485783212866,-1.2569821191648196,0.1443850267379679,0.6090874149211043,1.0,10/25,17.10%,ATP1B3;ACTN2;DMD;WNK4;SLC6A9;TRPC6;NDUFA4;COX17;ATP1B1;GLRX
prerank,organic acid transport (GO:0015849),-0.2922185790907348,-1.256673343054435,0.08333333333333333,0.6068867050938077,1.0,12/94,2.99%,SLC7A11;SLC7A2;SLC6A13;ABCC4;SLC13A3;ACSL1;ABCG2;SLCO2B1;SLC26A7;SLCO1C1;SLC6A12;PDPN
prerank,response to cholesterol (GO:0070723),0.551608867643716,1.2561206915790193,0.19672131147540983,0.8388429700364616,1.0,3/17,3.19%,LRP6;GRAMD1A;TGFBR2
prerank,regulation of amyloid-beta formation (GO:1902003),-0.34785584903365385,-1.2559058511845629,0.10606060606060606,0.6058676463582949,1.0,9/34,12.25%,EPHA4;IGF1;SP1;APOE;GGA3;ABCG1;CASP3;SORL1;NTRK2
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.5907181995362981,1.2556972131969166,0.1910919540229885,0.8393514526882334,1.0,4/12,14.08%,ESR1;NCOR2;NCOR1;ZC3H12A
prerank,phospholipid dephosphorylation (GO:0046839),0.4921366652258236,1.2546059294584426,0.17906976744186046,0.8427190451000764,1.0,16/37,24.98%,MTMR11;PLPP3;PLPP5;PLPP1;OCRL;INPP5F;INPP5K;PLPPR3;MTMR6;MTMR1;PIP4P1;PLPP2;INPP5B;PTEN;SGPP1;MTM1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.563372325348114,1.2540506869627719,0.18950064020486557,0.8438307460147441,1.0,5/18,17.44%,FBN1;LRRC17;TLR4;IL4;GPR137B
prerank,respiratory tube development (GO:0030323),0.5097732321521085,1.2536735421984784,0.1875,0.844238240732736,1.0,5/28,7.49%,FGF7;PCSK5;VEGFA;FGF2;GLI2
prerank,eosinophil chemotaxis (GO:0048245),0.5869700986498622,1.253374215140857,0.18983957219251338,0.8428311467092272,1.0,2/14,12.90%,CCL8;CCL13
prerank,eosinophil migration (GO:0072677),0.5869700986498622,1.253374215140857,0.18983957219251338,0.8428311467092272,1.0,2/14,12.90%,CCL8;CCL13
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5614978079271524,1.2533227680276262,0.19016817593790428,0.8417272491142418,1.0,4/18,11.78%,LAX1;MIA3;AKT1;GPNMB
prerank,regulation of protein kinase B signaling (GO:0051896),0.43561760207415,1.253268865316227,0.05215646940822467,0.8406222114574886,1.0,35/193,13.14%,AREG;MYOC;CD80;ESR1;FGF18;AXL;FGF7;EGFR;IRS1;FGFR1;BTC;FYN;FGF2;MST1R;PIK3R2;OTUD3;TCF7L2;PTPRJ;RCN3;C1QBP;RET;SRC;BANK1;GAS6;FLCN;FLT3LG;PIK3CA;PHLPP2;INPP5K;AKT1;MAGI2;IRS2;EGF;FLT3;PLEKHA1
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.33312931522569356,-1.252929433099013,0.1188118811881188,0.611082340895831,1.0,16/43,10.57%,BMP6;WNT4;IGF1;BMP7;MEF2C;PRKD1;ZHX3;IL6R;NELL1;ATRAID;BMPR2;YAP1;NPNT;RUNX2;LRP3;BMP2
prerank,regulation of macrophage cytokine production (GO:0010935),0.5847670939640437,1.2529215018803326,0.2087912087912088,0.8407957797557409,1.0,3/13,2.91%,TGFB3;IRAK3;TGFB2
prerank,cell-matrix adhesion (GO:0007160),0.45385605777752996,1.2526698418134548,0.10754912099276112,0.8405606854585714,1.0,24/95,14.67%,CD34;COL3A1;THBS3;COL17A1;ITGA11;CD44;ITGBL1;ITGB3;ADAM9;TNN;PPFIA2;PKD1;ITGA2;ITGB5;TIMM10B;SRC;TESK2;ITGAV;L1CAM;TAOK2;ADAM15;SGCE;DDR1;PPFIA1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4737753510751931,1.252572845314765,0.16213275299238303,0.8396101937976922,1.0,20/51,24.31%,DBN1;DCLK1;TAOK3;TRIO;DTNBP1;WASF1;SNX1;KIF20B;TAOK2;SLC9A6;ANKRD27;SRGAP2;SHTN1;GPM6A;NBL1;GAS7;CTTN;MAP1S;CNTNAP1;ALS2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4292786817094179,1.2525657953883804,0.007,0.8382888394732967,1.0,91/390,16.35%,ANGPTL1;GHR;SYK;DDR2;EPHB2;FGF18;COL1A1;AXL;ARHGEF28;NCF4;FGF7;SRMS;EGFR;TNK1;POLR2H;IRS1;HPN;FGFR1;EFNA5;DNM1;FLRT2;EIF2AK3;HNRNPA1;GRB10;EPHA3;SULF2;FYN;ITGB3;VEGFA;MMP2;FGF2;MST1R;PIK3R2;MAPK14;ATP6V0A2;SLC39A14;ANKS1B;NFATC4;TRIM71;PTPRJ;SOCS2;FOXO1;AP2A2;RET;SRC;ACTR3;SULF1;POLR1G;PRKD2;ABI1;PIK3CA;PSEN1;FOXC2;SIRT2;MAPK11;ITGAV;RHOQ;EFS;EPHB3;MUSK;HNRNPH1;AKT1;ATP6V1E1;RBFOX2;EPHA10;IRS2;FLRT3;NGEF;SHOC2;ATP6AP1;POLR2D;POLR2G;FLT3;RHOA;AAMP;CBL;PDGFRA;FER;DDR1;HSP90AA1;RAPGEF1;GTF2F1;ATP6V0A1;ATP6V1D;AHI1;ACTG1;ATP6V1B2;ARPC1A;SOS1;HGF;NCK1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5430543036750675,1.2524968348349497,0.18870346598202825,0.8372185424208808,1.0,5/19,14.87%,LBP;TIRAP;TLR4;IRAK1;CD14
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5899423372322034,1.2520583635515814,0.2062841530054645,0.8377751521337616,1.0,4/13,12.62%,SRI;CAMK2D;PDE4D;CALM2
prerank,synaptic vesicle exocytosis (GO:0016079),0.4872920026365062,1.2514745439662471,0.17747440273037543,0.8390306346659269,1.0,15/40,18.84%,SYT2;STX2;STX1A;STX11;STX1B;STX4;SNAP23;SNAP25;SNAP47;SNAPIN;SNPH;SYT1;STX3;VAMP2;RIMS2
prerank,actomyosin structure organization (GO:0031032),-0.2996351653674414,-1.2513648514400468,0.06666666666666667,0.612228338013905,1.0,10/75,3.56%,TJP1;SORBS1;TPM1;ACTN2;PGM5;FRMD5;PHACTR1;EPB41;F11R;MYO18A
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.46120707924782905,1.2512414946027821,0.13426423200859292,0.838721348807557,1.0,13/63,17.74%,EPHB2;CD80;ANXA1;MIF;CLCF1;CD81;TIRAP;TNFSF13B;IRS2;IL4;IL6;NCK1;IL18
prerank,primary neural tube formation (GO:0014020),0.504941536710181,1.251195438809456,0.182883939038687,0.8375687434148781,1.0,4/30,4.06%,LRP6;TGFB2;COBL;SKI
prerank,tube closure (GO:0060606),0.501861517530125,1.2509362510697675,0.18128654970760233,0.8373170155715594,1.0,4/31,4.06%,LRP6;TGFB2;COBL;SKI
prerank,artery development (GO:0060840),-0.4036986881342035,-1.2508633038980796,0.17989417989417988,0.6104692060971078,1.0,9/23,9.63%,ROBO1;ENG;ROBO2;NRP1;TBX1;BMPR2;STRA6;HECTD1;PDE2A
prerank,organelle fission (GO:0048285),0.5287420872393209,1.2499153950332986,0.19047619047619047,0.8404480258820779,1.0,3/24,5.15%,SEC16B;DNM1;GDAP1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.6053179160771178,1.249897057476026,0.2409288824383164,0.8391993210891967,1.0,2/10,8.90%,TARBP2;AGO2
prerank,Golgi localization (GO:0051645),0.605699105025534,1.2498409223072198,0.21875,0.8380995506435422,1.0,2/11,1.49%,ARHGAP21;STK25
prerank,protein targeting (GO:0006605),0.44076857887740906,1.2497443201688077,0.09591836734693877,0.8371711011532941,1.0,60/118,33.06%,AP4B1;PEX16;GDAP1;EDEM1;ZDHHC7;SPCS1;VPS37D;TIMM10B;TRAK2;TIMM9;HPS4;AP4E1;TAOK2;ZDHHC2;VPS37C;PEX12;PEX1;SEC63;GIPC1;TIMM22;SEC61A1;ZDHHC4;AP4M1;ZDHHC24;VPS37B;ZDHHC21;TIMM8B;ZDHHC20;NACA;BCAP31;TOMM5;AP1S3;ZDHHC18;ICMT;TIMM17A;ATG3;SDCBP;FUT10;SRPRB;FIS1;TOMM40;KIF13B;MICALL1;PITRM1;NLGN1;PRKCI;SPCS3;ZDHHC15;PARD3;MYO1C;GOLGA7B;PIKFYVE;MFN2;CDC37;TOMM34;ARL6;CHM;AP4S1;PEX19;ZDHHC3
prerank,canonical Wnt signaling pathway (GO:0060070),0.46208906677261313,1.2496193750156188,0.13493723849372385,0.8363962480044917,1.0,8/68,5.14%,SFRP4;LRP6;WNT10B;WNT2;WNT9A;PLPP3;AXIN1;TCF7L2
prerank,intracellular cholesterol transport (GO:0032367),0.5770119295153442,1.2495103301882495,0.20971867007672634,0.8355071984172578,1.0,3/15,7.00%,LRP6;OSBPL2;ABCA1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5315872002029647,1.249433048846449,0.2,0.8344922342146754,1.0,6/21,16.35%,EIF2AK3;SYVN1;CREB3L1;HERPUD1;SELENOS;NCK1
prerank,Golgi inheritance (GO:0048313),0.6000940113465905,1.2492850406386629,0.21621621621621623,0.8338155433162684,1.0,2/11,3.58%,STK25;STX5
prerank,mRNA transport (GO:0051028),0.4500288066563974,1.2487573556214049,0.10743801652892562,0.8348182857836036,1.0,44/101,28.07%,SRSF2;SRSF6;NXF1;DDX19B;ZFP36L1;NUP93;MCM3AP;NUP107;U2AF1;SRSF3;NUP98;CPSF4;SRSF11;THOC7;ZFP36;POLDIP3;SMG7;THOC2;THOC1;ZC3H11A;SMG6;FYTTD1;NUP37;CPSF2;DDX39A;SRRM1;NUP50;SLBP;U2AF2;TPR;CPSF1;AGFG1;WDR33;NUP133;NUP85;ALYREF;UPF3B;NUP188;UPF1;NUP88;SMG5;CDC40;THOC5;CPSF3
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5293482160340425,1.2485611586329448,0.2146341463414634,0.834394867461249,1.0,8/22,17.41%,VEGFA;RASSF2;GPNMB;CALM2;TAOK2;NBN;TNKS1BP1;RAD50
prerank,regulation of exosomal secretion (GO:1903541),0.54769823423443,1.2483639932875854,0.19083969465648856,0.8339347085208727,1.0,3/19,5.87%,SMPD3;VPS4B;ATP9A
prerank,positive regulation of heart contraction (GO:0045823),-0.4206958053426149,-1.2480971172910447,0.13471502590673576,0.6145642250227749,1.0,6/19,15.58%,ATP1A2;KCNQ1;RYR2;EDN1;ADM;EDN3
prerank,protein localization to cell junction (GO:1902414),-0.39425664764940005,-1.24805028978328,0.13636363636363635,0.6117768907349591,1.0,4/22,4.52%,TJP1;CGNL1;TJP2;PCLO
prerank,regulation of phospholipase activity (GO:0010517),0.6090621806984324,1.247672160394549,0.20646067415730338,0.835821991566555,1.0,2/10,1.44%,LRP1;FGFR1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5637854899400513,1.2472971573923473,0.21130551816958276,0.8360957684785365,1.0,8/15,21.76%,TGFBR2;IRX5;TWIST1;SIX1;PDGFRA;TGFBR1;NIPBL;LHX1
prerank,regulation of fibrinolysis (GO:0051917),0.5854968975634585,1.246954981707485,0.21485411140583555,0.8363398922379077,1.0,2/13,3.63%,FAP;KLKB1
prerank,regulation of biomineral tissue development (GO:0070167),0.5128539179326682,1.2465789176005593,0.2037037037037037,0.8367633368360086,1.0,10/26,16.45%,DDR2;ECM1;GAS6;CYP27B1;BMP2K;SGMS2;CEBPB;FBXO5;TWIST1;NBR1
prerank,regulation of osteoclast differentiation (GO:0045670),0.49342972603137336,1.2465700233987698,0.1795774647887324,0.835502273513154,1.0,7/33,17.44%,FBN1;MTOR;LRRC17;TLR4;CEBPB;IL4;GPR137B
prerank,regulation of intracellular transport (GO:0032386),0.48960576285361135,1.2458167621070526,0.19399538106235567,0.8375911888444677,1.0,14/38,23.19%,GAS1;NDEL1;RBM4;ATP9A;RINT1;INPP5F;SCFD1;ANTKMT;DYNC1H1;REEP5;CAPN10;NUMA1;GRIPAP1;CRYAB
prerank,regulation of centrosome cycle (GO:0046605),0.5290095477342711,1.2456593631467978,0.21231155778894473,0.837081362179823,1.0,4/21,10.70%,XRCC3;ATF5;VPS4B;NPM1
prerank,response to alcohol (GO:0097305),0.5116528060452984,1.2450134652622813,0.19858989424206816,0.8386515252703169,1.0,7/27,18.39%,SLIT3;SLIT2;TGFBR2;GRIN3A;PMVK;GRIN2A;TGFBR1
prerank,response to peptide (GO:1901652),0.5049286209860072,1.2449073529249801,0.18514150943396226,0.8378413184730219,1.0,5/33,8.10%,ANXA1;IRS1;FYN;MMP2;STAT5A
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.3468285878375832,-1.2446435502903714,0.10526315789473684,0.6177811174164719,1.0,10/35,8.63%,PLXNA2;NRP2;PLXNA4;SEMA5A;SEMA7A;PLXND1;SEMA6A;NRP1;SEMA3B;PLXNB1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.45257101254292986,1.2434488811975866,0.14776274713839752,0.842781797939948,1.0,13/75,8.12%,DCN;TNMD;ANGPT4;ISM1;SPARC;TGFB2;CD160;ATP2B4;HOXA5;CXCL10;THBS4;SULF1;SERPINF1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.44612384625674756,1.2433910509095132,0.11692307692307692,0.8417282057026044,1.0,26/110,18.04%,SYK;GSN;VEGFA;CDC42EP2;MPP7;AIDA;GNL3L;PREB;FARP2;SRC;ABCA1;HDAC6;STX1B;TFIP11;HJURP;TIRAP;BMF;NAPA;BAK1;ULK1;HSP90AA1;NOP53;HRK;SPIDR;PEX5;IAPP
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5189976709432028,1.2428546412255508,0.19544364508393286,0.8428540629718405,1.0,6/24,16.30%,GHR;F2R;IL10RA;PIBF1;IL4;IL6
prerank,antibacterial humoral response (GO:0019731),0.5662296082564204,1.2419482537936182,0.2154046997389034,0.8455852042451559,1.0,4/16,12.31%,ANG;DMBT1;SLPI;RNASE6
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.5474408946329323,1.241867448886466,0.22264631043256997,0.8446275243470402,1.0,6/18,18.84%,SLC4A8;RAP1B;DTNBP1;SNAPIN;PREPL;RIMS2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.5287478816469483,1.241708084812199,0.20050761421319796,0.8439911643633011,1.0,6/22,9.54%,ABT1;URB1;KRI1;ERI3;NOP9;EXOSC7
prerank,protein glycosylation (GO:0006486),0.44534890212033046,1.2412712018388306,0.0898876404494382,0.8446506144617535,1.0,26/125,16.48%,GFPT2;PLOD2;ST3GAL2;B4GALT1;B3GALNT1;GFPT1;FUT2;MGAT1;POMGNT2;GALNT10;GALNT18;OGA;PLOD3;ALG1;LARGE1;FUT9;B3GNT8;GALNT1;ST3GAL4;MGAT5;MGAT2;MGAT4B;TUSC3;B3GALNT2;OGT;TMEM165
prerank,ribosomal small subunit biogenesis (GO:0042274),0.4912507813719832,1.2410708647383943,0.17126436781609194,0.844195634575603,1.0,14/39,20.91%,RPSA;MRPS11;RIOK1;RRP36;NPM1;RPS27L;RPS5;SNU13;RRP7A;DDX52;PWP2;SRFBP1;RIOK2;RPS25
prerank,regulation of peptidase activity (GO:0052547),0.5408499952274923,1.24075028751668,0.21446700507614214,0.8443166538222888,1.0,4/19,10.48%,MAPK12;ECM1;RCN3;CSTB
prerank,anion transmembrane transport (GO:0098656),-0.30110104721974723,-1.240249734819833,0.0967741935483871,0.6263888208262599,1.0,14/67,9.55%,SLC7A2;SLC6A13;SLC1A3;SLC16A12;SLC13A4;SLC13A3;SLC39A8;SLC7A5;SLC6A9;SLC25A42;SLC3A2;LRRC8B;SLC38A5;SLC25A11
prerank,epithelial cell differentiation (GO:0030855),0.44676385709495714,1.2400273204661603,0.13655462184873948,0.84615702726684,1.0,17/88,16.56%,FSTL1;DHRS9;ANXA1;WT1;VEGFA;ZDHHC7;TPP1;FZD7;JAG1;TDRD7;ACADVL;AKT1;DMBT1;SIX1;VDAC1;ANXA4;BDH2
prerank,regulation of neuroinflammatory response (GO:0150077),0.5411926104072998,1.239163235429706,0.21231155778894473,0.8485528474846671,1.0,9/19,17.74%,IL33;NR1D1;DAGLA;CD200R1;TNFRSF1B;IL4;NUPR1;IL6;IL18
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5406864751516013,1.2391002889609433,0.19343065693430658,0.847527135512689,1.0,5/22,11.34%,LBP;RAB7B;NR1D1;TIRAP;WDFY1
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4203863174161518,-1.2389926219433722,0.16334661354581673,0.6268585522782234,1.0,4/17,6.08%,PRKAG2;PRKAA2;PPARA;CAV1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5238439106701626,1.2389919892128898,0.20496894409937888,0.8466841161087338,1.0,5/22,8.44%,AREG;FGF7;SRSF6;ZFP36L1;VDR
prerank,protein secretion (GO:0009306),0.4678456400081237,1.2389277366017928,0.14594594594594595,0.8457084357847998,1.0,11/56,11.41%,ANXA1;NECAB3;PCSK5;STEAP3;PREB;MIA3;RCN3;ABCA1;ADCYAP1;ARFGAP3;RAB3D
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.34752200013699824,-1.23886070856764,0.1111111111111111,0.6242698048304672,1.0,8/37,6.12%,ALCAM;TENM4;PTPRD;FAT4;CADM1;HMCN1;CXADR;VCAM1
prerank,monocarboxylic acid transport (GO:0015718),-0.32455131987326397,-1.2388232551775313,0.11494252873563218,0.6214434761531515,1.0,9/51,2.26%,SLC6A13;SLC16A12;ABCC4;SLC16A2;ABCG2;SLCO2B1;SLCO1C1;SLC16A6;SLC6A12
prerank,respiratory system development (GO:0060541),0.494634358786016,1.2383709021797695,0.20139697322467986,0.8469839336171893,1.0,6/32,7.49%,FGF7;WT1;DISP1;VEGFA;FGF2;GLI2
prerank,positive regulation of chemotaxis (GO:0050921),-0.3322842208980757,-1.2381326738503475,0.13953488372093023,0.6202652768547493,1.0,14/43,12.23%,PTN;F3;THBS1;PRKD1;SEMA5A;KDR;IL6R;NRP1;NTRK3;PDGFRB;CDH13;MDK;TGFB1;PPM1F
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5566540122357565,1.2379385315053923,0.19240837696335078,0.8475610287797655,1.0,4/17,11.41%,SLC4A8;STX1A;SCAMP5;RAB3D
prerank,positive regulation of response to external stimulus (GO:0032103),-0.2807156773240796,-1.2376305106853955,0.09090909090909091,0.6187592422708108,1.0,38/128,17.80%,PTN;BMP6;ETS1;SASH1;APP;THBS1;SNCA;WNT5A;GPR4;PLSCR1;POLR3C;OPTN;NAPEPLD;AGTR1;POLR3B;DDX60;PUM2;PDGFRB;TLR3;FEM1A;CX3CL1;PDE2A;GBP5;MDK;RIPK1;TGFB1;PPM1F;USF1;NFKBIA;LY86;NMI;SERPINE1;USP15;LY96;LPL;DHX58;CYBA;RARRES2
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5433241384602551,1.2373613867636712,0.22033898305084745,0.8488254954479035,1.0,4/20,8.17%,IGFBP5;LRP1;SLIT2;NDRG4
prerank,cellular response to lipid (GO:0071396),0.42976032783803614,1.237103946303517,0.07028112449799197,0.8487377611122542,1.0,40/191,16.64%,LBP;AR;CD80;UCP1;ESR1;AXL;WNT10B;WNT2;EGFR;IRS1;EPHA3;WNT9A;ADAM9;ATP1A3;ATP1A1;MAPK14;NR1D1;CXCL10;NCOA3;CARD16;RET;PID1;ABL2;FZD7;TLR4;SIRPA;URI1;IRAK1;ADCY8;ZFP36;ADAM15;RHOA;TNFRSF1B;ZC3H12A;CD14;FZD4;SELENOS;PDCD4;IL6;HTRA2
prerank,regulation of histone modification (GO:0031056),0.5733411899431995,1.2370044426602396,0.20777479892761394,0.8479078208254256,1.0,6/13,14.66%,FLCN;UBE2N;CDK9;PARG;AKAP8;SETD5
prerank,regulation of protein import into nucleus (GO:0042306),0.4871614958153751,1.236939062598296,0.19069767441860466,0.8468939417333605,1.0,17/36,22.68%,ZPR1;PIK3R2;RAB23;MDFIC;PSEN1;RBM22;HDAC3;JUP;CABP1;ZC3H12A;DMAP1;CHP1;IPO5;UFM1;FLNA;BAG3;TPR
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.3579594953830437,-1.2363370708721475,0.1527777777777778,0.6191690138897212,1.0,5/32,4.40%,PRKAG2;SORBS1;APOE;PRKAA2;PPARA
prerank,positive regulation of T cell differentiation (GO:0045582),0.4830585312357377,1.2363308280205636,0.1649122807017544,0.8483132538740836,1.0,7/36,14.82%,TNFSF9;ZMIZ1;GLI2;ZBTB1;BCL6;GLI3;IL4
prerank,cGMP metabolic process (GO:0046068),-0.4724943059590253,-1.235958027009048,0.22794117647058823,0.6173042334770038,1.0,4/12,12.97%,GUCY1B1;NPR1;PDE2A;GUCY1A1
prerank,camera-type eye development (GO:0043010),0.5180958846318938,1.2354169156007195,0.19809069212410502,0.8511339806966646,1.0,7/25,12.56%,FBN1;WT1;VEGFA;SKI;TENM3;TSKU;ALDH1A3
prerank,embryonic limb morphogenesis (GO:0030326),0.49674387870704934,1.2352510346785512,0.19168591224018475,0.850591063355904,1.0,9/34,13.56%,LRP6;AFF3;MBNL1;TGFB2;SKI;ECE1;FBXW4;GLI3;TWIST1
prerank,secondary palate development (GO:0062009),0.5709631385550434,1.2352143555928243,0.22416107382550335,0.8494996035640239,1.0,4/14,3.68%,TGFB3;TGFB2;TGFBR2;SMAD4
prerank,cellular response to cytokine stimulus (GO:0071345),0.4253058576487516,1.234557756098475,0.019,0.851111852450275,1.0,92/416,17.97%,IL4R;GHR;SYK;LBP;LIF;COL1A2;HAS2;CD80;DUOX1;AXL;CCL8;IRF4;ANXA1;NUMBL;IL16;CTF1;GRB10;FYN;VEGFA;IRAK3;MMP2;FGF2;STX1A;NFE2L2;ZFP36L1;CLCF1;PTPRJ;SOCS2;USP10;FOXO1;NR1D1;CSK;CXCL10;MUC1;FSCN1;RC3H1;PID1;ABL2;GAS6;IL10RA;FLT3LG;ZFP36L2;STAT5A;CHUK;PIK3CA;CDK9;CCL25;TLR4;STX4;UBE2G2;MAPK11;INPP5K;CD47;SIRPA;IRAK4;BCL6;AKT1;SLC26A6;CSF2RA;IRAK1;STK39;UBA52;CDC34;ZFP36;CCL13;FLT3;CDKN1A;CCND1;IL5;RHOA;TWIST1;TNFRSF1B;CBL;ZC3H12A;FER;CNTFR;HSP90AA1;IL4;RAPGEF1;BAG4;SOCS6;SOS1;IL6;HGF;STAT5B;HTRA2;ZEB1;CXCR4;PTPN5;IL18;EPRS1;STX3
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5412563369308641,1.234541304762383,0.20959595959595959,0.8499059434813684,1.0,7/19,17.16%,HPN;MAPK7;TMEM106A;KLF2;EGF;KLF4;CHRNA7
prerank,protein O-linked glycosylation via serine (GO:0018242),0.5976166237554756,1.2341636974588894,0.2207977207977208,0.8502818897132767,1.0,5/10,23.98%,GALNT16;GALNT1;MGAT5B;POGLUT2;GALNT4
prerank,glycolipid metabolic process (GO:0006664),0.4734582486458064,1.2340952446706754,0.17620650953984288,0.8493182593924653,1.0,11/47,13.74%,SMPD3;ST3GAL2;ARSA;B3GALNT1;FUT2;GBA2;ST3GAL4;GLA;CERK;GLTP;PIGW
prerank,L-amino acid transport (GO:0015807),-0.3729223759850945,-1.2337388651938554,0.18,0.6199825508860045,1.0,6/28,9.21%,SLC7A2;SLC1A3;SLC7A5;SLC3A2;CTNS;SLC38A5
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.3395567525988169,-1.2337080405716303,0.13846153846153847,0.6172631847161519,1.0,14/38,17.72%,BMP6;SASH1;PLSCR1;POLR3C;POLR3B;DDX60;PUM2;GBP5;LY86;NMI;USP15;LY96;DHX58;CYBA
prerank,RNA export from nucleus (GO:0006405),0.44383290842029655,1.2325065499441226,0.12293388429752067,0.8551059800405202,1.0,43/100,28.07%,SRSF2;HNRNPA1;SRSF6;NXF1;DDX19B;NUP93;MCM3AP;NUP107;U2AF1;SRSF3;NUP98;CPSF4;SRSF11;THOC7;POLDIP3;SMG7;THOC2;THOC1;ZC3H11A;SMG6;FYTTD1;NUP37;CPSF2;DDX39A;SRRM1;NUP50;SLBP;U2AF2;TPR;CPSF1;AGFG1;WDR33;NUP133;NUP85;ALYREF;UPF3B;NUP188;UPF1;NUP88;SMG5;CDC40;THOC5;CPSF3
prerank,chromatin assembly (GO:0031497),0.4905769505120271,1.2323033218315904,0.19106145251396647,0.8547823558317523,1.0,21/38,29.87%,CHAF1B;NOC2L;SPTY2D1;POLE3;NPM1;ANP32B;EZH1;BAHD1;GRWD1;NAP1L2;CTCF;PRDM9;PAF1;BRD2;KAT6B;NAP1L3;H1-0;LIN54;ATRX;TP53;SOX9
prerank,regulation of spindle assembly (GO:0090169),0.5157669816324372,1.2322170094286082,0.20752427184466019,0.8538851237334917,1.0,9/25,22.68%,GPSM2;VPS4B;CCSAP;CEP97;DYNC1H1;SENP6;NUMA1;PDCD6IP;TPR
prerank,regulation of signal transduction (GO:0009966),0.4309687044896172,1.2321953655370441,0.07515030060120241,0.8527344404468439,1.0,35/190,10.07%,IGFBP5;CD80;CD55;ESR1;MGLL;SRMS;PLCE1;FYN;CD177;GAS1;DGKQ;IGFBP6;CDKN2AIP;RUNX1;LLGL1;WWTR1;AXIN1;ACVR1;GNG4;IGFBP4;ZDHHC7;MTCH1;SOCS2;TSPEAR;DTNBP1;CSK;SRC;YWHAG;SULF1;ADCYAP1;FOXL1;MDFIC;RFNG;GSKIP;USP33
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.5003102088070669,1.2318988031363531,0.18556701030927836,0.852731461020827,1.0,15/33,22.79%,IRS1;PIK3C2B;PIK3R2;CD160;ZFP36L1;C1QBP;PIK3CA;SIRT2;AKT1;PLEKHA1;TYRO3;PTEN;PIK3CG;NF1;HTR2A
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5153288874713188,1.2317034827856979,0.21480582524271843,0.8523690107224304,1.0,4/24,5.35%,MYOC;VEGFA;S100A10;PTPRJ
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4928306346759871,1.231461464374324,0.20094562647754138,0.8521785543009118,1.0,4/33,2.55%,IGFBP5;TGFB3;ANG;OGN
prerank,myoblast differentiation (GO:0045445),0.5644404976525355,1.2310714800016875,0.22,0.852647192037827,1.0,6/14,16.59%,MAPK12;MBNL1;TCF7L2;JAG1;DDX17;DDX5
prerank,positive regulation of axon extension (GO:0045773),0.5265688034044593,1.230905595984167,0.1977329974811083,0.8521117675331082,1.0,9/22,17.87%,DBN1;VEGFA;NTN1;ISLR2;DSCAM;L1CAM;MAPT;GOLGA4;SHTN1
prerank,regulation of cell differentiation (GO:0045595),0.43509620342271904,1.2308543932389155,0.10030395136778116,0.8511014053767064,1.0,36/148,16.98%,LIF;AR;PHLDB1;TRPS1;SCIN;FGFR1;EPHA3;RUNX1;BIN1;ZFP36L1;HOPX;HEMGN;TAF8;NR1D2;NR1D1;ZFHX3;TRIP4;YWHAG;CDK9;PDCD2;PLEKHB2;BCL6;CEBPB;ANP32B;KLK6;ST7;GDNF;DDX17;SIX1;FADS1;KLF4;KLHL41;CDK5RAP2;DDX5;SNAI2;FLOT2
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5467102481648004,1.230467221034613,0.22531645569620254,0.8514973423700471,1.0,5/17,12.62%,DGKQ;SIRT2;INPP5K;PPEF2;CALM2
prerank,regulation of cell morphogenesis (GO:0022604),0.49731503623594375,1.2301975042863782,0.199288256227758,0.8514947826665464,1.0,7/30,11.10%,EFNA5;SPARC;CD44;ZRANB1;MYO9A;LARP4;CAMSAP1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.509700549372705,1.2301667223665687,0.19586374695863748,0.8503951285678829,1.0,8/27,15.06%,AHNAK;JSRP1;ANK2;CAMK2D;YWHAE;PDE4D;CALM2;CACNB1
prerank,intermediate filament organization (GO:0045109),0.5458696295388742,1.230117774125322,0.20707732634338138,0.8493522480678974,1.0,2/17,6.68%,KRT20;NEFL
prerank,negative regulation of viral entry into host cell (GO:0046597),0.5887045360871235,1.229828073717967,0.233983286908078,0.8493950490404519,1.0,3/12,10.83%,GSN;MID2;TRIM11
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5753982198400589,1.2295735007526187,0.2395693135935397,0.8492409094046555,1.0,4/12,17.74%,IL33;NUPR1;IL6;IL18
prerank,amino acid transport (GO:0006865),-0.3205704075762778,-1.229133493598882,0.12931034482758622,0.6263890414813037,1.0,13/49,13.34%,SLC7A11;SLC7A2;SLC6A12;PDPN;SLC38A11;SLC7A5;SLC3A2;SLC38A5;SLC25A44;SLC6A17;SLC6A6;SLC43A1;SLC7A14
prerank,muscle contraction (GO:0006936),-0.27183069216976796,-1.2286907740397621,0.0,0.6247931293592657,1.0,29/126,18.87%,SORBS1;TPM1;MYLK;CALD1;ACTN2;ITGA1;DMD;DTNA;DYSF;TMOD3;MYOF;EDNRA;MYL9;MYH11;SMTN;FXYD1;KCNJ12;ACTA2;NOS1;DES;MYOM1;MYL12A;CLCN1;MYBPC1;GJC1;UTRN;MYL6;ROCK1;TNNT3
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.46617279684543284,1.2279399750129234,0.18991416309012876,0.855067395352877,1.0,16/57,15.54%,CDC14B;FANCD2;EME1;TIPIN;TAOK3;RFWD3;RINT1;DTL;FBXO31;TAOK2;RPS27L;CDKN1A;ABRAXAS1;CCND1;NBN;NOP53
prerank,sensory perception of chemical stimulus (GO:0007606),0.5603830478313083,1.2277347506444887,0.22207621550591328,0.8546938369982938,1.0,2/15,14.11%,GNAS;BBS4
prerank,response to purine-containing compound (GO:0014074),0.5427170657174469,1.2276709160181312,0.22251308900523561,0.8537432613769709,1.0,2/17,2.74%,DUOX1;DGKQ
prerank,protein import into nucleus (GO:0006606),0.45732207619746557,1.2274569334129195,0.15409139213602552,0.853402039857197,1.0,28/66,27.02%,SYK;SPRN;NUP93;KPNA2;NUP107;AKT1;IPO9;TNPO2;E2F3;IPO5;NUP50;NXT2;KPNA1;RPL23;RANBP6;TPR;IPO11;CBLB;IPO13;TSC2;NUP133;NUP85;TNPO1;KPNA6;FAM53C;NUP188;KPNB1;NUP88
prerank,response to lipopolysaccharide (GO:0032496),0.43221474116252784,1.2272921514025201,0.11764705882352941,0.8528845440102162,1.0,30/138,16.30%,LBP;CD80;AXL;IRAK3;FOXP1;F2R;S100A8;S100A9;ADAM9;MAPK14;NR1D1;CXCL10;CARD16;CYP27B1;TIRAP;TLR4;SMAD6;SIRPA;SLPI;IRAK1;ZFP36;RHOA;TNFRSF1B;ZC3H12A;FER;GGT7;CD14;SELENOS;PDCD4;IL6
prerank,epithelium development (GO:0060429),0.4362152093522413,1.226438205184738,0.13786008230452676,0.8553970740843483,1.0,23/107,16.59%,CD34;DHRS9;WNT2;WT1;MEOX2;VEGFA;PKD1;SOX10;DACT1;TRIM71;RCN3;PKD2;TPP1;SOX8;NDRG4;ACADVL;DMBT1;SIX1;VDAC1;AHI1;ANXA4;BDH2;SNAI2
prerank,negative regulation of axonogenesis (GO:0050771),0.5102528663201485,1.2264147453161154,0.19759036144578312,0.8542839391170312,1.0,8/27,14.33%,FGF13;PTPRS;TRIM46;GDI1;ULK2;RHOA;ULK1;DCC
prerank,regulation of telomere maintenance (GO:0032204),0.5024437421862329,1.226193434478815,0.2171837708830549,0.853942508691707,1.0,15/26,29.30%,HNRNPD;ERCC4;XRCC5;NBN;USP7;SMG6;PML;RAD50;TINF2;TERF2IP;ERCC1;UPF1;SMG5;HDAC8;ATRX
prerank,regulation of GTPase activity (GO:0043087),-0.26585484655703634,-1.225716735944339,0.0,0.6297122355147863,1.0,43/177,10.63%,PLXNA2;PKP4;PRKG1;EPHA4;RAPGEF2;RAPGEF3;CHN2;ITGA6;RAP1GDS1;NET1;PLXNA4;FGD4;CHN1;CDKL5;F11R;FGD5;DAB2IP;DOCK8;TGM2;PLXND1;RASGRP2;SIPA1L1;RASIP1;LRCH1;MAP4K4;RGS6;DVL3;DOCK9;CPEB2;BCAR3;PLXNB1;ERBB2;CX3CL1;SFRP1;CAV2;STMN3;ZC3H15;USP6NL;LIMS1;AGRN;TBC1D30;ARL2;RGP1
prerank,response to thyroid hormone (GO:0097066),0.565541423153379,1.2254321893284532,0.22593582887700533,0.8559764640052319,1.0,2/13,7.15%,HPN;GAS2L1
prerank,negative regulation of phosphorylation (GO:0042326),0.43699364652237765,1.2249444240136338,0.16132368148914167,0.8568599792105474,1.0,33/85,24.13%,EPHB2;LRP6;NIBAN1;SLIT2;WWTR1;PLPP3;TARDBP;MYADM;INHA;PID1;PIP5KL1;TIGAR;INPP5K;SIRPA;MAPT;IRS2;CDKN1A;NCOR1;HDAC4;ZC3H12A;NUPR1;CHP1;PPIA;IBTK;FKBP8;CORO1C;PTEN;CDKN2C;TERF2IP;FBLN1;ANKLE2;ATG14;DYNLL1
prerank,cellular response to cAMP (GO:0071320),0.5011413771657112,1.2245520215899826,0.20921985815602837,0.8572967827653971,1.0,8/30,11.33%,IGFBP5;WT1;ZFP36L1;RAP1B;PKD2;INPP5K;HCN4;SLC26A6
prerank,replicative senescence (GO:0090399),-0.4599830523669416,-1.224546335676367,0.21428571428571427,0.6298969812198009,1.0,7/12,31.67%,ATM;TERT;SERPINE1;PLA2R1;CHEK1;ATR;WNT16
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5828858999482504,1.2244548898430223,0.22752808988764045,0.8564693756071824,1.0,4/12,13.66%,SRM;ODC1;TRH;SMS
prerank,cytokine-mediated signaling pathway (GO:0019221),0.4211763863515354,1.2244342768023404,0.008,0.8553573165804287,1.0,104/532,17.97%,MID1;IL4R;TNFSF9;GHR;ACKR3;SYK;LBP;LIF;COL1A2;CD80;DUOX1;CCL8;IL1RL1;IRF4;ANXA1;IRS1;NUMBL;IL16;CTF1;PSMC4;CD44;GRB10;FYN;ANXA2;VEGFA;IRAK3;MMP2;FGF2;STX1A;MIF;SMAD4;RAP1B;CLCF1;PTPRJ;SOCS2;CAMK2D;FOXO1;IL33;CSK;CXCL10;MUC1;TNFRSF11B;PSMC6;SRC;FSCN1;PELI3;IL17RA;ABL2;IL10RA;UBE2N;FLT3LG;STAT5A;TNFRSF18;CHUK;PIK3CA;PSMD8;TNFSF13B;CCL25;STX4;SAMHD1;ARF1;SQSTM1;IRAK4;BCL6;AKT1;CSF2RA;IRAK1;UBA52;PLVAP;IRS2;CD27;CCL13;FLT3;CDKN1A;TRAF3IP2;CCND1;IL5;TWIST1;TNFRSF1B;CBL;FER;CNTFR;HSP90AA1;IL4;RAPGEF1;SMARCA4;EDA;BAG4;TRIM68;TRAF3;SOCS6;PDCD4;SOS1;IL6;HGF;STAT5B;ZEB1;PML;MAP3K14;PPIA;CXCR2;IL18;ILK;STX3
prerank,RNA metabolic process (GO:0016070),0.43078818822702364,1.224426492456413,0.13549039433771487,0.8541698779038365,1.0,40/127,19.99%,POLR2H;ADARB1;HNRNPA1;RNASE4;RBM4;BICD1;PRPF4;ATXN2;TFIP11;AGO2;DUSP11;HNRNPD;EXOSC7;SIDT2;HNRNPH1;DHX8;CELF2;RBFOX2;RNASE6;POLR2D;POLR2G;MPHOSPH10;DDX17;HNRNPA3;ZC3H12A;RBM3;THOC1;GTF2F1;DDX20;AGO4;NUFIP1;TENT2;RBM6;RBM39;SUPV3L1;DDX24;HNRNPUL1;AGO3;NOVA1;PTBP1
prerank,body fluid secretion (GO:0007589),0.5640302483600725,1.2243967907184476,0.2363150867823765,0.8531041370667751,1.0,2/15,2.76%,GPAT4;VEGFA
prerank,negative regulation of cellular component organization (GO:0051129),0.4503324513913603,1.2241454305886321,0.15800636267232238,0.8530045698772656,1.0,12/74,7.93%,AR;TMEFF2;FAP;EPHA3;VEGFA;IRAK3;SYT11;AIDA;SRC;HDAC6;SCAMP5;TFIP11
prerank,telomere capping (GO:0016233),0.5467032599846751,1.2239331587120987,0.23443708609271524,0.8527118282777831,1.0,11/16,27.65%,CTC1;ACD;TFIP11;TERF1;NBN;RAD50;TINF2;DCLRE1A;TERF2IP;PRKDC;STN1
prerank,regulation of keratinocyte migration (GO:0051547),0.598338819148638,1.2234877215181723,0.23333333333333334,0.8533817174990765,1.0,8/12,28.74%,FGF7;ADAM9;MTOR;ARF6;PTEN;IQSEC1;FGF10;MAPRE2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.4408985164199321,1.22318248581778,0.1353305785123967,0.8533875283080655,1.0,42/96,28.07%,SRSF2;SRSF6;NXF1;DDX19B;NUP93;MCM3AP;NUP107;U2AF1;SRSF3;NUP98;CPSF4;SRSF11;THOC7;POLDIP3;SMG7;THOC2;THOC1;ZC3H11A;SMG6;FYTTD1;NUP37;CPSF2;DDX39A;SRRM1;NUP50;SLBP;U2AF2;TPR;CPSF1;AGFG1;WDR33;NUP133;NUP85;ALYREF;UPF3B;NUP188;UPF1;NUP88;SMG5;CDC40;THOC5;CPSF3
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4331603255071708,1.2229919366206616,0.11770726714431934,0.8529411000997114,1.0,24/128,10.84%,COL3A1;COL1A2;AMH;TMEM100;TGFB3;ZMIZ1;TGFB2;TGFBR2;ADAM9;SMAD4;SMURF2;SKI;ACVR1;BMP15;ITGB5;FAM83G;RNF111;SRC;SMAD5;STUB1;PARD6A;BMP8A;SMAD6;AMHR2
prerank,negative regulation of angiogenesis (GO:0016525),0.4425387470724692,1.222506359720242,0.15822130299896586,0.8538234013009832,1.0,15/84,8.12%,DCN;TNMD;ANGPT4;ISM1;SPARC;TGFB2;CD160;KLF2;ATP2B4;HOXA5;CREB3L1;CXCL10;THBS4;SULF1;SERPINF1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.40595083931009,-1.222470899464274,0.15609756097560976,0.6325342889207486,1.0,5/20,8.53%,GRK3;MGRN1;SNCA;CRY1;APLP1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4991157704935491,1.2222283092015636,0.21160822249093109,0.853885787825023,1.0,9/27,14.87%,IRAK3;TLR5;TIRAP;TLR4;IRAK4;IRAK1;TNIP1;UBA52;CD14
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.4900203671284265,1.2219461314070164,0.19248826291079812,0.8538894985807512,1.0,11/32,14.32%,ANXA1;MEOX2;VEGFA;FGF2;HDAC9;HDAC7;FOXC2;AKT3;RHOJ;RHOA;KLF4
prerank,regulation of immunoglobulin production (GO:0002637),0.5115306099688763,1.2214463659078794,0.228287841191067,0.8547355170599176,1.0,5/23,16.30%,EPHB2;CLCF1;STX4;IL4;IL6
prerank,regulation of lymphocyte migration (GO:2000401),0.5995651373208977,1.2205839990125311,0.24964336661911554,0.857166481729609,1.0,5/10,27.25%,MIA3;AKT1;SLC8B1;STK10;WASL
prerank,negative regulation of cell junction assembly (GO:1901889),-0.3774157233490083,-1.2197537063647546,0.18478260869565216,0.63704020581668,1.0,5/25,5.19%,PHLDB2;ARHGAP6;THBS1;APOD;ROBO2
prerank,regulation of ossification (GO:0030278),0.474717259427143,1.2195639394034694,0.22170900692840648,0.8605796473659686,1.0,9/36,10.09%,DDR2;LRP6;TGFB2;ECM1;ACVR1;CYP27B1;BMP2K;SGMS2;SMAD6
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.4738909732999688,1.2194589763624506,0.1989010989010989,0.8598583209989228,1.0,14/44,16.31%,TRIAP1;CD44;VEGFA;CARD16;SRC;GAS6;CAST;DPEP1;YWHAE;GPX1;AKT1;SFN;KLF4;HGF
prerank,regulation of protein sumoylation (GO:0033233),0.5470182300692676,1.2192638171577004,0.2471190781049936,0.8594889152108398,1.0,5/17,13.86%,ZMIZ1;GNL3L;PIAS3;UBA2;HDAC4
prerank,tRNA 5'-leader removal (GO:0001682),0.566038821482928,1.2190810596384412,0.24,0.8590422874417045,1.0,5/13,15.93%,RPP25;RPP21;PRORP;RPP25L;POP4
prerank,negative regulation of blood coagulation (GO:0030195),0.47810789736516307,1.2187676315929588,0.20089786756453423,0.8591775676969189,1.0,3/38,3.63%,CD34;C1QTNF1;KLKB1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.5415963962536007,1.218640137945927,0.21428571428571427,0.858548292574766,1.0,7/18,17.29%,CDK4;RAD51B;VPS4B;DTL;FBXO5;CCND1;RCC2
prerank,positive regulation of double-strand break repair (GO:2000781),-0.3369004493411652,-1.218215044221095,0.1440677966101695,0.6382831269570247,1.0,18/39,19.43%,WDR48;SPIRE1;KMT5B;SHLD1;DTX3L;SLF2;KMT5C;ARID2;MGMT;MRNIP;PNKP;RIF1;SMCHD1;SETMAR;PARP9;FANCB;TIMELESS;MAD2L2
prerank,regulation of macrophage activation (GO:0043030),0.4925432807074743,1.2181923185920633,0.20595238095238094,0.8593381785411667,1.0,10/30,19.87%,LBP;MIF;IL33;TLR4;ZC3H12A;IL4;LRFN5;IL6;GPR137B;IL31RA
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.42806104270352985,1.2181793490118615,0.11425682507583418,0.8582126639752867,1.0,22/138,10.43%,ANGPTL1;SYK;LIF;DDR2;EPHB2;AXL;SRMS;EGFR;TNK1;FGFR1;EPHA3;FYN;MST1R;TRIO;RET;PTPRF;SRC;POLR1G;ABI1;EFS;EPHB3;MUSK
prerank,regulation of leukocyte activation (GO:0002694),-0.4305602071664573,-1.2180451616261414,0.203125,0.635809569747079,1.0,6/14,15.78%,LYN;MYO18A;PLSCR1;CD200;GPER1;CD74
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.4747246705878563,1.2175451447672347,0.19955156950672645,0.8596171453652184,1.0,22/42,31.04%,MARS2;TARS1;SARS2;VARS1;HARS1;GARS1;VARS2;EEF1E1;EPRS1;QARS1;AIMP1;EARS2;AIMP2;NARS1;PPA1;YARS1;SARS1;PPA2;DARS1;WARS2;AARS1;LARS2
prerank,regulation of cellular protein localization (GO:1903827),0.4714723835250765,1.2172662119147846,0.2040586245772266,0.859563384686617,1.0,12/45,16.66%,RAB11FIP5;GPC6;GPC3;NDEL1;TRIM46;TOR1A;MAPT;SETD2;EGF;PIN1;HSP90AA1;SPIDR
prerank,regulation of T cell migration (GO:2000404),-0.4038027672476746,-1.217056549758399,0.19665271966527198,0.6356241716342025,1.0,5/18,5.61%,APP;APOD;DOCK8;CXCL12;LRCH1
prerank,glycogen biosynthetic process (GO:0005978),0.5796563799551401,1.2158734012143095,0.21595598349381018,0.8632536790700001,1.0,4/12,12.79%,UGP2;NR1D1;PGM2L1;PPP1R3C
prerank,glucan biosynthetic process (GO:0009250),0.5796563799551401,1.2158734012143095,0.21595598349381018,0.8632536790700001,1.0,4/12,12.79%,UGP2;NR1D1;PGM2L1;PPP1R3C
prerank,regulation of bone mineralization (GO:0030500),-0.317855781149369,-1.2156305308447848,0.17647058823529413,0.6366234141587809,1.0,15/55,7.95%,PTN;BMP6;WNT4;ADGRV1;ENPP1;BMP7;MEF2C;OSR1;ANKH;KL;NELL1;ATRAID;S1PR1;NOTUM;BMPR2
prerank,retinoid metabolic process (GO:0001523),0.44737862802665834,1.215596802745214,0.17770767613038907,0.8632071367541015,1.0,6/71,2.21%,AKR1B1;DHRS9;LRP1;CYP2S1;GPC6;GPC3
prerank,epithelial structure maintenance (GO:0010669),-0.4670544276593471,-1.2151295672349745,0.22181818181818183,0.6352334449954343,1.0,2/11,6.08%,RBP4;CXADR
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.44079042622913045,1.2144153002090927,0.14915966386554622,0.8671153346851187,1.0,19/87,14.03%,COL3A1;COL1A2;TGFB3;ZMIZ1;TGFB2;TGFBR2;ADAM9;SMAD4;SKI;ACVR1;ITGB5;SRC;SMAD5;PARD6A;SMAD6;AMHR2;UBA52;RHOA;CBL
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.5843368425277811,1.2142567320415365,0.2396576319543509,0.8666144953520013,1.0,4/10,21.60%,RC3H1;ZC3H12A;IL4;RC3H2
prerank,acute-phase response (GO:0006953),0.5836516360790205,1.2140096318915776,0.2403846153846154,0.8664746386380129,1.0,4/12,18.59%,LBP;CEBPB;IL6;MBL2
prerank,growth hormone receptor signaling pathway (GO:0060396),0.5641225541676473,1.2139762506450829,0.2602921646746348,0.8654446498310011,1.0,3/14,8.10%,GHR;SOCS2;STAT5A
prerank,regulation of supramolecular fiber organization (GO:1902903),0.5192033156194209,1.2137447769873007,0.23449131513647642,0.8651810512885216,1.0,8/22,11.50%,MAP1B;AKAP13;MAPRE3;PIK3CA;GPX1;CAMSAP1;MAPT;GBA2
prerank,in utero embryonic development (GO:0001701),0.5080470448910333,1.2131148941842342,0.22399020807833536,0.8665740846078215,1.0,7/25,8.12%,TGFB3;MBNL1;VEGFA;LMX1B;PKD1;FLCN;SOX8
prerank,mRNA destabilization (GO:0061157),0.47986513536254677,1.2128089998869662,0.22119815668202766,0.8666633626707653,1.0,12/38,17.50%,DIS3L2;ZFP36L1;TRIM71;TARDBP;RC3H1;ZFP36L2;PUM1;ZFP36;POLR2D;ZC3H12A;YTHDF1;YTHDF2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.4817670358911552,1.2126432415130295,0.22273781902552203,0.8661830359748338,1.0,20/33,32.58%,CEL;SLC4A8;NRG3;PXK;BTBD9;GRID1;FABP5;GRIK5;GRIK2;BCR;GRIK4;EIF4EBP2;GRID2;NLGN1;NLGN3;IQSEC2;PSMC5;NLGN2;NGF;LRRC4C
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.510810322106799,1.2124157018582058,0.23680981595092024,0.8659396089034817,1.0,5/24,7.85%,TNMD;GRB10;ITGB3;ITGA5;PRKD2
prerank,homologous chromosome segregation (GO:0045143),0.5228717278671947,1.212109405648896,0.25566750629722923,0.8659846942990463,1.0,6/20,21.28%,FANCD2;RNF212B;TERB1;CENPC;PRDM9;FMN2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.43320961608501407,1.2118662604867712,0.13217213114754098,0.8657881360372648,1.0,22/112,10.84%,COL3A1;COL1A2;WNT2;TGFB3;CLEC3B;MAPK7;ZMIZ1;TGFB2;TGFBR2;ADAM9;SMAD4;SKI;ACVR1;ZFP36L1;ITGB5;SRC;SMAD5;ZFP36L2;PARD6A;SOX5;SMAD6;AMHR2
prerank,peptide catabolic process (GO:0043171),0.5140909706503239,1.2118413019358765,0.20838471023427868,0.8647321954803618,1.0,8/23,16.88%,ANPEP;LNPEP;DPEP1;TPP1;ECE1;NPEPPS;GGT7;IDE
prerank,peptidyl-lysine modification (GO:0018205),0.4375175128987257,1.2117705475862408,0.15827338129496402,0.8638466665374601,1.0,17/99,10.03%,PLOD2;LOXL2;LIPT2;STX1A;HDAC9;RNF212B;NUP93;PIAS3;HDAC6;NUP107;UBA2;PLOD3;NUP98;SIRT2;KAT2B;LOXL1;NDUFAB1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5937705392893056,1.2111690555721033,0.25952045133991536,0.8640606694313587,1.0,4/11,12.62%,SRI;PKD2;GSTM2;CALM2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5937705392893056,1.2111690555721033,0.25952045133991536,0.8640606694313587,1.0,4/11,12.62%,SRI;PKD2;GSTM2;CALM2
prerank,chondrocyte differentiation (GO:0002062),0.49047011526934287,1.2109954764150501,0.22584400465657742,0.8636033475410045,1.0,8/32,9.27%,WNT10B;EIF2AK3;SULF2;RUNX1;SLC39A14;NFIB;SULF1;SOX5
prerank,placenta development (GO:0001890),0.577773682980786,1.2106245202615968,0.23415977961432508,0.864010509985664,1.0,2/12,4.55%,ANG;ADAM19
prerank,regulation of filopodium assembly (GO:0051489),0.4791287874945228,1.2105508024954503,0.2108843537414966,0.863177394158933,1.0,16/38,24.32%,ARHGAP44;TGFB3;GAP43;MYO10;FSCN1;PALM;RHOQ;BCAS3;ARF6;FXR2;ARAP1;GPM6A;RALA;ABITRAM;DOCK11;DMTN
prerank,neuron cell-cell adhesion (GO:0007158),0.5530523000709688,1.2104525230339045,0.24183006535947713,0.8624542893869954,1.0,10/14,32.87%,CEL;RET;NRXN3;CNTN4;NLGN1;NLGN3;NRXN1;NLGN2;NCAM2;NRXN2
prerank,relaxation of cardiac muscle (GO:0055119),0.5694893234558556,1.2104467168070285,0.23255813953488372,0.8613311025850056,1.0,6/13,11.17%,GSN;ATP1A1;KCNJ2;CAMK2D;PIK3CA;GSTM2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.3501947855472724,-1.2101073842665568,0.16417910447761194,0.6452979422064115,1.0,10/29,12.75%,ACSL1;ELOVL7;ACSL4;HACD1;ACSL3;CBR4;HACD2;ACSL6;SCD;ELOVL1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4514915040669151,1.2099983275986972,0.1751592356687898,0.8621159962704577,1.0,16/66,14.55%,CDK2AP2;EGFR;ANXA1;FHL1;PKD1;CDK4;DACT1;PRMT2;PKD2;BRD7;AKT1;GPNMB;CDKN1A;CCND1;KLF4;INO80
prerank,endosome organization (GO:0007032),0.46859658103021906,1.2093991539586357,0.22591743119266056,0.8635260793598074,1.0,17/41,27.53%,DNM1;HOOK2;PLEKHF1;PI4K2B;TMEM9;SQSTM1;USP50;PHETA2;VPS11;ANXA8;ANXA8L1;VPS33B;CORO1C;PI4K2A;ALS2;SNX33;ARFGEF2
prerank,global genome nucleotide-excision repair (GO:0070911),0.5047201600753533,1.209389107388556,0.22576687116564417,0.8624188686091663,1.0,7/26,13.25%,GTF2H3;RAD23B;RNF111;ERCC3;UBA52;ERCC4;DDB1
prerank,blood circulation (GO:0008015),0.45408862689456203,1.2093881833202502,0.21973094170403587,0.8612720350072923,1.0,10/49,12.89%,AVPR1A;GCLC;MEOX2;TNNI3;ELN;CXCL10;HCN4;GPX1;SGCZ;SERPING1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.4192830049119252,1.2093820631280499,0.06406406406406406,0.8601552999178704,1.0,66/291,17.31%,IGFBP5;LBP;CD80;UCP1;ESR1;AXL;WNT10B;WNT2;EGFR;WT1;IRS1;EPHA3;CAPN2;WNT9A;SLIT2;ADAM9;MAPK14;P2RX3;ZFP36L1;RAP1B;MTOR;ATP2B4;FOXO1;NR1D1;CXCL10;NCOA3;CARD16;RET;PID1;ABL2;PKD2;DPEP1;CHUK;FZD7;TIRAP;TLR4;INPP5K;HCN4;SIRPA;CAMKK2;SSH1;AKT1;SLC26A6;MAPT;IRAK1;TSHR;MTR;ZFP36;RHOA;NSMF;RRAGD;TNFRSF1B;GNB1;ZC3H12A;PDGFRA;FER;KCNC2;CD14;RAPGEF1;FZD4;SELENOS;PDCD4;IL6;HTRA2;CPEB1;AKAP9
prerank,regulation of actin filament-based movement (GO:1903115),0.59444220366001,1.2093429144089543,0.23638968481375358,0.8591830424884038,1.0,4/10,15.37%,ANK2;SRI;PDE4D;STC1
prerank,microtubule anchoring at centrosome (GO:0034454),0.5940068630550591,1.209247513821422,0.2538569424964937,0.8584317766682952,1.0,6/10,21.33%,DCTN1;KIF3A;BBS4;NIN;CCDC120;PCM1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.42577068047475547,1.2089734877190872,0.1393939393939394,0.8584677561820256,1.0,16/140,10.16%,ACKR3;CD55;ESR1;C1QTNF1;LPAR3;NPTN;PLCE1;F2R;DLG4;LPAR1;P2RX3;ADCYAP1;ABL2;GPR20;ACKR4;CALCA
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.5561029457653747,1.2086609559155501,0.24863387978142076,0.8585843692215028,1.0,6/14,26.92%,TSEN54;RTRAF;CPSF4;TRPT1;CPSF1;DDX1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4727175466045375,1.2085201667248966,0.23076923076923078,0.8580211455995418,1.0,18/38,26.43%,UBE2J2;USP36;HPS4;LMAN1;NPEPPS;BAG4;HTRA2;VPS11;ARIH2;ATG13;SREBF1;UBE2D3;SAE1;CSNK2A2;PARL;LEPROT;FBXW7;RNF31
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.4715344967354595,1.2079059903410978,0.20748299319727892,0.8595221457585951,1.0,12/38,18.73%,ANK2;BIN1;DSC2;KCNJ2;CAMK2D;YWHAE;HCN4;JUP;KCNJ3;SCN4B;AKAP9;KCNH2
prerank,negative regulation of coagulation (GO:0050819),0.5689738876285401,1.2076692527206445,0.2547683923705722,0.8593331403257254,1.0,2/14,4.72%,CD34;PROCR
prerank,protein localization to chromosome (GO:0034502),0.4824872374071047,1.2076415771411226,0.21016166281755197,0.8583186449996312,1.0,9/34,18.67%,ESR1;PARP3;CHMP7;ACD;TPP1;XRCC5;IFFO1;TINF2;CTCF
prerank,neurotrophin signaling pathway (GO:0038179),-0.3866457309729566,-1.2074023502975912,0.23318385650224216,0.64988848419325,1.0,6/21,12.46%,RAPGEF2;SORT1;ZFYVE27;CASP3;NTRK2;BDNF
prerank,ureteric bud morphogenesis (GO:0060675),0.552243341936202,1.2073602907483498,0.24083769633507854,0.8584321425498156,1.0,5/16,13.71%,WT1;FGF2;PKD2;GDNF;SIX1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.46287595010242355,1.20729223071349,0.2127894156560088,0.8576058300917553,1.0,9/46,12.46%,IGFBP5;ANG;OGN;FOXP1;ELN;TCF7L2;NDRG4;AKT1;XRCC5
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.4133994248502754,-1.207145939781742,0.21008403361344538,0.6479466442679196,1.0,4/16,4.84%,RANBP3L;MEF2C;IGFBP3;PLCB1
prerank,cardiac muscle tissue development (GO:0048738),-0.318881092046704,-1.2068787924657047,0.19318181818181818,0.645928896624854,1.0,12/50,10.57%,GJB6;BMP5;ADAMTS9;BMP7;RBP4;NOTCH1;TBX18;GJA1;BMPR2;TBX2;SIK1;BMP2
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5048688519570146,1.2066255220288526,0.23205741626794257,0.8592092811186811,1.0,14/25,27.31%,HDAC6;STUB1;UBE2W;CUL3;TOR1A;CLPP;NGLY1;ZER1;AUP1;UGGT1;DERL1;ZYG11B;UFD1;UGGT2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.47477383243525084,-1.2061442778065377,0.23161764705882354,0.6449697803414896,1.0,1/12,0.65%,IL1R1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6053414592328494,1.2061205449165158,0.2411242603550296,0.8602544215959008,1.0,5/10,24.85%,IRF4;IL4;IL18;PRKCZ;RARA
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5503911439748197,1.206115614151503,0.2709677419354839,0.8580239019100313,1.0,4/15,12.63%,ZFP36L1;ZFP36L2;AGO2;ZFP36
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5503911439748197,1.206115614151503,0.2709677419354839,0.8580239019100313,1.0,4/15,12.63%,ZFP36L1;ZFP36L2;AGO2;ZFP36
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.4889611647894949,-1.2061091111339433,0.26199261992619927,0.6423593384193124,1.0,5/11,6.25%,ADAMTS9;EPN2;THBS1;PIK3CB;SEMA6A
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.599573660785269,1.2060622518281134,0.24619640387275243,0.8571416110752705,1.0,3/10,9.83%,C1QTNF1;CD9;ADAMTS18
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.3601225735472882,-1.2058909751181979,0.17105263157894737,0.6403280535164145,1.0,6/28,8.53%,SORT1;BCL2;DAB2IP;CASP8AP2;DELE1;GABARAP
prerank,positive regulation of translation (GO:0045727),0.43706640981722195,1.2055351180949048,0.18200620475698034,0.8582054479415088,1.0,33/94,22.31%,NIBAN1;DAZL;MTOR;C1QBP;LARP4;AGO2;HNRNPD;MRPS27;NPM1;PASK;EIF6;LARP1;POLR2D;RPS27L;POLR2G;BCL3;ZCCHC4;POLDIP3;CDC123;RBM3;EIF3E;PKM;IL6;EIF3D;FXR2;YTHDF1;YTHDF2;RCC1L;RMND1;PCIF1;EIF5A2;MPV17L2;YTHDF3
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.6049156121728899,1.2052272256756806,0.2649930264993027,0.8583027960419543,1.0,6/10,24.13%,EMC1;EMC10;EMC8;EMC3;EMC2;EMC6
prerank,aorta development (GO:0035904),-0.4438113863699321,-1.2043826614844628,0.19213973799126638,0.6415139459951825,1.0,8/14,9.63%,ROBO1;ADAMTS9;ROBO2;TBX1;PDGFRB;HECTD1;TBX2;PDE2A
prerank,response to progesterone (GO:0032570),0.5310074797305296,1.2037874122128005,0.2553729456384324,0.8633053717558875,1.0,4/18,6.81%,TGFB3;TGFB2;CATSPERB;SRC
prerank,autophagy of nucleus (GO:0044804),0.5464477816705864,1.2037642741120385,0.23116883116883116,0.8622888777218143,1.0,8/16,21.77%,ATG2B;WIPI2;WDR45B;ULK2;ATG2A;ULK1;ATG13;ATG3
prerank,RNA splicing (GO:0008380),0.43067384046447044,1.2036637970594746,0.1535312180143296,0.8616125771614266,1.0,29/95,21.08%,SRSF2;WT1;MBNL1;DHX16;ZCRB1;TARDBP;LSM4;PRPF4;U2AF1;PRPF3;USP39;TCERG1;DHX8;SRSF11;MPHOSPH10;SF3B4;BCAS2;SNRPG;SNRPD3;PPP1R9B;LUC7L3;PDCD7;SRRM1;ZMAT5;NOVA1;PTBP1;SF3B2;SF3B1;SRPK1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.4201792407628607,-1.2033660823896095,0.22709163346613545,0.6417753457832195,1.0,8/16,22.96%,TRIM25;CAV1;NECTIN2;TRIM62;TRIM21;EXOC2;TRIM5;TRIM6
prerank,response to nutrient levels (GO:0031667),0.5359469718579182,1.2029692258061055,0.25617685305591675,0.863408202594708,1.0,3/17,6.04%,UCP1;MTOR;MEAK7
prerank,regulation of DNA metabolic process (GO:0051052),0.47132413998683104,1.2029651007336937,0.2283464566929134,0.8623141538050472,1.0,20/44,27.95%,KPNA2;UBE2N;CDK9;HNRNPD;PARG;MPHOSPH8;XRCC5;NBN;THOC1;SMG6;KPNA1;KDM1B;TERF2IP;WDR18;POLH;KAT7;ALYREF;UPF1;SMG5;HDAC8
prerank,mRNA export from nucleus (GO:0006406),0.43463058892280426,1.2023439202400918,0.14803312629399587,0.8637842391903485,1.0,44/102,28.07%,SRSF2;SRSF6;NXF1;DDX19B;NUP93;MCM3AP;NUP107;U2AF1;SRSF3;NUP98;CPSF4;SRSF11;THOC7;POLR2D;POLDIP3;SMG7;THOC2;THOC1;ZC3H11A;SMG6;FYTTD1;NUP37;CPSF2;DDX39A;SRRM1;NUP50;SLBP;U2AF2;TPR;CPSF1;AGFG1;WDR33;PABPN1;NUP133;NUP85;ALYREF;UPF3B;NUP188;UPF1;NUP88;SMG5;CDC40;THOC5;CPSF3
prerank,positive regulation of synaptic transmission (GO:0050806),0.4456318562337771,1.2023007340195155,0.18907563025210083,0.8628710469670193,1.0,26/72,24.63%,EPHB2;NPTN;DLG4;NFATC4;DTNBP1;MPP2;GRIN2D;STX1B;STX4;SQSTM1;CACNG2;LGI1;ADCY8;ZDHHC2;SLC8A2;GRIN2A;CHRNA7;SYT1;VAMP2;RIMS2;CLSTN3;NMU;FLOT1;GRIK2;PRKCZ;BAIAP3
prerank,mitochondrial transport (GO:0006839),0.45284156536749626,1.2019902960898394,0.20152505446623092,0.8630511680416362,1.0,21/53,25.09%,SLC25A31;GDAP1;TIMM10B;TIMM9;SLC25A4;SLC25A16;BAK1;HSP90AA1;TIMM22;SPG7;FLVCR1;TIMM8B;BCAP31;BCS1L;TOMM5;ABCB10;COX18;TIMM17A;FIS1;TMEM14A;TOMM40
prerank,spliceosomal snRNP assembly (GO:0000387),0.4730205417083077,1.201906135041161,0.2113163972286374,0.8622657831313917,1.0,11/38,18.71%,GEMIN6;CD2BP2;USP4;LSM4;WDR77;PRPF3;TGS1;DDX20;SNRPG;SNRPD3;STRAP
prerank,ventricular septum morphogenesis (GO:0060412),0.4915936460240448,1.2016941819558873,0.2304921968787515,0.8620395542555503,1.0,7/27,7.56%,TGFB2;SLIT3;SLIT2;TGFBR2;SMAD4;ACVR1;ZFPM2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.5947769806194405,1.2015863668658084,0.25957446808510637,0.8614052772694428,1.0,4/11,16.59%,EGFR;MAP2K2;IL6;DDX5
prerank,tRNA aminoacylation (GO:0043039),0.4772941548499548,1.2014945667964918,0.22514285714285714,0.8606783490027546,1.0,21/37,31.04%,MARS2;TARS1;SARS2;VARS1;HARS1;GARS1;EEF1E1;EPRS1;QARS1;AIMP1;QRSL1;AIMP2;NARS1;PPA1;YARS1;SARS1;PPA2;DARS1;WARS2;AARS1;LARS2
prerank,androgen metabolic process (GO:0008209),0.5287216006245057,1.201422135056367,0.2437417654808959,0.8598727518595529,1.0,5/18,23.86%,DHRS9;SRD5A1;HSD17B4;HSD17B11;SRD5A3
prerank,positive regulation of protein kinase activity (GO:0045860),0.42177323014474877,1.2013798333007428,0.12651821862348178,0.8589467194834449,1.0,30/148,14.60%,NOX4;DDR2;CAMKK1;ITGB3;VEGFA;TGFB2;TGFBR2;DLG4;TAOK3;AXIN1;MAP2K3;MAPRE3;ETAA1;RASSF2;SRC;ADCYAP1;GAS6;STRADA;SYAP1;SRCIN1;IQGAP1;CALCA;XRCC5;CALM2;TAOK2;CDKN1A;RHOA;SLC8A2;STK3;HSP90AA1
prerank,protein localization to organelle (GO:0033365),0.4258943818525892,1.2013726338634885,0.14052953156822812,0.8578834123380195,1.0,48/133,29.03%,COL1A1;TSPAN17;SIX4;RAB6A;ANK2;STX1A;STX5;LMNA;UBE2J2;GET4;ALDH3A2;BICD1;BBS9;WDR83OS;YWHAE;TOR1A;TRAM2;TMEM30A;SGTA;SIX1;ARFRP1;BBS4;TRAM1;MTCH2;ARF6;ATP6V1D;RAB33B;RAB35;AUP1;VAMP2;TOLLIP;PAF1;CROCC;PACSIN2;EMD;DVL1;SEC61B;MDM2;CALR;DCP1A;GBF1;DDX1;MICALL1;DNAJA1;TOPORS;CNTLN;ZBTB7A;PRNP
prerank,kidney development (GO:0001822),0.44709059909087207,1.2009494743882576,0.1853035143769968,0.8586184666877255,1.0,10/65,7.49%,HAS2;WT1;PCSK5;SULF2;VEGFA;TGFB2;C1GALT1;PKD1;SULF1;GLI2
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.4649927873851054,1.2008097015001298,0.2210065645514223,0.8581067678407264,1.0,16/46,20.75%,ANTXR1;TMEFF2;ITGB3;NTN4;RADIL;MEGF9;SRCIN1;ITGAV;EPHB3;ATRN;RHOA;FER;SRGAP2;ILK;LAMC1;TYRO3
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5266271910640733,1.1999045107179296,0.24645161290322581,0.8605950726329504,1.0,9/19,20.19%,UGDH;EXT1;B3GAT3;XYLT1;HS2ST1;HS3ST5;GLCE;NDST2;XYLT2
prerank,regulation of phosphate metabolic process (GO:0019220),0.5258891399642094,1.1997790494242948,0.2643229166666667,0.8599776636676316,1.0,6/16,15.16%,TIGAR;PSEN1;SIRT2;SMG7;IL4;SMG6
prerank,protein import into peroxisome matrix (GO:0016558),0.5651128725820009,1.199708746491303,0.26170798898071623,0.859177635912419,1.0,6/12,21.44%,PEX16;PEX12;PEX1;PEX5L;PEX5;PEX2
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5520902122466791,1.1994750142518944,0.25100133511348466,0.8590676002573214,1.0,4/14,15.94%,CARD16;PELI3;GAS6;NLRP2B
prerank,cellular response to drug (GO:0035690),-0.3785040803978118,-1.1992554298270879,0.21468926553672316,0.6502556321350275,1.0,8/25,12.23%,PPM1E;MEF2C;ACER2;AIM2;TFRC;KCNQ1;CERS1;PPM1F
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.48185503376676025,1.1989603282195698,0.2517814726840855,0.8601238314108917,1.0,10/30,18.66%,HNRNPA1;CTC1;GNL3L;SRC;ACD;ERCC4;CDKN1A;TERF1;TENT4B;TINF2
prerank,heart contraction (GO:0060047),-0.3295164854045116,-1.1988754260214116,0.15384615384615385,0.6486315763566636,1.0,3/41,1.52%,ATP1A2;TPM1;DMD
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5027377788898474,1.1982741716081224,0.25,0.8617596579721167,1.0,9/24,14.42%,SRSF6;RUNX1;ZFP36L1;NCOA3;CYP27B1;VDR;ZFP36;NME2;HOXA7
prerank,alpha-amino acid catabolic process (GO:1901606),-0.3660444062025819,-1.198055499452919,0.22826086956521738,0.6483147032374178,1.0,14/29,33.11%,DDO;PRODH;ALDH4A1;SARDH;BLMH;CBS;THNSL2;KYNU;HSD17B10;HOGA1;FAH;HGD;IL4I1;HAAO
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.3391001131291226,-1.1975355838955475,0.14285714285714285,0.647072697776041,1.0,14/39,12.92%,ROBO1;TSPAN14;EPN2;MAML3;CREBBP;NOS3;NOTCH1;ROBO2;JAG2;YAP1;MAML2;NOTCH4;EP300;PDCD10
prerank,regulation of peptide hormone secretion (GO:0090276),-0.28776421568164956,-1.197073278143055,0.1016949152542373,0.6455888466771855,1.0,11/67,5.33%,ITPR1;RAPGEF4;CHD7;RAPGEF3;SLC2A1;CACNA1E;KCNB1;CACNA1D;HADH;ITPR3;KCNS3
prerank,skeletal muscle contraction (GO:0003009),0.5222463492858929,1.1969745618876613,0.2573248407643312,0.866118183320047,1.0,3/19,9.10%,JSRP1;TNNI3;MYH14
prerank,RNA processing (GO:0006396),0.41894873722003667,1.1968415590904329,0.11871227364185111,0.8655692558126621,1.0,57/176,21.68%,SRSF2;WT1;MBNL1;ADARB1;TSEN54;DHX16;RBM4;ZCRB1;TENT4A;TARDBP;BICD1;LSM4;PRPF4;U2AF1;TFIP11;PRPF3;AURKAIP1;CPSF6;USP39;DUSP11;HNRNPD;SON;HNRNPH1;TCERG1;DHX8;CELF2;SRSF11;MPHOSPH10;DDX17;RBM3;THOC1;SF3B4;DDX20;ZCCHC8;BCAS2;SF3A1;SNRPG;SNRPD3;NUFIP1;TENT2;PPP1R9B;LUC7L3;PDCD7;SRRM1;RBM6;RBM39;TENT4B;HNRNPUL1;U2AF2;ZMAT5;NOVA1;PTBP1;SF3B2;SF3B1;SRPK1;AKAP8L;KIN
prerank,relaxation of muscle (GO:0090075),0.5646723291994715,1.1967382820799315,0.26229508196721313,0.8649095941457556,1.0,6/13,11.17%,GSN;ATP1A1;KCNJ2;CAMK2D;PIK3CA;GSTM2
prerank,endothelial cell migration (GO:0043542),0.4732718343397676,1.196650633545738,0.22814982973893302,0.8641980356772969,1.0,5/37,2.76%,FSTL1;LOXL2;DPP4;FAP;VEGFA
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5934559278314478,1.1961469372552254,0.26628895184135976,0.865176686515308,1.0,6/10,25.88%,DLGAP4;DLGAP3;DLGAP1;AKAP9;NPTX1;BEGAIN
prerank,cellular response to increased oxygen levels (GO:0036295),0.5739099837311494,1.1960699351679942,0.2608695652173913,0.8644580765495733,1.0,5/11,19.69%,ATP6V0A2;FOXO1;ATP6AP1;CCDC115;TMEM199
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4271984400232912,1.1957215428844994,0.18717683557394002,0.8647682764559933,1.0,33/95,24.11%,ASPN;HTRA3;LDLRAD4;SKIL;TGFBR2;PMEPA1;SMAD4;SMURF2;SKI;RNF111;STUB1;FLCN;SMAD6;PEG10;SLC2A10;VASN;UBA52;PIN1;BCL9;GIPC1;DKK3;SNX6;HTRA4;TGFBR1;STRAP;PPM1A;SMURF1;CD109;SDCBP;FKBP1A;SKOR2;LATS1;ZEB2
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.47750060089485785,1.1954546123082965,0.23604651162790696,0.8648330764482627,1.0,15/37,26.91%,ENTPD2;NUDT1;HNRNPD;EXOSC7;SIDT2;NUDT16;RNASE6;DNASE1L2;NUDT5;ENTPD6;SUPV3L1;DFFB;RNASEH2C;DNASE1L1;ADPRM
prerank,amide transport (GO:0042886),-0.3637196040070194,-1.1953044986202417,0.19626168224299065,0.647718802022178,1.0,7/26,9.21%,PLTP;ABCG2;PDPN;PLEKHA8;CERT1;AQP11;SLC38A5
prerank,metal ion export (GO:0070839),0.4828159960600906,1.1951965856138358,0.2553191489361702,0.8648469155610689,1.0,8/31,12.04%,KCNK5;KCNT2;ATP1A3;ATP1A4;ATP1A1;ATP2B4;SLC4A4;SLC9A1
prerank,inflammatory response (GO:0006954),0.41711165902492786,1.1951681046690985,0.10552763819095477,0.8639003597964867,1.0,34/195,17.74%,NOX4;MGLL;CCL8;ANXA1;CD44;F2R;S100A8;S100A9;HDAC9;NFATC4;ITCH;CXCL10;TLR5;CHUK;CCL25;TLR4;LTB4R2;CEBPB;GPR68;HSPG2;PXK;ADCY8;ACKR1;CCL13;TRAF3IP2;HDAC4;TUSC2;IL4;CD14;IL6;CXCR4;ABCF1;CXCR2;IL18
prerank,regulation of viral transcription (GO:0046782),0.4655273705469882,1.1944599007101613,0.2254335260115607,0.8658022874917845,1.0,12/39,16.12%,POLR2H;TARBP2;MID2;MDFIC;CDK9;TRIM11;ZFP36;POLR2D;POLR2G;CTDP1;GTF2F1;UBP1
prerank,regulation of T cell cytokine production (GO:0002724),0.5342045871615079,1.1940645481700543,0.27828348504551365,0.8663486857183389,1.0,1/15,0.49%,CD55
prerank,protein transport (GO:0015031),0.41121642414598775,1.1939220637965653,0.07,0.8658839880653133,1.0,112/332,23.64%,SGSM2;LRP1;COPA;NECAB3;STX2;RAB32;RABGAP1L;RAB6A;STEAP3;STX1A;TMED1;STX5;STX11;ATP6V0A2;SEC31A;RAB23;ARRDC2;RAB19;RAB6B;PREB;MIA3;TOM1;SCFD2;SCAMP3;RCN3;ARF4;SCG5;TBCK;AP3D1;ABCA1;HDAC6;STX1B;SCAMP5;CLTC;SNX1;IL10RA;ACD;USO1;TBC1D2B;ARFGAP3;STX4;TBC1D17;GGA1;SCFD1;ARF1;STX12;NPM1;SEC23IP;COPB2;VPS33A;RAB3D;ATP6V1E1;TBC1D10A;NAPA;LRP1B;STX17;ATP6AP1;RUFY1;KIF3A;RAB43;RPGR;KIF3B;CMTM6;ARFRP1;SYNDIG1;ARF6;GGA2;REP15;ATP6V0A1;ATP6V1D;GOLGA4;NSF;EVI5;SGSM1;ATP6V1B2;SPTBN1;COPZ2;BLZF1;EVI5L;AP4M1;NAPG;TBC1D13;RAB1B;RAB5B;RAB5C;PREPL;STX3;SNX6;ARCN1;ADPRH;VAMP2;TBC1D22B;TBC1D15;RAB24;LRSAM1;MON1A;TMED2;VPS33B;RAB10;COPG1;RUNDC1;CTTN;VAMP4;NAPB;STX16;SEL1L;GOLPH3L;TBC1D8B;ATP6V0B;TBC1D12;PICK1;RABL3
prerank,positive regulation of mitochondrial fission (GO:0090141),0.5321747420282505,1.1936256944769046,0.24904701397712833,0.8660010143116362,1.0,3/18,8.59%,DCN;MIEF2;MCU
prerank,heart morphogenesis (GO:0003007),-0.3040934747814684,-1.193075865039473,0.17475728155339806,0.6509377448267479,1.0,14/50,11.15%,CHD7;INSR;ENG;EPHB4;NOS3;NOTCH1;TBX3;TGFBR3;HEYL;TBX1;SOX17;TBX2;BMP2;RYR2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.389172635177102,-1.1928179822536655,0.21395348837209302,0.6463153962410403,1.0,4/20,4.22%,INSR;IGF1;APP;PRKAA2
prerank,positive regulation of glycolytic process (GO:0045821),-0.389172635177102,-1.1928179822536655,0.21395348837209302,0.6463153962410403,1.0,4/20,4.22%,INSR;IGF1;APP;PRKAA2
prerank,phospholipid homeostasis (GO:0055091),0.5891096782369476,1.1924453419406658,0.2768361581920904,0.8698297750040412,1.0,3/11,7.00%,TLCD2;RCN3;ABCA1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.4996797517490998,1.1917846463962634,0.25690276110444177,0.8715399566311649,1.0,7/25,13.61%,ITGB3;ITGA5;DSC2;JAM3;ITGAV;JUP;CD200R1
prerank,establishment of mitotic spindle localization (GO:0040001),0.4915725440848854,1.1914105264415724,0.25868263473053893,0.871968117996682,1.0,9/28,22.51%,GPSM2;DCTN1;NDEL1;ZW10;CDK5RAP2;PAFAH1B1;CLASP2;NUMA1;FBXW11
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.5035234212891976,1.1911299736894594,0.24692874692874692,0.8720495550982268,1.0,5/23,16.30%,GHR;F2R;IL10RA;MGAT5;IL6
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.45798903547608394,-1.191017605617089,0.2572463768115942,0.6484952540763312,1.0,5/11,15.14%,EFNB2;MEF2C;TGFB1;GPER1;MYOCD
prerank,regulation of exit from mitosis (GO:0007096),0.4693046966331937,1.189689558331698,0.248868778280543,0.8768208357602977,1.0,14/38,26.29%,CDC14B;ZW10;SIRT2;CDC23;ANAPC5;UBA52;CDC27;CDC26;PPP1R9B;ANAPC4;ANAPC10;ANAPC15;CDC14A;ANAPC2
prerank,T cell homeostasis (GO:0043029),0.5844866236160459,1.189320761981741,0.28733997155049784,0.8771741056985669,1.0,2/10,11.30%,ZC3H8;AKT1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.578881526910435,1.189208225961334,0.2815126050420168,0.8765028578105163,1.0,3/10,8.17%,LRP1;PTPRJ;NDRG4
prerank,establishment of protein localization to organelle (GO:0072594),0.43939303802487467,1.1890933912593666,0.21141649048625794,0.8758677733626528,1.0,27/72,27.02%,SYK;TSPAN17;SPRN;NUP93;NUP107;IL10RA;AKT1;IPO9;TNPO2;E2F3;IPO5;NUP50;NXT2;LRSAM1;RALA;RANBP6;TPR;IPO11;IPO13;TSC2;NUP133;NUP85;TNPO1;FAM53C;NUP188;KPNB1;NUP88
prerank,regulation of stress fiber assembly (GO:0051492),-0.30036504124782654,-1.188712814891602,0.14634146341463414,0.6517645666877261,1.0,15/74,6.55%,TJP1;CGNL1;PHLDB2;ARHGAP28;TPM1;ARHGAP6;PPM1E;RAPGEF3;CCN2;F11R;RHPN2;LIMCH1;FHOD1;NRP1;RGCC
prerank,epithelial cell migration (GO:0010631),0.4664455582281184,1.1885460507123329,0.2335928809788654,0.8771350653918077,1.0,4/37,1.79%,FSTL1;LOXL2;DPP4;FAP
prerank,cell-substrate junction assembly (GO:0007044),-0.33438475467616097,-1.1884174133467365,0.16911764705882354,0.6499857421428671,1.0,7/33,5.86%,PTPRK;SORBS1;ACTN2;ITGA6;THSD1;ITGB4;PIP5K1A
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.499151071062843,1.1881529531200699,0.24667472793228537,0.8776975605884925,1.0,13/27,28.67%,RNASE4;NYNRIN;ERN1;NUDT16;RNASE6;ZC3H12A;RPP30;KHNYN;RNASE1;TRIR;NHP2;CPSF3;PDE12
prerank,response to steroid hormone (GO:0048545),0.48092661663303926,1.1880789343695197,0.24639423076923078,0.876932901403634,1.0,6/31,3.99%,AR;TGFB3;TGFB2;CATSPERB;ATP1A3;ATP1A1
prerank,C4-dicarboxylate transport (GO:0015740),0.5475691509136895,1.188042262694827,0.2831168831168831,0.8760137685873427,1.0,2/14,4.54%,LRRC8D;SLC1A6
prerank,regulation of rRNA processing (GO:2000232),0.5366637657205753,1.188031834078554,0.2646675358539765,0.8749833137246938,1.0,7/16,19.78%,DIMT1;USP36;RIOK1;KAT2B;NUDT16;YTHDF2;RIOK2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.5464896318128997,1.1879638621761228,0.2700135685210312,0.8741893092195295,1.0,6/13,26.46%,XRCC3;DYNC1LI1;CDK5RAP2;ANAPC15;TPR;DUSP1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.5305870764548372,1.1878619436524809,0.2522639068564036,0.8735246850618252,1.0,5/18,10.78%,DDR2;RUNX1;FSCN1;MELTF;COLGALT1
prerank,nucleoside catabolic process (GO:0009164),-0.4525681345146603,-1.1877891249212287,0.2698961937716263,0.6489801421130491,1.0,4/11,8.10%,DPYD;UPB1;NT5E;DERA
prerank,cellular response to chemical stress (GO:0062197),0.42694373497108645,1.18757715868763,0.19404517453798767,0.8736171871459605,1.0,19/96,17.21%,NOX4;NCF4;LRRC8D;STX2;NFE2L2;FOXO1;PKD2;BRF2;PIK3CA;SIRT2;STX4;GPX1;EIF2S1;ZC3H12A;SOD3;SELENOS;HTRA2;KEAP1;PPIA
prerank,nucleoside salvage (GO:0043174),0.5940121314975788,1.1868777650228515,0.2809457579972184,0.8753917036499705,1.0,2/10,5.50%,TK1;TK2
prerank,protein localization to phagophore assembly site (GO:0034497),0.5872885822382058,1.186734666629618,0.2766531713900135,0.8749079342961791,1.0,5/11,18.78%,PACS2;WIPI2;WDR45B;STX17;ATG13
prerank,negative regulation of B cell proliferation (GO:0030889),-0.470158574583873,-1.1863509272148303,0.27906976744186046,0.6500619382304857,1.0,4/11,13.50%,LYN;TNFRSF21;ATM;CD300A
prerank,ovarian follicle development (GO:0001541),0.5594307376412203,1.1862207205866442,0.2718707940780619,0.8760588761980287,1.0,5/13,14.19%,ANG;VEGFA;INHA;CEBPB;LHCGR
prerank,negative regulation by host of viral process (GO:0044793),0.593381499944862,1.1860996332961542,0.2824858757062147,0.8754710780575438,1.0,2/10,14.08%,CCL8;ZC3H12A
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.2811339107147974,-1.1856877832736004,0.13924050632911392,0.6492387784117487,1.0,13/62,8.79%,LYN;H3-3A;MEF2C;CREBBP;KMT2E;THBS1;CDK6;PURB;HSPA9;MEIS1;MYL9;PRKCQ;CTR9
prerank,mitochondrial genome maintenance (GO:0000002),0.5765358920709813,1.185526596903846,0.27361111111111114,0.8767696867730519,1.0,5/11,22.34%,SLC25A4;AKT3;SLC25A36;SLC25A33;MGME1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.48451878473653087,1.184531743593859,0.25589622641509435,0.8797688483569126,1.0,4/29,11.82%,FANCD2;RNF212B;SYCP2;TERB1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.45887585643474904,1.1841760204069047,0.24164810690423164,0.8801884652948317,1.0,9/44,16.35%,GSN;SCIN;CDC42EP2;BIN1;PFN2;FCHSD1;FER;ARF6;NCK1
prerank,prostanoid metabolic process (GO:0006692),0.5595986282296348,1.184155717765364,0.2716216216216216,0.8792028131561106,1.0,4/13,23.15%,CYP2S1;PTGR1;ACOX1;GSTM1
prerank,dendritic cell differentiation (GO:0097028),0.5069643959347895,1.1839965822162057,0.2549019607843137,0.8787768280530635,1.0,5/22,14.82%,AXL;TGFBR2;GAS6;FLT3;IL4
prerank,regulation of myotube differentiation (GO:0010830),0.5014867211271188,1.1838435949859865,0.24875,0.8783367272871562,1.0,6/24,13.86%,TMEM119;HDAC9;MAPK14;ATP11A;HDAC3;HDAC4
prerank,protein N-linked glycosylation (GO:0006487),0.4404909137547202,1.1837118998118823,0.2068230277185501,0.8777685779501352,1.0,19/66,24.67%,GFPT2;B4GALT1;GFPT1;MGAT1;LMAN1;ALG1;MGAT5;MGAT2;MGAT4B;TUSC3;TMEM165;ST3GAL1;DDOST;UGGT1;MGAT5B;KRTCAP2;SRD5A3;DPM2;PGM3
prerank,male gonad development (GO:0008584),0.4755258264532856,1.1833024300254784,0.2543352601156069,0.8784088018631236,1.0,6/34,9.98%,AR;WT1;SIX4;TGFB2;SOX8;COL9A3
prerank,thyroid hormone generation (GO:0006590),0.5917089601038155,1.1832073382754844,0.28245363766048504,0.8777769478095612,1.0,1/10,0.50%,DUOX1
prerank,positive regulation of signaling (GO:0023056),0.4708380439339821,1.1829602944190178,0.23804100227790434,0.8777272274943606,1.0,15/37,23.03%,CD80;ANXA2;CDKN2AIP;DLG4;INPP5F;ECE1;HCRT;LGI1;NSF;SYT1;ILK;RIMS2;CLSTN3;NMU;GRIK2
prerank,response to muscle stretch (GO:0035994),0.5424785375893082,1.1815999463725047,0.27331606217616583,0.8821966894570782,1.0,3/15,12.04%,GSN;PIK3CA;SLC9A1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.43481098145928226,1.1810873997462086,0.22994652406417113,0.8832031814304314,1.0,12/73,7.85%,LIF;EGFR;CD44;VEGFA;MIF;AXIN1;ATP2B4;DOCK7;PFN2;HDAC6;GAS6;PRKD2
prerank,negative regulation of catabolic process (GO:0009895),0.45308647143532466,1.1809946213580582,0.24611973392461198,0.8825686286109725,1.0,14/47,21.70%,EGFR;IRAK3;ZDHHC7;MDM4;TIGAR;SIRT2;PIN1;NCOR1;PDE3B;HDAC4;NUPR1;FLNA;FMN2;AZIN2
prerank,myelin assembly (GO:0032288),0.5878478802160113,1.1806365270795132,0.27008310249307477,0.8829229105158272,1.0,2/10,1.65%,CD9;PMP22
prerank,cell projection organization (GO:0030030),0.4841172937112395,1.1803000477992418,0.24851367419738407,0.8832751988479709,1.0,4/30,10.05%,GSN;SCIN;RHOJ;RHOQ
prerank,positive regulation of wound healing (GO:0090303),0.46917395085987024,1.1801599209362947,0.24592074592074592,0.8828280784977056,1.0,9/36,11.72%,DUOX1;ANXA1;F2R;SMOC2;PLPP3;MTOR;FOXC2;KANK1;ST3GAL4
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.4495487693495812,1.179930555820611,0.2446927374301676,0.8827417542161164,1.0,4/45,5.60%,MID1;IRF4;CD44;CAMK2D
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.5516892582214024,1.1798566357688707,0.28058510638297873,0.8820093339629967,1.0,4/13,15.36%,CD2BP2;USP4;PRPF3;DDX20
prerank,7-methylguanosine mRNA capping (GO:0006370),0.4765750864978444,1.179854568323612,0.2549476135040745,0.879934684025529,1.0,8/31,15.40%,POLR2H;GTF2H3;ERCC3;POLR2D;POLR2G;CCNH;GTF2F1;CMTR2
prerank,7-methylguanosine RNA capping (GO:0009452),0.4765750864978444,1.179854568323612,0.2549476135040745,0.879934684025529,1.0,8/31,15.40%,POLR2H;GTF2H3;ERCC3;POLR2D;POLR2G;CCNH;GTF2F1;CMTR2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.5513463021874643,1.1798489114067139,0.26,0.8789233348244356,1.0,5/14,12.63%,MAPK14;DAZL;TARDBP;TIRAP;ZFP36
prerank,vesicle organization (GO:0016050),0.452222847198622,1.1796799902389936,0.23448275862068965,0.878583902000736,1.0,11/46,18.19%,CD34;DNM1;HOOK2;PLEKHF1;PI4K2B;SQSTM1;USP50;PHETA2;VPS11;ANXA8;ANXA8L1
prerank,response to acidic pH (GO:0010447),0.5506843738790115,1.1793252851884533,0.2777017783857729,0.8789881924223257,1.0,3/13,15.24%,RAB11FIP5;SLC9A1;CHP1
prerank,inositol phosphate dephosphorylation (GO:0046855),0.5725788733122201,1.1793027396567695,0.2923076923076923,0.8770250301729094,1.0,5/11,27.87%,OCRL;INPP5K;INPP5B;PTEN;SYNJ2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.5725788733122201,1.1793027396567695,0.2923076923076923,0.8770250301729094,1.0,5/11,27.87%,OCRL;INPP5K;INPP5B;PTEN;SYNJ2
prerank,positive regulation of cellular component organization (GO:0051130),0.42033508947522263,1.1792473371551366,0.20263424518743667,0.8762163428124543,1.0,20/107,12.18%,SYK;AR;LRP1;TGFB3;DCTN1;GPC3;NEUROD2;VEGFA;TGFB2;CDC42EP2;RUNX1;MPP7;GNL3L;SURF4;LMAN1;TIRAP;GPX1;BMF;BAK1;TMEM30A
prerank,negative regulation of multicellular organismal process (GO:0051241),0.41093264718643874,1.1790430012529423,0.11983887210473314,0.875995653077078,1.0,35/199,11.91%,ADAMTS5;LOXL2;PARP3;WNT10B;RAB11FIP5;EGFR;HPN;NPTN;LDLRAD4;SRSF6;F2R;HDAC9;SYT11;PROCR;TRPV3;ATP2B4;DOCK7;NR1D1;NFIB;PFN2;LNPEP;GAS6;FLCN;SPX;WDR77;FOXC2;TLR4;PAEP;SMAD6;ALPK2;HS3ST5;SLC6A4;GPNMB;VASN;PGAM5
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.47000842299382467,-1.1788225967797012,0.3092105263157895,0.6649145088349322,1.0,4/10,29.57%,APPL2;CD300A;C3;TREM2
prerank,positive regulation of cytokine production (GO:0001819),0.4068625261992771,1.178511475041721,0.1041041041041041,0.8771879712640737,1.0,38/292,11.89%,CD34;SYK;LBP;CD80;CCBE1;IRF4;POLR2H;ANXA1;IL16;GLMN;EIF2AK3;RAB7B;SULF2;FOXP1;F2R;RFTN1;RUNX1;MIF;TMEM106A;MAPK14;IL33;CGAS;TLR5;SULF1;SCAMP5;IL17RA;DHX33;POLR3E;PRKD2;TIRAP;TLR4;PAEP;MAPK11;POLR3D;CEBPB;IRAK1;PDE4D;PIBF1
prerank,transport along microtubule (GO:0010970),0.5497489525510052,1.1782935474367535,0.2779255319148936,0.8770641178026873,1.0,6/13,22.58%,ARHGAP21;APBA1;DYNC1I1;CLIP3;COPG1;BAG3
prerank,neuron remodeling (GO:0016322),-0.4721943254782345,-1.1780431756922818,0.2525597269624573,0.6645337455986596,1.0,7/10,22.66%,APP;EPHA8;ANKS1A;CX3CL1;C1QA;C3;SCARF1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.5450446649174954,1.1778426966190372,0.28383705650459923,0.8779864140081786,1.0,5/14,18.58%,ENTPD2;NUDT1;NUDT16;NUDT5;ENTPD6
prerank,defense response to fungus (GO:0050832),0.5332342714407876,1.1777447353928951,0.2707808564231738,0.8773610785528871,1.0,2/17,3.54%,S100A8;S100A9
prerank,purine nucleotide biosynthetic process (GO:0006164),0.5569417479086599,1.1773430197838575,0.28416779431664413,0.8779748553531651,1.0,5/12,16.62%,AMPD2;GART;PRPSAP1;PRPS1;PRPS1L1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.44816544521638196,-1.176723465677649,0.27692307692307694,0.665573934408262,1.0,3/12,3.36%,CDH5;SNCA;DYRK1A
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5366710116268081,1.1766816647495173,0.296,0.8796350567186242,1.0,5/16,13.71%,WT1;FGF2;PKD2;GDNF;SIX1
prerank,tRNA 5'-end processing (GO:0099116),0.5323030270975567,1.1766568460479403,0.2733333333333333,0.8787012899909745,1.0,5/15,15.93%,RPP25;RPP21;PRORP;RPP25L;POP4
prerank,positive regulation of viral process (GO:0048524),0.43326876491226796,1.1756661769473424,0.22848034006376194,0.8815563860047694,1.0,14/60,15.31%,AXL;POLR2H;TARBP2;ADARB1;KPNA2;MDFIC;CDK9;LARP1;POLR2D;POLR2G;DDB1;CTDP1;GTF2F1;HACD3
prerank,epithelial cell-cell adhesion (GO:0090136),0.5775419362561138,1.175606729679135,0.2802197802197802,0.8807787949405879,1.0,6/11,23.82%,SERPINB8;ITGB5;THBS4;JUP;KIFC3;CCN3
prerank,oligodendrocyte development (GO:0014003),0.5303454199068085,1.1753166945798446,0.2808842652795839,0.8809494512864394,1.0,8/15,28.07%,PRDM8;SOX10;PLP1;EIF2B1;CNTNAP1;EIF2B2;B4GALT5;MYRF
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.565650995409767,1.1752635908725377,0.3013888888888889,0.8801485672226605,1.0,1/11,0.45%,GSN
prerank,cytoplasmic translational initiation (GO:0002183),0.5354590957325372,1.1749784326423398,0.28309305373525556,0.8802456292310636,1.0,9/17,27.14%,RBM4;EIF4A1;EIF3A;EIF3D;EIF2S2;EIF4H;EIF4G1;DHX29;EIF3M
prerank,positive regulation of cellular protein localization (GO:1903829),0.4329436790895659,1.1748812100746422,0.21535181236673773,0.879634248820284,1.0,21/69,23.07%,LIF;EIF2AK3;FYN;WWTR1;SYT11;GNL3L;MEAK7;BICD1;PARD6A;STX4;AKT1;MAPT;GPR137B;STX3;ENTR1;NUMA1;MAP1A;SESN2;CROCC;CCDC88A;TRAPPC12
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.4300958708062413,1.174713485161339,0.21177685950413222,0.8793070146506389,1.0,18/93,14.08%,MID1;SH3RF3;STK25;GADD45G;VEGFA;TGFB2;TAOK3;AXIN1;KLHDC10;RASSF2;FZD7;SEMA3A;TIRAP;EMC10;ANKRD6;CD27;TAOK2;ZC3H12A
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.4018918848229702,-1.174646621909388,0.23255813953488372,0.6687469498144254,1.0,3/17,2.00%,PRKG1;TPM1;MEF2C
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5545559733834561,1.1744920356104194,0.287292817679558,0.8791959705615966,1.0,5/12,19.69%,TMEM9;VPS33A;CCDC115;TMEM165;TMEM199
prerank,epidermis development (GO:0008544),0.446192193923795,1.173939956157713,0.247557003257329,0.8803963871597268,1.0,10/56,17.18%,COL17A1;FGF7;SCEL;EMP1;ALDH3A2;SVEP1;ATP2A2;EVPL;FLOT2;FABP5
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4864401110023687,1.173747771581847,0.2804878048780488,0.8801328854306202,1.0,2/24,2.49%,SYK;CD177
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5716315894383637,1.1737411210883084,0.2861072902338377,0.8791491442334503,1.0,6/11,20.60%,TIPIN;FBXO5;GMNN;BLM;SMARCAL1;DONSON
prerank,regulation of fat cell differentiation (GO:0045598),0.43050551549531546,1.1737304714475623,0.22198505869797225,0.8781898795204202,1.0,17/74,14.39%,MEDAG;WNT10B;WWTR1;TRIO;ZFP36L1;TAF8;FOXO1;NR1D1;ZFPM2;ZFP36L2;SYAP1;SIRT2;CEBPB;AKT1;ZFP36;ZC3H12A;WDFY2
prerank,negative regulation of viral life cycle (GO:1903901),0.5394350798349133,1.1735719514855476,0.28304405874499333,0.8778032819443425,1.0,3/15,10.83%,GSN;MID2;TRIM11
prerank,modulation by host of viral genome replication (GO:0044827),0.5569839015958353,1.17310726639665,0.2851351351351351,0.8787334754235295,1.0,3/13,14.08%,CCL8;FBXL2;ZC3H12A
prerank,negative regulation of RNA metabolic process (GO:0051253),0.5173297514264846,1.172646165521164,0.28258064516129033,0.8796261104915596,1.0,8/18,21.97%,ESR1;KAT2B;NUDT16;NCOR2;NCOR1;ZC3H12A;PTBP1;PTBP2
prerank,monoacylglycerol metabolic process (GO:0046462),0.5556032441709206,1.1725653273410803,0.291497975708502,0.8789582556302604,1.0,1/13,0.62%,MGLL
prerank,positive regulation of lyase activity (GO:0051349),-0.4177070455113533,-1.1724596298063816,0.25390625,0.6716669048464201,1.0,4/14,13.05%,NOS3;CACNA1D;NOS1;ISCU
prerank,negative regulation of kinase activity (GO:0033673),0.4365000907099637,1.1714526115431327,0.23516720604099245,0.8824051349366592,1.0,19/62,17.85%,LRP6;TARBP2;CAMK2N1;WWTR1;DTNBP1;RTRAF;YWHAG;GSKIP;INPP5K;AKT1;MAPT;IRS2;SFN;DEPTOR;SMCR8;CHP1;CEP85;PPIA;QARS1
prerank,hepaticobiliary system development (GO:0061008),-0.3876318179619806,-1.1712625387583229,0.2383177570093458,0.6722210149855777,1.0,6/20,9.20%,ARID5B;WNT4;LSR;TGFBR3;PHF2;CITED2
prerank,positive regulation of protein polymerization (GO:0032273),0.4381417902724457,1.1712323866274874,0.23068669527896996,0.8822929331058846,1.0,22/65,21.98%,DCTN1;CDC42EP2;BIN1;CLIP1;PSRC1;PFN2;TOGARAM1;MAPRE1;MAPT;FCHSD1;TPPP3;SLAIN2;FER;HSP90AA1;ARF6;CDK5RAP2;NCK1;AKAP9;NAV3;NUMA1;PYCARD;CTTN
prerank,protein palmitoylation (GO:0018345),0.47483074837611106,1.1709276549567522,0.2589595375722543,0.8825282109270983,1.0,13/30,23.21%,ZDHHC16;ZDHHC7;HHAT;SELENOK;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;CLIP3;ZDHHC18;ZDHHC8;ZDHHC5
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5710036310679246,1.1706269266831868,0.2692307692307692,0.8806591287796008,1.0,6/12,23.88%,CUL3;CDC23;ANAPC5;CDC27;ANAPC4;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5710036310679246,1.1706269266831868,0.2692307692307692,0.8806591287796008,1.0,6/12,23.88%,CUL3;CDC23;ANAPC5;CDC27;ANAPC4;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5710036310679246,1.1706269266831868,0.2692307692307692,0.8806591287796008,1.0,6/12,23.88%,CUL3;CDC23;ANAPC5;CDC27;ANAPC4;NSMCE2
prerank,regulation of response to stress (GO:0080134),0.5769147897010982,1.1701018866148973,0.2880886426592798,0.881751094084032,1.0,2/10,12.54%,CORO2B;ADCY8
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.5462279178728531,1.1696106877291164,0.2665799739921977,0.8826981022084673,1.0,4/14,8.17%,IGFBP5;LRP1;SLIT2;NDRG4
prerank,striated muscle contraction (GO:0006941),-0.2973539050294478,-1.1695978331788708,0.11842105263157894,0.6740276116550731,1.0,5/53,2.81%,ATP1A2;TPM1;DMD;RCSD1;DTNA
prerank,muscle cell development (GO:0055001),-0.3558092474232881,-1.1695687742748226,0.20625,0.6715560561702704,1.0,8/30,8.77%,NEBL;ENG;DMD;IGF1;DYSF;CXADR;MYOF;MYH11
prerank,regulation of monooxygenase activity (GO:0032768),0.4942112680521844,1.1689446335852443,0.27556109725685785,0.8843524261380503,1.0,8/23,17.32%,CYGB;EGFR;VDR;AKT1;POR;GDNF;HSP90AA1;ZDHHC21
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.427790259767647,-1.1685784728865711,0.3048780487804878,0.6716452521415572,1.0,7/14,17.24%,PLCG1;THBS1;ITGA4;RGCC;ECSCR;GPER1;CD40
prerank,glucose transmembrane transport (GO:1904659),-0.3980532631893693,-1.1682910525310815,0.2644230769230769,0.6698657266351098,1.0,3/18,3.65%,SORT1;SLC2A1;SLC5A3
prerank,regulation of neuron migration (GO:2001222),0.4814012761501266,1.1682129490066142,0.28352941176470586,0.886207523367935,1.0,9/26,18.94%,COL3A1;IGSF10;TNN;SEMA3A;KIF20B;NSMF;SRGAP2;SHTN1;NIPBL
prerank,regulation of endothelial cell proliferation (GO:0001936),0.41990077481191196,1.168047841080339,0.2171664943123061,0.8858616867138582,1.0,19/88,12.37%,TNMD;FGF18;PRKCA;SPARC;ANG;ITGB3;VEGFA;FGF2;ECM1;FUT2;THBS4;SULF1;PRKD2;STAT5A;AKT3;EMC10;NRAS;AKT1;EGF
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4660017966674758,1.1679944290365138,0.2672919109026964,0.8850736248197805,1.0,8/34,9.05%,WNT10B;WWTR1;TRIO;FOXO1;ZFPM2;FLCN;ZFP36L2;SIRT2
prerank,cAMP metabolic process (GO:0046058),-0.441339953970193,-1.167730291652801,0.2792452830188679,0.6687743639604073,1.0,4/13,9.13%,ADCY5;ADCY1;ADCY4;ADCY9
prerank,nucleus organization (GO:0006997),0.45437328920351416,1.1676200847124842,0.2643805309734513,0.8855745235498765,1.0,9/47,9.04%,BIN1;USP36;REEP3;NUP93;CHMP7;VPS4B;SYNE1;NUP98;TOR1A
prerank,leukotriene biosynthetic process (GO:0019370),-0.42598903539076033,-1.1672977329377243,0.26153846153846155,0.6673443437470977,1.0,9/14,33.13%,GGT5;GGTA1;MGST3;GGT1;PLA2G4A;PLA2G5;ALOX5AP;MGST2;ALOX5
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.5532822132327118,1.167007460018768,0.3031161473087819,0.8870236371965343,1.0,1/12,1.26%,PRKCA
prerank,toll-like receptor signaling pathway (GO:0002224),0.42237333023307283,1.166712411669253,0.21780104712041884,0.8871373493485833,1.0,36/84,30.46%,LBP;IRAK3;RFTN1;S100A8;S100A9;TLR5;SCARA3;CHUK;TIRAP;TLR4;IRAK4;IRAK1;TNIP1;UBA52;EPG5;CD14;TRAF3;ITGAM;UBE2D3;TAB2;MAP3K7;TNIP2;CTSK;TICAM1;HSP90B1;CTSB;CTSL;BCL10;CASP8;MAPKAPK3;SFTPA1;SFTPA2;MYD88;TRIL;LGALS9;TRAF6
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.44439457383464925,-1.1667092470345555,0.25,0.666436904050347,1.0,5/11,12.14%,WNT4;BMP5;SIRT1;BMP2;FGFR4
prerank,regulation of protein catabolic process (GO:0042176),0.4170563569632663,1.1666499933658714,0.21743589743589745,0.8863915802744627,1.0,24/99,16.88%,EGFR;GPC3;IRAK3;STX5;SMURF2;AXIN1;DACT1;ITCH;FOXO1;SEC22B;MDM4;EGLN2;WDR91;DTL;SIRT2;ODC1;HECW2;TMEM9;PIN1;ZDHHC2;DDB1;NSF;HACE1;IDE
prerank,cellular response to oxidative stress (GO:0034599),0.41575423922559857,1.1665952211343082,0.20609137055837565,0.8855986528553358,1.0,25/118,17.21%,NOX4;UCP1;NCF4;EGFR;STX2;NFE2L2;FOXO1;PKD2;BRF2;CHUK;SIRT2;STX4;GPX1;CAMKK2;AKT1;MAPT;EIF2S1;ZC3H12A;PDGFRA;FER;SOD3;SELENOS;HTRA2;KEAP1;PPIA
prerank,response to insulin (GO:0032868),0.42418263645318804,1.1662728776498357,0.21789473684210525,0.8859357603733574,1.0,31/80,21.65%,IRS1;HDAC9;PIK3R2;ZFP36L1;SLC39A14;FOXO1;MEAK7;MYO5A;INSIG2;SYAP1;EPM2AIP1;KAT2B;INPP5K;RHOQ;AKT1;IRS2;EIF6;PDE3B;FER;PKM;SELENOS;OGT;CPEB1;EPRS1;VAMP2;CAPN10;GPLD1;LPIN3;GOT1;RAB10;SLC25A33
prerank,amino acid transmembrane transport (GO:0003333),-0.3138533986022378,-1.1658575740849846,0.17142857142857143,0.6664074708845602,1.0,7/45,6.69%,SLC7A11;SLC6A13;SLC16A2;SLC38A11;SLC7A5;SLC22A4;SLC3A2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.423256754141831,1.1658064289968817,0.22520661157024793,0.886800432287023,1.0,23/84,14.55%,FGF18;PRKCA;FGFR1;ANGPT4;SPARC;ITGB3;VEGFA;FGF2;FOXP1;SMOC2;MAPK14;PLPP3;MAP2K3;PRKD2;STAT5A;FOXC2;AKT3;EMC10;AKT1;EGF;AAMP;ZC3H12A;BCAS3
prerank,regulation of multicellular organism growth (GO:0040014),0.5315213005652404,1.1657891028934664,0.30678851174934724,0.8858788504378788,1.0,2/15,8.10%,GHR;STAT5A
prerank,regulation of complement activation (GO:0030449),0.4547425069988733,1.1655574320123536,0.25727069351230425,0.8858029614954537,1.0,8/40,13.58%,CD55;CFH;C7;C1QBP;CD81;C4B;SERPING1;CR2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.30637508748316417,-1.1653871224180024,0.19791666666666666,0.6652349929254637,1.0,7/51,4.61%,PTN;IL34;VEGFC;HMGB1;THBS1;CXCL12;IL6R
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5053660649041798,1.1653679160075592,0.273989898989899,0.8855891288967702,1.0,5/19,18.77%,IRS1;IRS2;TWIST1;DAGLB;ANGPTL3
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.3721856728028424,-1.1652486711046617,0.2192513368983957,0.6631557139504312,1.0,3/22,4.40%,SORBS1;APOE;PPARA
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.5248625225619298,1.1649934603473568,0.2851511169513798,0.8860806558884032,1.0,4/14,13.56%,IRS1;AKT1;IRS2;TWIST1
prerank,regulation of fibroblast proliferation (GO:0048145),0.4509232054133294,1.1648116000419912,0.2582106455266138,0.8858239253921454,1.0,7/45,7.92%,DDR2;WNT2;MIF;SKI;CDK4;GAS6;S100A6
prerank,cardiac myofibril assembly (GO:0055003),-0.41385357237733855,-1.1644537788112541,0.23043478260869565,0.6628192275328926,1.0,1/15,0.08%,NEBL
prerank,nucleosome disassembly (GO:0006337),0.5362475124468611,1.1643881290920874,0.28378378378378377,0.8855495737886055,1.0,6/14,17.70%,SMARCD2;SMARCD1;SMARCC2;SMARCA4;GRWD1;SET
prerank,chromatin disassembly (GO:0031498),0.5362475124468611,1.1643881290920874,0.28378378378378377,0.8855495737886055,1.0,6/14,17.70%,SMARCD2;SMARCD1;SMARCC2;SMARCA4;GRWD1;SET
prerank,positive regulation of developmental process (GO:0051094),0.4107751601659237,1.1642925184916735,0.1841046277665996,0.8849798832487481,1.0,26/164,9.27%,DCN;AR;PHLDB1;BMP1;WT1;FGFR1;TLE6;TMEM119;NEUROD2;VEGFA;COBL;DLG4;LMNA;SMURF2;ACVR1;KRT10;NCOA3;C1QBP;SRC;MIEF2;HMCES;SOX8;MCU;PSEN1;AGO2;SOX5
prerank,outflow tract septum morphogenesis (GO:0003148),0.490197049555981,1.1640442346349344,0.28182941903584674,0.8849752448882342,1.0,7/24,10.09%,SEMA3C;TGFB2;TGFBR2;SMAD4;ACVR1;ZFPM2;SMAD6
prerank,N-terminal protein amino acid modification (GO:0031365),0.5358380925721631,1.1640357571586373,0.2859025032938076,0.8840316417005015,1.0,6/14,21.79%,NTMT1;NAA15;METAP2;NAA50;METAP1;METAP1D
prerank,peptidyl-methionine modification (GO:0018206),0.5456223418568602,1.1638026650374151,0.2903225806451613,0.883944639077647,1.0,6/12,23.22%,NAA15;METAP2;NAA20;METAP1;METAP1D;NAA30
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.32024032858526535,-1.1637143616932768,0.2524271844660194,0.662367948492518,1.0,8/41,6.77%,TPM1;ENG;CPE;MEF2C;NOTCH1;TGFBR3;FGFR2;HEYL
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.32481253733781124,-1.16370781647656,0.19047619047619047,0.6599714096808074,1.0,5/31,3.69%,RANBP3L;TMEM64;PTCH1;NOTCH1;CDK6
prerank,protein homooligomerization (GO:0051260),0.4164903938822546,1.1635548649851053,0.22676200204290092,0.8839454294141647,1.0,20/114,14.86%,SCARA5;SLC1A5;DISP1;MIF;P2RX3;TK1;KCNJ2;MPP2;OSBPL2;PKD2;ZBTB1;SAMHD1;VSTM5;ADCY8;ALDH1A3;TMEM120A;GLS;NACC2;KCNC2;CRYZ
prerank,dendrite self-avoidance (GO:0070593),0.5229019134845521,1.1633431355080994,0.2866578599735799,0.8838138934493817,1.0,7/16,21.46%,NPTN;TNN;DSCAM;IGSF9;PALLD;CNTN4;CNTN2
prerank,protein K63-linked deubiquitination (GO:0070536),0.47426017015366073,1.1632724294066836,0.2622754491017964,0.8830931702005907,1.0,9/31,14.79%,ZRANB1;SPATA2;OTUD1;USP33;OTUD7B;USP50;ABRAXAS1;STAMBPL1;USP7
prerank,gonad development (GO:0008406),0.456209014760803,1.163255470957822,0.25900900900900903,0.8822025979024126,1.0,8/41,9.98%,AR;WT1;SIX4;TGFB2;IRX5;NUP107;SOX8;COL9A3
prerank,regulation of postsynapse organization (GO:0099175),-0.34312901093056225,-1.1631633302233462,0.19607843137254902,0.6588810692357112,1.0,7/28,5.38%,EPHA4;PDLIM5;CDKL5;WNT5A;SHANK3;SIPA1L1;ABHD17C
prerank,fatty acid beta-oxidation (GO:0006635),0.43562492409169656,1.1629179549741435,0.2591362126245847,0.882482900576229,1.0,18/51,22.15%,EHHADH;ETFA;CRAT;AUH;SCP2;ACADVL;SLC25A17;ACOX1;ETFDH;ETFB;BDH2;ABCD3;MCAT;HSD17B4;ACAT1;CPT2;PEX2;CROT
prerank,proton transmembrane transport (GO:1902600),0.4525322395222217,1.1625463492828496,0.27809965237543455,0.8829559566320982,1.0,7/36,12.04%,UCP1;ATP1A3;ATP1A4;ATP1A1;SLC25A27;ATP5PO;SLC9A1
prerank,inositol lipid-mediated signaling (GO:0048017),0.4451717605225793,1.1624670373987058,0.2426550598476605,0.8823030039463172,1.0,15/50,17.17%,IRS1;FGFR1;PLCE1;PIK3C2B;PIK3R2;PLCB4;INPP5F;PIK3CA;IRS2;RHOA;PI4KB;PDGFRA;PI4KA;OGT;PLCD4
prerank,negative regulation of endopeptidase activity (GO:0010951),0.44769210565693074,1.1624485968083988,0.2738225629791895,0.8814182485660188,1.0,9/47,12.89%,TIMP2;SERPINB8;BIN1;SERPINE3;SERPINF1;SERPINH1;AKT1;RECK;SERPING1
prerank,muscle organ development (GO:0007517),0.4371366127852608,1.1624062306753464,0.25164113785557984,0.880614848362286,1.0,10/54,10.55%,COL6A3;MAPK12;CTF1;FHL1;ITGA11;SRI;MEF2D;CXCL10;LARGE1;CHD2
prerank,regulation of mononuclear cell migration (GO:0071675),-0.3653595542531237,-1.1623478880400855,0.27860696517412936,0.6586477924077381,1.0,4/23,2.72%,LYN;IL34;BMP5;THBS1
prerank,negative regulation of cell migration (GO:0030336),0.40720826527447657,1.1623160491356719,0.20445344129554655,0.879987741319457,1.0,31/137,15.37%,COL3A1;IGFBP5;HAS1;LRP1;TMEFF2;ADARB1;LDLRAD4;FGF2;SLIT2;MIF;TNN;GTPBP4;MIA3;PTPRJ;SRGAP1;PFN2;SULF1;PIP5KL1;FLCN;DPEP1;NDRG4;JAG1;KANK1;MITF;MAGI2;RECK;ADAM15;STK24;HOXA7;IL4;STC1
prerank,negative regulation of metabolic process (GO:0009892),0.4349987913654522,1.162126998450924,0.24620390455531455,0.8797698757118076,1.0,9/54,9.07%,ADAMTS5;WNT10B;ZDHHC7;DOCK7;NR1D1;LNPEP;FLCN;FOXC2;TLR4
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5306895646402244,1.1618461697390492,0.2896825396825397,0.8798712517841741,1.0,8/15,23.96%,TCF7L2;GAS6;YWHAE;RBM22;ANP32B;BAG3;TPR;EMD
prerank,regulation of mitochondrion organization (GO:0010821),0.44111134523602363,1.1618438164467186,0.2633371169125993,0.87892225060929,1.0,20/47,26.67%,USP36;MIEF2;HDAC6;PID1;FLCN;SQSTM1;MAPT;VDAC1;HTRA2;IAPP;SREBF1;STAT2;CSNK2A2;PARL;FIS1;RHOT2;FBXW7;MUL1;INF2;PLSCR3
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5754630916017979,1.1616362268983844,0.3209366391184573,0.8787778711554035,1.0,3/10,11.30%,MIA3;TLR4;AKT1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.505934138816523,1.1610372815680283,0.2942643391521197,0.8801182999505618,1.0,10/20,25.76%,PPIL6;NKTR;PPIC;PIN1;PPIA;FKBP4;FKBP1A;PPIG;CWC27;PPIH
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4711909095918486,1.1606112349855,0.2863849765258216,0.8808084406677305,1.0,10/30,16.59%,AR;FOXP1;PRMT2;HDAC6;NCOR2;NCOR1;SMARCA4;RNF14;TRIM68;DDX5
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.4914846545835402,1.1599419625344984,0.27770700636942675,0.8824671119868004,1.0,8/23,20.50%,SCNN1B;SLC12A8;SLC12A4;SLC9A1;SLC12A5;SLC9A7;KCNH2;SLC12A6
prerank,spindle assembly (GO:0051225),0.42830892894034844,1.1598902607578712,0.2348008385744235,0.8817029036697865,1.0,22/67,21.06%,KIFC2;MAPRE3;STARD9;TOGARAM1;KIF2A;ARHGEF10;SMC1A;HDAC3;MAPRE1;HAUS3;PIBF1;NCOR1;ABRAXAS1;RHOA;KIF3B;INO80;NEK7;STAG2;FLNA;CLASP2;NUMA1;TUBGCP5
prerank,anterograde axonal transport (GO:0008089),0.460667640243552,1.1597496365929743,0.2787456445993031,0.8813143186055448,1.0,12/37,21.22%,DTNBP1;DLG2;NEFL;TRAK2;AP3D1;KIF3A;KIF3B;BLOC1S2;RAB27B;SNAPIN;MAP1A;AP3B2
prerank,T cell differentiation in thymus (GO:0033077),0.5406596933709901,1.1592807487508026,0.29112271540469975,0.8821885454206769,1.0,3/14,11.60%,ZFP36L1;ZFP36L2;GLI3
prerank,lung development (GO:0030324),0.4628368151307662,1.1589873651606521,0.26697892271662765,0.8823887699177327,1.0,6/33,7.49%,FGF7;VEGFA;FGF2;PKD1;RCN3;GLI2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4744826561979252,1.158904002745093,0.2890243902439024,0.8817772512308513,1.0,11/27,24.62%,IRS1;GRB10;TNS2;PID1;INPP5K;KANK1;NCK1;PIP4K2C;PIP4K2B;TSC2;PRKCZ
prerank,negative regulation of locomotion (GO:0040013),-0.4321836976580369,-1.158818858218919,0.2756183745583039,0.6653253044206023,1.0,4/12,16.72%,FRMD5;CCDC125;PTPN2;SPINT2
prerank,neural tube closure (GO:0001843),0.4581494342364575,1.158517309956612,0.2643020594965675,0.8823008288604004,1.0,4/34,4.06%,LRP6;TGFB2;COBL;SKI
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.2944444098262732,-1.1584386309097447,0.18333333333333332,0.6640218488163605,1.0,27/61,24.30%,PRKAG2;PPARA;PSMC1;CAV1;PSMA5;PSMD12;SIRT5;PSMF1;PSMA2;SIRT1;PSME2;PSMA3;FGFR4;PSME1;PSMB10;PSMA1;PSMB8;PSMB9;NR1H4;PSMB4;PSMA8;PDK4;PSMD6;NQO1;PSMD11;PSMD10;PSMD9
prerank,negative regulation of complement activation (GO:0045916),0.5684351154330172,1.1580728051592037,0.3125,0.8830660483083862,1.0,3/10,13.58%,CD55;SERPING1;CR2
prerank,regulation of gastrulation (GO:0010470),-0.42331405446767645,-1.1572526062241368,0.23622047244094488,0.6647151293316061,1.0,3/14,2.28%,PHLDB2;TENM4;OSR1
prerank,interstrand cross-link repair (GO:0036297),0.4411923598582209,1.1572162131523074,0.25054466230936817,0.8854532716676912,1.0,12/53,14.21%,FANCD2;XRCC3;EME1;RFWD3;FANCL;FAAP100;FANCE;EXO5;UBA52;ERCC4;FAN1;FANCG
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.4308968837119849,-1.1570711936759486,0.25396825396825395,0.662786202609089,1.0,5/13,11.92%,NOS3;PPARA;PINK1;ENO1;NOS1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.4228791234521629,1.1569600854897721,0.2572347266881029,0.8855418366114038,1.0,14/66,14.30%,LIF;EIF2AK3;ZPR1;PIK3R2;WWTR1;MEPCE;PSEN1;RBM22;HDAC3;AKT1;CCT7;JUP;ZC3H12A;DMAP1
prerank,transepithelial transport (GO:0070633),-0.42083035927350576,-1.1568859786314685,0.2511013215859031,0.6609361017175799,1.0,4/15,6.08%,SLC1A3;ABCG2;SLC12A2;CXADR
prerank,protein-DNA complex disassembly (GO:0032986),0.5229259857615495,1.1567041887360092,0.28761651131824234,0.8856198262082032,1.0,7/16,19.50%,SMARCD2;SMARCD1;SMARCC2;SMARCA4;GRWD1;SET;RPL23
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.34911589978568924,-1.1565864163523811,0.23863636363636365,0.6593383153933465,1.0,10/25,23.81%,TMTC2;SNCA;CAV1;CNNM2;KCNA1;JPH2;MT3;ANK3;GRIN1;CIB2
prerank,BMP signaling pathway (GO:0030509),0.42867307889062817,1.1563438825721408,0.263724434876211,0.886082546369731,1.0,12/62,10.84%,AMH;TMEM100;TGFB3;TGFB2;SMAD4;ACVR1;BMP15;FAM83G;SMAD5;BMP8A;SMAD6;AMHR2
prerank,ventricular septum development (GO:0003281),0.4526076591303787,1.1563381591634616,0.26832018038331457,0.8851576403508237,1.0,8/37,7.56%,TGFB2;SLIT3;SLIT2;TGFBR2;SMAD4;ACVR1;MDM4;ZFPM2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.5365971355323502,1.1563123147933474,0.31432360742705573,0.8843227043288652,1.0,6/14,19.25%,WNT9A;CHADL;SNAI2;EFEMP1;TGFBR1;RFLNA
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.40870531281316885,1.1562720973989005,0.18484848484848485,0.8835536653065319,1.0,24/152,14.19%,ADGRD1;GNAS;VIPR2;LPAR3;GPR12;GNAI3;LPAR1;GLP2R;CXCL10;S1PR2;ABCA1;HTR1F;ADCYAP1;ADGRG2;CRHR1;GNAZ;CALCA;AKAP12;GPR161;GPR37L1;TSHR;ADCY8;GPR37;LHCGR
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.495881833638838,1.1561316860175614,0.3007518796992481,0.8831550595040896,1.0,7/22,16.99%,EIF2AK3;MTOR;DHX33;UBTF;DDX11;SMARCA4;IPPK
prerank,carboxylic acid transport (GO:0046942),-0.2963580645751093,-1.1560251593956143,0.22535211267605634,0.6585274620495599,1.0,18/55,15.86%,SLC6A13;SLC16A12;SLC13A3;SLC16A2;SLC16A6;SLC6A12;SLC7A5;SLC16A11;SLC6A9;SLC3A2;SLC16A4;SLC38A5;SLC6A17;SLC6A6;SLC6A7;SLC16A13;LLGL2;SLC38A6
prerank,TOR signaling (GO:0031929),0.48423680131564134,1.1559509911975132,0.31845597104945716,0.8828852624663432,1.0,14/26,29.14%,MTOR;MEAK7;FLCN;SYAP1;AKT1;LARP1;CARD11;CCDC88A;TIPRL;MAPKAP1;EIF4EBP2;PRR5;RHEBL1;FNIP1
prerank,cellular response to sterol (GO:0036315),0.5465302894139487,1.1548540426060792,0.2992125984251969,0.886220901099435,1.0,3/13,8.51%,LRP6;GRAMD1A;INSIG2
prerank,maturation of LSU-rRNA (GO:0000470),0.4815030073320691,1.1547210176955287,0.2875739644970414,0.885762037536987,1.0,10/26,22.24%,DDX18;URB1;ZNHIT6;RPL10A;EIF6;SNU13;RSL1D1;RPF2;MAK16;NOP2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.5286932077807116,1.1546378099732786,0.29069767441860467,0.8851477911710951,1.0,3/16,4.58%,IGFBP5;IGFBP6;IGFBP4
prerank,negative regulation of cell growth (GO:0030308),0.4087617844173449,1.154530842708515,0.22998986828774062,0.8846211619062857,1.0,25/121,15.05%,WT1;DCBLD2;FHL1;DACT3;FGF13;TGFB2;SLIT3;SLIT2;PTPRS;CDKN2AIP;SMAD4;GNG4;PSRC1;PTPRJ;TRIM46;FLCN;CYP27B1;BCL6;DNAJB2;ULK2;ADAM15;CDKN1A;ULK1;DCC;SMARCA4
prerank,actin-myosin filament sliding (GO:0033275),-0.3169633755612308,-1.1543342601903066,0.19014084507042253,0.658254626854011,1.0,3/38,1.52%,TPM1;ACTN2;DMD
prerank,muscle filament sliding (GO:0030049),-0.3169633755612308,-1.1543342601903066,0.19014084507042253,0.658254626854011,1.0,3/38,1.52%,TPM1;ACTN2;DMD
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.39689676490094183,-1.1541921356369529,0.2314410480349345,0.6563727666054299,1.0,6/17,17.82%,ATP1A2;GJA1;RYR2;ATP1B1;GJC1;GJD3
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.4792425148485546,1.1540827745088704,0.3108433734939759,0.8854516284172153,1.0,5/26,9.05%,IRAK3;ITCH;CARD16;C1QBP;SIRT2
prerank,cellular protein localization (GO:0034613),0.4033179810370937,1.1540075949009037,0.124,0.8847883883172522,1.0,100/285,23.64%,FGF7;SGSM2;EGFR;COPA;STX2;RAB32;RABGAP1L;CD177;RAB6A;ANK2;STX1A;TMED1;STX5;STX11;SEC31A;RAB23;RAB19;RAB6B;SCFD2;JAM3;USP4;ARF4;SCG5;TBCK;BICD1;AP3D1;HDAC6;STX1B;CLTC;SNX1;ACD;PACS2;USO1;TBC1D2B;ARFGAP3;STX4;TBC1D17;GGA1;SCFD1;WIPI2;ARF1;STX12;WDR45B;NPM1;SEC23IP;COPB2;VPS33A;TBC1D10A;NAPA;DUOXA1;STX17;RAB43;RPGR;HPS6;RRAGD;ARFRP1;BBS4;SYNDIG1;PIGK;ARF6;GGA2;AHI1;NSF;EVI5;SGSM1;COPZ2;EVI5L;AP4M1;NAPG;TBC1D13;RAB1B;RAB5B;RAB5C;STX3;SNX6;ARCN1;ADPRH;TBC1D22B;ATG13;TBC1D15;NIPBL;RAB24;TMED2;VPS33B;FLNA;COX18;CNTN2;ABHD17A;RUNDC1;CTTN;SMURF1;CROCC;SEPTIN9;NAPB;STX16;CNTNAP1;TBC1D8B;TBC1D12;PICK1;RABL3
prerank,positive regulation of developmental growth (GO:0048639),0.4385976047938953,1.1539523397510485,0.2785793562708102,0.8840446038953901,1.0,11/49,18.84%,GHR;DBN1;SYT2;NTN1;ISLR2;L1CAM;MAPT;GOLGA4;SYT1;SHTN1;RIMS2
prerank,vesicle transport along microtubule (GO:0047496),0.4882529174212519,1.1539387150624316,0.296875,0.8831570896235289,1.0,10/23,26.54%,NDEL1;TRAK2;DYNC1I1;KIF3A;KIF3B;DYNC1H1;PAFAH1B1;FBXW11;RAB1A;KIFAP3
prerank,glutamate metabolic process (GO:0006536),0.5121688135614518,1.1539215485386356,0.3189873417721519,0.8822878002401306,1.0,6/19,15.42%,GCLC;ALDH18A1;GLS2;GLS;ALDH5A1;GLUD1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4507670813098996,1.1539186836988637,0.27570621468926554,0.8813672448665133,1.0,14/39,20.71%,MYOC;CORO2B;EFNA5;MELTF;FZD7;JAG1;KANK1;ADAM15;RHOA;HOXA7;FZD4;RCC2;RASA1;CORO1C
prerank,mitotic recombination (GO:0006312),0.522010103705757,1.1538947991202215,0.29172141918528255,0.880536345865413,1.0,8/15,26.42%,XRCC3;SMC5;SMC6;RAD50;TEP1;ERCC1;NSMCE2;RAD51D
prerank,base conversion or substitution editing (GO:0016553),0.5488876541675956,1.1538897277128148,0.31095890410958904,0.879629753526724,1.0,2/11,11.59%,ADARB1;NUDT16
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5170721975535439,1.1538328492329564,0.30937098844672656,0.8789551010642265,1.0,1/16,0.24%,ACKR3
prerank,histone ubiquitination (GO:0016574),0.4939353980612608,1.1537226039070558,0.2889733840304182,0.878469970427018,1.0,9/21,25.69%,UBE2B;UBE2N;ATXN7L3;PHC1;UBE2A;USP22;PAF1;UBR2;RNF20
prerank,negative regulation of secretion by cell (GO:1903531),0.454910139538671,1.1537177414809459,0.2695852534562212,0.877563311104444,1.0,4/38,5.42%,LIF;ANXA1;SYT11;RHBDF1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.4904399453757577,1.153430206102911,0.2805486284289277,0.877767582746336,1.0,7/24,12.62%,JSRP1;SRI;CAMK2D;PKD2;GSTM2;PDE4D;CALM2
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.4925690855184806,1.153215020266354,0.303970223325062,0.877691671231211,1.0,2/22,8.30%,CD55;ZBTB1
prerank,inner ear morphogenesis (GO:0042472),0.48437751601200196,1.1531674589309349,0.30925221799746516,0.8769699102876414,1.0,5/22,13.71%,EPHB2;HPN;MYO3B;TTC39C;SIX1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.510018472947396,1.1530829213720233,0.31716417910447764,0.8763649650948193,1.0,10/20,22.92%,SPATA2;STUB1;HSP90AA1;NUPR1;OGT;FLOT2;PDCD6IP;SDCBP;CYLD;FLOT1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5758633629728294,1.1529273164903897,0.30813124108416545,0.8751275605721869,1.0,5/10,19.14%,NFATC4;NFATC1;PPP3CC;PPP3CA;PPP3CB
prerank,calcineurin-mediated signaling (GO:0097720),0.5758633629728294,1.1529273164903897,0.30813124108416545,0.8751275605721869,1.0,5/10,19.14%,NFATC4;NFATC1;PPP3CC;PPP3CA;PPP3CB
prerank,positive regulation of DNA metabolic process (GO:0051054),0.4300343990397665,1.1524017613369213,0.26559139784946234,0.8761629550961598,1.0,16/61,17.41%,PARP3;EGFR;WT1;FGF2;SMOC2;STPG4;EYA2;UBE2N;PRKD2;TIGAR;ABRAXAS1;NBN;USP7;HGF;PML;RAD50
prerank,striated muscle tissue development (GO:0014706),-0.3440765327048988,-1.1519575864578564,0.2465753424657534,0.659917588895085,1.0,9/29,11.33%,BMP5;PGM5;BMP7;MEF2C;RBP4;CAV1;BMPR2;TBX2;CFLAR
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.325692250054445,-1.1518837504531543,0.1678832116788321,0.6577969038680904,1.0,9/36,12.46%,SGMS1;BCL2;DAB2IP;TPD52L1;DAPK2;ING5;CX3CL1;FAS;BDNF
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.492299993972899,1.1518447246242374,0.3046192259675406,0.8773603882393095,1.0,8/22,22.45%,EDEM3;SYVN1;EDEM1;EDEM2;UBA52;AMFR;UGGT1;SEL1L
prerank,aorta morphogenesis (GO:0035909),-0.3834212239368589,-1.1515345203536036,0.2754237288135593,0.6563634024013145,1.0,6/17,9.45%,MYLK;ADAMTS9;ENG;TBX1;PDGFRB;TBX2
prerank,regulation of endocytosis (GO:0030100),0.4341464518890326,1.1515156332394807,0.25026968716289105,0.8776990188495438,1.0,18/61,19.46%,STON2;LRP1;GPC3;EPHA3;CD177;SYT11;SRC;RIT2;SCAMP5;ABL2;ARFGAP1;RUFY1;CALY;RAB5B;RAB5C;SMPD1;CLIP3;LRSAM1
prerank,histone H3-K36 demethylation (GO:0070544),-0.46290274486988947,-1.1511346299249634,0.29595015576323985,0.6551290168591525,1.0,2/10,2.52%,KDM7A;KDM4A
prerank,positive regulation of GTPase activity (GO:0043547),-0.23411836089460497,-1.1510213741404618,0.0,0.6531252249024402,1.0,46/188,11.94%,ARHGAP29;PKP4;TBC1D4;RAPGEF2;RAPGEF3;TBC1D1;ITGA6;RAP1GDS1;NET1;CDKL5;F11R;ARHGAP24;RALGAPA1;DOCK8;TGM2;RASGRP2;SIPA1L1;ARHGEF26;MAP4K4;PIP5K1A;RGS6;DVL3;NTRK3;RANGAP1;TBC1D25;DOCK9;GRTP1;CCDC125;TBC1D16;BCAR3;PLXNB1;ERBB2;CX3CL1;SFRP1;CAV2;MTSS2;ZC3H15;USP6NL;LIMS1;AGRN;TBC1D30;RGP1;RALGAPA2;TBC1D10B;TBC1D8;SCRIB
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4907629317049725,1.1504981623726682,0.3173431734317343,0.879740846780573,1.0,9/22,22.78%,ZDHHC7;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;CLIP3;ZDHHC18;ZDHHC8
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4907629317049725,1.1504981623726682,0.3173431734317343,0.879740846780573,1.0,9/22,22.78%,ZDHHC7;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;CLIP3;ZDHHC18;ZDHHC8
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.49632204107179817,1.1504325460767084,0.30205655526992287,0.8790698281285648,1.0,7/20,19.45%,TARBP2;TRIM71;AGO2;PUM1;AGO4;SNIP1;AGO3
prerank,negative regulation of interleukin-12 production (GO:0032695),0.5318227271451587,1.1501126513684619,0.2998661311914324,0.8793762328397223,1.0,3/14,11.89%,IRAK3;C1QBP;PIBF1
prerank,regulation of cytoplasmic transport (GO:1903649),0.5560080559461672,1.149897985173056,0.3251798561151079,0.8793456499222081,1.0,5/11,21.04%,ATP9A;SRC;USP7;MAP2K2;MAPK1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.49648280768904235,1.1498685609305148,0.2995049504950495,0.8785521108590578,1.0,10/20,17.66%,CAMK2D;PACS2;PSEN1;HERPUD1;SELENOK;BAK1;THADA;ATP2A2;PML;BCAP31
prerank,ephrin receptor signaling pathway (GO:0048013),0.4171699063532517,1.1497127856093254,0.25654450261780104,0.8782287350583308,1.0,31/82,25.16%,EPHB2;ARHGEF28;EFNA5;DNM1;EPHA3;FYN;MMP2;ANKS1B;AP2A2;SRC;ACTR3;PSEN1;EPHB3;EPHA10;NGEF;RHOA;ACTG1;ARPC1A;SDC2;ARPC2;EPHB1;RASA1;TIAM1;YES1;SDCBP;AP2M1;VAV2;NCK2;EPHA5;ITSN1;RAC1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.4103612019495768,1.1486092228236497,0.24254881808838644,0.8815545938311096,1.0,19/101,16.30%,LBP;CD80;AXL;ADAM9;MAPK14;NR1D1;CXCL10;CARD16;TLR4;SIRPA;IRAK1;ZFP36;RHOA;TNFRSF1B;ZC3H12A;CD14;SELENOS;PDCD4;IL6
prerank,non-motile cilium assembly (GO:1905515),0.46949028507272006,1.1484490014863795,0.29572446555819476,0.8812776470795761,1.0,11/30,21.35%,DCTN1;ARL13B;TOGARAM1;PIBF1;VANGL2;BBS4;TTC8;RPGRIP1;CEP89;PCM1;IFT57
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.4678820493241126,1.1484374273564781,0.28095238095238095,0.8804126812987132,1.0,7/30,16.59%,ACKR3;CD44;MIF;FBXO5;TWIST1;THOC1;SNAI2
prerank,Golgi organization (GO:0007030),0.4079321852118468,1.1481592658279587,0.2379979570990807,0.8805742335454695,1.0,46/112,28.30%,SEC16B;ATP8B1;ARHGAP21;STK25;TMED1;STX5;FBXW8;FHDC1;ZW10;LYSMD3;RAB30;PI4K2B;SEC22B;SYNE1;SURF4;LMAN1;RAB2A;SEC23IP;STX17;RAB43;BCAS3;BLZF1;HACE1;DYNC2H1;ARFGEF1;TMED2;CLASP2;ATP8B2;VAMP4;TJAP1;PI4K2A;STX16;GOLPH3L;TRAPPC12;VTI1A;BAG5;RAB29;RAB1A;GOSR2;GBF1;ARHGEF7;GORASP1;CUL7;VCPIP1;NPLOC4;TMED3
prerank,positive regulation of cartilage development (GO:0061036),0.5085396560536982,1.1477879449646764,0.3216601815823606,0.8810753608380709,1.0,3/17,9.27%,LOXL2;BMP1;SOX5
prerank,ceramide transport (GO:0035627),-0.43727143395825807,-1.1477644196674202,0.2831541218637993,0.6594864575075848,1.0,3/12,3.81%,PLTP;PLEKHA8;CERT1
prerank,regulation of microtubule polymerization (GO:0031113),0.44382583422745747,1.1477028532316753,0.27878103837471785,0.8804843089244823,1.0,16/40,20.64%,DCTN1;CLIP1;PSRC1;MAPRE3;TOGARAM1;MAPRE1;CAMSAP1;MAPT;GBA2;SLAIN2;TUBB4A;CDK5RAP2;AKAP9;NAV3;CLIP3;NUMA1
prerank,anterior/posterior pattern specification (GO:0009952),0.43941977208972915,1.1476870034575135,0.2649945474372955,0.8796534473702736,1.0,10/53,14.58%,HOXA3;WT1;PCSK5;BHLHE40;SKI;HOXA5;HOXA4;HOXA7;HOXC4;HOXA9
prerank,negative regulation of protein phosphorylation (GO:0001933),0.39990687283418225,1.1476774818691453,0.21116751269035533,0.8787975307230703,1.0,38/150,16.35%,EPHB2;LRP6;NIBAN1;TARBP2;LDLRAD4;DGKQ;SLIT2;CAMK2N1;PMEPA1;WWTR1;PLPP3;DTNBP1;RTRAF;RASSF2;TARDBP;MYADM;MLXIPL;YWHAG;PID1;PIP5KL1;SIRT2;GSKIP;INPP5K;SMAD6;SIRPA;AKT1;PPEF2;PDE4D;SFN;CALM2;DEPTOR;SMCR8;TWIST1;ZC3H12A;CHP1;NLRP2B;CEP85;NCK1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.42837135695621764,1.1474770837661805,0.27292340884573896,0.8786688995126086,1.0,16/62,19.35%,ACKR3;MAPK7;NFE2L2;SYVN1;CREB3L1;SRC;NOC2L;HERPUD1;URI1;AKT1;SELENOS;SNAI2;HTRA2;PPIA;PLAUR;MCL1
prerank,positive regulation of integrin activation (GO:0033625),0.5528760452237271,1.1473865369883243,0.3132867132867133,0.8781212743279556,1.0,2/11,6.81%,RAP1B;SRC
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.40970604288094864,1.1473470108848753,0.21747967479674796,0.877379179099107,1.0,24/129,13.17%,SFRP4;COL1A1;DKK2;EGFR;SCEL;GPC3;PSMC4;UBE2B;SMURF2;AXIN1;DACT1;DAAM2;PSMC6;PSMD8;GSKIP;PLEKHA4;KANK1;TMEM9;CSNK1G1;CSNK1G3;PRDM15;JUP;EGF;PIN1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4353657223094569,1.1467399757317707,0.2777777777777778,0.8787187681561328,1.0,18/47,25.16%,MYOC;EFNA5;S100A10;MYADM;C1QBP;MELTF;KANK1;TRIOBP;LIMS2;RAC3;RCC2;ILK;FLNA;CORO1C;FBLN1;DMTN;CALR;RAC1
prerank,regulation of cytoskeleton organization (GO:0051493),0.4092603874321166,1.1463176148534193,0.22895277207392198,0.8794276816753732,1.0,23/108,16.20%,PHLDB1;CDK2AP2;CORO2B;ARHGAP44;LRP1;EFNA5;EPHA3;CAPN2;S100A8;S100A9;SORBS3;MTOR;FSCN1;BICD1;IQGAP1;RHOQ;MAPT;TAOK2;MAP6;RHOA;DIAPH1;RND3;RAC3
prerank,DNA geometric change (GO:0032392),0.4837919779435609,1.1461533579254601,0.2995169082125604,0.8791355874725725,1.0,10/24,18.62%,ANXA1;ASCC3;DNA2;DDX11;NBN;HMGB3;RECQL;RAD50;BLM;SUPV3L1
prerank,protein deubiquitination (GO:0016579),0.3984928947362543,1.1459736914336685,0.174,0.8789444331060079,1.0,87/242,27.59%,AR;ESR1;UCHL1;DESI2;PSMC4;JOSD2;SMAD4;SMURF2;USP36;COPS5;OTUD3;ZRANB1;SPATA2;FOXK2;USP32;USP10;RAD23B;IL33;USP29;USP4;PSMC6;MDM4;OTUD1;UCHL5;ADRM1;PSMD8;SENP8;ATXN7L3;KAT2B;POLB;USP26;USP33;OTUD7B;ACTR5;USP48;USP50;TNIP1;UBA52;USP5;ABRAXAS1;RHOA;NFRKB;ZC3H12A;RCE1;INO80;STAMBPL1;RNF128;USP7;TRAF3;USP22;OGT;KEAP1;CCP110;WDR20;TGFBR1;NEDD8;SKP2;SUDS3;KDM1B;FOXO4;USP35;TRRAP;PTEN;USP13;CLSPN;USP19;CYLD;MAP3K7;RNF123;TNIP2;TFPT;PSMD3;STAM;PSMD4;MDM2;ASXL1;UFD1;OTUD4;USP49;PSMB3;INO80C;CFTR;OTULIN;USP38;VCPIP1;USP9Y;PSMB2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5270006477012977,1.1457224928660332,0.3119891008174387,0.8789836414763939,1.0,4/14,15.83%,SYVN1;CREB3L1;HERPUD1;SELENOS
prerank,generation of neurons (GO:0048699),0.4022954874996475,1.145699788855713,0.18072289156626506,0.8781715446010384,1.0,33/190,15.34%,LMX1A;LHX8;NAV1;WNT10B;WNT2;MAP1B;FGFR1;CTF1;SIX4;NEUROD2;WNT9A;FGF13;TGFB2;BHLHE40;RUNX1;LMX1B;IRX5;POMGNT2;DOCK7;LRP12;FZD7;SEMA3A;NRBP2;FUT9;MAPT;PIN1;SIX1;TAFA1;ARTN;THOC2;POU3F2;MDGA1;FZD4
prerank,regulation of humoral immune response (GO:0002920),0.44340124741189635,1.145656327211224,0.2809364548494983,0.8774444591198728,1.0,8/44,13.58%,CD55;CFH;C7;C1QBP;CD81;C4B;SERPING1;CR2
prerank,regulation of glucose metabolic process (GO:0010906),0.4575327730422849,1.1454603607450324,0.30384167636786963,0.8772900790970188,1.0,10/34,19.54%,IRS1;DGKQ;FOXK2;AKT1;IRS2;USP7;ZNF692;SELENOS;OGT;GPLD1
prerank,mRNA stabilization (GO:0048255),0.4476573255135556,1.1454182156996942,0.3002232142857143,0.8765761176370533,1.0,9/40,13.07%,TENT5B;MAPK14;DAZL;TARDBP;TIRAP;IGF2BP1;LARP1;ZFP36;GDNF
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.4652334997973307,1.145136409456105,0.2877871825876663,0.8758509653354895,1.0,7/29,22.15%,GPAT4;ACLY;ACOT6;ACOT9;ACOT1;ACAT1;CROT
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.4652334997973307,1.145136409456105,0.2877871825876663,0.8758509653354895,1.0,7/29,22.15%,GPAT4;ACLY;ACOT6;ACOT9;ACOT1;ACAT1;CROT
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.5548623268291144,1.1449810185433666,0.32727272727272727,0.8755465724408559,1.0,6/11,26.46%,SLIT2;MIF;PADI2;NBL1;CCN3;DUSP1
prerank,response to organic cyclic compound (GO:0014070),0.43400704154147723,1.1444920318356946,0.278814489571899,0.8764419170474805,1.0,5/52,8.43%,IGFBP5;ESR1;ANXA1;SOCS2;CYP27B1
prerank,mitochondrion transport along microtubule (GO:0047497),0.5375217715555384,1.1444048342110442,0.32727272727272727,0.8758862706744626,1.0,6/13,25.60%,NEFL;SYBU;MAPT;UXT;MAP1S;RHOT2
prerank,glycosphingolipid metabolic process (GO:0006687),0.4388448643699136,1.1441757082390076,0.2795580110497238,0.8757938869783858,1.0,8/42,13.63%,SMPD3;ARSA;B3GALNT1;LARGE1;GBA2;GLA;CERK;GLTP
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.36447120781914844,-1.1440906591810902,0.25888324873096447,0.6664324779908455,1.0,8/21,10.06%,CNOT2;SAMD4A;CNOT9;PAN3;CNOT7;TUT4;CNOT11;TUT7
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5669026261470022,1.1437823964014733,0.3545706371191136,0.876398589726695,1.0,2/10,8.10%,GHR;STAT5A
prerank,regulation of neuron death (GO:1901214),0.416987977437526,1.1436104922849861,0.25556733828207845,0.8761738227755382,1.0,21/82,19.92%,CD34;SNCB;FYN;KIR3DL2;EGLN2;AKT1;MAPT;GPNMB;NSMF;CD200R1;EIF2S1;TNFRSF1B;DCC;CHP1;HTRA2;SARM1;CHRNA7;FAIM2;EPHB1;RRAS2;ITGAM
prerank,double-strand break repair via homologous recombination (GO:0000724),0.4149045501081615,1.1431408026277015,0.24242424242424243,0.8770960742144233,1.0,26/95,18.94%,REV3L;XRCC3;SFR1;RAD51B;RFWD3;UBE2N;HELQ;AP5S1;SAMHD1;MCM3;SMC5;RMI1;ERCC4;FAN1;SEM1;SMC6;NBN;INO80;RECQL;SPIDR;RNF138;RAD50;ERCC5;BLM;MORF4L1;NIPBL
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5597729862996836,1.1429583241387606,0.28706199460916443,0.876863307117523,1.0,7/11,28.37%,ZMIZ1;SMARCD1;PADI2;ELOF1;SERTAD2;ARID1A;ARID1B
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.4842817822163348,1.1428318487129014,0.29799764428739695,0.8764954722724959,1.0,5/24,12.28%,SEMA3C;VEGFA;SEMA3A;DSCAM;SEMA3D
prerank,negative regulation of translation (GO:0017148),0.41318233565135587,1.1422982283451835,0.2536231884057971,0.8776641622903786,1.0,21/87,19.65%,IGFBP5;EIF2AK3;RBM4;PAIP2B;TRIM71;SAMD4B;MRPL13;AGO2;PUM1;IGF2BP1;UNK;LARP1;CNOT10;EIF3E;FXR2;CPEB1;YTHDF1;YTHDF2;EPRS1;PAIP2;PCIF1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.41640942824739896,1.1414488943895538,0.2635494155154091,0.8799899159691551,1.0,19/78,16.15%,AR;EPHB2;EGFR;LRP1;EPHA3;TMBIM1;ATP2B4;ZDHHC7;PID1;CLTC;STX4;RHOQ;SQSTM1;AKT1;ZDHHC2;PPFIA1;ARF6;PLS1;SPTBN1
prerank,protein modification by small protein removal (GO:0070646),0.39649853547189906,1.1413445425892665,0.181,0.8794810795124012,1.0,85/252,25.98%,AR;ESR1;UCHL1;DESI1;DESI2;PSMC4;JOSD2;SMAD4;SMURF2;USP36;COPS5;OTUD3;ZRANB1;FOXK2;USP32;USP10;RAD23B;IL33;USP29;USP4;PSMC6;MDM4;OTUD1;UCHL5;ADRM1;PSMD8;SENP8;TOR1A;KAT2B;POLB;USP26;USP33;OTUD7B;ACTR5;USP48;USP50;TNIP1;UBA52;USP5;ABRAXAS1;RHOA;NFRKB;ZC3H12A;RCE1;INO80;STAMBPL1;RNF128;USP7;TRAF3;USP22;OGT;KEAP1;SENP6;CCP110;WDR20;TGFBR1;COPS4;NEDD8;SKP2;SUDS3;KDM1B;FOXO4;USP35;TRRAP;PTEN;USP13;CLSPN;USP19;CYLD;MAP3K7;RNF123;TNIP2;TFPT;PSMD3;STAM;GPS1;SENP5;PSMD4;MDM2;ASXL1;UFD1;OTUD4;USP49;PSMB3;INO80C
prerank,NAD biosynthetic process (GO:0009435),-0.3649159597638922,-1.1412286771132967,0.26,0.6713363696783095,1.0,7/20,17.35%,NAMPT;PTGS2;PTGIS;PARP10;NUDT12;NMNAT3;PARP9
prerank,glycoprotein biosynthetic process (GO:0009101),0.41633509411470654,1.1409649854326467,0.284375,0.8800262036241217,1.0,17/79,11.99%,ST3GAL2;B3GALNT1;CSGALNACT2;FUT2;CHST10;TMEM106A;MGAT1;GAL3ST3;CHST12;FOXL1;XYLT1;ALG1;LARGE1;FUT9;B3GNT8;ST3GAL4;TNIP1
prerank,steroid hormone biosynthetic process (GO:0120178),0.4702154571045971,1.1407732611487553,0.29545454545454547,0.8798362246068329,1.0,6/29,23.86%,AKR1B1;SRD5A1;HSD17B8;FDX1;HSD17B11;SRD5A3
prerank,cellular response to growth factor stimulus (GO:0071363),0.3990204792823882,1.1406622731109428,0.21392532795156408,0.8793973801481484,1.0,41/151,16.74%,HAS2;HAS1;TMEM100;WNT2;EGFR;ANXA1;CLEC3B;CD44;MAPK7;GAS1;VEGFA;PDE8A;TGFBR2;ZPR1;SMAD4;MAPK14;ACVR1;ZFP36L1;MAP2K3;PRKD2;ZFP36L2;SYAP1;SIRT2;IQGAP1;SOX5;INPP5K;ERN1;URI1;AMHR2;AKT1;MAPT;MAGI2;KIDINS220;ZFP36;KLF4;RAPGEF1;HGF;STAT5B;SNAI2;HTRA2;RAB35
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.5191543939769945,1.140117901482821,0.3175416133162612,0.8805822015943436,1.0,5/16,18.22%,SRSF6;RBM17;DDX17;DDX5;PUF60
prerank,regulation of mitochondrial fission (GO:0090140),0.48013308310041414,1.140078467702328,0.3128834355828221,0.879862084421726,1.0,10/24,26.56%,DCN;MIEF2;MCU;MAPT;DDHD1;RALA;STAT2;FIS1;MUL1;INF2
prerank,histone H3 deacetylation (GO:0070932),0.5154097846492462,1.1400010456293486,0.32476319350473615,0.8792911502302594,1.0,5/15,16.19%,HDAC9;SIRT2;HDAC3;HDAC4;PER1
prerank,development of primary male sexual characteristics (GO:0046546),0.4584569988797679,1.1396302752098415,0.30197444831591175,0.8798754050324767,1.0,6/34,9.98%,AR;WT1;SIX4;TGFB2;SOX8;COL9A3
prerank,regulation of phospholipase C activity (GO:1900274),0.5199310362396086,1.1395911400349203,0.3247753530166881,0.8791466273022323,1.0,5/15,7.45%,ESR1;FGFR1;FGF2;BICD1;ABL2
prerank,negative regulation of cytokine production (GO:0001818),0.3995357168660039,1.1394023112648202,0.22289766970618036,0.8789731766830079,1.0,31/163,16.86%,CD34;AXL;ANXA1;NPTN;IRAK3;HDAC9;HDAC7;SYT11;ITCH;C1QBP;INHA;GAS6;TLR4;SIRPA;OTUD7B;SLC2A10;GPNMB;PIBF1;ZFP36;PIN1;BCL3;CD200R1;ZC3H12A;KLF4;RNF216;SELENOS;ILRUN;PDCD4;IL6;ANXA4;TAX1BP1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5315044667660853,1.139140718994449,0.3091655266757866,0.8789912056537679,1.0,3/12,13.56%,IRS1;IRS2;TWIST1
prerank,protein localization to cell surface (GO:0034394),0.48044737711290186,1.139092790310716,0.2932692307692308,0.8783093685293957,1.0,9/26,14.77%,FGF7;CD177;ANK2;JAM3;USP4;GGA1;PIGK;ARF6;GGA2
prerank,actin nucleation (GO:0045010),0.4891150594970112,1.1390804310150546,0.30363864491844417,0.8775125075071529,1.0,6/21,17.42%,SCIN;ACTR3;MAGEL2;ARPC5L;ARPC1A;ARPC2
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5002386237481978,1.13886519981275,0.31186868686868685,0.8774461596459833,1.0,1/18,0.18%,TNFSF9
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.39067809618174487,1.1386089822905456,0.123,0.8774856070797722,1.0,51/348,12.37%,CD34;SFRP4;AR;GSN;EPHB2;AMH;FGF18;SEC16B;FGF7;C1QTNF1;WT1;HPN;TMEM119;PKP3;EIF2AK3;ANXA2;MAPK7;ANK2;DGKQ;VEGFA;FGF2;CAMK2N1;ZPR1;NFE2L2;RBMS3;MAPK14;ADAM19;KLF2;MTOR;ITCH;HOXA5;DTNBP1;IL33;PID1;GAS6;INPP5F;VDR;PSEN1;AGO2;ECE1;TLR4;MAPK11;MUSK;MPHOSPH8;MITF;KRAS;AKT1;SLC2A10;MAGI2;NAT8;EGF
prerank,response to tumor necrosis factor (GO:0034612),0.41163291795211404,1.1381176484822944,0.2691511387163561,0.8784969035872824,1.0,18/91,15.58%,HAS2;CCL8;AFF3;ADAM9;NFE2L2;ZFP36L1;NR1D1;PID1;ZFP36L2;CHUK;CCL25;INPP5K;AKT1;ZFP36;CCL13;ZC3H12A;GGT7;BAG4
prerank,positive regulation of secretion (GO:0051047),0.5483156454660877,1.1380218379167768,0.3333333333333333,0.8779728014703447,1.0,3/11,19.54%,SCIN;TRH;GPLD1
prerank,endochondral bone morphogenesis (GO:0060350),-0.44915834667117244,-1.1376994224436394,0.2846975088967972,0.6784315328011806,1.0,7/11,16.52%,MEF2C;FOXC1;COL13A1;INPPL1;BMPR2;TRPV4;FGFR3
prerank,response to lipid (GO:0033993),0.4074123447975375,1.1375057785169422,0.26136363636363635,0.8789911336497963,1.0,17/105,11.73%,LBP;ESR1;ANXA1;IRAK3;FOXP1;F2R;S100A8;S100A9;VPS4B;SOCS2;FOXO1;CYP27B1;TIRAP;TLR4;SMAD6;SLPI;IRAK1
prerank,cellular response to nitrogen compound (GO:1901699),0.4934232482775205,1.1373035149588087,0.311787072243346,0.8788677199751344,1.0,10/20,29.97%,ATP2B4;EPG5;DDX11;SPIDR;BLM;NSMCE3;RIOK3;PDE12;ATRX;HSF1
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.33054050377768085,-1.1364046171180975,0.22580645161290322,0.6795731852042156,1.0,7/32,7.51%,INSR;IGF1;APP;PRKAA2;PPARA;PINK1;ENO1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.49986377825565287,1.1360978357479077,0.3243589743589744,0.8824285560752964,1.0,5/17,17.21%,MAPK7;NFE2L2;AKT1;HTRA2;PPIA
prerank,acetyl-CoA metabolic process (GO:0006084),0.5180413354940195,1.135656979329714,0.30563002680965146,0.8832379848878138,1.0,7/15,25.37%,ACLY;MVK;NUDT7;PMVK;DIP2A;ACAT1;MVD
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.43044106825855516,1.1356512376585952,0.29017857142857145,0.8823922562384179,1.0,8/46,9.07%,ADAMTS5;WNT10B;DOCK7;NR1D1;LNPEP;FLCN;FOXC2;TLR4
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.3520946513554312,-1.1356034054361996,0.2722222222222222,0.6794445564331654,1.0,4/23,2.10%,PRKAG2;CEMIP;BMP7;APP
prerank,regulation of hippo signaling (GO:0035330),-0.37084854235048237,-1.1348926664690762,0.28957528957528955,0.6790827673457384,1.0,9/17,19.05%,MOB3B;VGLL4;WTIP;WWC1;MARK3;AJUBA;SOX11;NF2;WWC2
prerank,endomembrane system organization (GO:0010256),0.3956578798527544,1.134785422327469,0.21327967806841047,0.8847453825989814,1.0,43/178,18.19%,SEC16B;ATP8B1;ARHGAP21;DNM1;EIF2AK3;TMED1;HOOK2;SEC31A;FBXW8;REEP3;TOR1AIP2;ZW10;NUP93;MIA3;TLCD2;PLEKHF1;LYSMD3;RAB30;PI4K2B;SYNE1;OSBPL2;AP3D1;SURF4;LMAN1;TOR1A;SQSTM1;RAB2A;SEC23IP;USP50;LNPK;STX17;RAB43;BCAS3;SEC61A1;SPTBN1;PHETA2;BLZF1;HACE1;REEP5;DYNC2H1;VPS11;ANXA8;ANXA8L1
prerank,high-density lipoprotein particle assembly (GO:0034380),0.5766681137484927,1.1345575499932576,0.33242506811989103,0.8847226552605817,1.0,2/10,7.00%,BMP1;ABCA1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.41234908606890325,1.1341863977661144,0.26813880126182965,0.8852495583278601,1.0,13/85,5.88%,FGF18;FGF7;EGFR;HPN;SIX4;SRSF6;VEGFA;FGF2;TGFB2;FUT2;ZFP36L1;TCF7L2;NR1D1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.44751585010974604,1.1341859108024304,0.3030646992054484,0.8843910345085254,1.0,15/39,23.57%,TTC7A;PIK3C2B;PIK3R2;SOCS2;PI4K2B;PIK3CA;PI4KB;PI4KA;SOCS6;PIP4K2C;IP6K1;PIP4K2B;PIK3CG;PI4K2A;TTC7B
prerank,response to reactive oxygen species (GO:0000302),0.4329988388529118,1.1340413844145134,0.29392624728850325,0.8840309490380662,1.0,14/54,14.37%,UCP1;EGFR;STK25;FYN;ADAM9;PKD2;CHUK;GPX1;CAMKK2;AKT1;MAPT;PDGFRA;FER;STK24
prerank,response to copper ion (GO:0046688),0.5004897754066719,1.1338933889799248,0.3231162196679438,0.8837166788222233,1.0,1/20,0.82%,LOXL2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.4701882873225986,1.1337274390583647,0.2946859903381642,0.8835157014137269,1.0,7/26,17.44%,FBN1;INHA;LRRC17;TLR4;HOXA7;IL4;GPR137B
prerank,autophagosome assembly (GO:0000045),0.43192795584715354,1.1337180291858007,0.3031624863685932,0.8826997007362785,1.0,21/52,24.13%,RAB23;RAB19;ATG2B;PACS2;WIPI2;STX12;WDR45B;ULK2;STX17;RAB43;ATG2A;ATP2A2;ULK1;RAB1B;ATG16L2;ATG13;ATG16L1;ATG3;SMURF1;ATG14;EMC6
prerank,mRNA catabolic process (GO:0006402),0.4424497290162686,1.1328256616978258,0.28967813540510545,0.8852105393038541,1.0,19/44,28.67%,DIS3L2;RC3H1;ZFP36L2;NUDT16L1;ERN1;NUDT16;ZFP36;CNOT10;DDX5;AGO4;YTHDF2;SUPV3L1;AGO3;THRAP3;EXOSC10;UPF1;LSM5;AGO1;PDE12
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.42530237233524487,1.132806875474988,0.2855567805953694,0.8844122679963973,1.0,19/52,23.21%,EPHB2;GPSM2;EGFR;LRP1;EPHA3;ATP2B4;STX4;SQSTM1;AKT1;ARF6;PLS1;SPTBN1;STX3;CLIP3;NUMA1;STAC3;ZDHHC8;EPB41L2;ZDHHC5
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.4434277282868272,1.1327894491035182,0.3160270880361174,0.8836239549939856,1.0,5/37,4.00%,IGFBP5;TGFB3;MMP2;FGF2;MEF2D
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.438928674472041,-1.1325708901187581,0.30739299610894943,0.6828949692658695,1.0,5/13,11.92%,GLUL;NOS3;PRODH;ALDH4A1;NOS1
prerank,triglyceride biosynthetic process (GO:0019432),0.5049955782743105,1.1324837318731895,0.3009198423127464,0.883950165789128,1.0,6/18,20.27%,GPAT4;MOGAT1;MOGAT2;GPAT3;GPAM;LPIN3
prerank,defense response to Gram-positive bacterium (GO:0050830),0.4480627501967158,1.1324709595365365,0.2943820224719101,0.8831488771732462,1.0,7/40,18.59%,LBP;ANG;TIRAP;DMBT1;RNASE6;IL6;MBL2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.3785020364337004,-1.1323361342677016,0.3027027027027027,0.6812588798790354,1.0,13/20,29.45%,WNT4;BMP5;ACADL;SIK1;BMP2;CEACAM1;GPER1;ABCA2;BRCA1;ERLIN2;TRIB3;ASXL3;APOC1
prerank,endothelial cell differentiation (GO:0045446),0.5323471014652162,1.1321995615145615,0.33026315789473687,0.8832809125629377,1.0,2/12,8.92%,FSTL1;JAG1
prerank,organelle assembly (GO:0070925),0.39114028991335364,1.132108232559889,0.122,0.8827743977185574,1.0,121/385,24.53%,CD34;GSN;NME8;CDC14B;RAB32;ABLIM1;PKD1;RAB23;RAB19;FHDC1;CHMP7;VPS4B;CENPT;MAPRE3;MVB12A;UBAP2L;VPS37D;FARP2;STARD9;ARF4;BICD1;RC3H1;ACTR3;HDAC6;LSM4;BBS9;ATAT1;ATXN2;ATG2B;PACS2;ARL13B;TMEM138;OCRL;CPLANE1;HPS4;CNGB1;EHD2;WIPI2;NUDCD3;STX12;WDR45B;DZIP1;HDAC3;NPM1;MAPRE1;TTC39C;HAUS3;AVIL;TEKT5;MAPT;PIBF1;ULK2;DYNC2I2;KIF3A;RAB43;ATG2A;NCOR1;RPGR;ATP2A2;VPS37C;KIF3B;IFT46;EIF2S1;ATXN2L;TTLL3;ULK1;BBS4;INO80;TMOD2;TTC8;DYNC1H1;KLHL41;ATP6V1D;AHI1;CENPC;RAB1B;VPS37B;CEP164;YTHDF1;YTHDF2;DYNC2H1;ATG16L2;CEP89;AUP1;DYNC2I1;CEP83;CCDC28B;RP2;ATG13;CENPE;BBS5;NEK7;BBIP1;IFT52;EXOC4;CC2D2A;SPAG16;FLNA;VPS36;TUBGCP5;ATG16L1;PCM1;DNAH5;ATG3;FBF1;EIF2A;PDCD6IP;TMEM231;YTHDF3;OGFOD1;TCTN2;ATG14;IST1;EDC3;RAB11FIP3;PDE6D;STAM;EMC6;DYNLL1;G3BP1;TCTN1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5568270124999505,1.1320463503559608,0.32865168539325845,0.8821599367833614,1.0,6/11,27.55%,MOSPD3;BNIP1;RTN4;ATL1;LPCAT3;VCPIP1
prerank,positive regulation of exosomal secretion (GO:1903543),0.5166283116177961,1.1313932236375768,0.3285340314136126,0.883821514808869,1.0,6/15,26.13%,SMPD3;VPS4B;PDCD6IP;SDCBP;STAM;SDC4
prerank,connective tissue development (GO:0061448),0.44421832096973596,1.1313264029142243,0.31285551763367464,0.8832128028691308,1.0,8/35,10.13%,CD44;SULF2;SLC39A13;PKD1;SULF1;SOX8;SOX5;COL2A1
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.38661352764100726,-1.1312249301976385,0.24434389140271492,0.6819429764435757,1.0,2/18,0.55%,ATP1A2;NEDD4L
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.5331318286500671,1.1308011120964414,0.33565459610027853,0.8843002459552077,1.0,3/13,10.58%,B3GALNT1;GAL3ST3;B3GNT8
prerank,cellular response to organic substance (GO:0071310),0.400337094439782,1.1303412945562041,0.27505112474437626,0.8851704609820277,1.0,26/116,18.39%,GHR;IGFBP5;UCP1;CLEC3B;MAPK7;SLIT3;SLIT2;TGFBR2;ACVR1;SOCS2;NCOA3;HDAC6;PID1;CDK9;INPP5K;URI1;AMHR2;FLT3;RHOA;KLF4;STAT5B;HTRA2;CXCR4;PTPN5;IL18;TGFBR1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4250014610232606,1.1302106668995362,0.3216245883644347,0.884801236614586,1.0,20/54,28.10%,SYK;SPATA2;CARD16;PELI3;GAS6;CHUK;SPPL2B;MADD;NLRP2B;RBCK1;TAX1BP1;CLIP3;PYCARD;CPNE1;CYLD;UBE2K;RNF31;OTULIN;CASP8;LAPTM5
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.4675753472020848,1.1301979901094263,0.31912302070645554,0.8840004636287035,1.0,5/26,11.99%,ST3GAL2;GK5;LARGE1;ST3GAL4;TNIP1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.3910628588211592,-1.1299973086644277,0.2727272727272727,0.6828345383213924,1.0,15/16,46.95%,CEACAM1;CYRIB;PTPRC;AGER;LILRB1;FADD;IL12A;IL12RB1;IL23A;KLRD1;IL23R;IL12B;RIPK3;XCL1;KLRC1
prerank,mRNA processing (GO:0006397),0.39285041589526,1.1298818327618319,0.158,0.8842812826927067,1.0,111/287,28.89%,GEMIN6;POLR2H;SRSF2;CD2BP2;HNRNPA1;GTF2H3;SRSF6;DHX16;RBM4;ZCRB1;DDX42;LSM4;PRPF4;U2AF1;SRSF3;TFIP11;PRPF3;GPATCH1;AURKAIP1;CPSF6;USP39;HNRNPD;RBM22;DNAJC8;ERN1;SNRPB2;SON;CPSF4;HNRNPH1;TCERG1;DHX8;RBM17;ERCC3;PRPF40A;SRSF11;THOC7;POLR2D;POLR2G;SNU13;HNRNPA3;AQR;POLDIP3;CCNH;THOC2;THOC1;SF3B4;ZC3H11A;GTF2F1;ZCCHC8;CMTR2;BCAS2;SF3A1;CPSF2;PHF5A;DDX5;SNRPA;SNRPG;SNRPD3;PNN;SNIP1;PDCD7;DDX39A;SRRM1;RBM6;PUF60;GCFC2;PRCC;HNRNPUL1;U2AF2;ELAVL2;ZMAT5;NOVA1;LSM7;PTBP1;SF3B2;SF3B1;AKAP8L;KIN;PRPF38A;GPKOW;RBM5;RNMT;SNRPA1;CSTF2T;CPSF1;RALY;CPSF7;WDR33;PABPN1;POLR2C;CWC27;RAMAC;ALYREF;UPF3B;PPIH;USP49;RBMX;PRPF19;CRNKL1;PRPF6;LSM5;CDC40;THOC5;WDR83;CELF1;CPSF3;RBM15;HNRNPC;SNRPC;WBP11;SRSF5
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5076942831151083,1.1297806340813417,0.338562091503268,0.8838308151388111,1.0,3/15,12.04%,PRKCA;CAMK2D;SLC9A1
prerank,cellular response to acid chemical (GO:0071229),0.466522991091269,1.1294873316580885,0.3250883392226148,0.8840946480666851,1.0,10/27,22.92%,CAPN2;VEGFA;KLF2;MTOR;NSMF;RRAGD;CPEB1;IPO5;SESN2;SLC38A9
prerank,positive regulation of response to stimulus (GO:0048584),0.4391460099169965,1.1293883938063625,0.3258173618940248,0.8835668378270777,1.0,9/40,19.01%,CD80;TGFB2;CDKN2AIP;CGAS;YPEL3;FXR2;EEF1E1;ILK;SELENON
prerank,positive regulation of signal transduction (GO:0009967),0.3913183320949489,1.1289215651981095,0.19019019019019018,0.8844660488712008,1.0,44/238,12.88%,RSPO2;MN1;CD80;CCBE1;AXL;PRKCA;IRS1;NPTN;GRB10;SULF2;ITGB3;ZMIZ1;TGFB2;CDKN2AIP;DLG4;TEDC1;SMOC2;SKI;ADAMTS3;SLC39A14;DACT1;ITGA5;ZRANB1;KLF2;SRC;UCHL5;STX1B;SULF1;ESM1;GAS6;PRKD2;PKD2;CYP27B1;JAG1;KAT2B;BMP2K;ITGAV;ERN1;KANK1;ENHO;BAK1;KLK6;TUBD1;MGAT5
prerank,carboxylic acid metabolic process (GO:0019752),0.45587863663541695,1.1288711477003583,0.3062645011600928,0.883824767277196,1.0,11/33,18.68%,CYP2S1;LIPT2;MIF;PON3;SLC23A1;SLC23A2;SLC2A3;GLUD1;GSTO2;ST3GAL1;GNE
prerank,ceramide biosynthetic process (GO:0046513),-0.31250070144069403,-1.128731323009576,0.2578125,0.6839164188220337,1.0,13/40,14.59%,SGMS1;ST8SIA4;ST6GALNAC3;SPTSSA;SAMD8;ST6GALNAC5;DEGS2;ST8SIA2;CERS1;CERS5;ST8SIA6;SPTLC2;SPTSSB
prerank,positive regulation of cellular metabolic process (GO:0031325),0.40585038962635533,1.1286859033501466,0.26424870466321243,0.8836747705886937,1.0,22/98,15.86%,SFRP4;HPN;ANXA2;VEGFA;LIPT2;TGFBR2;MAPK14;ACLY;PID1;DHRS4;INPP5F;ECE1;AKT1;MAGI2;EGF;CDKN1A;ZC3H12A;KLF4;IL4;GHITM;AHI1;NSF
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.5151049250422038,1.1286061617746521,0.29958960328317374,0.8831291483996078,1.0,2/13,7.49%,ZC3H8;GLI2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.4081474878882282,-1.1280649932797728,0.29961089494163423,0.6833853487182088,1.0,11/13,42.47%,OAS2;STAT1;CRLF1;IL27;OASL;CANX;IL27RA;STAT3;JAK1;TYK2;EBI3
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.48854138522062546,1.1280607721640625,0.3181818181818182,0.8834556936266903,1.0,8/19,24.65%,POLR2H;ACD;POLR2D;POLR2G;TERF1;TINF2;TERF2IP;POLR2C
prerank,regulation of DNA recombination at telomere (GO:0072695),0.48854138522062546,1.1280607721640625,0.3181818181818182,0.8834556936266903,1.0,8/19,24.65%,POLR2H;ACD;POLR2D;POLR2G;TERF1;TINF2;TERF2IP;POLR2C
prerank,purine ribonucleotide metabolic process (GO:0009150),0.4164460372053723,1.12783265466639,0.27848101265822783,0.8834394293275045,1.0,16/68,22.48%,GNAI3;GPAT4;AMPD2;RAB23;ACLY;ACOT6;BPNT2;RHOQ;ACOT9;ACOT1;SULT4A1;ABHD14B;ACAT1;TPST2;CROT;ADSS2
prerank,vasodilation (GO:0042311),0.5357675972029267,1.1273358640600972,0.3401920438957476,0.8843923050112827,1.0,2/13,4.86%,KCNMA1;KLF2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.3937846951690968,-1.1269834799464917,0.2850877192982456,0.6840460046901888,1.0,2/16,1.52%,ATP1A2;DMD
prerank,regulation of dendritic spine development (GO:0060998),0.4960188239638054,1.1269363312942444,0.31679389312977096,0.8850755078351458,1.0,7/19,14.69%,PTPRS;PPFIA2;GRIN3A;PSEN1;TANC2;LLPH;ARF6
prerank,negative regulation of wound healing (GO:0061045),0.45891647140035624,1.1263846795802142,0.3280871670702179,0.8862661844748101,1.0,2/28,2.88%,CD34;FGF2
prerank,neuron projection organization (GO:0106027),0.5074959839653885,1.126227276520008,0.34070221066319895,0.8859653642233559,1.0,8/15,23.55%,DCTN1;ATP1A3;PSEN1;ARF1;PLS1;CHRNA7;MAP1A;PICK1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.453013558642119,1.1260134379289768,0.3060747663551402,0.8858975870788681,1.0,3/33,5.24%,MN1;PKD1;ATP2B4
prerank,translesion synthesis (GO:0019985),0.43853790997835024,1.1257863655646483,0.31620111731843575,0.8859492547723042,1.0,17/42,28.17%,REV3L;POLDIP2;USP10;ZBTB1;DTL;POLI;UBA52;PCLAF;RFC4;POLD1;FAAP20;REV1;POLH;UFD1;POLE2;NPLOC4;RFC3
prerank,macromolecule catabolic process (GO:0009057),0.46944157692433763,1.1257469485473495,0.33052884615384615,0.8852610226691757,1.0,10/26,23.83%,MTOR;MVB12A;TPP1;CLPX;SIAH1;IDE;LRSAM1;SMURF1;USE1;TRIM24
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.46989037939718004,1.1252556843583597,0.330498177399757,0.8862068489633429,1.0,8/25,18.49%,ARHGAP44;SLIT2;PFN2;KANK1;CEP97;EVI5L;CCP110;ODF2L
prerank,membrane organization (GO:0061024),0.3920319773496885,1.1251889118944,0.2046138415245737,0.88562956426095,1.0,66/227,24.21%,STON2;AREG;TRIP10;EGFR;TIMM50;SYT2;DNM1;MOSPD3;BTC;ANK2;BIN1;TMEM43;STX11;REEP3;TOR1AIP2;NUP93;CHMP7;VPS4B;TLCD2;MTCH1;AP2A2;MYADM;OSBPL2;SLC18A3;AP3D1;ACTR3;CLTC;USO1;OCRL;TOR1A;SNAP23;NAPA;UBA52;EGF;SGCZ;GLTP;CBL;CHP1;FZD4;ACTG1;ARPC1A;SPTBN1;IGF2R;HACE1;NAPG;SYT1;ARPC2;VAMP2;VPS33B;CORO1C;COX18;CNTN2;ARRB1;AZIN2;CTTN;VAMP4;PDCD6IP;LDLR;CCDC88A;PACSIN2;TMEM33;AP2M1;PICK1;STAM;EMD;AGFG1
prerank,modification-dependent protein catabolic process (GO:0019941),0.3920309059937119,1.124829656925354,0.23971915747241726,0.8861241068520264,1.0,74/193,26.29%,UBE2B;SPSB1;SPSB4;UBA6;SMURF2;SYVN1;ITCH;RBBP6;RNF111;SPSB2;RC3H1;STUB1;WDR91;ADRM1;SIAH1;MYLIP;CUL3;DTL;UBE2G2;FBXW4;USP33;HERPUD1;SQSTM1;CDC23;ANAPC5;RNF7;UBE2A;UBA52;CDC34;NDFIP1;DDB1;CDC27;CBL;UBR4;AMFR;RNF128;TRPC4AP;RNF14;HACE1;KEAP1;CDC26;UBE2G1;FBXO11;ANAPC4;NTAN1;ARIH2;UBE2R2;NEDD8;RNF19A;UBE3C;TOLLIP;KCTD6;ARIH1;KCTD10;ANAPC10;KCTD21;ARRB1;RC3H2;SMURF1;ANAPC15;RNF6;RNF114;RNF13;PSMD3;UBQLN4;MDM2;RNF166;UFD1;FBXO22;RNF20;RNF126;UBE2K;RNF167;ANAPC2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4672101085013296,1.1247527834443853,0.32,0.8855679229427191,1.0,8/25,17.31%,ANK2;FGF13;DSC2;CAMK2D;HCN4;JUP;ATP2A2;AKAP9
prerank,positive chemotaxis (GO:0050918),0.5071226906633628,1.1246022225531287,0.35233160621761656,0.8852844931806685,1.0,4/17,11.78%,FGF7;VEGFA;PTPRJ;GPNMB
prerank,axon development (GO:0061564),0.4114365304222094,1.124588869681159,0.31413612565445026,0.8845147702519596,1.0,29/78,26.08%,EPHB2;MAP1B;GAP43;ZPR1;LLGL1;DOCK7;S100A6;EPHB3;PLP1;L1CAM;MAPT;MTR;TAOK2;RTN4RL1;DCC;SHTN1;CNTN4;SLITRK4;RAB10;MAP1A;SPTBN4;MAP1S;NTNG2;RTN4;MARK2;PAX2;ATL1;NRCAM;SLITRK5
prerank,negative regulation of bone remodeling (GO:0046851),0.546252787909107,1.1245294795196195,0.34344827586206894,0.8839227679256625,1.0,4/11,17.44%,TMEM119;CALCA;IL6;GPR137B
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.4512954904719907,1.1244256698369037,0.3211764705882353,0.8834845068753858,1.0,5/31,11.78%,CD80;GLMN;RC3H1;CEBPB;GPNMB
prerank,histone H4-K16 acetylation (GO:0043984),0.4903415923300584,1.1241428628619825,0.3396704689480355,0.8836769003017222,1.0,8/19,20.13%,MSL2;MSL3;ING4;MSL1;WDR5;KANSL3;OGT;KMT2A
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3112643341487699,-1.1236807238761028,0.21666666666666667,0.690668978983808,1.0,4/41,1.98%,TJP1;GCNT2;PODXL;BMP7
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5032558838804324,1.1234942836977662,0.3333333333333333,0.885121133061491,1.0,4/17,8.91%,THBS4;C1QBP;MCU;TIRAP
prerank,protein depolymerization (GO:0051261),0.46719463876927203,1.123346577628931,0.33495736906211937,0.8848162796538658,1.0,8/27,20.38%,GSN;VPS4B;KIF2A;TWF1;MICAL2;CKAP5;MICAL1;STMN4
prerank,histone H2A ubiquitination (GO:0033522),0.48629990340265344,1.123079801946432,0.3381201044386423,0.8849610105587555,1.0,8/17,22.64%,UBE2B;RNF2;RYBP;UBE2A;DDB1;RING1;KDM2B;UBR2
prerank,negative regulation by host of viral transcription (GO:0043922),0.5262479233889089,1.1228075173632968,0.3462566844919786,0.8851063721982173,1.0,4/12,21.89%,TARDBP;INPP5K;TFAP4;JUN
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.349949438503123,-1.1227781790985658,0.28169014084507044,0.6906126689515205,1.0,4/23,6.76%,TPM1;ADAMTS9;TGFBR3;FGFR2
prerank,error-free translesion synthesis (GO:0070987),0.4758561252328339,1.1225490864657848,0.32019704433497537,0.8852200286731114,1.0,12/22,33.17%,POLDIP2;UBA52;RFC4;POLD1;REV1;POLH;UFD1;NPLOC4;RFC3;SPRTN;RPA3;RCHY1
prerank,positive regulation of viral transcription (GO:0050434),0.460799203331631,1.1220106948316655,0.3277310924369748,0.8864102827267506,1.0,7/25,15.09%,POLR2H;MDFIC;CDK9;POLR2D;POLR2G;CTDP1;GTF2F1
prerank,regulation of axon regeneration (GO:0048679),-0.4264031416728244,-1.121791914681487,0.31785714285714284,0.690909354333703,1.0,2/12,0.51%,PTN;EPHA4
prerank,negative regulation of ossification (GO:0030279),-0.35840733825585913,-1.121775024683717,0.2647058823529412,0.6887325998053356,1.0,7/23,14.47%,ENPP1;MEF2C;NOTCH1;SFRP1;MDK;SRGN;BCOR
prerank,positive regulation of growth (GO:0045927),0.41315010582700656,1.121759616152647,0.3066385669125395,0.8864974217274841,1.0,9/64,4.22%,EGFR;HPN;TGFB2;RFTN1;CDKN2AIP;S100A8;S100A9;ZPR1;DDX49
prerank,regulation of exocytosis (GO:0017157),0.43548841262059823,1.1216996843667328,0.3196448390677026,0.885905472285892,1.0,19/46,27.68%,ANXA1;STX4;RAB3D;ATP6AP1;RAB27B;NSF;SYT1;VAMP2;RIMS2;RAB2B;RALA;CLASP2;RAB10;STXBP5L;RAB12;RAB3C;CFTR;IL1RAPL1;RAB8B
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.4090504487649225,1.1215908462473427,0.2755741127348643,0.8854622663194148,1.0,34/83,30.03%,DCTN1;ODF2;ATF5;YWHAG;SSNA1;YWHAE;ALMS1;NPM1;MAPRE1;HAUS3;SFI1;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;CCP110;AKAP9;CEP164;CKAP5;PAFAH1B1;PCM1;DCTN2;NEDD1;DYNLL1;CEP78;CSNK1E;ACTR1A;CETN2;CEP152;TP53;CENPJ;PLK4;SDCCAG8
prerank,actin filament depolymerization (GO:0030042),0.5403809942580895,1.1214478441632127,0.3412587412587413,0.8851843791583947,1.0,3/11,11.23%,GSN;TWF1;MICAL2
prerank,mesenchymal to epithelial transition (GO:0060231),0.564043843061496,1.1213100810357877,0.33972602739726027,0.8848587705019985,1.0,2/10,8.19%,WT1;FZD7
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.533110154850273,1.1212035685485555,0.34196891191709844,0.8844168582754204,1.0,5/12,18.61%,FOXP1;TIRAP;TLR4;KLF4;MBP
prerank,inositol phosphate-mediated signaling (GO:0048016),0.4960718341941609,1.1208242256929346,0.3413098236775819,0.8849850117289378,1.0,6/19,19.14%,PLCE1;NFATC4;NFATC1;PPP3CC;PPP3CA;PPP3CB
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5587131611807664,1.1204510509684757,0.3607681755829904,0.8854701729392036,1.0,2/10,3.49%,IRF4;RUNX1
prerank,GPI anchor biosynthetic process (GO:0006506),0.4570688018507716,1.1195500228646593,0.3412042502951594,0.8879834858367801,1.0,9/30,14.92%,PIGT;GPAA1;PIGZ;PIGC;MPPE1;PIGS;PIGW;PIGK;PIGM
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4022962058395399,1.119239436666926,0.2831765935214211,0.8882587346177709,1.0,23/93,17.31%,LIF;EGFR;CD44;VEGFA;MIF;AXIN1;ATP2B4;DOCK7;RASSF2;MLXIPL;PFN2;HDAC6;GAS6;PRKD2;INPP5K;AKT1;PDE4D;HSP90AA1;TNKS1BP1;NLRP2B;IL6;NCK1;AKAP9
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.40483629731696735,1.1191777024683844,0.29855371900826444,0.8876416253326522,1.0,30/84,24.93%,MBNL1;HNRNPA1;SRSF6;RBM4;C1QBP;SRSF3;NSRP1;NUP98;MBNL2;SON;CELF2;RBFOX2;DDX17;RBM3;SF3B4;DDX5;FXR2;SAP18;RBM39;PUF60;U2AF2;NOVA1;PTBP1;SRPK1;THRAP3;LARP7;RBM5;DAZAP1;RBM24;CELF3
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.40217739897107263,1.1191557290479737,0.29149377593361,0.8869218091511489,1.0,30/88,21.51%,AP1G2;AP4B1;LLGL1;ACBD3;AP1M1;DTNBP1;SCAMP3;CLTC;MYO5A;CLVS2;STX4;SCFD1;SNAP23;ARF1;AP4E1;AP1S2;PUM1;NAPA;CORO7;AP4M1;GOPC;SORCS1;VAMP2;RP2;SH3D19;CLVS1;EXOC4;RAB10;AP1S3;ARRB1
prerank,positive regulation of MAPK cascade (GO:0043410),0.38906627517776726,1.118541626105254,0.209,0.8883357665944852,1.0,40/245,13.10%,MID1;ACKR3;LIF;FGF18;CCL8;PRKCA;EGFR;FGFR1;STK25;CD44;VEGFA;PDE8A;FGF2;TGFB2;MST1R;F2R;MIF;LPAR1;TAOK3;TMEM106A;KLHDC10;PTPRJ;RET;RIT2;ADCYAP1;GAS6;DHX33;PRKD2;NDRG4;TIRAP;CCL25;IQGAP1;GPR37L1;IRAK1;GPNMB;EGF;ATP6AP1;TAOK2;CCL13;FLT3
prerank,diterpenoid metabolic process (GO:0016101),0.42322391375150076,1.1184557447949144,0.31624863685932386,0.8878363262536392,1.0,5/55,5.79%,AKR1B1;LRP1;GPC6;GPC3;ALDH3A2
prerank,glycerol metabolic process (GO:0006071),0.5525638201741774,1.118192845931875,0.34744525547445254,0.8879989362021874,1.0,6/10,28.42%,GK5;COQ3;ANGPTL3;GOT1;COQ2;PGP
prerank,"base-excision repair, gap-filling (GO:0006287)",0.43868080811896415,1.117676621345392,0.33791523482245134,0.8890021733128548,1.0,3/35,9.94%,MPG;POLB;PARG
prerank,negative regulation of protein secretion (GO:0050709),0.44065730236589407,1.1175873480432517,0.3119906868451688,0.8885167423349405,1.0,6/38,9.59%,RAB11FIP5;IRS1;F2R;MIDN;RHBDF1;BMP8A
prerank,positive regulation of ERAD pathway (GO:1904294),0.5258517416869019,1.1174376263617327,0.33012379642365886,0.8882528554563893,1.0,6/13,21.67%,NFE2L2;TMEM259;HERPUD1;SGTA;BCAP31;USP13
prerank,T cell proliferation (GO:0042098),-0.4184859151630446,-1.1170771320494062,0.32452830188679244,0.6984413824260222,1.0,3/13,4.77%,CTPS1;DOCK8;CADM1
prerank,negative regulation of B cell activation (GO:0050869),0.47645227543803137,1.1169931602937462,0.33902439024390246,0.8890458931419329,1.0,4/21,7.01%,PARP3;INHA;BANK1;RC3H1
prerank,nuclear pore complex assembly (GO:0051292),0.555818665536084,1.1167214993056458,0.35443037974683544,0.8892022608210025,1.0,4/10,8.69%,NUP93;AHCTF1;NUP107;NUP98
prerank,multivesicular body assembly (GO:0036258),0.4533633662988363,1.1165328907634586,0.3431952662721893,0.8890784284105214,1.0,10/30,23.94%,CHMP7;VPS4B;MVB12A;VPS37D;VPS37C;VPS37B;VPS36;PDCD6IP;IST1;STAM
prerank,cellular potassium ion homeostasis (GO:0030007),0.5210010649898741,1.1164658782405088,0.3333333333333333,0.8885124612630441,1.0,5/13,5.51%,KCNMA1;ATP1A3;ATP1A4;ATP1A1;KCNJ2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.47873169303821683,1.1163397482562023,0.3296432964329643,0.8881548797095499,1.0,3/21,2.97%,EPHB2;TGFB2;SLIT2
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.39812411489325605,1.1162110924952355,0.27631578947368424,0.8878339372185345,1.0,31/136,16.86%,SFRP4;ESR1;IRAK3;BHLHE40;GLIS2;PKD1;TCF7L2;ITCH;PRMT2;TBX6;GAS6;RNF2;PKD2;CHUK;TAF3;IRAK1;NWD1;COMMD6;HDAC4;ZC3H12A;KLF4;USP7;NUPR1;CHP1;NLRP2B;TRAF3;RBCK1;ANXA4;KEAP1;UFL1;TAX1BP1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3687997215273223,-1.1158689584668227,0.3113207547169811,0.6994820112869781,1.0,7/21,12.97%,ADCY5;ADCY1;GUCY1B1;ADCY4;ADCY9;NPR1;GUCY1A1
prerank,erythrocyte differentiation (GO:0030218),-0.29018472019990843,-1.115672833881739,0.28695652173913044,0.6977714058291037,1.0,11/44,13.99%,LYN;KMT2E;KIT;TGFBR3;HSPA9;CASP3;RPS14;INHBA;PTPN2;TAL1;HIPK2
prerank,dendritic spine organization (GO:0097061),0.46626712992152197,1.1156288808366088,0.33415536374845867,0.8891098177985877,1.0,9/26,18.12%,EPHB2;FYN;DLG4;ARF1;EPHB3;CTNND2;DIP2A;CHRNA7;EPHB1
prerank,positive regulation of T cell activation (GO:0050870),0.4102966364439897,1.1154490682404923,0.32585470085470086,0.8889787418337776,1.0,11/62,16.98%,CD80;ANXA1;ZMIZ1;CD81;ZBTB1;CD47;SIRPA;IL4;IL6;NCK1;FLOT2
prerank,cellular response to misfolded protein (GO:0071218),0.48798362883912844,1.115391145678486,0.35006273525721454,0.8883768978344438,1.0,10/20,27.31%,STUB1;UBE2W;CUL3;TOR1A;AUP1;UGGT1;DERL1;UFD1;RNF126;UGGT2
prerank,mononuclear cell differentiation (GO:1903131),0.4641798237290495,1.1153400380473895,0.3337453646477132,0.8877463999649183,1.0,5/24,14.82%,AXL;VEGFA;GAS6;FLT3;IL4
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.4702208900522238,1.1151863586427155,0.32971014492753625,0.887495435038238,1.0,8/23,21.15%,TIMM10B;TIMM9;AGK;BMF;HSP90AA1;TIMM22;TIMM8B;COX18
prerank,regulation of actin filament depolymerization (GO:0030834),-0.40669587528199447,-1.1148351646884855,0.3176470588235294,0.6977300097313722,1.0,2/12,3.27%,PLEKHH2;SEMA5A
prerank,positive regulation of lipid localization (GO:1905954),0.5346640125189611,1.1146333778274256,0.34104046242774566,0.8885729211124512,1.0,2/11,14.08%,LRP1;ZC3H12A
prerank,defense response to bacterium (GO:0042742),0.3961634187505839,1.1145624123601123,0.2948328267477204,0.8880058829584401,1.0,11/105,12.31%,SYK;LBP;ANG;S100A8;S100A9;TIRAP;TLR4;CEBPB;DMBT1;SLPI;RNASE6
prerank,cell-cell junction assembly (GO:0007043),-0.2712418081872313,-1.113854414453723,0.26229508196721313,0.6980092821688966,1.0,12/63,7.74%,TJP1;PKP4;CDH5;GJB6;CLDN5;PATJ;GJB2;CDH6;ACTB;TLN2;GJA1;CDH7
prerank,regulation of protein phosphorylation (GO:0001932),0.3836765420187539,1.1136844552606493,0.22522522522522523,0.8902836999130131,1.0,76/256,22.92%,EPHB2;LRP6;FGF18;NIBAN1;FGF7;EGFR;EFNA5;TMEM119;NPTN;EIF2AK3;PLCE1;CCDC88C;FYN;ITGB3;VEGFA;PDE8A;FGF2;SLIT2;WWTR1;PLPP3;AXIN1;TARDBP;MYADM;PID1;PIP5KL1;GAS6;FLCN;INPP5K;SIRPA;TWF1;MUSK;HDAC3;NPM1;CAMKK2;CEBPB;KRAS;AKT1;GPNMB;PIN1;CCND1;AKAP8;ZC3H12A;FER;WDFY2;HSP90AA1;CHP1;NOP53;PPIL4;HGF;FXR2;PML;PPP2R5B;CHRNA7;PPIA;PLAUR;ILK;IBTK;THPO;CLIP3;BMPER;FKBP8;CORO1C;ACVR2A;PTEN;MOB1B;AKAP8L;ARRB1;NSD1;SESN2;TERF2IP;ATF4;SPTBN4;CCDC88A;STAT2;FBLN1;FLOT1
prerank,regulation of cardiac conduction (GO:1903779),-0.2774471977283982,-1.1135348345947533,0.21428571428571427,0.6966354018238787,1.0,12/54,12.11%,ATP1A2;ITPR1;ATP1B3;AHCYL1;SLC8A3;ABCC9;ITPR3;NPR1;FXYD1;RYR2;NOS1;ATP2A3
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.3760548047751931,-1.1133568234467324,0.2857142857142857,0.6949156607340748,1.0,9/16,23.56%,SHLD1;HELB;KLHL15;RIF1;SMCHD1;FANCB;MAD2L2;RMI2;PARPBP
prerank,fat cell differentiation (GO:0045444),0.4178434269912207,1.1132534721894345,0.32044198895027626,0.8910440500240815,1.0,12/57,14.32%,UCP1;ATF5;METRNL;TCF7L2;FOXO1;PID1;BBS9;SOX8;SMAD6;TMEM120A;BBS4;KLF4
prerank,regulation of protein localization to nucleus (GO:1900180),0.42851624026298557,1.1130861826239034,0.33751425313568983,0.8908182222555866,1.0,8/43,15.97%,LIF;EIF2AK3;WWTR1;FLCN;OTUD7B;AKT1;PIN1;ILRUN
prerank,negative regulation of developmental process (GO:0051093),0.4127418489954602,1.1128326775594939,0.31189710610932475,0.8909057102973148,1.0,15/69,12.33%,LOXL2;PARP3;NEUROD2;PTPRS;MIF;HOPX;GRIN3A;NFIB;RC3H1;GAS6;WDR77;KANK1;ALPK2;MAPT;ANP32B
prerank,positive regulation of histone deacetylation (GO:0031065),0.5384470921803737,1.1128040573808595,0.35269709543568467,0.8902105958572378,1.0,6/12,21.50%,VEGFA;PRKD2;AKAP8;NIPBL;CTBP1;AKAP8L
prerank,regulation of metal ion transport (GO:0010959),0.49399356639254105,1.1126060637856776,0.3351063829787234,0.8901353540784607,1.0,3/16,3.40%,IL16;ANK2;SRI
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.5526696090261526,1.1124892592497844,0.3473389355742297,0.8897811155370194,1.0,3/10,18.92%,DIS3L2;UBA52;NEDD8
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.42065267085842645,1.1122213939196781,0.3192436040044494,0.8898908694402442,1.0,12/48,17.50%,IRAK3;SLIT3;SLIT2;CARD16;PELI3;GAS6;SAMHD1;PARP14;NLRP2B;IL6;PADI2;YTHDF2
prerank,positive regulation of cell communication (GO:0010647),0.46228362755794966,1.1122184652171694,0.33174791914387636,0.889105686009994,1.0,11/28,23.03%,CD80;CDKN2AIP;DLG4;HCRT;LGI1;SYT1;ILK;RIMS2;CLSTN3;NMU;GRIK2
prerank,xenobiotic transport (GO:0042908),-0.3814215271168156,-1.111994715449864,0.31718061674008813,0.6962795139725327,1.0,7/17,18.36%,ABCG2;SLC7A5;SLC22A4;GJA1;ABCA3;SLC22A2;SLC22A18
prerank,protein O-linked glycosylation (GO:0006493),0.4040267680613851,1.1114868325825837,0.3084886128364389,0.890916414906131,1.0,29/96,24.67%,PLOD2;ST3GAL2;GALNT16;C1GALT1;POFUT2;POMGNT2;GALNT10;MUC1;GALNT18;OGA;PLOD3;LARGE1;B3GNT8;GALNT1;ST3GAL4;B3GALNT2;OGT;ST3GAL1;ST3GAL3;GALNTL6;PLOD1;MGAT5B;CRPPA;TMTC3;GXYLT1;POGLUT2;GALNT4;DPM2;PGM3
prerank,organic hydroxy compound transport (GO:0015850),-0.31469545368132346,-1.1108240503059934,0.23943661971830985,0.6974334602166024,1.0,9/36,12.72%,ABCC4;SLCO2B1;SLCO1C1;RBP4;SLC5A3;STRA6;NCOA1;CEACAM1;OSBP
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.45386982297635975,1.1103824357547096,0.3395348837209302,0.8940567308115577,1.0,12/32,21.72%,CDC14B;TAOK3;RINT1;DTL;TAOK2;CDKN1A;ABRAXAS1;NBN;NOP53;BLM;DONSON;CLSPN
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.428151239034107,1.1103384815655033,0.3268348623853211,0.8934209637168863,1.0,18/46,23.96%,ZPR1;PIK3R2;TCF7L2;GAS6;YWHAE;PSEN1;CPSF6;RBM22;HDAC3;JUP;ANP32B;ZC3H12A;DMAP1;IPO5;FLNA;BAG3;TPR;EMD
prerank,regulation of DNA replication (GO:0006275),0.4159591219532656,1.1100116507246467,0.32447397563676633,0.8937735961662584,1.0,11/49,14.84%,EGFR;CTC1;GTPBP4;RBBP6;GLI2;FBXO5;EGF;TERF1;DNA2;EHMT2;GMNN
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4528405968543485,1.1097455535458887,0.3402187120291616,0.8939317696832868,1.0,11/28,24.62%,IRS1;GRB10;TNS2;PID1;INPP5K;KANK1;NCK1;PIP4K2C;PIP4K2B;TSC2;PRKCZ
prerank,myelination (GO:0042552),0.4275099101093748,1.1088113151151686,0.32560706401766004,0.8963972361055141,1.0,12/46,18.61%,MYOC;PMP22;SKI;SOX10;MAL2;SIRT2;ARHGEF10;PLP1;KLK6;MARVELD1;CXCR4;MBP
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.4457997783934705,-1.1081736596188243,0.3388704318936877,0.7025332089509478,1.0,5/10,16.29%,ATP5F1C;ATP5F1D;ATP5PD;ATP5MG;ATP5MC2
prerank,bicarbonate transport (GO:0015701),0.46343495991169276,1.108038673414873,0.36097560975609755,0.8983750388283285,1.0,5/25,11.33%,SLC4A10;SLC4A8;SLC4A3;SLC4A4;SLC26A6
prerank,anterior/posterior axis specification (GO:0009948),-0.4005876952598684,-1.1079768075014356,0.32286995515695066,0.7007843797107729,1.0,2/15,3.49%,WLS;TBX3
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.4522075919745867,1.1068121539591838,0.3548780487804878,0.901876976007147,1.0,7/27,16.30%,HAS2;CD44;CD47;SIRPA;IRAK1;RHOA;IL6
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.5340612622260261,1.1064683196228104,0.36147757255936674,0.9023235763813157,1.0,3/11,10.38%,CD44;SRC;KANK1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.3895633096427687,-1.1061878237613905,0.31679389312977096,0.7031778636354634,1.0,2/14,3.30%,ADAM10;WNT5A
prerank,T cell mediated immunity (GO:0002456),0.5259546015065685,1.1060538358490142,0.3695054945054945,0.9029529283236795,1.0,3/13,15.16%,CD55;JAG1;BTN3A3
prerank,retinol metabolic process (GO:0042572),0.5214804824745072,1.1059698587039968,0.37317397078353254,0.9024628981434103,1.0,1/14,0.74%,DHRS9
prerank,RNA 3'-end processing (GO:0031123),0.4096191251804126,1.1059489335092592,0.31668437832093516,0.9017408586251275,1.0,30/69,28.89%,SRSF2;SRSF6;TENT4A;U2AF1;SRSF3;CPSF4;SRSF11;THOC7;POLDIP3;THOC2;THOC1;ZC3H11A;CPSF2;TENT2;DDX39A;SRRM1;TENT4B;SUPV3L1;U2AF2;CSTF2T;CPSF1;CPSF7;WDR33;PABPN1;ALYREF;UPF3B;CDC40;THOC5;CPSF3;SRSF5
prerank,blood vessel endothelial cell migration (GO:0043534),-0.3616617212058183,-1.105668079376718,0.31137724550898205,0.702552753427147,1.0,8/22,8.35%,ROBO1;CDH5;EFNB2;EPHB4;KDR;NRP1;ID1;EMP2
prerank,negative regulation of transferase activity (GO:0051348),0.45596569353606936,1.1049857088548318,0.34323040380047504,0.904323650113861,1.0,8/28,13.42%,SRC;INPP5K;MAPT;FBXO5;IRS2;ERCC4;ZFP36;TERF1
prerank,negative regulation of protein modification process (GO:0031400),0.3978627182392489,1.1047594388084678,0.3150684931506849,0.9043225656014101,1.0,28/79,23.52%,EPHB2;LRP6;NIBAN1;SLIT2;WWTR1;PLPP3;ATP2B4;TARDBP;MYADM;PID1;PIP5KL1;INPP5K;SIRPA;MAPT;P3H1;ZC3H12A;CDYL;CHP1;PPIA;TINF2;IBTK;FKBP8;CORO1C;PTEN;TERF2IP;YWHAB;FBLN1;ATG14
prerank,regulation of catabolic process (GO:0009894),0.4948917532114334,1.1043556833189128,0.3590062111801242,0.9049525112035857,1.0,5/18,13.23%,FAP;ZDHHC7;ODC1;TMEM9;ZDHHC2
prerank,negative regulation of signal transduction (GO:0009968),0.38176018878571116,1.1035042603552783,0.23671013039117353,0.9072168252388957,1.0,37/249,11.64%,SFRP4;DCN;IGFBP5;TNMD;SRMS;EGFR;LRP1;IRS1;GPC3;GRB10;SULF2;DACT3;IRAK3;FGF2;TNS2;TMBIM1;GLIS2;ACVR1;DACT1;PTPRJ;NFATC1;CREB3L1;BEND6;CARD16;NTN1;PID1;SULF1;NDRG4;PALM;SIAH1;INPP5K;CD47;TSKU;KANK1;AKT1;GLI3;SLC2A10
prerank,regulation of secretion by cell (GO:1903530),0.4184639229255311,1.1028474579151597,0.3318918918918919,0.9087756395202939,1.0,20/54,27.68%,ANXA1;DISP1;LLGL1;RHBDF1;SCG5;STX4;RAB3D;HCRT;P3H1;NSF;SYT1;VAMP2;RIMS2;RALA;RAB10;STXBP5L;RAB12;RAB3C;VAMP3;RAB8B
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.408678123732284,1.1028145047181064,0.3235294117647059,0.9080842237275828,1.0,18/70,17.93%,ANTXR1;TMEFF2;ITGB3;NTN4;RADIL;DACT2;MEGF9;ARL13B;SRCIN1;ITGAV;EPHB3;ATRN;UNK;RHOA;FER;SRGAP2;YTHDF2;ILK
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3781458617353118,1.1022145159406416,0.197,0.9093936326735409,1.0,62/348,13.43%,GHR;LIF;DDR2;CD80;FGF18;NIBAN1;FGF7;EGFR;TGFB3;EFNA5;ANGPT4;TMEM119;NPTN;CAMKK1;CD44;ITGB3;DGKQ;VEGFA;PDE8A;FGF2;TGFB2;MIF;SMAD4;AXIN1;ACVR1;BMP15;ITGA5;MAP2K3;ATP2B4;PTPRJ;DOCK7;MAPRE3;RASSF2;THBS4;INHA;SRC;PFN2;S1PR2;BANK1;HDAC6;ADCYAP1;GAS6;FLCN;PRKD2;CD81;CDK9;IQGAP1;BMP8A;MUSK;HDAC3;CAMKK2;KRAS;AKT1;GPNMB;EGF;XRCC5;CALM2;TAOK2;CDKN1A;PIN1;CCND1;IL5
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5425009425942678,1.1020813408951347,0.3919308357348703,0.9090769544620235,1.0,2/10,9.27%,LOXL2;SOX5
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.4551298396603876,1.101956748865665,0.3576555023923445,0.9087056193061803,1.0,14/27,26.42%,MRGBP;ATAT1;MSL3;KAT2B;NAT8;MORF4L1;NAA50;TAF6L;TRRAP;SGF29;KAT6B;KAT5;KAT7;BRD8
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.46918454557208156,1.101696145743703,0.3577639751552795,0.9088492250642267,1.0,10/22,28.35%,VPS4B;MVB12A;VPS37D;VPS37C;VPS37B;UBAP1;VPS36;STAM;RNF126;PTPN23
prerank,cell part morphogenesis (GO:0032990),0.5229166286756427,1.1013490747795973,0.3751763046544429,0.9092851133493371,1.0,7/13,24.98%,WASF1;PID1;MYH14;SUPV3L1;PACSIN2;FIS1;MTM1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4746348432270848,1.1011278184331885,0.3681592039800995,0.9092653030437584,1.0,8/21,22.52%,EFNA5;EPHA3;SLK;SLC9A1;RHOA;ACTG1;CORO1C;LDB1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.3136709900846024,-1.1008673107645055,0.27007299270072993,0.7133818396046968,1.0,11/38,12.44%,SP100;BMP5;BCL2L1;NOS3;THBS1;SFRP1;FAS;ICAM1;CFLAR;RIPK1;TNFSF10
prerank,regulation of translation (GO:0006417),0.3836182894459275,1.1005552395368392,0.2880161127895267,0.9104787956965736,1.0,59/173,27.22%,IGFBP5;NIBAN1;PKP3;EIF3B;EIF2AK3;RBM4;PAIP2B;CTIF;MTOR;TRIM71;SAMD4B;ATXN2;LARP4;MRPL13;HNRNPD;EIF1;NPM1;IGF2BP1;PASK;EIF6;LARP1;LTN1;RPS27L;BCL3;ZCCHC4;CNOT10;NOLC1;POLDIP3;RBM3;EIF3E;GSPT1;IL6;EIF3D;FXR2;YTHDF1;EPRS1;PAIP2;PCIF1;MTIF2;METAP1;NEMF;EIF2A;YTHDF3;OGFOD1;TRAP1;EIF4G3;EIF4H;CALR;LARP6;GRM5;CYFIP1;UPF3B;EIF2B2;EIF4G1;EIF4E2;UPF1;DDX1;TSC1;PRKDC
prerank,triglyceride catabolic process (GO:0019433),0.48461881183672484,1.1004953210065889,0.3634053367217281,0.9098879736071388,1.0,4/19,18.64%,FABP12;FABP5;LIPC;LIPH
prerank,cellular response to retinoic acid (GO:0071300),0.42629851365388594,1.1003104358026232,0.3523489932885906,0.9097705184959559,1.0,7/42,8.19%,WNT10B;WNT2;EPHA3;WNT9A;RET;ABL2;FZD7
prerank,regulation of protein localization to Cajal body (GO:1904869),0.5340052778762244,1.0996883514750682,0.38264580369843526,0.9103130841127374,1.0,5/11,27.82%,MEPCE;CCT7;LARP7;CCT4;CCT6A
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.5340052778762244,1.0996883514750682,0.38264580369843526,0.9103130841127374,1.0,5/11,27.82%,MEPCE;CCT7;LARP7;CCT4;CCT6A
prerank,synaptic membrane adhesion (GO:0099560),0.50903294416818,1.0995464503694035,0.3797814207650273,0.910019427570204,1.0,3/14,6.77%,GPC6;PTPRS;PTPRF
prerank,microtubule polymerization (GO:0046785),0.44687134574985043,1.0991163599138802,0.36556603773584906,0.9107501955062001,1.0,12/29,23.10%,FGF13;NDEL1;MAPT;TPPP3;PIN1;SLAIN2;MAP7D3;AKAP9;CKAP5;CLASP2;TUBGCP5;TUBG2
prerank,glycogen metabolic process (GO:0005977),-0.3382243200811308,-1.0989797479555787,0.29878048780487804,0.7162153402217081,1.0,6/27,5.33%,PRKAG2;PHKB;PYGM;GYS1;GBE1;AGL
prerank,neutrophil activation involved in immune response (GO:0002283),0.3761167837834288,1.0988797663183079,0.2,0.9108058107182873,1.0,104/428,21.60%,SYK;TIMP2;GSN;CD55;ARSA;B4GALT1;CD44;CD177;ANXA2;RAB6A;ANPEP;ACTR1B;TMBIM1;MIF;S100A8;S100A9;SPTAN1;MAPK14;AP1M1;ACLY;RAP1B;TMEM63A;PTPRJ;TOM1;PLEKHO2;AP2A2;PRCP;RAB37;IDH1;DOK3;TCN1;ATP11A;COPB1;SURF4;CAPN1;ARHGAP9;DYNC1LI1;PSEN1;IQGAP1;ABCA13;SNAP23;ITGAV;CD47;LPCAT1;SIRPA;CSTB;NRAS;RAB3D;SLPI;GLA;JUP;TMEM30A;XRCC5;NIT2;SNAP25;RHOA;CMTM6;TNFRSF1B;NME2;SLC2A3;UBR4;SLC15A4;HSP90AA1;CD14;DIAPH1;ATP6V0A1;DYNC1H1;GAA;ATP6V1D;PKM;CAP1;IGF2R;CANT1;FABP5;CTSD;PPIA;PADI2;ILF2;RAB5B;RAB5C;SLC44A2;CXCR2;COTL1;TMEM179B;PLAUR;VAMP2;PYGB;PRG2;ALDOA;APAF1;RAB24;DDOST;TOLLIP;ITGAM;ACP3;QSOX1;RAB10;PYCARD;COMMD9;MAPK1;ANXA3;ERP44;CAB39;CPNE1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.30088060516907594,-1.098842642881546,0.30656934306569344,0.7144513171813182,1.0,11/39,11.49%,CDH5;PLCG1;THBS1;SEMA5A;KDR;ITGA4;NDNF;RGCC;ICAM1;ECSCR;TEK
prerank,calcium ion transport (GO:0006816),-0.24742233805174058,-1.0987959696616119,0.125,0.712364956958378,1.0,25/113,14.12%,ITPR1;TRPM3;SLC24A3;TRPM6;CALCRL;NALCN;CACNA1E;ATP2C1;SLC8A3;RAMP1;CACNB2;CACNA1D;TRPC5;CAV1;SLC3A2;TRPC6;TRPC4;ORAI2;CACNG8;RYR2;ATP2A3;TRPV4;SLC24A5;TRPC7;TRPC3
prerank,cellular response to BMP stimulus (GO:0071773),0.40530912415166337,1.098710517326346,0.34796573875803,0.9106175625766587,1.0,12/66,10.84%,AMH;TMEM100;TGFB3;TGFB2;SMAD4;ACVR1;BMP15;FAM83G;SMAD5;BMP8A;SMAD6;AMHR2
prerank,positive regulation of macrophage migration (GO:1905523),-0.3741631913424017,-1.0981468924355282,0.297029702970297,0.7118401812867236,1.0,6/19,13.27%,IL34;THBS1;CX3CL1;MDK;MAPK3;PTK2
prerank,protein K11-linked ubiquitination (GO:0070979),0.4549491920819078,1.0981047491194837,0.3527272727272727,0.9120068749059007,1.0,10/27,20.90%,UBE2B;UBE2W;CDC23;ANAPC5;UBE2A;CDC27;CDC26;ANAPC4;UBE2D3;ANAPC10
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4253317383494701,1.0979122554018637,0.3515625,0.9118716172439661,1.0,9/44,10.15%,MYOC;TGFB3;S100A10;SORBS3;LPAR1;PFN2;ARHGEF10L;ARHGEF10;CD47
prerank,regulation of cell growth (GO:0001558),0.38235924238479896,1.0977810934276093,0.2768304914744233,0.9115404086768346,1.0,37/204,13.16%,EGFR;WT1;HPN;DCBLD2;FHL1;PLCE1;DACT3;SGK3;SGK2;TGFB2;SLIT3;SLIT2;CDKN2AIP;S100A8;S100A9;SMAD4;DDX49;GNG4;PSRC1;MTOR;ITCH;PTPRJ;SOCS2;CAMK2D;EGLN2;MELTF;FLCN;CYP27B1;NRG3;URI1;BCL6;AKT1;DNAJB2;LGI1;TAOK2;ADAM15;CDKN1A
prerank,neural crest cell migration (GO:0001755),0.4393387271591134,1.0976555338682248,0.3504566210045662,0.9111787782736532,1.0,7/36,13.07%,SEMA3C;RADIL;SOX10;SOX8;SEMA3A;SEMA3D;GDNF
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.41792199116672496,1.0976205292255314,0.3362255965292842,0.9105047528146932,1.0,13/56,13.53%,EGFR;ANXA1;CDK4;RAD51B;VPS4B;CUL3;DTL;CDC23;AKT1;ANAPC5;FBXO5;CCND1;CDC27
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.3379885942556839,-1.0974803891037233,0.2923076923076923,0.7113604321551437,1.0,4/23,4.22%,INSR;IGF1;APP;PRKAA2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.53555195403036,1.0971430887503195,0.3703170028818444,0.9114299210661801,1.0,5/11,18.73%,ATP1A1;KCNJ2;YWHAE;KCNJ3;KCNH2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.3965669728699672,1.0971162188683135,0.33814432989690724,0.9107284331421763,1.0,23/92,14.69%,FGF7;PRKCA;ANGPT4;SPARC;ITGB3;VEGFA;FGF2;TGFB2;FOXP1;ADAM9;SMOC2;MTOR;SRC;HDAC6;PRKD2;FOXC2;EMC10;AKT1;EGF;AAMP;ZC3H12A;BCAS3;ARF6
prerank,regulation of necroptotic process (GO:0060544),0.47305805917004357,1.0966138014919562,0.36784409257003653,0.9116852080715362,1.0,10/23,22.92%,SPATA2;STUB1;SLC25A4;HSP90AA1;OGT;FLOT2;PDCD6IP;SDCBP;CYLD;FLOT1
prerank,regulation of protein transport (GO:0051223),0.4496691302183487,1.096567218047283,0.356718192627824,0.911053100793024,1.0,8/27,15.24%,DISP1;LLGL1;NDEL1;RHBDF1;SCFD1;NDFIP1;P3H1;CHP1
prerank,response to growth factor (GO:0070848),0.42787014388383865,1.0964705406988495,0.340522133938706,0.910582916990682,1.0,16/41,25.15%,MAPK7;TGFBR2;ACVR1;HDAC6;URI1;AMHR2;AKT1;KLF4;STAT5B;HTRA2;TGFBR1;ACVR2A;BMPR1A;EMD;ACVR1B;LRP2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.4340138507653688,1.0962282671828443,0.36023391812865496,0.9106697432102056,1.0,11/36,17.85%,TAOK3;DACT1;AIDA;ITCH;FOXO1;SIRPA;HDAC3;NCOR1;PER1;PPIA;QARS1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3820752742767143,1.0959989987335865,0.261,0.9106748918611949,1.0,91/241,28.89%,GEMIN6;POLR2H;SRSF2;CD2BP2;HNRNPA1;SRSF6;DHX16;RBM4;ZCRB1;DDX42;LSM4;PRPF4;U2AF1;SRSF3;TFIP11;PRPF3;GPATCH1;USP39;HNRNPD;RBM22;DNAJC8;SNRPB2;CPSF4;HNRNPH1;DHX8;RBM17;PRPF40A;SRSF11;POLR2D;POLR2G;SNU13;HNRNPA3;AQR;SF3B4;GTF2F1;ZCCHC8;BCAS2;SF3A1;CPSF2;PHF5A;DDX5;SNRPA;SNRPG;SNRPD3;PNN;SNIP1;PDCD7;DDX39A;SRRM1;RBM6;PUF60;GCFC2;PRCC;HNRNPUL1;U2AF2;ELAVL2;ZMAT5;NOVA1;LSM7;PTBP1;SF3B2;SF3B1;PRPF38A;GPKOW;RBM5;SNRPA1;CSTF2T;CPSF1;RALY;CPSF7;WDR33;PABPN1;POLR2C;CWC27;ALYREF;UPF3B;PPIH;USP49;RBMX;PRPF19;CRNKL1;PRPF6;LSM5;CDC40;WDR83;CPSF3;RBM15;HNRNPC;SNRPC;WBP11;SRSF5
prerank,regulation of axon extension (GO:0030516),0.4340977197133885,1.0959062604092031,0.3512585812356979,0.9102527887164925,1.0,8/37,11.37%,DBN1;PTPRS;NTN1;TRIM46;ISLR2;SEMA3A;L1CAM;MAPT
prerank,hemopoiesis (GO:0030097),0.3999542868957573,1.0959039623648226,0.33263816475495306,0.909482598202645,1.0,11/87,8.92%,CD34;MFAP5;WNT10B;TGFB2;TGFBR2;RUNX1;FLCN;FLT3LG;ZFP36L2;TIRAP;JAG1
prerank,protein dephosphorylation (GO:0006470),-0.24170464752529836,-1.0958112786248488,0.15384615384615385,0.7137226441772294,1.0,34/135,14.45%,PTPRK;PTPN14;EYA1;PTPRG;PTPRB;PPM1E;PPM1H;CTTNBP2NL;PTPRD;PPM1D;DUSP10;PTPN9;PTPRM;PTPRN2;PTPRZ1;SSU72;RPRD1B;PTPRO;PTPN1;UBLCP1;PPP2R2C;PPP1R15B;PPP2R5A;PPM1L;PTPRT;PTPN2;PPM1F;PTPN4;PTPN21;UBASH3B;DUSP7;PPP1CB;PPP4R1;CTDNEP1
prerank,epiboly involved in wound healing (GO:0090505),0.495472765675289,1.09546579568615,0.3690176322418136,0.9102745602138949,1.0,5/16,14.52%,TMEFF2;CD44;TOR1A;RHOA;DDR1
prerank,autophagosome organization (GO:1905037),0.4160322111147168,1.0952739306051587,0.35877862595419846,0.9101871719880801,1.0,20/50,25.67%,RAB23;RAB19;ATG2B;PACS2;WIPI2;STX12;WDR45B;ULK2;RAB43;ATG2A;ATP2A2;ULK1;RAB1B;ATG16L2;ATG13;ATG16L1;ATG3;ATG14;EMC6;RAB1A
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.47896494424184793,1.0951965232210161,0.3691358024691358,0.9096716643386461,1.0,5/19,14.82%,THBS4;C1QBP;MCU;TIRAP;IL4
prerank,positive regulation of nuclear division (GO:0051785),-0.34299914821041794,-1.0950960762761828,0.29411764705882354,0.7134860729103848,1.0,6/25,8.67%,INSR;TGFA;IGF1;RGCC;IGF2;PDGFRB
prerank,negative regulation of macrophage activation (GO:0043031),0.49128743270841535,1.095080680635351,0.3580729166666667,0.9092919459337636,1.0,7/16,22.53%,SYT11;NR1D1;ZC3H12A;IL4;LRFN5;IL31RA;LDLR
prerank,nucleic acid metabolic process (GO:0090304),0.4019505735507464,1.0948669076237476,0.3554603854389722,0.9092353894708001,1.0,26/69,28.67%,POLR2H;HNRNPA1;KPNA2;ATXN2;DNASE2;DUSP11;HNRNPD;HNRNPH1;RBFOX2;POLR2D;POLR2G;DNA2;HNRNPA3;DNASE1L2;GTF2F1;RAD50;DDX24;PTBP1;POLR2C;DNASE1L1;RBMX;DDX1;MMS19;LSM1;HNRNPC;PDE12
prerank,immunoglobulin mediated immune response (GO:0016064),0.5337022847476777,1.0947073672061136,0.3756983240223464,0.9089789754311631,1.0,2/10,12.21%,CD81;CD27
prerank,regulation of actin filament-based process (GO:0032970),0.40480179288783463,1.0946061390417778,0.3379383634431456,0.9085521084337329,1.0,13/70,16.20%,CORO2B;ARHGAP44;LRP1;EFNA5;EPHA3;MTOR;FSCN1;IQGAP1;RHOQ;TAOK2;RHOA;RND3;RAC3
prerank,glutathione metabolic process (GO:0006749),0.4320854654001398,1.094585146339104,0.3594994311717861,0.9078661394328222,1.0,8/38,14.50%,GCLC;DPEP1;HAGH;CNDP2;GPX1;GSTM2;NAT8;GGT7
prerank,cochlea morphogenesis (GO:0090103),0.5369903400289763,1.0943559629238309,0.37716763005780346,0.9078604355587553,1.0,2/10,7.53%,HPN;MYO3B
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.517444525469906,1.0943504613226103,0.3668407310704961,0.9071054016269114,1.0,7/13,28.37%,ZMIZ1;SMARCD1;PADI2;ELOF1;SERTAD2;ARID1A;ARID1B
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.473414218674269,1.094222584227701,0.36079900124843944,0.9067893524750231,1.0,5/22,13.25%,GTF2H3;RAD23B;ERCC3;UBA52;DDB1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.40727362924804844,1.0941547221591372,0.3470715835140998,0.906276545898719,1.0,11/55,14.08%,UCP1;TGFBR2;MAPK14;COQ7;ARF4;PID1;DHRS4;SIRT2;EIF6;CDKN1A;ZC3H12A
prerank,gene expression (GO:0010467),0.37801113373609646,1.094043356842165,0.239,0.9058984891890262,1.0,79/348,19.51%,NOX4;RPSA;TSPAN17;POLR2H;SRSF2;ADARB1;MRPS11;SRSF6;NXF1;RRBP1;DDX19B;COPS5;RBM4;MRPS18B;NUP93;IGHMBP2;MCM3AP;BICD1;NUP107;PRPF4;STUB1;U2AF1;SRSF3;TFIP11;PPP5C;MRPL13;MRPS17;NUP98;AGO2;DUSP11;HNRNPD;CPSF4;GSPT2;HNRNPH1;RPL10A;DHX8;MRPL10;CELF2;MRPL55;TNIP1;SRSF11;THOC7;POLR2D;POLR2G;MPHOSPH10;DDX17;RPS5;BCL3;MRPL36;POLDIP3;RBM3;DNAJB11;SMG7;TASP1;THOC2;MRPL3;THOC1;GSPT1;ZC3H11A;SMG6;FYTTD1;DDX20;RPL6;NUP37;MRPL51;HARS1;CPSF2;ABCF1;NUFIP1;DDX39A;SRRM1;RBM6;RBM39;NUP50;SLBP;HNRNPUL1;U2AF2;RPL23;RPL17
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3879319278613254,1.093798054214971,0.33434343434343433,0.9059519205759768,1.0,25/142,18.07%,ACKR3;CD55;ESR1;C1QTNF1;LPAR3;NPTN;PLCE1;F2R;DLG4;LPAR1;ATP2B4;ADCYAP1;ABL2;YWHAE;ACKR4;CALCA;SLC35G1;ADCY8;SLC8A2;PDGFRA;CXCR4;CXCR2;BCAP31;IAPP;ATP2B1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4163381986515358,1.0933602706127334,0.351409978308026,0.9066891165425127,1.0,14/50,17.83%,TRIAP1;CD44;VEGFA;CARD16;SRC;GAS6;DPEP1;YWHAE;GPX1;AKT1;SFN;KLF4;HGF;PLAUR
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.4243427106959056,1.0933386453117102,0.36622807017543857,0.90600444027591,1.0,8/47,14.08%,CD34;FYN;ATP2B4;WDTC1;ACADVL;SIRPA;GLA;ZC3H12A
prerank,positive regulation of proteolysis (GO:0045862),0.4096914013999789,1.0930059208314762,0.3712121212121212,0.9064096389644072,1.0,17/55,23.59%,CCBE1;MAPK12;ADAM9;RCN3;STUB1;AURKAIP1;TBC1D10A;TNIP1;BAK1;TNFRSF1B;ZC3H12A;OGT;GPLD1;SH3D19;FBXW11;PACSIN3;IST1
prerank,cellular glucose homeostasis (GO:0001678),0.4328717214218005,1.0928734344427715,0.36613272311212813,0.9060862270922575,1.0,9/41,12.54%,LRRC8D;PIK3R2;SLC39A14;FOXK2;FOXO1;NR1D1;GAS6;ERN1;ADCY8
prerank,hydrogen peroxide metabolic process (GO:0042743),0.4747241246330031,1.092646351194553,0.3570520965692503,0.9061033181514838,1.0,4/19,17.99%,DUOX1;GPX1;ACOX1;PXDN
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5113810887958807,1.0923422125300508,0.3754993342210386,0.906395547295773,1.0,5/15,14.21%,EGFR;RHBDF1;MVB12A;EGF;FER
prerank,inositol phosphate metabolic process (GO:0043647),-0.2995343390824564,-1.0921323884078258,0.3103448275862069,0.7194922480254698,1.0,13/46,11.72%,ITPKB;INPP4B;PLCG1;ISYNA1;NUDT4;PLCB1;INPPL1;ITPK1;INPP5D;MINPP1;NUDT3;ITPKC;PLCD3
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.48042182498601627,1.0919704547327893,0.37659033078880405,0.9069352978557533,1.0,1/18,0.61%,LAX1
prerank,regulation of microtubule depolymerization (GO:0031114),0.4573104585634126,1.091955382663438,0.35844471445929527,0.9062237064404163,1.0,7/25,22.56%,MAP1B;FGF13;CAMSAP1;NAV3;CLASP2;MAP1A;MAP1S
prerank,positive regulation of neutrophil migration (GO:1902624),0.48415801592223284,1.0918544433230608,0.37531172069825436,0.9058219911252883,1.0,4/18,8.91%,THBS4;C1QBP;MCU;TIRAP
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.4580583833416616,1.0917060659223499,0.3709090909090909,0.9055666162468664,1.0,6/25,14.69%,ITGB3;DLG4;ATXN2;PSEN1;ITGAV;ARF6
prerank,inorganic ion transmembrane transport (GO:0098660),0.5191078841782384,1.0916808037350745,0.37158469945355194,0.9048961770555568,1.0,6/12,28.27%,P2RX3;PKD2;ASIC2;ABCC8;KCNJ11;CACNA1H
prerank,response to metal ion (GO:0010038),0.4047030550495491,1.0915842497921966,0.3425827107790822,0.9044892711672409,1.0,11/67,12.62%,LOXL2;KCNMA1;SNCB;ADAM9;CRIP1;SEC31A;MTF1;SLC11A2;PPP5C;MAPT;CALM2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.49643074212130767,1.0915436194622388,0.3647214854111406,0.9038549485021299,1.0,5/15,18.73%,ATP1A1;KCNJ2;YWHAE;KCNJ3;KCNH2
prerank,establishment of melanosome localization (GO:0032401),-0.3605356676768788,-1.0913240803844741,0.3246753246753247,0.7195634184557965,1.0,8/19,17.83%,SHROOM2;BLOC1S5;RAB11A;BBS7;MREG;RAB27A;BLOC1S6;MLPH
prerank,positive regulation of chemokine production (GO:0032722),0.41746465509221614,1.0911931756903137,0.36199095022624433,0.9043012037124398,1.0,10/44,18.61%,SYK;IL33;ADCYAP1;IL17RA;TIRAP;TLR4;TWIST1;IL6;IL18;MBP
prerank,mRNA 3'-end processing (GO:0031124),0.3991023782156187,1.0911668953819582,0.33016877637130804,0.9036235271376141,1.0,33/78,28.07%,SRSF2;SRSF6;SCAF8;U2AF1;SRSF3;CPSF6;CPSF4;SRSF11;THOC7;POLR2D;POLDIP3;THOC2;THOC1;ZC3H11A;CPSF2;PAPOLB;TENT2;DDX39A;SRRM1;TENT4B;SLBP;U2AF2;PAF1;CSTF2T;CPSF1;CPSF7;WDR33;PABPN1;ALYREF;UPF3B;CDC40;THOC5;CPSF3
prerank,UV protection (GO:0009650),0.5435502322650416,1.0909151693562218,0.37202797202797205,0.9037518268730131,1.0,3/10,17.52%,SCARA3;GPX1;ERCC5
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.38138283469846423,-1.090828796466415,0.32489451476793246,0.7186350939295533,1.0,3/17,4.69%,ATP1A2;CACNB2;CACNA1D
prerank,glucose homeostasis (GO:0042593),0.39943299065473103,1.0907948273594434,0.3474128827877508,0.9034074403226325,1.0,12/83,9.96%,MTNR1B;IRS1;LRRC8D;CRTC2;PIK3R2;FOXK2;TCF7L2;FOXO1;NR1D1;MLXIPL;MCU;INPP5K
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.2629032611992967,-1.0907697338681068,0.22950819672131148,0.7166135636693955,1.0,18/70,12.99%,SORT1;BCL2L1;SMAD3;BCL2;DAB2IP;IL6R;CASP8AP2;TNFSF12;DELE1;CASP3;GABARAP;TLR3;INHBA;FAS;RIPK1;TGFB1;CASP9;BCL2L2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.34742882057452695,-1.0905999670409714,0.26582278481012656,0.7149419620044006,1.0,6/26,4.69%,NEDD4L;ATP1B3;ACTN2;DLG1;WWP2;CACNA1D
prerank,DNA packaging (GO:0006323),0.48885242991887545,1.0901262882882303,0.3868520859671302,0.9050206520030184,1.0,2/16,7.60%,CHAF1B;NOC2L
prerank,digestive tract development (GO:0048565),0.4367876284712063,1.0897086748183344,0.36023391812865496,0.9056966907698523,1.0,8/33,15.10%,PCSK5;TGFB2;COBL;PKD1;GLI2;EPHB3;GLI3;CHD8
prerank,acute inflammatory response (GO:0002526),0.4647324429998269,1.0891570052561406,0.3682896379525593,0.9068888972331796,1.0,1/23,0.28%,LBP
prerank,regulation of lamellipodium assembly (GO:0010591),0.43600962443521674,1.0889663832160152,0.3629032258064516,0.9067825304055719,1.0,9/34,14.21%,PLCE1;SLIT2;AKIRIN1;FSCN1;ACTR3;PIK3CA;TWF1;AVIL;FER
prerank,chromatin organization (GO:0006325),0.3851862715471299,1.0883909317658629,0.31739572736520855,0.9079855509573196,1.0,53/132,30.39%,ESR1;LOXL2;SMARCD2;MCM3AP;SMARCD1;PHF1;ZBTB1;SETD7;KAT2B;KDM5C;SATB2;HDAC3;NPM1;SMARCC2;SETD2;KDM5B;DR1;DDX11;HDAC4;EZH1;GATAD1;INO80;SETD5;SMARCA4;NUDT5;BAZ2B;CHD1;PADI2;SUPV3L1;TAF6L;EZH2;BAZ2A;SETDB1;KDM4C;SETDB2;BAZ1A;INO80C;TCF7L1;HP1BP3;SAFB;ARID1A;JARID2;HDAC8;SUV39H1;CHRAC1;KDM4B;TADA2A;PBRM1;ZBTB7A;ATRX;SOX9;HCFC2;HCFC1
prerank,positive regulation of phosphorylation (GO:0042327),0.37654609526101146,1.0878724919504583,0.2912912912912913,0.9089788849201446,1.0,56/240,18.12%,DDR2;AR;EPHB2;FGF18;AXL;NIBAN1;FGF7;EGFR;FGFR1;EFNA5;TMEM119;GLMN;NPTN;EPHA3;ANG;ITGB3;VEGFA;PDE8A;FGF2;MST1R;MIF;AXIN1;RET;MLXIPL;GAS6;FLCN;FZD7;PSEN1;EPHB3;MUSK;DSCAM;HDAC3;CAMKK2;SLC4A4;KRAS;AKT1;EPHA10;GPNMB;EGF;FLT3;PIN1;CCND1;PDGFRA;NBN;WDFY2;DDR1;HSP90AA1;KCTD20;HGF;FXR2;CHRNA7;PPIA;RAD50;PLAUR;ILK;EPHB1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4385073285417231,1.0878083337054263,0.3654524089306698,0.9084471667220201,1.0,10/33,20.86%,SCIN;RAB7B;MAPK14;HOXA5;MAPK11;STAT5B;PITHD1;THPO;ABCB10;ACVR2A
prerank,manganese ion transport (GO:0006828),-0.4022927124332086,-1.0875244691242332,0.34444444444444444,0.7210007369303525,1.0,8/14,14.12%,ATP2C1;SLC30A10;SLC39A8;TRPC5;TRPC6;TRPC4;TRPC7;TRPC3
prerank,negative regulation of telomere maintenance (GO:0032205),0.4939583357420194,1.087212855745512,0.3875338753387534,0.9096659096535132,1.0,7/15,22.85%,ERCC4;TERF1;NBN;SMG6;RAD50;TERF2IP;ERCC1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.33057421471472703,-1.0871352550083206,0.2733333333333333,0.7200079241562709,1.0,6/27,9.21%,SLC7A2;SLC1A3;SLC7A5;SLC6A9;SLC3A2;SLC38A5
prerank,positive regulation of protein import into nucleus (GO:0042307),0.44684582266195794,1.0869607964885397,0.37424058323207776,0.9097696763248655,1.0,12/28,22.68%,ZPR1;PIK3R2;PSEN1;RBM22;HDAC3;JUP;ZC3H12A;DMAP1;IPO5;FLNA;BAG3;TPR
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3769047651167069,1.086121735181042,0.278,0.9118494252921827,1.0,100/264,28.89%,GEMIN6;POLR2H;SRSF2;CD2BP2;HNRNPA1;SRSF6;DHX16;RBM4;ZCRB1;DDX42;LSM4;PRPF4;U2AF1;SRSF3;TFIP11;WDR77;PRPF3;GPATCH1;USP39;HNRNPD;RBM22;DNAJC8;SNRPB2;CPSF4;HNRNPH1;DHX8;RBM17;PRPF40A;SRSF11;TGS1;POLR2D;POLR2G;DDX17;SNU13;HNRNPA3;AQR;SF3B4;GTF2F1;DDX20;ZCCHC8;BCAS2;SF3A1;CPSF2;PHF5A;DDX5;SNRPA;SNRPG;SNRPD3;PNN;SNIP1;PDCD7;DDX39A;SRRM1;RBM6;PUF60;GCFC2;PRCC;STRAP;HNRNPUL1;U2AF2;ELAVL2;ZMAT5;NOVA1;LSM7;PTBP1;SF3B2;SF3B1;SRPK1;PRPF38A;GPKOW;RBM5;SMN1;SNRPA1;COIL;CSTF2T;CPSF1;RALY;CPSF7;WDR33;PABPN1;POLR2C;CWC27;ALYREF;UPF3B;PPIH;USP49;RBMX;PRPF19;CRNKL1;PRPF6;DDX1;LSM5;CDC40;WDR83;CPSF3;RBM15;HNRNPC;SNRPC;WBP11;SRSF5
prerank,cell-cell junction maintenance (GO:0045217),0.5310473986370229,1.085893598324715,0.38873239436619716,0.9119215539864594,1.0,4/11,8.24%,CD177;F2R;MYADM;PARD6A
prerank,regulation of macrophage migration (GO:1905521),0.5309707428741142,1.0858068516344637,0.38571428571428573,0.9114921306246563,1.0,3/10,21.90%,CD81;CD200R1;CSF1
prerank,negative regulation of cartilage development (GO:0061037),0.5119465139101451,1.0857869181265323,0.3758480325644505,0.9108105052267333,1.0,5/13,18.39%,WNT9A;CHADL;SNAI2;EFEMP1;TGFBR1
prerank,negative regulation of JNK cascade (GO:0046329),0.44017038217427,1.085784382526048,0.37170263788968827,0.910070826608889,1.0,9/31,16.19%,TAOK3;DACT1;AIDA;ITCH;SIRPA;HDAC3;NCOR1;PDCD4;PER1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.39724271843215875,1.0855424380744423,0.35645677694770544,0.9101585652894424,1.0,13/72,16.86%,SYK;AXL;IRAK3;RUNX1;SPATA2;ABCE1;GAS6;CHUK;SPPL2B;IRAK1;MADD;RBCK1;TAX1BP1
prerank,neural crest cell differentiation (GO:0014033),0.47796378698882774,1.0853507771112094,0.38107098381070986,0.9100417757995569,1.0,4/18,16.59%,LRP6;SOX8;NOLC1;SNAI2
prerank,regulation of B cell apoptotic process (GO:0002902),0.5156837120204438,1.085348773023041,0.39348710990502034,0.9093029587906392,1.0,4/12,12.14%,FOXP1;NOC2L;BCL6;IRS2
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.4126895673196254,1.0853483637399226,0.35888888888888887,0.9085573853231251,1.0,14/46,25.09%,TIMM50;GDAP1;TIMM10B;TIMM9;AKT1;GRPEL2;TIMM22;TIMM8B;BCAP31;TOMM5;RALA;TIMM17A;FIS1;TOMM40
prerank,protein localization to kinetochore (GO:0034501),0.5011865792430137,1.0851011025167931,0.38337801608579086,0.9086604137622967,1.0,3/14,5.95%,CHAMP1;ZW10;CENPT
prerank,positive regulation of neurogenesis (GO:0050769),-0.2758741311518098,-1.0849461848183213,0.26785714285714285,0.723715804918316,1.0,22/68,15.56%,PLXNA2;ROBO1;CUX1;PLXNA4;PTPRD;CDKL5;SHANK3;TGM2;PLXND1;ROBO2;NUMB;PLXNB1;CX3CL1;SS18L1;SMARCD3;NTRK2;SLITRK1;CTNNB1;TRIM32;CUX2;GPER1;SOX11
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.3288894255576011,-1.0844868444318914,0.2981366459627329,0.7227849170736699,1.0,5/29,5.24%,SORBS1;APOE;SCARB1;PPARA;NR1H3
prerank,response to axon injury (GO:0048678),0.4759946605676541,1.0844385168338417,0.3739021329987453,0.9101622091097017,1.0,9/18,29.94%,GAP43;FLRT3;MTR;RTN4RL1;SARM1;MORN4;P2RX4;DHFR;MAPK8IP3
prerank,protein modification process (GO:0036211),0.3959109597475691,1.084401138806923,0.3503184713375796,0.9095362349107262,1.0,28/76,26.45%,PLOD2;LOXL2;RABGGTA;GGCX;PHKA2;ABL2;FBXO2;FBXL2;CSNK1G3;UBA52;CDC34;FBXO11;ST3GAL1;ADPRH;LOX;STK38;NEDD8;UBE2D3;FBXW2;ICMT;YES1;ATG3;MMP15;RABGGTB;UBA7;FBXO22;PIGH;DUSP12
prerank,peroxisome organization (GO:0007031),0.4498970608004901,1.0842768599341535,0.37333333333333335,0.9092370108818726,1.0,8/25,24.14%,SEC16B;PEX16;PEX12;PEX1;PEX3;ABCD3;PEX2;FIS1
prerank,positive regulation of phospholipase activity (GO:0010518),0.4624202435778254,1.0842513780930354,0.37484737484737485,0.9085707468733537,1.0,5/22,7.45%,ESR1;FGFR1;FGF2;ARF4;ABL2
prerank,translational elongation (GO:0006414),0.38897127302986007,1.0839720260864252,0.34647302904564314,0.9087709008227872,1.0,24/101,16.83%,MRPS11;MRPL38;EEF2K;MRPS18B;GTPBP2;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;MRPL30;MRPL10;GFM1;DAP3;MRPL55;MRPS10;LTN1;MRPL36;MRPL3;MRPL21;MRPS34;MRPL51;EEF1B2;EEF1G
prerank,axonal fasciculation (GO:0007413),0.5181128193790924,1.0839282739638645,0.3748290013679891,0.9081742615998829,1.0,3/12,10.29%,EPHB2;EPHA3;EPHB3
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.40799477215549995,-1.0838542447618011,0.34710743801652894,0.7223504355435421,1.0,5/13,10.53%,SORBS1;IGF2;ECHDC3;SORL1;SIRT1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.4258104576852599,1.0834445112939868,0.3837342497136312,0.9090981694193867,1.0,16/38,26.47%,OTUD3;PTPRJ;BANK1;FLCN;PHLPP2;INPP5K;AKT1;MAGI2;PLEKHA1;NOP53;PPP2R5B;SFRP5;PTEN;TSC2;DDIT3;MUL1
prerank,regulation of Golgi organization (GO:1903358),0.47460187807685494,1.0832081471442288,0.38441558441558443,0.9091249194484096,1.0,9/17,27.62%,STX5;MYO5A;MAP2K2;RAB33B;AKAP9;ARMH3;MAPK1;RBSN;PDE4DIP
prerank,cellular response to hexose stimulus (GO:0071331),-0.33929393973539446,-1.0831612293572523,0.2864583333333333,0.7219453237072392,1.0,5/23,4.62%,UNC13B;IGF1R;PRKAA2;KCNB1;TRA2B
prerank,negative regulation of protein localization to membrane (GO:1905476),0.4610640100619048,1.0831173373532743,0.38613861386138615,0.9086646372537548,1.0,10/24,24.39%,TMBIM1;PID1;CLTC;INPP5K;RHOQ;GDI1;PPFIA1;AP2M1;DMTN;MRAP2
prerank,ameboidal-type cell migration (GO:0001667),0.41408864108723026,1.0827498331435688,0.36123348017621143,0.9092446422674617,1.0,11/51,13.07%,SEMA3C;GPC3;RADIL;SOX10;SOX8;SEMA3A;PDXDC1;AKT1;PDLIM1;SEMA3D;GDNF
prerank,spliceosomal complex assembly (GO:0000245),0.41489594711678734,1.082666407107344,0.36644591611479027,0.9087692261047928,1.0,25/46,32.89%,SRSF6;USP39;KHDC4;CELF2;SF3A1;SNRPG;LUC7L3;PUF60;GCFC2;LUC7L2;SF3B1;SRPK1;RBM5;SMN1;CELF3;PRPF19;CRNKL1;PRPF6;DDX1;CELF1;SRSF5;CELF4;SF1;SF3A2;DDX39B
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.40663833526027127,1.0826148176877282,0.3511777301927195,0.9082038896371101,1.0,17/67,14.60%,AXL;NCF4;FYN;ITGB3;VEGFA;PIK3R2;MAPK14;SRC;SULF1;PRKD2;ABI1;PIK3CA;MAPK11;ITGAV;RHOA;AAMP;HSP90AA1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3945098685195775,1.0823183571531334,0.36947368421052634,0.9084503206705561,1.0,28/72,28.67%,RNASE4;GTF2H3;EDC4;PNRC2;ERCC3;UBA52;ERCC4;RNASE6;FAN1;DDB1;DNA2;ZC3H12A;DNASE1L2;RFC4;RAD50;ERCC5;POLD1;OGG1;ERCC1;EDC3;DNASE1L1;RNASE1;DCP1A;DCP1B;MEI4;DDX1;RFC3;PDE12
prerank,receptor-mediated endocytosis (GO:0006898),0.380758383595592,1.081684014871807,0.3350253807106599,0.9098647901510736,1.0,16/132,8.35%,ACKR3;SYK;LRP6;CD9;LRP1;DNM1;AP1G2;SPARC;COLEC11;WASF1;AP2A2;PDLIM7;CLTC;SNX1;CD81;INPP5F
prerank,aminoglycan catabolic process (GO:0006026),0.4422688835848309,1.08134336937976,0.37876960193003617,0.9102707517944786,1.0,7/28,17.87%,GPC6;GPC3;HSPG2;NAGLU;IDUA;SDC2;OVGP1
prerank,regulation of ion transport (GO:0043269),0.3969040950433173,1.0813011499347722,0.3378661087866109,0.9096714434840164,1.0,19/76,18.56%,SYT2;ITGB3;ATP1A1;SYT12;SYT11;SYT13;KCNJ2;DTNBP1;TOR1A;CLDN10;KCNA2;PXK;GDNF;KCNJ3;STC1;PER1;SYT1;SNX6;VAMP2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.4878276603944775,1.0804650301477245,0.3869281045751634,0.9118606495527272,1.0,9/15,32.61%,ACTR3;MAGEL2;ARPC5L;ARPC1A;ARPC2;ARPC4;ARPC5;WHAMM;TRIM27
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3860835418661009,1.0804350847874455,0.35612244897959183,0.9112100120610507,1.0,38/107,23.42%,NIBAN1;EIF2AK3;PIK3R2;RASGRF1;SYVN1;TMEM259;CREB3L1;RCN3;THBS4;SCAMP5;ERN1;HERPUD1;SELENOK;CEBPB;BAK1;BBC3;QRICH1;ATP2A2;EIF2S1;UFC1;PDIA3;SELENOS;NCK1;UFL1;BCAP31;UFM1;ATF6;ERP44;TMTC3;JUN;ATF4;DERL1;SEL1L;USP19;TMEM33;FLOT1;ATG10;UBXN6
prerank,nucleosome assembly (GO:0006334),0.44329095899517157,1.0802439679263032,0.3732558139534884,0.9111007230702028,1.0,16/31,32.82%,CHAF1B;SPTY2D1;NPM1;ANP32B;UBN1;GRWD1;NAP1L2;BRD2;KAT6B;NAP1L3;ATRX;HIRA;SOX9;IPO4;RSF1;NASP
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.41114110996638437,1.0799023619063357,0.38232044198895027,0.9115557605376147,1.0,23/52,28.98%,MBNL1;HNRNPA1;SRSF6;RBM4;NSRP1;MBNL2;CELF2;RBFOX2;DDX17;DDX5;FXR2;SAP18;PUF60;NOVA1;PTBP1;THRAP3;RBM5;RBM24;CELF3;RBMX;CELF1;RBM15;ZBTB7A
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.4604449560643913,1.0795831252803343,0.3839611178614824,0.9119082852942744,1.0,5/26,14.59%,LBP;TLR5;TIRAP;WDFY1;SLC15A4
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.42754176734691385,-1.0794134440742233,0.32781456953642385,0.7299565941325071,1.0,2/10,3.30%,ADAM10;WNT5A
prerank,protein processing (GO:0016485),0.3847362809044808,1.0791060281871778,0.368366285119667,0.9128359978883842,1.0,25/102,19.06%,PCSK6;PCSK5;KLKB1;PRSS12;ADAMTS3;TMEM208;ADAM19;PCSK4;SPCS1;PSEN1;ECE1;SEC11C;XPNPEP3;EEF1AKMT4-ECE2;ECE2;KLK1;KLK6;RCE1;FAM111A;OGT;HTRA2;SPG7;MMP16;METAP2;PCSK7
prerank,protein oxidation (GO:0018158),0.5282737026538487,1.078931798826807,0.41422594142259417,0.9126460229023811,1.0,3/11,18.51%,LOXL2;LOXL1;LOX
prerank,response to prostaglandin E (GO:0034695),-0.4314589411061189,-1.078882227274711,0.3568904593639576,0.729268351982967,1.0,5/10,25.17%,TGFBR3;SFRP1;GNG2;CCL19;ADCY6
prerank,error-prone translesion synthesis (GO:0042276),0.46923438410658275,1.0788760223109235,0.3858764186633039,0.912102552659448,1.0,8/21,28.17%,REV3L;POLI;UBA52;RFC4;REV1;POLH;POLE2;RFC3
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.4735379132434306,1.077803272388458,0.39510939510939513,0.9149804049769068,1.0,5/17,10.71%,AR;ATP1A3;ATP1A1;SRC;URI1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.4386726003389691,1.0776909820129719,0.37885985748218526,0.9146394499511752,1.0,10/29,19.53%,MRPS11;ABT1;KRI1;NOP9;RRP36;WDR46;DCAF13;PWP2;TBL3;NOL10
prerank,female gonad development (GO:0008585),0.474490907410008,1.0771322811848292,0.38616352201257864,0.9157373278382211,1.0,7/19,14.19%,ANG;VEGFA;INHA;NUP107;COL9A3;CEBPB;LHCGR
prerank,regulation of Ras protein signal transduction (GO:0046578),0.38833220969416093,1.0770475579345287,0.3670103092783505,0.915283428548692,1.0,21/86,16.37%,EPHB2;ARHGEF28;ARHGAP44;AKAP13;PLCE1;TGFB2;RASGRF1;RASGEF1A;MYO9B;FLCN;ARFGAP1;KANK1;SQSTM1;IRS2;SHOC2;DENND1A;ARF6;RAPGEF1;MADD;EPS8L2;OGT
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.3839040751833635,-1.0767847323342705,0.34285714285714286,0.7328281421046521,1.0,8/16,14.18%,IGF1;MEF2C;NOTCH1;TGFBR3;FGFR2;TBX2;AKAP6;EDN1
prerank,regulation of axon guidance (GO:1902667),0.5381754332050792,1.0766192259548057,0.407514450867052,0.915952747403915,1.0,5/10,17.46%,VEGFA;ZSWIM4;MYCBP2;ZSWIM8;YTHDF1
prerank,multivesicular body organization (GO:0036257),0.4337006710057043,1.076243013637587,0.4016489988221437,0.9164997405811453,1.0,10/31,23.94%,CHMP7;VPS4B;MVB12A;VPS37D;VPS37C;VPS37B;VPS36;PDCD6IP;IST1;STAM
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.4197503145962132,1.0760726335057331,0.37265711135611906,0.9163391147013986,1.0,13/43,21.72%,CDC14B;INTS3;TAOK3;RINT1;DTL;TAOK2;CDKN1A;ABRAXAS1;NBN;NOP53;BLM;DONSON;CLSPN
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5267481723466367,1.0759634299028245,0.3911764705882353,0.9159606843350221,1.0,4/10,15.83%,GRB10;PID1;INPP5K;SELENOS
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4192970360002586,1.075836903139095,0.3723756906077348,0.915634810720366,1.0,5/43,4.00%,IGFBP5;MMP2;FGF2;FOXP1;MEF2D
prerank,peptidyl-threonine modification (GO:0018210),0.39899827884162614,1.0755901750665187,0.3658008658008658,0.9157262892474122,1.0,23/66,24.76%,PRKCA;DYRK4;TGFBR2;GALNT16;ACVR1;CAMK2D;PRKD2;DYRK2;GALNT1;AKT1;STK39;ULK1;HIPK4;TGFBR1;GALNTL6;CIT;OXSR1;HIPK3;MAPK1;CSNK2A2;GALNT4;ACVR1B;MARK2
prerank,membrane depolarization (GO:0051899),-0.30729616454607145,-1.0754148345659813,0.30666666666666664,0.7343525021601535,1.0,13/32,27.15%,CACNA1E;YWHAH;SCN3A;CAV1;CACNG4;ABL1;CACNB3;SCN7A;SCN3B;CHRNA4;CACNA1B;CACNB4;SCN5A
prerank,positive regulation of gene expression (GO:0010628),0.36742121915335446,1.07534574464573,0.247,0.9158238150515932,1.0,71/442,14.82%,CD34;SFRP4;AR;GSN;EPHB2;AMH;FGF18;SEC16B;NIBAN1;FGF7;C1QTNF1;EGFR;POLR2H;WT1;HPN;TMEM119;PKP3;GLMN;EIF2AK3;ANK2;DGKQ;VEGFA;FGF2;CAMK2N1;MIF;ZPR1;NFE2L2;RBMS3;MAPK14;ADAM19;MTOR;HOXA5;DTNBP1;IL33;TENT4A;PID1;SCAMP5;GAS6;POLR1G;LARP4;VDR;PSEN1;AGO2;TLR4;HNRNPD;RBM22;KAT2B;MAPK11;ERN1;MUSK;NPM1;MITF;DDX21;KRAS;AKT1;SLC2A10;PASK;NAT8;EIF6;EGF;NWD1;RPS27L;BCL3;ZCCHC4;TWIST1;POLDIP3;ZC3H12A;RBM3;KLF4;EIF3E;IL4
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.40558451920838867,1.0751480689908681,0.3765093304061471,0.9157633822976754,1.0,6/53,14.19%,LPAR3;MTNR1B;ANXA1;HTR1F;TSHR;LHCGR
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4357080288001472,1.0748926265949972,0.38275862068965516,0.9159032341560837,1.0,11/33,20.58%,GCLC;ALDH18A1;ART4;GLS2;GLS;NIT2;ALDH5A1;GLUD1;PYCR1;DDAH2;GOT1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5004045875035583,1.074859630824928,0.3768506056527591,0.9152720955145964,1.0,6/15,23.78%,TENT4A;AGO2;ZFP36;POLR2G;TENT4B;TNRC6A
prerank,protein O-linked mannosylation (GO:0035269),-0.3615288991081099,-1.0748278728834764,0.3125,0.7337996042867453,1.0,3/18,3.02%,TMTC1;TMTC4;TMTC2
prerank,regulation of acute inflammatory response (GO:0002673),0.48356225616183257,1.0745364666485173,0.40025906735751293,0.9156436251032826,1.0,3/18,16.30%,KLKB1;IL4;IL6
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5284717269959642,1.074318146476548,0.394109396914446,0.9156914795821,1.0,1/10,1.21%,DPP4
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.40710995960781665,-1.074259530126169,0.3651452282157676,0.7332564825556437,1.0,4/13,6.39%,BMP7;SOX13;NAPEPLD;PTGS2
prerank,modulation by symbiont of host process (GO:0044003),-0.4285730647181266,-1.0741470028243443,0.3630573248407643,0.7314089574980814,1.0,4/10,18.89%,B2M;ENO1;PGK1;MRC1
prerank,metal ion transport (GO:0030001),-0.24780220655516091,-1.0731410466392992,0.24528301886792453,0.7319863027730898,1.0,20/86,12.55%,ITPR1;CALCRL;SLC41A1;CACNA1E;ATP2C1;SLC8A3;RAMP1;SLC39A8;CACNA1D;TRPC5;CAV1;SLC3A2;SLC30A1;TRPC4;CACNG8;RYR2;NDFIP2;ATP2A3;TRPV4;NIPA2
prerank,lymphocyte migration (GO:0072676),0.4395414971734788,1.0726781903557552,0.3962485345838218,0.9204745797584577,1.0,4/32,12.90%,CCL8;RET;CCL25;CCL13
prerank,cilium organization (GO:0044782),0.37410872779602206,1.0726073072711897,0.34168336673346694,0.9199865504809415,1.0,74/210,27.68%,GSN;NME8;CDC14B;ODF2;ABLIM1;PKD1;RAB23;FHDC1;ARF4;ACTR3;HDAC6;BBS9;PKD2;ATAT1;ARL13B;TMEM138;OCRL;CPLANE1;CNGB1;EHD2;NUDCD3;DZIP1;TTC39C;AVIL;TEKT5;PIBF1;DYNC2I2;KIF3A;RPGR;KIF3B;IFT46;TTLL3;BBS4;TTC8;ATP6V1D;FAM161B;AHI1;CCP110;CEP164;DYNC2H1;CEP89;DYNC2I1;CEP83;CCDC28B;RP2;BBS5;BBIP1;IFT52;EXOC4;CC2D2A;SPAG16;FLNA;PCM1;DNAH5;FBF1;TMEM231;TCTN2;RAB11FIP3;PDE6D;CFAP126;DYNLL1;CEP78;TCTN1;CDC14A;NEK1;CEP126;RAB1A;CFAP70;KIFAP3;GBF1;FUZ;IFT81;PTPDC1;RAB8B
prerank,carbohydrate derivative transport (GO:1901264),0.4800433147604201,1.0723497669306272,0.38549618320610685,0.9200970025891815,1.0,1/18,0.28%,LBP
prerank,dicarboxylic acid transport (GO:0006835),-0.321334030450925,-1.0722437341323543,0.31210191082802546,0.732233702413167,1.0,6/28,7.61%,SLC1A3;SLC13A3;SLC26A7;PDPN;SLC22A6;GJA1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.39120383463978436,1.0722151479404143,0.3729166666666667,0.9198275712075424,1.0,12/88,12.13%,SYK;SMPD3;PRKCA;VEGFA;CDC42EP2;MPP7;GNL3L;VPS4B;PFN2;TIRAP;BMF;BAK1
prerank,mitotic nuclear membrane organization (GO:0101024),0.40381169099178205,1.07191630243945,0.3685932388222465,0.9193797760428466,1.0,24/51,32.29%,LMNA;REEP3;NUP93;CHMP7;AHCTF1;NUP107;NUP98;SIRT2;NUP37;PPP2R2A;CC2D1B;ANKLE2;IST1;EMD;NUP133;NUP85;NUP188;KPNB1;SUMO1;CHMP4C;SEC13;CHMP4A;CHMP4B;NUP160
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.40381169099178205,1.07191630243945,0.3685932388222465,0.9193797760428466,1.0,24/51,32.29%,LMNA;REEP3;NUP93;CHMP7;AHCTF1;NUP107;NUP98;SIRT2;NUP37;PPP2R2A;CC2D1B;ANKLE2;IST1;EMD;NUP133;NUP85;NUP188;KPNB1;SUMO1;CHMP4C;SEC13;CHMP4A;CHMP4B;NUP160
prerank,positive regulation of secretion by cell (GO:1903532),-0.25518693110539714,-1.071890334139573,0.2753623188405797,0.7310921426252673,1.0,12/70,6.55%,BMP6;UNC13B;FRMD4A;IGF1;CD2AP;SLC12A2;SNCA;MYO18A;KCNB1;STXBP5;ABCG1;RGCC
prerank,nucleocytoplasmic transport (GO:0006913),0.4218572539613782,1.0718019978582836,0.39631336405529954,0.919018765662568,1.0,12/40,22.98%,GEMIN6;HNRNPA1;NUP98;NPM1;BACH2;DDX20;SNRPG;SNRPD3;NXT2;NEMF;HTATIP2;SMN1
prerank,positive regulation of cation channel activity (GO:2001259),0.42430204555023066,1.0715266974086524,0.37139561707035756,0.9191747524980142,1.0,7/40,14.04%,EPHB2;ANK2;PKD2;GSTM2;CALM2;ANTKMT;CASQ1
prerank,potassium ion homeostasis (GO:0055075),0.45282730434718665,1.0710181981579525,0.39146800501882056,0.9202086446436532,1.0,7/23,7.78%,KCNMA1;ATP1A3;ATP1A4;ATP1A1;SLC12A8;KCNJ2;SLC12A4
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.42679639234649175,1.0707197419924486,0.39096045197740115,0.9204889076234812,1.0,9/40,15.86%,SFRP4;ANXA2;VEGFA;BICD1;MAGI2;EGF;CBL;IL4;AHI1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5033674650767707,1.0706333503077725,0.4228723404255319,0.9200371974833887,1.0,4/13,10.36%,CHST1;NAGK;OGA;LARGE1
prerank,ubiquinone metabolic process (GO:0006743),0.48659683471546245,1.0703220194888745,0.4015748031496063,0.9203415956619693,1.0,4/15,10.63%,COQ10B;COQ7;AIFM2;COQ3
prerank,positive regulation of kinase activity (GO:0033674),0.3776497199467546,1.0702417807519695,0.3739754098360656,0.9198655266915177,1.0,26/107,14.52%,DDR2;EPHB2;AXL;EGFR;FGFR1;CAMKK1;EPHA3;MST1R;MAP2K3;MAPRE3;RASSF2;RET;ADCYAP1;GAS6;TIGAR;IQGAP1;EPHB3;MUSK;MAPT;EPHA10;XRCC5;FLT3;CDKN1A;PDGFRA;NBN;DDR1
prerank,negative regulation of protein transport (GO:0051224),-0.3332855964584287,-1.0699486231341149,0.33678756476683935,0.7343319979900701,1.0,8/25,12.23%,APOE;WWP2;SNX3;HMGCR;RHBDF2;NDFIP2;PKDCC;PPM1F
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.39174638653009375,1.0693374511361786,0.3844559585492228,0.9221111552394977,1.0,17/87,14.32%,CDK2AP2;FHL1;PSMC4;ZFP36L1;CDK4;DACT1;PRMT2;PSMC6;PKD2;ZFP36L2;PSMD8;AVEN;BRD7;GPNMB;FBXO5;CDKN1A;KLF4
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.49298913860934973,1.0693232968697874,0.39944521497919555,0.9214363244709227,1.0,2/13,7.57%,AXL;GAS6
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.4343646255742288,1.069313295496261,0.3788235294117647,0.9207549390849281,1.0,6/31,12.23%,DBN1;ARHGAP44;PPFIA2;SRCIN1;TANC2;NGEF
prerank,positive regulation of glucose metabolic process (GO:0010907),0.4880474434063062,1.0688963045298954,0.40408163265306124,0.9213961381507877,1.0,5/14,19.54%,IRS1;AKT1;IRS2;DDB1;GPLD1
prerank,negative regulation of vascular permeability (GO:0043116),0.506749888105892,1.0688585288411316,0.41456953642384103,0.9208055567129307,1.0,3/12,5.35%,VEGFA;SLIT2;PTPRJ
prerank,regulation of cytokine production (GO:0001817),0.3804449353207786,1.0687739671852863,0.35539714867617106,0.920341995803993,1.0,26/126,18.08%,ANXA1;GLMN;NPTN;FOXP1;MIF;HDAC9;MAPK14;SYT11;IL33;SCAMP5;CD47;SIRPA;BCL6;GPNMB;LRRC19;IGF2BP1;ACKR1;TNFRSF1B;MOG;BTN3A3;TRAF3;PER1;IL6;SNAI2;ATP2B1;VTCN1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4572006724711354,1.0687729428205115,0.36888331242158096,0.9196241304498732,1.0,7/22,22.98%,TIMP2;ADAM9;TNFRSF1B;GPLD1;SH3D19;PTPN3;PACSIN3
prerank,dorsal/ventral pattern formation (GO:0009953),0.4617534333460055,1.068329469769658,0.4,0.9203893483120682,1.0,4/20,7.49%,LMX1B;ACVR1;AIDA;GLI2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.286785778847582,-1.0678808515561762,0.3644859813084112,0.7381720898627244,1.0,18/42,24.94%,WDR48;SHLD1;ARID2;HELB;MRNIP;KLHL15;RIF1;SMCHD1;PPP4C;FANCB;TIMELESS;MAD2L2;RPA2;RMI2;RAD51;PARPBP;CHEK1;WRAP53
prerank,regulation of B cell activation (GO:0050864),0.44797587758193114,1.0673468154290968,0.3888888888888889,0.9229403373696359,1.0,5/25,16.30%,ZFP36L1;BANK1;ZFP36L2;IL4;IL6
prerank,secondary alcohol metabolic process (GO:1902652),0.41747345172731026,1.0672296788230071,0.39032620922384703,0.9226295199379819,1.0,12/42,21.00%,IDH1;ABCA1;LCAT;TSKU;GBA2;IL4;PIP4P1;FDX1;ANGPTL3;IDH3G;IDH3B;SOAT1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.4988513637116513,1.0672061302393168,0.40554821664464996,0.9219870183546636,1.0,5/14,19.99%,SRSF6;C1QBP;SAP18;U2AF2;PTBP1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.43257688740832956,1.0670936519936267,0.4061032863849765,0.9216479421558795,1.0,14/30,26.43%,UBE2J2;USP36;HPS4;NPEPPS;HTRA2;VPS11;ARIH2;ATG13;UBE2D3;SAE1;CSNK2A2;LEPROT;FBXW7;RNF31
prerank,response to ionizing radiation (GO:0010212),0.39473785485681157,1.0668271023404847,0.3670886075949367,0.921818581382909,1.0,17/70,18.57%,ANXA1;FANCD2;INTS3;MAPK14;RFWD3;COP1;IKBIP;INIP;RHNO1;RAD1;CDKN1A;ABRAXAS1;INO80;TNKS1BP1;SPIDR;BLM;SMPD1
prerank,cytosolic transport (GO:0016482),0.38096043776623056,1.0667689581781759,0.364476386036961,0.9212906884228113,1.0,52/108,32.02%,DCTN1;BET1L;RAB6A;STX5;HOOK2;HEATR5A;RAB6B;VPS52;CLTC;SNX1;WDR91;MAGEL2;TBC1D17;GGA1;TBC1D10A;TBC1D23;GOSR1;ARFRP1;TMEM87A;EVI5;PHETA2;CORO7;ANKRD27;AP4M1;PREPL;SNX6;DENND2A;STX16;ANKFY1;VTI1A;BAIAP3;SNX16;RAB29;RNF126;GOSR2;GBF1;RBSN;VAMP3;YKT6;LAPTM5;STX8;PTPN23;RHOBTB3;TBC1D5;SPAG9;RAB9B;PIKFYVE;RAB14;AP2A1;TMEM87B;SNX5;ARL1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5179422147870525,1.0663440564837339,0.4048991354466859,0.9205448835458371,1.0,7/11,30.74%,SLC25A16;PANK1;PANK3;DCAKD;ACAT1;ACOT7;PANK2
prerank,coenzyme A biosynthetic process (GO:0015937),0.5179422147870525,1.0663440564837339,0.4048991354466859,0.9205448835458371,1.0,7/11,30.74%,SLC25A16;PANK1;PANK3;DCAKD;ACAT1;ACOT7;PANK2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5179422147870525,1.0663440564837339,0.4048991354466859,0.9205448835458371,1.0,7/11,30.74%,SLC25A16;PANK1;PANK3;DCAKD;ACAT1;ACOT7;PANK2
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.477441894953266,1.066065051326705,0.4012903225806452,0.9207683944341414,1.0,3/18,9.59%,IRS1;MIDN;BMP8A
prerank,regulation of protein localization to cell periphery (GO:1904375),0.4740628223767393,1.0658399067321351,0.43149807938540335,0.9207840186869741,1.0,4/18,16.15%,AR;ZDHHC7;ZDHHC2;SPTBN1
prerank,neural tube development (GO:0021915),0.49743678507309136,1.0657378281942234,0.41863517060367456,0.9203668270526024,1.0,5/15,8.01%,PKD1;DACT1;TRIM71;PKD2;ARL13B
prerank,electron transport chain (GO:0022900),0.4895009389040673,1.0656146234773185,0.40581717451523547,0.9200231081359767,1.0,6/15,17.75%,ETFA;ENOX2;POR;ETFDH;ETFB;CYB561
prerank,negative regulation of axon extension (GO:0030517),0.4373107248595908,1.065467450540576,0.4002333722287048,0.9198014552616832,1.0,5/30,12.28%,SEMA3C;PTPRS;TRIM46;SEMA3A;SEMA3D
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.514901761165541,1.0653801745030707,0.4056338028169014,0.919390487958692,1.0,6/11,29.45%,CREB3L1;CEBPB;ATF6;ATF4;DDIT3;TP53
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.4914935082144047,1.0653564205026225,0.40339425587467365,0.9187479487380041,1.0,6/15,22.68%,HECW2;CDC23;CDC27;CENPE;RIOK2;TPR
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.4048781840208345,1.0652253912163117,0.38037486218302097,0.9184424666468445,1.0,19/51,28.61%,HNRNPA1;CTC1;GNL3L;SRC;ACD;CCT7;XRCC5;TERF1;SMG6;TENT4B;TINF2;NEK7;MAPK1;CCT4;EXOSC10;SMG5;STN1;CCT6A;HNRNPC
prerank,cellular response to superoxide (GO:0071451),-0.4362620306618322,-1.0651211133637923,0.3554006968641115,0.743440556935887,1.0,5/10,18.61%,NOS3;PRDX1;SOD1;PRDX2;MT3
prerank,myeloid cell development (GO:0061515),0.4733106164602663,1.064812984264127,0.40960809102402024,0.9190521355358342,1.0,3/18,6.81%,ANXA2;FOXP1;SRC
prerank,regulation of macroautophagy (GO:0016241),0.37946806533204114,1.0648037889253112,0.38256410256410256,0.9183709866477998,1.0,24/105,16.13%,DCN;UCHL1;GNAI3;USP36;ATP6V0A2;MTOR;PRKAB2;HDAC6;CAPN1;GPSM1;PIK3CA;NRBP2;ERN1;AKT1;ATP6V1E1;SESN3;LARP1;SMCR8;RRAGD;ULK1;IL4;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.49655444456930786,1.0647478344847252,0.41136671177266576,0.9178066322800023,1.0,7/14,24.22%,CPSF6;ERN1;CPSF4;CPSF2;CSTF2T;CPSF1;CPSF7
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.47020968439517774,1.0647319223663076,0.399734395750332,0.9171513669167735,1.0,3/17,10.94%,CD160;PTPRJ;UBASH3A
prerank,regulation of protein localization to centrosome (GO:1904779),0.5179813281274886,1.0645667078837389,0.4240766073871409,0.9169571435162914,1.0,2/10,8.24%,BICD1;PARD6A
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.4251435557883435,1.0644700008174066,0.3864168618266979,0.9165814320129172,1.0,17/31,32.26%,DIS3L2;LSM4;EDC4;EXOSC7;POLR2G;EXOSC1;LSM7;EDC3;DCP1A;DCP1B;LSM5;HBS1L;LSM1;PATL1;EXOSC3;CNOT8;LSM6
prerank,neutrophil degranulation (GO:0043312),0.3642267916179792,1.0640683198989056,0.284,0.9172619338945078,1.0,103/425,21.60%,TIMP2;GSN;CD55;ARSA;B4GALT1;CD44;CD177;ANXA2;RAB6A;ANPEP;ACTR1B;TMBIM1;MIF;S100A8;S100A9;SPTAN1;MAPK14;AP1M1;ACLY;RAP1B;TMEM63A;PTPRJ;TOM1;PLEKHO2;AP2A2;PRCP;RAB37;IDH1;DOK3;TCN1;ATP11A;COPB1;SURF4;CAPN1;ARHGAP9;DYNC1LI1;PSEN1;IQGAP1;ABCA13;SNAP23;ITGAV;CD47;LPCAT1;SIRPA;CSTB;NRAS;RAB3D;SLPI;GLA;JUP;TMEM30A;XRCC5;NIT2;SNAP25;RHOA;CMTM6;TNFRSF1B;NME2;SLC2A3;UBR4;SLC15A4;HSP90AA1;CD14;DIAPH1;ATP6V0A1;DYNC1H1;GAA;ATP6V1D;PKM;CAP1;IGF2R;CANT1;FABP5;CTSD;PPIA;PADI2;ILF2;RAB5B;RAB5C;SLC44A2;CXCR2;COTL1;TMEM179B;PLAUR;VAMP2;PYGB;PRG2;ALDOA;APAF1;RAB24;DDOST;TOLLIP;ITGAM;ACP3;QSOX1;RAB10;PYCARD;COMMD9;MAPK1;ANXA3;ERP44;CAB39;CPNE1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3711060161745953,1.0639937860219608,0.34168336673346694,0.916801762153058,1.0,48/248,15.34%,SFRP4;LRP6;COL1A1;DKK2;EGFR;TLE6;CCDC88C;SCEL;GPC3;PSMC4;UBE2B;DACT3;CDK14;AMER3;IGFBP6;WWTR1;SMURF2;RBMS3;KREMEN1;AXIN1;IGFBP4;DACT1;TCF7L2;DAAM2;PSMC6;FZD7;PSMD8;PSEN1;CUL3;GSKIP;TLE2;PLEKHA4;KANK1;TMEM9;CSNK1G1;CSNK1G3;PRDM15;ANKRD6;TPBG;GLI3;JUP;EGF;PIN1;STK3;AMFR;CTNND2;CHD8;FZD4
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.47801863043428394,1.0636941538062965,0.40860215053763443,0.9171049355389627,1.0,4/16,18.93%,EME1;RMI1;ERCC4;TOP2B
prerank,lysosome localization (GO:0032418),0.42898417369981423,1.0635608287823248,0.4020857473928158,0.9168505862169769,1.0,12/37,21.27%,NDEL1;HDAC6;FLCN;VPS33A;MAP6;HPS6;BLOC1S2;SNAPIN;PIP4P1;KXD1;VPS33B;PIK3CG
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.3859364377237647,1.063369173970148,0.39585492227979274,0.9167651001240577,1.0,19/84,19.65%,IGFBP5;EIF2AK3;BIN1;RBM4;PAIP2B;TRIM71;SAMD4B;MRPL13;ORMDL2;IGF2BP1;LARP1;PIN1;CNOT10;RTN3;FXR2;CHRNA7;EPRS1;PAIP2;PCIF1
prerank,neuron projection extension (GO:1990138),-0.2968178377026785,-1.0633064585300307,0.3492063492063492,0.746405698705447,1.0,4/32,3.27%,ALCAM;AUTS2;NRP2;SEMA5A
prerank,lipoprotein catabolic process (GO:0042159),-0.4239391650342522,-1.0632298135020917,0.3854166666666667,0.7445916577761477,1.0,3/11,7.55%,APOE;ABHD17C;NOTUM
prerank,regulation of viral life cycle (GO:1903900),0.45936721297069727,1.0631495858975306,0.4155019059720457,0.916767996200351,1.0,6/21,20.75%,AXL;KPNA2;HS3ST5;TRIM68;PPIA;TYRO3
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.48356324459655364,1.063145248952647,0.4007731958762887,0.9160802363980746,1.0,6/16,23.47%,AMPD2;PAICS;GART;ATIC;ADSS2;LHPP
prerank,mRNA splice site selection (GO:0006376),0.4381594942940664,1.063063638735902,0.4085510688836104,0.9156275172325202,1.0,15/30,31.97%,SRSF6;KHDC4;CELF2;SF3A1;PSIP1;LUC7L3;PUF60;LUC7L2;CELF3;CELF1;SNRPC;SRSF5;CELF4;SF1;SF3A2
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.33847831302907694,-1.0623591617931996,0.3476190476190476,0.7448501359948929,1.0,10/22,31.71%,WNT5A;SLC7A5;LACC1;SPHK2;NOD2;TRIM6;BTK;CCR2;TNFRSF14;LILRB1
prerank,regulation of cellular metabolic process (GO:0031323),0.4188587868091429,1.0621761370973999,0.37206703910614525,0.9177629603938261,1.0,16/45,24.50%,ACLY;COQ7;ARF4;PID1;STUB1;ARF1;SSH1;EIF6;MBOAT7;NCOR2;MKLN1;RNF41;CYP1B1;FLOT1;PARL;RSPO1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.32500443455620603,-1.0620676883155684,0.3333333333333333,0.7436030450987461,1.0,10/27,16.89%,PLTP;PTCH1;APOE;NR1H3;CAV1;SIRT1;ABCA3;NFKBIA;EEPD1;ABCA5
prerank,regulation of nuclear division (GO:0051783),0.4707309514511767,1.0617893991361624,0.3944374209860936,0.9183262521140791,1.0,5/20,13.95%,CCDC8;KIF20B;FBXO5;PIN1;CUL9
prerank,positive regulation of protein transport (GO:0051222),-0.26197607031268005,-1.0615470098321094,0.28125,0.7429838941219877,1.0,11/67,6.01%,BMP6;UNC13B;FRMD4A;IGF1;CD2AP;ATP2C1;MYO18A;CEP290;ABCG1;ACSL3;PRR5L
prerank,cellular response to amino acid stimulus (GO:0071230),0.42555311692232994,1.0614284934663125,0.4071510957324106,0.9188037255624869,1.0,13/33,22.92%,FYN;CAPN2;MTOR;SESN3;NSMF;RRAGD;CPEB1;IPO5;CASTOR2;SESN2;UBR2;KLHL22;SLC38A9
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.4953110608147665,1.0614082346225178,0.4158686730506156,0.9181783060158623,1.0,4/13,16.59%,CD44;MIF;TWIST1;SNAI2
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3839283476521025,-1.0612418264696493,0.3560606060606061,0.7417902000044051,1.0,6/14,17.80%,IL34;THBS1;MDK;MAPK3;PTK2;RARRES2
prerank,RNA interference (GO:0016246),0.46688614978897575,1.0610946942397788,0.42292490118577075,0.9184641115374564,1.0,6/17,27.88%,TARBP2;AGO2;AGO4;AGO3;AGO1;CELF1
prerank,negative regulation of intracellular protein transport (GO:0090317),0.45025804440782025,1.0610550489195552,0.42785445420326224,0.9179010798931081,1.0,9/22,18.62%,RAB23;MDFIC;LMAN1;INPP5K;GDI1;CABP1;CHP1;BAG4;UFM1
prerank,stabilization of membrane potential (GO:0030322),0.48585176163713406,1.061046373680039,0.4010416666666667,0.9172298952116814,1.0,3/16,9.44%,KCNK5;KCNK13;KCNK9
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3144919913200009,-1.0609741623952123,0.3150684931506849,0.7404321047680692,1.0,4/28,3.74%,ITPR1;BCL2;DAB2IP;CASP4
prerank,regulation of cell-cell adhesion (GO:0022407),0.4211321063637072,1.0609503581390671,0.4052511415525114,0.9168504419509597,1.0,12/39,16.98%,DPP4;EFNA5;GTPBP4;TENM3;SRC;JAG1;CD47;EPHB3;FUT9;ZDHHC2;MDGA1;FLOT2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.444429563835013,1.0609231290461119,0.39611178614823817,0.9162502013954805,1.0,8/25,20.38%,FGF13;KIF2A;MAPT;TPPP3;PIN1;MAP7D3;CKAP5;STMN4
prerank,neutrophil mediated immunity (GO:0002446),0.36310907691615985,1.0608270869419465,0.287,0.9158632468524723,1.0,105/432,21.60%,TIMP2;GSN;CD55;ARSA;B4GALT1;CD44;CD177;ANXA2;RAB6A;ANPEP;ACTR1B;TMBIM1;MIF;S100A8;S100A9;SPTAN1;MAPK14;AP1M1;ACLY;RAP1B;TMEM63A;PTPRJ;TOM1;PLEKHO2;AP2A2;PRCP;RAB37;IDH1;DOK3;TCN1;ATP11A;COPB1;SURF4;CAPN1;ARHGAP9;DYNC1LI1;PSEN1;IQGAP1;ABCA13;SNAP23;ITGAV;CD47;LPCAT1;SIRPA;CSTB;IRAK4;NRAS;RAB3D;SLPI;GLA;JUP;TMEM30A;XRCC5;NIT2;SNAP25;RHOA;CMTM6;TNFRSF1B;NME2;SLC2A3;UBR4;SLC15A4;HSP90AA1;CD14;DIAPH1;ATP6V0A1;DYNC1H1;GAA;ATP6V1D;PKM;CAP1;IL6;IGF2R;CANT1;FABP5;CTSD;PPIA;PADI2;ILF2;RAB5B;RAB5C;SLC44A2;CXCR2;COTL1;TMEM179B;PLAUR;VAMP2;PYGB;PRG2;ALDOA;APAF1;RAB24;DDOST;TOLLIP;ITGAM;ACP3;QSOX1;RAB10;PYCARD;COMMD9;MAPK1;ANXA3;ERP44;CAB39;CPNE1
prerank,regulation of viral entry into host cell (GO:0046596),0.42470795805406986,1.0608157710988373,0.40860215053763443,0.9152015116540664,1.0,6/30,15.77%,GSN;MID2;LGALS1;TRIM11;HS3ST5;TRIM68
prerank,regulation of cell aging (GO:0090342),0.5135358139643896,1.0602898964357184,0.401673640167364,0.9161939280992575,1.0,4/11,17.49%,MIF;LMNA;RSL1D1;NEK4
prerank,positive regulation of protein metabolic process (GO:0051247),0.3768264489374008,1.0602835303479181,0.4108053007135576,0.9155182792960823,1.0,25/110,17.74%,CD80;GPC3;MAPK7;STX5;SMURF2;AXIN1;DACT1;KLF2;ITCH;FOXO1;SEC22B;EGLN2;PSEN1;DTL;PAEP;HECW2;AKT1;DDB1;KLF4;NSF;HACE1;IDE;CHRNA7;RAB1B;IL18
prerank,negative regulation of immune response (GO:0050777),0.3743640502139823,1.0600412255817855,0.38827098078867545,0.9156393055760642,1.0,23/154,14.21%,COL3A1;SYK;VIPR2;FYN;IRAK3;MAPK14;ITCH;GLP2R;C1QBP;SRC;RC3H1;ADCYAP1;DPEP1;CRHR1;GPR20;SIRT2;CALCA;GPR45;TSHR;ADCY8;GNB1;LHCGR;FER
prerank,microtubule anchoring (GO:0034453),0.5125564500511696,1.0599641867563045,0.39944903581267216,0.915187651747738,1.0,4/12,21.33%,SAXO1;BICD1;CLASP2;PCM1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.4563382300276272,1.0599283463523441,0.41854636591478694,0.914604270082992,1.0,5/20,17.74%,LBP;TLR4;IRAK1;CD14;IL18
prerank,response to organonitrogen compound (GO:0010243),0.4130099478505735,1.0598617006587512,0.39816933638443935,0.9141416501115831,1.0,5/38,6.12%,IRAK3;SYVN1;MTOR;MEAK7;RCN3
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.4528282779967127,1.0594405139639633,0.3948339483394834,0.9148265177669193,1.0,6/22,18.61%,CD44;MAPK7;MYADM;KLF4;FLOT2;MBP
prerank,diacylglycerol metabolic process (GO:0046339),0.45429569285741633,1.0593779647732218,0.3866995073891626,0.9143315816884182,1.0,6/23,12.97%,PLCE1;ANG;DGKQ;MOGAT1;DAGLA;MOGAT2
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5133179151267704,1.0590725971757653,0.40902872777017785,0.9146491471466097,1.0,4/10,13.42%,CORO2B;MAPT;NDFIP1;TERF1
prerank,negative regulation of viral release from host cell (GO:1902187),0.5044227537382132,1.0586315343055526,0.4174757281553398,0.9153510384944601,1.0,5/13,23.61%,MID2;TRIM11;PML;TRIM35;TRIM8
prerank,regulation of mast cell degranulation (GO:0043304),0.48039728409031335,1.0586236368929414,0.4247448979591837,0.9146827724255736,1.0,1/14,0.24%,SYK
prerank,neuromuscular process (GO:0050905),0.47780100692600663,1.0582358261212268,0.4204244031830239,0.9153100877241476,1.0,3/16,7.89%,DCTN1;MYCBP2;TPP1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.5240985723258842,1.0582191789281752,0.4315937940761636,0.914680666297227,1.0,6/10,28.17%,C1QBP;SEC14L1;TSPAN6;UFD1;RIOK3;NPLOC4
prerank,regulation of protein export from nucleus (GO:0046825),-0.3276581458116836,-1.0581121308935393,0.3882978723404255,0.7459505642746211,1.0,3/23,1.29%,PTPN14;SP100;RAPGEF3
prerank,peptidyl-serine modification (GO:0018209),0.3702465281097106,1.0579083837249426,0.37286432160804023,0.9150214856266857,1.0,29/166,14.06%,PRKCA;MAPK12;EIF2AK3;RPS6KA2;DYRK4;DGKQ;SGK3;SGK2;TGFBR2;GALNT16;MAPK14;PKD1;MTOR;CAMK2D;NTMT1;MAST4;GAS6;PRKD2;CHUK;AKT3;DYRK2;CSNK1G1;CSNK1G3;GALNT1;AKT1;STK39;ULK2;ULK1;HIPK4
prerank,protein targeting to lysosome (GO:0006622),-0.34858944858808627,-1.0577782404428553,0.36792452830188677,0.7448152534708175,1.0,5/20,11.22%,SCARB2;GGA3;RAB7A;SORL1;GCC2
prerank,regulation of B cell proliferation (GO:0030888),0.40525678931321335,1.0573674484972235,0.40044994375703036,0.916080600263172,1.0,9/44,14.82%,EPHB2;MIF;CLCF1;RC3H1;CD81;TIRAP;TNFSF13B;IRS2;IL4
prerank,positive regulation of protein binding (GO:0032092),-0.278287540353266,-1.0573107546522114,0.2987012987012987,0.7440002638298807,1.0,18/56,13.99%,RAPGEF2;VTN;CLDN5;APP;APOE;EPB41;CAV1;B2M;DTX3L;MARK3;NMD3;HIP1R;BMP2;TERT;ABL1;BDNF;TRIM21;HIPK2
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.46156298321804573,1.0570125888599216,0.41516709511568123,0.9165105530847752,1.0,9/19,28.82%,USP36;HDAC6;CAMKK2;VDAC1;HTRA2;SREBF1;CSNK2A2;FBXW7;SREBF2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.4472714590998219,1.0569816052113008,0.4064039408866995,0.9159227150565648,1.0,3/22,7.92%,AHNAK;SRI;CRHR1
prerank,inhibitory synapse assembly (GO:1904862),0.5171423423584373,1.0567078309707427,0.4127906976744186,0.9161435050317347,1.0,2/11,2.87%,LGI2;FGF13
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5221742468226185,1.0566369001348703,0.4310595065312046,0.9156827766840968,1.0,4/10,15.90%,ETFA;ACADVL;ETFDH;ETFB
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3841812774337543,1.0565386079239545,0.40208333333333335,0.9152871144285174,1.0,17/87,16.20%,CORO2B;ARHGAP44;LRP1;EFNA5;EPHA3;MTOR;FSCN1;ABL2;PIK3CA;IQGAP1;RHOQ;TWF1;TAOK2;RHOA;PDGFRA;RND3;RAC3
prerank,telomere maintenance (GO:0000723),0.39905957954879373,1.0564633465278277,0.3988888888888889,0.9148443357148566,1.0,23/50,28.52%,PARP3;XRCC3;CTC1;ACD;SMC5;ERCC4;XRCC5;TERF1;DNA2;SMC6;NBN;RAD50;BLM;POLD1;TINF2;TEP1;TERF2IP;NSMCE2;LTO1;RAD51D;PRKDC;STN1;XRCC6
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5238385099057292,1.0563368421396777,0.4165477888730385,0.9145618406591968,1.0,7/10,27.95%,SIRT2;NCK1;DNAJB1;JUN;BAG3;VHL;IMPACT
prerank,Wnt signaling pathway (GO:0016055),0.38163316021060645,1.056192466815447,0.40061475409836067,0.914362044839542,1.0,10/92,5.14%,SFRP4;LRP6;WNT10B;WNT2;CCDC88C;WNT9A;PLPP3;AXIN1;ZRANB1;TCF7L2
prerank,mitochondrial protein processing (GO:0034982),-0.4131962427503385,-1.0557380290306217,0.38380281690140844,0.7461152398057539,1.0,4/11,17.55%,IMMP2L;ATP23;YME1L1;STOML2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.40277055752879365,1.0557367277402212,0.41235955056179774,0.9151066070483088,1.0,11/48,15.01%,JSRP1;ANK2;F2R;SRI;CAMK2D;CXCL10;GSTM2;PDE4D;CALM2;CASQ1;DIAPH1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.48547540998513056,1.0555072665160319,0.4153645833333333,0.9151546145149203,1.0,4/15,15.94%,DHX33;TLR4;USP50;NLRP2B
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.32386108675443986,-1.0553785487949332,0.36257309941520466,0.7430990247911397,1.0,4/23,3.17%,TFDP2;BCL2;PPP1R13B;YWHAH
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.32386108675443986,-1.0553785487949332,0.36257309941520466,0.7430990247911397,1.0,4/23,3.17%,TFDP2;BCL2;PPP1R13B;YWHAH
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.3850347408823265,-1.0551504744629487,0.3389830508474576,0.7396724528043351,1.0,2/14,1.57%,ABCG2;SLCO2B1
prerank,heme catabolic process (GO:0042167),-0.3850347408823265,-1.0551504744629487,0.3389830508474576,0.7396724528043351,1.0,2/14,1.57%,ABCG2;SLCO2B1
prerank,cellular response to alkaloid (GO:0071312),-0.35218194924093194,-1.0551297207991377,0.4020100502512563,0.7377289562581117,1.0,8/17,22.37%,TGM2;CASP3;CASP7;RYR2;CASP6;HTR1B;CASQ2;RAD51
prerank,nervous system development (GO:0007399),0.36183023512931484,1.0550274715150194,0.309,0.915992540887325,1.0,99/429,19.88%,GSN;EPHB2;NAV2;AXL;NAV1;DCLK1;WNT2;SCIN;EFNA5;NUMBL;MBNL1;PMP22;DCTN1;NEUROD2;VEGFA;FGF13;FGF2;MST1R;GLIS2;APBA1;DLG4;WWTR1;DPF2;LPAR1;PKD1;ACAN;SOX10;DACT1;NAB1;VCAN;TRIM71;MARCKS;ALDH3A2;JRKL;DPF1;TRAK2;MTF1;FARP1;ADAM22;TBX6;SCRG1;PKD2;TPP1;SOX8;SH3GL1;DAGLA;SIAH1;MYLIP;JAG1;GDA;PCDHA1;LSAMP;DSCAM;L1CAM;IRF2BPL;AVIL;GBA2;RBFOX2;IGF2BP1;FLRT3;LGI1;KLK6;MTR;MOBP;GDNF;GJB1;ASIC2;HDAC4;NDUFV2;ARTN;MOG;CNTFR;TMOD2;POU3F2;SH3GL3;DAGLB;ALDH5A1;NR2C2;CDK5RAP2;AHI1;NAGLU;PRPS1;SPG7;CXCR4;BTD;CNTN4;EPHB1;GPM6A;TGFBR1;GMFB;SMPD1;MBP;NAV3;SNTG2;APAF1;COX7B;NBL1;SCD5;WDR62
prerank,positive regulation of cell aging (GO:0090343),0.5113553990125316,1.0549698244614503,0.43661971830985913,0.915490043457581,1.0,4/11,17.25%,LMNA;CGAS;YPEL3;EEF1E1
prerank,positive regulation of biosynthetic process (GO:0009891),0.4173432954165999,1.0545569612752559,0.42134831460674155,0.9161258585676372,1.0,8/40,11.30%,TGFB3;F2R;RUNX1;MTOR;CREB3L1;MLXIPL;TLR4;AKT1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.4176172328566058,1.0539430169891177,0.39954853273137697,0.9174203483302068,1.0,4/39,5.35%,AREG;EGFR;BTC;PTPRJ
prerank,regulation of response to cytokine stimulus (GO:0060759),0.45865203469955823,1.0536104392659276,0.4276729559748428,0.9178276218968279,1.0,4/19,14.32%,MAPK7;RUNX1;IRAK1;KLF4
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.4403744274220114,1.0534566090736235,0.4076827757125155,0.917644529624247,1.0,13/25,28.94%,SCAF8;EAF2;SETD5;THOC1;EAF1;TCEA2;LDB1;ELL;KAT7;ALYREF;HTATSF1;THOC5;WDR43
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.4919757895399437,1.0533365344791914,0.42857142857142855,0.9173512987152631,1.0,5/13,17.16%,EPHB2;SQSTM1;ADCY8;ZDHHC2;CHRNA7
prerank,negative regulation of biosynthetic process (GO:0009890),-0.361671096091373,-1.052549605091247,0.37037037037037035,0.7425569034128684,1.0,8/16,28.20%,SLC30A10;PPARA;CEACAM1;GPER1;CIITA;SLC18A2;PARK7;ASXL3
prerank,positive regulation of catabolic process (GO:0009896),0.39128236017190143,1.0521903459878899,0.4025834230355221,0.9202286324216736,1.0,15/65,16.88%,GPC3;STX5;SMURF2;AXIN1;DACT1;ITCH;FOXO1;SEC22B;EGLN2;DTL;HECW2;DDB1;NSF;HACE1;IDE
prerank,regulation of cellular response to heat (GO:1900034),0.382556879054362,1.052104326700367,0.4090909090909091,0.9198158061849254,1.0,26/77,26.14%,CD34;NUP93;MTOR;CAMK2D;DNAJC2;NUP107;YWHAE;NUP98;MAPT;HSP90AA1;HSBP1;CHORDC1;NUP37;BAG4;FKBP4;NUP50;MAPK1;DNAJB1;BAG3;TPR;CRYAB;BAG5;NUP133;NUP85;HSPH1;NUP188
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.4105852186206997,-1.0518449215814043,0.3917525773195876,0.7425184666141135,1.0,9/11,46.84%,PRKCQ;MALT1;NFKBID;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A
prerank,nuclear envelope organization (GO:0006998),0.46211738515880635,1.0518022110674496,0.42034313725490197,0.9201296764316917,1.0,4/20,9.04%,TMEM43;REEP3;NUP93;TOR1A
prerank,midbody abscission (GO:0061952),0.46516561744086893,1.0516554043409485,0.43958868894601544,0.9199026725467672,1.0,2/17,5.32%,CHMP7;VPS4B
prerank,negative regulation of DNA binding (GO:0043392),-0.30162616675995246,-1.0514892803905178,0.34210526315789475,0.7415331361510655,1.0,2/28,0.77%,LEF1;SP100
prerank,cellular response to interferon-gamma (GO:0071346),0.37945446817574197,1.050828127183768,0.406282722513089,0.9217910562130919,1.0,11/88,12.90%,MID1;CCL8;IRF4;CD44;CAMK2D;CCL25;TLR4;CD47;SIRPA;SLC26A6;CCL13
prerank,protein prenylation (GO:0018342),0.5113100087537071,1.050611276863697,0.42917847025495753,0.9218158413422823,1.0,6/10,33.61%,RABGGTA;RCE1;RABGGTB;CHML;CHM;FNTB
prerank,response to X-ray (GO:0010165),0.4888685803125754,1.0495187921000857,0.41709183673469385,0.9246008800802711,1.0,5/14,18.94%,ANXA1;IKBIP;XRCC5;BLM;NIPBL
prerank,cilium assembly (GO:0060271),0.36389284622615786,1.0494758333700476,0.366,0.9240640718528759,1.0,104/297,27.73%,GSN;NME8;DCTN1;CDC14B;ODF2;ABLIM1;PKD1;RAB23;FHDC1;ARF4;YWHAG;ACTR3;HDAC6;BBS9;SSNA1;ATAT1;ARL13B;TOGARAM1;YWHAE;TMEM138;OCRL;CPLANE1;RSPH1;CNGB1;EHD2;ALMS1;NUDCD3;DZIP1;MAPRE1;TTC39C;HAUS3;AVIL;TEKT5;PIBF1;VANGL2;DYNC2I2;KIF3A;SFI1;RPGR;KIF3B;IFT46;CEP97;TTLL3;BBS4;DNAAF3;HSP90AA1;TUBB4A;TUBA4A;TTC8;DYNC1H1;ATP6V1D;CDK5RAP2;AHI1;DYNC2LI1;CCP110;AKAP9;CEP164;RPGRIP1;DYNC2H1;CEP89;CKAP5;DYNC2I1;CEP83;CCDC28B;RP2;BBS5;PAFAH1B1;BBIP1;IFT52;EXOC4;CC2D2A;SPAG16;FLNA;PCM1;IFT57;DYNLRB1;DNAH5;FBF1;DCTN2;TMEM231;DCX;TCTN2;NEDD1;RAB11FIP3;PDE6D;DYNLL1;CEP78;TCTN1;CDC14A;NEK1;TNPO1;CEP126;RAB1A;CSNK1E;CFAP70;ACTR1A;KIFAP3;CETN2;GBF1;FUZ;IFT81;PTPDC1;RAB8B;E2F4
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3902030854804659,1.0494007229522377,0.40549102428722283,0.9236192142431869,1.0,18/71,21.35%,SYK;FYN;WIPF1;PIK3R2;MYO10;SRC;ACTR3;ABI1;PIK3CA;MYH2;HSP90AA1;ACTG1;ARPC1A;NCK1;ARPC2;PLD2;MAPK1;YES1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.4720359599211738,1.049322058150102,0.40691489361702127,0.9225017506808961,1.0,5/15,21.22%,DTNBP1;AP3D1;BLOC1S2;SNAPIN;AP3B2
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.4720359599211738,1.049322058150102,0.40691489361702127,0.9225017506808961,1.0,5/15,21.22%,DTNBP1;AP3D1;BLOC1S2;SNAPIN;AP3B2
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4268982458332204,1.048884227543142,0.4206815511163337,0.9231747210729478,1.0,7/32,11.21%,PLCE1;AKIRIN1;SRC;FSCN1;ACTR3;PIK3CA;AVIL
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.39088434404281946,1.0486457458635372,0.4057203389830508,0.9232928122681427,1.0,18/70,21.35%,SYK;FYN;WIPF1;PIK3R2;MYO10;SRC;ACTR3;ABI1;PIK3CA;MYH2;HSP90AA1;ACTG1;ARPC1A;NCK1;ARPC2;PLD2;MAPK1;YES1
prerank,cellular response to inorganic substance (GO:0071241),0.44881781131157716,1.0481846589174282,0.4230769230769231,0.924069240312535,1.0,8/21,22.08%,FOXO1;DPEP1;MTR;DDX11;KCNC2;SPIDR;BLM;NSMCE3
prerank,actin cytoskeleton reorganization (GO:0031532),0.39181436066500064,1.048175973104355,0.40748663101604277,0.9234192780600164,1.0,9/63,10.06%,ANTXR1;GSN;FGF7;ANXA1;DTNBP1;FARP2;S1PR2;MCU;EFS
prerank,oligosaccharide biosynthetic process (GO:0009312),0.4530241414367488,1.0480046730858246,0.41719342604298354,0.9232549232749792,1.0,5/20,11.72%,ST3GAL2;B4GALT1;FUT2;FUT9;ST3GAL4
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4159073799183584,1.0478143406390137,0.41637426900584795,0.9231814384420813,1.0,12/34,25.16%,MYOC;S100A10;MYADM;C1QBP;TRIOBP;LIMS2;RAC3;ILK;FLNA;DMTN;CALR;RAC1
prerank,mitochondrion morphogenesis (GO:0070584),0.5118036888082602,1.0475635466474247,0.4420289855072464,0.9232516895139978,1.0,6/11,24.98%,WASF1;PID1;MYH14;SUPV3L1;FIS1;MTM1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4537196138807469,1.0475452927027469,0.4151898734177215,0.9226423968810926,1.0,6/22,14.04%,ANK2;PKD2;GSTM2;SLC9A1;CALM2;CASQ1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5171810596057822,1.0471738959864845,0.4403409090909091,0.9230930351879685,1.0,2/10,3.66%,NPTN;DLG4
prerank,negative regulation of cell population proliferation (GO:0008285),0.3614944286519133,1.047103527968611,0.361,0.922634413890684,1.0,42/351,10.14%,NOX4;SFRP4;MN1;IGFBP5;AR;SCIN;TGFB3;WT1;HPN;DIS3L2;GLMN;FAP;RPS6KA2;ADARB1;ANG;OGN;WNT9A;TNS2;TGFB2;CAMK2N1;F2R;IGFBP6;LMNA;TNN;ATF5;SKI;GTPBP4;PTPRJ;ZBTB7C;MDM4;PLPP1;FLCN;PKD2;ABI1;NDRG4;CYP27B1;VDR;SIRT2;KAT2B;ING4;SMAD6;BRD7
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.3619731685074787,-1.0467754457453813,0.38257575757575757,0.7523311273294664,1.0,5/15,21.63%,PRKCH;AGTR1;MAPK9;LPL;MSR1
prerank,negative regulation of protein metabolic process (GO:0051248),0.4018849974172598,1.046705082179711,0.42251950947603123,0.9232311407679423,1.0,20/48,29.03%,EGFR;ITGB3;IRAK3;MDM4;SIRT2;ITGAV;PIN1;FLOT2;PFDN6;IAPP;FLNA;FMN2;AZIN2;LDLR;CRYAB;VBP1;PFDN2;PRKCG;NFKB1;PRNP
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.417225343070932,1.0466533391706498,0.4036697247706422,0.9227237385317816,1.0,8/33,17.83%,AREG;BTC;DOK1;AKT1;EGF;CBL;ARAP1;PLAUR
prerank,gene silencing by miRNA (GO:0035195),0.41473717482009553,1.0465709727357801,0.4091981132075472,0.9223234448583167,1.0,10/32,19.45%,TARBP2;RBM4;TRIM71;AGO2;PUM1;EIF6;ZFP36;AGO4;SNIP1;AGO3
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.3107879813733236,-1.0464925312683173,0.41420118343195267,0.7509864790732196,1.0,11/26,16.03%,CNOT2;STRN3;PIAS2;CNOT9;HEYL;CRY1;SFRP1;SIRT1;KANK2;VPS18;DAB2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.5067491415988367,1.0464526550340234,0.42795389048991356,0.9220279147555829,1.0,5/10,31.13%,CRHR1;GNB5;GPR35;DRD2;CALM1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.36836389431467725,1.046408236484493,0.39738430583501005,0.9214816901965565,1.0,27/175,16.05%,TNFSF9;HAS2;CCL8;PSMC4;NFE2L2;ZFP36L1;NR1D1;TNFRSF11B;PSMC6;PID1;ZFP36L2;TNFRSF18;CHUK;PSMD8;TNFSF13B;CCL25;INPP5K;AKT1;PLVAP;CD27;ZFP36;CCL13;TNFRSF1B;ZC3H12A;EDA;BAG4;TRAF3
prerank,maturation of SSU-rRNA (GO:0030490),0.41793096501306326,1.0461936887557632,0.41480611045828436,0.9214690677782221,1.0,18/34,32.26%,MRPS11;RIOK1;RRP36;WDR46;SNU13;DCAF13;DDX52;PWP2;SRFBP1;NOL10;RIOK2;TSR3;RIOK3;TSR1;NAT10;RPS28;NOL11;LSM6
prerank,chromatin assembly or disassembly (GO:0006333),0.5106766118538165,1.0460850491257143,0.4281767955801105,0.9211530237077736,1.0,2/11,7.60%,CHAF1B;NOC2L
prerank,mesoderm formation (GO:0001707),0.46581532186269614,1.0460102982606625,0.4197218710493047,0.920726536967926,1.0,2/17,4.49%,ITGB3;ITGA2
prerank,fatty acid oxidation (GO:0019395),0.39231641491628066,1.0453517249590996,0.41409691629955947,0.922181798925899,1.0,15/57,22.15%,EHHADH;ALDH3A2;AUH;SCP2;ACADVL;SLC25A17;ACOX1;BDH2;ABCD3;MCAT;HSD17B4;ACAT1;CPT2;PEX2;CROT
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.44233034891221856,1.0453439004977618,0.40417690417690416,0.9215407144460878,1.0,6/24,11.21%,PLCE1;AKIRIN1;FSCN1;ACTR3;PIK3CA;AVIL
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.37954445907227263,-1.0447722077918822,0.3705179282868526,0.7536473624673762,1.0,3/13,5.35%,ENPP1;ENTPD1;ENPP3
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.4917230491589781,1.0446275588293241,0.4250681198910082,0.923180288185195,1.0,4/12,11.75%,WT1;JAG1;IQGAP1;MAGI2
prerank,mitochondrial fission (GO:0000266),0.4731437873722485,1.044512317957867,0.43911917098445596,0.922857850738288,1.0,4/16,16.42%,DNM1;GDAP1;SLC25A46;MTFR1L
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3209520506253049,-1.0444393687887228,0.39790575916230364,0.7525004380351272,1.0,11/25,28.95%,IGF1;NIBAN2;TGFB1;SOX11;MAD2L2;HEY1;TRIM6;HEY2;RB1;PARK7;SIN3A
prerank,positive regulation of mRNA processing (GO:0050685),0.4519852097328977,1.0441633739219207,0.43300248138957814,0.9233065825617451,1.0,12/21,34.08%,NUP98;RBM3;SF3B4;PAF1;THRAP3;DAZAP1;CELF3;RBMX;CELF4;CIRBP;NCBP2;NCL
prerank,somite development (GO:0061053),0.497990463517465,1.0438614160417157,0.43377001455604075,0.9236037129897773,1.0,1/11,1.62%,MEOX2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.4179734398327132,-1.0436504680155605,0.3824561403508772,0.7526419720239648,1.0,1/11,0.50%,LYN
prerank,response to interferon-alpha (GO:0035455),0.47131830187564727,1.0436047981961052,0.4296875,0.9237425858381196,1.0,2/16,7.57%,AXL;GAS6
prerank,regulation of striated muscle contraction (GO:0006942),-0.3158955962985944,-1.0430588317712215,0.38461538461538464,0.7522247020838358,1.0,3/27,3.48%,ATP1A2;DMD;SLC8A3
prerank,regulation of cell motility (GO:2000145),0.3640818535872013,1.0425970817519326,0.42083758937691523,0.9261520929987876,1.0,22/121,13.56%,DUOX1;FGF18;FGF7;EGFR;BTC;FGF2;SGK3;LMNA;MEAK7;NTN1;ABL2;SLK;INPP5F;SRCIN1;KIF2A;PLXNA3;AKT1;CCDC25;EGF;PIN1;RHOA;TWIST1
prerank,positive regulation of cell differentiation (GO:0045597),0.363121745894936,1.0425764141878098,0.394,0.925546945645035,1.0,25/237,6.02%,CD34;MEDAG;DDR2;CDON;AR;COL1A1;LOXL2;TMEM100;TGFB3;FGFR1;MAPK12;TMEM119;NEUROD2;TGFB2;TGFBR2;SMAD4;WWTR1;MAPK14;ACVR1;ZFP36L1;RBM4;MTOR;HOXA5;AKIRIN1;BEND6
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4604441545785968,1.042569337282532,0.4351145038167939,0.9249029469286157,1.0,7/18,19.86%,LLGL1;RAP1B;KANK1;KIF20B;BCAS3;SHTN1;ARFGEF1
prerank,membrane fusion (GO:0061025),0.41893753901625314,1.0425412992695524,0.4332939787485242,0.9243232412624576,1.0,11/33,20.24%,DNM1;STX11;USO1;SNAP23;NAPA;CHP1;NSF;HACE1;NAPG;VAMP2;VPS33B
prerank,cellular response to organonitrogen compound (GO:0071417),0.3754125097898423,1.0425127309252167,0.41709577754891863,0.9237471507390429,1.0,25/99,19.26%,IGFBP5;WT1;CAPN2;SLIT2;P2RX3;ZFP36L1;RAP1B;MTOR;PKD2;INPP5K;HCN4;SSH1;SLC26A6;TSHR;JUP;LARP1;NSMF;RRAGD;RAPGEF1;DIAPH1;CPEB1;AKAP9;IPO5;HCN1;GABRG2
prerank,negative regulation of cell death (GO:0060548),0.3811198329907869,1.042464820509637,0.4375,0.923247680174095,1.0,16/88,17.33%,CD34;FYN;KIR3DL2;SRSF6;CCN5;PDE8A;FGF2;VPS4B;TIGAR;AKT1;GPNMB;CD200R1;TNFRSF1B;NCK1;HTRA2;SRGAP2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.4863289071890806,1.0417728028257247,0.4206241519674355,0.924771662336445,1.0,4/13,23.03%,SLC4A10;SLC8A2;SHISA6;GRIK2
prerank,calcium ion import across plasma membrane (GO:0098703),0.4832304963295034,1.0415867069320288,0.44609164420485176,0.9247054556678684,1.0,6/14,26.25%,TRPV3;ATP2B4;SLC8A2;CACNA2D1;TRPV2;SLC24A2
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.3703774339295703,1.0415002694413928,0.419917864476386,0.9243236347685566,1.0,21/113,12.37%,AREG;FGF7;PRKCA;EGFR;HPN;ANG;ITGB3;SRSF6;VEGFA;FGF2;ECM1;TCF7L2;THBS4;PRKD2;STAT5A;FZD7;AKT3;EMC10;NRAS;AKT1;EGF
prerank,negative regulation of insulin secretion (GO:0046676),0.4637799493866501,1.0412933115734166,0.4434447300771208,0.9243160860639508,1.0,3/17,9.59%,IRS1;MIDN;BMP8A
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3652178796895254,1.041014634012502,0.42943548387096775,0.924542046876904,1.0,27/153,14.06%,PRKCA;MAPK12;EIF2AK3;RPS6KA2;DYRK4;DGKQ;SGK3;SGK2;TGFBR2;MAPK14;PKD1;MTOR;CAMK2D;MAST4;GAS6;PRKD2;CHUK;AKT3;ERN1;DYRK2;CSNK1G1;CSNK1G3;AKT1;STK39;ULK2;ULK1;HIPK4
prerank,B cell receptor signaling pathway (GO:0050853),0.4141496997405251,1.040720957970129,0.4215349369988545,0.9247829174796215,1.0,2/32,3.34%,SYK;RFTN1
prerank,glycoprotein catabolic process (GO:0006516),0.4707570524924519,1.040605321638065,0.4456094364351245,0.9244664761039846,1.0,5/17,8.70%,EDEM1;OGA;FBXO2;EDEM2;FBXO17
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4800961513253572,1.0404022343657107,0.4555112881806109,0.9244090668118867,1.0,4/15,10.36%,CHST1;NAGK;OGA;LARGE1
prerank,spermatid development (GO:0007286),0.41351996035714994,1.04011968181164,0.4216725559481743,0.9246149724200229,1.0,5/32,14.65%,TOPAZ1;DPY19L2;RSPH1;BBS4;CDYL
prerank,membrane repolarization during action potential (GO:0086011),0.48331694119460245,1.0399419961157612,0.43036211699164345,0.9244974735893764,1.0,3/13,8.26%,ATP1A1;KCNJ2;YWHAE
prerank,cellular response to gamma radiation (GO:0071480),-0.3459145640034592,-1.0396077425643555,0.36681222707423583,0.7596349614233718,1.0,8/17,20.32%,MAP3K20;YAP1;ATM;TMEM109;RPL26;WRN;HRAS;TSPYL5
prerank,serine family amino acid metabolic process (GO:0009069),0.4717151357211895,1.039430065041728,0.42362002567394097,0.9254364060346402,1.0,1/16,0.79%,GCLC
prerank,fatty acid catabolic process (GO:0009062),0.3802324688548744,1.0391833540138493,0.41523605150214593,0.9255225609284342,1.0,19/67,22.15%,EHHADH;CEL;NUDT7;ALDH3A2;AUH;SCP2;ACADVL;SLC25A17;ACOX1;BDH2;NUDT19;ABCD3;MCAT;LPIN3;HSD17B4;ACAT1;CPT2;PEX2;CROT
prerank,negative regulation of MAPK cascade (GO:0043409),0.3757286347180106,1.0391479862167239,0.42767950052029136,0.9249878604913473,1.0,21/87,18.57%,EPHB2;UCHL1;IRAK3;CAMK2N1;SMAD4;PIK3R2;PTPRJ;FOXO1;FLCN;TLR4;INPP5K;SIRPA;PRDM15;PPEF2;TNIP1;PIN1;PPIA;QARS1;SYNJ2BP;STK38;SMPD1
prerank,positive regulation of cilium assembly (GO:0045724),0.4564384827835254,1.0390625348372942,0.44387096774193546,0.9245888550051602,1.0,9/18,29.21%,SAXO1;BBS4;CCP110;ENTR1;CROCC;SEPTIN9;CCDC88A;FUZ;KCTD17
prerank,transferrin transport (GO:0033572),0.4114453268713376,1.038831548474083,0.43137254901960786,0.9246176390022577,1.0,9/33,16.13%,STEAP3;ATP6V0A2;CLTC;ATP6V1E1;ATP6AP1;REP15;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,negative regulation of nervous system development (GO:0051961),-0.3531783417498119,-1.038148909698876,0.39908256880733944,0.7615000559664948,1.0,5/17,10.51%,NOTCH1;ROBO2;B2M;APPL2;SORL1
prerank,regulation of cell cycle (GO:0051726),0.3595301340562002,1.0376732319081545,0.4012036108324975,0.9275825794131283,1.0,65/271,19.03%,LRP6;MAPK12;FAP;GADD45G;CDC14B;RPS6KA2;ADARB1;CKS1B;TGFB2;CAMK2N1;TRNP1;MIF;BIN1;PKD1;CDK4;JUND;TCF7L2;TTC28;RASSF1;TARDBP;INHA;MLXIPL;GAS2L1;PKD2;MYBL2;DTL;CDK9;SIRT2;IQGAP1;BEX2;KAT2B;ING4;ERN1;SON;KIF20B;PUM1;MAGI2;FBXO5;LIN9;PCLAF;CDKN1A;FBXL3;CCND1;PLAGL1;CDC123;NBN;UHRF2;GMNN;NUPR1;NOP53;NUDT6;MADD;NLRP2B;PDCD4;HTRA2;E4F1;TFAP4;PML;CDC26;PPP1R9B;TBRG1;TGFBR1;PRCC;SKP2;NEK7
prerank,neuron projection development (GO:0031175),0.3616219736863651,1.0376674856573982,0.425832492431887,0.9269510697274818,1.0,46/168,18.29%,DBN1;MYOC;EPHB2;DCLK1;ZPR1;DLG4;TAOK3;RASGRF1;UNC5A;TRIO;DOCK7;DTNBP1;LRP12;ADCYAP1;TOR1A;TSKU;EPHB3;PLP1;L1CAM;CAMSAP1;MAPT;KIF20B;TBC1D23;FLRT3;LGI1;TAOK2;GDNF;ULK1;ATCAY;BLOC1S2;CTNND2;MANF;MAP4;SLC9A6;SNAPIN;IL6;DIP2A;ANKRD27;RAB35;SRGAP2;PPP1R9B;SHTN1;STX3;CNTN4;EPHB1;GPM6A
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4530211443175853,1.037437756366184,0.43198992443324935,0.926971942339986,1.0,4/20,6.84%,VEGFA;SMAD4;NFE2L2;SMAD5
prerank,embryonic digestive tract development (GO:0048566),0.4548738334307074,1.0364949915308193,0.43974358974358974,0.9292216463333526,1.0,6/18,18.94%,PCSK5;TGFB2;GLI2;GLI3;PDGFRA;NIPBL
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.389958697042781,1.0364871242136358,0.4410480349344978,0.9285910027159391,1.0,21/56,29.06%,LBP;S100A8;S100A9;TLR5;TLR4;IRAK4;IRAK1;UBA52;CD14;TRAF3;TAB2;MAP3K7;CTSK;HSP90B1;CTSB;CTSL;BCL10;MAPKAPK3;SFTPA1;SFTPA2;MYD88
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.38525715135417893,-1.0362875847731936,0.38461538461538464,0.7644956555988828,1.0,9/14,25.87%,TFB1M;MTERF2;FASTKD1;TEFM;PNPT1;POLRMT;TWNK;FASTKD5;TFB2M
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.4035885942643476,1.0359053513580605,0.44332210998877664,0.929775935339495,1.0,16/44,27.88%,ZFP36L1;RC3H1;ZFP36L2;AGO2;ZC3HAV1;PUM1;ZFP36;POLR2G;ZC3H12A;YTHDF1;YTHDF2;YTHDF3;TNRC6A;RBM24;UPF1;CELF1
prerank,phospholipid metabolic process (GO:0006644),0.38398089456833323,1.0357539158695441,0.4547390841320554,0.9295695345660206,1.0,16/71,20.46%,SMPD3;PLPP3;PLPP1;LCAT;AGPAT3;LPCAT1;PLPPR3;AGPAT5;FADS1;PLA2G4E;PIP4P1;PLPP2;GPAM;SMPD1;ANGPTL3;PIP4K2B
prerank,protein methylation (GO:0006479),0.4088403324361077,1.0355329065090129,0.45955056179775283,0.929551546708707,1.0,14/40,26.53%,RAB6A;PRMT2;NTMT1;EHMT2;GSPT1;SNRPD3;EEF2KMT;N6AMT1;ICMT;NSD1;CARM1;EZH2;CAMKMT;EEF1AKMT3
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3771929703933678,1.0354310114096714,0.42022940563086547,0.9292109263304553,1.0,13/72,14.13%,DCN;MYOC;FGFR1;FGF2;TGFB2;F2R;SRC;PIK3CA;IRS2;EGF;FLT3;CBL;PDGFRA
prerank,regulation of autophagosome assembly (GO:2000785),0.4235069365692102,1.0354210141254279,0.4252336448598131,0.928579778375322,1.0,18/33,33.91%,SEC22B;SCFD1;SMCR8;NUPR1;RAB1B;PIP4K2C;ADPRH;LRSAM1;PIP4K2B;TBC1D12;MTM1;TMEM39A;PIKFYVE;IFT20;CHMP4A;CHMP4B;RAB3GAP1;FEZ1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.46025746476253615,1.0352277282717208,0.4263565891472868,0.928537950152699,1.0,7/18,23.83%,MAPK7;NFE2L2;AKT1;HTRA2;PPIA;TRAP1;BAG5
prerank,chromatin remodeling (GO:0006338),0.37503230915937985,1.0349953809544514,0.42901234567901236,0.9285903181504953,1.0,44/100,30.39%,ESR1;SMARCD2;SMARCD1;ZBTB1;KAT2B;KDM5C;POLE3;SATB2;NPM1;ACTR5;SMARCC2;KDM5B;DR1;HDAC4;EZH1;GATAD1;INO80;SMARCA4;CHD8;SRCAP;BAHD1;NUDT5;BAZ2B;CHD3;TAF6L;BAZ2A;KDM4C;BAZ1A;MBD2;INO80C;ARID1A;JARID2;CHRAC1;KDM4B;ARID1B;HNRNPC;TADA2A;PBRM1;ZBTB7A;ATRX;SOX9;MBD3;HCFC2;HCFC1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4092545885329667,1.0349933601324381,0.45720984759671746,0.9279438950314273,1.0,6/33,10.94%,CD160;PTPRJ;RC3H1;PRKD2;CD81;UBASH3A
prerank,cellular zinc ion homeostasis (GO:0006882),0.42684639207911224,1.0348179044286803,0.427536231884058,0.9278263074223986,1.0,5/26,16.58%,SLC39A13;SLC39A14;SLC39A7;SLC30A9;SLC30A5
prerank,negative regulation of organelle assembly (GO:1902116),0.41675893606373166,1.0341884344459655,0.43742824339839265,0.9290689611834382,1.0,12/35,19.74%,SMAD4;SEC22B;KAT2B;SCFD1;SMCR8;CEP97;NUPR1;CDK5RAP2;EVI5L;CCP110;ODF2L;MDM1
prerank,ganglion development (GO:0061548),-0.41760355996963583,-1.034107627820397,0.38549618320610685,0.7686726055974742,1.0,2/11,6.33%,NRP2;NRP1
prerank,neuron projection morphogenesis (GO:0048812),0.3657917198978496,1.034075492817626,0.41354903943377147,0.9287473573118469,1.0,50/137,26.08%,DBN1;EPHB2;DCLK1;MAP1B;LLGL1;DLG4;TNN;TAOK3;TRIO;DOCK7;DTNBP1;FARP1;S100A6;IQGAP1;EPHB3;KIF20B;FLRT3;TAOK2;MAP6;DCC;CTNND2;SLC9A6;DIP2A;ANKRD27;SDC2;SRGAP2;SHTN1;CNTN4;EPHB1;GPM6A;NBL1;GAS7;SLITRK4;RAB10;PTEN;MAP1A;ABITRAM;CPNE1;CTTN;SPTBN4;MAP1S;CNTNAP1;NTNG2;ALS2;DVL1;LRP2;PAX2;ATL1;NRCAM;SLITRK5
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.31032064421674166,-1.0340242780800433,0.38323353293413176,0.7668673523170281,1.0,8/27,13.27%,FLT1;PRKD1;KIT;EPHA8;PDGFRB;TEK;TGFB1;PTK2
prerank,protein localization to lysosome (GO:0061462),-0.3082566007457955,-1.0338146294279995,0.37888198757763975,0.7654634527985901,1.0,7/28,11.22%,SCARB2;GGA3;RAB7A;MFSD1;LAMTOR5;SORL1;GCC2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.37336528288186577,1.0337793921122251,0.4490216271884655,0.9289829315775869,1.0,17/110,14.19%,ADGRD1;GNAS;LPAR3;GPR12;LPAR1;CXCL10;S1PR2;ABCA1;ADCYAP1;ADGRG2;CRHR1;CALCA;GPR161;TSHR;ADCY8;GNB1;LHCGR
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.38408419188276266,1.033747174455072,0.4343220338983051,0.9284437866701295,1.0,18/73,21.35%,SYK;FYN;WIPF1;PIK3R2;MYO10;SRC;ACTR3;ABI1;PIK3CA;MYH2;HSP90AA1;ACTG1;ARPC1A;NCK1;ARPC2;PLD2;MAPK1;YES1
prerank,positive regulation of tissue remodeling (GO:0034105),0.5082512456890375,1.033738011527025,0.45043731778425655,0.9278232599123184,1.0,2/10,17.74%,TMBIM1;IL18
prerank,positive regulation of protein sumoylation (GO:0033235),0.5183834547602798,1.033601883217817,0.45132743362831856,0.9275895757730387,1.0,5/10,26.47%,PIAS3;UBA2;HDAC4;SAE1;MUL1
prerank,positive regulation of response to wounding (GO:1903036),-0.33246761067352004,-1.0332155480526737,0.3869047619047619,0.7651271592061546,1.0,9/24,13.27%,PTN;MYLK;VTN;OCLN;PRKCE;ADRA2A;MDK;CLDN1;PTK2
prerank,hexose transmembrane transport (GO:0008645),0.4449170500590392,1.0329686970186134,0.44649446494464945,0.9288475206182659,1.0,5/21,18.05%,SLC5A9;SLC50A1;SLC2A10;SLC2A3;SLC45A1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.4191929891938738,-1.0329419124127313,0.43434343434343436,0.7638679491422439,1.0,3/10,4.65%,NEDD4L;OSR1;PRKCE
prerank,negative regulation of growth (GO:0045926),0.3657841319815309,1.0327574881085322,0.4298780487804878,0.9288403736898243,1.0,19/121,13.16%,WT1;DCBLD2;FHL1;DACT3;TGFB2;SLIT3;SLIT2;CDKN2AIP;SMAD4;GNG4;PSRC1;PTPRJ;FLCN;CYP27B1;ING4;BCL6;DNAJB2;ADAM15;CDKN1A
prerank,tRNA processing (GO:0008033),0.38559771828094747,1.0327429246576936,0.439312567132116,0.9282382252504613,1.0,20/61,24.60%,ANKRD16;TSEN54;TRMT6;RPP21;RTRAF;TRMT61A;FTSJ1;CPSF4;TRMT10B;TRMT1;DTWD1;TRPT1;QTRT1;TYW5;PTCD1;TRUB1;METTL1;RPP30;CPSF1;WDR4
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.400657208587648,-1.0325302786363735,0.375968992248062,0.7629894421655915,1.0,2/12,1.98%,GCNT2;BMP7
prerank,regulation of kinase activity (GO:0043549),0.37187627325792005,1.0323980064188107,0.45359749739311783,0.9286400869235979,1.0,19/89,14.52%,DDR2;EPHB2;AXL;EGFR;FGFR1;PLCE1;EPHA3;MST1R;RET;EPHB3;MUSK;CAMKK2;MAPT;EPHA10;IRS2;FLT3;PDGFRA;NBN;DDR1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.3625403715257154,1.032329308150058,0.4420946626384693,0.928197095485128,1.0,59/185,26.73%,DCTN1;CDC14B;PSMC4;ODF2;PKD1;ZFP36L1;ZW10;PSMC6;YWHAG;SSNA1;ZFP36L2;YWHAE;PSMD8;CUL3;SIRT2;ALMS1;HECW2;CDC23;MAPRE1;HAUS3;ANAPC5;FBXO5;ERCC3;UBA52;SFI1;DDB1;CDC27;INO80;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;TFAP4;CCP110;CDC26;AKAP9;CEP164;PPP1R9B;ANAPC4;CKAP5;CENPE;PAFAH1B1;RIOK2;ANAPC10;PCM1;DCTN2;ANAPC15;NEDD1;PSMD3;DYNLL1;CEP78;PSMD4;CDC14A;CSNK1E;PSMB3;ANAPC2;ACTR1A;CETN2
prerank,embryonic axis specification (GO:0000578),-0.3606968984237182,-1.032014311526704,0.38934426229508196,0.7625798106105366,1.0,3/15,3.49%,PTCH1;CXXC4;TBX3
prerank,skeletal muscle tissue development (GO:0007519),0.4095973625373899,1.0319510648391788,0.4214689265536723,0.9287024537919816,1.0,7/32,19.01%,SIX4;SKI;SVIL;MYH14;SIX1;KLHL41;SELENON
prerank,positive regulation of cell growth (GO:0030307),0.369052338894091,1.0313502206794325,0.4254658385093168,0.9299185949900424,1.0,27/96,22.86%,DBN1;EGFR;HPN;SYT2;TGFB2;CDKN2AIP;S100A8;S100A9;DDX49;NTN1;ISLR2;L1CAM;AKT1;MAPT;LGI1;INO80;GOLGA4;SYT1;SHTN1;TGFBR1;SUPV3L1;RIMS2;N6AMT1;SLC25A33;SMURF1;SDCBP;KLHL22
prerank,positive regulation of transport (GO:0051050),0.3774737943109007,1.0312746495809233,0.44375,0.9294999229848939,1.0,21/85,20.96%,SCIN;ANXA1;LRP1;GPC3;ANXA2;SGK2;GAS6;INPP5K;CD47;SIRPA;BAK1;CALY;CHP1;DYNC1H1;SMPD1;CAPN10;CLIP3;GPLD1;KMT2A;NUMA1;PYCARD
prerank,positive regulation of intracellular protein transport (GO:0090316),0.36181466313404287,1.0311684244652621,0.4254032258064516,0.929155983453295,1.0,54/144,26.43%,SEC16B;FYN;ZPR1;PIK3R2;UBE2J2;USP36;TCF7L2;MIEF2;YWHAG;GAS6;CD81;YWHAE;HPS4;B3GAT3;PSEN1;RBM22;HDAC3;PPP3CC;KIF20B;JUP;TMEM30A;ANP32B;SFN;NPEPPS;BBC3;ZDHHC2;ZC3H12A;DMAP1;BCAS3;CHP1;HTRA2;IPO5;VPS11;ARIH2;VAMP2;ATG13;ITGAM;UBE2D3;FLNA;SAE1;PCM1;ICE1;YWHAB;BAG3;TPR;CSNK2A2;LEPROT;EMD;FIS1;MTCL1;RAB29;FBXW7;OAZ1;RNF31
prerank,regulation of cation channel activity (GO:2001257),0.37333350672786025,1.0307470829879066,0.44363256784968685,0.9298169010597606,1.0,20/89,19.71%,AHNAK;JSRP1;ANK2;CNIH3;FGF13;DLG4;CAMK2D;DLG2;NEFL;CAPN1;GRIA2;CACNG2;PDE4D;CALM2;CACNB1;FGF14;GRIN2A;VAMP2;SELENON;GRIA3
prerank,neural crest cell development (GO:0014032),0.402036898604089,1.0307215832321432,0.4304932735426009,0.929249729603026,1.0,8/44,13.74%,SEMA3C;RADIL;SOX10;SOX8;SEMA3A;SEMA3D;GDNF;NOLC1
prerank,negative regulation of neuron death (GO:1901215),0.37234217665952435,1.0306238265218477,0.44432882414151925,0.9289060064289608,1.0,22/93,22.18%,CD34;TGFB3;SIX4;KIR3DL2;F2R;CLCF1;NFATC4;NRBP2;AKT1;GPNMB;GDNF;CD200R1;SIX1;TNFRSF1B;HTRA2;SET;SNX6;RASA1;TYRO3;KDM2B;CSF1;ATF4
prerank,negative regulation of cellular process (GO:0048523),0.3531562092128423,1.0305817348447308,0.381,0.9284027694891711,1.0,98/521,17.33%,NOX4;CD34;SFRP4;AR;EPHB2;CD9;SCIN;TGFB3;WT1;DIS3L2;GLMN;DCBLD2;FHL1;EIF2AK3;RPS6KA2;TMEM98;ADARB1;DACT3;SRSF6;CCN5;PDE8A;WNT9A;FGF2;TNS2;TGFB2;SLIT3;SLIT2;CAMK2N1;F2R;IGFBP6;CDKN2AIP;MIF;SMAD4;LMNA;ATF5;SKI;SYT11;GNG4;HOPX;GTPBP4;DACT2;PSRC1;MIA3;VPS4B;PTPRJ;ZBTB7C;INHA;MDM4;PLPP1;TGFBI;ADAM22;FLCN;PKD2;ABI1;CYP27B1;VDR;SIRT2;PLXNA3;KAT2B;ING4;SMAD6;BRD7;SIRPA;DSCAM;NPM1;BCL6;MAGI2;GPNMB;FBXO5;DNAJB2;ANP32B;ADAM15;SPOCD1;CDKN1A;P3H1;TMEM127;PDE3B;TNFRSF1B;DNAJA3;NACC2;DDX4;ORC6;KLF4;GMNN;SMARCA4;NUPR1;NUDT6;NLRP2B;PDCD4;IL6;NCK1;HTRA2;CD164;TFAP4;PML;NME1;EEF1E1;SRGAP2
prerank,regulation of NMDA receptor activity (GO:2000310),0.4150366153839012,1.029391869952677,0.4511904761904762,0.9313147960985816,1.0,6/32,9.38%,EPHB2;DLG4;DLG2;NEFL;CAPN1;GRIA2
prerank,cardiac atrium morphogenesis (GO:0003209),-0.3559789333419605,-1.029067812234838,0.41350210970464135,0.7685980030489373,1.0,4/16,10.57%,ENG;NOTCH1;BMPR2;BMP2
prerank,retrograde axonal transport (GO:0008090),0.46073814868157587,1.0289081797067754,0.44599745870393903,0.9321431135836851,1.0,7/16,22.51%,DST;DLG2;NEFL;DYNC1H1;PAFAH1B1;MAP1A;FBXW11
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.35029566602753837,1.0288233108994427,0.358,0.9317460153089998,1.0,158/834,16.39%,LMX1A;DCN;LIF;AR;LRP6;ESR1;NFIX;IRF4;WNT2;EGFR;TGFB3;WT1;MEOX2;TRIAP1;HSF2;ELF4;MAPK7;ZMIZ1;VEGFA;FGF2;TGFB2;PBX1;GLIS2;RUNX1;CRTC2;SMAD4;NFE2L2;PIK3R2;ATF5;WWTR1;DPF2;LMX1B;AKNA;MEF2D;SKI;PKD1;COPS5;ACVR1;FOXK2;KLF2;JUND;MAFF;TCF7L2;NR1D2;NFATC1;HOXA5;SMARCD2;MEIS2;FOXO1;IL33;AKIRIN1;NR1D1;NFIB;RTRAF;CXCL10;NCOA3;MUC1;SSBP3;NFIA;RNF111;ZFHX3;DPF1;MEPCE;ARF4;MLXIPL;SMAD5;ACTR3;MTF1;PID1;SMARCD1;ADCYAP1;GLI2;ZFPM2;FLCN;PRKD2;PKD2;CD81;SOX8;CHUK;VDR;MYBL2;FOXC2;AGO2;JAG1;CDK9;SIRT2;TLR4;BEX1;ONECUT1;KAT2B;MED24;ATAD2B;RHOQ;RNF10;SATB2;HELZ2;SQSTM1;HDAC3;NPM1;MZF1;TCERG1;MITF;PRDM15;IRF2BPL;CSRNP3;TOX2;SLC30A9;MICAL2;CEBPB;GLI3;DCAF6;ZNF462;TNIP1;SLC9A1;AKIRIN2;UBA52;KANSL3;JUP;CCNC;DR1;GDNF;ATF1;DDX17;PEG3;PIN1;MED13;TWIST1;SIX1;HDAC4;RFX5;PLAGL1;NME2;ZC3H12A;EAF2;KLF4;HOXA7;BCL9;PTOV1;HOXC4;INO80;BCAS3;PPP3CA;POU3F2;IL4;SMARCA4;GTF2F1;CHD8;MLXIP;NR2C2;E2F3;AHI1;UBP1;PER1;IL6;HGF;NCK1;OGT;STAT5B
prerank,negative regulation of myotube differentiation (GO:0010832),0.48950629264586926,1.0287596002503603,0.46311475409836067,0.9313192992720237,1.0,3/12,13.86%,TMEM119;HDAC3;HDAC4
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.4970759788957683,1.028581512131254,0.46494992846924177,0.9312234364585781,1.0,2/11,7.57%,AXL;GAS6
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.42555434569913936,1.0285463195505264,0.44768856447688565,0.9306985923317496,1.0,10/26,19.35%,FGFR1;MAPK7;RET;EYA2;AKT1;GDNF;PPP2R1B;SNAI2;HTRA2;MCL1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.35500244253848423,-1.0284210350329914,0.4166666666666667,0.7685006806368161,1.0,7/17,20.35%,NEDD4L;GPD1L;KCNQ1;RYR2;KCNE4;SNTA1;SCN3B
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.41480863592534833,1.028277085844285,0.445993031358885,0.9309009869640573,1.0,9/34,17.06%,RAB7B;IRAK3;PTPRS;NR1D1;TLR4;CD14;GRAMD4;NLRP2B;SARM1
prerank,Rap protein signal transduction (GO:0032486),-0.4130704764764634,-1.0278375358710496,0.44694533762057875,0.7680597093278749,1.0,2/10,1.29%,RAPGEF2;RAPGEF3
prerank,axon guidance (GO:0007411),0.35658412213064516,1.0277949936457158,0.4221105527638191,0.9317749665348749,1.0,44/201,14.33%,SEMA3C;EPHB2;PRKCA;EFNA5;NPTN;GRB10;EPHA3;FYN;MAPK7;GAP43;VEGFA;SLIT3;SLIT2;NTN4;SLIT1;SPTAN1;DOK1;UNC5A;SPTA1;NFIB;PDLIM7;RET;SRC;NTN1;GLI2;SEMA3A;PIK3CA;SIAH1;PLXNA3;DOK4;USP33;EPHB3;DSCAM;UNC5D;L1CAM;EPHA10;IRS2;SEMA3D;LGI1;IGSF9;GDNF;PALLD;ARTN;DCC
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4093748365787834,1.0268404028738023,0.4511627906976744,0.9340453256599678,1.0,14/36,29.56%,GHR;F2R;IL10RA;EGF;BCL3;IL6;CYP1B1;LEPROT;VHL;HES1;JAK2;SOCS3;ERBB4;CENPJ
prerank,B cell activation (GO:0042113),0.37797945881888545,1.0267690476740403,0.4520255863539446,0.9336474960893572,1.0,10/68,14.82%,EPHB2;LAX1;HDAC9;CLCF1;PTPRJ;BANK1;FLT3;CR2;HDAC4;IL4
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.4586155836246583,1.0265480692386222,0.4529032258064516,0.9336931960024869,1.0,4/18,11.36%,EIF2AK3;MAF1;DHX33;UBTF
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3590350932782617,1.025971559808437,0.4391959798994975,0.9348175269124357,1.0,49/166,20.68%,NIBAN1;EGFR;IRS1;CTC1;FGF2;SMOC2;KLF2;MTOR;NR1D1;MLXIPL;GLI2;PRKD2;PKD2;LARP4;EPM2AIP1;TLR4;HNRNPD;DYRK2;NPM1;AKT1;ELOVL5;PASK;IRS2;DUOXA1;EIF6;EGF;RPS27L;BCL3;DDB1;ZCCHC4;DNA2;POLDIP3;RBM3;KLF4;HSP90AA1;EIF3E;GIPC1;CHP1;IL6;HGF;EIF3D;FXR2;YTHDF1;SREBF1;GPLD1;PCIF1;DDAH2;ABCB10;OPN3
prerank,positive regulation of organelle assembly (GO:1902117),0.39712591953348814,1.025944208710301,0.4322508398656215,0.9342627574558339,1.0,19/44,27.27%,GPSM2;SAXO1;FSCN1;IL5;BBS4;DYNC1H1;CCP110;PIP4K2C;LRSAM1;ENTR1;PIP4K2B;NUMA1;CROCC;PDCD6IP;CCDC88A;SDCBP;G3BP1;SDC4;FUZ
prerank,P-body assembly (GO:0033962),0.48949319801359303,1.02577989896448,0.4491180461329715,0.9341501539050091,1.0,4/12,15.34%,RC3H1;LSM4;ATXN2;DYNC1H1
prerank,positive regulation of macroautophagy (GO:0016239),0.39806209689243066,1.0257197836396363,0.4585201793721973,0.9336830936977952,1.0,16/48,22.99%,DCN;GNAI3;GPSM1;SLC25A4;SESN3;LARP1;SMCR8;IL4;VDAC1;PIP4K2C;LRSAM1;VPS13D;PIP4K2B;SESN2;BAG3;MAP3K7
prerank,DNA duplex unwinding (GO:0032508),0.390264529315697,1.0256624212147294,0.434640522875817,0.9332060360469945,1.0,13/50,18.62%,ANXA1;GTF2H3;RAD23B;ASCC3;ERCC3;UBA52;DDB1;DDX11;NBN;RECQL;RAD50;BLM;SUPV3L1
prerank,negative regulation of cell differentiation (GO:0045596),0.3593375116706726,1.025639892062625,0.43517587939698493,0.9326419310624873,1.0,39/181,18.56%,COL5A2;COL5A1;WNT10B;EGFR;HPN;LDLRAD4;ITGB3;WNT9A;HDAC7;TNN;WWTR1;SKI;TRIO;HOPX;MEIS2;FOXO1;ABCA1;ZFPM2;ZFP36L2;CHADL;SOX8;JAG1;SIRT2;ITGAV;SMAD6;TSKU;VASN;ANP32B;TWIST1;HOXA9;PDCD4;IL6;NBR1;SNAI2;EFEMP1;YTHDF2;CNTN4;TGFBR1;SDHAF2
prerank,negative regulation of glycolytic process (GO:0045820),0.4960500302879207,1.0255320035218196,0.43546099290780144,0.9317091121564576,1.0,4/10,15.11%,TIGAR;NCOR1;HDAC4;NUPR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4960500302879207,1.0255320035218196,0.43546099290780144,0.9317091121564576,1.0,4/10,15.11%,TIGAR;NCOR1;HDAC4;NUPR1
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.3021668335236983,-1.0254669086861976,0.38235294117647056,0.7725169397065286,1.0,6/26,13.86%,LYN;EPHA4;AIM2;TTBK1;PSME2;PSME1
prerank,myeloid cell differentiation (GO:0030099),-0.26823508686580083,-1.025448730668694,0.4019607843137255,0.7706055654125651,1.0,21/47,26.62%,LYN;KMT2E;KIT;HSPA9;CASP3;PRDX3;RPS14;INHBA;PTPN2;TAL1;HIPK2;SNRK;ACIN1;UBA5;SPI1;JAK3;RASGRP4;KAT8;ALAS2;CEBPA;HCLS1
prerank,organelle disassembly (GO:1903008),0.41283192519584433,1.0251704630655367,0.4544378698224852,0.9321603089777426,1.0,10/33,21.05%,STX5;KLC1;ATG2B;ULK2;ATG2A;ULK1;UFC1;UFL1;UFM1;MTIF2
prerank,phospholipid transport (GO:0015914),0.38943014862226344,1.0250994496392403,0.43777292576419213,0.931747541178978,1.0,11/52,12.70%,ATP8B1;TRIAP1;ATP9A;OSBPL2;ABCA1;PRELID3A;ATP11A;SCP2;ATP9B;TMEM30A;ABCC1
prerank,nuclear export (GO:0051168),0.3732973094042962,1.0249596047171101,0.4382845188284519,0.9315372873607976,1.0,29/80,27.44%,SRSF2;DESI1;HNRNPA1;SRSF6;NXF1;PKD1;U2AF1;STRADA;SRSF3;SRSF11;THOC7;POLDIP3;THOC2;THOC1;ZC3H11A;CHP1;DDX39A;SRRM1;U2AF2;NEMF;SMURF1;TPR;XPO7;CALR;ALYREF;UPF3B;NUP188;CDC40;THOC5
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3839817813693377,1.0248423873960275,0.442371020856202,0.9312393168036747,1.0,10/56,10.09%,TGFB3;LDLRAD4;TGFB2;PMEPA1;SMAD4;ACVR1;BMP15;INHA;BMP8A;SMAD6
prerank,regulation of actin filament polymerization (GO:0030833),0.3775664400362949,1.024777926728673,0.4653887113951012,0.9308028941772873,1.0,23/69,24.09%,DBN1;SLIT2;CDC42EP2;BIN1;MYADM;PFN2;TWF1;KANK1;SSH1;GBA2;FCHSD1;FER;ARF6;NCK1;COTL1;ARFGEF1;RASA1;PYCARD;ABITRAM;SSH3;CTTN;LATS1;NCK2
prerank,protein stabilization (GO:0050821),0.3615053799306564,1.0247527066948658,0.4627016129032258,0.9302494473681633,1.0,55/168,26.47%,WNT10B;SAXO1;UBE2B;ANK2;PLPP3;USP36;OTUD3;GTPBP4;SYVN1;RASSF2;MDM4;PFN2;HPS4;USP33;STX12;CCT7;CDKN1A;PIN1;P3H1;IFT46;CCNH;STK3;HSP90AA1;USP7;CHP1;NOP53;BAG4;FLOT2;NAPG;NAA15;TBRG1;RPL23;FLNA;PTEN;USP13;SEL1L;BAG3;USP19;FLOT1;CRYAB;TNIP2;RABL3;PER3;CCT4;BAG5;DVL1;RTN4;TRIM44;CRTAP;CALR;VHL;AFM;FBXW7;STXBP4;MUL1
prerank,triglyceride metabolic process (GO:0006641),0.3908804098282946,1.0245721650913209,0.4541387024608501,0.9301702104962233,1.0,12/48,22.45%,GPAT4;FABP12;MOGAT1;GK5;MOGAT2;GPAT3;FABP5;GPAM;LIPC;LIPH;LPIN3;SEL1L
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.4189908230344862,-1.0242760064576948,0.43006993006993005,0.7720526159985487,1.0,5/10,31.71%,CEACAM1;ARRB2;PTPRC;FCGR2B;LILRB1
prerank,positive regulation of hormone secretion (GO:0046887),-0.3521589501086083,-1.0242150365690186,0.38461538461538464,0.7702704357646435,1.0,6/17,15.75%,C1QTNF3;SPP1;EDN1;SOX11;EDN3;HFE
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.39108266738124436,1.0239349249991179,0.4358695652173913,0.9314827695159252,1.0,9/51,10.15%,MYOC;TGFB3;S100A10;SORBS3;LPAR1;PFN2;ARHGEF10L;ARHGEF10;CD47
prerank,regulation of histone deacetylation (GO:0031063),0.4816801926707938,1.0237937005953148,0.46987951807228917,0.9312636618081306,1.0,5/13,21.50%,CAMK2D;AKAP8;NIPBL;CTBP1;AKAP8L
prerank,regulation of cell population proliferation (GO:0042127),0.3501468983024452,1.0230055888183607,0.396,0.9330751814317217,1.0,115/691,14.32%,NOX4;SFRP4;LIF;AREG;AR;HAS2;AVPR1A;FGF18;FGF7;DPP4;WNT2;EGFR;SCIN;TGFB3;WT1;IRS1;FGFR1;DIS3L2;GLMN;CTF1;RPS6KA2;ADARB1;BTC;SIX4;VEGFA;WNT9A;FGF2;TNS2;SGK3;SGK2;TGFB2;MST1R;CAMK2N1;F2R;TGFBR2;TRNP1;IGFBP6;RUNX1;TIPIN;LMNA;ELN;ATF5;WWTR1;SKI;ZFP36L1;CDK4;GTPBP4;JUND;CLCF1;TCF7L2;TRIM71;PTPRJ;MEIS2;GLP2R;MEAK7;ZBTB7C;CXCL10;INHA;MDM4;MLXIPL;S1PR2;PLPP1;MELTF;ESM1;TBX6;PKD2;FLT3LG;DNAJA2;ABI1;CD81;STAT5A;CAPN1;WDR77;CYP27B1;VDR;CUL3;JAG1;SIRT2;STX4;KAT2B;ING4;ITGAV;SMAD6;BRD7;CD47;NPM1;BCL6;KRAS;AKT1;RBFOX2;KIF20B;MAGI2;GPNMB;FBXO5;TSHR;UBE2A;DNAJB2;JUP;IRS2;EGF;XRCC5;GDNF;FLT3;CDKN1A;P3H1;RHOA;TMEM127;SIX1;DNAJA3;NACC2;HDAC4;CDC123;PDGFRA;FER;KLF4
prerank,mitochondrial translational elongation (GO:0070125),0.37029114465720214,1.0229207295349008,0.4707112970711297,0.9326985584443691,1.0,19/88,15.58%,MRPS11;MRPL38;MRPS18B;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;MRPL30;MRPL10;GFM1;DAP3;MRPL55;MRPS10;MRPL36;MRPL3;MRPL21;MRPS34;MRPL51
prerank,hemidesmosome assembly (GO:0031581),0.4824451625589199,1.022723516956877,0.451831750339213,0.9326330648796082,1.0,2/11,5.04%,COL17A1;DST
prerank,cellular response to insulin stimulus (GO:0032869),0.3595198582343551,1.022695524168874,0.44933469805527126,0.9320744273673193,1.0,38/124,20.86%,IRS1;GRB10;HDAC9;PIK3R2;ATP6V0A2;ZFP36L1;SLC39A14;ZDHHC7;FOXO1;MYO5A;INSIG2;FOXC2;SYAP1;KAT2B;INPP5K;RHOQ;AKT1;ATP6V1E1;IRS2;ATP6AP1;PDE3B;FER;ATP6V0A1;ATP6V1D;PKM;SELENOS;ATP6V1B2;SOS1;IDE;CPEB1;EPRS1;VAMP2;CAPN10;GPLD1;LPIN3;GOT1;RAB10;FOXO4
prerank,metanephric mesenchyme development (GO:0072075),0.5054168087997745,1.0225527374773258,0.46544428772919605,0.9318773485797928,1.0,4/10,13.71%,WT1;SIX4;PKD2;SIX1
prerank,regulation of microtubule nucleation (GO:0010968),0.49965602372681656,1.0221261773564103,0.46573426573426574,0.9325330022537558,1.0,4/10,28.23%,DCTN1;CKAP5;ARHGEF7;RANGRF
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4200150369939653,1.0220092298975645,0.469678953626635,0.9322689363840676,1.0,7/29,17.52%,GTF2H3;RAD23B;ERCC3;UBA52;DDB1;CCNH;ERCC5
prerank,double-strand break repair (GO:0006302),0.36180216115523867,1.0219273280029375,0.46814964610717896,0.9318629048849834,1.0,40/158,19.59%,PARP3;REV3L;XRCC3;EME1;SFR1;RAD51B;RFWD3;KPNA2;TENT4A;CYREN;UBE2N;PPP5C;HELQ;AP5S1;SAMHD1;POLB;SMC5;ACTR5;RMI1;ERCC4;FAN1;XRCC5;ABRAXAS1;SEM1;DNA2;BRIP1;SMC6;NBN;INO80;TNKS1BP1;IFFO1;RECQL;SPIDR;RNF138;RAD50;ERCC5;BLM;MORF4L1;DCLRE1A;SMARCAL1
prerank,organonitrogen compound catabolic process (GO:1901565),0.38458388173658586,1.0217584662665515,0.44613710554951036,0.9317464631353054,1.0,20/57,27.12%,ANPEP;MTOR;NAGK;LNPEP;TPP1;CLPX;SIAH1;PDXDC1;PNPLA8;NPEPPS;IDE;MPST;LIPC;LRSAM1;TXN2;USE1;TRIM24;CTH;PLA2G7;PPT1
prerank,translational termination (GO:0006415),0.3675247030544521,1.0217577859392588,0.47291666666666665,0.9311206047010917,1.0,21/95,15.58%,MRPS11;MRPL38;MRPS18B;ABCE1;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;GSPT2;MRPL30;MRPL10;DAP3;MRPL55;MRPS10;MRPL36;MRPL3;GSPT1;MRPL21;MRPS34;MRPL51
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.47133933587502974,1.0217444222284828,0.4517374517374517,0.9305361721983713,1.0,6/15,20.35%,TRIAP1;GPX1;AKT1;GHITM;HGF;PRELID1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.4874247945293221,1.0215307448033346,0.45883940620782726,0.929880828544659,1.0,4/12,15.24%,ATP2B4;DYRK2;RCAN1;CHP1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4874247945293221,1.0215307448033346,0.45883940620782726,0.929880828544659,1.0,4/12,15.24%,ATP2B4;DYRK2;RCAN1;CHP1
prerank,calcium ion import into cytosol (GO:1902656),0.46634470010031115,1.0213655837132114,0.45466666666666666,0.9297262674656187,1.0,6/15,26.25%,TRPV3;ATP2B4;SLC8A2;CACNA2D1;TRPV2;SLC24A2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.41834735820481866,1.0209727551153192,0.45872641509433965,0.930259939800735,1.0,11/29,24.57%,ESR1;RUNX1;AXIN1;UFL1;VPS11;GPAM;UFM1;KCTD6;CARM1;LATS1;UFSP2
prerank,signal transduction by p53 class mediator (GO:0072331),0.4191412165019782,1.0209349533912695,0.45605700712589076,0.9297478512385677,1.0,9/30,21.94%,TRIAP1;USP10;MDM4;BCL3;FHIT;NBN;DDX5;PYCARD;SESN2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.4064999122721942,1.0202456496620074,0.4443155452436195,0.931170632710291,1.0,8/31,21.64%,TIMM50;PEX16;GRPEL2;PEX12;PEX1;PEX5;PEX2;TIMM17A
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.38479831188852115,1.0200971022264431,0.46923076923076923,0.9310253925220132,1.0,18/52,23.21%,EPHB2;EGFR;LRP1;EPHA3;ATP2B4;STX4;SQSTM1;AKT1;ZDHHC2;ARF6;PLS1;CNST;SPTBN1;STX3;CLIP3;STAC3;ZDHHC8;ZDHHC5
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.3846953087413617,-1.0200646128718416,0.4267241379310345,0.7795295759626647,1.0,3/13,10.57%,BMP5;APOE;BMP2
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.3180779725811992,-1.0198648198812774,0.39634146341463417,0.7781109926299717,1.0,6/22,14.70%,SLC16A2;NES;PTPRZ1;APPL2;MDK;TOX
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.4235291999150375,1.0198514681039637,0.4540023894862604,0.9311433606177754,1.0,7/27,16.59%,EGFR;AGO2;PUM1;ZFP36;MAP2K2;IL6;DDX5
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.35963455283969503,1.0194344267389506,0.4798387096774194,0.9317705796720686,1.0,23/161,11.60%,SFRP4;LRP6;DKK2;TLE6;CCDC88C;PSMC4;DACT3;IGFBP6;TNN;WWTR1;RBMS3;KREMEN1;AXIN1;IGFBP4;DACT1;TCF7L2;PSMC6;PSMD8;CUL3;TLE2;ANKRD6;TPBG;GLI3
prerank,positive regulation of programmed cell death (GO:0043068),0.35235858763606387,1.0189813254057036,0.4644644644644645,0.9324255645682268,1.0,75/272,24.04%,SFRP4;SYK;WNT10B;KCNMA1;SCIN;TGFB3;AKAP13;GADD45G;RPS6KA2;SLIT2;BIN1;TRIO;ADAMTSL4;MTCH1;HOXA5;FOXO1;PRMT2;RASSF2;C1QBP;ARHGEF3;HDAC6;PIP5KL1;AIFM2;FLCN;SIAH1;PSEN1;PDCD2;RYBP;ING4;TIAM2;SQSTM1;CSRNP3;BCL6;BMF;ERCC3;UBA52;BAK1;NGEF;QRICH1;DIABLO;STK3;MLLT11;MTCH2;CALHM2;DDX20;HRK;NLRP2B;SOS1;IL6;HTRA2;TFAP4;SAP18;CTSD;EEF1E1;IAPP;SMPD1;SUDS3;APAF1;CLIP3;GPLD1;TRIM35;ATF6;TIAM1;PYCARD;JUN;NF1;ATF4;CYP1B1;UBE2Z;RBM5;HTATIP2;VAV2;RRP1B;TFPT;LATS1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.35456490046578637,-1.0188406192492347,0.38095238095238093,0.7789917762648809,1.0,5/16,17.97%,PDK1;SCARB2;SIRT1;PDK3;ADIPOR1
prerank,regulation of activated T cell proliferation (GO:0046006),0.4121677799333295,1.0188312304573328,0.4638196915776987,0.9322382912027651,1.0,2/30,7.01%,TNFSF9;RC3H1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.4220990867603841,1.0187900532611653,0.45510455104551045,0.9317461069086765,1.0,2/25,3.88%,EPHB2;CNRIP1
prerank,activation of protein kinase B activity (GO:0032148),-0.30213968482669373,-1.0183865298444215,0.40588235294117647,0.7783076022367384,1.0,8/29,8.97%,INSR;IGF1;WNT5A;OSBPL8;PINK1;NTRK3;FGF1;ADRA2A
prerank,carbohydrate biosynthetic process (GO:0016051),0.4381465544423901,1.018101027372839,0.45202020202020204,0.9331290964591905,1.0,5/21,11.72%,ST3GAL2;B4GALT1;FUT2;FUT9;ST3GAL4
prerank,positive regulation of protein catabolic process (GO:0045732),0.36827337006522903,1.0178553412283027,0.4755970924195223,0.9332536145581992,1.0,22/84,20.46%,GPC3;STX5;ADAM9;SMURF2;AXIN1;DACT1;ITCH;FOXO1;SEC22B;EGLN2;DTL;HECW2;DDB1;TNFRSF1B;HSP90AA1;NSF;HACE1;IDE;VPS11;GPLD1;SH3D19;RNF41
prerank,base-excision repair (GO:0006284),0.3817349511099719,1.0176547331535688,0.44175824175824174,0.9331939402928234,1.0,8/48,20.44%,MPG;POLB;PARG;DNA2;RFC4;ERCC5;POLD1;OGG1
prerank,sodium ion homeostasis (GO:0055078),0.43535481214688565,1.0176501378132952,0.43875,0.9325839313128278,1.0,4/21,3.99%,SCNN1B;ATP1A3;ATP1A4;ATP1A1
prerank,protein maturation (GO:0051604),0.36574208882295683,1.0169291765235229,0.4672216441207076,0.9341393337266751,1.0,26/95,21.66%,PCSK6;TSPAN17;PCSK5;LIPT2;ADAMTS3;ADAM19;PCSK4;STUB1;PSEN1;ECE1;NDUFAB1;XPNPEP3;EEF1AKMT4-ECE2;ECE2;DNAJB11;TASP1;CIAO2B;OGT;NAA15;MMP16;METAP2;NAA50;PCSK7;BACE1;CCS;CPZ
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3987547518668623,1.0168185453595644,0.46091015169194866,0.9338457357883277,1.0,10/38,22.60%,ESR1;USP10;NR1D1;OTUD7B;TNIP1;ZC3H12A;PER1;PPM1A;PYCARD;RORA
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.48410203863104995,1.016732441417639,0.4732510288065844,0.9334698087833686,1.0,3/12,11.30%,MIA3;FUT9;AKT1
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.40821905336258335,-1.01670675892122,0.40559440559440557,0.7810081614972081,1.0,2/10,9.37%,MLLT3;SFRP1
prerank,protein deacetylation (GO:0006476),0.39318992526234103,1.0166979699046197,0.46420581655480986,0.9329529473626755,1.0,13/41,20.33%,HDAC9;HDAC7;HDAC6;SIN3B;MSL3;SIRT2;RCOR3;HDAC3;HDAC4;MORF4L1;SUDS3;MIER1;FLNA
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.4982109553377473,1.0166350181371047,0.45750708215297453,0.9325148661660754,1.0,5/10,13.61%,UBE2B;PDE11A;PDE4D;CDC34;PDE3B
prerank,polarized epithelial cell differentiation (GO:0030859),0.4754921537127008,1.016106917277875,0.456021650879567,0.9334608132462241,1.0,4/13,20.69%,ZDHHC7;MYO9A;RHOA;RAB10
prerank,inorganic cation transmembrane transport (GO:0098662),0.3504402784464906,1.0158357045584878,0.45190380761523047,0.9336178821025728,1.0,48/268,16.58%,SCARA5;KCNK5;SCNN1B;UCP1;HPN;KCNV1;SLC4A8;SLC39A13;ATP1A3;ATP1A4;ATP1A1;PKD1;P2RX3;SLC39A14;TRPV3;ATP2B4;KCNJ2;SLC9A9;KCND1;SLC6A8;SLC11A2;ABCB8;GAS6;SLC25A27;PKD2;ATP5PO;KCNK13;KCNK9;ITGAV;HCN4;SLC39A7;KCNA2;SLC4A4;KCNA6;KCNAB3;SLC6A11;SLC6A4;SLC9A1;ATP2A2;ASIC2;SLC8A2;KCNC2;TRPC4AP;SLC9A7;SLC9A6;SCN4B;TMEM165;SLC30A5
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.39989393745911445,1.0157466807444198,0.4644495412844037,0.933267186433597,1.0,15/40,25.74%,GLMN;DESI1;AXIN1;RAD23B;SGTA;UFL1;PML;RPL23;PTEN;SMURF1;UBE3A;CSNK2A2;LATS1;UBQLN4;FBXW7
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.46049680893934647,1.015621419465916,0.47698209718670076,0.9330218758811791,1.0,5/15,18.58%,ENTPD2;NME2;CMPK2;AK8;ENTPD6
prerank,regulation of cellular component movement (GO:0051270),0.38539766616542864,1.0153821531715574,0.46622369878183834,0.9331197441306327,1.0,16/49,18.39%,CD9;EGFR;BTC;VEGFA;ZSWIM4;HDAC6;ABL2;MYCBP2;INPP5F;EGF;RHOA;DIAPH1;ZSWIM8;ARAP1;YTHDF1;TGFBR1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.4645398833998392,1.0153719056939992,0.4477211796246649,0.9325277303843117,1.0,8/15,25.55%,REEP3;LNPK;RTN3;RAB10;TMEM33;RAB18;RTN4;ATL1
prerank,regulation of organelle assembly (GO:1902115),0.3764216505923795,1.0150819645537628,0.47151898734177217,0.9327382163034799,1.0,26/73,24.97%,GSN;CEP295NL;ATXN2;TBC1D2B;TBC1D17;ALMS1;NPM1;TBC1D10A;ATXN2L;EVI5;DYNC2LI1;SENP6;TBC1D13;RAB1B;VPS11;ADPRH;TBC1D22B;TBC1D15;TBC1D19;ATG3;PDCD6IP;CYLD;TRAPPC12;TBC1D12;STAM;CDKL1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4486989450504053,1.0149906733176082,0.4743083003952569,0.9324136583392272,1.0,3/16,12.04%,PRKCA;CAMK2D;SLC9A1
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.40103844050671655,-1.0145856836242106,0.40977443609022557,0.7847816692091238,1.0,2/11,6.35%,ABCG1;AGTR1
prerank,zinc ion homeostasis (GO:0055069),0.4157650017407125,1.0145377113259793,0.4553140096618358,0.9331461634200161,1.0,5/28,16.58%,SLC39A13;SLC39A14;SLC39A7;SLC30A9;SLC30A5
prerank,copper ion transport (GO:0006825),0.4931185074596469,1.01427251559227,0.48216833095577744,0.9332833759423174,1.0,2/11,7.16%,STEAP3;SLC11A2
prerank,negative regulation of interleukin-17 production (GO:0032700),0.5011284376399859,1.0139334676171454,0.47788873038516405,0.9336741256128976,1.0,5/10,36.35%,TLR4;DDIT3;PRNP;NCKAP1L;VSIR
prerank,anterograde trans-synaptic signaling (GO:0098916),0.3498325769717381,1.0139308192756413,0.477,0.9330655224230249,1.0,46/224,19.89%,LRP6;LPAR3;SNCB;MTNR1B;APBA3;PMP22;CEL;RPS6KA2;CAMKK1;APBA1;DLG4;SLC1A6;GABRR3;DLG2;SLC18A3;RIT2;HTR1F;SLC12A4;GRIA2;PLP1;CAMKK2;HCRT;SLC12A5;SNAP25;ASIC2;DLGAP1;GABRG3;GAD2;CACNB1;GIPC1;GRIN2A;GRM1;CHRNA7;CHRFAM7A;SYT1;AKAP9;CHRNA5;SYNJ2BP;HTR2C;MBP;PAFAH1B1;PRKAR2A;GABRG2;GRIA3;NOVA1;EXOC4
prerank,negative regulation of phosphatase activity (GO:0010923),0.41985909126944737,1.01390344537187,0.43504901960784315,0.9325127499098644,1.0,13/25,30.20%,TGFB2;PPP1R1B;URI1;CHP1;SH2D4A;FKBP1A;TIPRL;PPP1R26;CRY2;PTPA;GPATCH2;FKBP1B;BOD1
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.33872299290301017,-1.0138402330718315,0.45714285714285713,0.7848059520588483,1.0,3/17,3.21%,CDH5;CLDN5;F11R
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.394190380084953,1.0136081207801182,0.4594594594594595,0.932705649108072,1.0,4/43,5.35%,AREG;EGFR;BTC;PTPRJ
prerank,regulation of secretion (GO:0051046),0.47164292536883873,1.0134972489742105,0.48783783783783785,0.9324043357439422,1.0,3/13,12.37%,SCIN;POFUT2;EGF
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4431028664769967,1.0134202018476242,0.45466491458607095,0.9319859177943881,1.0,2/19,4.64%,DBN1;FBXW8
prerank,regulation of cellular localization (GO:0060341),0.39184102460354386,1.0133057170466246,0.46792035398230086,0.9316982378817725,1.0,14/46,20.64%,GSN;EFNA5;CAMK2D;NR1D1;TRIM46;PARD6A;GOSR1;FER;HSP90AA1;DYNC1H1;REEP5;TTL;TRIM67;NUMA1
prerank,regulation of pH (GO:0006885),0.4910586707966227,1.0132374379132236,0.46296296296296297,0.9312782833353146,1.0,4/11,15.88%,ATP1A4;SLC9A1;ATP6AP1;SLC9A7
prerank,protein targeting to mitochondrion (GO:0006626),0.378934093206806,1.0130563016271985,0.47978142076502733,0.9311743616361082,1.0,17/52,28.04%,TIMM50;GDAP1;TIMM10B;TIMM9;AGK;GRPEL2;HSP90AA1;IMMP1L;TIMM22;TIMM8B;BCAP31;TOMM5;TIMM17A;FIS1;TOMM40;NDUFA13;PITRM1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.368269601304772,1.0129145164470312,0.4859228362877998,0.9309572052014379,1.0,14/88,13.60%,IGFBP5;EIF2AK3;CAMK2N1;RBM4;PAIP2B;TRIM71;SAMD4B;HDAC6;MRPL13;CSTB;AKT1;IGF2BP1;LARP1;CNOT10
prerank,inositol phosphate catabolic process (GO:0071545),0.48129287607537224,1.0126193986425591,0.4654939106901218,0.9311674245502173,1.0,5/12,27.87%,OCRL;INPP5K;INPP5B;PTEN;SYNJ2
prerank,regulation of glycogen metabolic process (GO:0070873),0.48075104379519945,1.0121028953965505,0.46774193548387094,0.9320649723919352,1.0,5/12,24.10%,INPP5K;AKT1;PPP1R3C;PPP1R3D;PPP1R3E
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3510277373211963,1.0119092247253352,0.473,0.9320351803480752,1.0,103/314,26.29%,UCHL1;PSMC4;UBE2B;SPSB1;SPSB4;NFE2L2;UBE2J2;SMURF2;SYVN1;TRIM71;ITCH;EDEM1;RAD23B;RMND5B;RNF121;COP1;PSMC6;SPSB2;STUB1;UBE2W;ANKZF1;FBXO2;PSMD8;SIAH1;FBXO17;CUL3;SIRT2;FBXL2;ECPAS;UBE2G2;FBXW4;HECW2;FBXL20;HERPUD1;CDC23;ANAPC5;FBXO5;FBXO31;UBE2A;DNAJB2;UBA52;CDC34;LTN1;TMUB2;DDB1;FBXL3;SGTA;CDC27;AMFR;RNF216;SELENOS;RNF187;RBCK1;ZSWIM8;HACE1;PML;CDC26;DMAC2;KCTD2;UBE2G1;FBXL5;ANAPC4;AUP1;SKP2;PCNP;UBE2D3;FBXL19;CUL5;KCTD10;ANAPC10;JKAMP;NEMF;ARRB1;UBXN11;SMURF1;ANAPC15;DERL1;SEL1L;FBXW11;UBR2;USP19;KLHL22;ECRG4;SPSB3;IFI27;FBXO38;PSMD3;DCAF12;RHBDD2;FBXL12;PSMD4;SEC61B;MDM2;AGAP3;KAT5;HSP90B1;UFD1;DDIT3;FBXW7;RNF126;PSMB3;UBE2K;ANAPC2
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.46845558434536894,1.0117773279554014,0.4681139755766621,0.9318072298020794,1.0,5/14,14.82%,SYT11;NR1D1;CD200R1;TNFRSF1B;IL4
prerank,endocardial cushion morphogenesis (GO:0003203),0.4442896719617889,1.0114906947810756,0.47036082474226804,0.9320766516490506,1.0,4/18,6.76%,TGFB2;TGFBR2;ACVR1;MDM4
prerank,negative regulation of mRNA processing (GO:0050686),0.46362036682182434,1.0112642623050945,0.4851228978007762,0.9320894163956053,1.0,5/15,19.99%,SRSF6;C1QBP;SAP18;U2AF2;PTBP1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.35132705666108915,-1.0112242869132664,0.44621513944223107,0.7900681827009567,1.0,8/15,26.63%,TNK2;PIK3CB;HIP1R;DAB2;NEU3;SCYL2;AAK1;SMAP1
prerank,negative regulation of cell motility (GO:2000146),0.3583703894773418,1.0110729617966994,0.48612538540596095,0.9320476402081669,1.0,21/108,13.17%,IGFBP5;TMEFF2;ADARB1;LDLRAD4;SLIT2;MIF;GTPBP4;MIA3;PTPRJ;SRGAP1;SULF1;PIP5KL1;FLCN;DPEP1;JAG1;KANK1;MITF;MAGI2;RECK;ADAM15;PIN1
prerank,histone mRNA catabolic process (GO:0071044),-0.3579733248264714,-1.0109826425866448,0.4316546762589928,0.7887666574297315,1.0,6/15,16.74%,SSB;TUT1;TUT4;TUT7;ATM;MTPAP
prerank,protein localization to chromatin (GO:0071168),0.4559804469887225,1.0106724677508467,0.4732142857142857,0.9326204997052248,1.0,2/18,5.04%,ESR1;CHMP7
prerank,response to hydroxyurea (GO:0072710),0.4840012233080983,1.0103390008529705,0.47285714285714286,0.932981130825697,1.0,6/11,29.30%,DDX11;SPIDR;BLM;NSMCE3;KAT7;ATRX
prerank,positive regulation of inflammatory response (GO:0050729),0.3645751662090418,1.0102487179600663,0.47604166666666664,0.9326123494308457,1.0,16/86,19.13%,LBP;IL16;S100A8;S100A9;IL33;IL17RA;CD81;TLR4;CD47;TNIP1;ABCC1;NUPR1;PDCD4;IL6;IL18;IFI35
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.44503371564376193,1.009797324319862,0.4670886075949367,0.9332463230929431,1.0,6/20,14.67%,TMBIM1;CSK;PID1;CLTC;RHOQ;PPFIA1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.3700671268677447,1.0097290522976956,0.48038176033934255,0.9328260305376084,1.0,11/67,16.20%,FBLN2;MYOC;VIT;S100A10;MYADM;C1QBP;CCL25;JUP;TRIOBP;LIMS2;RAC3
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.41402899209746347,1.0093722209329359,0.48444976076555024,0.933261371862666,1.0,11/30,23.83%,UCHL5;RYBP;FHIT;SGTA;USP7;GIPC1;NOP53;OGT;MAP1A;SDCBP;BAG5
prerank,negative regulation of response to external stimulus (GO:0032102),0.35702338805586004,1.0088839432926135,0.46680497925311204,0.934008548842749,1.0,20/105,15.97%,MAPK7;IRAK3;FGF2;PTPRS;METRNL;ITCH;MVK;NR1D1;CARD16;C1QBP;INPP5F;SIRT2;FNDC4;SIRPA;RTN4RL1;KLF4;IL4;LRFN5;SELENOS;ILRUN
prerank,cellular response to cadmium ion (GO:0071276),0.4355199542512646,1.0084396077602515,0.47094430992736075,0.934680331001836,1.0,8/24,29.97%,EGFR;CHUK;AKT1;MAPK1;JUN;SUMO1;FOS;HSF1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.4196206818059902,1.0075361653629697,0.46450809464508097,0.936620654813567,1.0,2/25,3.89%,CD55;CD160
prerank,positive regulation of rRNA processing (GO:2000234),0.5017705330404064,1.0073962531064673,0.502865329512894,0.9363992095763948,1.0,2/10,4.77%,DIMT1;RIOK1
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3857011184369195,1.006884274096502,0.48233995584988965,0.9372840432386879,1.0,12/45,19.78%,EGFR;DIMT1;ZPR1;RIOK1;RBM22;ERN1;MAP2K2;IL6;DDX5;SUPV3L1;U2AF2;RIOK2
prerank,positive regulation of dendritic spine development (GO:0060999),0.43433558423055696,1.0064308992959576,0.4782051282051282,0.9380173817634802,1.0,3/20,13.86%,DBN1;PSEN1;LLPH
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.4543209441109163,1.006325207163566,0.47556142668428003,0.9376948760614249,1.0,3/17,6.37%,CD55;PRKCA;CARD16
prerank,postsynaptic membrane organization (GO:0001941),0.455535215713341,1.0062947757831582,0.49222797927461137,0.9371648359880665,1.0,4/17,13.81%,CEL;DLG4;MUSK;DNAJA3
prerank,T cell migration (GO:0072678),-0.38042800480154915,-1.0062098028141897,0.42105263157894735,0.8001093847992963,1.0,4/13,10.47%,SLC12A2;S1PR1;PIK3CD;CXCL16
prerank,negative regulation of cyclase activity (GO:0031280),0.46184207340477645,1.0061740322080224,0.503968253968254,0.9369136185005308,1.0,3/14,9.25%,GNAI3;PALM;LTB4R2
prerank,positive regulation of immunoglobulin production (GO:0002639),0.40292732161086076,1.0061306796380067,0.4758539458186101,0.936441239187118,1.0,4/31,9.18%,EPHB2;CLCF1;HMCES;STX4
prerank,response to interleukin-6 (GO:0070741),-0.416596122254012,-1.0059969322693723,0.4641638225255973,0.7987446399786262,1.0,3/10,11.03%,ST3GAL6;PTGIS;PTPRT
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4736424930804656,1.0059231681803968,0.4766355140186916,0.9364046334362347,1.0,3/13,17.26%,STX1A;SCAMP5;SYT1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.3770933992884934,1.0053058274007762,0.48743169398907105,0.937548020696423,1.0,19/59,24.76%,PRKCA;DYRK4;TGFBR2;ACVR1;CAMK2D;PRKD2;DYRK2;AKT1;STK39;ULK1;HIPK4;TGFBR1;CIT;OXSR1;HIPK3;MAPK1;CSNK2A2;ACVR1B;MARK2
prerank,digestive tract morphogenesis (GO:0048546),-0.3571422792878758,-1.0052760476605458,0.40458015267175573,0.7987988509160159,1.0,6/14,15.56%,RBPMS2;FGFR2;SOX17;STRA6;BBS7;SOX11
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.4781789503672971,1.0051831117213583,0.48686030428769017,0.9373015881386049,1.0,6/12,26.38%,STX4;ADCY8;PPP3CB;GPLD1;BAIAP3;CFTR
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.4576272593050604,1.005151884851928,0.47706422018348627,0.9367926282334739,1.0,4/16,12.38%,PRCP;SPX;GPR37L1;KLK1
prerank,positive regulation of interferon-beta production (GO:0032728),-0.2795996221620999,-1.0048113409060155,0.4411764705882353,0.7981008708519796,1.0,7/33,10.02%,TRIM56;POLR3C;MAVS;POLR3B;TLR3;OAS2;RNF135
prerank,positive regulation of cell junction assembly (GO:1901890),0.3783067809174781,1.004563981062849,0.47811816192560175,0.9378653831161042,1.0,5/56,5.35%,MYOC;EPHB2;VEGFA;S100A10;PTPRJ
prerank,ncRNA catabolic process (GO:0034661),0.4117610994286368,1.0044989910155364,0.47613504074505236,0.9374398429092714,1.0,6/28,18.36%,DIS3L2;NUDT16L1;EXOSC7;NUDT16;ZCCHC8;TENT4B
prerank,protein K48-linked ubiquitination (GO:0070936),0.38097847026682863,1.0042717579211824,0.4814410480349345,0.9375326551292076,1.0,23/54,26.06%,UBE2B;SYVN1;ITCH;CUL3;UBE2G2;UBE2A;CDC34;AMFR;RNF216;RNF187;HACE1;UBE2G1;ARIH2;UBE2R2;SKP2;UBE2D3;UBE2Q2;UBE3A;RNF6;IFI27;FBXO38;RNF126;UBE2K
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.3985882417716037,-1.0039584947223976,0.42857142857142855,0.7985746543985542,1.0,3/10,7.93%,DPYD;UPB1;NT5E
prerank,positive regulation of mitochondrial translation (GO:0070131),0.46205870691227946,1.0036168355178607,0.4719387755102041,0.9388219610269034,1.0,5/14,21.41%,C1QBP;MRPS27;RCC1L;RMND1;MPV17L2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.44431785878520064,1.0035948059313704,0.4816223067173637,0.9382768551322366,1.0,5/21,6.28%,TGFB3;SMAD4;WWTR1;NUP93;SH2B1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.39836311032075755,-1.0035637192020412,0.43462897526501765,0.797841673062525,1.0,3/11,6.08%,NEDD4L;ACTN2;CAV1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.3754385837274929,-1.003275642082918,0.4416058394160584,0.7966738141479133,1.0,4/12,14.86%,PTPN14;KHDRBS1;TGFB1;NUP214
prerank,inorganic anion transport (GO:0015698),-0.2656440645630468,-1.0032038096795894,0.4069767441860465,0.7949579725564909,1.0,13/53,17.08%,SLC13A4;SLC26A7;ENPP1;ANO1;ENPP3;CLIC5;SLC5A5;SLC25A11;FXYD1;CLCN2;PACC1;ANO8;CLCN1
prerank,negative regulation of protein catabolic process (GO:0042177),0.39293414427647466,1.003040667060116,0.46734234234234234,0.9392167867305575,1.0,5/40,9.05%,TIMP2;EGFR;IRAK3;MDM4;SIRT2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3618192068633247,1.0030032411298115,0.4824016563146998,0.9387144920408799,1.0,33/101,23.59%,NIBAN1;DACT1;MTOR;STUB1;LARP4;AURKAIP1;HNRNPD;NPM1;AKT1;TBC1D10A;PASK;BAK1;EIF6;RPS27L;BCL3;ZCCHC4;POLDIP3;RBM3;KLF4;HSP90AA1;EIF3E;IL6;OGT;EIF3D;FXR2;YTHDF1;VPS11;PCIF1;CSF1;YTHDF3;FBXW11;ATG10;IST1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.46357367203560795,1.002908923011744,0.5013262599469496,0.938380946504529,1.0,4/15,14.82%,ADAM9;MAPK14;EHD2;IL4
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.2991717565793467,-1.0028568243117195,0.44516129032258067,0.7939463191607362,1.0,9/29,13.27%,FLT1;PRKD1;KIT;DGKZ;EPHA8;PDGFRB;TEK;TGFB1;PTK2
prerank,rRNA pseudouridine synthesis (GO:0031118),0.4895000912959644,1.002673992457084,0.48985507246376814,0.9384559982138396,1.0,2/10,9.45%,RPUSD1;GAR1
prerank,regulation of defense response to virus by host (GO:0050691),0.40438773486273916,1.0025096358170054,0.4721233689205219,0.9382977747575827,1.0,7/30,15.17%,TARBP2;CGAS;TRAF3IP2;ZC3H12A;HSP90AA1;IL4;RNF216
prerank,response to UV (GO:0009411),0.3630081133750363,1.0022239608228696,0.4808686659772492,0.9385144655665008,1.0,31/95,24.07%,EGFR;TRIAP1;UBE2B;NOC2L;SCARA3;ZBTB1;RHNO1;DTL;NPM1;GPX1;AKT1;BMF;ERCC3;UBE2A;BAK1;ERCC4;PCLAF;BCL3;CCND1;EIF2S1;INO80;UVSSA;ERCC5;POLD1;SMPD1;NSMCE3;ATF4;SDE2;RELA;REV1;POLH
prerank,morphogenesis of an epithelium (GO:0002009),0.41920644644871835,1.0022040314030922,0.4741275571600481,0.9379670312732546,1.0,7/25,21.76%,LRP6;SOX10;SOX8;AHI1;ACTG1;KDM2B;LHX1
prerank,negative regulation of DNA replication (GO:0008156),0.4592239711652816,1.0021652621105626,0.47346938775510206,0.9374780148552442,1.0,3/13,14.84%,GTPBP4;TERF1;GMNN
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.3621221777335368,1.0021539498977712,0.5062111801242236,0.9369133366917349,1.0,40/95,30.03%,DCTN1;ODF2;YWHAG;SSNA1;YWHAE;ALMS1;MAPRE1;HAUS3;SFI1;CEP97;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;AHI1;CCP110;AKAP9;CEP164;CEP89;CKAP5;CEP83;PAFAH1B1;CC2D2A;PCM1;FBF1;DCTN2;TCTN2;NEDD1;DYNLL1;CEP78;TCTN1;CSNK1E;ACTR1A;CETN2;CEP152;TMEM216;CENPJ;PLK4;SDCCAG8
prerank,negative regulation of gene expression (GO:0010629),0.34648396678720134,1.0020815319684044,0.495,0.9365061956098938,1.0,51/302,14.32%,CD34;IGFBP5;ESR1;DIS3L2;NPTN;EIF2AK3;DGKQ;VEGFA;FGF2;TGFB2;FOXP1;RUNX1;MIF;HDAC9;RBMS3;SYT11;RBM4;PAIP2B;ATP2B4;TRIM71;SAMD4B;CREB3L1;CREBZF;TARDBP;MYADM;FLCN;ZFP36L2;PHF1;VDR;MRPL13;PSEN1;AGO2;NUDT16L1;KAT2B;ERN1;MPHOSPH8;PARP14;MAPT;NUDT16;SLC2A10;GPNMB;IGF2BP1;NDFIP1;LARP1;ZFP36;SMCR8;NCOR2;NCOR1;CNOT10;ZC3H12A;KLF4
prerank,intraciliary retrograde transport (GO:0035721),0.48837463249632274,1.0017633696132942,0.5,0.9368490825113646,1.0,4/12,18.23%,DYNC2I2;DYNC2LI1;DYNC2H1;DYNC2I1
prerank,regulation of lipid storage (GO:0010883),0.4232751094370793,1.001724403375704,0.46905940594059403,0.9363824558955635,1.0,5/22,16.30%,ITGB3;ALKBH7;ITGAV;ZC3H12A;IL6
prerank,cardiac cell development (GO:0055006),0.4845171594868085,1.0013828614955316,0.4759887005649718,0.9367682890182204,1.0,3/11,10.89%,VEGFA;JAG1;ALPK2
prerank,lipid biosynthetic process (GO:0008610),0.3657238517197123,1.0013427617962494,0.48520084566596194,0.9362905620728326,1.0,19/77,19.72%,GPAT4;ACLY;MVK;SCP2;SRD5A1;GGPS1;NDUFAB1;AGPAT3;LPCAT1;AGPAT5;FADS1;HSD17B8;GPAM;LIPC;LIPH;SREBF1;ABCD3;MCAT;SCD5
prerank,cGMP biosynthetic process (GO:0006182),-0.41651398408958296,-1.0013070446148147,0.4417808219178082,0.7961875095426955,1.0,4/10,21.82%,GUCY1B1;NPR1;GUCY1A1;GUCY2C
prerank,positive regulation of protein import (GO:1904591),0.4077880865219983,1.0012661747266305,0.4867149758454106,0.9358906749398733,1.0,12/30,22.68%,ZPR1;PIK3R2;PSEN1;RBM22;HDAC3;JUP;ZC3H12A;DMAP1;IPO5;FLNA;BAG3;TPR
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.34615998285871025,1.0010956125683061,0.5145145145145145,0.9357870586331918,1.0,114/341,26.29%,UCHL1;PSMC4;UBE2B;SPSB1;SPSB4;NFE2L2;UBA6;SMURF2;ZRANB1;SYVN1;TRIM71;ITCH;VPS4B;RAD23B;RMND5B;RBBP6;MVB12A;VPS37D;COP1;RNF111;PSMC6;SPSB2;RC3H1;STUB1;UBE2W;WDR91;ADRM1;PSMD8;SIAH1;MYLIP;CUL3;DTL;SIRT2;UBE2G2;FBXW4;HECW2;USP33;OTUD7B;HERPUD1;SQSTM1;CDC23;ANAPC5;RNF7;UBE2A;CDC34;NDFIP1;DDB1;VPS37C;CDC27;CBL;UBR4;AMFR;RNF128;RNF216;TRPC4AP;RNF14;RNF187;RBCK1;ZSWIM8;HACE1;KEAP1;PML;CDC26;KCTD2;VPS37B;UBE2G1;FBXO11;ANAPC4;NTAN1;ARIH2;UBAP1;UBE2R2;NEDD8;SKP2;PCNP;RNF19A;UBE3C;TOLLIP;UBE2D3;KCTD6;FBXL19;ARIH1;KCTD10;ANAPC10;KCTD21;ARRB1;RC3H2;UBXN11;SMURF1;ANAPC15;RNF6;FBXW11;KLHL22;RNF114;SPSB3;IFI27;RNF13;PSMD3;UBQLN4;PSMD4;MDM2;AGAP3;KAT5;RNF166;UFD1;FBXO22;RNF20;DDIT3;FBXW7;RNF126;PSMB3;UBE2K;RNF167;ANAPC2
prerank,regulation of cell development (GO:0060284),0.3986748906894049,1.0009719432832234,0.475484606613455,0.9355336276320191,1.0,5/36,11.30%,BHLHE40;HDAC9;DOCK7;FOXO1;AKT1
prerank,phagosome-lysosome fusion (GO:0090385),0.4928427380846266,1.0007417882049203,0.5007235890014472,0.9356104381584658,1.0,1/10,2.11%,RAB7B
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3781824898287312,1.0004862871938465,0.5165421558164355,0.9357413837086032,1.0,27/59,29.87%,CDK4;TCF7L2;MED24;MITF;CEBPB;CCNC;CDKN1A;MED13;CCND1;TWIST1;MED15;IL6;AGO4;MED23;MED6;AGO3;PTEN;JUN;MED7;TNRC6A;RELA;MED26;AGO1;NFKB1;BAX;TP53;SOX9
prerank,positive regulation of cellular respiration (GO:1901857),-0.38413800422161143,-0.9997487840413077,0.46206896551724136,0.798492127124868,1.0,4/11,13.05%,IFNAR1;IL10RB;PINK1;ISCU
prerank,cellular response to UV (GO:0034644),0.3650828338932173,0.9996143079570419,0.48680042238648363,0.9375726311718396,1.0,23/76,22.85%,TRIAP1;MMP2;CRIP1;CARD16;NOC2L;ZBTB1;RHNO1;NPM1;ACTR5;BMF;BAK1;ERCC4;CDKN1A;DDB1;EIF2S1;INO80;POLD1;SMPD1;OPN3;NSMCE3;ATF4;SDE2;ERCC1
prerank,positive regulation of cellular process (GO:0048522),0.3419628415119478,0.9995445312526103,0.512,0.9371734529562021,1.0,93/565,14.82%,LBP;LIF;AREG;AR;HAS2;LRP6;AVPR1A;FGF18;FGF7;DPP4;WNT2;PRKCA;EGFR;LRP1;TGFB3;IRS1;HPN;FGFR1;CTF1;BTC;VEGFA;FGF2;TGFB2;MST1R;F2R;TGFBR2;CDKN2AIP;S100A8;S100A9;TIPIN;LMNA;WWTR1;DDX49;P2RX3;ZFP36L1;CDK4;ACLY;CLCF1;PTPRJ;POFUT2;MEIS2;GLP2R;ZFHX3;C1QBP;MLXIPL;S1PR2;ESM1;TBX6;GAS6;FLCN;PRKD2;FLT3LG;DNAJA2;CD81;TNFRSF18;FZD7;CAPN1;WDR77;CUL3;SIRT2;TLR4;STX4;ITGAV;RNF10;CD47;SIRPA;SMC5;NPM1;KRAS;AKT1;MAPT;KIF20B;FBXO5;TSHR;UBE2A;IRS2;LGI1;EGF;ZFP36;GDNF;FLT3;CCND1;SMC6;TNFRSF1B;HDAC4;CDC123;ZC3H12A;PDGFRA;FER;INO80;PPP3CA;POU3F2;IL4
prerank,positive regulation of cell death (GO:0010942),-0.24699875684435918,-0.9995370106956911,0.5,0.7971557634011543,1.0,7/59,5.43%,SLC6A13;EFNB2;ACER2;SNCA;WNT5A;PRODH;AXIN2
prerank,regulation of centrosome duplication (GO:0010824),0.4094018157097771,0.9994156049426656,0.47245017584994137,0.9369371693515076,1.0,5/30,10.70%,XRCC3;CEP295NL;VPS4B;ALMS1;NPM1
prerank,regulation of isotype switching (GO:0045191),0.4561569190075813,0.9992038781211696,0.49868766404199477,0.9369587519041307,1.0,4/14,14.82%,PARP3;HMCES;SLC15A4;IL4
prerank,cell-cell junction organization (GO:0045216),0.3633473189409405,0.998474185754149,0.4794520547945205,0.9384258216503137,1.0,13/79,8.24%,CADM3;TGFB3;PKP3;ANG;CD177;TGFB2;F2R;NECTIN3;CSK;MYADM;FSCN1;FLCN;PARD6A
prerank,positive regulation of T cell cytokine production (GO:0002726),0.4343615083221302,0.9983816346738301,0.48575129533678757,0.9380872800896481,1.0,7/20,24.62%,CD55;CD81;IL4;IL6;IL18;MAP3K7;PRKCZ
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.33943618402586256,0.9980832202689432,0.515,0.9383443114345548,1.0,210/1082,16.87%,LMX1A;DCN;LIF;AR;LRP6;CD80;ESR1;COL1A1;NFIX;FGF7;IRF4;WNT2;EGFR;CREB5;TGFB3;WT1;ZC3H8;MEOX2;TRIAP1;EIF2AK3;HSF2;SIX4;ELF4;MAPK7;ZMIZ1;VEGFA;FGF2;PBX1;F2R;GLIS2;SFR1;RUNX1;ZPR1;CRTC2;SMAD4;NFE2L2;PIK3R2;ATF5;WWTR1;DPF2;LMX1B;AKNA;MEF2D;SKI;PKD1;CXXC1;COPS5;AXIN1;SOX10;ACVR1;FOXK2;KLF2;MAP2K3;JUND;MAFF;PSRC1;TCF7L2;MTOR;NR1D2;NFATC1;HOXA5;SCAF8;SMARCD2;MEIS2;FOXO1;IL33;AKIRIN1;NR1D1;NFIB;RTRAF;MAPRE3;EBF3;PRMT2;CXCL10;NCOA3;SSBP3;NFIA;RNF111;ZFHX3;DPF1;RET;ARF4;TRIP4;MLXIPL;SMAD5;DNAJC2;ACTR3;MTF1;PID1;SMARCD1;ADCYAP1;GLI2;ZFPM2;DHX33;FLCN;MDFIC;PRKD2;PKD2;CD81;SOX8;CHUK;FZD7;VDR;MYBL2;PSEN1;FOXC2;AGO2;JAG1;CDK9;SIRT2;TLR4;HNRNPD;ATXN7L3;BEX1;RYBP;ONECUT1;KAT2B;MED24;ATAD2B;INPP5K;RHOQ;RNF10;SATB2;BRD7;HELZ2;SQSTM1;HDAC3;NPM1;MZF1;TCERG1;MITF;PRDM15;CAMKK2;SMARCC2;IRF2BPL;CSRNP3;TOX2;SLC30A9;CEBPB;AKT1;UBTF;GLI3;DCAF6;ZNF462;TNIP1;SLC9A1;AKIRIN2;UBA52;KANSL3;JUP;EGF;CCNC;QRICH1;DR1;GDNF;ATF1;DDX17;PEG3;PIN1;MED13;BCL3;TWIST1;RAI1;SIX1;HDAC4;RFX5;PLAGL1;NME2;ZC3H12A;EAF2;KLF4;TASP1;HOXA7;MLLT11;BCL9;PTOV1;HOXC4;INO80;BCAS3;THOC1;PPP3CA;POU3F2;IL4;SMARCA4;GTF2F1;CHD8;MLXIP;FZD4;NR2C2;MAP2K2;E2F3;RNF14;CDK5RAP2;AHI1;RNF187;UBP1;USP22;PER1;HIVEP3;IL6;HGF;NCK1;OGT;STAT5B;PHF5A;E4F1;BCLAF3;PITHD1;TFAP4;PML
prerank,regulation of phagocytosis (GO:0050764),0.3761593418611406,0.9980386862004861,0.49504950495049505,0.9378695139631705,1.0,6/53,10.19%,SYK;SYT11;GAS6;ITGAV;CD47;SIRPA
prerank,protein lipidation (GO:0006497),0.3769300169050626,0.9978842005342098,0.49083063646170444,0.9377078321238528,1.0,21/59,24.18%,ZDHHC16;ZDHHC7;PIGZ;WIPI2;HHAT;PIGC;WDR45B;SELENOK;MPPE1;ZDHHC2;PIGW;PIGM;ZDHHC21;ZDHHC20;GPLD1;ZDHHC18;ZDHHC8;ZDHHC5;ATG10;PIGL;DPM2
prerank,ketone body metabolic process (GO:1902224),-0.3974863864445914,-0.9977020739403907,0.4504792332268371,0.7999584973893346,1.0,3/10,9.59%,ACSS3;HMGCS2;AACS
prerank,postreplication repair (GO:0006301),0.38298617870702467,0.9969344495351424,0.4830230010952902,0.9398373022369519,1.0,15/45,24.47%,UBE2B;USP10;UBE2N;ZBTB1;DTL;POLI;UBE2A;UBA52;PCLAF;RFC4;POLD1;FAAP20;REV1;POLH;WDR33
prerank,regulation of apoptotic process (GO:0042981),0.3404665798466894,0.9967966770470637,0.534,0.9396268466886075,1.0,153/676,20.48%,SFRP4;COMP;TNFSF9;FSTL1;AXL;GCLC;WNT10B;ARHGAP10;KCNMA1;EGFR;SCIN;ANXA1;TGFB3;WT1;AKAP13;HPN;RABGGTA;ANGPT4;TRIAP1;GADD45G;RPS6KA2;SIX4;CD44;GAS1;VEGFA;SLIT2;STEAP3;MIF;BIN1;ATF5;USP36;COPS5;TRIO;ITCH;ADAMTSL4;MTCH1;SOCS2;CBX4;HOXA5;DDX42;FOXO1;PRMT2;CXCL10;RASSF2;TARDBP;C1QBP;ARF4;SRC;EGLN2;ARHGEF3;PIP5KL1;AIFM2;HS1BP3;GAS6;FLCN;DPEP1;SLK;SOX8;SIAH1;PSEN1;PDCD2;BEX2;RYBP;AVEN;LGALS1;ING4;TIAM2;SMAD6;SON;SQSTM1;HDAC3;NPM1;ALPK2;CSRNP3;BCL6;AKT1;BMF;IRAK1;ERCC3;NAT8;UBA52;BAK1;CD27;NGEF;ANP32B;QRICH1;DIABLO;GLS2;GDNF;FLT3;BCL3;NSMF;WDR73;DNAJA3;NME2;CBL;STK3;MLLT11;MTCH2;CALHM2;HSP90AA1;IL4;NUPR1;VDAC1;DDX20;RSL1D1;NOP53;BAG4;HRK;AHI1;MADD;NLRP2B;SOS1;IL6;HGF;ANXA4;HTRA2;TFAP4;TAX1BP1;SAP18;NME1;CTSD;PPIA;EEF1E1;ERCC5;FAIM2;FBXO11;TMBIM4;PLAUR;NAA15;IAPP;VTCN1;SMPD1;UFM1;SUPV3L1;PRDM9;SKP2;DSTYK;SUDS3;APAF1;CLIP3;MCL1;GPLD1;IL31RA;HIPK3;STK26;RASA1;TRIM35;ATF6;FLNA;PRELID1;DDAH2;TIAM1
prerank,protein modification by small protein conjugation (GO:0032446),0.3418163315935391,0.9965587057062416,0.517,0.9396570219759485,1.0,133/361,27.84%,TSPAN17;MIB2;UBE2B;NEUROD2;SPSB1;SPSB4;STX1A;NFE2L2;UBA6;UBE2J2;SMURF2;RNF212B;FBXW8;SYVN1;NUP93;ITCH;RFWD3;PIAS3;MSL2;GAN;RNF111;SPSB2;NUP107;STUB1;UBA2;MYCBP2;UBE2N;UBE2W;FBXO2;NUP98;MYLIP;CUL3;FBXL2;UBE2G2;ASB12;HECW2;CDC23;TRIM11;RNF7;UBE2A;UBA52;CDC34;USP5;BSPRY;DDB1;FBXL3;CDC27;PEX12;CUL9;CBL;AMFR;USP7;UHRF2;UFC1;TRPC4AP;KLHL41;NUP37;UVSSA;RNF14;TRIM68;SELENOS;RNF187;ZSWIM8;HACE1;RNF138;KEAP1;UFL1;UBE2G1;FBXL5;FBXO11;PEX5;VPS11;ARIH2;NUP50;UBE2R2;UFM1;NEDD8;PCNP;BRAP;UBE2D3;TRIM35;ARIH1;RNF41;CUL5;KCTD10;SAE1;PEX2;PAF1;ARRB1;ATG3;UBE2Q2;KLHL9;SMURF1;FBXO24;DERL1;RNF6;UBE2Z;FBXW11;SDE2;UBR2;TPR;LZTR1;DTX2;ATG10;TRIM24;RTF1;NSMCE2;RNF157;MKRN2;TRIM44;NUP133;MDM2;BCL11A;NUP85;UBA7;VHL;RNF20;FBXW7;UBE2K;NUP188;MUL1;OTULIN;UBE2F;NUP88;DCUN1D1;CUL7;PRKDC;URM1;BCL10;VCPIP1;DTX3;EIPR1;WWP1
prerank,protein K48-linked deubiquitination (GO:0071108),0.424347351361544,0.9965522104179916,0.49814585908529047,0.9390844849622366,1.0,5/23,12.26%,OTUD3;USP33;OTUD7B;USP50;USP5
prerank,negative regulation of developmental growth (GO:0048640),0.40312594673312674,0.9963520230979962,0.49191685912240185,0.9390575442019276,1.0,8/30,14.33%,FGF13;PTPRS;TRIM46;SLC6A4;ULK2;CDKN1A;ULK1;DCC
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.35756599730454386,-0.9961805175927849,0.47035573122529645,0.8020438870464874,1.0,7/15,21.57%,RPS7;DTX3L;ABL1;RPL5;MAD2L2;BAG2;MAD2L1
prerank,MAPK cascade (GO:0000165),0.3451317291393016,0.9960432816874772,0.53,0.9392772640736913,1.0,54/295,14.35%,AREG;FGF18;FGF7;EGFR;IRS1;FGFR1;MAPK12;PSMC4;BTC;FYN;FGF13;FGF2;DLG4;PIK3R2;TAOK3;SPTAN1;RASGRF1;ZFP36L1;SPTA1;DLG2;RET;NEFL;PSMC6;RASGEF1A;RIT2;FLT3LG;ZFP36L2;CHUK;YWHAE;RGL1;PPP5C;PIK3CA;PSMD8;CUL3;MAPK11;RGL2;ITGAV;CAMKK2;NRAS;KRAS;CSF2RA;UBA52;PLVAP;IRS2;EGF;SHOC2;ZFP36;TAOK2;GDNF;FLT3;IL5;PDGFRA;ARTN;RCE1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.36318635990919196,0.9959954057408313,0.5010548523206751,0.9388329424353523,1.0,17/72,18.45%,POLR2H;GTF2H3;COPS5;ERCC3;UBA52;ERCC4;POLR2D;POLR2G;DDB1;AQR;CCNH;USP7;UVSSA;RFC4;ERCC5;POLD1;COPS4
prerank,insulin receptor signaling pathway (GO:0008286),0.36359743267232414,0.995423940586443,0.4841101694915254,0.9397433114723747,1.0,19/69,16.88%,IRS1;GRB10;PIK3R2;ATP6V0A2;SLC39A14;FOXO1;PIK3CA;FOXC2;RHOQ;AKT1;ATP6V1E1;IRS2;ATP6AP1;FER;ATP6V0A1;ATP6V1D;ATP6V1B2;SOS1;IDE
prerank,arachidonic acid metabolic process (GO:0019369),0.3944726440465162,0.9953992643635549,0.48891481913652274,0.9392212633711065,1.0,7/35,17.77%,MGLL;CYP2S1;DAGLA;GPX1;PNPLA8;DAGLB;EPHX1
prerank,keratan sulfate catabolic process (GO:0042340),0.4880046294916741,0.9946997274755042,0.5,0.9405309211744375,1.0,2/11,4.27%,OGN;ACAN
prerank,positive regulation of fat cell differentiation (GO:0045600),0.38092860335835116,0.9946950306182257,0.5067415730337078,0.9399481792495825,1.0,10/47,14.39%,MEDAG;ZFP36L1;METRNL;SYAP1;CEBPB;AKT1;ZFP36;SIX1;ZC3H12A;WDFY2
prerank,negative regulation of platelet activation (GO:0010544),0.45181032031794827,0.9945045594392784,0.48124191461837,0.9398770272875809,1.0,4/16,14.13%,C1QTNF1;CD9;ADAMTS18;PDGFRA
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.45349526535149853,0.9943105069679882,0.49226804123711343,0.9398211591064367,1.0,9/16,31.28%,NUP98;RBM3;SF3B4;THRAP3;DAZAP1;CELF3;RBMX;CELF4;CIRBP
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.3036173465319482,-0.9941871587180283,0.4739583333333333,0.805815186121562,1.0,6/23,12.04%,CBFA2T3;PPARA;CRY1;C1QTNF3;SIK1;EP300
prerank,negative regulation of cellular component movement (GO:0051271),-0.36186732163430885,-0.993776204486302,0.4666666666666667,0.8051367286286979,1.0,5/15,10.93%,SP100;FRMD5;TGFBR3;CCDC125;ACTN1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3794505172240632,0.9935801896790575,0.49671772428884026,0.9412814416273304,1.0,14/57,20.96%,DCN;MIEF2;MCU;CAMKK2;BMF;BAK1;BBC3;MLLT11;HRK;HTRA2;PLAUR;DDHD1;RALA;PYCARD
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.4658895685099119,0.9934590733104475,0.5162162162162162,0.9410293027709946,1.0,3/13,9.25%,GNAI3;PALM;LTB4R2
prerank,regulation of phosphorylation (GO:0042325),0.3491222815306864,0.9933499207550982,0.513677811550152,0.9407629198194751,1.0,43/120,25.39%,AR;EGFR;GLMN;CCDC88C;ANG;MIF;NUP93;INHA;NUP107;FLCN;FZD7;NUP98;PSEN1;SIRT2;DSCAM;EIF6;EGF;CDKN1A;PIN1;FER;IL4;NOP53;NUP37;KCTD20;OGT;PML;ILK;NUP50;CORO1C;CDKN2C;SESN2;LDB2;LDB1;CCDC88A;STAT2;TPR;SDCBP;ANKLE2;ATG14;DYNLL1;NUP133;NUP85;GRM5
prerank,purine-containing compound biosynthetic process (GO:0072522),0.4126900087398905,0.9932101180180852,0.48444976076555024,0.9405532525156493,1.0,6/25,16.62%,AMPD2;PAICS;GART;PRPSAP1;PRPS1;PRPS1L1
prerank,mesenchyme development (GO:0060485),-0.34162372530826246,-0.9930812805876673,0.4444444444444444,0.8050873010544528,1.0,4/15,10.57%,BMP7;FGFR2;BMPR2;BMP2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.3394144141302974,-0.9930443555420828,0.43805309734513276,0.8032867258440094,1.0,7/16,17.55%,ATP5F1C;ATP5F1D;ATP5F1E;ATP5PD;ATP5MG;ATP5MC2;STOML2
prerank,purine nucleotide metabolic process (GO:0006163),0.41849995092690917,0.993023746453324,0.5134803921568627,0.9404880481380546,1.0,7/24,16.62%,GDA;GPX1;FHIT;GART;PRPSAP1;PRPS1;PRPS1L1
prerank,nuclear pore organization (GO:0006999),0.4608269510696591,0.9926867752846593,0.4979757085020243,0.9408340653492036,1.0,4/14,8.69%,NUP93;AHCTF1;NUP107;NUP98
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.41163366729302026,0.9925318453287215,0.4993849938499385,0.9406840488556418,1.0,6/26,17.07%,PRKCA;SMOC2;MEIS2;CUL3;USP22;TTL
prerank,regulation of neuroblast proliferation (GO:1902692),-0.3481551301955026,-0.9921738275943571,0.44357976653696496,0.8036463508179886,1.0,5/15,16.61%,PTN;CX3CL1;SMARCD3;CTNNB1;DISC1
prerank,pre-miRNA processing (GO:0031054),0.4579865505098335,0.9918184056189253,0.4810810810810811,0.942071502493487,1.0,4/14,19.45%,TARBP2;AGO2;AGO4;AGO3
prerank,sodium-independent organic anion transport (GO:0043252),0.48121379006265647,0.9915876227386827,0.47875354107648727,0.9420774354820463,1.0,1/10,0.43%,SLCO2A1
prerank,nuclear membrane reassembly (GO:0031468),0.36948607062466327,0.9915435007312295,0.5016111707841031,0.9416194888845879,1.0,24/54,32.29%,LMNA;REEP3;NUP93;CHMP7;AHCTF1;NUP107;NUP98;SIRT2;NUP37;PPP2R2A;CC2D1B;ANKLE2;IST1;EMD;NUP133;NUP85;NUP188;KPNB1;SUMO1;CHMP4C;SEC13;CHMP4A;CHMP4B;NUP160
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3791322549857958,0.9912405746910112,0.5005500550055005,0.9418629201568635,1.0,17/49,24.14%,EIF2AK3;S100A8;S100A9;SRC;NOC2L;SIAH1;HERPUD1;URI1;BMF;BBC3;NUPR1;BCAP31;PLAUR;MCL1;PYCARD;CYLD;FIS1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.3601706892508578,-0.990855830770154,0.46887966804979253,0.8053331583367477,1.0,6/14,12.56%,VEGFC;FOXC1;KDR;NRP1;PIK3CD;FLT4
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3580612159617373,0.9906710000563032,0.5082474226804123,0.9428160727422796,1.0,22/101,14.00%,FGF18;EGFR;FGFR1;VEGFA;FGF2;MST1R;PKD1;PSRC1;ATP2B4;MAPRE3;ETAA1;SRC;PKD2;SYAP1;AKT1;IRAK1;EGF;CALM2;FLT3;CCND1;RHOA;SLC8A2
prerank,calcium ion import (GO:0070509),-0.3075374856747247,-0.9899074667987017,0.461038961038961,0.806008336962301,1.0,6/28,12.49%,CACNA1E;CACNB2;CACNA1D;MICU2;TRPC4;TRPV4
prerank,embryonic organ development (GO:0048568),0.36910957705618924,0.989805727824373,0.5021505376344086,0.9445939780564768,1.0,14/61,13.07%,PCSK5;TGFB2;PBX1;TGFBR2;COBL;GLI2;FLT3LG;NDRG4;COL2A1;GLI3;ERCC3;TBC1D23;ALDH1A3;GDNF
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.43317084388741095,0.9897575412875921,0.5160891089108911,0.9441362086442537,1.0,3/20,12.28%,SEMA3C;SEMA3A;SEMA3D
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3362208536817217,0.9897267979551072,0.574,0.9436169885953377,1.0,302/1667,16.94%,LMX1A;EBF2;DCN;PRRX1;LIF;AR;LRP6;LHX8;ESR1;HOXA3;PAX9;EBF1;LOXL2;TRPS1;SP9;FOXP2;NFIX;IRF4;WNT2;EGFR;CREB5;TGFB3;WT1;ZFHX4;MEOX2;TRIAP1;TLE6;TBX15;SCRT2;ZNF367;HSF2;TADA1;CCNL2;SIX4;HOXA2;ELF4;HIVEP2;NEUROD2;MAPK7;SKIL;GTF2H3;ZMIZ1;DGKQ;VEGFA;KLF3;TSHZ2;FGF2;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;RUNX1;TEF;CRTC2;SMAD4;NFE2L2;HDAC9;ZNF25;PIK3R2;ATF5;WWTR1;DPF2;LMX1B;AKNA;MEF2D;SMURF2;SKI;MAPK14;PKD1;PAX1;COPS5;SOX10;ACVR1;CDK4;IRX5;HOPX;DACT1;RFX1;FOXK2;KLF2;TCF25;JUND;ZBTB12;NFATC4;MED13L;MAFF;TCF7L2;MRGBP;NR1D2;ATP2B4;NFATC1;CBX4;RBAK;HOXA5;CAMK2D;CREB3L1;SMARCD2;MEIS2;FOXO1;IL33;AKIRIN1;NR1D1;PIAS3;NFIB;RTRAF;EBF3;ZBTB7C;CXCL10;NCOA3;CREBZF;MUC1;SSBP3;NFIA;RNF111;ZFHX3;DPF1;C1QBP;ARF4;MDM4;MLXIPL;SMAD5;ACTR3;MYT1;MTF1;HOXA4;SIN3B;PID1;SMARCD1;ADCYAP1;GLI2;ZFPM2;TBX6;NOC2L;BRD9;RNF2;MAMSTR;FLCN;FOXL1;PRKD2;PKD2;ETV3;CD81;STAT5A;SOX8;CHUK;ZBTB1;WDR77;VDR;NR6A1;MYBL2;ZNF260;KDM3B;PSEN1;FOXC2;AGO2;JAG1;CDK9;SIRT2;TLR4;ATXN7L3;SOX5;BEX1;RCOR3;ELP4;ONECUT1;KAT2B;MED24;ATAD2B;RHOQ;SMAD6;RNF10;SATB2;BRD7;HELZ2;ZMYM5;MYPOP;OTUD7B;SQSTM1;ZNF3;CHD2;HDAC3;NPM1;URI1;MZF1;TAF3;TCERG1;MITF;PRDM15;ATF7;SMARCC2;IRF2BPL;CSRNP3;BCL6;ZHX2;TOX2;SLC30A9;CEBPB;GLI3;DCAF6;ZNF462;TNIP1;SLC9A1;AKIRIN2;UBA52;KANSL3;JUP;ZFP36;BACH2;LIN9;CCNC;KDM5B;ZNF691;DR1;ZNF112;NCOR2;GDNF;ATF1;DDX17;PEG3;CDKN1A;PIN1;MED13;NCOR1;IKZF5;PROX2;CCND1;CRYM;TWIST1;BRIP1;RAI1;SIX1;DNAJA3;NACC2;HDAC4;RFX5;PLAGL1;EZH1;NME2;ZC3H12A;CCNH;EHMT2;ZNF569;PLAGL2;DMAP1;EAF2;KLF4;HOXA7;BCL9;CTDP1;PTOV1;HOXC4;INO80;BCAS3;HOXA9;HSBP1;PPP3CA;POU3F2;IL4;ZNF692;SMARCA4;GTF2F1;CHD8;CCNQ;MLXIP;DDX20;NFE2L3;NR2C2;YEATS2;NOP53;SRCAP;E2F3;PPIL4;HMGB3;RNF14;AHI1;ZFP28;ZBTB25;MED15;ZBTB5;PSIP1;UBP1;PER1;HIVEP3;IL6;HGF;BAZ2B;NCK1;OGT;STAT5B;ANXA4;CHD1;DDX5;SNAI2;CHD3;E4F1;BCLAF3;TFAP4;ZEB1;SAP18;AGO4
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.4163903299275044,0.9894767703285527,0.49759615384615385,0.943737473488531,1.0,7/26,14.60%,TMEM106A;KLF2;PKD2;TLR4;AKT1;KLF4;HSP90AA1
prerank,negative regulation of autophagy (GO:0010507),0.3752973611505968,0.9894534909701734,0.4978540772532189,0.9432155361604927,1.0,26/54,30.72%,USP36;FOXK2;MTOR;IL10RA;PIK3CA;SIRT2;NRBP2;AKT1;BMF;SMCR8;NUPR1;HGF;DAP;MCL1;QSOX1;TAB2;KLHL22;EIF4G3;LEPR;EIF4G1;CTSA;TSC1;ZKSCAN3;LZTS1;TLK2;RUBCN
prerank,cellular response to arsenic-containing substance (GO:0071243),0.45168537324216834,0.989027402416265,0.4896373056994819,0.9438271427563197,1.0,3/15,17.77%,HNRNPA1;ZC3H12A;GSTO2
prerank,cholesterol transport (GO:0030301),0.38507748107526374,0.9890031199519358,0.5126791620727673,0.943312403244957,1.0,7/45,10.41%,CEL;ABCG4;OSBPL2;ABCA1;LCAT;TSKU;STX12
prerank,DNA metabolic process (GO:0006259),0.34220672109147193,0.9889325755854897,0.5410821643286573,0.942931559091703,1.0,59/270,19.01%,MPG;PARP3;INTS3;UBE2B;GTF2H3;XRCC3;CTC1;NUDT1;RAD51B;TCF7L2;KPNA2;IGHMBP2;UBE2N;ACD;INIP;ZBTB1;FANCL;DNASE2;SAMHD1;POLB;POLE3;PARG;MCM3;SMC1A;NPM1;DDX21;POLI;ERCC3;UBE2A;UBA52;CDC34;RAD1;ERCC4;FAN1;XRCC5;DDB1;TERF1;DNA2;ORC6;DBF4;FANCG;NBN;INO80;USP7;UHRF2;GMNN;DNASE1L2;NOP53;RFC4;HMGB3;RECQL;RAD50;ERCC5;BLM;POLD1;SUPV3L1;TINF2;TOP2B;NOC3L
prerank,cellular response to organic cyclic compound (GO:0071407),0.3477936774070816,0.9887143148444928,0.5313131313131313,0.9429723097598569,1.0,32/141,19.26%,IGFBP5;AR;ESR1;EGFR;WT1;ATP1A3;ATP1A1;P2RX3;ZFP36L1;RAP1B;NCOA3;PKD2;INPP5K;HCN4;URI1;SSH1;SLC26A6;JUP;LARP1;ADCY8;EPG5;GNB1;ZC3H12A;RAPGEF1;DIAPH1;SPIDR;AKAP9;IL18;BLM;NRIP1;HCN1;GABRG2
prerank,histone modification (GO:0016570),0.3522205310866376,0.9884963435225644,0.5164609053497943,0.9429734416934048,1.0,33/109,22.80%,UBE2B;HDAC9;USP36;MRGBP;PRMT2;NTMT1;HDAC6;SIN3B;EYA2;UBE2N;MSL3;SIRT2;ATXN7L3;RCOR3;PHC1;UBE2A;HDAC4;EHMT2;USP22;UFL1;PADI2;MORF4L1;NAA50;SUDS3;TAF6L;MIER1;TRRAP;NSD1;SGF29;CARM1;EZH2;KAT6B;BAZ2A
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.34482043333191276,-0.9884179121711932,0.4419642857142857,0.8082868114492239,1.0,7/17,23.61%,APOE;ABCG1;FGF1;SOD1;MBTPS2;ABCA2;ERLIN2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3908417028848138,0.9883354894950355,0.5046511627906977,0.9428391642500532,1.0,5/36,5.24%,DCN;ANGPT4;FGF2;SLIT2;ATP2B4
prerank,regulation of interferon-alpha production (GO:0032647),0.4181177269662507,0.9882146855069326,0.5066991473812423,0.9425679318464022,1.0,4/23,11.81%,PTPRS;CHUK;TLR4;SETD2
prerank,response to ATP (GO:0033198),0.4391334034882348,0.9881656585245008,0.5143603133159269,0.9421115266461965,1.0,3/18,10.99%,DGKQ;P2RX3;SSH1
prerank,fluid transport (GO:0042044),-0.37047872034955787,-0.9881056387860289,0.4844290657439446,0.8071782739049357,1.0,2/12,8.86%,PDPN;AQP11
prerank,protein localization to condensed chromosome (GO:1903083),0.47340190741413235,0.9880548062485521,0.5041322314049587,0.9418518420488614,1.0,2/12,4.97%,CHAMP1;ZW10
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.3358765638815957,-0.9880278305776963,0.46017699115044247,0.8054939456404492,1.0,7/17,17.55%,ATP5F1C;ATP5F1D;ATP5F1E;ATP5PD;ATP5MG;ATP5MC2;STOML2
prerank,positive regulation of potassium ion transport (GO:0043268),0.39130990668184096,0.9878482789915326,0.5074455899198167,0.9418518678424243,1.0,4/38,5.51%,KCNMA1;FHL1;ANK2;KCNJ2
prerank,defense response to tumor cell (GO:0002357),0.48370537446128015,0.9878386379928313,0.48554913294797686,0.941295802022644,1.0,3/10,14.32%,RBMS3;DLEC1;KLF4
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4860710579679819,0.9877918617542142,0.5184094256259205,0.9408323490590099,1.0,3/10,11.89%,INPP5F;PARP14;PIBF1
prerank,negative regulation of receptor binding (GO:1900121),0.48350274449686775,0.987540848872703,0.5113960113960114,0.9409195045914971,1.0,3/10,13.33%,PTPRF;ADAM15;ATP2A2
prerank,DNA replication (GO:0006260),0.3585042335817237,0.9873914350033741,0.5301327885597549,0.9407388572521393,1.0,34/105,25.21%,REV3L;TIPIN;IGHMBP2;NT5M;RHNO1;POLG2;POLB;POLE3;ING4;MCM3;RMI1;RAD1;PCLAF;DNA2;BRIP1;ORC6;DBF4;NBN;FAM111A;RFC4;GRWD1;RAD50;SET;BLM;TBRG1;POLD1;DONSON;KIN;CLSPN;REV1;ORC2;BAZ1A;KAT5;KAT7
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.46594081244804986,0.9872443860898727,0.4993234100135318,0.9405769028190963,1.0,3/12,9.97%,ITGB3;ABCA1;ITGAV
prerank,regulation of response to external stimulus (GO:0032101),0.34723077566297555,0.987201500418249,0.5386199794026777,0.940100737838978,1.0,21/121,17.00%,EPHB2;CD55;MGLL;ANXA1;FOXP1;F2R;AKNA;SPATA2;NR1D2;TIRAP;CNGB1;SAMHD1;BCL6;SAG;LRRC19;PDGFRA;STK24;DAGLB;TRAF3;UFL1;CXCR4
prerank,melanosome organization (GO:0032438),0.406179750558092,0.9868793049289737,0.4902200488997555,0.9404339075258514,1.0,7/26,16.18%,RAB32;AP1M1;DTNBP1;AP3D1;HPS4;BLOC1S2;SNAPIN
prerank,regulation of establishment of protein localization (GO:0070201),0.4531335849525504,0.986689391616425,0.49733333333333335,0.9403473754650101,1.0,8/14,30.56%,CORO2B;SCFD1;SPIDR;CTSD;GAPVD1;DNAJA1;CENPJ;CEP295
prerank,response to cadmium ion (GO:0046686),0.4216616804475285,0.9863439891290071,0.4927536231884058,0.9406996001939355,1.0,8/26,29.97%,EGFR;CHUK;AKT1;MAPK1;JUN;SUMO1;FOS;HSF1
prerank,central nervous system neuron development (GO:0021954),0.44880241716639635,0.98621830421528,0.4899057873485868,0.940444311512254,1.0,4/15,14.60%,LHX8;MAPT;GBA2;HSP90AA1
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.35216891233692166,-0.9861825806790613,0.45525291828793774,0.8086032027868854,1.0,6/15,21.15%,OSBPL8;PPARA;PNPLA2;LPL;ABHD5;FITM2
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.35144419149103606,0.9861560492029335,0.5292307692307693,0.9400320180006608,1.0,32/102,20.69%,IRS1;HDAC9;PIK3R2;ZFP36L1;SLC39A14;FOXO1;SRC;MYO5A;CRHR1;INSIG2;SYAP1;KAT2B;INPP5K;RHOQ;AKT1;TSHR;IRS2;ADCY8;PDE3B;LHCGR;FER;PKM;SELENOS;CPEB1;EPRS1;VAMP2;CAPN10;PRKAR2A;GPLD1;LPIN3;GOT1;RAB10
prerank,protein catabolic process (GO:0030163),0.3735856063374558,0.9857889012983654,0.5209903121636168,0.9404704092418626,1.0,22/59,24.38%,MTOR;NR1D1;OGA;TPP1;FBXO2;CLPX;SIAH1;FBXO17;UBE2G2;DDB1;HSP90AA1;NGLY1;SOCS6;HTRA2;IDE;CTSD;UBE2G1;LRSAM1;RNF41;USE1;TRIM24;RAB12
prerank,axonogenesis (GO:0007409),0.3426418971083331,0.9857417499773903,0.5395395395395396,0.9400254000347724,1.0,55/237,18.12%,SEMA3C;EPHB2;PRKCA;MAP1B;EFNA5;NPTN;GRB10;EPHA3;FYN;MAPK7;SLIT3;SLIT2;NTN4;LLGL1;SLIT1;SPTAN1;DOK1;UNC5A;SPTA1;DOCK7;PDLIM7;RET;SRC;GLI2;S100A6;SEMA3A;PIK3CA;SIAH1;DOK4;USP33;EPHB3;DSCAM;UNC5D;L1CAM;EPHA10;IRS2;ULK2;SEMA3D;LGI1;TAOK2;IGSF9;GDNF;PALLD;ULK1;ARTN;DCC;HSP90AA1;SLC9A6;SPTBN1;SOS1;NRXN3;CXCR4;SHTN1;CNTN4;EPHB1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.36002215753717515,-0.9856133518247783,0.46586345381526106,0.808300074358931,1.0,6/14,21.07%,DMD;WNK4;ATP1B1;GLRX;ACTN4;ANK3
prerank,maintenance of protein localization in organelle (GO:0072595),0.42879772326877746,0.9856102854995709,0.4884910485933504,0.9398256627280938,1.0,6/19,16.87%,TAF8;TAF3;AKT1;BCL3;BBS4;PML
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.4770819865363309,0.9852836457586897,0.5021156558533145,0.940132500725267,1.0,6/11,27.89%,MPHOSPH8;TPR;SETDB1;SETDB2;TASOR;ATF7IP
prerank,activation of protein kinase activity (GO:0032147),0.35007340726805314,0.9851663719203831,0.5269709543568465,0.9398796762781094,1.0,20/106,14.82%,GHR;ANG;ITGB3;VEGFA;TGFB2;TGFBR2;TAOK3;AXIN1;MTOR;GAS6;STRADA;TIRAP;CALCA;AKT1;IRAK1;PIBF1;ADCY8;TAOK2;STK3;IL4
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.307759106376061,-0.9851243036522482,0.46153846153846156,0.8077628159915422,1.0,8/21,23.14%,HK2;DERA;PGLS;TALDO1;RBKS;RPE;GPI;RPIA
prerank,positive regulation of peptidase activity (GO:0010952),0.42715343681509044,0.9850032502729508,0.49874371859296485,0.9397555109446776,1.0,2/20,6.12%,MAPK12;RCN3
prerank,serine family amino acid catabolic process (GO:0009071),-0.40481777285087817,-0.9849178274601028,0.44485294117647056,0.8064940274940738,1.0,8/10,37.12%,DLD;CBS;GCSH;THNSL2;SHMT2;SHMT1;AMT;DAO
prerank,methylguanosine-cap decapping (GO:0110156),0.4832788673815674,0.9845240922189237,0.5071225071225072,0.9404620175374497,1.0,7/10,29.68%,EDC4;PNRC2;EDC3;DCP1A;DCP1B;LSM1;PATL1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.47044881339059863,0.9841933833502826,0.5156462585034014,0.9408315223615433,1.0,4/13,6.28%,TGFB3;SMAD4;NUP93;SH2B1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.3264022230893474,-0.9840608606722542,0.4523809523809524,0.807064521248817,1.0,4/20,4.65%,NEDD4L;ACTN2;OSR1;PRKCE
prerank,mitotic metaphase plate congression (GO:0007080),0.37720657531263696,0.9840255477186984,0.5252747252747253,0.9407323915379564,1.0,13/51,22.87%,CHAMP1;ZW10;CHMP7;PSRC1;VPS4B;CUL3;CDC23;PIBF1;CENPC;CENPE;PDCD6IP;DCTN2;RMDN1
prerank,motor neuron axon guidance (GO:0008045),0.4477493665234398,0.9837865974021809,0.49267643142476697,0.9407974122036975,1.0,4/15,8.24%,SLIT2;SLIT1;NTN1;SEMA3A
prerank,negative regulation of TOR signaling (GO:0032007),-0.2761019346964524,-0.9837257116856614,0.5112781954887218,0.8060791315272048,1.0,9/36,16.50%,RNF152;UBR1;EPM2A;PRKAA2;SIRT1;ATM;SPAAR;SESN1;TNFAIP8L1
prerank,regulation of glycolytic process (GO:0006110),-0.24599244871015113,-0.9836644694447146,0.4788732394366197,0.8043955224123623,1.0,11/68,7.78%,PRKAG2;INSR;IGF1;APP;PRKAA2;CBFA2T3;PPARA;NUP35;NDC1;RAE1;PGAM1
prerank,positive regulation of filopodium assembly (GO:0051491),0.41841461758151344,0.9834461266850099,0.5006031363088058,0.9411507075786265,1.0,11/24,28.16%,TGFB3;FSCN1;PALM;RHOQ;BCAS3;ARAP1;GPM6A;RALA;DOCK11;WASL;NLGN1
prerank,bile acid metabolic process (GO:0008206),0.40603158541543405,0.9834121504966478,0.4993983152827918,0.9406690933791167,1.0,6/27,11.50%,OSBPL3;OSBPL2;SCP2;HSD3B7;OSBPL6;GBA2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3437659199171348,0.9830598409728522,0.5576730190571715,0.9410927133792019,1.0,27/186,11.60%,SFRP4;LRP6;DKK2;LRP1;TLE6;CCDC88C;PSMC4;GRB10;DACT3;IGFBP6;WWTR1;RBMS3;KREMEN1;AXIN1;IGFBP4;DACT1;TCF7L2;NFATC1;PSMC6;PSMD8;CUL3;TLE2;TSKU;ALPK2;ANKRD6;TPBG;GLI3
prerank,V(D)J recombination (GO:0033151),-0.3861569396297556,-0.9830084158084154,0.4831081081081081,0.8043285582644237,1.0,1/11,2.72%,HMGB1
prerank,glycerolipid catabolic process (GO:0046503),0.42581708996149464,0.9826183501336901,0.48567870485678705,0.9417035849252455,1.0,1/19,0.62%,MGLL
prerank,positive regulation of apoptotic process (GO:0043065),0.33886225026676225,0.9825347149767844,0.5365365365365365,0.9413601621616899,1.0,77/293,22.57%,SFRP4;WNT10B;KCNMA1;SCIN;TGFB3;AKAP13;FAP;GADD45G;RPS6KA2;TGFB2;SLIT2;BIN1;TRIO;ADAMTSL4;MTCH1;HOXA5;FOXO1;PRMT2;RASSF2;C1QBP;ARHGEF3;PIP5KL1;AIFM2;FLCN;SIAH1;PSEN1;SIRT2;PDCD2;RYBP;ING4;TIAM2;SQSTM1;CSRNP3;BCL6;BMF;ERCC3;UBA52;BAK1;NGEF;QRICH1;DIABLO;ZC3H12A;STK3;MLLT11;MTCH2;CALHM2;NUPR1;DDX20;HRK;NLRP2B;SOS1;IL6;HTRA2;TFAP4;PTRH2;SAP18;CTSD;EEF1E1;IAPP;TGFBR1;SMPD1;SUDS3;APAF1;CLIP3;GPLD1;TRIM35;BACE1;ATF6;TIAM1;PYCARD;BTG1;JUN;NF1;ATF4;CYP1B1;UBE2Z;RBM5
prerank,regulation of myoblast fusion (GO:1901739),0.4810983591084433,0.9823429800784959,0.5207756232686981,0.9413146298214641,1.0,4/11,22.92%,MAPK14;EHD2;IL4;FLOT1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.4225413428701832,0.9819548006089585,0.4866504854368932,0.9417820728762777,1.0,4/22,14.08%,GADD45G;VEGFA;EMC10;ZC3H12A
prerank,regulation of cell adhesion (GO:0030155),0.3468876333601662,0.9817843160367928,0.537525354969574,0.9416629425350492,1.0,24/129,10.55%,EPHB2;PRKCA;EFNA5;VEGFA;FUT2;DACT2;MIA3;PTPRJ;ZFHX3;MYADM;C1QBP;RET;SRC;TGFBI;ADAM22;ABL2;FLCN;PRKD2;TNFRSF18;STX4;PLXNA3;ITGAV;EPHB3;DSCAM
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.340962559068053,0.9817367440784668,0.5653923541247485,0.9412241358209287,1.0,40/234,17.21%,DDR2;AR;LRP6;ESR1;WNT2;RAB7B;NEUROD2;VEGFA;IRAK3;S100A8;S100A9;CRTC2;MID2;PLPP3;COPS5;CARD16;DHX33;UBE2N;PRKD2;CHUK;TIRAP;TLR4;BEX1;NPM1;AKT1;IRAK1;UBA52;JUP;ADCY8;HDAC4;FER;STK3;SMARCA4;EDA;FZD4;TRIM68;RBCK1;IL6;FLOT2;PPIA
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.47422885607845366,0.9817272441269377,0.5055555555555555,0.9406767759463577,1.0,8/12,31.70%,RFWD3;FBXO31;RPS27L;CCND1;SDE2;PRKDC;TP53;WAC
prerank,myeloid leukocyte differentiation (GO:0002573),0.3665958302630134,0.9816140641669038,0.5267094017094017,0.9404096555670975,1.0,8/65,7.43%,VEGFA;FOXP1;TGFBR2;RUNX1;MAPK14;CDK4;FARP2;OSTM1
prerank,neuron development (GO:0048666),0.3468706653865564,0.9815779359041791,0.5233739837398373,0.9399267110527947,1.0,38/141,18.29%,MYOC;UGDH;TGFB2;PBX1;RUNX1;RASGRF1;UNC5A;TENM3;DOCK7;DTNBP1;LRP12;ADCYAP1;GLI2;TOR1A;PLP1;L1CAM;CAMSAP1;MAPT;GBA2;TBC1D23;UNK;FLRT3;LGI1;GDNF;ULK1;THOC2;ATCAY;BLOC1S2;POU3F2;MANF;MAP4;SNAPIN;IL6;RAB35;PPP1R9B;STX3;CNTN4;GPM6A
prerank,negative regulation of response to wounding (GO:1903035),0.42238892752277,0.9814542050666328,0.4974293059125964,0.9396726593629275,1.0,4/19,13.45%,FGF2;PTPRS;INPP5F;RTN4RL1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.39511370255177747,0.981293758955064,0.4928571428571429,0.9395300749479976,1.0,8/29,19.45%,TARBP2;TRIM71;DGCR8;AGO2;PUM1;AGO4;SNIP1;AGO3
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.4596674490294055,0.9812138694391739,0.49794238683127573,0.939143840737177,1.0,5/13,19.47%,ABT1;KRI1;NOP9;RCL1;TBL3
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.3888544201179511,0.9811812723019047,0.5195402298850574,0.9386610694274817,1.0,9/39,11.30%,MAPK7;VEGFA;AKNA;GTPBP4;MIA3;MYADM;FXYD5;JAG1;AKT1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.3572085976589937,0.9811336519618266,0.5478443743427971,0.9382209274376864,1.0,15/75,12.37%,PRKCA;FGFR1;ANG;ITGB3;VEGFA;FGF2;ECM1;THBS4;PRKD2;STAT5A;AKT3;EMC10;NRAS;AKT1;EGF
prerank,post-translational protein modification (GO:0043687),0.33939024619605007,0.9811069611917519,0.561,0.9377264521080351,1.0,101/332,27.77%,IGFBP5;FSTL1;FBN1;WSB1;RABGGTA;GPC3;PSMC4;PRSS23;SPSB1;SPSB4;COPS5;BMP15;IGFBP4;FBXW8;CALU;VCAN;MIA3;SOCS2;CCDC8;WDTC1;COP1;TULP4;GAN;PSMC6;SPSB2;MELTF;GAS6;FBXO2;PSMD8;FBXO17;CUL3;DTL;SENP8;ASB12;FBXW4;LGALS1;FBXL20;WDR5;RAB2A;RNF7;DCAF6;FBXO31;DDB1;FBXL3;DCAF13;ASB8;CUL9;KLHL41;MXRA8;SOCS6;DCAF10;IL6;SDC2;KEAP1;CHRDL1;RAB1B;FBXL5;FBXO11;COPS4;NEDD8;SKP2;LAMC1;KCTD6;FBXL19;FBXW9;FBXW2;QSOX1;CUL5;PRKCSH;ICMT;CSF1;KLHL9;SUMF2;FBXW11;KLHL22;SPSB3;DCAF5;KLHL11;PSMD3;GPS1;FBXL12;PSMD4;DNAJC3;RABGGTB;SERPINC1;HSP90B1;VHL;FBXO22;RAB1A;FBXW7;FBXO30;PSMB3;UBE2F;MBTPS1;DCUN1D1;CUL7;MEN1;FBXO41;PSMB2;COPS6;CHML
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.3780669527512834,-0.9809344362067226,0.4763636363636364,0.8079292155453515,1.0,3/12,4.18%,APP;DOCK8;CXCL12
prerank,vascular process in circulatory system (GO:0003018),0.45497416931592843,0.9808162428231997,0.511049723756906,0.9373659528284976,1.0,1/13,0.79%,GCLC
prerank,regulation of tube diameter (GO:0035296),0.45497416931592843,0.9808162428231997,0.511049723756906,0.9373659528284976,1.0,1/13,0.79%,GCLC
prerank,lymphocyte chemotaxis (GO:0048247),0.394069897957371,0.9807883454735462,0.5277136258660509,0.9368816209023255,1.0,6/34,12.90%,CCL8;CXCL10;GAS6;CCL25;HSD3B7;CCL13
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4633400076991611,0.9807147344421892,0.5175675675675676,0.9364869542816986,1.0,4/13,17.66%,EDEM1;EDEM2;UBE2G2;BCAP31
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3386467637976613,0.9805486196938453,0.56,0.9363546153869748,1.0,73/336,17.49%,PARP3;MAPK12;INTS3;ZDHHC16;UBE2B;GTF2H3;XRCC3;FOXP1;CDKN2AIP;CRIP1;UBA6;TAOK3;MAPK14;NUDT1;RAD51B;RFWD3;USP10;FOXO1;RBBP6;ETAA1;ALKBH7;IGHMBP2;CGAS;PHF1;HMCES;INIP;ZBTB1;TIGAR;FANCL;PSEN1;SETD7;DTL;SAMHD1;POLB;POLE3;SMC5;DYRK2;SMC1A;NPM1;BCL6;POLI;FBXO31;ERCC3;UBE2A;BAK1;RAD1;ERCC4;FAN1;XRCC5;SFN;PCLAF;TAOK2;CDKN1A;BCL3;DDB1;CCND1;SMC6;TNFRSF1B;DDX11;ZC3H12A;FANCG;NBN;INO80;FAM111A;NOP53;RFC4;RECQL;HTRA2;SPIDR;UFL1;PML;RAD50;NEK4
prerank,vesicle transport along actin filament (GO:0030050),-0.3245911463003184,-0.980524513541412,0.4528301886792453,0.8072216759320149,1.0,5/19,13.52%,MYO1B;FNBP1L;MYO1D;MYO5B;MYO19
prerank,vacuolar acidification (GO:0007035),0.41640980888303314,0.9804927350906297,0.508578431372549,0.9359310789184431,1.0,8/21,27.12%,ATP6V0A2;TMEM9;DMXL2;CCDC115;ATP6V0A1;TMEM199;DMXL1;PPT1
prerank,positive regulation of cell population proliferation (GO:0008284),0.3367884977584085,0.9804292079374017,0.579,0.9355562896633408,1.0,67/423,14.21%,LIF;DDR2;AREG;AR;HAS2;AVPR1A;FGF18;FGF7;DPP4;WNT2;EGFR;TGFB3;IRS1;FGFR1;TMEM119;CTF1;BTC;VEGFA;FGF2;TGFB2;MST1R;FOXP1;F2R;TGFBR2;MIF;TIPIN;WWTR1;CDK4;CLCF1;TCF7L2;MEIS2;GLP2R;MLXIPL;S1PR2;PID1;ESM1;ZFPM2;TBX6;GAS6;FLT3LG;S100A6;DNAJA2;CD81;SOX8;CAPN1;WDR77;CUL3;STX4;ITGAV;CD47;NPM1;KRAS;AKT1;KIF20B;FBXO5;TSHR;UBE2A;IRS2;EGF;GDNF;FLT3;CDKN1A;HDAC4;NME2;CDC123;PDGFRA;FER
prerank,tRNA wobble base modification (GO:0002097),-0.3626843351502509,-0.9803356048619954,0.48872180451127817,0.8058625746127762,1.0,2/14,3.44%,ELP3;TRMT9B
prerank,organophosphate biosynthetic process (GO:0090407),0.38445232912256133,0.9803318242168755,0.504524886877828,0.9352446813753714,1.0,10/37,20.19%,FGF2;GK5;AGPAT3;LPCAT1;AGPAT5;NFS1;FADS1;IPPK;GPAM;IP6K1
prerank,regulation of gene expression (GO:0010468),0.3331347654278725,0.979541328415965,0.598,0.9368218298988874,1.0,156/903,16.98%,CD34;SFRP4;AHNAK2;AR;GSN;EPHB2;AMH;ESR1;AHNAK;FGF18;SEC16B;AFF3;FGF7;C1QTNF1;BNC2;C1D;WT1;HPN;AFF2;MBNL1;TMEM119;PKP3;GLMN;SCRT2;EIF2AK3;PRDM8;ANK2;DGKQ;VEGFA;FGF2;TGFB2;MLF2;FOXP1;CAMK2N1;BHLHE40;RUNX1;MIF;ZPR1;NFE2L2;ATF5;WWTR1;CRIP1;LMX1B;RBMS3;MAPK14;USP36;CXXC1;ZFP36L1;CDK4;ADAM19;FOXK2;NAB1;MTOR;CLK1;COQ7;NR1D2;ATP2B4;TRIM71;SPIN4;RBAK;HOXA5;CREB3L1;DTNBP1;IL33;IGSF1;NFIA;TARDBP;ZFHX3;MYADM;TRIP4;MLXIPL;RC3H1;HDAC6;MYT1;NUP107;STX1B;PID1;GAS6;FLCN;PHF1;MSL3;SPTY2D1;FZD7;LARP4;VDR;MYBL2;PSEN1;AGO2;TLR4;HNRNPD;TDRD7;RYBP;ONECUT1;MAPK11;TSKU;SIRPA;MBNL2;SON;MUSK;CPSF4;HNRNPH1;MZF1;TRIM11;MITF;ALPK2;ACTR5;ATF7;GPX1;PARP14;BCL6;CEBPB;KRAS;AKT1;MAPT;SLC2A10;PUM1;LRRC19;ZNF462;IGF2BP1;NAT8;EGF;NDFIP1;LARP1;SMCR8;NWD1;GDNF;PEG3;PIN1;TWIST1;SIX1;HDAC4;SLC8A2;ZC3H12A;FADS1;KLF4;MOG;IL4;BTN3A3;NR2C2;RPL6;MAP2K2;RNF14;TRIM68;ACTG1;RNF187;TRAF3;PER1;IL6;DIP2A;SNAI2;CHD3;EFEMP1;PML;PTRH2;AGO4;FLOT2
prerank,negative regulation of defense response (GO:0031348),0.35443691377055736,0.9795290692219626,0.5026680896478122,0.9362945987754668,1.0,15/77,15.97%,MAPK7;IRAK3;METRNL;ITCH;MVK;NR1D1;C1QBP;SIRT2;FNDC4;SIRPA;KLF4;IL4;LRFN5;SELENOS;ILRUN
prerank,cell cycle checkpoint signaling (GO:0000075),0.4641462759412331,0.9792089172288128,0.5100671140939598,0.9366029262993474,1.0,3/12,18.48%,ZW10;ZWINT;PRCC
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3510449050375044,0.9790754017801186,0.5286885245901639,0.9363922642744449,1.0,27/100,21.27%,DCN;MYOC;EGFR;FGFR1;FGF2;TGFB2;F2R;SRC;PIK3CA;FBXL2;PIK3IP1;IRS2;EGF;FLT3;TWIST1;CBL;PDGFRA;NOP53;HGF;PPP2R5B;PIP4K2C;IL18;DIPK2A;PIP4K2B;MAPK1;PTEN;PIK3CG
prerank,Golgi to endosome transport (GO:0006895),-0.33575271982069604,-0.9788345769136731,0.4838709677419355,0.8081675595454348,1.0,4/16,13.37%,SORT1;VPS13A;DOP1B;EPS15
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3627151273866988,0.9783004464857766,0.5319829424307037,0.9378896758721817,1.0,17/64,22.29%,MGLL;DAGLA;SCP2;SLC27A3;GPX1;GSTM2;PNPLA8;ELOVL5;ACOT1;FADS1;DAGLB;ACAD9;ACOX1;EPHX1;HSD17B4;CPT2;CYP1B1
prerank,regulation of membrane depolarization (GO:0003254),0.42870512964191904,0.9782874078089613,0.5084306095979247,0.9373624871438133,1.0,3/18,10.04%,FHL1;CAMK2D;HCN4
prerank,regulation of focal adhesion assembly (GO:0051893),0.36794900549905923,0.9782232038712659,0.5292171995589857,0.9369787989565674,1.0,16/54,21.11%,MYOC;EFNA5;EPHA3;VEGFA;S100A10;PTPRJ;SRC;SLK;SLC9A1;RHOA;BCAS3;ACTG1;RCC2;CLASP2;CORO1C;PTEN
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3454211732991045,0.977703324371465,0.5435222672064778,0.937756360112369,1.0,27/138,15.63%,AR;ESR1;POLR2H;GTF2H3;HDAC9;HDAC7;WWTR1;TAF8;NR1D2;NR1D1;VDR;NR6A1;CDK9;KAT2B;HDAC3;TAF3;ERCC3;POLR2D;DR1;POLR2G;NCOR2;NCOR1;GTF2A2;CCNH;GTF2F1;NR2C2;E2F3
prerank,ureteric bud development (GO:0001657),0.4363411378032423,0.977639003530786,0.5195954487989887,0.9373653837690998,1.0,4/17,7.85%,WT1;GPC3;SLIT2;PKD2
prerank,positive regulation of nervous system process (GO:0031646),-0.3329856287766971,-0.9775037167332693,0.4876847290640394,0.8098077131149587,1.0,2/18,0.93%,UNC13B;TENM4
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3603595376323588,0.9773488917880538,0.544689800210305,0.9376296393526183,1.0,24/80,23.56%,TGFB3;SAXO1;PLCE1;CDC42EP2;NDEL1;AKIRIN1;FSCN1;ACTR3;PALM;PIK3CA;RHOQ;AVIL;BBS4;BCAS3;EPS8L2;CCP110;ARAP1;ARPC2;GPM6A;ENTR1;RALA;CROCC;CCDC88A;DOCK11
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.4481422124007036,0.9772562317678121,0.5197368421052632,0.937319990844723,1.0,2/15,9.12%,SMPD3;ORMDL2
prerank,central nervous system development (GO:0007417),0.3397056344741582,0.9771489820608966,0.5845845845845846,0.9370303186311538,1.0,65/250,23.09%,GSN;DCLK1;SCIN;AFF2;VIT;UGP2;PBX1;TGFBR2;GLIS2;ZPR1;PKD1;ACAN;SOX10;VCAN;MARCKS;MEIS2;ALDH3A2;JRKL;NFIB;GRIN2D;ZFHX3;MTF1;ADAM22;TBX6;PKD2;TPP1;SOX8;NDRG4;SH3GL1;EEF1AKMT4-ECE2;GBA2;TBC1D23;HSPG2;KLK6;SLC23A1;ASIC2;MOG;SH3GL3;MDGA1;UFC1;CHD8;ALDH5A1;CDK5RAP2;AHI1;GRIN2A;CXCR4;QARS1;BTD;CNTN4;MBP;UFM1;EML1;NIPBL;SNTG2;COX7B;ITGAM;PITPNM1;PTEN;NF1;DCX;UBE3A;MAP1S;ECRG4;ANKLE2;NPTX1
prerank,chemical synaptic transmission (GO:0007268),0.3353658701236222,0.9770340562969759,0.561,0.9367784544575555,1.0,67/284,23.09%,LRP6;LPAR3;SNCB;MTNR1B;APBA3;PMP22;CEL;RPS6KA2;CAMKK1;STX1A;APBA1;DLG4;SLC1A6;GABRR3;DLG2;GRIN2D;SLC18A3;RIT2;HTR1F;ERC2;SLC12A4;GRIA2;PLP1;CAMKK2;NAPA;FCHSD1;HCRT;SLC12A5;SNAP25;NSG1;ASIC2;DLGAP1;GABRG3;GAD2;CACNB1;GIPC1;GRID1;SNAPIN;GRIN2A;GRM1;CHRNA7;CHRFAM7A;SNPH;SYT1;AKAP9;CHRNA5;SYNJ2BP;HTR2C;VAMP2;MBP;PAFAH1B1;PRKAR2A;GABRG2;GRIA3;NOVA1;EXOC4;SLC12A6;STAC3;MAPK1;PTEN;SHISA6;NAPB;SDCBP;HTR2A;GRIK5;GRIK2;NPTX1
prerank,snRNA processing (GO:0016180),0.4429857448568621,0.9768439325450192,0.5346666666666666,0.9367238896174404,1.0,5/16,18.59%,INTS3;INTS10;INTS6;INTS2;INTS12
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.43452158061490986,0.9768054193920598,0.5062814070351759,0.9362537470346013,1.0,10/18,31.31%,DLG4;STX1B;CHRNA7;RIMS2;PTEN;PRKCZ;NLGN1;NLGN3;NRXN1;NLGN2
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.4503729812529533,0.9764196178066499,0.5124835742444153,0.9366972278376229,1.0,2/14,8.91%,AVPR1A;ECE1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.31684786981979307,-0.9761343823253502,0.48223350253807107,0.8116082092938512,1.0,7/22,18.25%,PPM1E;PPM1D;DUSP10;PPM1F;DUSP7;DUSP6;PPP2CA
prerank,regulation of dephosphorylation (GO:0035303),0.44866647283783223,0.9760663022859866,0.5187667560321716,0.9370717579193938,1.0,5/15,15.53%,SRC;INPP5K;SMG7;SMG6;MTMR1
prerank,mitotic spindle organization (GO:0007052),0.3443475178264171,0.975997827926829,0.5562248995983936,0.9367177512763979,1.0,37/153,20.62%,GPSM2;DYNC1LI2;CLIP1;NDEL1;ZW10;KIFC2;AHCTF1;CENPT;NUP107;TOGARAM1;ZWINT;DYNC1LI1;NUP98;DYNC1I1;KIF2A;ARHGEF10;SMC1A;MAPRE1;PIBF1;SBDS;ABRAXAS1;RHOA;KIF3B;DYNC1H1;NUP37;MAP4;CENPC;PPP1CC;RCC2;CKAP5;CENPE;EML1;PAFAH1B1;WDR62;STAG2;FLNA;CLASP2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.35923378420326607,0.9759527669892224,0.5430672268907563,0.9362774416890126,1.0,19/80,17.66%,SYK;TRIAP1;CD44;VEGFA;F2R;CARD16;SRC;GAS6;DPEP1;YWHAE;GPX1;AKT1;SFN;KLF4;GRAMD4;HGF;HTRA2;CTSD;BCAP31
prerank,protein polyubiquitination (GO:0000209),0.3366720790899295,0.9757471466711751,0.5725725725725725,0.9362474741430715,1.0,103/297,26.47%,WSB1;MIB2;PSMC4;UBE2B;SPSB1;HECTD2;UBE2J2;SMURF2;FBXW8;SYVN1;TRIM71;ITCH;RBBP6;PSMC6;RC3H1;PELI3;LNPEP;STUB1;ANKRD39;UBE2N;UBE2W;FBXO2;PSMD8;MAGEL2;SIAH1;FBXO17;MYLIP;CUL3;DTL;UBE2G2;FBXW4;HECW2;FBXL20;CDC23;ANAPC5;FBXO31;UBE2A;UBA52;CDC34;THOP1;UNKL;NPEPPS;FBXO28;FBXL3;TRAF3IP2;CDC27;AMFR;RNF216;RNF14;TRIM68;RNF187;TRAF3;RBCK1;HACE1;CDC26;UBE2G1;FBXL5;FBXO11;ANAPC4;ARIH2;UBE2R2;SKP2;RNF19A;UBE3C;LRSAM1;UBE2D3;FBXL19;TPP2;FBXW9;FBXW2;ARIH1;RNF41;ANAPC10;RC3H2;UBE2Q2;SMURF1;UBE3A;RNF6;FBXW11;UBR2;RNF114;TRIM36;IFI27;TRAF5;FBXO38;PSMD3;FBXL12;PSMD4;MDM2;RNF166;FBXO22;RNF20;FBXW7;FBXO30;ZNRF2;RNF126;PSMB3;UBE2K;RNF167;ANAPC2;PRPF19;RNF31;MUL1
prerank,isotype switching (GO:0045190),-0.3932047410564365,-0.9754416001237062,0.47766323024054985,0.8115749795055355,1.0,4/10,23.08%,MSH2;BATF;RNF8;LIG4
prerank,replication fork processing (GO:0031297),0.3869931874486431,0.9754320252326965,0.5255391600454029,0.936528454655632,1.0,11/38,19.59%,EME1;RFWD3;ETAA1;CDK9;SAMHD1;DNA2;DDX11;THOC1;FAM111A;BLM;SMARCAL1
prerank,positive regulation of vasculature development (GO:1904018),0.3479170796709457,0.975369897513745,0.5468589083419155,0.9361406346796832,1.0,9/94,3.87%,CD34;FGF18;PRKCA;ANGPT4;VEGFA;FGF2;ECM1;RUNX1;SMOC2
prerank,calcium import into the mitochondrion (GO:0036444),0.48600183376540285,0.9752705734811918,0.5325034578146611,0.9358260390040298,1.0,2/10,11.49%,MCU;MCUB
prerank,defense response to Gram-negative bacterium (GO:0050829),0.3807257882937399,0.974955814320354,0.5375139977603584,0.9361153600477565,1.0,5/42,16.30%,LBP;TLR4;DMBT1;RNASE6;IL6
prerank,lipid transport (GO:0006869),0.3513791689696309,0.9747471809971101,0.5466804979253111,0.936099311383988,1.0,12/97,9.70%,LBP;SLCO2A1;ATP8B1;TRIAP1;SLC51A;ABCG4;OSBPL2;ABCA1;PRELID3A;SCP2;SLC27A3;ABCA13
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.42344915079890383,0.9746871511628555,0.5106649937264742,0.9357103713169567,1.0,5/18,16.91%,SLC25A31;ALKBH7;SLC25A4;BAK1;SPG7
prerank,response to exogenous dsRNA (GO:0043330),0.43103261080339894,0.9744068953248465,0.5062814070351759,0.9358814971193649,1.0,3/18,6.69%,IRAK3;RFTN1;CGAS
prerank,negative regulation of autophagosome assembly (GO:1902902),0.46543425923702414,0.9743759961905648,0.5231607629427792,0.9354120224397043,1.0,9/13,33.91%,SEC22B;SCFD1;SMCR8;NUPR1;MTM1;TMEM39A;CHMP4A;CHMP4B;FEZ1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.3436682512957316,-0.9743185967882025,0.4870689655172414,0.8127468209995501,1.0,4/17,9.13%,RAPGEF2;ADRA1B;ADRA2A;ADCY9
prerank,platelet aggregation (GO:0070527),0.3990892624293649,0.9742479042569978,0.5316901408450704,0.9351903167536746,1.0,10/33,21.27%,GNAS;ITGB3;PDGFRA;ACTG1;PPIA;ILK;FLNA;TYRO3;METAP1;PIK3CG
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.46503112011629216,0.9741997556236347,0.52,0.9347606019503715,1.0,4/12,22.87%,CHAMP1;CENPC;CENPE;RMDN1
prerank,cellular protein metabolic process (GO:0044267),0.3358076251242681,0.9740560760010867,0.579,0.9346056908932465,1.0,85/396,21.35%,PLOD2;IGFBP5;FSTL1;RPSA;FBN1;LOXL2;RABGGTA;PCSK5;GPC3;PRSS23;MRPS11;MMP2;IGFBP6;RRBP1;TMEM208;COPS5;BMP15;IGFBP4;MRPS18B;GGCX;CALU;MSRB1;VCAN;MIA3;PHKA2;SPCS1;IGHMBP2;MELTF;ABL2;GAS6;FBXO2;MRPL13;MRPS17;PSEN1;AGO2;SEC11C;FBXL2;UBE2G2;LGALS1;GSPT2;RPL10A;CSNK1G3;MRPL10;CSF2RA;DMBT1;MRPL55;NAPSA;TNIP1;UBA52;CDC34;RPS5;ZDHHC2;MRPL36;MRPL3;GSPT1;MXRA8;RPL6;MRPL51;HARS1;IL6;HTRA2;SDC2;IDE;SPG7;ABCF1;CHRDL1;UBE2G1;FBXO11;ST3GAL1;ADPRH;FDX1;LOX;STK38;NEDD8;RPL23;RPL17;UBE2D3;LAMC1;FBXW2;QSOX1;D2HGDH;PRKCSH;RPS25;ICMT;YES1
prerank,positive regulation of reproductive process (GO:2000243),0.39051436026490094,0.9737721350291745,0.5174418604651163,0.9347912113265219,1.0,5/31,9.05%,VEGFA;SMURF2;C1QBP;AGO2;SIRT2
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.3072770293072463,-0.9737618639805389,0.46842105263157896,0.8124343433719088,1.0,7/23,12.16%,ENG;SMAD3;LTBP4;ITGA3;TGFBR3;TRIM33;TGFB1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.44453771317568913,0.9736814571575514,0.5294117647058824,0.9344821033209653,1.0,2/15,1.29%,SRMS;EGFR
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.45493967826723375,0.9732551162892649,0.5094086021505376,0.9350221294795876,1.0,1/13,0.51%,TNMD
prerank,cellular response to leucine starvation (GO:1990253),0.477951105718289,0.9720667104866226,0.5392156862745098,0.9375106738707872,1.0,5/10,27.95%,MTOR;SESN3;RRAGD;SESN2;IMPACT
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.4021015109194573,0.9714402541592475,0.5055624227441285,0.9385594593051421,1.0,12/25,31.93%,PRPF4;PRPF3;MPHOSPH10;SF3B4;BCAS2;SRRM1;SF3B1;PRPF6;WDR83;LSM1;PRPF8;GEMIN2
prerank,regulation of vasoconstriction (GO:0019229),0.4023852185333645,0.9713625835671166,0.5023809523809524,0.9382085214523225,1.0,3/27,8.91%,AVPR1A;F2R;ECE1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.409631407689,0.9711024508828159,0.5199501246882793,0.9383418708802773,1.0,4/22,12.04%,PRKCA;SMAD4;CAMK2D;SLC9A1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.4866676926518758,0.9704062013652345,0.5354223433242506,0.9395784741174614,1.0,5/10,22.29%,JAM3;MUC1;PDE3B;SNAI2;CYP1B1
prerank,cellular iron ion homeostasis (GO:0006879),0.36312744775283656,0.9702095758739862,0.5461454940282302,0.9395446575778585,1.0,5/55,7.16%,SCARA5;SMAD4;ATP6V0A2;SLC39A14;SLC11A2
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.3779985246575127,-0.9700520154024214,0.4717741935483871,0.8203741941606493,1.0,4/12,10.53%,SORBS1;IGF2;SORL1;SIRT1
prerank,nucleotide-excision repair (GO:0006289),0.3453871097455104,0.9697974666462034,0.5369609856262834,0.9400744131595763,1.0,23/101,18.45%,POLR2H;GTF2H3;COPS5;RAD23B;RNF111;POLB;SLC30A9;ERCC3;UBA52;ERCC4;FAN1;POLR2D;POLR2G;DDB1;BRIP1;AQR;CCNH;USP7;UVSSA;RFC4;ERCC5;POLD1;COPS4
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.37386765406140904,-0.9694063000036424,0.5112540192926045,0.820247688284388,1.0,4/11,10.97%,WTIP;PUM2;XPO5;AJUBA
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3502347518059094,0.9694053588602558,0.5633367662203913,0.9405338576934201,1.0,32/100,25.85%,GLMN;DESI1;RAD23B;COP1;UCHL5;STUB1;SIRT2;RYBP;HERPUD1;DNAJB2;USP5;FHIT;USP7;GIPC1;NOP53;RNF14;ZER1;OGT;KEAP1;UFL1;ARIH2;RNF19A;ARIH1;MAP1A;SDCBP;ZYG11B;BAG5;UBQLN4;DVL1;MDM2;FBXO22;CSNK1E
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.38531174821791747,0.9692255560908759,0.5365005793742758,0.9404559396863589,1.0,14/37,23.83%,UCHL5;RYBP;FHIT;SGTA;USP7;GIPC1;NOP53;OGT;PML;RPL23;MAP1A;SDCBP;CSNK2A2;BAG5
prerank,cellular response to light stimulus (GO:0071482),0.35684849131487506,0.9690599605842427,0.5543595263724435,0.940324348118493,1.0,19/66,22.61%,TRIAP1;NOC2L;ZBTB1;RHNO1;CNGB1;NPM1;BMF;SAG;BAK1;ERCC4;EIF2S1;GNB1;INO80;POLD1;SMPD1;OPN3;NSMCE3;ATF4;SDE2
prerank,protein complex oligomerization (GO:0051259),0.3519754602037272,0.9690294306231549,0.5501551189245087,0.9398484523614917,1.0,27/85,26.22%,UGDH;LRRC8D;ZNHIT6;MPP2;PKD2;ZBTB1;MCU;CPSF6;VSTM5;MAT2A;SLC9A1;ADCY8;TMEM120A;NACC2;ZC3H12A;KCNC2;BLM;CARD11;PYCARD;PDCD6IP;KCNC1;CPSF7;ALS2;ATL1;GLRA3;RBMX;HGSNAT
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.3782965235510698,0.9686627436062722,0.5297482837528604,0.9402639961536551,1.0,11/39,22.85%,GTF2H3;ERCC3;UBA52;ERCC4;FAN1;DDB1;RFC4;ERCC5;POLD1;OGG1;ERCC1
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.31574155708770524,-0.9685659418390388,0.4830917874396135,0.8207022891653065,1.0,6/18,14.55%,DAB2IP;FTH1;SFRP1;PARP10;CD300A;TRIM32
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3825638325579278,0.9684229640692331,0.5448354143019296,0.9403338695882683,1.0,12/40,20.60%,EME1;TIPIN;RFWD3;ETAA1;CDK9;DDX11;THOC1;FAM111A;BLM;POLD1;SMARCAL1;DONSON
prerank,regulation of response to biotic stimulus (GO:0002831),0.40271845899176656,0.968239973830549,0.514792899408284,0.9402416145284732,1.0,4/28,9.65%,CD55;FOXP1;TIRAP;SAMHD1
prerank,microvillus organization (GO:0032528),-0.3716821580396855,-0.9678824310653317,0.5055762081784386,0.8206492933744539,1.0,3/13,5.72%,RAPGEF2;TNIK;MAP4K4
prerank,regulation of cell size (GO:0008361),0.41498114525586577,0.9672705583729232,0.5431789737171464,0.9420804868981888,1.0,8/23,25.84%,RAP1GAP2;MTOR;DEPTOR;RHOA;PTEN;VAV2;RAC1;RARG
prerank,apoptotic DNA fragmentation (GO:0006309),-0.32846474888600186,-0.9669780241750537,0.4975369458128079,0.8211618266295417,1.0,3/16,7.77%,CECR2;HMGB1;CASP3
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.4606158978662663,0.9669695432993314,0.5140939597315436,0.9423268321810808,1.0,4/11,14.37%,STK25;GSKIP;DIABLO;STK24
prerank,positive regulation of leukocyte migration (GO:0002687),0.3902910492130119,0.9668345277280518,0.539906103286385,0.942111270035272,1.0,7/27,16.30%,VEGFA;MIA3;JAM3;TNFRSF18;PLVAP;IL4;IL6
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4208839904589217,0.9665666432278289,0.519280205655527,0.9422564783590317,1.0,2/20,2.91%,HAS2;TGFB2
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.327576949930729,0.9660458107097882,0.722,0.9430292472189624,1.0,291/1645,16.90%,LMX1A;EBF2;PRRX1;AR;LRP6;CD80;LHX8;ESR1;HOXA3;PAX9;COL1A1;EBF1;GCLC;ATP8B1;LOXL2;TRPS1;SP9;FOXP2;NFIX;FGF7;BNC2;IRF4;EGFR;CREB5;TGFB3;WT1;ZFHX4;ZC3H8;MEOX2;TBX15;SCRT2;ZNF367;HSF2;PRDM8;TADA1;CCNL2;SIX4;HOXA2;ELF4;HIVEP2;NEUROD2;ZMIZ1;DGKQ;VEGFA;KLF3;TSHZ2;FGF2;PBX1;KLF12;MLF2;CDK14;FOXP1;F2R;BHLHE40;TLX3;GLIS2;SFR1;RUNX1;TEF;SMAD4;NFE2L2;HDAC9;ZNF25;ATF5;WWTR1;DPF2;LMX1B;MEF2D;SMURF2;MAPK14;PAX1;CXXC1;AXIN1;SOX10;ACVR1;TSC22D4;IRX5;HOPX;RFX1;FOXK2;KLF2;MAP2K3;JUND;ZBTB12;NAB1;NFATC4;MED13L;MAFF;PSRC1;TCF7L2;MRGBP;NR1D2;ATP2B4;SPIN4;NFATC1;CBX4;RBAK;HOXA5;CAMK2D;CREB3L1;SMARCD2;MEIS2;FOXO1;NR1D1;PIAS3;NFIB;MAPRE3;EBF3;PRMT2;ZBTB7C;IGSF1;CREBZF;NFIA;RNF111;ZFHX3;DPF1;RET;MDM4;TRIP4;MLXIPL;SMAD5;DNAJC2;HDAC6;MYT1;MTF1;HOXA4;NUP107;SMARCD1;GLI2;ZFPM2;TBX6;GAS6;BRD9;MAMSTR;FOXL1;MDFIC;BRF2;PHF1;MSL3;ETV3;STAT5A;SOX8;SPTY2D1;CHUK;FZD7;ZBTB1;WDR77;VDR;NR6A1;MYBL2;ZNF260;MAGEL2;KDM3B;PSEN1;FOXC2;SIRT2;HNRNPD;ATXN7L3;SOX5;RCOR3;RYBP;ELP4;ONECUT1;CIPC;MED24;KDM5C;ING4;INPP5K;SMAD6;TLE2;RNF10;SATB2;BRD7;CALCA;MYPOP;PHC3;ZNF3;PHC1;CHD2;HDAC3;NPM1;URI1;SAMD1;MZF1;MPHOSPH8;MITF;PRDM15;ACTR5;ATF7;CAMKK2;SMARCC2;IRF2BPL;CSRNP3;BCL6;ZHX2;TOX2;CEBPB;AKT1;RBFOX2;GLI3;FBXO5;EGF;XRCC5;BACH2;LIN9;CCNC;KDM5B;QRICH1;ZNF691;ZNF112;NCOR2;ATF1;DDX17;PEG3;CDKN1A;MED13;NCOR1;BCL3;IKZF5;PROX2;CBFA2T2;TWIST1;BRIP1;RAI1;SIX1;NACC2;HDAC4;RFX5;PLAGL1;NME2;CCNH;ZNF569;FADS1;PLAGL2;DMAP1;KLF4;TASP1;HOXA7;MLLT11;HOXC4;HOXA9;SETD5;THOC1;POU3F2;IL4;GMNN;ZNF692;SMARCA4;CHD8;CCNQ;MLXIP;FZD4;NFE2L3;NR2C2;RPL6;YEATS2;SRCAP;MAP2K2;E2F3;HMGB3;RNF14;CDK5RAP2;BAHD1;ZFP28;ZBTB25;RNF187;ZBTB5;PSIP1;UBP1;USP22;PDCD4;PER1;HIVEP3;IL6;BAZ2B;OGT;STAT5B;ANXA4;CHD1;PHF5A;DDX5;SNAI2;CHD3;EFEMP1;E4F1;PITHD1;TFAP4;ZEB1;DKK3;PML;SAP18
prerank,mitochondrial translational termination (GO:0070126),0.34923865523450603,0.9659830896421279,0.5559038662486938,0.9426330391536833,1.0,18/88,15.58%,MRPS11;MRPL38;MRPS18B;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;MRPL30;MRPL10;DAP3;MRPL55;MRPS10;MRPL36;MRPL3;MRPL21;MRPS34;MRPL51
prerank,endodermal cell fate commitment (GO:0001711),-0.38807153114068005,-0.965907185937401,0.46710526315789475,0.8220009065653123,1.0,2/10,8.79%,SOX17;CTR9
prerank,regulation of acrosome reaction (GO:0060046),-0.3857727367334702,-0.9653611152597447,0.47101449275362317,0.8216703053063488,1.0,1/10,4.84%,PLCB1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.36035657112525016,0.9652509236409462,0.5488322717622081,0.943959154084734,1.0,11/65,14.21%,AREG;EGFR;BTC;DOK1;PTPRJ;RHBDF1;MVB12A;AKT1;EGF;CBL;FER
prerank,regulation of angiogenesis (GO:0045765),0.3344143383875827,0.9651281681187549,0.5758793969849246,0.9437387746118807,1.0,32/192,14.32%,CD34;DCN;TNMD;FGF18;PRKCA;ANGPT4;ISM1;SPARC;VEGFA;FGF2;TGFB2;ECM1;RUNX1;SMOC2;CD160;ATP2B4;HOXA5;CXCL10;THBS4;SULF1;PRKD2;SERPINF1;AGO2;RHOJ;EMC10;GPNMB;JUP;HSPG2;TWIST1;PDE3B;ZC3H12A;KLF4
prerank,mitotic spindle assembly (GO:0090307),0.3750638041019755,0.9651019655673968,0.5347533632286996,0.9432484814252482,1.0,12/42,20.62%,KIFC2;TOGARAM1;KIF2A;ARHGEF10;SMC1A;PIBF1;ABRAXAS1;RHOA;KIF3B;STAG2;FLNA;CLASP2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4536185794485297,0.9649477500896465,0.5395284327323162,0.9430893948159406,1.0,2/13,5.94%,NFATC4;NFIB
prerank,positive regulation of phospholipid transport (GO:2001140),0.4748361089181907,0.9649379973213423,0.5314685314685315,0.94256750449236,1.0,4/10,23.76%,TRIAP1;TMEM30A;PRELID1;ABCB4
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4524121418842221,0.9649324806712782,0.5368852459016393,0.9420400497249091,1.0,6/13,24.22%,CPSF6;CPSF4;CPSF2;CSTF2T;CPSF1;CPSF7
prerank,microvillus assembly (GO:0030033),-0.36059708365286924,-0.964791400108886,0.4669260700389105,0.8213965608414086,1.0,3/14,5.72%,RAPGEF2;TNIK;MAP4K4
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.35105672102973234,0.964341510277429,0.5675675675675675,0.9429573135142337,1.0,23/86,21.98%,DCTN1;CDC42EP2;BIN1;CLIP1;PSRC1;PFN2;TOGARAM1;PSEN1;MAPRE1;COLGALT1;GPX1;MAPT;FCHSD1;SLAIN2;FER;ARF6;CDK5RAP2;NCK1;AKAP9;NAV3;NUMA1;PYCARD;CTTN
prerank,regulation of cell division (GO:0051302),0.3548363589668537,0.9642517047896215,0.5435244161358811,0.9426313043961891,1.0,15/72,14.16%,CDK2AP2;TLE6;AHCTF1;NCOA3;FSD1;FLCN;SIRT2;PRDM15;SETD2;PRPF40A;SFN;CALM2;PIN1;BBS4;ORC6
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.40850091903962865,0.9638575152853827,0.5400485436893204,0.943091542418397,1.0,3/23,8.28%,INTS3;ZW10;ZWINT
prerank,protein acylation (GO:0043543),0.3799972892942577,0.9637687714348933,0.5361990950226244,0.9427580001097817,1.0,13/38,23.21%,ZDHHC16;ZDHHC7;FOXO1;KAT2B;ING4;HHAT;SELENOK;ZDHHC2;ZDHHC21;ZDHHC20;ZDHHC18;ZDHHC8;ZDHHC5
prerank,tricarboxylic acid metabolic process (GO:0072350),0.46150291923745995,0.9637558918104218,0.5213793103448275,0.9422498465293251,1.0,6/12,20.84%,ACLY;IDH1;ACO2;GLUD1;IDH3G;IDH3B
prerank,homotypic cell-cell adhesion (GO:0034109),0.3866989562693647,0.9631621960063311,0.5535097813578826,0.9432179894821835,1.0,12/39,21.27%,GNAS;ITGB3;PLPP3;DSC2;PDGFRA;ACTG1;PPIA;ILK;FLNA;TYRO3;METAP1;PIK3CG
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.42648448163292485,0.9623398794394508,0.5229960578186597,0.9446965561980715,1.0,8/16,31.64%,CHMP7;TMEM50A;VPS36;LEPROT;STAM;CHMP4C;CHMP4A;CHMP4B
prerank,regulation of sodium ion transport (GO:0002028),-0.27543635213437784,-0.9621823406118973,0.5,0.8263378006263731,1.0,10/34,12.41%,WNK4;YWHAH;AHCYL1;DLG1;GPD1L;SIK1;NKAIN4;NKAIN3;NOS1;NKAIN1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.3309692881877129,-0.9620436438327795,0.4975845410628019,0.8249318154853394,1.0,7/19,9.45%,MEF2C;RBP4;VGLL4;NOTCH1;TGFBR3;FGFR2;TBX2
prerank,regulation of T cell differentiation (GO:0045580),0.38302282693791384,0.9616000463262737,0.5390898483080513,0.9460143553126182,1.0,4/33,8.30%,ZMIZ1;RUNX1;TNFRSF18;ZBTB1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3426429853935137,0.9614811198013704,0.5772357723577236,0.9457821697413369,1.0,35/125,24.90%,GPSM2;DYNC1LI2;CLIP1;NDEL1;ZW10;AHCTF1;CENPT;NUP107;ZWINT;DYNC1LI1;NUP98;DYNC1I1;KIF2A;MAPRE1;SETD2;SBDS;KIF3B;DYNC1H1;NUP37;MAP4;CENPC;PPP1CC;RCC2;CKAP5;CENPE;EML1;PAFAH1B1;WDR62;CLASP2;DCTN2;RMDN1;TUBG2;DYNLL1;NUP133;NUP85
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.3646419132224086,0.9613066932595735,0.552863436123348,0.9456873924325472,1.0,13/49,20.13%,SCIN;RAB7B;RUNX1;DPY30;KAT2B;WDR5;EIF6;PITHD1;AGO4;THPO;AGO3;KMT2C;KMT2A
prerank,determination of left/right symmetry (GO:0007368),-0.2720092437229234,-0.9611946549783915,0.4782608695652174,0.8251630717596442,1.0,21/37,36.25%,NOTCH1;TBX1;CITED2;BBS7;GALNT11;DNAH11;ENKUR;STIL;ZIC3;CFAP53;DLL1;ODAD2;ODAD3;FOXJ1;MEGF8;ODAD4;SHH;OFD1;CCDC40;LEFTY1;DNAAF4
prerank,positive regulation of ATPase activity (GO:0032781),-0.26479288913636917,-0.9610315742610686,0.5157894736842106,0.8237907532721398,1.0,12/41,18.87%,TPM1;ATP1B3;PLSCR1;SSBP1;MSH3;RYR2;PFN1;MSH2;ATP1B1;SETMAR;DYNLL2;TNNT3
prerank,sterol metabolic process (GO:0016125),-0.23649036531118883,-0.9608530025343419,0.4603174603174603,0.8224443405352001,1.0,6/60,6.07%,PRKAG2;CYP7B1;APOE;CYP26B1;ABCG1;HMGCR
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.4183119129103633,0.9607364358955258,0.529192546583851,0.9465532766071526,1.0,7/20,22.52%,ZFP36L1;HOXA5;MEIS2;ZFP36;HOXA9;PAF1;LDB1
prerank,quinone biosynthetic process (GO:1901663),0.44148965076854874,0.960383159198058,0.5316622691292876,0.9469097669485789,1.0,6/14,25.83%,COQ10B;COQ7;COQ3;COQ5;COQ2;COQ10A
prerank,regulation of JNK cascade (GO:0046328),0.34821651818435073,0.9603640719816804,0.5897435897435898,0.9464121377087141,1.0,19/101,13.20%,SH3RF3;EGFR;GADD45G;TAOK3;COPS5;AXIN1;DACT1;AIDA;ITCH;RASSF2;FZD7;SEMA3A;TIRAP;SIRPA;HDAC3;ANKRD6;CD27;TAOK2;NCOR1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.4213052851882617,0.9601429067032833,0.5293398533007335,0.9464023161777071,1.0,6/19,21.08%,PAPSS2;BPNT2;SULT4A1;SLC26A1;ABHD14B;TPST2
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3565098755352473,0.9601240380921583,0.5711252653927813,0.9459038804255282,1.0,18/75,15.88%,ATP1A3;ATP1A4;ATP1A1;SLC12A8;SLC39A14;TRPV3;ATP2B4;KCNJ2;SLC9A9;SLC12A4;KCNK9;HCN4;SLC9A1;SLC12A5;KCNJ3;SLC8A2;SLC9A7;SLC9A6
prerank,regulation of oxidoreductase activity (GO:0051341),0.4438572542191551,0.9599285956680118,0.5180722891566265,0.945848804540845,1.0,2/13,7.45%,HDAC6;ABL2
prerank,mitochondrial transcription (GO:0006390),-0.39031448628306276,-0.9588743842050116,0.5016077170418006,0.8258035860851446,1.0,6/10,25.87%,TFB1M;MTERF2;TEFM;POLRMT;TWNK;TFB2M
prerank,cell cycle G1/S phase transition (GO:0044843),0.3604997666537156,0.9588743543420849,0.5566343042071198,0.9479270680645356,1.0,14/61,15.63%,ACVR1;CDK4;TRIM71;USP29;BCAT1;CUL3;USP26;CDC34;CDKN1A;CCND1;CCNH;DBF4;GSPT1;E2F3
prerank,regulation of lipid kinase activity (GO:0043550),0.4672794433007681,0.9587549747372166,0.5299727520435967,0.9476794455789674,1.0,2/11,8.16%,PIK3R2;WDR91
prerank,regulation of cell-substrate adhesion (GO:0010810),0.367368025732698,0.9584205634051093,0.5633333333333334,0.9479933782397137,1.0,5/42,8.19%,FBLN2;CORO2B;VIT;MYADM;FZD7
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.30706863172794785,-0.9576484321386921,0.5247524752475248,0.827139488093494,1.0,5/22,14.88%,APOD;ADRA2A;PPP2R5A;CEACAM1;GPER1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3344747059993097,0.9570508512212379,0.6016016016016016,0.9508866627591326,1.0,27/214,13.17%,ACKR3;SYK;EPHB2;CCL8;PRKCA;EGFR;CD44;PDE8A;FGF2;CAMK2N1;F2R;MIF;SMAD4;ADCYAP1;GAS6;FLCN;PRKD2;NDRG4;TIRAP;CCL25;TLR4;SIRPA;GPNMB;TNIP1;ATP6AP1;CCL13;PIN1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.4409731944089751,0.9566230234548045,0.5460526315789473,0.9514083647916762,1.0,4/17,12.73%,TIMM50;BAK1;SFN;BBC3
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3129664946860825,-0.9566114590566311,0.5294117647058824,0.8278484836710566,1.0,6/21,13.50%,ITGA1;MEF2C;PDGFRB;PPP1R15B;BMP2;CD300A
prerank,regulation of centriole replication (GO:0046599),0.43424336227213645,0.9565289847525312,0.546975546975547,0.9510962025858658,1.0,6/18,19.74%,CEP295NL;KAT2B;ALMS1;NPM1;CDK5RAP2;MDM1
prerank,cellular response to calcium ion (GO:0071277),0.3547983700882387,0.9565065273667847,0.5662778366914104,0.9506156244521908,1.0,10/67,9.18%,SYT2;NEUROD2;CPNE8;SYT12;SYT11;SYT13;CAMK2D;PKD2;DPEP1;IQGAP1
prerank,regulation of proteolysis (GO:0030162),0.36521569551630156,0.956067922785303,0.5483870967741935,0.951173642087858,1.0,16/48,23.67%,CAMK2N1;ITCH;HDAC6;STUB1;AURKAIP1;CSTB;AKT1;TBC1D10A;BAK1;TRAF3;OGT;PLAUR;NEDD8;FBXW11;IST1;PARL
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.38740222584769984,0.955842696121196,0.535840188014101,0.9512109138500876,1.0,12/32,26.30%,GPAT4;CHKB;SLC44A1;LCAT;LPCAT1;CEPT1;SLC44A2;LPIN3;PCTP;CSNK2A2;SLC27A1;LPCAT3
prerank,response to nitric oxide (GO:0071731),0.44514214238272143,0.9555161651647617,0.5420560747663551,0.9515077738415741,1.0,4/13,14.62%,FOXO1;DPEP1;MTR;KCNC2
prerank,nuclear body organization (GO:0030575),0.4616483285324303,0.9550313301954902,0.541029207232267,0.9521686761737448,1.0,4/12,16.87%,AFF2;ZPR1;USP50;PML
prerank,proteasomal protein catabolic process (GO:0010498),0.3346469892936349,0.9547653870461569,0.6412825651302605,0.9523029829028253,1.0,63/201,26.34%,UCHL1;PSMC4;UBE2B;SPSB1;SPSB4;NFE2L2;SMURF2;SYVN1;TRIM71;ITCH;RAD23B;RMND5B;NR1D1;RCN3;COP1;PSMC6;SPSB2;STUB1;UBE2W;PSMD8;SIAH1;CUL3;SIRT2;HECW2;UBE2A;CDC34;DDB1;RNF216;RNF187;SOCS6;RBCK1;ZSWIM8;HACE1;PML;KCTD2;UBE2G1;SKP2;PCNP;UBE2D3;FBXL19;RNF41;KCTD10;ARRB1;UBXN11;SMURF1;DERL1;SEL1L;FBXW11;KLHL22;SPSB3;IFI27;UBXN6;PSMD3;PSMD4;MDM2;AGAP3;KAT5;DDIT3;FBXW7;RNF126;PSMB3;UBE2K;PRPF19
prerank,positive regulation of synapse assembly (GO:0051965),0.39023015000145445,0.9547346950930763,0.5203349282296651,0.9518393504180767,1.0,13/27,31.31%,EPHB2;EPHB3;VSTM5;SYNDIG1;EPHB1;CLSTN3;IL1RAPL1;GRID2;NLGN1;NLGN3;LRRC4B;NRXN1;NLGN2
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.41602018777170036,0.9546516236596237,0.5500650195058517,0.9515024581921583,1.0,7/20,12.57%,KCNMA1;ATP1A3;ATP1A4;ATP1A1;KCNJ2;SLC9A1;ATP6AP1
prerank,regulation of cellular component organization (GO:0051128),0.33476440104964234,0.9545113012474759,0.5949494949494949,0.951319081338903,1.0,27/135,15.75%,STON2;PLCE1;CD177;IRAK3;SGK3;SGK2;ATF5;RAP1B;MTOR;ITCH;SOCS2;CAMK2D;EGLN2;RIT2;MELTF;ABL2;ARFGAP1;HJURP;NRG3;URI1;SLC2A10;RUFY1;TAOK2;HSP90AA1;SETD5;RAPGEF1;RAB33B
prerank,cellular transition metal ion homeostasis (GO:0046916),0.34339311884524376,0.9544082562716236,0.5754422476586889,0.9510362676723432,1.0,16/91,17.48%,SCARA5;SLC39A13;SMAD4;ATP6V0A2;SLC39A14;COX19;SLC11A2;ARF1;SLC39A7;SLC30A9;NDFIP1;ATP6AP1;CCDC115;SLC30A5;FLVCR1;FBXL5
prerank,monocyte chemotaxis (GO:0002548),0.38997529594578884,0.9543716235311398,0.529685681024447,0.9505832090025559,1.0,6/32,16.30%,CCL8;ANXA1;CCL25;CALCA;CCL13;IL6
prerank,determination of bilateral symmetry (GO:0009855),-0.2988599740869108,-0.9542496450116629,0.5026455026455027,0.8321718680939716,1.0,13/25,30.03%,NOTCH1;TBX1;CITED2;BBS7;GALNT11;DNAH11;STIL;ZIC3;CFAP53;DLL1;ODAD2;ODAD3;FOXJ1
prerank,sphingolipid metabolic process (GO:0006665),0.3404474094875469,0.9541399376534833,0.5760980592441267,0.9506250245190535,1.0,20/108,13.63%,SMPD3;CERS6;ARSA;B3GALNT1;PLPP3;ALDH3A2;TECR;PLPP1;PRKD2;ORMDL2;AGK;SGMS2;PDXDC1;FA2H;GBA2;ELOVL5;GLA;CERK;PRKD3;GLTP
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3573459715393356,-0.9540532006524866,0.5084033613445378,0.830846540652356,1.0,4/13,15.49%,RNF152;ATM;SPAAR;SESN1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3257217801997137,0.9539360571566015,0.683,0.9505717137723908,1.0,110/497,19.65%,IGFBP5;PAX9;GCLC;ATP8B1;LOXL2;FOXP2;WT1;ZC3H8;EIF2AK3;SIX4;FOXP1;BHLHE40;GLIS2;SMAD4;HDAC9;ATF5;DPF2;SMURF2;TSC22D4;RBM4;PAIP2B;GTPBP4;FOXK2;NAB1;TCF7L2;NR1D2;TRIM71;CBX4;RBAK;SAMD4B;CREB3L1;FOXO1;NR1D1;PRMT2;CREBZF;DPF1;MLXIPL;HDAC6;ZFPM2;GAS6;MDFIC;SOX8;VDR;MAGEL2;MRPL13;SIRT2;RCOR3;CIPC;KDM5C;ING4;INPP5K;TLE2;BRD7;CALCA;PHC3;PHC1;HDAC3;SAMD1;MPHOSPH8;SMARCC2;BCL6;ZHX2;RBFOX2;GLI3;IGF2BP1;PASK;XRCC5;LARP1;NCOR2;CDKN1A;NCOR1;BCL3;CBFA2T2;TERF1;TWIST1;CNOT10;NACC2;HDAC4;DMAP1;KLF4;HOXA7;IL4;GMNN;SMARCA4;CHD8;YEATS2;SELENOS;BAHD1;PDCD4;PER1;FXR2;TFAP4;ZEB1;DKK3;PML;SAP18;SET;EPRS1;QARS1;SNX6;DAP;GCFC2;CTCF;NIPBL;PAIP2;BTAF1;SUDS3;RING1;PCGF6;PCIF1
prerank,positive regulation of histone modification (GO:0031058),0.3784091549093104,0.9538881306965016,0.5251461988304094,0.9501619821749188,1.0,10/33,21.51%,UBE2N;CDK9;BRD7;AKAP8;NIPBL;GLYR1;CTBP1;PAF1;AKAP8L;ARRB1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.35974160824341933,-0.9538174558693353,0.5057915057915058,0.8297186866614729,1.0,2/14,1.20%,ATP1B3;ACTN2
prerank,cholesterol metabolic process (GO:0008203),0.355525423943309,0.953733252650744,0.5726587728740581,0.9500288446594631,1.0,14/68,18.77%,CEL;ACLY;MVK;ABCA1;INSIG2;LCAT;GGPS1;TSKU;GBA2;IL4;PMVK;PIP4P1;FDX1;ANGPTL3
prerank,pulmonary valve morphogenesis (GO:0003184),0.4256525276579345,0.9536934948582477,0.5526315789473685,0.949589707513119,1.0,5/17,10.09%,TGFB2;SLIT2;NFATC1;JAG1;SMAD6
prerank,metal ion homeostasis (GO:0055065),0.36588460163149533,0.9536090922671306,0.5388026607538803,0.9492601877395702,1.0,10/40,20.50%,SCNN1B;SLC12A8;SLC12A4;CYP27B1;COX11;SLC12A5;CNNM4;KCNH2;SELENON;SLC12A6
prerank,cellular response to UV-A (GO:0071492),0.47017392864407376,0.9534583108405097,0.5523809523809524,0.9490713376209761,1.0,1/11,2.85%,MMP2
prerank,regulation of transport (GO:0051049),-0.2712451916980304,-0.9534553103940101,0.5324675324675324,0.8288459153214293,1.0,9/36,11.63%,EPB41;SNCA;ICA1;ACTB;WWC1;NRP1;PINK1;RAB11A;CDK5
prerank,mitotic nuclear division (GO:0140014),0.34647856852899556,0.9530102361229502,0.5653082549634274,0.9496790957444523,1.0,15/71,14.55%,NDEL1;ZW10;CHMP7;KIFC2;TOGARAM1;ZWINT;KIF2A;ARHGEF10;SMC1A;PIBF1;ABRAXAS1;RHOA;KIF3B;CTDP1;INO80
prerank,regulation of gene silencing by RNA (GO:0060966),0.3635228409763215,0.95292376414882,0.5700110253583242,0.9488124465278504,1.0,20/50,27.66%,POLR2H;NUP93;TRIM71;NUP107;NUP98;AGO2;PUM1;POLR2D;POLR2G;NUP37;NUP50;TPR;TNRC6A;POLR2C;NUP133;NUP85;NUP188;EIF4G1;NUP88;AGO1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3635228409763215,0.95292376414882,0.5700110253583242,0.9488124465278504,1.0,20/50,27.66%,POLR2H;NUP93;TRIM71;NUP107;NUP98;AGO2;PUM1;POLR2D;POLR2G;NUP37;NUP50;TPR;TNRC6A;POLR2C;NUP133;NUP85;NUP188;EIF4G1;NUP88;AGO1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.38414248040908605,0.9528637081454746,0.552046783625731,0.9484219583646587,1.0,8/34,10.24%,ANXA1;GAS1;VEGFA;MAPK14;MAP2K3;PRKD2;PIK3CA;ERN1
prerank,T-helper cell differentiation (GO:0042093),0.44162862848137746,0.9528449012337246,0.5465994962216625,0.9479340880078917,1.0,4/14,16.30%,TMEM98;FOXP1;IL4;IL6
prerank,lung epithelium development (GO:0060428),0.4738088968490158,0.9527700801518396,0.5419630156472262,0.9475871365784043,1.0,2/10,6.12%,PKD1;RCN3
prerank,negative regulation of potassium ion transport (GO:0043267),-0.3678299291173312,-0.9527178940799182,0.5245901639344263,0.8288777826521516,1.0,3/13,6.08%,NEDD4L;ACTN2;CAV1
prerank,mesonephric tubule development (GO:0072164),0.4391391356059787,0.9526012978552219,0.517555266579974,0.9474742112331114,1.0,4/15,7.85%,WT1;SLIT2;PKD1;PKD2
prerank,positive regulation of type 2 immune response (GO:0002830),0.43996272453116664,0.9522636794313585,0.5580774365821095,0.9478011427649562,1.0,6/14,24.85%,CD81;IL4;IL6;IL18;PRKCZ;RARA
prerank,negative regulation of protein kinase activity (GO:0006469),0.3443336975313194,0.9519242951876344,0.5833333333333334,0.9480595487685907,1.0,21/88,17.85%,LRP6;TARBP2;ADARB1;CAMK2N1;WWTR1;DTNBP1;RTRAF;YWHAG;SRCIN1;GSKIP;INPP5K;NPM1;AKT1;SFN;DEPTOR;SMCR8;CDKN1A;CHP1;CEP85;PPIA;QARS1
prerank,bile acid biosynthetic process (GO:0006699),0.40123818847758097,0.9517973868451491,0.5526960784313726,0.947837011882195,1.0,5/24,9.72%,OSBPL3;OSBPL2;SCP2;HSD3B7;OSBPL6
prerank,response to amino acid (GO:0043200),0.3826724256522198,0.9517420892283309,0.5331010452961672,0.9474377131426578,1.0,9/31,22.92%,CAPN2;MTOR;MEAK7;NSMF;RRAGD;CPEB1;IPO5;SESN2;SLC38A9
prerank,brain morphogenesis (GO:0048854),0.4558917034017945,0.9516703311811582,0.5447154471544715,0.9470742450340537,1.0,7/12,28.55%,SLC6A4;BBS4;PAFAH1B1;PTEN;FBXW11;PAX2;SPEF2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.46602827992081286,0.9516643189117014,0.5563282336578581,0.9465593972984144,1.0,6/11,27.31%,TOR1A;AUP1;UGGT1;DERL1;UFD1;UGGT2
prerank,intracellular protein transmembrane transport (GO:0065002),0.3655816881069189,0.9512384748562689,0.5457589285714286,0.9470526689196803,1.0,12/42,25.09%,TIMM50;PEX16;GRPEL2;PEX12;PEX1;SEC63;SEC61A1;PEX5;PEX2;TIMM17A;SEC61B;TOMM40
prerank,negative regulation of protein binding (GO:0032091),0.3495798636640176,0.9512300602353609,0.582010582010582,0.9465443878731887,1.0,15/71,15.09%,DACT1;GNL3L;CARD16;PTPRF;TFIP11;USP33;AKT1;SLPI;DNAJB2;ADAM15;CDKN1A;PIN1;ATP2A2;DDX11;GTF2F1
prerank,regulation of endothelial cell migration (GO:0010594),0.34346636325523033,0.95091635067847,0.5662525879917184,0.9467943378559226,1.0,21/85,15.37%,DCN;PRKCA;ANGPT4;SPARC;ITGB3;VEGFA;FGF2;SLIT2;FOXP1;SMOC2;PRCP;PRKD2;FOXC2;RHOJ;EMC10;AKT1;EGF;AAMP;ZC3H12A;BCAS3;STC1
prerank,cation transport (GO:0006812),0.33512901911878795,0.9506024400049393,0.6156941649899397,0.9470347801078304,1.0,24/167,14.00%,KCNK5;SCNN1B;SLC5A9;PIEZO2;KCNMA1;KCNV1;FGF13;SLC7A6;ATP1A4;SLC47A1;KCNJ2;SLC11A2;KCNK9;CNGB1;HCN4;KCNA2;SLC4A4;KCNA6;KCNAB3;NDFIP1;SLC23A1;KCNJ3;CATSPER3;SLC8A2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4225730173211847,0.9504832754708289,0.5477124183006536,0.9468273750302023,1.0,4/17,16.59%,CD44;MIF;TWIST1;SNAI2
prerank,cellular response to glucose starvation (GO:0042149),-0.25839110925881603,-0.9504084895543885,0.5769230769230769,0.8331332347596184,1.0,5/41,4.59%,PRKAG2;SIK2;NUAK1;PRKAA2;NIM1K
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4120762420675501,0.9502205336002489,0.5384615384615384,0.9469509535758677,1.0,6/20,14.69%,LLGL1;FMNL1;RHOQ;FMNL3;FHOD3;ARF6
prerank,negative regulation of cell development (GO:0010721),0.39907555314557297,0.9498597651557049,0.5380952380952381,0.947298204146934,1.0,1/25,0.36%,FBN1
prerank,negative regulation of lyase activity (GO:0051350),0.42649743299477405,0.9494411067300897,0.56282722513089,0.9477685541401206,1.0,3/16,9.25%,GNAI3;PALM;LTB4R2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.28391925754191166,-0.9494313094843105,0.51875,0.8338213061305876,1.0,10/29,14.88%,THBS1;CAV1;TNFSF12;SFRP1;INHBA;WWOX;RIPK1;TNFSF10;DEDD2;GPER1
prerank,protein ubiquitination (GO:0016567),0.32505252206107266,0.9493321430429489,0.687,0.9474984107892629,1.0,168/471,28.25%,WSB1;SH3RF3;TSPAN17;MIB2;PSMC4;UBE2B;NEUROD2;SPSB1;SPSB4;HECTD2;NFE2L2;UBA6;UBE2J2;SMURF2;FBXW8;SYVN1;TRIM71;ITCH;RFWD3;RBBP6;MSL2;GAN;RNF111;PSMC6;SPSB2;RC3H1;PELI3;LNPEP;STUB1;MYCBP2;UBE2N;UBE2W;FBXO2;PSMD8;FANCL;SIAH1;FBXO17;MYLIP;CUL3;DTL;FBXL2;UBE2G2;ASB12;FBXW4;HECW2;FBXL20;RNF10;PHC1;CDC23;TRIM11;RNF7;FBXO31;RNF141;UBE2A;UBA52;CDC34;USP5;THOP1;UNKL;NPEPPS;BSPRY;FBXO28;DDB1;FBXL3;CDC27;PEX12;CUL9;CBL;AMFR;USP7;UHRF2;TRPC4AP;KLHL41;UVSSA;RNF14;TRIM68;SELENOS;RNF187;USP22;RBCK1;ZSWIM8;HACE1;RNF138;KEAP1;UBE2G1;FBXL5;FBXO11;PEX5;VPS11;ARIH2;UBE2R2;NEDD8;SKP2;PCNP;RNF19A;UBE3C;LRSAM1;BRAP;UBE2D3;FBXL19;TRIM35;TPP2;FBXW9;FBXW2;ARIH1;RNF41;CUL5;KCTD10;PEX2;PAF1;ARRB1;RC3H2;ATG3;UBE2Q2;KLHL9;SMURF1;FBXO24;DERL1;UBE3A;RNF6;UBE2Z;FBXW11;SDE2;UBR2;LZTR1;DTX2;KLHL22;RNF114;TRIM36;RNF13;TRIM24;RTF1;PSMD3;RNF157;MKRN2;FBXL12;PSMD4;TRIM44;MDM2;RNF166;VHL;FBXO22;RNF20;FBXW7;FBXO30;ZNRF2;RNF126;PSMB3;UBE2K;RNF167;PRPF19;RNF31;MUL1;KLHL12;OTULIN;CUL7;PRKDC;BCL10;VCPIP1;FBXO41;PSMB2;DTX3;EIPR1;WWP1;UBE3B;TOPORS;CRBN;PSMD5
prerank,DNA repair (GO:0006281),0.32893226403183673,0.9486449051728985,0.656,0.9486584485930075,1.0,50/284,15.70%,MPG;PARP3;FANCD2;INTS3;UBE2B;GTF2H3;XRCC3;EME1;NUDT1;RAD51B;RFWD3;RAD23B;KPNA2;TENT4A;IGHMBP2;UBE2N;INIP;ZBTB1;RHNO1;PPP5C;FANCL;FAAP100;POLB;FANCE;SMC1A;EXO5;NPM1;ACTR5;ASCC3;SLC30A9;POLI;SETD2;ERCC3;UBE2A;UBA52;RAD1;ERCC4;FAN1;XRCC5;DDB1;ABRAXAS1;DNA2;BRIP1;FANCG;NBN;INO80;FAM111A;TNKS1BP1;NOP53;RFC4
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.41589410907406305,0.9485942570720014,0.550185873605948,0.948245364298573,1.0,7/20,13.33%,ANK2;TNNI3;CAMK2D;GSTM2;SLC9A1;CALM2;ATP2A2
prerank,autonomic nervous system development (GO:0048483),0.42526389884283444,0.9479607083421181,0.5503105590062112,0.9492107693755487,1.0,4/17,13.07%,SOX10;SOX8;SEMA3A;GDNF
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.41748726750607335,0.9476306971273796,0.5503978779840849,0.9494605435457744,1.0,5/17,24.49%,ANK2;SCN4B;AKAP9;KCNH2;CACNA2D1
prerank,acidic amino acid transport (GO:0015800),-0.3242891719896669,-0.947512212600501,0.5242718446601942,0.8369364911424105,1.0,4/17,7.61%,SLC6A13;SLC1A3;SLC6A1;GJA1
prerank,negative regulation of cell cycle (GO:0045786),-0.23391030589221967,-0.9474736118157415,0.6140350877192983,0.8352493663718747,1.0,14/73,12.16%,PTPRK;NR2F2;BMP7;SMAD3;PPP1R13B;FOXC1;CDK6;TAF6;BRINP3;INHBA;BMP2;CDKN1C;SCRIB;TGFB1
prerank,apoptotic nuclear changes (GO:0030262),-0.28931880920305386,-0.9474001218905218,0.5384615384615384,0.8336711214484683,1.0,9/24,23.64%,CECR2;HMGB1;CASP3;DEDD2;GPER1;BLCAP;ACIN1;TOP2A;FOXL2
prerank,cardiac muscle cell development (GO:0055013),-0.30726777705874264,-0.9473622561264092,0.5071090047393365,0.8319980339279011,1.0,5/20,8.77%,SORBS2;PDLIM5;CXADR;PDGFRB;MYH11
prerank,cellular protein catabolic process (GO:0044257),0.35470862144149407,0.9473339612858992,0.56957928802589,0.9496425644605951,1.0,21/59,27.80%,FAP;CAPN2;AP2A2;CLTC;CLPX;MYLIP;UBE2G2;RSPRY1;CLPP;HTRA2;IDE;UBE2G1;AFG1L;RNF123;AP2M1;RAB12;CTSK;MDM2;CTSB;CTSL;CASP8
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.45215065131728893,0.9472942050395361,0.5612813370473537,0.949207192733438,1.0,2/12,10.58%,B3GALNT1;B3GNT8
prerank,regulation of protein acetylation (GO:1901983),-0.3550558013505788,-0.947186287485276,0.5259259259259259,0.8307396248695142,1.0,3/12,15.12%,RAPGEF3;SIRT1;TAOK1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3626583777520373,0.9470646127199286,0.5620842572062085,0.9492570476270266,1.0,8/46,13.17%,EPHB2;CAMK2N1;SMAD4;FLCN;TLR4;SIRPA;TNIP1;PIN1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.4175989050580276,0.9467422623846166,0.5551232166018158,0.9494819904230763,1.0,6/18,22.45%,SYVN1;EDEM2;UBA52;AMFR;UGGT1;SEL1L
prerank,positive regulation of MAP kinase activity (GO:0043406),0.35145006809088297,0.9465870197233957,0.5778947368421052,0.9493156574781971,1.0,7/66,4.01%,FGF18;EGFR;FGFR1;VEGFA;FGF2;MST1R;TAOK3
prerank,regulation of developmental growth (GO:0048638),0.3863082085576887,0.946575427219458,0.5766509433962265,0.948816298758765,1.0,7/29,18.94%,GHR;SIX4;STAT5A;MUSK;SIX1;STAT5B;NIPBL
prerank,regulation of endopeptidase activity (GO:0052548),0.3549808954053233,0.946255308547279,0.5661605206073753,0.9490696260331111,1.0,7/59,12.89%,TIMP2;SERPINB8;SERPINE3;SERPINF1;SERPINH1;AKT1;SERPING1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3466824743145119,0.9462406859857199,0.5769633507853403,0.9485720327226093,1.0,20/77,20.35%,AR;TRIAP1;ACVR1;TCF7L2;SRC;PELI3;NOC2L;ITGAV;HERPUD1;URI1;GPX1;AKT1;IL4;GHITM;HGF;PLAUR;QARS1;TGFBR1;MCL1;PRELID1
prerank,macrophage differentiation (GO:0030225),0.4432720467345419,0.9460589152563755,0.5488621151271754,0.9484925580578164,1.0,4/13,27.80%,VEGFA;IL31RA;CSF1;CASP8
prerank,metanephros development (GO:0001656),0.4009368521336565,0.9459777854461189,0.5703794369645043,0.9481596545039892,1.0,6/26,13.71%,WT1;SIX4;PKD1;PKD2;GDNF;SIX1
prerank,stress fiber assembly (GO:0043149),0.43569009921065494,0.9458522311048227,0.5482625482625483,0.9474262778700417,1.0,6/15,13.49%,ITGB5;FHDC1;SRC;CUL3;PDLIM1;RHOA
prerank,contractile actin filament bundle assembly (GO:0030038),0.43569009921065494,0.9458522311048227,0.5482625482625483,0.9474262778700417,1.0,6/15,13.49%,ITGB5;FHDC1;SRC;CUL3;PDLIM1;RHOA
prerank,cellular lipid catabolic process (GO:0044242),0.38985261362041856,0.9457128368723728,0.5405078597339782,0.9472505562371796,1.0,7/27,22.29%,CEL;SIRT2;ACOX1;NUDT19;ANGPTL3;LPIN3;CYP1B1
prerank,cellular macromolecule catabolic process (GO:0044265),0.3638475945759092,0.9451543670125538,0.5622895622895623,0.9480745290647976,1.0,18/49,24.95%,OGA;FBXO2;FBXO17;HNRNPD;UBE2G2;EXOSC7;SIDT2;RNASE6;DNASE1L2;NGLY1;HTRA2;IDE;UBE2G1;SUPV3L1;RAB12;DFFB;RNASEH2C;DNASE1L1
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.43923451586269247,0.9446563493905128,0.5436241610738255,0.9486844115213388,1.0,2/13,3.68%,TGFBR2;SMAD4
prerank,response to sterol (GO:0036314),0.4550324813989223,0.9444633747813362,0.5607734806629834,0.948643725875083,1.0,4/11,22.60%,TGFBR2;PMVK;TGFBR1;RORA
prerank,protein deneddylation (GO:0000338),0.47181550164328556,0.9443600988868528,0.5517751479289941,0.9483537572695581,1.0,7/10,31.27%,COPS5;TOR1A;COPS4;GPS1;COPS6;COPS3;COPS7B
prerank,cranial nerve development (GO:0021545),-0.36410978570075775,-0.9440573762795363,0.5463917525773195,0.8370031665371438,1.0,2/11,6.43%,CHD7;SALL1
prerank,potassium ion transmembrane transport (GO:0071805),0.33277665300834586,0.943785129826108,0.6142131979695431,0.9492346615290933,1.0,26/135,15.88%,KCNK5;KCNT2;HPN;KCNV1;ATP1A3;ATP1A4;ATP1A1;SLC12A8;KCNJ2;SLC9A9;KCND1;ABCB8;SLC12A4;PKD2;KCNK13;KCNK9;HCN4;KCNA2;KCNA6;KCNAB3;SLC9A1;SLC12A5;KCNJ3;KCNC2;SLC9A7;SLC9A6
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.3349737323664235,0.9436003781018382,0.6262626262626263,0.9491397606438404,1.0,30/146,17.82%,DCTN1;FHL1;PSMC4;ODF2;CDK4;RAD51B;VPS4B;PSMC6;YWHAG;SSNA1;YWHAE;PSMD8;DTL;AVEN;ALMS1;MAPRE1;HAUS3;FBXO5;SFI1;CCND1;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;CCP110;RCC2;AKAP9;CEP164;CKAP5
prerank,regulation of neuron projection development (GO:0010975),0.3307934530896228,0.9435451340820783,0.6272727272727273,0.9487447694951938,1.0,34/163,13.45%,DBN1;ARHGAP44;NPTN;EPHA3;PTPRS;S100A9;LPAR1;PPFIA2;NDEL1;TENM3;RET;RIT2;STX1B;ABL2;FRMD7;NDRG4;SEMA3A;RTN4IP1;PSEN1;MYLIP;SRCIN1;TSKU;TWF1;EPHB3;KANK1;FUT9;AVIL;AKT1;MAGI2;TANC2;KIDINS220;P3H1;CBFA2T2;RTN4RL1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.38846402141612896,0.9435187425043962,0.5508982035928144,0.9482818789835512,1.0,12/27,28.72%,CCDC88C;CHUK;MAPK11;UBA52;TAOK2;MAPK1;FBXW11;MAP3K7;TNIP2;KAT7;NFKB1;CUL1
prerank,prostaglandin metabolic process (GO:0006693),0.3909442802925467,0.9433912604857777,0.5618247298919568,0.9480713412243555,1.0,6/26,15.83%,CYP2S1;MIF;PTGR1;PNPLA8;DAGLB;ACOX1
prerank,nitric oxide metabolic process (GO:0046209),-0.3418267358060197,-0.9433468233892647,0.5236220472440944,0.8370196960645564,1.0,4/14,12.21%,NOS3;GCH1;NOS1;SPR
prerank,negative regulation of anoikis (GO:2000811),0.43655301419896325,0.9429135187673657,0.5526315789473685,0.9487137392056051,1.0,6/14,19.35%,ITGA5;SRC;PIK3CA;SNAI2;PTRH2;MCL1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.262078962446098,-0.9428695018706189,0.552,0.8365328330331129,1.0,6/39,4.65%,NEDD4L;DMD;OSR1;WNK4;YWHAH;PRKCE
prerank,translation (GO:0006412),0.32971344783543105,0.9427049441103523,0.6392785571142284,0.9486806780094963,1.0,78/208,31.08%,RPSA;MRPS11;RRBP1;COPS5;EEF2K;MRPS18B;MARS2;ABCE1;IGHMBP2;GTPBP2;FTSJ1;MRPL13;MRPS17;AGO2;GSPT2;RPL10A;MRPL10;TARS1;SARS2;MRPL55;TNIP1;UBA52;RPS5;MRPL36;VARS1;MRPL3;GSPT1;MRPS34;RPL6;MRPL51;EEF1B2;HARS1;GARS1;EEF1G;ABCF1;EEF1E1;EPRS1;QARS1;AIMP1;RPL22L1;RPL23;RPL17;N6AMT1;RWDD1;QRSL1;RPS25;RSL24D1;NOA1;AIMP2;RPL22;NARS1;APEH;EIF4EBP2;EIF4G1;MRPL34;PPA1;EEF1D;RPL34;ASMT;YARS1;RPS29;HBS1L;TMA7;SARS1;RPS26;PPA2;IGF2BP3;DARS1;RPS15;RPS20;WARS2;RPL31;RPLP2;RPS28;MRPL23;AARS1;LARS2;RPS6
prerank,Golgi to lysosome transport (GO:0090160),-0.3651554083612245,-0.9424641926199078,0.5,0.8358901507132942,1.0,5/11,23.77%,SORT1;AP1G1;CLN3;EHD3;CCDC91
prerank,negative regulation of interferon-beta production (GO:0032688),0.46360128674256146,0.9424624131237691,0.5590327169274538,0.9487520599255983,1.0,2/10,10.19%,PTPRS;SIRPA
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.38992571940544174,0.9423666853516846,0.5633293124246079,0.9484554782669473,1.0,2/26,2.27%,AREG;BTC
prerank,regulation of endocytic recycling (GO:2001135),0.4504113373655341,0.9423658541505284,0.554904831625183,0.9479368027842113,1.0,4/11,15.33%,ATP9A;INPP5F;EHD2;PLA2G4E
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.335086593801383,0.9409042477736879,0.6195320447609359,0.9508728125609354,1.0,40/119,25.17%,TTC7A;FGF2;PIK3C2B;PIK3R2;SOCS2;PIGZ;PI4K2B;FIG4;OCRL;INPP5F;PIK3CA;ARF1;INPP5K;PIGC;PLEKHA4;MPPE1;MBOAT7;RUFY1;INPP4A;PLEKHA1;PIGW;PI4KB;PIGM;MTMR6;PI4KA;MTMR1;SOCS6;PIP4K2C;CDIPT;PITPNM1;IP6K1;PIP4K2B;PTEN;PIK3CG;PI4K2A;TTC7B;PIGL;DPM2;MTM1;SLC27A1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.2759762735858311,-0.9406986253486844,0.5289855072463768,0.83852718699901,1.0,8/32,13.50%,CDH5;ITGA1;PPP1R16B;PDGFRB;PPP1R15B;PPP2R5A;TGFB1;CD300A
prerank,entry into host (GO:0044409),0.45711693591463776,0.940239183951642,0.5653950953678474,0.9519362481568397,1.0,5/13,17.21%,SRC;ITGAV;CBL;CXCR4;PPIA
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3227189007584884,0.9398796023927001,0.734,0.9522935779108969,1.0,91/476,16.87%,AR;LRP6;CD80;ESR1;COL1A1;FGF7;IRF4;EGFR;CREB5;TGFB3;WT1;SIX4;ELF4;ZMIZ1;FGF2;F2R;GLIS2;SFR1;RUNX1;SMAD4;ATF5;CXXC1;AXIN1;SOX10;ACVR1;FOXK2;KLF2;MAP2K3;PSRC1;NR1D2;NFATC1;FOXO1;NR1D1;NFIB;MAPRE3;EBF3;PRMT2;RNF111;ZFHX3;RET;TRIP4;MLXIPL;SMAD5;DNAJC2;GLI2;MDFIC;SOX8;CHUK;FZD7;PSEN1;FOXC2;HNRNPD;ATXN7L3;RYBP;MED24;INPP5K;RNF10;BRD7;NPM1;MITF;CAMKK2;SMARCC2;CEBPB;AKT1;GLI3;EGF;QRICH1;MED13;BCL3;RAI1;SIX1;HDAC4;NME2;KLF4;TASP1;MLLT11;IL4;SMARCA4;CHD8;FZD4;MAP2K2;RNF14;CDK5RAP2;RNF187;USP22;HIVEP3;IL6;PHF5A;PITHD1;TFAP4;PML
prerank,vitamin D metabolic process (GO:0042359),0.4475411716107001,0.9393494205106524,0.5692307692307692,0.9530428799592519,1.0,5/13,27.48%,CYP27B1;VDR;GC;LRP2;CYP2R1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.3521204443869137,0.9391845095557483,0.6048988285410011,0.9529561223631192,1.0,10/70,9.97%,NCF4;PSMC4;ITGB5;SEC22B;PSMC6;LNPEP;CHUK;PSMD8;SNAP23;ITGAV
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.4109471093709567,0.9385056687530728,0.5774647887323944,0.9540394289387859,1.0,5/20,14.67%,TMBIM1;PID1;CLTC;RHOQ;PPFIA1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3404526878209709,0.9382590758464467,0.5989473684210527,0.9541006406332798,1.0,18/74,19.35%,AR;SCRT2;MAPK7;TMBIM1;ACVR1;TCF7L2;SRC;PELI3;EYA2;ITGAV;GPX1;AKT1;GDNF;IL4;SNAI2;FAIM2;TGFBR1;MCL1
prerank,phagolysosome assembly (GO:0001845),0.44897909732238156,0.938076984328026,0.5634588563458857,0.9540118581539551,1.0,1/12,2.11%,RAB7B
prerank,regulation of chromatin organization (GO:1902275),-0.3469606505583115,-0.9380708912101581,0.5398230088495575,0.8432992352124948,1.0,3/14,8.11%,MLLT3;SSRP1;IGF2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.4166834357487449,0.9380603929655849,0.547144754316069,0.9535265851067473,1.0,6/15,29.43%,CUL3;NPM1;PAF1;EZH2;STXBP4;GLI1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.36253081038345764,-0.93779823187446,0.5308219178082192,0.8423137355339104,1.0,3/11,6.63%,NOVA2;PCBP3;IGF2BP2
prerank,regulation of cell cycle process (GO:0010564),0.335557921738687,0.9371916213106459,0.6153846153846154,0.9550475112255407,1.0,28/104,23.66%,TIPIN;ATF5;CCDC8;AHCTF1;FSD1;FLCN;NUDT16;KIF20B;FBXO5;SETD2;PRPF40A;CALM2;PIN1;CUL9;BBS4;DBF4;DYNC1H1;CEP85;E4F1;CCP110;TTL;YTHDF2;ENTR1;NUMA1;KLHL9;USP19;CSNK2A2;RAB11FIP3
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.387869646762931,0.9369390016899309,0.5820543093270366,0.9551006349860944,1.0,8/29,10.99%,SLIT2;SMAD4;MYADM;PFN2;PIK3CA;TWF1;KANK1;SSH1
prerank,pore complex assembly (GO:0046931),0.41785613106828634,0.9365703787699305,0.585427135678392,0.9554444438581557,1.0,4/19,8.69%,NUP93;AHCTF1;NUP107;NUP98
prerank,positive regulation of exocytosis (GO:0045921),0.37270649626734204,0.9365496822204311,0.5702764976958525,0.9549710711614764,1.0,12/35,26.38%,SMPD3;VPS4B;RAB3D;ATP6AP1;RAB27B;RAB2B;CLASP2;PDCD6IP;SDCBP;STAM;SDC4;CFTR
prerank,positive regulation of locomotion (GO:0040017),0.37905184709427453,0.9360276446357056,0.5776173285198556,0.9556562233875261,1.0,5/27,13.56%,DUOX1;NTN1;STX4;CCDC25;TWIST1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.44817010424525217,0.9359729818638213,0.5498614958448753,0.9552671645360741,1.0,3/11,14.08%,FAP;SIRT2;ZC3H12A
prerank,O-glycan processing (GO:0016266),0.35516755564438335,0.9354691120083196,0.5910577971646674,0.9559308391384519,1.0,7/54,11.72%,ST3GAL2;C1GALT1;GALNT10;MUC1;B3GNT8;GALNT1;ST3GAL4
prerank,positive regulation of chromatin organization (GO:1905269),0.44025434083502824,0.9352116578531482,0.5624142661179699,0.9560101961460629,1.0,6/12,22.09%,UBE2N;ACD;TERF1;TINF2;MIER1;TERF2IP
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.339766431719611,0.9349688199940456,0.6080084299262382,0.9560409920673026,1.0,29/80,27.70%,NIBAN1;SMPD3;MTOR;LARP4;HNRNPD;NPM1;PASK;EIF6;RPS27L;BCL3;ZCCHC4;POLDIP3;RBM3;EIF3E;IL6;EIF3D;FXR2;CHRNA7;YTHDF1;PCIF1;NSMAF;YTHDF3;LRRTM3;RELA;LARP6;UPF3B;SLC2A13;PRKDC;IFNGR1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.38120583449336,0.934789700272431,0.5765983112183354,0.9559722243588492,1.0,11/28,30.49%,CD47;SIRPA;IL6;PYCARD;TNIP2;TICAM1;CCDC88B;FGF10;PRKDC;XRCC6;SH3KBP1
prerank,regulation of sequestering of calcium ion (GO:0051282),0.4460882548826664,0.9344967503136555,0.5597826086956522,0.9561509059230578,1.0,3/12,15.01%,ANK2;CASQ1;DIAPH1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.38092886472544646,0.934332696411233,0.5644599303135889,0.9560353353126554,1.0,4/29,13.07%,PKP3;TENT5B;LARP1;GDNF
prerank,nitric oxide biosynthetic process (GO:0006809),-0.3472981352083265,-0.9339769930108213,0.5627376425855514,0.8501463595616267,1.0,4/13,12.21%,NOS3;GCH1;NOS1;SPR
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3869253402118738,0.9339008694559523,0.5840386940749698,0.9565245122448792,1.0,6/27,18.41%,F2R;LPAR1;GPR20;CALCA;GRM1;HTR2C
prerank,regulation of myelination (GO:0031641),0.3902177842079919,0.9338437561101003,0.5735115431348724,0.9561266850933771,1.0,6/25,13.72%,EIF2AK3;TMEM98;ZPR1;SIRT2;RNF10;TNFRSF1B
prerank,protein autophosphorylation (GO:0046777),0.3263747422607751,0.9336921562199287,0.6576032225579054,0.9559771780161728,1.0,31/157,14.52%,DDR2;SRMS;EGFR;TNK1;FGFR1;STK25;EIF2AK3;TAOK3;EEF2K;MTOR;CAMK2D;SRC;PRKD2;SLK;ERN1;EPHB3;MUSK;CAMKK2;STK16;AKT1;IRAK1;PASK;STK39;ULK2;TAOK2;FLT3;ULK1;PDGFRA;FER;STK24;DDR1
prerank,aortic valve morphogenesis (GO:0003180),0.37737505140036826,0.9336683531378853,0.5729411764705883,0.9555081656070699,1.0,8/30,16.59%,SLIT3;SLIT2;ELN;NFATC1;JAG1;SMAD6;TWIST1;SNAI2
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.3758701932438262,-0.9334499894615947,0.5576923076923077,0.8497448823302778,1.0,2/10,8.87%,RAPGEF2;CTNS
prerank,neuromuscular junction development (GO:0007528),-0.290490113636356,-0.9331892732793202,0.5748792270531401,0.8486813102703199,1.0,5/24,5.48%,UNC13B;PDZRN3;UNC13C;CACNB2;PPFIBP2
prerank,protein phosphorylation (GO:0006468),0.32033788082824155,0.9328837099009307,0.738,0.9567824518051762,1.0,80/479,14.52%,SYK;DDR2;EPHB2;SRMS;DCLK1;PRKCA;EGFR;TNK1;FGFR1;MAPK12;STK25;EIF2AK3;RPS6KA2;CDKL2;EPHA3;DYRK4;FYN;GTF2H3;DGKQ;IRAK3;SGK3;SGK2;TGFB2;LMTK3;CDK14;TGFBR2;TAOK3;MAPK14;PKD1;ACVR1;CDK4;EEF2K;MTOR;CAMK2D;CSK;RET;MAST4;TBCK;SRC;ABL2;GAS6;STRADA;PRKD2;SLK;ABI1;TNNI3K;CHUK;TESK2;CDK9;TLR4;CDK20;AKT3;BMP2K;NRBP2;ERN1;EPHB3;DYRK2;MUSK;CSNK1G1;AMHR2;CSNK1G3;CAMKK2;STK16;AKT1;MAP3K6;IRAK1;PASK;STK39;ULK2;PXK;TAOK2;FLT3;ULK1;HIPK4;PDGFRA;CCNH;FER;STK24;STK3;DDR1
prerank,long-term memory (GO:0007616),0.40893473499532185,0.9327877003324722,0.5599489795918368,0.956497553623092,1.0,2/19,5.07%,RASGRF1;NFATC4
prerank,regulation of cell cycle phase transition (GO:1901987),0.3400875712892034,0.9327602750000209,0.6119711042311662,0.9560515545642745,1.0,16/91,17.67%,MN1;PSMC4;ATP2B4;PSMC6;PSMD8;CDC23;ANAPC5;FBXO5;ERCC3;CDKN1A;DDB1;CDC27;DBF4;TFAP4;CDC26;ANAPC4
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.4457008552853868,0.9325643485373187,0.5714285714285714,0.9560234828571097,1.0,2/11,9.18%,CD177;STX4
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.2975644976128183,-0.9322965088032795,0.5714285714285714,0.8491048298719328,1.0,9/22,20.72%,PSMA5;PSMA2;PSMA3;PSMB10;PSMA1;PSMB8;PSMB9;PSMB4;PSMA8
prerank,male meiosis I (GO:0007141),0.4155176061718473,0.9322590179960084,0.5498059508408797,0.9562058838738692,1.0,3/16,18.64%,SLC25A31;DDX4;FOXJ2
prerank,cellular response to hydroxyurea (GO:0072711),0.460418906290198,0.9322114283119247,0.563768115942029,0.9558062827604964,1.0,5/10,29.30%,DDX11;SPIDR;BLM;NSMCE3;ATRX
prerank,monocyte differentiation (GO:0030224),0.4536689763983498,0.9318900652040895,0.5550724637681159,0.9560565843550186,1.0,1/10,2.76%,VEGFA
prerank,regulation of lamellipodium organization (GO:1902743),0.43141939299473747,0.9316617679785143,0.5682704811443433,0.956086583750698,1.0,5/14,25.16%,CD44;TWF1;FER;DMTN;RAC1
prerank,ATP transport (GO:0015867),0.4627715777796161,0.9315543479937765,0.5687943262411348,0.9558094025574586,1.0,3/10,14.88%,SLC25A4;CD47;SLC25A17
prerank,cellular response to interleukin-1 (GO:0071347),0.3300858213347806,0.9312703133124723,0.665989847715736,0.9559303445962295,1.0,21/143,12.90%,HAS2;CCL8;PSMC4;IRAK3;USP10;NR1D1;PSMC6;RC3H1;PELI3;UBE2N;CHUK;PSMD8;CCL25;MAPK11;CD47;SIRPA;SQSTM1;IRAK4;IRAK1;UBA52;CCL13
prerank,peptide hormone secretion (GO:0030072),0.3891258821340479,0.9306385904894868,0.5736342042755345,0.9568557706375469,1.0,5/26,18.84%,ANXA1;ADCYAP1;CRHR1;IL6;RIMS2
prerank,second-messenger-mediated signaling (GO:0019932),0.3373565168142318,0.9305908122752709,0.6205450733752621,0.9564581521955412,1.0,8/82,10.97%,ACKR3;EIF2AK3;PLCE1;RCAN3;MCU;ACKR4;RCAN1;CAMKK2
prerank,heterochromatin organization (GO:0070828),0.43213625493438473,0.9305102427782934,0.5585464333781965,0.9561407105252011,1.0,8/14,26.27%,LOXL2;SETD7;POLE3;EZH1;BAHD1;SETDB1;SETDB2;HP1BP3
prerank,cellular response to ATP (GO:0071318),0.43236481674561583,0.9303133278872904,0.5809018567639257,0.9560710650307499,1.0,2/14,10.99%,P2RX3;SSH1
prerank,negative regulation of cell activation (GO:0050866),0.43350834726675264,0.9300316123622967,0.5702702702702702,0.9561967488148041,1.0,3/14,14.13%,C1QTNF1;NR1D1;PDGFRA
prerank,tRNA methylation (GO:0030488),0.3675989192696355,0.9300214168036665,0.5942196531791908,0.9557071856977273,1.0,7/34,15.07%,PRORP;TYW3;TRMT61A;FTSJ1;DALRD3;THADA;TRMT1
prerank,neuron migration (GO:0001764),0.3554025555376125,0.9296257716599301,0.5986696230598669,0.9561018320197302,1.0,8/48,8.24%,NAV1;MAP1B;FGFR1;VEGFA;FGF13;POMGNT2;LRP12;SEMA3A
prerank,apoptotic cell clearance (GO:0043277),0.38383823813738904,0.9294902004124505,0.5712589073634204,0.9559023962558464,1.0,5/30,9.97%,ANXA1;LRP1;ITGB3;GAS6;ITGAV
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3556778753296054,0.9294840576481321,0.5901639344262295,0.9554065035726896,1.0,7/53,7.05%,GLMN;DESI1;PKD1;RHBDF1;RAD23B;PSMC6;UCHL5
prerank,cellular protein modification process (GO:0006464),0.3168709143222762,0.929340730231934,0.839,0.9552502349404115,1.0,271/983,25.74%,PLOD2;COL3A1;IGFBP5;FSTL1;SYK;FBN1;LOXL2;LORICRIN;PARP3;WSB1;DCLK1;ST3GAL2;PRKCA;TNK1;ANXA1;TIMM50;FGFR1;RABGGTA;STK25;CEL;EIF2AK3;CDC14B;GPC3;PSMC4;PRSS23;B3GALNT1;CDKL2;FYN;IRAK3;SGK3;SGK2;TGFB2;SPSB1;LMTK3;SPSB4;CDK14;TGFBR2;PIGT;PTPRS;FUT2;TAOK3;GPAA1;ART4;COPS5;ACVR1;CDK4;BMP15;IGFBP4;KRT10;FBXW8;GGCX;CALU;MGAT1;VCAN;MTOR;MIA3;PTPRJ;SOCS2;CCDC8;WDTC1;CAMK2D;PHKA2;CSK;COP1;TULP4;GAN;ILKAP;RET;ARF4;PSMC6;TBCK;PTPRF;SPSB2;MELTF;PARP6;ABL2;GAS6;STRADA;OGA;PRKD2;TNNI3K;FBXO2;CHUK;PPP5C;TESK2;PSMD8;FBXO17;CTDSP2;CUL3;DTL;DUSP11;CDK9;PPM1G;SENP8;SIRT2;CDK20;FBXL2;ASB12;FBXW4;AKT3;BMP2K;NRBP2;LGALS1;WIPI2;FBXL20;LOXL1;ERN1;DYRK2;ALG1;LARGE1;WDR5;WDR45B;FUT9;B3GNT8;RAB2A;ZC3HAV1;AMHR2;CSNK1G3;PPP3CC;CAMKK2;SSH1;PARP14;AKT1;MAP3K6;RNF7;DCAF6;HS3ST5;ST3GAL4;IRAK1;PPEF2;FBXO31;PASK;STK39;UBA52;CDC34;PXK;PIGS;TAOK2;DDB1;FBXL3;P3H1;DCAF13;ASB8;CUL9;ULK1;FER;RCE1;TRIOBP;STK24;STK3;PIGK;CTDP1;PPP3CA;PPP2R1B;MTMR6;EVPL;KLHL41;MXRA8;NGLY1;SOCS6;DCAF10;B3GALNT2;IL6;PPP1CC;SDC2;KEAP1;UFL1;PPP2R5B;CHRDL1;RAB1B;FBXL5;NEK4;PDP2;FBXO11;PTPN5;ST3GAL1;ILK;ST3GAL3;STK19;ADPRH;METAP2;TGFBR1;COPS4;GMFB;LOX;STK38;SDHAF2;NEDD8;SKP2;NEK7;PPP3CB;PPP2R2A;DDOST;UBE2D3;LAMC1;KCTD6;CTBP1;OXSR1;HIPK3;STK26;FBXL19;PTPN3;FBXW9;FBXW2;QSOX1;PPM1A;CUL5;PRKCSH;ACVR2A;BMPR1A;MAPK1;SRPK1;PTEN;METAP1;PPP6C;ICMT;YES1;ATG3;METAP1D;CSF1;KLHL9;BRD2;CDKL4;SUMF2;OGFOD1;FBXW11;JMJD7;CDC25B;KLHL22;CSNK1G2;SPSB3;ATG10;FUT10;CTDSP1;PTPN18;LHPP;DCAF5;UST;PICK1;KLHL11;PSMD3;VRK2;FAM20B;LATS1;BCR;WNK2;GPS1;STK10;FBXL12;PSMD4;PRKCZ;MMP15;ACVR1B;MARK2;RARA;CDKL1;MTM1;DNAJC3;RABGGTB;SERPINC1;UBA7;NRBP1;NEK1;HSP90B1;CTH;VHL;FBXO22;PARP16;RAB1A;FBXW7;FBXO30
prerank,epithelial tube morphogenesis (GO:0060562),0.3778938242438524,0.9292388838635965,0.5981198589894242,0.9549794329437653,1.0,6/32,7.85%,SLIT2;PKD1;ACVR1;GLI2;PRKD2;PKD2
prerank,regulation of DNA damage checkpoint (GO:2000001),0.4589908105168927,0.9291954106079986,0.5603328710124826,0.9545714572222818,1.0,3/10,14.71%,RFWD3;ETAA1;THOC1
prerank,negative regulation of transport (GO:0051051),0.3481837490495501,0.9287714113436358,0.5703296703296703,0.9550255854696983,1.0,10/51,12.49%,EPHA3;ITGB3;SYT11;SCAMP5;ITGAV;SIRPA;YRDC;EGF;NDFIP1;PXK
prerank,sprouting angiogenesis (GO:0002040),0.3512812315145102,0.9286666376757138,0.6155555555555555,0.9547631100871841,1.0,7/51,7.53%,CCBE1;LOXL2;VEGFA;FGF2;SLIT2;MIA3;ESM1
prerank,regulation of cellular respiration (GO:0043457),-0.3120112824443203,-0.9283084789708678,0.5462555066079295,0.8573341977237985,1.0,4/17,7.68%,IFNAR1;CBFA2T3;IL10RB;PRDM16
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.4438797832090512,0.9280276468098246,0.5977808599167822,0.9557319603749386,1.0,6/12,28.82%,DGKQ;SREBF1;LPCAT3;KPNB1;MBTPS1;SREBF2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.418947740333769,0.9279393898118774,0.5561426684280053,0.95543263698951,1.0,2/17,5.71%,IGFBP5;DOCK7
prerank,rRNA modification (GO:0000154),0.39695240192846626,0.9278364212775407,0.5728770595690748,0.9551444971557846,1.0,11/21,35.54%,DIMT1;GAR1;ZCCHC4;TSR3;FTSJ3;NHP2;NAT10;FBL;NSUN3;BUD23;THUMPD1
prerank,regulation of inflammatory response (GO:0050727),0.31954918457480963,0.9276587569422579,0.6666666666666666,0.9550490147641143,1.0,38/190,19.13%,MGLL;ANXA1;IL16;MAPK7;FOXP1;S100A8;S100A9;AKNA;METRNL;SPATA2;NR1D2;MVK;IL33;NR1D1;IL17RA;DAGLA;TLR4;FNDC4;CD47;SIRPA;BCL6;LRRC19;TNIP1;ABCC1;CD200R1;TNFRSF1B;KLF4;IL4;LRFN5;DAGLB;SELENOS;PDCD4;IL6;UFL1;IL18;SNX6;VAMP2;IFI35
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33510626895233925,0.9273390283109395,0.6076759061833689,0.9552693959212519,1.0,11/75,12.39%,MGLL;PLCE1;DGKQ;GNG4;SLC39A14;ZDHHC7;ADCYAP1;CNGB1;USP33;SAG;KLK6
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.3618444897323758,-0.9271892138227296,0.5555555555555556,0.8582781496071322,1.0,4/11,10.42%,WNT5A;FGFR2;TBX1;STAT1
prerank,regulation of phosphatase activity (GO:0010921),0.38886730636204364,0.9268241888251662,0.571078431372549,0.9559528607504486,1.0,10/24,28.88%,PPP6R2;URI1;CHP1;SH2D4A;TIPRL;HSP90B1;PPP1R26;TSC1;PTPA;GPATCH2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.33095372080460306,0.9264091888675187,0.6663275686673449,0.956418775189486,1.0,30/109,21.27%,MTMR11;FGF2;PIK3C2B;PIK3R2;PI4K2B;FIG4;OCRL;INPP5F;PIK3CA;ARF1;INPP5K;PLEKHA4;MBOAT7;RUFY1;INPP4A;PLEKHA1;PIGW;PI4KB;MTMR6;PLA2G4E;PI4KA;MTMR1;PIP4P1;PIP4K2C;CDIPT;INPP5B;PITPNM1;PIP4K2B;PTEN;PIK3CG
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.4361671989421131,0.9261822277381935,0.5744125326370757,0.956423948349133,1.0,3/14,16.77%,PKD1;PKD2;KEAP1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.3821018798112112,0.925605208619849,0.5880952380952381,0.9572227723462352,1.0,12/27,30.09%,BHLHE40;RBM4;FBXL3;PER1;PPP1CC;PML;PER3;FBXL12;CRY2;CRTC1;TP53;FBXL8
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.4218052194848548,0.9251690189478207,0.5858310626702997,0.9577357190062649,1.0,2/15,7.49%,LRP6;GLI2
prerank,sphingoid metabolic process (GO:0046519),0.44216563801426684,0.924897700319246,0.5726141078838174,0.9578684564864299,1.0,4/12,24.28%,PLPP3;PLPP1;PLPP2;SGPP1
prerank,"phototransduction, visible light (GO:0007603)",0.42552145935307495,0.9244986503135109,0.584573748308525,0.9582548864085472,1.0,3/14,13.75%,CNGB1;SAG;GNB1
prerank,regulation of protein secretion (GO:0050708),0.3242876956717352,0.9244837628371513,0.636734693877551,0.9577789482926898,1.0,12/119,5.42%,DPP4;PRKCA;MTNR1B;TGFB3;DISP1;ANG;CACNA2D2;TGFB2;STX1A;ADAM9;LLGL1;RHBDF1
prerank,regulation of cell death (GO:0010941),0.33424442173955027,0.9244344507859069,0.6350515463917525,0.9573868361742526,1.0,28/94,27.95%,SNCB;LRP1;SRSF6;CCN5;PDE8A;FGF2;VPS4B;TNFRSF1B;ZC3H12A;DCC;CHP1;NCK1;SARM1;CHRNA7;SRGAP2;EPHB1;RRAS2;DUS2;CRYAB;CCN3;NOA1;RAB29;PARP16;EIF4G1;ADNP2;TSC1;CELF1;IMPACT
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3646819349701807,0.9244043541270194,0.5957446808510638,0.9569504167427827,1.0,12/37,25.36%,MAPK14;IL17RA;TLR4;SIRPA;ZC3H12A;PDCD4;PER1;IL6;PYCARD;CUEDC2;CHID1;TICAM1
prerank,alcohol catabolic process (GO:0046164),0.4557592577915135,0.9242707898796632,0.5857142857142857,0.9567477176091704,1.0,1/10,1.78%,CEL
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.3446843247078841,-0.9240317155923166,0.555956678700361,0.8645948479263209,1.0,4/12,8.15%,PROM1;NKD1;CEP290;SDK2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.29577719997030616,-0.924017035761012,0.5531914893617021,0.8628711815573886,1.0,4/23,8.41%,CADM1;AP1G1;NECTIN2;PIK3R6
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.44668643793800067,0.9240068378769304,0.5750332005312085,0.956818935050669,1.0,3/12,11.89%,WDTC1;ACADVL;PIBF1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.3595810080505896,0.9238686832659372,0.5912743972445464,0.9566185729422481,1.0,10/40,19.35%,RFWD3;ETAA1;UBE2N;CDK9;PARG;MAPT;FBXO5;FXR2;NEK4;MCL1
prerank,organic anion transport (GO:0015711),0.3370240270694923,0.9237831818605287,0.619098712446352,0.9562973620568592,1.0,11/76,13.01%,SLCO2A1;SLC4A10;LRRC8D;SLC4A8;SLC4A3;SLC35B1;SLC25A4;SLC4A4;SLC26A6;SLC2A10;SLC23A1
prerank,regulation of DNA binding (GO:0051101),-0.24769692911610403,-0.9234557049833596,0.6702127659574468,0.862556797403988,1.0,5/44,3.59%,LEF1;SP100;IGF1;HMGB1;FOXC1
prerank,defense response to symbiont (GO:0140546),-0.2128143057893816,-0.9230562951795733,0.7560975609756098,0.8619246978990819,1.0,14/92,10.42%,BCL2L1;SERINC3;BCL2;TRIM56;PLSCR1;IFITM3;ABCC9;MAVS;CNOT7;IFIT1;IFIT2;TLR3;OAS2;STAT1
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.4568694705718733,0.9230038500915271,0.5813630041724618,0.9571327731564006,1.0,1/10,3.21%,CDC42EP2
prerank,regulation of pseudopodium assembly (GO:0031272),0.4568694705718733,0.9230038500915271,0.5813630041724618,0.9571327731564006,1.0,1/10,3.21%,CDC42EP2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.32040033944330004,0.9217955086688615,0.713,0.9593474864004174,1.0,90/260,27.68%,GSN;NME8;PMP22;CDC14B;EMP3;ABLIM1;EMP1;PKD1;RAB23;FHDC1;RAP1B;ARF4;FSCN1;NTN1;S1PR2;ACTR3;HDAC6;BBS9;ATAT1;ARL13B;FXYD5;TMEM138;OCRL;CPLANE1;CNGB1;EHD2;INPP5K;NUDCD3;DZIP1;TTC39C;AVIL;TEKT5;VSTM5;PIBF1;DYNC2I2;KIF3A;RPGR;KIF3B;IFT46;TTLL3;BBS4;ARF6;TTC8;ATP6V1D;AHI1;SRGAP2;CEP164;PPP1R9B;DYNC2H1;CEP89;SHTN1;DYNC2I1;CEP83;CCDC28B;RP2;BBS5;BBIP1;IFT52;EXOC4;STK26;CC2D2A;SPAG16;FLNA;PCM1;DNAH5;FBF1;TMEM231;CCDC88A;SDCBP;TCTN2;RAB11FIP3;PDE6D;DYNLL1;DMTN;TCTN1;RAC1;CDC14A;NEK1;CYFIP1;CEP126;RAB1A;CFAP70;SPATA13;RAP1A;GBF1;ARHGEF7;FUZ;IFT81;PTPDC1;RAB8B
prerank,sympathetic nervous system development (GO:0048485),-0.32655542702659224,-0.9217463189947496,0.575,0.8632749644894789,1.0,4/15,15.56%,NRP2;NRP1;CTNNB1;SOX11
prerank,B cell differentiation (GO:0030183),0.3561028098188503,0.9214596906946991,0.5896279594137542,0.9595768149466172,1.0,8/46,14.82%,HDAC9;SYVN1;CLCF1;PTPRJ;FLT3;CR2;HDAC4;IL4
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.38022511261005576,-0.9214125472555115,0.5294117647058824,0.8624955570974564,1.0,3/10,12.13%,PCGF5;IGF2;ZFP57
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.40456284561205025,0.9213549677158627,0.5808080808080808,0.9593075873560382,1.0,4/18,13.86%,TMEM119;FZD7;HDAC3;HDAC4
prerank,reverse cholesterol transport (GO:0043691),-0.34965797627483064,-0.9213230502151941,0.5365853658536586,0.8609625300165747,1.0,3/13,5.80%,APOE;SCARB1;ABCG1
prerank,dendritic cell migration (GO:0036336),-0.31634605781543845,-0.9211249059425571,0.5514018691588785,0.859680516900821,1.0,2/16,2.72%,EPS8;HMGB1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.43899971566694906,0.920744521607723,0.5798319327731093,0.9601779237334587,1.0,2/11,14.82%,TMEM106A;IL4
prerank,positive regulation of neuron migration (GO:2001224),-0.35242264140897056,-0.9205899710655907,0.5547703180212014,0.8593210494046275,1.0,4/11,10.66%,RAPGEF2;DAB2IP;SEMA6A;MDK
prerank,regulation of nervous system development (GO:0051960),-0.2555283697932037,-0.9205259587563518,0.631578947368421,0.857725452209391,1.0,6/37,9.28%,PTN;TENM4;PTPRZ1;HEYL;CX3CL1;YAP1
prerank,sister chromatid segregation (GO:0000819),0.36930362645854853,0.9202587892915134,0.5931603773584906,0.9606926554663264,1.0,9/31,24.04%,CHAMP1;ZW10;ZWINT;SMC1A;INO80;TOP2B;KLHL22;TUBG2;LATS1
prerank,organic substance transport (GO:0071702),0.32223551780877424,0.9201753065810819,0.6510681586978637,0.9603624794487372,1.0,20/121,13.57%,SLCO2A1;DISP1;SLC50A1;ARRDC2;SLC47A1;MIA3;TOM1;SCAMP3;RCN3;ABCG4;ABCA1;SCAMP5;TCN1;ABCA13;SLC6A4;LRP1B;RUFY1;KIF3A;SLC23A1;CMTM6
prerank,sulfate transport (GO:0008272),-0.3354274498359139,-0.9201677234804212,0.5506072874493927,0.8568043141990291,1.0,2/14,1.69%,SLC13A4;SLC26A7
prerank,protein destabilization (GO:0031648),0.3714001212394174,0.919513808946532,0.5887191539365453,0.9614105961904437,1.0,4/32,8.86%,GSN;CCDC88C;NR1D1;CUL3
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.45233277233906677,0.9194747011315729,0.5807365439093485,0.9609900719825409,1.0,2/10,13.49%,MYO9A;RHOA
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.395732764260414,0.9194318482492531,0.5867665418227216,0.960063184875526,1.0,5/21,17.52%,GTF2H3;ERCC3;ERCC4;DDB1;ERCC5
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.395732764260414,0.9194318482492531,0.5867665418227216,0.960063184875526,1.0,5/21,17.52%,GTF2H3;ERCC3;ERCC4;DDB1;ERCC5
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.35968046268286114,0.9193147663440465,0.584192439862543,0.9598366093084028,1.0,6/42,12.08%,MYOC;VEGFA;S100A10;PTPRJ;CCL25;JUP
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.31436336086978334,0.9190190898803207,0.774,0.9600105021610876,1.0,76/509,14.13%,DCN;LIF;AREG;MYOC;CD80;ESR1;FGF18;AXL;FGF7;EGFR;AKAP13;IRS1;FGFR1;MIB2;BTC;FYN;NEUROD2;VEGFA;FGF2;TGFB2;ECM1;MST1R;F2R;MIF;S100A8;S100A9;PIK3R2;LPAR1;MID2;TMEM106A;P2RX3;TCF7L2;PTPRJ;CARD16;C1QBP;RET;CGAS;SRC;RIT2;GAS6;DHX33;FLCN;UBE2N;TFG;PRKD2;FLT3LG;CHUK;PPP5C;PIK3CA;SIAH1;TIRAP;TLR4;IQGAP1;LGALS1;ITGAV;HDAC3;IRAK4;DDX21;BMF;GPR37L1;PUM1;IRAK1;LRRC19;IRS2;CD27;EGF;NDFIP1;BBC3;SMCR8;FLT3;TRAF3IP2;RHOA;RRAGD;GPR37;CBL;PDGFRA
prerank,positive regulation of viral genome replication (GO:0045070),0.37177786456633555,0.9189901925524335,0.5947556615017878,0.9595760387917298,1.0,8/29,21.08%,TARBP2;ADARB1;LARP1;DDB1;HACD3;PPIA;TOP2B;SRPK1
prerank,cholesterol homeostasis (GO:0042632),-0.23647726416956344,-0.9188195821605841,0.6285714285714286,0.8584208334058159,1.0,10/64,8.48%,CYP7B1;GRAMD1B;APOE;SCARB1;TTC39B;NR1H3;ABCG1;CAV1;LDLRAP1;EPHX2
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.3033496813072091,-0.9184777496646798,0.583756345177665,0.8575500062234066,1.0,6/18,13.63%,VGLL4;DAB2IP;NELL1;ATRAID;RGP1;RIC1
prerank,Ras protein signal transduction (GO:0007265),0.3182363633634942,0.9183529157523072,0.6551724137931034,0.9605062709663387,1.0,29/137,16.49%,COL1A2;GPSM2;PLCE1;FGF2;CDC42EP2;MAPK14;RAP1B;RASSF1;WASF1;FARP2;NTN1;RIT2;ARHGEF3;MYO9B;MAPK11;RGL2;GDI1;NRAS;KRAS;USP50;SHOC2;CDKN1A;RHOA;GNB1;RAPGEF1;HACD3;EPS8L2;SOS1;HACE1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3687933516671928,0.9182513946274198,0.6075514874141876,0.9602351991035318,1.0,20/37,32.66%,DYNC2I2;KIF3A;KIF3B;IFT46;DYNC2LI1;DYNC2H1;DYNC2I1;IFT52;PCM1;IFT57;DYNLRB1;DYNLL1;TNPO1;KIFAP3;IFT81;IFT20;KIF3C;IFT172;TRAF3IP1;KIF17
prerank,sensory perception of smell (GO:0007608),0.4440279763314312,0.9181209777010353,0.5768156424581006,0.9600492693154724,1.0,4/11,36.33%,BBS4;SLC24A4;DRD2;ADCY3
prerank,regulation of MAPK cascade (GO:0043408),0.3224709497545801,0.9180953060619521,0.6998992950654582,0.9596050303302247,1.0,27/157,16.45%,SYK;LIF;MYOC;EGFR;FGFR1;FGF2;F2R;PIK3R2;LPAR1;TAOK3;TMEM106A;PTPRJ;RET;RIT2;DHX33;IQGAP1;PRDM15;GPR37L1;PPEF2;EGF;TAOK2;FLT3;GPR37;STK3;MAP2K2;IL6;NBR1
prerank,pulmonary valve development (GO:0003177),0.4051780948797201,0.9178020330691101,0.5914396887159533,0.9597597171748417,1.0,6/18,13.72%,TGFB2;SLIT2;NFATC1;JAG1;SMAD6;TNFRSF1B
prerank,DNA double-strand break processing (GO:0000729),0.4065576955850095,0.9175609092799157,0.5801033591731266,0.9597787837830808,1.0,6/18,18.32%,UBE2N;DNA2;NBN;RNF138;RAD50;BLM
prerank,negative regulation of cellular senescence (GO:2000773),-0.3419574535101945,-0.9175359443626039,0.5305343511450382,0.858341641560257,1.0,8/13,23.58%,SLC30A10;CDK6;MAP3K3;SIRT1;TERT;RBL1;TERF2;HMGA2
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.3329012067226901,-0.9171025283461621,0.5648535564853556,0.857670299334923,1.0,2/14,2.54%,AUTS2;KMT2E
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3374823371605062,0.9169356846727159,0.6230031948881789,0.9606461581329275,1.0,11/65,9.05%,ANGPT4;VEGFA;LMNA;ZFP36L1;MTOR;CARD16;MDM4;EGLN2;STUB1;TIGAR;SIRT2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.40751992479924115,0.9167165935596079,0.5662805662805663,0.9606414286611398,1.0,6/18,20.13%,SETD7;SETD2;EHMT2;PRDM9;SETD1B;KMT2A
prerank,regulation of protein polymerization (GO:0032271),0.3679124303626393,0.9165735765778763,0.6071005917159763,0.9604447254068063,1.0,13/35,21.98%,DBN1;MAPRE3;PFN2;CAMSAP1;MAPT;GBA2;FCHSD1;TPPP3;HSP90AA1;COTL1;RASA1;ABITRAM;CTTN
prerank,sterol homeostasis (GO:0055092),-0.23533324263848449,-0.9165309690603379,0.6363636363636364,0.8574084734687353,1.0,10/65,8.48%,CYP7B1;GRAMD1B;APOE;SCARB1;TTC39B;NR1H3;ABCG1;CAV1;LDLRAP1;EPHX2
prerank,histone exchange (GO:0043486),0.3631546365209996,0.9164814363257603,0.5852272727272727,0.9601525413552159,1.0,9/37,22.38%,CENPT;SPTY2D1;HJURP;NPM1;DMAP1;SRCAP;CENPC;ZNHIT1;VPS72
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.3993202727135774,0.9163735393361341,0.5871212121212122,0.9598834326644431,1.0,4/17,5.30%,VEGFA;FGF2;SLIT2;MIA3
prerank,dendrite morphogenesis (GO:0048813),0.36670648379817583,0.9161657875261389,0.6006984866123399,0.959848260103064,1.0,13/35,21.43%,EPHB2;DLG4;FARP1;EPHB3;TAOK2;MAP6;CTNND2;DIP2A;SDC2;CHRNA7;EPHB1;PTEN;ABITRAM
prerank,RNA modification (GO:0009451),0.3488564161928096,0.9159935134618478,0.6303162486368593,0.95972870831717,1.0,18/54,28.44%,ADARB1;ANKRD16;TRMT6;MEPCE;TRMT61A;FTSJ1;TRMT1;DTWD1;QTRT1;TYW5;TRUB1;METTL1;NOP2;TSR3;WDR4;FTSJ3;URM1;RBM15
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3237827824766534,0.9158128884291035,0.6804853387259858,0.9596355525589043,1.0,15/151,9.02%,ACKR3;CCL8;PRKCA;EGFR;CD44;PDE8A;FGF2;F2R;MIF;ADCYAP1;GAS6;PRKD2;NDRG4;TIRAP;CCL25
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3466306615049938,0.9157510129525311,0.630457933972311,0.9592688065245754,1.0,12/60,16.31%,HNRNPA1;FGF2;SMOC2;PRKD2;ACD;POLG2;CCT7;XRCC5;KLF4;HSP90AA1;RFC4;HGF
prerank,organelle organization (GO:0006996),0.31464260896059293,0.9153898826201781,0.745,0.9595534990879623,1.0,115/388,25.95%,SEC16B;ATP8B1;ARHGAP21;ARHGAP10;EIF2AK3;PLCE1;RAB32;ODF2;DIAPH3;PEX16;TMED1;BIN1;SEC31A;FBXW8;TOR1AIP2;ZRANB1;CLUH;ZW10;CHMP7;DST;MIA3;VPS4B;PLEKHF1;CENPT;LYSMD3;RAB30;PI4K2B;MAST4;SYNE1;MIEF2;PKD2;SURF4;LARP4;LMAN1;TOR1A;STX4;POLG2;RAB2A;SEC23IP;CAMSAP1;MICAL2;PRPF40A;LNPK;STX17;KIF3A;RAB43;CCL13;HPS6;PALLD;WDR73;FMNL3;DNAJA3;PEX12;FANCG;PTCD2;BCAS3;PEX1;GEM;DIAPH1;SEC61A1;FAM161B;ANK1;PEX3;BLZF1;HACE1;REEP5;PPIA;YTHDF1;YTHDF2;DYNC2H1;BCS1L;AUP1;VPS11;MICAL1;RANBP10;SLC25A36;ABCD3;SH3D19;ARFGEF1;TMED2;PLD2;VPS13D;CLASP2;NUMA1;PEX2;SLC25A33;ATP8B2;ZMYM3;TJAP1;PDCD6IP;GABPA;PI4K2A;YTHDF3;AFG1L;GOLPH3L;PACSIN2;PACSIN3;TRAPPC12;CNTNAP1;SYNE3;BNIP1;ESRRA;CFAP126;BAG5;RAB18;DMTN;CEP78;STX7;ATP5F1B;RAB29;ATL1;RHOT2;RAB1A;STRIP1;ZMYM6
prerank,histone deubiquitination (GO:0016578),0.4013160916133065,0.9152923782157092,0.5822622107969152,0.9592744440411449,1.0,5/18,20.88%,USP36;ATXN7L3;USP7;USP22;TRRAP
prerank,regulation of programmed cell death (GO:0043067),0.3204692483524362,0.9152826746476435,0.6881937436932392,0.958793002453827,1.0,28/161,15.90%,TNFSF9;RABGGTA;TRIAP1;GAS1;STEAP3;USP36;DDX42;CXCL10;TARDBP;AIFM2;HS1BP3;SLK;TIGAR;BEX2;LGALS1;ALPK2;BCL6;AKT1;ANP32B;GLS2;FLT3;BCL3;DNAJA3;NME2;HSP90AA1;RSL1D1;NOP53;MADD
prerank,fatty acid metabolic process (GO:0006631),0.3226996829571705,0.9150175427951314,0.6656410256410257,0.9588885327167017,1.0,27/115,22.15%,CEL;ACLY;ACOT6;CPT1C;ALKBH7;CRAT;SLC27A3;PON3;NDUFAB1;GPX1;FA2H;PNPLA8;ACOT1;HSD17B8;ACAD9;ACOX1;GPAM;LIPC;LIPH;NUDT19;ANGPTL3;ABCD3;MCAT;LPIN3;CPT2;PEX2;CROT
prerank,response to calcium ion (GO:0051592),0.3291743082395723,0.9149526998548985,0.6645962732919255,0.9585452871102986,1.0,13/102,9.18%,KCNMA1;SYT2;NEUROD2;CPNE8;ADAM9;SYT12;SYT11;SEC31A;SYT13;CAMK2D;PKD2;DPEP1;IQGAP1
prerank,negative regulation of phagocytosis (GO:0050765),-0.3185903314098165,-0.9148860085545182,0.5565217391304348,0.8597812741541162,1.0,4/17,4.53%,HMGB1;PLSCR1;SNX3;DYSF
prerank,positive regulation of cyclase activity (GO:0031281),-0.33977485949524233,-0.9148472416970052,0.5755102040816327,0.8581806118820371,1.0,5/14,12.96%,NOS3;CACNA1D;NOS1;MAPK8;MAPK3
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.34560623749207414,-0.9146917598699497,0.5384615384615384,0.8568483682093421,1.0,3/12,3.43%,F3;SNCA;APOD
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.45414526216196793,0.9145799361081103,0.6127167630057804,0.958871397464487,1.0,2/10,11.61%,MLXIPL;ELOVL5
prerank,lipid droplet formation (GO:0140042),-0.365477664697769,-0.9144792562301614,0.5508771929824562,0.855722071041651,1.0,4/10,21.70%,ZFYVE1;PLA2G4C;FITM2;CDS2
prerank,response to retinoic acid (GO:0032526),0.34059784055094566,0.9144389242387851,0.6294307196562836,0.958683982340488,1.0,7/59,8.19%,WNT10B;WNT2;EPHA3;WNT9A;RET;ABL2;FZD7
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3409960328163345,0.9144127587448196,0.6247288503253796,0.9582413066817326,1.0,16/59,21.82%,OSBPL3;ACLY;OSBPL2;SCP2;HSD3B7;OSBPL6;NDUFAB1;GAMT;ALDH1A3;HSD17B8;LIPC;LIPH;ABCD3;MCAT;HSD17B4;SRR
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.43747826044426125,0.9142988918680277,0.590027700831025,0.9580031467032812,1.0,4/12,27.82%,GNL3L;CCT7;CCT4;CCT6A
prerank,potassium ion import across plasma membrane (GO:1990573),0.3587901164524171,0.91424657931679,0.6175478065241845,0.957609507052087,1.0,10/41,13.35%,ATP1A3;ATP1A4;ATP1A1;SLC12A8;KCNJ2;SLC12A4;KCNK9;HCN4;SLC12A5;KCNJ3
prerank,regulation of calcium-mediated signaling (GO:0050848),0.375963306286652,0.9141123371313038,0.5990159901599016,0.9574080706126218,1.0,6/25,17.71%,NEUROD2;P2RX3;RIT2;MAPT;SLC8A2;TMBIM4
prerank,regulation of mRNA catabolic process (GO:0061013),0.3265669056121361,0.9136066103111006,0.6629327902240326,0.9579595775214986,1.0,47/121,31.72%,PRKCA;PKP3;PSMC4;ZFP36L1;SAMD4B;PSMC6;RC3H1;CARHSP1;ZFP36L2;PSMD8;HNRNPD;EXOSC7;ZC3HAV1;AKT1;PUM1;IGF2BP1;UBA52;ZFP36;ZC3H12A;EXOSC1;FXR2;YTHDF1;YTHDF2;SET;RC3H2;YWHAB;YTHDF3;PSMD3;PSMD4;RBM24;TNPO1;PSMB3;DCP1A;EIF4G1;UPF1;PSMB2;PSMD5;IGF2BP3;SERBP1;HSPA8;EXOSC3;PSMD14;PSMC3;PSMC5;CNOT8;FXR1;PSME4
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3272053975031461,0.9133454026824268,0.6846388606307223,0.9580360347362208,1.0,17/117,14.19%,SYK;VIPR2;FYN;MAPK14;GLP2R;SRC;ADCYAP1;DPEP1;CRHR1;CD81;GPR20;CALCA;GPR45;TSHR;ADCY8;GNB1;LHCGR
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.35679109593545644,0.9132918769696634,0.604494382022472,0.957662742693646,1.0,14/41,26.25%,FGF2;F2R;TRPV3;ATP2B4;GRIN2D;PKD2;SLC8A2;GRIN2A;HTR2C;IBTK;HTR2A;CACNA2D1;TRPV2;SLC24A2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.35419568505201154,0.9131664327479666,0.6179138321995464,0.9574416531207081,1.0,5/43,5.94%,WT1;FGF2;TGFB2;NFATC4;NFIB
prerank,plasma membrane invagination (GO:0099024),0.37426551688088716,0.9130065158488733,0.6057803468208093,0.957315941357585,1.0,1/29,0.45%,GSN
prerank,zinc ion transport (GO:0006829),0.3901819015057856,0.9129292826783305,0.5782983970406905,0.9569911489480024,1.0,6/21,19.98%,SLC39A13;SLC39A14;SLC39A7;SLC30A9;SLC30A5;SLC39A3
prerank,regulation of cellular response to stress (GO:0080135),0.3232198907277465,0.912668583268491,0.6628982528263104,0.957060904667479,1.0,39/115,26.18%,CORO2B;NUP93;MTOR;CAMK2D;DNAJC2;NUP107;AIFM2;YWHAE;NUP98;NPM1;CEBPB;MAPT;ADCY8;HSP90AA1;AMFR;HSBP1;NUPR1;CHORDC1;MANF;RSL1D1;NUP37;BAG4;NEK4;FKBP4;NUP50;MCL1;MAPK1;DNAJB1;ATF4;BAG3;USP19;TPR;CRYAB;BAG5;NUP133;NUP85;HSPH1;NUP188;EIF4G1
prerank,glucose import (GO:0046323),-0.3385842963107671,-0.9125775919604647,0.5625,0.858786170396615,1.0,2/13,1.84%,SORT1;SLC2A1
prerank,cellular response to glucose stimulus (GO:0071333),0.37570429828797514,0.9122725131408127,0.5909090909090909,0.9574320960620001,1.0,6/30,12.54%,RAB11FIP5;SLC39A14;MLXIPL;GAS6;ERN1;ADCY8
prerank,photoperiodism (GO:0009648),0.37532434797381187,0.9120320767617316,0.6242568370986921,0.9574420818877633,1.0,12/28,30.09%,BHLHE40;RBM4;FBXL3;PER1;PPP1CC;PML;PER3;FBXL12;CRY2;CRTC1;TP53;FBXL8
prerank,negative regulation of protein polymerization (GO:0032272),0.37989513382750906,0.911690493631143,0.6031363088057901,0.9577242836421678,1.0,11/27,21.54%,SLIT2;MYADM;PFN2;TWF1;KANK1;MAPRE1;SSH1;TUBB4A;CLIP3;ARFGEF1;SSH3
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4214871437664092,0.9101844625564709,0.6061415220293725,0.9605613081151061,1.0,3/13,9.48%,FGFR1;FGF2;AKT3
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.41737994860224237,0.9101385084371821,0.5904887714663144,0.9601704818524369,1.0,1/15,1.09%,SRM
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3982138399148712,0.9100351214606176,0.6017699115044248,0.9599002507239852,1.0,7/21,14.04%,ANK2;SRI;CAMK2D;GSTM2;PDE4D;CALM2;CASQ1
prerank,regulation of viral release from host cell (GO:1902186),0.38888580632018993,0.9098890775471326,0.60875,0.9597025756089658,1.0,7/21,23.61%,MID2;TRIM11;DDB1;PML;VPS37B;TRIM35;TRIM8
prerank,mitochondrial membrane organization (GO:0007006),0.37146695484273573,0.9097008905910557,0.6168539325842697,0.9595977715217036,1.0,10/32,21.87%,TIMM50;SLC25A31;SLC25A4;BAK1;GHITM;SPG7;RCC1L;MICOS10;APOOL;IMMT
prerank,negative regulation of receptor internalization (GO:0002091),0.4445000557149979,0.9096985732700282,0.6007905138339921,0.9591111403725425,1.0,2/12,7.91%,DLG4;ATXN2
prerank,aortic valve development (GO:0003176),0.36547468762393037,0.9096933338175656,0.6228172293364377,0.9586314787357809,1.0,9/34,16.59%,SLIT3;SLIT2;ELN;NFATC1;JAG1;SMAD6;TWIST1;TNFRSF1B;SNAI2
prerank,thymus development (GO:0048538),0.42881672835499035,0.9096666845507494,0.6177658142664872,0.9582070283855328,1.0,6/13,27.07%,ZBTB1;EPHB3;SIX1;TGFBR1;FGF10;HES1
prerank,histone lysine methylation (GO:0034968),0.3689034650941257,0.9093399135519612,0.6247030878859857,0.9584323477862069,1.0,15/33,28.36%,CXXC1;DPY30;WDR5;EHMT2;PRDM9;SETD1B;KMT2A;N6AMT1;EZH2;SETDB1;SETDB2;WDR5B;MEN1;SUV39H1;PRDM5
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.4326917858065834,0.909186804244924,0.5915300546448088,0.958271811867582,1.0,3/12,12.08%,BIN1;DSC2;JUP
prerank,positive regulation of positive chemotaxis (GO:0050927),0.40927400758812726,0.9089759109357022,0.5945241199478487,0.958225181050037,1.0,2/15,2.76%,IL16;VEGFA
prerank,apical protein localization (GO:0045176),0.4505791037145026,0.9083945609106748,0.5988700564971752,0.9590111112366876,1.0,5/10,20.66%,ATP8B1;JAM3;VANGL2;GOPC;SHROOM3
prerank,glycoprotein metabolic process (GO:0009100),0.3400146933757925,0.9083134659222694,0.6237623762376238,0.9586828180764866,1.0,10/53,15.68%,PCSK6;ST3GAL2;OGA;FBXO2;FBXO17;LARGE1;ST3GAL4;TNIP1;MGAT4B;NGLY1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.33816540951729457,0.907851900375575,0.6323210412147505,0.9591607346593373,1.0,17/64,22.52%,MYOC;EFNA5;EPHA3;SLK;JAG1;CCL25;SLC9A1;JUP;ADAM15;RHOA;HOXA7;ACTG1;RASA1;CORO1C;CSF1;NF1;LDB1
prerank,negative regulation of RNA splicing (GO:0033119),0.3991793648759436,0.9078165542229018,0.5914786967418546,0.9587454627899965,1.0,8/19,28.31%,SRSF6;C1QBP;SAP18;U2AF2;PTBP1;PTBP2;RBMX;RPS26
prerank,cellular response to topologically incorrect protein (GO:0035967),0.36866294374946934,0.9073747085428084,0.6305361305361306,0.959173317616373,1.0,7/31,15.32%,HDAC6;STUB1;HSPA13;UBE2W;ERN1;BAK1;HSPA14
prerank,ncRNA transcription (GO:0098781),0.4211596260803043,0.9068499107023613,0.5994623655913979,0.9598151412335437,1.0,4/13,21.73%,ANG;POLR1G;BRF1;SPIN1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.44682735114743344,0.9068327052576343,0.5827439886845828,0.9588713581896143,1.0,1/10,9.45%,CNGB1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.44682735114743344,0.9068327052576343,0.5827439886845828,0.9588713581896143,1.0,1/10,9.45%,CNGB1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.37306625764727164,-0.9066628446388149,0.5714285714285714,0.8713459540435917,1.0,4/10,28.61%,CAV1;KCNE4;ANK3;KCNAB1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.4150238724768537,0.9065883633240117,0.6135458167330677,0.9589225280676887,1.0,5/15,24.72%,NYNRIN;NUDT16;ZC3H12A;RPP30;KHNYN
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.38987308924454356,0.9065832664036032,0.6188118811881188,0.9584458892790202,1.0,4/21,13.56%,MED24;MITF;MED13;TWIST1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.33164978782500404,0.9065476683939945,0.6435331230283912,0.9580354248918299,1.0,22/76,22.77%,IRAK3;ITCH;PRMT2;CHUK;IRAK1;NWD1;COMMD6;ZC3H12A;KLF4;USP7;CHP1;NLRP2B;TRAF3;RBCK1;ANXA4;UFL1;TAX1BP1;DAP;PYCARD;ARRB1;CYP1B1;CYLD
prerank,negative regulation of interleukin-1 production (GO:0032692),0.3852865913060887,0.906099117944551,0.5865504358655044,0.9585040772394361,1.0,4/23,15.94%,CARD16;GAS6;ZC3H12A;NLRP2B
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.36294544243515664,0.9055995671283784,0.6375291375291375,0.9590581044309703,1.0,9/37,17.66%,S100A8;S100A9;SIAH1;BMF;BBC3;NACC2;NUPR1;NCK1;BCAP31
prerank,regulation of chemotaxis (GO:0050920),-0.2705728568602533,-0.9053567274943379,0.6217948717948718,0.8727533841636949,1.0,9/30,14.69%,EFNB2;ZSWIM6;THBS1;USP14;PDGFRB;PTPN2;TGFB1;PPM1F;ADGRA2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.29462357875097855,-0.9050422862334389,0.6462264150943396,0.8700698951932252,1.0,3/21,2.46%,EYA1;BCL2L1;BCL2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.29462357875097855,-0.9050422862334389,0.6462264150943396,0.8700698951932252,1.0,3/21,2.46%,EYA1;BCL2L1;BCL2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.38376509945239984,0.9048367007410283,0.6027742749054225,0.9602033473018082,1.0,6/23,15.06%,FYN;ANK2;CAMK2D;CASQ1;DIAPH1;CACNB1
prerank,amyloid-beta metabolic process (GO:0050435),-0.31768719873409057,-0.9047930229615462,0.5313807531380753,0.8690245985992693,1.0,3/16,3.36%,BACE2;MGAT3;DYRK1A
prerank,phagosome maturation (GO:0090382),0.3558088790613735,0.9047517924574987,0.6266044340723453,0.9599101340374915,1.0,7/35,16.13%,RAB32;ATP6V0A2;ATP6V1E1;RAB43;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,iron ion homeostasis (GO:0055072),0.337075193018007,0.9045246825911702,0.6391304347826087,0.9598990134043335,1.0,12/58,19.69%,SCARA5;SMAD4;ATP6V0A2;SLC11A2;NDFIP1;ATP6AP1;CCDC115;BDH2;FLVCR1;FBXL5;NEDD8;TMEM199
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.3411950572376899,0.9043473639082235,0.6531049250535332,0.9597899168235023,1.0,9/67,9.97%,NCF4;PSMC4;ITGB5;SEC22B;PSMC6;CHUK;PSMD8;SNAP23;ITGAV
prerank,hexose biosynthetic process (GO:0019319),0.350148683120462,0.9043306944396087,0.6177829099307159,0.9593369192424124,1.0,3/42,4.59%,AKR1B1;CRTC2;SLC39A14
prerank,icosanoid secretion (GO:0032309),0.42828081953821984,0.9043047233984668,0.6058981233243967,0.958901597548552,1.0,2/12,11.43%,ANXA1;PNPLA8
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3203070756735921,0.9041463377480494,0.6970618034447822,0.9587454823856323,1.0,24/140,10.44%,TRIP10;ARHGAP21;ARHGAP10;ARHGAP44;AKAP13;PLCE1;SLIT2;PIK3R2;RASGRF1;TRIO;SRGAP1;SRC;ARHGEF3;MYO9B;FLCN;MYO9A;OCRL;ARHGAP9;TAGAP;RHOJ;ITGAV;TIAM2;RHOQ;SQSTM1
prerank,negative regulation of cilium assembly (GO:1902018),0.43203067004423484,0.9041297740466647,0.6022099447513812,0.9582932109457625,1.0,5/12,18.49%,CEP97;MAP4;EVI5L;CCP110;ODF2L
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3171291295628784,0.9039719418794618,0.719758064516129,0.958138053069598,1.0,49/166,25.24%,AR;ESR1;POLR2H;GTF2H3;HDAC9;HDAC7;WWTR1;TAF8;NR1D2;NR1D1;POLR1G;BRF2;VDR;NR6A1;CDK9;KAT2B;HDAC3;TAF3;UBTF;ERCC3;POLR2D;POLR2G;NCOR2;NCOR1;GTF2A2;CCNH;BRF1;GTF2F1;NR2C2;E2F3;POLR3H;MED23;NR2C2AP;GTF2E2;POLR1C;RRN3;RORA;MED7;TBP;TAF13;NR3C1;ESRRA;NCOA6;POLR1B;POLR2C;RARA;GTF2E1;MED26;NRBP1
prerank,purine-containing compound salvage (GO:0043101),0.4313761717557846,0.9035668920944883,0.6102841677943166,0.9584788643092533,1.0,1/12,2.31%,AMPD2
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.2949558895272797,-0.9034229093597532,0.5885416666666666,0.8704989923534522,1.0,1/20,0.16%,NR2F2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.31800997545961496,0.9032798624176006,0.6971544715447154,0.9585867604279016,1.0,29/132,20.29%,DCN;IRS1;ADAM9;MID2;DACT1;ITCH;FOXO1;PLEKHF1;MLXIPL;RC3H1;FLCN;PSEN1;ZC3HAV1;SLC4A4;IRS2;TWIST1;TNFRSF1B;ULK1;ZC3H12A;HSP90AA1;DAGLB;TRIM68;ZSWIM8;UFL1;VPS11;SUPV3L1;GPLD1;SH3D19;ATF6
prerank,histone deacetylation (GO:0016575),0.34942721409773986,0.9024031883759315,0.6429378531073446,0.9599710760383314,1.0,12/43,20.07%,HDAC9;HDAC6;SIN3B;MSL3;SIRT2;RCOR3;HDAC3;HDAC4;PER1;MORF4L1;SUDS3;MIER1
prerank,defense response to protozoan (GO:0042832),0.43210805565840027,0.9023451251885333,0.6067567567567568,0.9596046156198887,1.0,1/12,1.14%,IRF4
prerank,response to amyloid-beta (GO:1904645),0.348901596529213,0.9023408947738258,0.6404867256637168,0.9591341742523922,1.0,11/44,17.99%,LRP1;FYN;MMP2;ATP1A3;PSEN1;TLR4;ABCC1;CACNB1;GRIN2A;CHRNA7;SNX6
prerank,negative regulation of apoptotic process (GO:0043066),0.30956724712250855,0.9020180221111912,0.816,0.9593379855224483,1.0,91/444,20.75%,COMP;FSTL1;AXL;GCLC;ARHGAP10;PRKCA;EGFR;ANXA1;TGFB3;WT1;HPN;ANGPT4;TRIAP1;SIX4;CD44;VEGFA;F2R;MIF;ATF5;COPS5;ITGA5;CLCF1;NFATC4;ITCH;SOCS2;CBX4;FOXO1;CARD16;ARF4;SRC;GAS6;DPEP1;SOX8;YWHAE;PIK3CA;PSEN1;AVEN;NRBP2;SMAD6;SON;SQSTM1;HDAC3;NPM1;GPX1;AKT1;IRAK1;NAT8;UBA52;CD27;SFN;GDNF;BCL3;WDR73;SIX1;NME2;CBL;ZC3H12A;KLF4;IL4;NUPR1;VDAC1;BAG4;AHI1;IL6;HGF;ANXA4;SNAI2;TAX1BP1;PTRH2;ERCC5;FAIM2;SET;TMBIM4;PLAUR;QARS1;SNX6;NAA15;VTCN1;UFM1;SUPV3L1;PRDM9;DSTYK;MCL1;IL31RA;HIPK3;RASA1;FLNA;PRELID1;DDAH2;OPN3;TYRO3
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.43740016170375834,0.9020159434771471,0.598893499308437,0.9588588544723008,1.0,7/12,27.25%,SLIT2;MIA3;AKT1;NBL1;CCN3;DUSP1;WASL
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.4059943359164051,0.9019257290854669,0.6152866242038216,0.9585651129784848,1.0,5/18,16.30%,SMAD4;SRC;CBL;FER;IL6
prerank,striated muscle cell development (GO:0055002),-0.3262418994510713,-0.9017163302564177,0.6219512195121951,0.8729244491882471,1.0,2/14,6.57%,PGM5;TMOD3
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3181503309266074,0.9016888338028087,0.7221664994984955,0.9585474205027671,1.0,24/163,16.35%,SYK;LAX1;PRAM1;PSMC4;FYN;RFTN1;PIK3R2;PTPRJ;CSK;PSMC6;RC3H1;UBE2N;PRKD2;CHUK;PIK3CA;PSMD8;FYB2;PDE4D;PLEKHA1;ZC3H12A;MOG;BTN3A3;RBCK1;NCK1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.3494476309092276,-0.9015364178459895,0.5740740740740741,0.8717002321439605,1.0,3/12,8.76%,DPYD;CTPS1;CTPS2
prerank,regulation of neutrophil migration (GO:1902622),0.4373967147033604,0.9014403531516008,0.5897435897435898,0.9586001153824251,1.0,2/10,11.70%,JAM3;MPP1
prerank,receptor catabolic process (GO:0032801),0.38170288949780323,0.9010472910794327,0.6099033816425121,0.9590014970904347,1.0,4/24,8.76%,AP2A2;MVB12A;CLTC;MYLIP
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.34282552998718885,0.9010159734648965,0.6341991341991342,0.9585823232990891,1.0,23/52,29.45%,UBE2J2;USP36;YWHAG;YWHAE;HPS4;PPP3CC;SFN;NPEPPS;BBC3;HTRA2;VPS11;ARIH2;ATG13;UBE2D3;SAE1;YWHAB;CSNK2A2;LEPROT;FBXW7;RNF31;CASP8;SREBF2;TP53
prerank,regulation of cholesterol transport (GO:0032374),0.39264656825992617,0.9009203960097962,0.6188630490956072,0.9583036099474356,1.0,3/20,9.72%,LRP1;ABCA13;OSBPL6
prerank,neuron projection fasciculation (GO:0106030),0.44656863997654545,0.900830558063992,0.6109510086455331,0.9580100583202168,1.0,2/10,10.29%,EPHB2;EPHB3
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.37654026110698335,0.9005466523646882,0.6154791154791155,0.9580921377991524,1.0,9/24,19.04%,UBE2B;PDE11A;CGAS;PDE4D;CDC34;PDE3B;PEX5L;TCP11;PRKAR2A
prerank,negative regulation of programmed cell death (GO:0043069),0.3091595398431106,0.9000806021905572,0.782,0.9585897203746789,1.0,72/355,20.68%,COMP;FSTL1;AXL;GCLC;ARHGAP10;EGFR;ANXA1;WT1;HPN;ANGPT4;TRIAP1;SIX4;CD44;VEGFA;MIF;ATF5;COPS5;ITCH;SOCS2;CBX4;FOXO1;ARF4;SRC;AIFM2;GAS6;DPEP1;SOX8;TIGAR;PSEN1;AVEN;SMAD6;SON;SQSTM1;HDAC3;NPM1;AKT1;IRAK1;NAT8;UBA52;CD27;GDNF;BCL3;WDR73;NME2;CBL;IL4;NUPR1;VDAC1;BAG4;AHI1;IL6;HGF;ANXA4;TAX1BP1;ERCC5;FAIM2;TMBIM4;PLAUR;NAA15;VTCN1;UFM1;SUPV3L1;PRDM9;DSTYK;MCL1;IL31RA;HIPK3;RASA1;FLNA;PRELID1;DDAH2;OPN3
prerank,regulated exocytosis (GO:0045055),0.3166890777941916,0.9000549461672621,0.7297297297297297,0.9581591444803893,1.0,35/173,20.69%,RAB11FIP5;CD9;SCIN;TGFB3;SYT2;CLEC3B;SPARC;ITGB3;VEGFA;TGFB2;ECM1;STX1A;SYT12;SYT11;SYT13;GTPBP2;GAS6;EGF;SERPING1;SNAP25;TUBA4A;RAB27B;MANF;LGALS3BP;SNAPIN;HGF;SYT1;VAMP2;RIMS2;ALDOA;PPP3CB;APOOL;QSOX1;FLNA;RAB10
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.37619625534367657,0.8998287015044891,0.5957446808510638,0.9581529300590008,1.0,3/22,10.94%,CD160;PTPRJ;UBASH3A
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3932409409315193,0.8997338284561739,0.6038461538461538,0.9578635953871059,1.0,10/19,29.17%,PARD3B;DLG2;FSCN1;SYNJ2BP;MARK2;MTCL1;CRB1;LRRC7;PRKCI;PARD3
prerank,positive regulation of protein localization to membrane (GO:1905477),0.32303353605141033,0.8995664201094437,0.6728205128205128,0.9577364646244164,1.0,20/98,16.15%,EPHB2;EGFR;LRP1;EPHA3;FYN;ATP2B4;MIEF2;YWHAG;CD81;YWHAE;STX4;SQSTM1;PPP3CC;AKT1;SFN;BBC3;ARF6;CHP1;PLS1;SPTBN1
prerank,Golgi ribbon formation (GO:0090161),-0.3291655612681441,-0.8995031830133147,0.6111111111111112,0.874899008411037,1.0,6/13,18.05%,STX6;MYO18A;OPTN;GCC2;GOLGA2;TRIP11
prerank,negative regulation of heart contraction (GO:0045822),-0.36175018628759154,-0.8994011978151473,0.6133828996282528,0.8734638273599102,1.0,1/11,0.02%,ATP1A2
prerank,T cell differentiation (GO:0030217),-0.24650227800642718,-0.8993918436541408,0.6504065040650406,0.8717984752889549,1.0,10/40,13.69%,CHD7;SOX13;KIT;TCF7;JAG2;PIK3CD;RHOH;PTPN2;GPR89B;GPR89A
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.426270549095577,0.8992149417025139,0.6002766251728907,0.9579792952043129,1.0,1/11,3.49%,RUNX1
prerank,mitochondrion localization (GO:0051646),0.39246812981504436,0.8982501073457796,0.606826801517067,0.9594896661230736,1.0,6/19,26.47%,TLE6;TRAK2;ATCAY;MARK2;MTM1;MUL1
prerank,retina homeostasis (GO:0001895),-0.29044262508565744,-0.8982135366980362,0.6108108108108108,0.8727734300615,1.0,7/23,16.98%,ACTB;POTEF;B2M;WHRN;PRDX1;HSPB1;SOD1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.37714511904953585,0.8979694697991399,0.6007416563658838,0.9595697054155927,1.0,9/21,24.32%,RASSF2;MLXIPL;INPP5K;PDE4D;NLRP2B;NCK1;PTEN;NCK2;DMTN
prerank,regulation of microglial cell activation (GO:1903978),0.41039595708754745,0.8976831110008817,0.5954907161803713,0.9596850882316548,1.0,4/15,22.53%,SYT11;NR1D1;IL6;LDLR
prerank,RNA methylation (GO:0001510),0.3328829467686213,0.8976640454679428,0.6631016042780749,0.9592450166884711,1.0,9/60,13.28%,DIMT1;TRMT6;TYW3;MEPCE;TRMT61A;FTSJ1;TGS1;THADA;ZCCHC4
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.2684716829705906,-0.8974536912737614,0.6184971098265896,0.8728844521397744,1.0,9/27,16.89%,PRKCH;PPARA;NR1H3;ABCG1;AGTR1;NFKBIA;MAPK9;LPL;ABCA5
prerank,positive regulation of cell cycle process (GO:0090068),0.32593677471071947,0.8967480715158767,0.6787190082644629,0.9606669011117642,1.0,18/91,15.34%,GPSM2;CDC14B;BTC;XRCC3;SVIL;RHNO1;DYNC1LI1;CUL3;SIRT2;NUDT16;KIF20B;EGF;RHOA;DDX11;DBF4;INO80;GIPC1;DYNC1H1
prerank,response to leucine (GO:0043201),0.44444165286468507,0.8963646764376069,0.6067415730337079,0.9604684860096998,1.0,6/10,22.86%,MTOR;SESN3;RRAGD;SESN2;UBR2;KLHL22
prerank,cellular response to leucine (GO:0071233),0.44444165286468507,0.8963646764376069,0.6067415730337079,0.9604684860096998,1.0,6/10,22.86%,MTOR;SESN3;RRAGD;SESN2;UBR2;KLHL22
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.3312462831979719,-0.8961213719053486,0.6138996138996139,0.8743507570521828,1.0,6/14,14.27%,STARD13;THBS1;NOTCH1;PDCD10;TBXA2R;HDAC5
prerank,protein localization to plasma membrane (GO:0072659),0.3162472019699234,0.8958093944500005,0.6945010183299389,0.9611267139959712,1.0,22/129,13.74%,LRP6;TTC7A;TSPAN17;PKP3;PRAM1;ANK2;FGF13;S100A10;NECTIN3;PLEKHF1;MYADM;MYO5A;GAS6;PACS2;CD81;EHD2;INPP5K;FYB2;RAB3D;JUP;ZDHHC2;PIGW
prerank,regulation of sprouting angiogenesis (GO:1903670),0.35912949804893846,0.8956454174981334,0.6355140186915887,0.9609719806628598,1.0,6/33,5.66%,FGF18;VEGFA;FGF2;ITGA5;KLF2;CREB3L1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.43388086605949316,0.8946450756051967,0.6297376093294461,0.9625504860948426,1.0,4/10,22.09%,ACD;TFIP11;DCLRE1A;TERF2IP
prerank,glycolipid biosynthetic process (GO:0009247),0.35711771622104305,0.8945571899635785,0.6318807339449541,0.9622439182093174,1.0,8/38,14.92%,ST3GAL2;PIGZ;PIGC;LARGE1;ST3GAL4;MPPE1;PIGW;PIGM
prerank,neutral amino acid transport (GO:0015804),0.36415947512126934,0.8935835991479036,0.6282352941176471,0.9637917162763718,1.0,2/28,5.23%,SLC1A5;SLC43A2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.35346938480576484,0.893425298129556,0.6405152224824356,0.9636436899226829,1.0,3/34,9.18%,EPHB2;CLCF1;STX4
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3304411114982137,0.8933539475989435,0.6680805938494168,0.9633090449644595,1.0,22/72,23.19%,FGF13;SLIT2;SMAD4;MYADM;PFN2;CHADL;PIK3CA;TWF1;KANK1;MAPRE1;SSH1;CAMSAP1;TUBB4A;PFDN6;IAPP;NAV3;CLIP3;ARFGEF1;CLASP2;SSH3;LDLR;CRYAB
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.318815582588975,0.8933279724024916,0.7286585365853658,0.9628821198484163,1.0,33/124,25.16%,SFRP4;CCDC88C;PSMC4;SMURF2;TCF7L2;NFATC1;AP2A2;PSMC6;CLTC;FZD7;PARD6A;PSMD8;AGO2;VANGL2;RHOA;GNB1;PPP3CA;FZD4;AGO4;DAAM1;SFRP5;PPP3CB;AGO3;TIAM1;GNAO1;SMURF1;MAP3K7;AP2M1;TNRC6A;PSMD3;DVL1;PSMD4;RAC1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3993229092484731,0.8932701573867109,0.6168582375478927,0.9625178125253682,1.0,4/18,12.54%,VEGFA;CRTC2;PRKD2;ADCY8
prerank,regulation of synapse assembly (GO:0051963),0.3475981220461037,0.8931997510457804,0.6726057906458798,0.9621856712360521,1.0,9/46,15.06%,EPHB2;GPC6;SLIT1;EPHB3;MUSK;SYNDIG1;SETD5;LRFN5;MDGA1
prerank,protein mannosylation (GO:0035268),-0.2797670073239422,-0.8931738866679688,0.5876288659793815,0.8795363492111188,1.0,6/22,13.39%,TMTC1;TMTC4;TMTC2;DPY19L4;FKRP;POMT2
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.4426723591264982,0.8930914134901363,0.6260387811634349,0.9619232160430855,1.0,1/10,0.47%,LRP6
prerank,protein-containing complex assembly (GO:0065003),0.3081595603401996,0.8928492325551238,0.7687687687687688,0.9619229038729703,1.0,79/259,27.80%,AREG;SEC16B;SEC24D;CNIH3;WIPF1;STX5;LLGL1;DLG4;GPAA1;AXIN1;SEC31A;ZW10;TCF7L2;PREB;ZNHIT6;SEC24A;WASF1;FARP2;SEC22B;MDM4;TFG;SEC23A;USO1;MCU;LMAN1;CUL3;SCFD1;TLE2;MITF;SEC23IP;NAPA;SLC9A1;ADCY8;CNIH1;TRAPPC2L;CDC123;ZC3H12A;BCL9;SMARCA4;NSF;TFAP4;PML;SPG7;NAPG;SEC24B;RAB1B;EPRS1;BLM;PYGO2;VAMP2;TMED2;LAMC1;KMT2A;TIAM1;TRRAP;PPP6C;TRAPPC6B;AP2M1;PYGO1;DMTN;NDUFAF1;MDM2;KAT5;TRAPPC4;RAB1A;PPIH;TCF7L1;HGSNAT;GOSR2;KIFAP3;KLHL12;TRAPPC2;HES1;GORASP1;VAMP3;WASL;MEN1;PDE4DIP;CASP8
prerank,histone H3-K4 methylation (GO:0051568),0.36629782400360755,0.8928327682348529,0.6201456310679612,0.9614789598157393,1.0,8/26,20.13%,CXXC1;DPY30;WDR5;OGT;PRDM9;KMT2C;SETD1B;KMT2A
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.3350515682776134,-0.8920373011965105,0.5846153846153846,0.8804760038502422,1.0,4/12,17.01%,HUS1;TOPBP1;SETMAR;ORC1
prerank,organophosphate ester transport (GO:0015748),0.379459566031606,0.8919628002529193,0.6333333333333333,0.962825937314101,1.0,9/24,22.53%,TRIAP1;OSBPL2;PRELID3A;SCP2;EPG5;PITPNM1;PRELID1;PCTP;LDLR
prerank,mitotic sister chromatid segregation (GO:0000070),0.32051618552086947,0.8917822650823152,0.6841025641025641,0.9627170239161956,1.0,24/98,23.10%,DIS3L2;ZW10;CHMP7;PSRC1;VPS4B;TENT4A;ZWINT;CUL3;SMC1A;CDC23;PIBF1;NCAPG;INO80;SMC2;SET;NAA50;CENPE;NIPBL;AKAP8L;PDCD6IP;DCTN2;KLHL22;CSNK2A2;TUBG2
prerank,fatty acid transport (GO:0015908),-0.31435303434251327,-0.891662133943238,0.6125,0.8797135169534592,1.0,2/17,2.45%,ACSL1;APOE
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.30408617071779487,-0.8914789062061478,0.6228813559322034,0.8784235944036423,1.0,6/16,18.03%,DCPS;CWC15;SNRNP200;SRSF12;SRSF1;WBP4
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3336685432035483,0.89085028012378,0.6561822125813449,0.9641365233387349,1.0,14/62,15.56%,POLR2H;GTF2H3;ADRM1;CDK9;ELP4;SETD2;ERCC3;POLR2D;POLR2G;CCNH;EAF2;CTDP1;GTF2F1;EAF1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.30875596477836154,0.890847193071343,0.798,0.963665470761522,1.0,59/306,18.38%,RPSA;ST3GAL2;POLR2H;MRPS11;RRBP1;TIPIN;EXT1;COPS5;EEF2K;MRPS18B;IGHMBP2;INHA;NT5M;GTPBP2;RHNO1;PPP5C;MRPL13;MRPS17;AGO2;POLE3;ING4;MCM3;LARGE1;FUT9;GSPT2;RPL10A;RMI1;MRPL10;MRPL55;ST3GAL4;TNIP1;RAD1;PCLAF;POLR2D;POLR2G;RPS5;BCL3;DNA2;BRIP1;MRPL36;ORC6;DBF4;NBN;MRPL3;FAM111A;GSPT1;RPL6;MRPL51;RFC4;EEF1B2;GRWD1;HARS1;EEF1G;ABCF1;RAD50;SET;BLM;TBRG1;POLD1
prerank,melanosome localization (GO:0032400),-0.2848412574746541,-0.8906828378878711,0.6194690265486725,0.8785725268196277,1.0,8/21,17.83%,SHROOM2;BLOC1S5;RAB11A;BBS7;MREG;RAB27A;BLOC1S6;MLPH
prerank,positive regulation of establishment of protein localization (GO:1904951),0.39098553020333154,0.8903467948869855,0.615681233933162,0.9642105061422581,1.0,7/19,30.56%,CORO2B;CCT7;CHP1;CCT4;CCT6A;CENPJ;CEP295
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.3499959119434727,0.8901833749748131,0.6397228637413395,0.9640689811959324,1.0,8/37,18.38%,GTF2H3;ERCC3;UBA52;ERCC4;DDB1;RFC4;ERCC5;POLD1
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.31724996152720686,-0.8901452109937142,0.6026200873362445,0.8782445355906907,1.0,5/16,10.53%,BMP7;SOX13;NAPEPLD;PTGS2;SIRT1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.41235940236982693,0.8900100295259789,0.6253333333333333,0.9639357476311752,1.0,5/14,22.09%,ACD;TPP1;XRCC5;TINF2;TERF2IP
prerank,positive regulation of protein acetylation (GO:1901985),-0.33684544548224227,-0.8899217418038098,0.5854545454545454,0.8770446687558686,1.0,2/12,4.22%,RAPGEF3;PRKAA2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3599065735112908,0.8899102887710255,0.6366863905325444,0.9636416139994065,1.0,13/31,29.17%,PARD3B;DLG2;MYO9A;RHOA;ANK1;SYNJ2BP;PDCD6IP;MARK2;MTCL1;CRB1;LRRC7;PRKCI;PARD3
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.3079908805896078,-0.8898848558781133,0.6371308016877637,0.8755171363736666,1.0,6/16,22.37%,SSBP1;PURA;WRN;MCMDC2;TWNK;RAD51
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.33018614789133877,0.8898510232974597,0.6849462365591398,0.9633022635518507,1.0,10/62,12.43%,COL3A1;AKAP13;F2R;LPAR1;RASGRF1;RASGEF1A;ARHGEF3;GPR20;IRS2;SHOC2
prerank,telomere organization (GO:0032200),0.3382878307188645,0.8897923269125914,0.6534988713318285,0.9629474480970227,1.0,12/43,18.66%,PARP3;CTC1;ACD;ERCC4;XRCC5;TERF1;DNA2;NBN;RAD50;BLM;POLD1;TINF2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3047946958596501,0.8895570735710778,0.835,0.9629700815165588,1.0,90/417,19.32%,PAX9;GCLC;ATP8B1;LOXL2;FOXP2;WT1;ZC3H8;SIX4;FOXP1;BHLHE40;GLIS2;SMAD4;HDAC9;ATF5;DPF2;SMURF2;TSC22D4;FOXK2;NAB1;TCF7L2;NR1D2;CBX4;RBAK;CREB3L1;FOXO1;NR1D1;PRMT2;CREBZF;DPF1;MLXIPL;HDAC6;ZFPM2;GAS6;MDFIC;SOX8;VDR;MAGEL2;SIRT2;RCOR3;CIPC;KDM5C;ING4;INPP5K;TLE2;BRD7;CALCA;PHC3;PHC1;HDAC3;SAMD1;MPHOSPH8;SMARCC2;BCL6;ZHX2;RBFOX2;GLI3;XRCC5;NCOR2;NCOR1;BCL3;CBFA2T2;TWIST1;NACC2;HDAC4;DMAP1;KLF4;HOXA7;IL4;GMNN;SMARCA4;CHD8;YEATS2;BAHD1;PDCD4;PER1;TFAP4;ZEB1;DKK3;PML;SAP18;SET;QARS1;SNX6;DAP;GCFC2;CTCF;NIPBL;BTAF1;SUDS3;RING1
prerank,negative regulation of protein processing (GO:0010955),0.4202254647883764,0.8894842480576679,0.6126005361930295,0.9626425654601883,1.0,1/12,2.62%,GAS1
prerank,protein localization to centrosome (GO:0071539),0.38715513554925135,0.8894837483574892,0.624031007751938,0.9621686016646993,1.0,7/17,23.47%,NUDCD3;PIBF1;BBS4;CEP83;PCM1;DCTN2;NEDD1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3380055696725699,0.8894403905220398,0.674217907227616,0.9617715599547606,1.0,25/60,29.87%,CDK4;TCF7L2;MED24;CEBPB;CCNC;CDKN1A;MED13;CCND1;MED15;IL6;AGO4;MED23;MED6;AGO3;PTEN;MED7;TNRC6A;RELA;MED26;AGO1;ATF7IP;NFKB1;BAX;TP53;SOX9
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.28675471367688976,-0.8894403637456889,0.6166666666666667,0.87485226626234,1.0,4/25,7.95%,CDH5;ENG;NOTCH1;BMPR2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3519596881930197,0.8892499027991849,0.6425233644859814,0.961683444810161,1.0,7/33,14.32%,ANGPT4;MEOX2;FGF2;ATP2B4;JUP;RHOA;KLF4
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3188373894687919,0.8891004062068417,0.7255102040816327,0.961527151879751,1.0,21/116,19.04%,SYK;VIPR2;FYN;MAPK14;GLP2R;SRC;ADCYAP1;DPEP1;CRHR1;GPR20;CALCA;GPR45;TSHR;ADCY8;GNB1;LHCGR;SELENOS;IL6;RXFP1;IAPP;PRKAR2A
prerank,regulation of insulin secretion (GO:0050796),0.3183123809524483,0.8888469212043151,0.6882051282051282,0.9615575742131557,1.0,18/101,16.30%,DPP4;PRKCA;MTNR1B;IRS1;EFNA5;CACNA2D2;STX1A;MIDN;TCF7L2;NR1D1;MCU;BMP8A;IRS2;TRH;SNAP25;KCNC2;GLUD1;IL6
prerank,synapse assembly (GO:0007416),-0.21951523520330318,-0.888817991131597,0.7,0.8746368856361804,1.0,16/67,13.24%,SPOCK2;CDH1;WNT5A;SHANK3;PLXND1;DNM3;RYK;SDK2;PLXNB1;LRRC4;GABRB3;SDK1;CDK5;BDNF;PCDHB14;SLITRK1
prerank,primary alcohol metabolic process (GO:0034308),0.37203080614205813,0.8887738428283564,0.6333333333333333,0.9612341032530027,1.0,2/25,5.79%,DHRS9;ALDH3A2
prerank,negative regulation of cell adhesion (GO:0007162),0.32232576878833036,0.8887207248263057,0.6757607555089192,0.9608680498578387,1.0,18/72,16.79%,EPHB2;CORO2B;GTPBP4;DACT2;MIA3;JAM3;MUC1;TGFBI;ADAM22;FZD7;JAG1;PLXNA3;DSCAM;RHOA;PDE3B;FZD4;SNAI2;CD164
prerank,regulation of ion transmembrane transport (GO:0034765),-0.255897375263641,-0.8884742578218711,0.6641221374045801,0.8738067101373042,1.0,6/33,12.80%,NEDD4L;AHCYL1;WWP2;KCNQ1;KCNJ12;AKAP6
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.40696210138101707,0.8883608069394373,0.6176084099868594,0.9611536445370021,1.0,5/15,15.67%,VEGFA;FGF2;ITGA5;KLF4;PKM
prerank,mitotic cytokinetic process (GO:1902410),0.3820633938596425,0.8882699777607924,0.6175,0.9608513249721927,1.0,3/20,13.49%,CHMP7;VPS4B;RHOA
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.4215433770091181,0.8882563072146927,0.6011080332409973,0.9604107951693818,1.0,2/12,5.71%,IGFBP5;DOCK7
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3363358438298462,0.8875886835065229,0.6434108527131783,0.9612937175255195,1.0,18/48,27.38%,MYOC;S100A10;FBXW8;MYADM;C1QBP;TRIOBP;LIMS2;RAC3;ILK;FLNA;DMTN;CALR;RAC1;IL1RAPL1;ARHGEF7;CUL7;PRKDC;CAPRIN2
prerank,rRNA transcription (GO:0009303),0.40008132118721523,0.887558320411639,0.6296774193548387,0.9608795553745547,1.0,6/17,23.54%,ANG;POLR1G;GTF3C2;BRF1;SPIN1;GTF3C5
prerank,outer dynein arm assembly (GO:0036158),0.40895259457900884,0.8872058973731812,0.6103723404255319,0.9611045608548217,1.0,4/15,22.56%,DNAH8;DNAAF5;DNAH5;DNAL1
prerank,regulation of interferon-gamma production (GO:0032649),0.3223082646348878,0.8870582046893349,0.6776947705442903,0.9609393410392927,1.0,10/71,14.87%,AXL;C1QBP;INHA;GAS6;TLR4;CD47;SIRPA;PDE4D;ZC3H12A;CD14
prerank,glial cell development (GO:0021782),0.3655897286767258,0.8868135740310998,0.6257521058965102,0.960962780123217,1.0,3/25,4.37%,PRDM8;S100A9;SOX10
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.31440897523944367,0.8866771630090733,0.7179226069246436,0.960782605043083,1.0,32/124,18.29%,MYOC;ODF2;RASGRF1;UNC5A;DOCK7;DTNBP1;LRP12;ADCYAP1;PKD2;TOR1A;PLP1;L1CAM;CAMSAP1;MAPT;TBC1D23;FLRT3;LGI1;GDNF;PLEKHA1;ULK1;ATCAY;BLOC1S2;MANF;MAP4;FAM161B;SNAPIN;IL6;RAB35;PPP1R9B;STX3;CNTN4;GPM6A
prerank,negative regulation of DNA recombination (GO:0045910),0.34463902572831784,0.8860124806087467,0.6542261251372119,0.9616262309572602,1.0,14/43,26.85%,PARP3;POLR2H;CGAS;ACD;POLR2D;POLR2G;TERF1;BLM;TINF2;TERF2IP;UBQLN4;POLR2C;H1-0;MSH6
prerank,organelle fusion (GO:0048284),0.38765967360957715,0.8859349706371561,0.6505576208178439,0.9613150540009504,1.0,9/22,30.71%,GDAP1;MIEF2;STX4;SPG7;VPS11;FIS1;CHCHD3;BAX;MFN2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.3259512738135698,-0.8858142596575814,0.6343612334801763,0.8782206689575778,1.0,4/13,12.21%,NOS3;GCH1;QDPR;SPR
prerank,regulation of cytoplasmic translation (GO:2000765),0.40736115640848564,0.8857949078175384,0.6297760210803689,0.961137814142038,1.0,5/14,28.81%,UNK;PKM;CPEB1;RBM24;CNBP
prerank,sensory perception of mechanical stimulus (GO:0050954),0.32204072646798154,0.8857831384319147,0.6989583333333333,0.9606936117395702,1.0,11/85,10.13%,COL1A1;PIEZO2;COL11A1;SLC26A5;PDZD7;TSPEAR;MYO1A;MYO3B;TIMM9;MYH14;COL2A1
prerank,rRNA methylation (GO:0031167),0.37690849086994443,0.8854044192950036,0.6012422360248447,0.9609931022278686,1.0,4/22,14.18%,DIMT1;FDXACB1;ZCCHC4;MRM3
prerank,regulation of calcium ion import (GO:0090279),0.3774324722042469,0.8853159007717329,0.6204744069912609,0.9607126517957403,1.0,4/21,15.37%,FYN;PKD2;EGF;STC1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.3342916820591754,0.8851997801643908,0.6851441241685144,0.9604608519563195,1.0,13/52,25.28%,GCLC;ALDH18A1;ACLY;IDH1;NIT2;ALDH5A1;MDH2;GOT1;D2HGDH;MTHFD2L;MTHFD2;MTRR;ME3
prerank,regulation of lymphocyte differentiation (GO:0045619),0.38984963734823275,0.8846434550168972,0.6164556962025316,0.9610687051297996,1.0,2/18,7.90%,ZFP36L1;ZFP36L2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.310901451227391,0.8845789124689851,0.771399798590131,0.9607361811655495,1.0,45/198,21.27%,GFPT2;EPHB2;PFKP;PLCE1;GFPT1;PLPP3;PLCB4;ACP2;MTOR;PLPP1;GK5;TIGAR;OCRL;PIK3CA;LCAT;AGK;INPP5K;AKT1;PGM2L1;CERK;PLPPR3;INPP4A;PPP3CA;PLA2G4E;PI4KA;NUDT5;G6PC3;SLC20A1;IPPK;PIP4P1;PLCD4;PLPP2;ANGPTL3;ALDOA;PPP3CB;PANK3;TOLLIP;INPP5B;ACYP1;ACP3;IP6K1;PPM1A;PIP4K2B;PTEN;PIK3CG
prerank,positive regulation of DNA binding (GO:0043388),-0.25003641817493555,-0.8844574331576174,0.6571428571428571,0.8795387966814185,1.0,4/31,3.59%,IGF1;NIBAN2;HMGB1;FOXC1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.26050760387857563,-0.884435361525401,0.6748466257668712,0.8779575887750527,1.0,8/30,12.44%,BMP5;BCL2L1;NOS3;FAS;ICAM1;CFLAR;RIPK1;TNFSF10
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.30215445236095806,0.8839982238099487,0.889,0.9614061191546915,1.0,157/572,25.90%,AR;ESR1;LOXL2;TRPS1;FOXP2;NFIX;WT1;TLE6;SCRT2;SKIL;VEGFA;KLF12;FOXP1;BHLHE40;GLIS2;RUNX1;SMAD4;HDAC9;ZNF25;DPF2;SMURF2;SKI;SOX10;DACT1;KLF2;TCF25;NFATC4;TCF7L2;NR1D2;CBX4;MEIS2;IL33;NR1D1;NFIB;ZFHX3;C1QBP;MDM4;SIN3B;GLI2;ZFPM2;TBX6;NOC2L;RNF2;FLCN;SOX8;ZBTB1;VDR;NR6A1;PSEN1;FOXC2;SIRT2;ZMYM5;MYPOP;OTUD7B;ZNF3;HDAC3;URI1;MZF1;TAF3;TCERG1;MITF;IRF2BPL;BCL6;ZHX2;CEBPB;GLI3;UBA52;ZFP36;DR1;NCOR2;PEG3;NCOR1;IKZF5;CCND1;CRYM;TWIST1;DNAJA3;NACC2;HDAC4;EZH1;EHMT2;DMAP1;KLF4;HOXA7;HSBP1;IL4;ZNF692;SMARCA4;CHD8;DDX20;NR2C2;YEATS2;NOP53;ZBTB5;PER1;DDX5;SNAI2;CHD3;E4F1;ZEB1;HIVEP1;NRIP1;CTCF;UXT;NIPBL;SUDS3;RPL23;KDM1B;UBE2D3;CTBP1;MIER1;PPM1A;DNAJB1;HSF4;PEX2;PAF1;KDM2B;NSD1;PHF21A;JUN;LARP7;EZH2;ATF4;VPS72;LDB2;LDB1;BAG3;TPR;SDCBP;ZNF431;GATAD2A;IFI27;NR3C1;PER3;SKOR2;RTF1;RELA;ZEB2;ORC2;LCOR;HEXIM1;MDM2;BCL11A;CALR;RARA;E2F7;KAT5;PHF12;PHF6;VHL;MBD2;MAFK;MYT1L;DDIT3;H1-0;RARG;CRY2
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.33485654992474945,-0.883906551056242,0.6415094339622641,0.8774957269934133,1.0,4/13,7.43%,IGF1;RAMP1;PLCB1;ALG10B
prerank,activation of adenylate cyclase activity (GO:0007190),-0.24997370766138988,-0.8838693138670527,0.6896551724137931,0.8759496949965302,1.0,6/35,9.13%,ADCY5;ADCY1;EDNRA;CAP2;ADCY4;ADCY9
prerank,innate immune response (GO:0045087),0.30574224091710106,0.8829897692855192,0.7903711133400201,0.9629165649919834,1.0,33/217,18.94%,SYK;LBP;SRMS;TNK1;FYN;ANG;MID2;MSRB1;COLEC11;CXCL10;SRC;CHUK;CYP27B1;TLR4;MASP2;IRAK4;TRIM11;DMBT1;SLPI;IRAK1;SETD2;RNASE6;ADAM15;CR2;FER;IL4;TRIM68;RNF187;PML;AKAP1;SMPD1;MBL2;SKP2
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.2744616285851197,-0.8829258318745601,0.6666666666666666,0.8765516917731562,1.0,7/26,12.37%,APOE;SCARB1;PIK3CB;NPR3;GCH1;TERT;S100A1
prerank,regulation of small molecule metabolic process (GO:0062012),-0.2661815584728855,-0.8829162146908673,0.6728395061728395,0.8749432679730528,1.0,7/28,10.53%,PDK1;APOE;TTC39B;PPARA;ACADL;EPHX2;SIRT1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.3701011605717372,0.8828593449134983,0.6239316239316239,0.9627180909643721,1.0,9/24,15.83%,IRS1;EPM2AIP1;INPP5K;DYRK2;AKT1;PASK;IRS2;PPP1R3C;SELENOS
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.33556157057901403,0.8819232882034185,0.664488017429194,0.9641236276205684,1.0,9/54,13.75%,KCNMA1;FHL1;BIN1;KCNJ2;YWHAE;KCNAB3;STK39;KCNJ3;GNB1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.40405594477011597,0.8816414250749565,0.6176084099868594,0.9642118079918542,1.0,6/14,27.46%,PRKD2;CD81;CARD11;RELA;RAB29;BCL10
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.24401929929634564,-0.8815650560454434,0.6956521739130435,0.8763035527065861,1.0,13/41,20.22%,PRKAG2;SCARB2;NUP35;NDC1;RAE1;PGAM1;NUP153;EP300;NUP214;POM121;NUP155;HIF1A;NUP205
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.27779266572331895,-0.8814855593462975,0.7151162790697675,0.8748449570581552,1.0,3/24,4.18%,LYN;HMGB1;CXCL12
prerank,positive regulation of neuron projection development (GO:0010976),0.3168662859373027,0.8812778563397834,0.6931106471816284,0.9645024818730177,1.0,17/85,13.39%,DBN1;NPTN;EPHA3;COBL;S100A9;TENM3;RET;RIT2;ABL2;NDRG4;TWF1;FUT9;AVIL;MAGI2;KIDINS220;P3H1;CBFA2T2
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.34744214134109086,-0.8809956217681626,0.6013289036544851,0.8743370836860078,1.0,9/11,42.47%,STAT1;IL12RB2;STAT4;CANX;IL27RA;STAT3;IL12A;JAK1;EBI3
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.3101058312693843,0.8809920781112667,0.7706237424547284,0.9646177040894285,1.0,50/172,23.22%,GPAT4;DGKQ;FGF2;PIK3C2B;PIK3R2;PI4K2B;FAR1;CHKB;FIG4;OCRL;INPP5F;PIK3CA;SLC44A1;LCAT;AGK;ARF1;INPP5K;AGPAT3;LPCAT1;PLEKHA4;MBOAT7;RUFY1;INPP4A;PLEKHA1;PI4KB;AGPAT5;GPAT3;MTMR6;CEPT1;PI4KA;MTMR1;PIP4K2C;SLC44A2;GPAM;CDIPT;LIPH;DDHD1;PLD2;PITPNM1;LPIN3;PIP4K2B;TAMM41;PTEN;PIK3CG;CPNE1;PCTP;PI4K2A;CSNK2A2;PTDSS1;ACP6
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.36395998612743774,0.8807501000161624,0.6287787182587666,0.964605737059873,1.0,7/26,12.77%,SRI;PKD2;CRHR1;YWHAE;GSTM2;CALM2;THADA
prerank,positive regulation of angiogenesis (GO:0045766),0.31320669496226383,0.8804552515447803,0.721025641025641,0.9647099775783602,1.0,10/108,4.65%,CD34;FGF18;PRKCA;ANGPT4;VEGFA;FGF2;ECM1;RUNX1;SMOC2;ITGA5
prerank,protein monoubiquitination (GO:0006513),0.3490598216663412,0.8804276865529224,0.6577415599534342,0.9642983066755807,1.0,15/36,28.12%,UBE2B;UBE2W;FANCL;CUL3;DTL;ATXN7L3;PEX12;UBE2R2;UBE2D3;PAF1;KLHL22;RNF20;RNF126;KLHL12;TOPORS
prerank,positive regulation of isotype switching (GO:0045830),-0.31009927991508834,-0.8802781910907943,0.6495726495726496,0.8743732866989127,1.0,9/15,21.65%,KMT5B;SHLD1;KMT5C;TFRC;RIF1;TGFB1;CD40;MAD2L2;TNFSF13
prerank,cellular response to interleukin-12 (GO:0071349),0.33420946190193457,0.8800504989324482,0.6691729323308271,0.9646117331500382,1.0,11/48,23.29%,ANXA2;MIF;RAP1B;ARF1;CD47;SIRPA;PDCD4;PPIA;RALA;SNRPA1;MTAP
prerank,carbohydrate derivative catabolic process (GO:1901136),0.39455787964216404,0.87991260975254,0.6440677966101694,0.9644316233113841,1.0,5/18,15.68%,OGA;FBXO2;FBXO17;SAMHD1;NGLY1
prerank,positive regulation of RNA splicing (GO:0033120),0.36229611038869475,0.8797206959936918,0.653755868544601,0.9643371401246368,1.0,14/29,31.28%,ZPR1;NUP98;RBM22;ERN1;RBM3;SF3B4;U2AF2;THRAP3;DAZAP1;CELF3;RBMX;HABP4;CELF4;CIRBP
prerank,negative regulation of lipid storage (GO:0010888),-0.29113961391685994,-0.8791875672153022,0.6330275229357798,0.8751330736856824,1.0,7/19,12.67%,TTC39B;OSBPL8;PPARA;NR1H3;ABCG1;PTPN2;NFKBIA
prerank,rRNA 3'-end processing (GO:0031125),0.43196192008161277,0.8785739987630926,0.6246376811594203,0.9661443153257748,1.0,2/10,9.54%,ERI3;EXOSC7
prerank,DNA recombination (GO:0006310),0.34758581397893645,0.878455794712971,0.6708428246013668,0.965912128631179,1.0,9/37,18.62%,XRCC3;RAD51B;IGHMBP2;RHNO1;HMGB3;RECQL;RAD50;BLM;SUPV3L1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.35108147476992324,0.8783222921649868,0.6712962962962963,0.9656937626622313,1.0,11/32,21.11%,MYOC;SRC;JAG1;ADAM15;HOXA7;BCAS3;RCC2;RASA1;CLASP2;CORO1C;PTEN
prerank,transcription by RNA polymerase II (GO:0006366),0.30302307352895425,0.8780303835174401,0.8186372745490982,0.9657877024860281,1.0,83/305,25.24%,PRRX1;AR;ESR1;NFIX;POLR2H;ZC3H8;INTS3;GTF2H3;ABT1;HDAC9;HDAC7;WWTR1;PAX1;TAF8;NR1D2;SCAF8;NR1D1;INTS10;ZBTB1;VDR;NR6A1;ADRM1;CDK9;SOX5;ELP4;KAT2B;INTS6;CPSF4;HDAC3;TAF3;DDX21;SETD2;ERCC3;POLR2D;POLR2G;NCOR2;NCOR1;GTF2A2;CCNH;EAF2;CTDP1;GTF2F1;BTF3;NFE2L3;NR2C2;EAF1;E2F3;CPSF2;DDX5;SNRPG;INTS2;SNRPD3;MED23;INTS12;SLBP;NR2C2AP;GTF2E2;MBD1;PAF1;ICE1;LHX1;TFCP2;ATF4;RORA;RNMT;ELL;MED7;TBP;TAF13;NR3C1;CSTF2T;ESRRA;TRIM24;RTF1;CPSF1;CPSF7;WDR33;PABPN1;POLR2C;RARA;GTF2E1;MED26;NRBP1
prerank,positive regulation of transferase activity (GO:0051347),0.3104425192711112,0.8778452343008147,0.75,0.9656740572327621,1.0,25/142,14.60%,DDR2;EPHB2;AXL;EGFR;FGFR1;EPHA3;MST1R;AXIN1;RET;UBE2N;ACD;EPM2AIP1;HNRNPD;POLG2;EPHB3;MUSK;EPHA10;XRCC5;FLT3;PIN1;PDGFRA;NBN;KLF4;DDR1;HSP90AA1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3051097703778702,0.8775333258153348,0.7741935483870968,0.965801155144929,1.0,57/208,23.89%,ESR1;AKAP13;MIB2;ECM1;F2R;LPAR1;MID2;TMEM106A;USP10;NR1D1;CARD16;UBE2N;TFG;CHUK;PPP5C;TIRAP;LGALS1;OTUD7B;SQSTM1;IRAK4;DDX21;IRAK1;TNIP1;NDFIP1;TRAF3IP2;RHOA;ZC3H12A;TRIM68;TRAF3;PER1;RBCK1;SLC20A1;UFL1;MAP3K14;CANT1;SLC44A2;CARD11;LURAP1;MIER1;UNC5CL;FLNA;PPM1A;GOLT1B;TSPAN6;PYCARD;TAB2;CPNE1;TRAF4;TERF2IP;RORA;ROR1;MAP3K7;FKBP1A;TRAF5;TNIP2;TRIM8;RELA
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.4188554617101197,0.8771943109915863,0.6602209944751382,0.9660156338431078,1.0,3/13,12.96%,AGO2;ZFP36;POLR2G
prerank,acyl-CoA biosynthetic process (GO:0071616),0.3896454239093059,0.8771056000143705,0.6463576158940397,0.965718234207056,1.0,5/16,21.00%,ACLY;HSD17B8;DIP2A;SCD5;ACAT1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.252247527936472,-0.8769663716704014,0.6692913385826772,0.8786246952232116,1.0,11/35,15.76%,VTN;TNK2;PIK3CB;B2M;LDLRAP1;HIP1R;HNRNPK;SGIP1;HIP1;HFE;SERPINE1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.2862952985372291,-0.8768228296901615,0.6228070175438597,0.8773549340134771,1.0,2/18,1.62%,UNC13B;UNC13C
prerank,modulation by host of symbiont process (GO:0051851),0.3533391688360227,0.8767878885990669,0.6371061843640606,0.9658979524989607,1.0,8/31,16.80%,HPN;TARDBP;INPP5K;LRRC19;CTDP1;SMARCA4;CHD1;TFAP4
prerank,nuclear transport (GO:0051169),0.3982130420826212,0.8765146992952615,0.6288659793814433,0.9659611507930739,1.0,4/16,18.49%,NUP98;NPM1;PSIP1;NXT2
prerank,autophagy of mitochondrion (GO:0000422),0.33994166762718747,0.8763258113005895,0.6421404682274248,0.9658379426657299,1.0,14/38,24.76%,ATG2B;WIPI2;SQSTM1;WDR45B;ULK2;ATG2A;ULK1;CISD2;ATG13;ATG3;ATG14;FIS1;CTSK;MARK2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.27166648417227857,-0.8749349122004063,0.6578947368421053,0.8798805159797863,1.0,6/24,11.02%,H3-3A;PPM1D;EED;SUZ12;EPC1;BMI1
prerank,negative regulation of leukocyte migration (GO:0002686),0.4317754956029618,0.8746255212761461,0.6286509040333796,0.9686389305629994,1.0,3/10,14.42%,SLIT2;CD200R1;HOXA7
prerank,protein deacylation (GO:0035601),0.36579951926055554,0.8741785081094535,0.6398514851485149,0.9690310594542466,1.0,5/23,13.86%,HDAC7;HDAC6;SIRT2;HDAC3;HDAC4
prerank,positive regulation of endocytosis (GO:0045807),0.34243723670980925,0.8741305907690876,0.6781354051054383,0.9686570516416997,1.0,9/45,14.82%,AXL;LRP1;GPC3;BICD1;TOR1A;ABCA13;CALY;CBL;IL4
prerank,negative regulation of neuron projection development (GO:0010977),0.33079575861671556,0.8741147800188782,0.6826086956521739,0.9682274672246683,1.0,20/56,25.53%,PTPRS;LPAR1;STX1B;SEMA3A;MYLIP;TSKU;GDI1;KANK1;NGEF;CBFA2T2;RTN4RL1;RHOA;DCC;FKBP4;CRMP1;PTEN;BAG5;RTN4;BCL11A;RAB29
prerank,mitotic cell cycle phase transition (GO:0044772),0.30542272521102637,0.8739484337046343,0.7837837837837838,0.9680880914309348,1.0,56/204,24.70%,DCTN1;ODF2;CDK14;ACVR1;CDK4;CHMP7;TRIM71;USP29;YWHAG;BCAT1;SSNA1;YWHAE;CUL3;PPP1R12B;ALMS1;USP26;CDC23;MAPRE1;HAUS3;CDC34;SFI1;CDKN1A;FBXL3;CCND1;CDC27;CCNH;DBF4;CTDP1;HSP90AA1;TUBB4A;TUBA4A;GSPT1;DYNC1H1;E2F3;CDK5RAP2;CCP110;AKAP9;CEP164;CKAP5;SKP2;PAFAH1B1;PPP2R2A;CUL5;CLASP2;PPP6C;PCM1;CDKN2C;DCTN2;FBXW11;CDC25B;NEDD1;LATS1;DYNLL1;CEP78;FBXL12;ACVR1B
prerank,sodium ion export across plasma membrane (GO:0036376),0.40913075469268395,0.8739294396007715,0.6151761517615176,0.9676573298806307,1.0,5/13,12.04%,ATP1A3;ATP1A4;ATP1A1;SLC4A4;SLC9A1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.32909559965894547,-0.8738892907775248,0.622895622895623,0.8805039539308548,1.0,2/12,1.62%,UNC13B;UNC13C
prerank,peptidyl-lysine acetylation (GO:0018394),-0.35791828787535274,-0.8737310230891384,0.6266233766233766,0.8792356231976743,1.0,3/10,12.04%,CREBBP;SIRT1;EP300
prerank,potassium ion transport (GO:0006813),0.31105326111825027,0.8736187744111754,0.7196738022426096,0.9678046210268745,1.0,22/120,15.88%,KCNK5;KCNMA1;HPN;KCNV1;ATP1A4;KCNJ2;SLC9A9;KCND1;ABCB8;PKD2;KCNK13;KCNK9;HCN4;KCNA2;KCNA6;KCNAB3;SLC9A1;KCNJ3;KCNC2;CHP1;SLC9A7;SLC9A6
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3735252595637507,0.8733959543371526,0.6458852867830424,0.9677568355249982,1.0,7/22,21.96%,GNAI3;CRHR1;PALM;LTB4R2;CAP1;STIM1;NF1
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.2903870425720204,-0.8731664323647803,0.6208333333333333,0.8788703223394908,1.0,7/18,20.57%,MSRA;ASPG;ASS1;ADI1;ASNS;NAT8L;FOLH1
prerank,negative regulation of histone methylation (GO:0031061),0.4256603885586704,0.8731578700717785,0.6342525399129173,0.9677830334616011,1.0,2/10,10.42%,PHF1;WDR5
prerank,cholesterol efflux (GO:0033344),0.38694375321386165,0.8731035865833627,0.6463104325699746,0.9674243571242129,1.0,4/20,10.41%,ABCG4;ABCA1;TSKU;STX12
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.43260516747302014,0.8731035699346987,0.6384839650145773,0.9669610312826784,1.0,3/10,12.14%,IRS1;AKT1;IRS2
prerank,negative regulation of hydrolase activity (GO:0051346),0.33393322285546934,0.8730494787583618,0.6734006734006734,0.966601698785221,1.0,12/49,19.94%,MAPK7;ECM1;SLC39A14;GPSM1;CSTB;URI1;BCAS3;CHP1;SH2D4A;RCC2;ARFGEF1;TMED2
prerank,protein import into mitochondrial matrix (GO:0030150),0.3775360891378751,0.8728082624192492,0.6381909547738693,0.9665884843990856,1.0,2/18,11.47%,TIMM50;GRPEL2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.3469884733456876,0.872743444815336,0.6604651162790698,0.9662408074720682,1.0,3/33,2.91%,WT1;FGF2;TGFB2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.43087355989092413,0.8725558904552605,0.6264044943820225,0.9661174217235031,1.0,5/10,20.64%,NCOA3;CYP27B1;VDR;NME2;NUMA1
prerank,cellular component assembly (GO:0022607),0.3011846998640144,0.8723225693043132,0.7967967967967968,0.9661039941963296,1.0,50/253,20.33%,HAS2;GSN;HAS1;SCIN;STK25;WIPF1;LLGL1;DLG4;CHAF1B;GPAA1;ZW10;TLCD2;WASF1;MDM4;FSCN1;GAS6;NOC2L;ACD;MYO9A;TOGARAM1;SYCP2;RSPH1;RHOJ;RHOQ;MITF;RHOA;RTN3;TTLL3;SPAG17;LIMS2;PLS1;ACTG1;SPTBN1;RAC3;TFAP4;PML;SPG7;NAPG;YTHDF1;YTHDF2;EPRS1;ILK;MICAL1;VAMP2;TINF2;LAMC1;KMT2A;SPAG16;QSOX1;FLNA
prerank,regulation of gluconeogenesis (GO:0006111),0.35335476315089354,0.8720271165472228,0.6580882352941176,0.9662119483555242,1.0,6/27,16.37%,DGKQ;DDB1;USP7;ZNF692;SELENOS;OGT
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.41313864958092195,0.8718872827231192,0.6441798941798942,0.9660179111898595,1.0,2/13,3.19%,VEGFA;TGFBR2
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3921880486677709,0.8718129915070099,0.6403622250970246,0.9657046573141677,1.0,8/17,33.72%,ALG1;DHDDS;SRD5A3;MVD;MPDU1;NUS1;ALG8;DOLPP1
prerank,substrate-dependent cell migration (GO:0006929),0.4079750458269643,0.871755961778989,0.6347469220246238,0.9653509954076743,1.0,3/14,6.86%,ITGA11;ITGA2;NTN1
prerank,bile acid and bile salt transport (GO:0015721),0.365507450075542,0.8717044809873722,0.654275092936803,0.9649861117249602,1.0,2/24,3.12%,ATP8B1;SLC51A
prerank,mesenchymal cell differentiation (GO:0048762),0.33091161874150576,0.8706230221572465,0.6811751904243744,0.9665796478636619,1.0,5/51,3.94%,LRP6;LOXL2;FGFR1;TGFB2;AKNA
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.30015381444394035,0.8705319662107761,0.7857142857142857,0.9663018288137869,1.0,55/190,22.77%,ESR1;UBE2B;SLIT2;HDAC7;PIK3R2;MAPK14;OTUD3;MAP2K3;ATP2B4;PTPRJ;PDE11A;USP10;NR1D1;MYADM;SRC;PDE10A;BANK1;NOC2L;FLCN;PHLPP2;INPP5K;OTUD7B;HERPUD1;URI1;PRDM15;AKT1;MAGI2;PPEF2;PDE4D;PIK3IP1;TNIP1;CDC34;DEPTOR;PLEKHA1;TMEM127;TWIST1;PDE3B;ZC3H12A;NOP53;PER1;PPP2R5B;PLAUR;SFRP5;IFI35;MCL1;CIT;PPM1A;TSPAN6;PYCARD;PTEN;CPNE1;NF1;RORA;UBR2;CYLD
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3046841345666739,0.8704778569247907,0.783702213279678,0.965953634658207,1.0,32/182,16.98%,CD34;ESR1;DGKQ;VEGFA;FGF2;TGFB2;FOXP1;RUNX1;MIF;DLG4;RBMS3;ATP2B4;CREB3L1;TARDBP;MYADM;FLCN;ATXN2;VDR;PSEN1;AGO2;PARP14;MAPT;SLC2A10;NDFIP1;SMCR8;ZC3H12A;KLF4;MAP2K2;DIP2A;PTRH2;AGO4;FLOT2
prerank,negative regulation of catalytic activity (GO:0043086),0.3666734538119174,0.8704613333469173,0.6415552855407047,0.9655314740220476,1.0,3/24,7.10%,APBA3;TMBIM1;HDAC6
prerank,histone H3 acetylation (GO:0043966),0.3371990645999283,0.8703113394064327,0.6821793416572077,0.9653712478430595,1.0,14/40,22.99%,TADA1;KAT2B;POLE3;ING4;WDR5;DR1;KAT14;YEATS2;PER1;TAF6L;SGF29;KAT6B;LDB1;MAP3K7
prerank,sulfation (GO:0051923),0.4167071346462805,0.8701254230881778,0.6556927297668038,0.9652784855503128,1.0,3/11,23.52%,HS3ST5;SULT4A1;UST
prerank,negative regulation of ATPase activity (GO:0032780),0.3930505487426408,0.8701139812674556,0.6413612565445026,0.9648397361746396,1.0,3/16,12.77%,TNNI3;PXK;THADA
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.3097215550942671,-0.8698774384884425,0.6666666666666666,0.8843407134315409,1.0,1/16,0.39%,PDS5B
prerank,regulation of MAP kinase activity (GO:0043405),0.3137327063569212,0.8698014864526216,0.7238193018480493,0.9649780751483488,1.0,9/92,5.35%,FGF18;EGFR;FGFR1;UCHL1;VEGFA;IRAK3;FGF2;MST1R;PTPRJ
prerank,negative regulation of lymphocyte migration (GO:2000402),0.43223159407165834,0.8696821757233586,0.6302521008403361,0.9647613284550653,1.0,4/10,17.22%,MIA3;AKT1;CD200R1;PADI2
prerank,glycerolipid metabolic process (GO:0046486),-0.33990457022582615,-0.869427505828397,0.6089965397923875,0.8837235509080859,1.0,7/11,24.63%,DGKB;DGKZ;PIP5K1A;PLA2G15;PNPLA3;GAL3ST1;DGKG
prerank,mesenchymal cell development (GO:0014031),-0.3006202231176316,-0.8692338769550315,0.681592039800995,0.882541112302389,1.0,6/18,17.28%,NOTCH1;FOXC1;HEYL;TAPT1;SOX11;CDH2
prerank,negative regulation of viral transcription (GO:0032897),0.40740800380290004,0.8692212608042332,0.6411682892906815,0.9651531233971439,1.0,6/13,24.78%,MID2;TRIM11;ZFP36;UBP1;LARP7;HEXIM1
prerank,cobalamin metabolic process (GO:0009235),0.38406798132606546,0.8687359250490015,0.6585365853658537,0.9656296366543087,1.0,6/17,24.87%,TCN1;MTR;ABCC1;MMADHC;MMAB;MTRR
prerank,clathrin-dependent endocytosis (GO:0072583),-0.2628176470863969,-0.8687156000187265,0.6666666666666666,0.8819726749056511,1.0,4/26,7.11%,DNAJC6;FNBP1L;GPR107;FCHSD2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.2778459154117801,-0.8686460933943334,0.6721311475409836,0.8805138792576898,1.0,2/23,1.98%,UACA;BMP7
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.33346072671444443,0.8683352312096259,0.6752232142857143,0.9659429548078202,1.0,7/45,9.59%,TGFB3;TGFB2;SMAD4;ACVR1;BMP15;INHA;BMP8A
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3217010738010928,0.8682802856086145,0.6992481203007519,0.9655924444967904,1.0,13/63,18.39%,AR;FGFR1;ACVR1;TCF7L2;SRC;PELI3;STX4;ITGAV;DEPTOR;IL4;MADD;PML;TGFBR1
prerank,cellular response to metal ion (GO:0071248),0.3085943466455592,0.8681037121718244,0.7433808553971487,0.9654797200011637,1.0,15/123,9.18%,EGFR;SYT2;NEUROD2;CPNE8;DLG4;SYT12;SYT11;SYT13;CAMK2D;DLG2;PKD2;DPEP1;CHUK;TIGAR;IQGAP1
prerank,positive regulation of TOR signaling (GO:0032008),0.3385887344812168,0.8680518112301965,0.6600877192982456,0.9651228745690899,1.0,10/40,22.92%,GAS6;FLCN;PIK3CA;HDAC3;SMCR8;RRAGD;PIP4P1;GPR137B;KLHL22;SLC38A9
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.394075073721336,0.8679157804503149,0.6478318002628121,0.9649210016621047,1.0,6/15,27.01%,ADAM9;TNFRSF1B;GPLD1;SH3D19;PACSIN3;SNX33
prerank,mitochondrial translation (GO:0032543),0.31078088620808303,0.8678813064437038,0.7318840579710145,0.964528525251581,1.0,20/104,15.98%,MRPS11;MRPL38;MRPS18B;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;MRPL30;MRPL10;GFM1;DAP3;MRPL55;MRPS10;MRPL36;MRPL3;MRPL21;MRPS34;MRPL51;HARS1
prerank,positive regulation of autophagy (GO:0010508),0.3170657894991725,0.8676408105527482,0.6908713692946058,0.9645027002866098,1.0,15/81,16.84%,DCN;GNAI3;MID2;FOXO1;PLEKHF1;FLCN;GPSM1;CAMKK2;SESN3;LARP1;ULK1;ZC3H12A;IL4;TRIM68;UFL1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.4235923755319604,0.8676150397376376,0.6237482117310443,0.9640952132120119,1.0,4/11,27.82%,CCT7;TERF1;CCT4;CCT6A
prerank,regulation of cell migration (GO:0030334),0.2982016886198996,0.8675101016453488,0.886,0.9638506976391874,1.0,54/382,12.88%,IGFBP5;SEMA3C;HAS2;MYOC;EPHB2;FGF18;COL1A1;FGF7;PRKCA;EGFR;ANXA1;IGSF10;TMEFF2;ADARB1;LDLRAD4;VEGFA;FGF2;SGK3;SLIT2;F2R;MIF;ADAM9;LMNA;ACVR1;GTPBP4;MIA3;PTPRJ;MEAK7;SRGAP1;MYADM;RET;SRC;SULF1;PIP5KL1;FLCN;DPEP1;SLK;SEMA3A;SRCIN1;JAG1;KIF2A;STX4;PLXNA3;KANK1;MAPRE1;MITF;AKT1;MAGI2;GPNMB;SEMA3D;EGF;RECK;ADAM15;MGAT5
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4204403649178049,0.8672883772943165,0.6523545706371191,0.9638206513709496,1.0,5/12,23.47%,PAICS;GART;ATIC;ADSS2;LHPP
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.350362961598718,0.8669757252835326,0.6501182033096927,0.9639608452792043,1.0,15/29,32.26%,LSM4;EDC4;EXOSC7;EXOSC1;LSM7;EDC3;DCP1A;DCP1B;LSM5;HBS1L;LSM1;PATL1;EXOSC3;CNOT8;LSM6
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.3576146343628769,0.8668266529912705,0.6894117647058824,0.9637981459535091,1.0,10/29,22.09%,ACD;GAR1;TERF1;HSP90AA1;TNKS1BP1;PPIA;RAD50;TINF2;PPP6C;TERF2IP
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.2955064886179053,0.8666677565878577,0.953,0.96363879986511,1.0,221/807,25.90%,AR;ESR1;PAX9;GCLC;ATP8B1;LOXL2;TRPS1;FOXP2;NFIX;WT1;ZC3H8;TLE6;SCRT2;SIX4;SKIL;VEGFA;KLF12;FOXP1;BHLHE40;GLIS2;RUNX1;SMAD4;HDAC9;ZNF25;ATF5;DPF2;SMURF2;SKI;SOX10;TSC22D4;DACT1;FOXK2;KLF2;TCF25;NAB1;TCF7L2;NR1D2;CBX4;RBAK;MAF1;CREB3L1;MEIS2;FOXO1;IL33;NR1D1;PRMT2;CREBZF;MUC1;ZFHX3;DPF1;C1QBP;MDM4;MLXIPL;HDAC6;SIN3B;GLI2;ZFPM2;TBX6;GAS6;NOC2L;RNF2;FLCN;MDFIC;SOX8;ZBTB1;VDR;NR6A1;MAGEL2;PSEN1;FOXC2;SIRT2;RCOR3;CIPC;KDM5C;ING4;INPP5K;TLE2;BRD7;CALCA;ZMYM5;MYPOP;OTUD7B;PHC3;ZNF3;PHC1;HDAC3;URI1;SAMD1;MZF1;MPHOSPH8;TAF3;TCERG1;MITF;SMARCC2;IRF2BPL;BCL6;ZHX2;CEBPB;RBFOX2;GLI3;UBA52;XRCC5;ZFP36;DR1;NCOR2;PEG3;NCOR1;BCL3;IKZF5;CBFA2T2;CCND1;CRYM;TWIST1;DNAJA3;NACC2;HDAC4;EZH1;EHMT2;DMAP1;KLF4;HOXA7;HSBP1;IL4;GMNN;ZNF692;SMARCA4;CHD8;DDX20;NR2C2;YEATS2;NOP53;BAHD1;ZBTB5;PDCD4;PER1;DDX5;SNAI2;CHD3;E4F1;TFAP4;ZEB1;DKK3;PML;SAP18;SET;QARS1;HIVEP1;SNX6;DAP;GCFC2;NRIP1;CTCF;UXT;NIPBL;BTAF1;SUDS3;RING1;RPL23;PCGF6;KDM1B;UBE2D3;CTBP1;MIER1;FLNA;PPM1A;DNAJB1;MBD1;HSF4;PEX2;PAF1;KDM2B;NSD1;PHF21A;LHX1;JUN;LARP7;EZH2;ATF4;KAT6B;VPS72;FBXW11;LDB2;LDB1;TPR;SDCBP;ZNF431;GATAD2A;CRYAB;IFI27;NR3C1;PER3;SKOR2;RTF1;RELA;ZEB2;ORC2;LCOR;SCMH1;L3MBTL3;SCML2;HEXIM1;MDM2;BCL11A;SETDB2;CALR;RARA;E2F7;KAT5;PHF12;KAT7;PAX2;DPF3;PHF6;VHL;MBD2;MAFK;MYT1L;DDIT3;H1-0;RARG;CRY2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.28386497036551217,-0.8666415165721963,0.6521739130434783,0.8833542279615372,1.0,6/20,12.99%,BCL2L1;BCL2;CASP3;FAS;CASP9;BCL2L2
prerank,alanine transport (GO:0032328),-0.33514804193705394,-0.8665376368946656,0.604982206405694,0.8820313608464243,1.0,2/10,12.50%,SLC6A17;SLC6A6
prerank,apoptotic mitochondrial changes (GO:0008637),0.3550223965278607,0.8663489281007196,0.6725768321513003,0.963797614720474,1.0,6/32,12.73%,TIMM50;AIFM2;NDUFS1;BAK1;SFN;BBC3
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3782513491663896,0.8662422660884705,0.6574307304785895,0.9635338353142021,1.0,5/18,17.98%,DACT1;CD81;HSP90AA1;RNF128;VPS11
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.34441011221406487,-0.865781241711239,0.6183745583038869,0.8820487376554158,1.0,3/10,12.96%,LYN;FAS;MAPK3
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3581864443940409,0.8655572169659124,0.6610978520286396,0.964378642653117,1.0,4/28,9.40%,PARP3;CYREN;TFIP11;NUDT16L1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.32766852873372027,-0.865457388625363,0.6335877862595419,0.881186148343619,1.0,5/13,9.45%,MEF2C;NOTCH1;TGFBR3;FGFR2;TBX2
prerank,regulation of protein kinase A signaling (GO:0010738),-0.2898530537708044,-0.865236705704481,0.6478260869565218,0.8800739344138995,1.0,7/20,17.69%,ADGRV1;AKAP7;PRKAR1B;AKAP6;PRKAR2B;TCIM;ADRB2
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.4208625020924085,0.8652140326011551,0.6323119777158774,0.9645683678552082,1.0,2/10,7.57%,AXL;GAS6
prerank,signal transduction in response to DNA damage (GO:0042770),0.3313346268521981,0.8649761409707954,0.6747252747252748,0.9645545150889906,1.0,18/49,29.45%,TRIAP1;MAPK14;USP10;MDM4;RHNO1;RAD1;BCL3;BRIP1;NBN;DONSON;CLSPN;SESN2;TIPRL;E2F7;PRPF19;RAD17;ATRX;TP53
prerank,heme biosynthetic process (GO:0006783),-0.28052826092351213,-0.8649041033889153,0.6568627450980392,0.8792525113827967,1.0,3/22,6.54%,ABCG2;PGRMC1;FECH
prerank,cellular response to ketone (GO:1901655),0.3423525344488256,0.8648924945226893,0.6655251141552512,0.9642553204162921,1.0,6/35,13.75%,AR;SRC;LARP1;ADCY8;ADAM15;GNB1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3203392226400325,0.8648349324292484,0.706441393875396,0.9639099331175821,1.0,23/67,25.16%,ATP8B1;GAP43;MYO10;FSCN1;TBC1D2B;TBC1D17;TWF1;TBC1D10A;FER;ARF6;EVI5;DYNC2LI1;FXR2;TBC1D13;TBC1D22B;TBC1D15;TBC1D19;ABITRAM;ATG3;CYLD;DMTN;CDKL1;RAC1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.42274885431538267,0.8643060944105988,0.635077793493635,0.964424229782199,1.0,1/10,2.76%,VEGFA
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3044833959713211,-0.8641601656228682,0.6475409836065574,0.879240179265221,1.0,6/15,22.06%,SCARB1;NR1H3;SIK1;CTDNEP1;FITM2;C3
prerank,artery morphogenesis (GO:0048844),0.3517589930463115,0.8639140922972667,0.6710059171597633,0.9646876855174555,1.0,5/30,8.92%,LRP1;VEGFA;TGFB2;PKD2;JAG1
prerank,mesoderm development (GO:0007498),0.38329580628518156,0.8638974583346921,0.6710013003901171,0.9642670541963443,1.0,3/18,8.76%,VEGFA;TBX6;FOXC2
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.340463388019031,0.8630356253682225,0.6670560747663551,0.9653903066634603,1.0,13/36,22.55%,NECTIN3;GGA1;ARFRP1;GGA2;GOLGA4;NSF;SPTBN1;BLZF1;PREPL;VAMP2;RAB10;VAMP4;GOLPH3L
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.27196425683238057,-0.8626024003910413,0.7164948453608248,0.8811110312274418,1.0,8/21,20.76%,EPHA7;AIM2;DELE1;TTBK1;BEX3;MT3;PSMB9;BIRC2
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.407099006323354,0.8623238970550933,0.6537433155080213,0.9662547726511513,1.0,3/13,14.57%,BMF;VDAC2;BLOC1S2
prerank,hexose metabolic process (GO:0019318),0.33484787077370504,0.8621384233343169,0.6990950226244343,0.9661674868691293,1.0,9/39,23.16%,CHST1;GALK1;IRS2;GAA;ALDOA;GALM;SLC37A4;SLC35A2;KCNJ11
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.38746613099037736,0.8619443483277845,0.629582806573957,0.9660761956338523,1.0,3/16,13.20%,WDTC1;ACADVL;NCOR1
prerank,regulation of protein localization (GO:0032880),0.32147053662059255,0.8613986747181908,0.7125683060109289,0.9666422642172287,1.0,18/58,25.85%,RABGAP1L;ITGB3;ZDHHC7;TRIM46;ADCYAP1;ATCAY;HSP90AA1;RSL1D1;TRIM68;UFL1;CTSD;TRIM67;TMEM231;TPR;FKBP1A;DVL1;FBXW7;CSNK1E
prerank,neurotransmitter transport (GO:0006836),0.3156948642576393,0.8612833283902841,0.7145899893503728,0.9663979372373065,1.0,17/73,18.56%,SLC1A7;STX1A;APBA1;PPFIA2;SLC1A6;SLC18A3;SLC6A4;GLS2;GLS;SNAP25;PPFIA1;GAD2;SNAPIN;SLC38A1;SNPH;SYT1;VAMP2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.3251456053420248,-0.8611334014146564,0.6460905349794238,0.8828356409980148,1.0,7/13,19.32%,ELOVL7;HACD1;HACD4;HACD2;ELOVL1;ELOVL4;TECRL
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3144931728218415,0.8610447751748938,0.7180851063829787,0.9663651670738441,1.0,20/69,25.11%,POLR2H;ZC3H8;INTS3;TAF8;INTS10;CDK9;INTS6;POLR2D;POLR2G;GTF2A2;GTF2F1;INTS2;INTS12;GTF2E2;ICE1;ELL;TBP;TAF13;POLR2C;GTF2E1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.26754955326672336,-0.8606696668401018,0.7125748502994012,0.8822050142395548,1.0,4/23,9.89%,CECR2;HMGB1;CASP3;REXO4
prerank,sodium ion transmembrane transport (GO:0035725),0.3112967313224447,0.8606289822439304,0.7375,0.9666955067679155,1.0,18/84,16.02%,SCNN1B;SLC4A8;ATP1A3;ATP1A4;ATP1A1;SLC9A9;SLC6A8;PKD2;HCN4;SLC4A4;SLC6A11;SLC6A4;SLC9A1;ASIC2;SLC8A2;SLC9A7;SLC9A6;SCN4B
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.2665431431621332,-0.8604921662458564,0.6962025316455697,0.8809757436259313,1.0,10/27,20.35%,NEDD4L;YWHAH;DLG1;GPD1L;FXYD1;NOS1;UTRN;SNTA1;SLMAP;SCN3B
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.20479396345490206,-0.8604676439528574,0.84,0.8794750496590177,1.0,32/87,20.76%,RPL13;SEC61A2;RPS7;RPL37;RPS27;RPS13;RPL19;RPL36;RPL30;RPL36A;SRP14;RPS14;RPL18A;RPS18;RPS21;RPL5;RPL7A;RPS24;RPS11;RPL39;RPL29;SRP72;RPL26;RPS23;RPL35;RPL14;SRP68;RPL37A;RPL24;RPL18;ZFAND2B;RPL9
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.41917327042661123,0.8597387230084966,0.6606397774687065,0.9678890906711168,1.0,4/12,15.05%,FOXP1;NCOR2;NCOR1;SMARCA4
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.32068618240696434,0.8594581782545632,0.7012987012987013,0.9679498649684182,1.0,14/64,15.56%,POLR2H;GTF2H3;ADRM1;CDK9;ELP4;SETD2;ERCC3;POLR2D;POLR2G;CCNH;EAF2;CTDP1;GTF2F1;EAF1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.35526335040626555,0.859413704107188,0.6687344913151365,0.9675837355932826,1.0,8/24,22.99%,ITCH;UBE2N;IRAK1;UBA52;AAMP;TAB2;CYLD;MAP3K7
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.35746910163455126,0.8591887081589802,0.6614457831325301,0.9675608948206598,1.0,6/27,17.25%,CD44;MIF;TWIST1;DDX5;SNAI2;EEF1E1
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.34690982858711006,0.858124725377132,0.6434474616292798,0.9690792609855535,1.0,12/30,22.55%,GGA1;ARFRP1;GGA2;GOLGA4;NSF;SPTBN1;BLZF1;PREPL;VAMP2;RAB10;VAMP4;GOLPH3L
prerank,cellular response to copper ion (GO:0071280),-0.31330173143453455,-0.8580976935755698,0.620253164556962,0.8827857547178043,1.0,1/16,3.22%,SNCA
prerank,regulation of autophagosome maturation (GO:1901096),-0.3229816173951395,-0.857773784701467,0.6809338521400778,0.8819349998151984,1.0,6/13,25.08%,UVRAG;TBC1D25;CLN3;ADRB2;IRGM;PHF23
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.41203037880110505,0.8577473546380946,0.6607387140902873,0.9693007367963353,1.0,5/12,20.69%,ZDHHC7;VANGL2;AHI1;ACTG1;RAB10
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.35692483469660885,0.8576441970280909,0.6726835138387485,0.9690584548058429,1.0,11/26,28.54%,EFNA5;NR1D1;STX4;ADCY8;PPP3CB;GPLD1;EPHA5;BAIAP3;STXBP4;CFTR;LRP5
prerank,defense response to virus (GO:0051607),-0.19737002909489015,-0.8575883237229841,0.9117647058823529,0.8807828886282804,1.0,27/100,21.80%,BCL2L1;SERINC3;BCL2;TRIM56;PLSCR1;IFITM3;ABCC9;MAVS;CNOT7;IFIT1;IFIT2;TLR3;OAS2;RNF135;STAT1;IFIT3;RNASEL;CLPB;PHB2;CD40;RSAD2;OPRK1;ZDHHC1;MLKL;BNIP3;TRIM5;IRF3
prerank,axon extension (GO:0048675),0.36403154973541557,0.8575081984222686,0.6650717703349283,0.9688489131885883,1.0,9/23,15.88%,MAP1B;SLIT3;SLIT2;SLIT1;SEMA3A;ULK2;ULK1;HSP90AA1;SLC9A6
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.3895517977766687,0.85726496387869,0.6640926640926641,0.9688386269688943,1.0,3/15,7.85%,FGF2;SMOC2;PRKD2
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.39892645106397584,0.8568630811073301,0.659919028340081,0.9691387581299297,1.0,5/13,26.30%,EIF2AK3;NUPR1;MANF;USP19;LPCAT3
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3446883409685674,0.8566015710591363,0.6862068965517242,0.9691725412361167,1.0,10/33,22.09%,CTC1;ACD;GAR1;TERF1;HSP90AA1;TNKS1BP1;RAD50;TINF2;PPP6C;TERF2IP
prerank,regulation of smooth muscle contraction (GO:0006940),0.370330996961226,0.8565249166369518,0.6641318124207858,0.9688641700227579,1.0,6/20,22.46%,PLCE1;F2R;ZDHHC21;ATP2B1;CTTN;NMU
prerank,gland development (GO:0048732),0.31949219566700754,0.8563011894381207,0.7095032397408207,0.9688322696443187,1.0,8/59,10.29%,ANXA1;TGFB3;WT1;COBL;GLI2;PKD2;ZBTB1;EPHB3
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.33069679849340866,-0.8560631097161168,0.6176470588235294,0.8824290040850756,1.0,11/11,66.96%,PKD1L3;LPO;RTP3;TAS1R2;GNAT3;GNAT2;PIGR;TAS1R3;RTP4;RTP2;PKD2L1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.3167201636478559,0.8558016065946475,0.7094379639448568,0.9692827090741692,1.0,10/66,16.30%,FOXP1;F2R;TMEM106A;CARD16;TLR4;SIRPA;USP50;ZC3H12A;NLRP2B;IL6
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.29892532695507423,-0.8557373583246715,0.6598360655737705,0.8815673642135455,1.0,3/16,7.93%,DPYD;UPB1;NT5E
prerank,histone H3-K9 demethylation (GO:0033169),-0.3431345157608301,-0.8555323080550065,0.6236559139784946,0.8804059810172691,1.0,2/11,2.52%,KDM7A;KDM4A
prerank,maturation of 5.8S rRNA (GO:0000460),0.3832951544896796,0.8553683029668429,0.6584415584415585,0.9696683622534789,1.0,7/17,27.22%,C1D;URB1;EIF6;MAK16;EXOSC10;FTSJ3;PRKDC
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.4176887273801807,0.8552841204535586,0.6680972818311874,0.9693630326961099,1.0,5/10,35.91%,TSKU;LAPTM4B;CDH3;HSP90AB1;FN1
prerank,hyaluronan catabolic process (GO:0030214),0.3778597627740893,0.8547676110812731,0.6823379923761118,0.9698557717375991,1.0,4/18,15.24%,CD44;FGF2;SLC9A1;CHP1
prerank,snRNA transcription (GO:0009301),0.31188398204842394,0.8543394245092892,0.7300743889479278,0.9701669049790359,1.0,20/70,25.11%,POLR2H;ZC3H8;INTS3;TAF8;INTS10;CDK9;INTS6;POLR2D;POLR2G;GTF2A2;GTF2F1;INTS2;INTS12;GTF2E2;ICE1;ELL;TBP;TAF13;POLR2C;GTF2E1
prerank,ubiquinone biosynthetic process (GO:0006744),0.3846283146976235,0.8540210858192279,0.6415584415584416,0.9703020762881164,1.0,6/15,25.83%,COQ10B;COQ7;COQ3;COQ5;COQ2;COQ10A
prerank,negative regulation of type I interferon production (GO:0032480),0.3319958552355155,0.8537850239921312,0.6925714285714286,0.9702646736540482,1.0,16/40,32.40%,PTPRS;ITCH;SIRPA;PIN1;RNF216;ILRUN;TAX1BP1;PYCARD;CYLD;UBA7;UFD1;HAVCR2;NPLOC4;CACTIN;TRAF3IP1;TBK1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.35854081336697813,0.8537527876171551,0.6847172081829122,0.9698771811371226,1.0,9/27,26.75%,NDEL1;FRMD7;PSEN1;AKT1;NCS1;PTEN;CCDC88A;NTNG2;IL1RAPL1
prerank,proteasome assembly (GO:0043248),0.41433548777947327,0.8537011453416504,0.6771545827633378,0.9695286326926069,1.0,2/11,8.48%,PSMG2;ADRM1
prerank,cellular response to osmotic stress (GO:0071470),0.37027572501024303,0.8535959487061457,0.6765067650676507,0.96926920210785,1.0,4/21,12.02%,LRRC8D;ZFP36L1;PKD2;STK39
prerank,regulation of protein metabolic process (GO:0051246),0.3313160234311374,0.8533188222781475,0.7055555555555556,0.969334996366244,1.0,15/44,24.79%,MAPK7;KLF2;ODC1;TMEM9;SSH1;ZDHHC2;KLF4;TRAF3;CHRNA7;PLAUR;NEDD8;LDLR;FKBP1A;PARL;MDM2
prerank,Notch signaling involved in heart development (GO:0061314),-0.32911418155784367,-0.8528502096756845,0.6642599277978339,0.8844817986907396,1.0,6/11,23.85%,NOTCH1;HEYL;GALNT11;HEY1;HEY2;DLL4
prerank,regulation of autophagy (GO:0010506),0.29747300398420845,0.8524710396691328,0.835506519558676,0.9704061500676887,1.0,70/216,27.00%,DCN;UCHL1;PIK3R2;MID2;USP36;ATP6V0A2;FOXK2;MTOR;USP10;PRKAB2;FOXO1;PLEKHF1;HDAC6;ABL2;FLCN;IL10RA;CAPN1;SIRT2;FBXL2;USP33;ERN1;AKT1;MAPT;BMF;ATP6V1E1;SMCR8;DRAM1;RRAGD;ULK1;ZC3H12A;CISD2;NUPR1;VDAC1;ATP6V0A1;ATP6V1D;TRIM68;ATP6V1B2;HGF;HTRA2;KEAP1;UFL1;PIP4K2C;GPR137B;SNX6;DAP;ATG13;SREBF1;MCL1;EXOC4;ATF6;PIP4K2B;TAB2;USP13;KLHL22;CSNK2A2;SLC38A9;ATP6V0B;TRIM8;EIF4G3;LEPR;DCAF12;RAB39B;KAT5;TICAM1;DDIT3;FBXW7;EIF4G1;CAPNS1;CTSA;TPCN1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.34807316298810165,0.8524100963425927,0.6784452296819788,0.9700759147355306,1.0,6/30,14.13%,POLR2H;GTF2H3;POLR1G;UBTF;ERCC3;CCNH
prerank,positive regulation of nervous system development (GO:0051962),0.3320561078649167,0.8523265915258638,0.6792873051224945,0.9697714993674722,1.0,7/42,19.42%,EPHB2;NUMBL;SERPINF1;EPHB3;SYNDIG1;EPHB1;CLSTN3
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.35778433749954447,0.8523095278655336,0.6782178217821783,0.9693541654820026,1.0,10/23,31.27%,COPS5;RAD23B;UBA52;DDB1;COPS4;GPS1;CETN2;COPS6;COPS3;COPS7B
prerank,cellular calcium ion homeostasis (GO:0006874),0.3027529152978984,0.8512424638644833,0.7830957230142567,0.9708647430247049,1.0,28/133,19.15%,CCL8;NPTN;ANK2;TNNI3;ATP2B4;CAMK2D;PACS2;YWHAE;MCU;PSEN1;CALCA;HERPUD1;SELENOK;ATP13A1;SLC35G1;MCUB;BAK1;ADCY8;CCL13;ATP2A2;SLC8A2;STC1;TMEM165;PML;CHRNA7;ATP2B1;HTR2C;STIM1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.30474754164301665,-0.8511870636393093,0.6810344827586207,0.8865288604712271,1.0,3/16,7.52%,CADM1;AP1G1;NECTIN2
prerank,sensory perception of sound (GO:0007605),0.3090318813907796,0.8511758837069243,0.7474012474012474,0.9705393752466949,1.0,11/88,10.13%,COL1A1;HPN;COL11A1;SLC26A5;PDZD7;TSPEAR;MYO1A;MYO3B;TIMM9;MYH14;COL2A1
prerank,lymphocyte differentiation (GO:0030098),0.3127956115734294,0.8511538871058261,0.7260127931769723,0.9701361154665132,1.0,10/68,16.01%,AXL;PBX1;HDAC9;CLCF1;PTPRJ;FLT3;CR2;HDAC4;IL4;LMBR1L
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3621076397884646,0.8510230342837186,0.6654040404040404,0.9699453640269042,1.0,6/21,24.49%,ANK2;SCN4B;AKAP9;KCNH2;FLNA;CACNA2D1
prerank,membrane protein proteolysis (GO:0033619),0.3357025156400223,0.850928347738371,0.6927502876869965,0.9696690795986105,1.0,17/37,30.76%,ADAM9;ADAM19;RET;PSEN1;SPPL2B;NAPSA;CLPP;BACE1;PARL;RELA;RBMX;MBTPS1;NFKB1;HM13;ADAM17;TRAF6;PSENEN
prerank,sodium ion transport (GO:0006814),0.30810753603868163,0.850753873836269,0.7397691500524659,0.9695309230969343,1.0,15/85,14.00%,SCNN1B;SLC5A9;SLC4A8;FGF13;ATP1A4;SLC6A8;PKD2;HCN4;SLC4A4;SLC6A11;SLC6A4;SLC23A1;ASIC2;CATSPER3;SLC8A2
prerank,negative regulation of inflammatory response (GO:0050728),0.2980077239047939,0.8507383274035131,0.8199195171026157,0.9691128130236045,1.0,29/182,16.30%,SYK;VIPR2;FYN;MAPK7;MAPK14;METRNL;MVK;NR1D1;GLP2R;SRC;ADCYAP1;DPEP1;CRHR1;GPR20;FNDC4;CALCA;SIRPA;GPR45;TSHR;ADCY8;CD200R1;TNFRSF1B;GNB1;LHCGR;KLF4;IL4;LRFN5;SELENOS;IL6
prerank,protein polyglutamylation (GO:0018095),-0.338608369100647,-0.8503550330322417,0.6604477611940298,0.8866250817893188,1.0,4/11,17.93%,TTLL5;CFAP20;TTLL1;CEP41
prerank,substantia nigra development (GO:0021762),0.3426663032497364,0.8503261581508069,0.6869965477560415,0.9694333043510274,1.0,14/37,25.80%,YWHAE;SIRT2;PLP1;RAD1;CALM2;RHOA;GLUD1;PADI2;MBP;NDRG2;SUDS3;DYNLL1;FGF9;MAPKAP1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.3328938962459118,-0.8501952569007913,0.6716981132075471,0.8854293600936037,1.0,4/11,12.21%,NOS3;GCH1;QDPR;SPR
prerank,regulation of ATP metabolic process (GO:1903578),-0.22135397368848803,-0.849676443400284,0.8369565217391305,0.8849426820403318,1.0,16/54,20.22%,PRKAG2;NUP35;NDC1;RAE1;PINK1;PGAM1;UQCC2;NUP153;EP300;NUP214;AK4;POM121;NUP155;SPHK2;HIF1A;NUP205
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.2726230771105349,-0.8495940030561037,0.6815642458100558,0.8836396579304241,1.0,4/21,6.44%,SLC30A10;PPARA;SIRT5;PINK1
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.2742598438726241,-0.8494554817510335,0.7156862745098039,0.8823568612744818,1.0,9/21,21.15%,NUDT4;NT5E;HPRT1;PDE2A;NUDT3;NT5C2;NT5C1A;AMPD3;FITM2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.39152316530724296,0.8494247846196404,0.6752910737386805,0.9705764847497018,1.0,5/15,23.37%,EDEM1;SPCS1;SEC61A1;RAB10;SRPRB
prerank,regulation of organelle organization (GO:0033043),0.30745066376524416,0.8492824024809433,0.7431578947368421,0.9703931825892308,1.0,28/80,27.62%,CAPN2;S100A8;S100A9;STX5;SYT11;PREB;MIEF2;MYO5A;SURF4;LMAN1;SQSTM1;MAPT;DIAPH1;RAB33B;AKAP9;ARMH3;VPS11;MAPK1;TMEM33;PARL;ZEB2;FIS1;MARK2;MTM1;RHOT2;MUL1;RBSN;PDE4DIP
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3143536949683564,0.849026123853162,0.7297872340425532,0.97043307860922,1.0,19/70,26.89%,GPAT4;PLAAT1;CHKB;SLC44A1;LCAT;LPCAT1;PNPLA8;MBOAT7;CEPT1;PLA2G4E;SLC44A2;LIPC;GPLD1;LPIN3;PCTP;CSNK2A2;SLC27A1;LPCAT3;PLA2G7
prerank,Golgi to plasma membrane transport (GO:0006893),0.3257881870086927,0.8487610174697381,0.7060133630289532,0.9704475750037139,1.0,15/47,22.55%,LLGL1;GGA1;ARFRP1;GGA2;GOLGA4;NSF;SPTBN1;BLZF1;GOPC;PREPL;VAMP2;EXOC4;RAB10;VAMP4;GOLPH3L
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.4091914454079931,0.8485437776540612,0.6860795454545454,0.9703833353533265,1.0,5/12,20.82%,SCP2;ELOVL5;FADS1;ACOX1;HSD17B4
prerank,inner mitochondrial membrane organization (GO:0007007),0.32901933653713256,0.8485353766325389,0.7065803667745415,0.9699475045343102,1.0,21/47,29.81%,TIMM10B;TIMM9;ATP5PO;AGK;ATP5ME;TIMM22;GHITM;SPG7;TIMM8B;UQCC3;MICOS10;APOOL;IMMT;ATP5MC3;DNAJC11;ATP5F1B;NDUFA13;LETM1;CHCHD3;ATP5F1A;CHCHD6
prerank,regulation of receptor recycling (GO:0001919),0.3810177386810497,0.8483029080141471,0.6459143968871596,0.9699373196268182,1.0,4/16,15.86%,ANXA2;INPP5F;ECE1;NSF
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.3585888508274708,0.848006033495145,0.6722151088348272,0.9700328518347583,1.0,7/22,16.74%,WASF1;AKT1;MAPT;MAGI2;KIDINS220;RAPGEF1;RAB35
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.29567218468176615,-0.8477774743813672,0.7260869565217392,0.8842214634160097,1.0,4/16,14.47%,AUTS2;CTR9;CTNNB1;BCOR
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.26913236324707485,-0.8476741600647457,0.6698564593301436,0.882926381486126,1.0,7/21,16.61%,NES;CX3CL1;MDK;SMARCD3;CTNNB1;TOX;DISC1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.28246087282955046,-0.8472880647391848,0.6844919786096256,0.8821388487133778,1.0,4/21,8.17%,RAP1GDS1;SLC8A3;TGM2;MICU2
prerank,nitrogen compound transport (GO:0071705),0.2949972182432725,0.8472488451891461,0.7898477157360406,0.9709704642472762,1.0,28/141,17.46%,SLC1A5;LRRC8D;SLC7A6;ARRDC2;SLC43A2;MIA3;TOM1;SCAMP3;RCN3;SLC6A8;SCAMP5;TCN1;SLC44A1;SLC16A10;SLC6A4;TMEM30A;SLC7A3;LRP1B;RUFY1;KIF3A;ABCC1;SLC23A1;CMTM6;SLC15A4;SEC14L1;SLC38A1;FLVCR1;SLC44A2
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.35617708332895565,0.847015672988367,0.68408262454435,0.970945625549205,1.0,11/24,29.35%,TGFB2;NUPR1;MCL1;ITGAM;BACE1;NF1;ATF4;DDIT3;FBXW7;PRNP;BAX
prerank,carnitine metabolic process (GO:0009437),0.3987850921624445,0.846924653519866,0.6602475928473177,0.9706671040496584,1.0,5/12,22.34%,CPT1C;CRAT;CPT2;CROT;ALDH9A1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.37740143687221606,0.8468234143117047,0.6854942233632862,0.9704070140144314,1.0,2/17,4.97%,CHAMP1;ZW10
prerank,cell cycle G2/M phase transition (GO:0044839),0.2998918239446342,0.8467932755057825,0.7865055387713998,0.970019981619015,1.0,48/130,30.09%,DCTN1;ODF2;CDK14;YWHAG;SSNA1;YWHAE;PPP1R12B;ALMS1;MAPRE1;HAUS3;SFI1;CDKN1A;FBXL3;AKAP8;CCNH;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;CCP110;AKAP9;CEP164;CKAP5;SKP2;PAFAH1B1;PPP2R2A;PCM1;AKAP8L;DCTN2;FBXW11;CDC25B;NEDD1;LATS1;DYNLL1;CEP78;FBXL12;CSNK1E;ACTR1A;CETN2;WEE1;CEP152;CUL1;FOXM1;CENPJ;PLK4;SDCCAG8;FBXL8
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.32926601391613625,0.8464208676602911,0.7054871220604704,0.97021354559154,1.0,7/41,20.33%,KCNMA1;ANK2;KCNJ2;KCNJ3;GNB1;KCNH2;FLNA
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.29965309743544727,-0.8462214653338721,0.6491228070175439,0.8828060498524212,1.0,5/16,12.11%,PDGFD;NRP1;PTPN1;PDGFRB;ABL1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.32737367552558805,0.8459760983051685,0.698645598194131,0.9705725144031836,1.0,17/45,25.59%,PKP3;TRIM71;RC3H1;ATXN2;LARP4;TDRD7;PUM1;LARP1;NOLC1;RBM3;PER1;PCIF1;METAP1;EIF2A;ATG14;GRM5;CYFIP1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.35737683926883085,0.8457953421122267,0.6850961538461539,0.9704518963640617,1.0,6/25,14.60%,KLF2;PKD2;TLR4;AKT1;KLF4;HSP90AA1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3044500546514627,0.8455764240526762,0.7654320987654321,0.9699815267570572,1.0,10/104,11.26%,SYK;PSMC4;FYN;MUC1;PSMC6;SRC;CHUK;PSMD8;NRAS;KRAS
prerank,cellular response to lectin (GO:1990858),0.3044500546514627,0.8455764240526762,0.7654320987654321,0.9699815267570572,1.0,10/104,11.26%,SYK;PSMC4;FYN;MUC1;PSMC6;SRC;CHUK;PSMD8;NRAS;KRAS
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.30373266410304484,0.8452784089480435,0.7687564234326825,0.9700469511303333,1.0,10/105,11.26%,SYK;PSMC4;FYN;MUC1;PSMC6;SRC;CHUK;PSMD8;NRAS;KRAS
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.24867412511911524,-0.845051220844484,0.7419354838709677,0.8837538631180039,1.0,8/29,15.90%,LEF1;CREBBP;TCF7;AXIN2;TERT;EP300;CTNNB1;TLE4
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.3366061410261638,0.8447459695170294,0.6946651532349603,0.9705540392395983,1.0,12/40,20.96%,TRIAP1;GPX1;AKT1;BMF;BBC3;MLLT11;HRK;GHITM;HGF;PLAUR;PRELID1;PYCARD
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3760655205254748,0.8446706111918755,0.6721105527638191,0.9702531215101946,1.0,7/18,29.35%,TMEM259;ERN1;BAK1;NCK1;USP13;DDIT3;BAX
prerank,granulocyte differentiation (GO:0030851),-0.2857570862179617,-0.8446069769785771,0.6854460093896714,0.8831481281234981,1.0,5/18,13.70%,LEF1;CBFA2T3;CDK2;EP300;TAL1
prerank,lamellipodium assembly (GO:0030032),-0.2540543270503979,-0.844352719613072,0.70625,0.8821400339522965,1.0,6/26,12.39%,PARVB;KIT;S1PR1;PTPRO;CDH13;ARHGEF4
prerank,genitalia development (GO:0048806),0.40699817535115623,0.8441815572617742,0.681881051175657,0.9706696248483742,1.0,2/12,4.15%,WT1;PKD1
prerank,membrane lipid biosynthetic process (GO:0046467),0.3195226215602279,0.8441806361497718,0.7311015118790497,0.9702286518604544,1.0,11/58,12.42%,CERS6;ST3GAL2;PLPP3;ALDH3A2;PLPP1;PRKD2;SGMS2;FA2H;ELOVL5;ST3GAL4;PRKD3
prerank,transcription preinitiation complex assembly (GO:0070897),0.4069549300112605,0.8441655656204844,0.6776859504132231,0.9698140940481444,1.0,5/12,23.46%,DR1;GTF2A2;TAF7L;TBP;BDP1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.33624605304585314,0.8440291179145198,0.7142857142857143,0.9696092548690872,1.0,11/33,24.63%,SCAF8;CPSF4;CPSF2;SNRPG;SNRPD3;SLBP;CSTF2T;CPSF1;CPSF7;WDR33;PABPN1
prerank,histone methylation (GO:0016571),0.3498833594317865,0.8438485068711213,0.6890243902439024,0.9694966703588176,1.0,11/26,31.65%,PRMT2;NTMT1;EHMT2;N6AMT1;NSD1;CARM1;EZH2;SUV39H1;PRMT8;SIRT7;PRMT7
prerank,regulation of JUN kinase activity (GO:0043506),-0.23799201616046262,-0.8436287166438562,0.7906976744186046,0.8820903463926201,1.0,10/33,20.40%,SASH1;DAB2IP;DUSP10;DVL3;TNFRSF11A;EDN1;MAP3K5;ARHGEF5;DUSP19;MAP3K10
prerank,linoleic acid metabolic process (GO:0043651),0.3820902253663925,0.8436227730283151,0.686092715231788,0.9694445118647069,1.0,4/17,14.27%,GSTM2;PNPLA8;ELOVL5;FADS1
prerank,prostanoid biosynthetic process (GO:0046457),-0.30736586920598113,-0.8433921704678324,0.6865671641791045,0.8810177039310286,1.0,6/15,15.78%,PTGDS;PTGS2;PTGIS;PTGES3;EDN1;CD74
prerank,fatty acid elongation (GO:0030497),-0.3187456287727237,-0.8428686986688797,0.696969696969697,0.8805715858550883,1.0,6/13,17.04%,ELOVL7;HACD1;HACD4;HACD2;ELOVL1;ELOVL4
prerank,synaptic vesicle cycle (GO:0099504),0.3384069900058542,0.8427624704131506,0.6783216783216783,0.9704794970262423,1.0,6/30,20.02%,STX1A;SNAP25;SYNDIG1;SNAPIN;VAMP2;PLD2
prerank,positive regulation of axonogenesis (GO:0050772),0.3207552683419639,0.8421802332854166,0.704337899543379,0.9710736230570288,1.0,10/43,13.49%,DBN1;SLIT2;NTN1;ISLR2;PLXNA3;TIAM2;L1CAM;MAPT;MAP6;RHOA
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3087696665171015,0.8420787348796209,0.74581589958159,0.9708049176617453,1.0,16/83,15.63%,CDK14;ACVR1;CDK4;TRIM71;USP29;BCAT1;CUL3;USP26;FBXO5;CDC34;CDKN1A;CCND1;CCNH;DBF4;GSPT1;E2F3
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.23456561890572167,-0.8419518762647048,0.7777777777777778,0.8809612478010943,1.0,13/41,20.22%,PRKAG2;LACC1;NUP35;NDC1;RAE1;PGAM1;NUP153;EP300;NUP214;POM121;NUP155;HIF1A;NUP205
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.31656779030229065,-0.8418822605773489,0.6356877323420075,0.879612530115072,1.0,3/13,12.16%,NOTCH1;TBX3;TGFB1
prerank,mitochondrion organization (GO:0007005),0.29419750759366786,0.8417645435177624,0.8147773279352226,0.9709381786118408,1.0,45/165,25.60%,TIMM50;DNM1;RAB32;CLUH;GDAP1;WASF1;TIMM10B;TRAK2;MIEF2;PID1;AIFM2;TIMM9;SLC25A4;TMEM70;MYH14;AKT3;POLG2;NDUFS1;DNAJA3;FANCG;ATCAY;PTCD2;TIMM22;MTFR1L;SPG7;TIMM8B;BCAP31;BCS1L;SUPV3L1;SLC25A36;VPS13D;TOMM5;TIMM17A;SLC25A33;GABPA;MGME1;AFG1L;ESRRA;FIS1;RAB5IF;MTM1;TOMM40;ATP5F1B;RAB29;RHOT2
prerank,protein localization to cell periphery (GO:1990778),0.29664818577753915,0.8414382433413671,0.7910750507099391,0.9710594571429825,1.0,25/133,16.98%,LRP6;TTC7A;TSPAN17;PKP3;PRAM1;ANK2;FGF13;S100A10;PLEKHF1;MYADM;MYO5A;GAS6;PACS2;CD81;EHD2;INPP5K;FYB2;RAB3D;JUP;ZDHHC2;PIGW;ANK1;SPTBN1;AP4M1;FLOT2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2883362564485202,0.8414270870285773,0.88,0.9706391862588846,1.0,107/366,26.27%,ESR1;BNC2;WT1;PKP3;SCRT2;PRDM8;MLF2;BHLHE40;ATF5;WWTR1;LMX1B;CXXC1;FOXK2;NAB1;NR1D2;SPIN4;RBAK;RBBP6;IGSF1;NFIA;ZFHX3;TRIP4;MLXIPL;MYT1;NUP107;ATXN2;PHF1;MSL3;SPTY2D1;FZD7;MYBL2;HNRNPD;RYBP;ONECUT1;MZF1;MITF;ACTR5;ATF7;CEBPB;FBXO5;SIX1;NOLC1;RBM3;EHMT2;FADS1;GMNN;NR2C2;RPL6;RNF14;SNAI2;CHD3;EFEMP1;PML;GON4L;MED23;GCFC2;TGFBR1;ZSCAN26;PCIF1;ELAVL2;JMJD1C;TAF6L;ASCC1;OGG1;FOXO4;TRRAP;METAP1;NSD1;USP13;SPIN1;BTG1;EIF2A;CARM1;TERF2IP;EZH2;ATF4;KAT6B;RNF6;LDB1;CCDC88A;RORA;BAZ2A;NCOA2;ZNF431;NFXL1;NR3C1;RABL3;ESRRA;TGFBRAP1;SAP30L;SKOR2;RELA;SERTAD3;DVL1;ACVR1B;CALR;PHF12;APBB2;KAT7;GRM5;VHL;CYFIP1;RNF20;DDIT3;TCF7L1;ZNF2;HP1BP3
prerank,positive regulation of innate immune response (GO:0045089),0.34296493476786916,0.841396151702069,0.7152941176470589,0.9702513372408119,1.0,4/30,14.59%,LBP;POLR3D;AKIRIN2;SLC15A4
prerank,carboxylic acid catabolic process (GO:0046395),0.4005224614216939,0.8413135625579978,0.680672268907563,0.9699638687131035,1.0,2/12,9.36%,NAGK;PON3
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.3388978822712353,0.8411139479810086,0.6935866983372921,0.9699003094926617,1.0,7/33,15.11%,MAPK7;NFE2L2;TCF7L2;GAS6;CAST;IL4;NUPR1
prerank,regulation of DNA recombination (GO:0000018),0.33986935088371634,0.8409729014467974,0.6872093023255814,0.9697145136283971,1.0,12/32,26.85%,KPNA2;SETD2;THOC1;IL4;SPIDR;RAD50;BLM;KPNA1;TERF2IP;ALYREF;H1-0;MSH6
prerank,response to unfolded protein (GO:0006986),0.32053076339369346,0.8408997623468263,0.7325966850828729,0.9693983222432027,1.0,24/48,34.60%,HSPA13;ERN1;HERPUD1;SERPINH1;DNAJB2;BAK1;HSP90AA1;HSPA14;DNAJB1;ERP44;DERL1;BAG3;TM7SF3;HSPH1;DDIT3;DNAJA1;BAX;HSPA8;HSF1;DNAJB5;HSPB8;HSPA5;HSP90AB1;HSPA4
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.39652497568961553,0.840766124546576,0.6842105263157895,0.9691765722266584,1.0,5/13,12.14%,IRS1;EPM2AIP1;DYRK2;AKT1;IRS2
prerank,positive regulation of neuron differentiation (GO:0045666),-0.22981912390844134,-0.8405543918023993,0.7264957264957265,0.8807165527292024,1.0,10/40,16.87%,TCF4;MEF2C;HEYL;BRINP3;VWC2;BMP2;MMD2;TRIM32;SOX11;HOXD3
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.30654276026623134,-0.8402564750219425,0.691699604743083,0.8797858915743522,1.0,15/15,69.38%,QDPR;KYNU;FAH;HGD;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD;TAT;KYAT1;GSTZ1;KMO
prerank,cellular response to purine-containing compound (GO:0071415),-0.33025786856771877,-0.8401311564979939,0.6611842105263158,0.8785533554772954,1.0,4/10,20.91%,RYR2;P2RY1;P2RY6;CASQ2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.41889944421003905,0.8400734546574313,0.682825484764543,0.9699534996406358,1.0,3/10,15.81%,PDZD7;TSKU;PLS1
prerank,regulation of Notch signaling pathway (GO:0008593),0.3100804055961035,0.839827922516464,0.72840790842872,0.9699316546666567,1.0,14/76,12.37%,EGFR;ZMIZ1;TGFB2;LLGL1;TSPEAR;BEND6;SRC;JAG1;RFNG;KAT2B;BMP2K;ENHO;AKT1;EGF
prerank,acylglycerol metabolic process (GO:0006639),0.33533857017007296,0.8396023241246815,0.714622641509434,0.96989714647445,1.0,3/37,7.63%,MGLL;DGKQ;GK5
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.40955119655162164,0.839403001440583,0.6689944134078212,0.969817206320745,1.0,2/11,8.07%,RFTN1;SCARA3
prerank,regulation of calcium ion transport (GO:0051924),0.3154116846703579,0.8392214610023503,0.706140350877193,0.9696980128711566,1.0,11/54,19.15%,IL16;ANK2;F2R;SRI;PKD2;INPP5K;EGF;CASQ1;STC1;ATP2B1;STIM1
prerank,cellular component maintenance (GO:0043954),-0.31595703014343196,-0.8391977717809795,0.6415770609318996,0.8788646190064849,1.0,3/12,4.00%,INSR;IGF1R;ITGA3
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.35966142920090444,0.839134743338665,0.6918316831683168,0.9694020425191114,1.0,3/22,11.15%,RUNX1;TNFRSF18;BCL6
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.343226289081863,-0.8391193253272105,0.6474820143884892,0.8775478905889837,1.0,4/10,23.18%,SIRT1;RIF1;DNMT1;BRCA1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3688864291776226,0.8390032111143211,0.6856780735107731,0.9691805528560447,1.0,5/20,18.39%,ZMIZ1;ITCH;DNAJB2;HSP90AA1;TGFBR1
prerank,positive regulation of sodium ion transport (GO:0010765),-0.3206721758444223,-0.8389323951322677,0.6317829457364341,0.8764665014998013,1.0,5/12,21.07%,AHCYL1;GPD1L;NOS1;SCN3B;ANK3
prerank,chemical homeostasis (GO:0048878),0.31365979212225575,0.8383404497082713,0.7387978142076502,0.9698769238856538,1.0,16/61,24.17%,SLC4A10;SLC4A8;SLC4A3;NR1D2;TLCD2;SLC4A4;PNPLA8;IRS2;THADA;ACOX1;TENT4B;ANGPTL3;EIF5A2;SLC4A2;ABCB4;WNK2
prerank,response to zinc ion (GO:0010043),0.35275246844341646,0.8382783233429656,0.6934487021013597,0.9695372199609158,1.0,7/25,31.87%,CRIP1;SLC30A5;D2HGDH;PAM;P2RX4;GLRA2;SLC30A4
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.4034773150702482,0.8381405376248078,0.6839309428950863,0.9693416901773606,1.0,2/12,7.01%,RUNX1;RC3H1
prerank,cellular respiration (GO:0045333),0.3241452278981699,0.8379545642558601,0.7170454545454545,0.9692191096914399,1.0,14/41,27.02%,COQ10B;ETFA;NDUFS1;SURF1;MDH2;ETFDH;ETFB;MTFR1L;UQCRH;UQCR10;ME3;SDHC;COQ10A;COX15
prerank,positive regulation of calcium ion import (GO:0090280),-0.3268151505935261,-0.8378260198183853,0.6631205673758865,0.8773055876970169,1.0,2/12,8.67%,CXCL12;PDGFRB
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.38845815260057476,0.8377763945332917,0.6828947368421052,0.9690931546952671,1.0,7/15,31.85%,IL17RA;TLR4;IL6;TICAM1;MYD88;IL17D;APPL1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.32754234187137443,0.8377277019048804,0.7021978021978021,0.9687374326523885,1.0,11/42,24.07%,USP10;ZBTB1;DTL;POLI;UBA52;PCLAF;RFC4;POLD1;FAAP20;REV1;POLH
prerank,positive regulation of blood coagulation (GO:0030194),-0.2789558949472046,-0.837651519110338,0.6966824644549763,0.8761863505198173,1.0,5/17,15.76%,F3;THBS1;ENPP4;USF1;SERPINE1
prerank,lipid phosphorylation (GO:0046834),-0.3427313587984507,-0.837357983130167,0.6879194630872483,0.8753025228741775,1.0,3/10,4.74%,DGKB;DGKE;DGKZ
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.29847657169409764,-0.8369309335444589,0.7142857142857143,0.8747610031878933,1.0,3/17,7.52%,CADM1;AP1G1;NECTIN2
prerank,triglyceride homeostasis (GO:0070328),-0.2631409827010027,-0.8368338547973695,0.726775956284153,0.8734982196661293,1.0,9/26,21.15%,APOE;SCARB1;NR1H3;C1QTNF3;SIRT1;LPL;NR1H4;MTLN;FITM2
prerank,RNA biosynthetic process (GO:0032774),-0.24796872087124291,-0.836417397512505,0.7635135135135135,0.8728273044138791,1.0,8/31,16.42%,PRIM2;TAF6;POLR2A;HELB;TERT;TAF7;TAF5;GTF2B
prerank,glucan catabolic process (GO:0009251),-0.30099872520302967,-0.8363921974841181,0.7112068965517241,0.8714454790721393,1.0,3/15,5.33%,PHKB;PYGM;AGL
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.3352445302978539,0.8363907303753313,0.7079439252336449,0.9706036424499481,1.0,6/36,14.60%,CYGB;EGFR;ATP2B4;AKT1;GLA;HSP90AA1
prerank,striated muscle cell differentiation (GO:0051146),0.3748425618944582,0.8362208834559052,0.6961690885072656,0.9704628814118926,1.0,2/16,4.06%,AKAP13;SKI
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.3877801200104323,0.8361806982923776,0.6892265193370166,0.9700965887072034,1.0,6/13,28.93%,STX4;STX3;MAP1A;SNX33;RANGRF;TM9SF4
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.3188694750367588,0.8353130905533729,0.7336244541484717,0.9711873992362556,1.0,16/48,26.82%,POLR2H;ZMIZ1;SMARCD1;POLR1G;KAT2B;ATAD2B;DDX21;PADI2;POLR1C;SF3B1;TBP;POLR1B;H1-0;ELOF1;SERTAD2;ARID1A
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2871300959894446,0.8350146504061674,0.881,0.9712589895032935,1.0,94/327,26.27%,ESR1;BNC2;WT1;SCRT2;PRDM8;ZMIZ1;MLF2;BHLHE40;ATF5;WWTR1;LMX1B;CXXC1;FOXK2;NAB1;NR1D2;SPIN4;RBAK;IGSF1;NFIA;ZFHX3;TRIP4;MLXIPL;MYT1;NUP107;PHF1;MSL3;SPTY2D1;FZD7;MYBL2;HNRNPD;RYBP;ONECUT1;MZF1;MITF;ACTR5;ATF7;CEBPB;SIX1;FADS1;NR2C2;RPL6;RNF14;SNAI2;CHD3;EFEMP1;PML;GON4L;MED23;GCFC2;TGFBR1;ZSCAN26;ELAVL2;JMJD1C;TAF6L;ASCC1;OGG1;FOXO4;TRRAP;NSD1;USP13;SPIN1;BTG1;CARM1;TERF2IP;EZH2;ATF4;KAT6B;RNF6;LDB1;RORA;BAZ2A;NCOA2;ZNF431;NFXL1;NR3C1;ESRRA;TGFBRAP1;SAP30L;SKOR2;RELA;SERTAD3;RALY;DVL1;ACVR1B;CALR;PHF12;APBB2;KAT7;VHL;RNF20;DDIT3;TCF7L1;ZNF2;HP1BP3
prerank,endothelial cell development (GO:0001885),0.34968365652786154,0.8347957578067496,0.7097186700767263,0.9712150159053422,1.0,7/25,15.37%,TNMD;RAP1B;MYADM;COL15A1;PDE4D;RAPGEF1;STC1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.2865516891447175,-0.8347703188616071,0.7342342342342343,0.8729969936492545,1.0,2/17,4.18%,HMGB1;CXCL12
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.400856863310145,0.8343983346059244,0.6804564907275321,0.9714879128973994,1.0,1/11,2.47%,FYN
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.31144426266565467,0.8341335212052101,0.7327586206896551,0.9715206626200648,1.0,12/57,17.31%,CNIH3;DLG4;DLGAP4;DLG2;NEFL;CAPN1;GRIA2;DLGAP3;CACNG2;DLGAP1;GRIN2A;AKAP9
prerank,mitochondrion disassembly (GO:0061726),0.32970146920335863,0.834032267694259,0.7175141242937854,0.9712511447900743,1.0,12/34,24.76%,ATG2B;WIPI2;SQSTM1;WDR45B;ULK2;ATG2A;ULK1;CISD2;ATG3;FIS1;CTSK;MARK2
prerank,tetrapyrrole metabolic process (GO:0033013),0.3671347393684708,0.8340272594643002,0.699614890885751,0.9708253982838442,1.0,6/18,24.87%,TCN1;MTR;ABCC1;MMADHC;MMAB;MTRR
prerank,negative regulation of endocytosis (GO:0045806),0.34781532830009637,0.8339387937675704,0.7130647130647131,0.9705542655266234,1.0,8/24,27.01%,EPHA3;SYT11;SCAMP5;ARF6;LRSAM1;PACSIN3;RAC1;SNX33
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.3257221324294196,-0.8337599248013523,0.6743295019157088,0.8734509116380612,1.0,3/12,7.20%,MAVS;CAV1;IFIT1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.30935806445462544,0.8336864178159923,0.756202804746494,0.970567020383695,1.0,21/68,24.63%,POLR2H;GTF2H3;SCAF8;POLR1G;CPSF4;UBTF;ERCC3;CCNH;CPSF2;SNRPG;SNRPD3;SLBP;POLR1C;SMN1;TBP;CSTF2T;POLR1B;CPSF1;CPSF7;WDR33;PABPN1
prerank,neuropeptide signaling pathway (GO:0007218),-0.21924136719263004,-0.8320792131014506,0.8227848101265823,0.8750766382056812,1.0,3/58,1.64%,RAPGEF2;SORT1;CPE
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.39789246238584886,0.8320184637754702,0.696969696969697,0.9729704130467289,1.0,5/12,12.14%,IRS1;EPM2AIP1;DYRK2;AKT1;IRS2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.35981126709779226,0.8319460134940687,0.6825980392156863,0.9726519590347835,1.0,3/21,8.08%,FOXP1;RUNX1;CD81
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.4019665816738018,0.8313847931088323,0.6869806094182825,0.973139475771568,1.0,6/11,37.63%,TENT4B;LARP7;EXOSC10;EXOSC3;FBL;PARN
prerank,embryonic heart tube morphogenesis (GO:0003143),0.3203398843286856,0.8312883203472836,0.7129943502824859,0.9728705095619302,1.0,9/44,15.86%,TGFBR2;ACVR1;TBX6;PKD2;NDRG4;MICAL2;VANGL2;BBS4;AHI1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.35999087307432887,0.8311060340600707,0.7041343669250646,0.9727478267304688,1.0,6/18,21.15%,COX19;SURF1;BCS1L;COX16;COX14;COX18
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.31396468820128126,0.8310722861576603,0.7384284176533907,0.9723730295216627,1.0,11/57,17.66%,SYK;FYN;F2R;TBC1D10A;USP50;BAK1;GRAMD4;HTRA2;GRIN2A;CTSD;BCAP31
prerank,regulation of mRNA stability (GO:0043488),0.2942089135886949,0.8309969600956354,0.8141414141414142,0.9720706594029256,1.0,51/145,31.72%,PRKCA;PSMC4;TENT5B;ZFP36L1;SAMD4B;PSMC6;RC3H1;CARHSP1;ZFP36L2;PSMD8;HNRNPD;EXOSC7;NPM1;AKT1;PUM1;IGF2BP1;UBA52;LARP1;ZFP36;GDNF;EXOSC1;FXR2;YTHDF1;YTHDF2;SET;THRAP3;RC3H2;YWHAB;YTHDF3;PSMD3;PSMD4;RBM24;TNPO1;PSMB3;DCP1A;EIF4G1;PSMB2;CELF1;PSMD5;PDE12;IGF2BP3;TBRG4;SERBP1;HSPA8;EXOSC3;PSMD14;PSMC3;PSMC5;CIRBP;FXR1;PSME4
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3384172880626533,0.8307846309353389,0.7222870478413069,0.9720106328944722,1.0,7/34,14.13%,IRS1;FGF2;PIK3R2;WDR91;PIK3IP1;FLT3;PDGFRA
prerank,regulation of mitotic spindle assembly (GO:1901673),0.36588554692906816,0.8304329716502378,0.6901408450704225,0.9721369872661537,1.0,5/19,22.68%,VPS4B;CCSAP;CEP97;PDCD6IP;TPR
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3241502154849995,0.8299408627922872,0.7242937853107345,0.9725361295243559,1.0,18/42,30.14%,SMARCD2;SPTY2D1;ACTR5;SMARCC2;DMAP1;INO80;SMARCA4;CHD8;SRCAP;CHD3;ZNHIT1;VPS72;MBD2;ARID1A;ARID1B;HNRNPC;PBRM1;MBD3
prerank,regulation of intracellular protein transport (GO:0033157),-0.24159080730748916,-0.8298975268898193,0.7534246575342466,0.8779002717818659,1.0,8/32,13.91%,PTPN14;CEP290;PRR5L;PTPN1;GCC2;TGFB1;PDCD10;RIPOR1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3485619312150631,0.8297519571889053,0.7199519230769231,0.9723915138663957,1.0,11/25,31.64%,CHMP7;VPS4B;MVB12A;TMEM50A;LYST;UBXN6;LEPROT;CHMP4C;LAPTM4B;CHMP4A;CHMP4B
prerank,activin receptor signaling pathway (GO:0032924),0.3805795290579028,0.829401896383319,0.696524064171123,0.9725618969105682,1.0,7/15,32.24%,ACVR1;AMHR2;TGFBR1;ACVR2A;ACVR1B;ACVR1C;INHBB
prerank,erythrocyte development (GO:0048821),0.41451677909458956,0.8291896438757194,0.7108938547486033,0.9724824109242854,1.0,5/10,36.15%,ABCB10;DMTN;ZBTB7A;NCKAP1L;MED1
prerank,blood vessel diameter maintenance (GO:0097746),0.3323736093011641,0.8291087852868321,0.7409568261376897,0.9721761973897923,1.0,3/34,8.91%,GCLC;KLF2;ECE1
prerank,chromosome organization (GO:0051276),0.2947236773148517,0.8289780874567962,0.7739938080495357,0.971968763464009,1.0,31/99,28.06%,COPS5;TCF7L2;RFWD3;RAD23B;CENPT;PHF1;SETD7;POLE3;HDAC3;UBA52;DDB1;EZH1;GATAD1;GEM;SMARCA4;BAHD1;PADI2;COPS4;TOP2B;EZH2;LDB1;LATS1;GPS1;NUP133;TCF7L1;SAFB;CETN2;MSH6;COPS6;HDAC8;SUV39H1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4032481989265046,0.828889010813385,0.7031463748290013,0.9716944372773333,1.0,2/11,8.90%,NECAB3;AGO2
prerank,cellular amide metabolic process (GO:0043603),0.29447674699448073,0.8287321952959977,0.7922755741127349,0.971521353620309,1.0,24/102,22.18%,SMPD3;GPAT4;PLPP3;PLAAT1;ACOT6;PLPP1;ORMDL2;ACOT9;THOP1;CERK;ACOT1;PLA2G4E;ABCB9;PLPP2;ST3GAL1;BTD;DNPEP;SMPD1;GNE;NIT1;MTHFD2L;NSMAF;CPZ;ATF4
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.3905685412664171,0.8285525611339495,0.6972111553784861,0.9713853683985506,1.0,6/13,26.59%,KPNA2;IPO5;KPNA1;CBLB;KPNA6;KPNB1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.3732864064132959,0.8284649650126316,0.7008985879332478,0.9710966356245228,1.0,5/16,22.86%,FLCN;RRAGD;PIP4P1;GPR137B;KLHL22
prerank,programmed necrotic cell death (GO:0097300),0.36213071965897253,0.8282534421540784,0.7106274007682458,0.9710167565364487,1.0,6/18,25.36%,ALKBH7;TLR4;PGAM5;CD14;CYLD;TICAM1
prerank,positive regulation of transporter activity (GO:0032411),0.3847110721489955,0.8278397899526835,0.7069199457259159,0.9712634357572874,1.0,3/13,20.13%,SGK2;STK39;KMT2A
prerank,cellular response to radiation (GO:0071478),0.32485994832947873,0.8278212012955282,0.7366071428571429,0.9708649292683295,1.0,10/40,22.08%,MAPK14;RHNO1;RAD1;CDKN1A;INO80;TNKS1BP1;SPIDR;BLM;OPN3;NSMCE3
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.408376793574108,0.8271237080695953,0.6842105263157895,0.9716202595925844,1.0,3/10,8.26%,SESTD1;BIN1;YWHAE
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3166787816707174,0.8267155498197414,0.7513691128148959,0.9718933381055163,1.0,6/55,9.40%,FHL1;PSMC4;ATF5;PSMC6;PSMD8;AVEN
prerank,Rac protein signal transduction (GO:0016601),0.3589254352181392,0.826608504067844,0.699475065616798,0.9716316984619705,1.0,7/18,25.59%,WASF1;FARP2;HACD3;HACE1;TIAM1;RAC1;CYFIP1
prerank,cell chemotaxis (GO:0060326),0.309098703702013,0.8262993362415717,0.7611940298507462,0.971745714021191,1.0,11/60,18.12%,ACKR3;VEGFA;LPAR1;CCL25;ACKR4;ABCC1;PDGFRA;HGF;CXCR4;CXCR2;EPHB1
prerank,zinc ion transmembrane transport (GO:0071577),0.3480337516561119,0.8261672742463556,0.7016029593094945,0.9715459863400802,1.0,5/22,19.98%,SLC39A13;SLC39A14;SLC39A7;SLC30A5;SLC39A3
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.30047379273389374,-0.8261381682348807,0.688715953307393,0.8835063944831789,1.0,7/13,26.60%,ATM;SPRED3;SPRED2;RPL26;PLA2R1;MSX1;ATR
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.3542532674389206,0.8255015359036411,0.7126865671641791,0.9722142388129791,1.0,4/21,20.62%,FGF13;CAMSAP1;NAV3;CLASP2
prerank,extracellular transport (GO:0006858),-0.31450840327805474,-0.8250875449565719,0.662962962962963,0.8840148965240789,1.0,9/13,36.25%,WWP2;ARRDC1;CABYR;ROPN1L;ADCY10;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,protein-containing complex disassembly (GO:0032984),0.31459020832707846,0.8250319517158308,0.7443365695792881,0.9725659709922965,1.0,7/54,13.15%,LRP6;AXIN1;LIX1L;WIPI2;VPS33A;STX17;EPG5
prerank,homeostasis of number of cells (GO:0048872),0.40121120351124395,0.8249144340117197,0.6919889502762431,0.9723306780688047,1.0,3/12,11.93%,F2R;UBAP2L;LRRC19
prerank,regulation of defense response (GO:0031347),0.29986998537809995,0.8246722085241079,0.768409818569904,0.9723181298855191,1.0,13/76,16.84%,MGLL;ANXA1;FOXP1;AKNA;SPATA2;NR1D2;TIRAP;SAMHD1;BCL6;LRRC19;DAGLB;TRAF3;UFL1
prerank,excitatory postsynaptic potential (GO:0060079),0.3647351301964903,0.8240574422417568,0.705655526992288,0.9729139927431051,1.0,9/19,32.92%,MPP2;GRIN2D;AKT1;GRIN2A;GRID2;NPAS4;DRD2;GSK3A;RAB3GAP1
prerank,cellular response to peptide (GO:1901653),0.3092478100860476,0.8239201118411943,0.7392703862660944,0.9727181191346215,1.0,13/56,19.50%,LRP1;FYN;ATP1A3;ZFP36L1;SRC;PSEN1;TLR4;ABCC1;DDX11;CACNB1;GRIN2A;SNX6;RPL23
prerank,small GTPase mediated signal transduction (GO:0007264),0.29231444171329524,0.8234132551398852,0.8057553956834532,0.9731217512638031,1.0,36/103,25.61%,PLCE1;CCDC88C;FGF2;MAPK14;RASSF1;NTN1;RIT2;RGL1;MAPK11;RGL2;TIAM2;NRAS;KRAS;USP50;RRAD;SHOC2;CDKN1A;GNB1;CHP1;HACD3;SOS1;SHTN1;RRAS2;BRAP;PLD2;TIAM1;RALA;JUN;NF1;CCDC88A;SETDB1;BCR;RAB18;G3BP1;RAC1;RGS19
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.3267158720606677,0.8227201294538481,0.7215639810426541,0.9737804327816068,1.0,4/31,7.56%,TGFB2;TNNI3;SMAD4;ZFPM2
prerank,lysine metabolic process (GO:0006553),0.3899859929835002,0.8227081982908371,0.6918844566712518,0.9729413023741099,1.0,1/12,0.85%,SLC25A21
prerank,lysine catabolic process (GO:0006554),0.3899859929835002,0.8227081982908371,0.6918844566712518,0.9729413023741099,1.0,1/12,0.85%,SLC25A21
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.28653004090592904,0.8225705690801025,0.8328298086606244,0.9727475499930466,1.0,22/159,13.94%,CDH26;CADM3;GPC6;NPTN;CD177;TGFB2;TGFBR2;NECTIN3;PTPRS;PKD1;ACVR1;TENM3;PTPRF;CDH22;CLDN10;DSCAM;UNC5D;L1CAM;FLRT3;IGSF9;PALLD;CLDN12
prerank,negative regulation of JUN kinase activity (GO:0043508),0.4095731763963174,0.8225085656051259,0.717032967032967,0.97242883066479,1.0,3/10,20.08%,AIDA;PDCD4;HIPK3
prerank,negative regulation of synaptic transmission (GO:0050805),0.34182755039845547,0.8222129163185865,0.726161369193154,0.9724907425926117,1.0,8/23,31.20%,SYT11;ARF1;ATAD1;PTEN;PICK1;SLC24A2;DRD2;CBLN1
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.3223258437049669,-0.8216941949119533,0.6918238993710691,0.8887255150166838,1.0,1/11,1.76%,H3-3A
prerank,positive regulation of cellular senescence (GO:2000774),0.40482833429312404,0.8216651364055966,0.6891701828410689,0.9729472441001737,1.0,3/10,17.25%,CGAS;YPEL3;EEF1E1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.21103389851554055,-0.8211960286428186,0.8395061728395061,0.8882537629009924,1.0,14/50,18.17%,NR3C2;SASH1;APP;NFAT5;TLR3;LIMS1;EP300;SPHK1;NOD1;CD86;NMI;PHB2;TCIM;ACTN4
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.3810053602240696,0.8209491684590697,0.7110215053763441,0.9736656176760058,1.0,5/14,24.32%,CD177;SLC2A10;LIMS2;FLNA;DMTN
prerank,nucleotide metabolic process (GO:0009117),0.34293074315504124,0.8209241576388969,0.7015643802647413,0.973286720223784,1.0,6/23,17.56%,REXO2;FHIT;NME2;NUDT5;CMPK2;AK8
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.24477761814437102,-0.8208238553477419,0.75,0.8875158541326472,1.0,10/30,19.61%,ACSL1;ELOVL7;HACD1;HACD4;HACD2;ACSL6;ELOVL1;ELOVL4;TECRL;SLC27A2
prerank,regulation of transferase activity (GO:0051338),-0.2807192605183252,-0.820642818281306,0.7247706422018348,0.8863868805921976,1.0,6/17,21.31%,EMP2;FEM1A;ATM;SPTSSB;PARP4;HMBOX1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.3566565179699418,0.8206369912076728,0.7220125786163522,0.9733141717793166,1.0,5/21,15.60%,ZFP36L1;ZFP36L2;ITGAV;EGF;MAP2K2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.34191609505547044,0.8204656345170538,0.7409200968523002,0.973163726121655,1.0,6/27,16.31%,FGF2;SMOC2;PRKD2;CDKN1A;SMG6;HGF
prerank,positive regulation of histone methylation (GO:0031062),-0.2563157470129151,-0.820415885370114,0.7103825136612022,0.8854153604729343,1.0,6/24,14.28%,AUTS2;TET1;CTR9;SIRT1;RIF1;CTNNB1
prerank,carbohydrate homeostasis (GO:0033500),0.3050047280812421,0.8202911884434292,0.7690655209452202,0.9730138364201298,1.0,8/67,12.54%,MTNR1B;IRS1;CRTC2;TCF7L2;MLXIPL;MCU;INPP5K;ADCY8
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.28840118114242347,-0.8197100149526023,0.7336244541484717,0.8851943601242366,1.0,3/16,5.33%,PHKB;PYGM;AGL
prerank,histone monoubiquitination (GO:0010390),0.34586751651498626,0.8195661237893969,0.7121212121212122,0.9737399415555975,1.0,7/24,21.49%,RNF2;ATXN7L3;RYBP;DDB1;RING1;PAF1;KDM2B
prerank,protein autoubiquitination (GO:0051865),0.3026824723432799,0.819532643860957,0.7537634408602151,0.9733673511316755,1.0,20/61,24.79%,SH3RF3;UBE2B;TRIM71;ITCH;STUB1;CUL3;RNF10;RNF141;UBE2A;AMFR;UHRF2;TRIM68;RNF187;LRSAM1;UBE2D3;RNF41;UBE3A;RNF13;RNF157;MDM2
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.32310820237682814,0.8186472610597965,0.7404494382022472,0.9743782927587834,1.0,8/39,14.76%,PPFIA2;NDEL1;MYO1A;TRAK2;MYO5A;DYNC1I1;TANC2;CCDC186
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.3688056091740626,0.8182847813490074,0.7211155378486056,0.9745589594147712,1.0,2/16,2.88%,VEGFA;FGF2
prerank,eye photoreceptor cell development (GO:0042462),0.3809070207021815,0.8180348197311821,0.7076719576719577,0.9745273416690944,1.0,3/15,17.45%,VEGFA;BBS4;RPGRIP1
prerank,positive regulation of cellular component movement (GO:0051272),0.34341853836418385,0.8178499690231434,0.724907063197026,0.9744136464798634,1.0,5/24,13.56%,DUOX1;VEGFA;NTN1;CCDC25;TWIST1
prerank,cardiac muscle contraction (GO:0060048),0.32539311263029763,0.817809588229201,0.7305458768873403,0.9740542658158998,1.0,4/34,8.49%,GSN;TNNI3;CAMK2D;PIK3CA
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.34572386220202966,0.8172986686401198,0.7168674698795181,0.974444916558012,1.0,6/26,15.24%,ATP2B4;STIMATE;DYRK2;RCAN1;SLC9A1;CHP1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.34502483607295625,0.8172402791972786,0.7052505966587113,0.974125566301922,1.0,2/26,1.34%,EGFR;ANXA1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.33729721572059035,0.8172353662634559,0.7263157894736842,0.9737084778213989,1.0,2/29,2.30%,HPN;LDLRAD4
prerank,sodium ion import across plasma membrane (GO:0098719),0.3699861528968331,0.817206872892049,0.7098039215686275,0.9733246919447821,1.0,5/17,15.88%,SLC9A9;HCN4;SLC9A1;SLC9A7;SLC9A6
prerank,regulation of T cell chemotaxis (GO:0010819),-0.31849779605294953,-0.816237357452503,0.6968641114982579,0.8897096568076384,1.0,2/11,3.30%,ADAM10;WNT5A
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.32876481069877217,0.8162211714041646,0.719626168224299,0.9744980068544209,1.0,10/32,23.85%,POLR2H;GTF2H3;POLR1G;UBTF;ERCC3;CCNH;POLR1C;RRN3;TBP;POLR1B
prerank,negative regulation of ion transport (GO:0043271),-0.2525869062416681,-0.8161228555710791,0.7938144329896907,0.8884940739340688,1.0,9/24,21.36%,ACTN2;WNK4;SNCA;ADRA2A;NOS1;GPM6B;HTR1B;CASQ2;PLN
prerank,positive regulation of cell migration (GO:0030335),0.28315008771740185,0.8161224257927141,0.8948948948948949,0.9742344623872947,1.0,37/253,14.82%,SEMA3C;DDR2;HAS2;MYOC;EPHB2;COL1A1;PRKCA;EGFR;VEGFA;TGFB2;F2R;ADAM9;SMURF2;ACVR1;MTOR;MIA3;MYADM;C1QBP;RET;SRC;HDAC6;TNFRSF18;SEMA3A;AGO2;STX4;MAPRE1;KIF20B;GPNMB;FBXO5;SEMA3D;EGF;MGAT5;NSMF;PDGFRA;FER;PPP3CA;IL4
prerank,peptide metabolic process (GO:0006518),0.29983036110938194,0.8160750962928949,0.7726315789473684,0.9738834231423577,1.0,13/75,12.52%,PCSK5;ANPEP;SPCS1;LNPEP;DPEP1;TPP1;PSEN1;SEC11C;GPX1;GSTM2;NAT8;THOP1;NPEPPS
prerank,peptide biosynthetic process (GO:0043043),0.2880174826166981,0.8158907797966878,0.8434343434343434,0.9737780406930933,1.0,23/153,15.98%,RPSA;PCSK5;MRPS11;RRBP1;COPS5;MRPS18B;IGHMBP2;MRPL13;MRPS17;AGO2;GSPT2;RPL10A;MRPL10;MRPL55;TNIP1;RPS5;MRPL36;GGT7;MRPL3;GSPT1;RPL6;MRPL51;HARS1
prerank,zymogen activation (GO:0031638),0.3214810910693484,0.8157912757978132,0.7391304347826086,0.9735130455211444,1.0,6/39,16.79%,KLKB1;PRSS12;TBC1D10A;BAK1;KLK1;GRIN2A
prerank,pyruvate metabolic process (GO:0006090),-0.21477024158233687,-0.8149903489399635,0.8809523809523809,0.8891307729184282,1.0,17/52,21.72%,BSG;ENO1;HK2;PGAM1;PGAM4;PGK1;PFKM;ALDOC;GAPDH;PFKL;DLD;TPI1;GAPDHS;ENO3;GPI;LDHB;NR4A3
prerank,amyloid precursor protein metabolic process (GO:0042982),0.3567008783476935,0.8146157706102618,0.7161125319693095,0.9749238154838759,1.0,5/18,13.64%,ADAM19;TMCC2;PSEN1;KLK6;NSG1
prerank,histone H2A monoubiquitination (GO:0035518),0.35453924273040677,0.8145859693248305,0.7159533073929961,0.9745461413610972,1.0,7/17,24.89%,RNF2;RYBP;DDB1;RING1;PCGF6;KDM2B;PCGF3
prerank,cardiac muscle cell action potential (GO:0086001),0.3362123267928643,0.8141580449839927,0.7460122699386503,0.9747865805513323,1.0,6/30,10.04%,ANK2;ATP1A1;SLC4A3;KCNJ2;YWHAE;HCN4
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.40296891354669495,0.8140693859826822,0.7091412742382271,0.9745039402863583,1.0,7/10,29.45%,MUC1;ING4;RPS27L;TFAP4;KAT5;FOXM1;TP53
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.38284277140841066,0.8140440949824918,0.7032520325203252,0.9741223141172091,1.0,4/12,27.33%,GAS2L1;BRD8;CTSB;CTSL
prerank,regulation of cytokinesis (GO:0032465),0.29848493406237775,0.8136554743273462,0.7896405919661733,0.9743247985035035,1.0,22/78,25.22%,CDC14B;SVIL;AHCTF1;FSD1;FLCN;CUL3;KIF20B;SETD2;PRPF40A;CALM2;PIN1;RHOA;BBS4;GIPC1;CCP110;CIT;ENTR1;KLHL9;CDC25B;RAB11FIP3;E2F7;CDC14A
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3777614796487492,0.8135767240038144,0.6783310901749664,0.9740381042906301,1.0,3/14,13.49%,FSCN1;MYO9A;RHOA
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.32546511671149586,0.8126456967553698,0.7471395881006865,0.9751189308037659,1.0,9/39,18.98%,TCF7L2;GRP;ADCYAP1;MCU;IRS2;TRH;GLUD1;CAPN10;AIMP1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2860833011444585,0.8126361000550857,0.865055387713998,0.9747133540064064,1.0,33/170,20.31%,AFF3;C1D;AFF2;FOXP1;CRIP1;ZFP36L1;CDK4;COQ7;TARDBP;STX1B;PSEN1;HNRNPD;ARF1;TSKU;SIRPA;TRIM11;ALPK2;ZNF462;IGF2BP1;GDNF;PEG3;PIN1;SLC8A2;ZC3H12A;MTMR1;TRIM68;RNF187;CTCF;PRDM9;MKLN1;NOVA1;RASA1;CIAO3
prerank,positive regulation of JNK cascade (GO:0046330),0.30581523494648244,0.8124773174215826,0.779874213836478,0.9745586058111846,1.0,11/70,12.80%,SH3RF3;GADD45G;TAOK3;AXIN1;RASSF2;FZD7;SEMA3A;TIRAP;ANKRD6;CD27;TAOK2
prerank,regulation of TOR signaling (GO:0032006),0.30092102309898144,0.8120972849914936,0.7845010615711253,0.9747323654463789,1.0,11/67,15.12%,DGKQ;TBCK;GAS6;FLCN;PIK3CA;HDAC3;DEPTOR;SMCR8;TMEM127;RRAGD;GPAT3
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.2681901084993201,-0.8119432382947265,0.728110599078341,0.8932007272187933,1.0,4/20,9.13%,RAPGEF2;ADRA1B;ADRA2A;ADCY9
prerank,regulation of telomere capping (GO:1904353),0.3443008781361716,0.8119304330917733,0.7316176470588235,0.9745760659924271,1.0,7/23,21.04%,HNRNPD;NBN;USP7;SMG6;RAD50;NEK7;MAPK1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.3145755015565836,-0.8111326495756629,0.6806083650190115,0.8932424328005849,1.0,4/11,27.46%,PINK1;HIF1A;NR4A3;PARK7
prerank,myeloid dendritic cell activation (GO:0001773),0.3850389906307579,0.8108952060338348,0.7318361955085865,0.9757750026293942,1.0,3/12,20.96%,TGFBR2;IL4;PYCARD
prerank,mRNA methylation (GO:0080009),0.37319132839747915,0.8105942789640525,0.699475065616798,0.9758202669616169,1.0,2/15,8.09%,TRMT6;TRMT61A
prerank,regulation of gene silencing by miRNA (GO:0060964),0.30082132459206146,0.810437916769176,0.7956756756756757,0.9756511406904262,1.0,21/62,27.66%,POLR2H;NUP93;TRIM71;NUP107;NUP98;AGO2;PUM1;ZFP36;POLR2D;POLR2G;NUP37;NUP50;TPR;TNRC6A;POLR2C;NUP133;NUP85;NUP188;EIF4G1;NUP88;AGO1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.38612321420078005,0.8103474012665908,0.7256267409470752,0.9753771231875206,1.0,1/12,2.03%,CDC14B
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.2884194566192565,-0.8100705494774317,0.7579365079365079,0.8936266171252778,1.0,3/14,5.80%,ADAM10;DYRK1A;ABCG1
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.20594896998661466,-0.8097777735137991,0.9142857142857143,0.8927016793977587,1.0,12/68,12.87%,PCCA;SLC2A1;ENPP1;PDXK;MTHFS;TCN2;RFK;CUBN;ALDH1L1;MMAA;MCCC2;SLC19A3
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2871369962150439,0.809523555121616,0.8446014127144299,0.9762532329576988,1.0,46/129,30.09%,DCTN1;ODF2;CDK14;YWHAG;SSNA1;YWHAE;PPP1R12B;ALMS1;MAPRE1;HAUS3;SFI1;CDKN1A;FBXL3;CCNH;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;CCP110;AKAP9;CEP164;CKAP5;SKP2;PAFAH1B1;PPP2R2A;PCM1;DCTN2;FBXW11;CDC25B;NEDD1;LATS1;DYNLL1;CEP78;FBXL12;CSNK1E;ACTR1A;CETN2;WEE1;CEP152;CUL1;FOXM1;CENPJ;PLK4;SDCCAG8;FBXL8
prerank,protein sumoylation (GO:0016925),0.3113808192733171,0.8086246157943588,0.7559055118110236,0.9772189000785938,1.0,19/49,29.16%,STX1A;RNF212B;NUP93;PIAS3;NUP107;UBA2;NUP98;NUP37;NUP50;SAE1;TPR;NSMCE2;NUP133;BCL11A;NUP85;NUP188;NUP88;TOPORS;SUMO1
prerank,ion transport (GO:0006811),0.2875311407434904,0.8084797967494253,0.8067831449126414,0.9770147741717677,1.0,22/111,17.16%,PIEZO2;SLC1A7;ATP1A4;SLC26A11;SLC1A6;SLC9A9;SLC12A4;SLC17A5;CNGB1;HCN4;SLC26A6;VDAC2;SLC9A1;SLC12A5;SLC8A2;SLC15A4;VDAC1;SLC9A7;SLC9A6;SLC20A1;SLC26A1;CHRNA7
prerank,negative regulation of cell projection organization (GO:0031345),0.3113951067903787,0.8083541257160486,0.7706725468577729,0.9768045577764056,1.0,11/48,14.33%,FYN;PTPRS;LPAR1;STX1B;SEMA3A;MYLIP;TSKU;KANK1;CBFA2T2;RTN4RL1;DCC
prerank,ceramide metabolic process (GO:0006672),0.30718285160513215,0.8082120559248444,0.746974697469747,0.9766174889382988,1.0,8/49,12.38%,CERS6;PLPP3;PLPP1;ORMDL2;AGK;SGMS2;FA2H;CERK
prerank,regulation of heart contraction (GO:0008016),0.2914017780305904,0.807821127606468,0.8161157024793388,0.9768279404869524,1.0,17/90,14.04%,ANK2;TGFB2;SRI;ATP1A3;ATP1A4;ATP1A1;ATP2B4;CAMK2D;TNNI3K;HCN4;CELF2;PDE4D;CALM2;TMEM65;ATP2A2;SLC8A2;CASQ1
prerank,filopodium assembly (GO:0046847),-0.2887045802679702,-0.8076048325257389,0.7260869565217392,0.8950871231983658,1.0,3/16,4.28%,FGD4;FGD5;DNM3
prerank,mesenchyme morphogenesis (GO:0072132),0.35988121966761927,0.8074949684277618,0.7237354085603113,0.9769197219984521,1.0,3/17,6.76%,TGFB2;ACVR1;MDM4
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2832391928343626,0.807340832125827,0.8466195761856711,0.9767449389515185,1.0,43/158,23.89%,AKAP13;MIB2;ECM1;F2R;LPAR1;MID2;TMEM106A;CARD16;UBE2N;TFG;CHUK;PPP5C;TIRAP;LGALS1;IRAK4;DDX21;IRAK1;NDFIP1;TRAF3IP2;RHOA;TRIM68;RBCK1;SLC20A1;MAP3K14;CANT1;SLC44A2;CARD11;LURAP1;MIER1;UNC5CL;FLNA;PPM1A;GOLT1B;TSPAN6;TAB2;TERF2IP;ROR1;MAP3K7;FKBP1A;TRAF5;TNIP2;TRIM8;RELA
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3450860183594727,0.8072650803364817,0.7216117216117216,0.9764552538109501,1.0,4/21,11.08%,ADAM9;ADAM19;PSEN1;SPPL2B
prerank,telomere maintenance via telomerase (GO:0007004),0.33485773338394126,0.8072282300144913,0.7565011820330969,0.9760887322674094,1.0,9/28,22.09%,ACD;GAR1;TERF1;HSP90AA1;TNKS1BP1;RAD50;TINF2;PPP6C;TERF2IP
prerank,glycerophospholipid metabolic process (GO:0006650),-0.19965913800347465,-0.8071894620333768,0.9090909090909091,0.8944654884963075,1.0,23/75,21.53%,GPCPD1;PLCG1;PLA1A;HDHD5;PIGN;PLCB1;PIGG;PIP5K1A;PIGP;PDGFRB;ABCA3;PIGB;PNPLA6;PLA2G15;CLN3;CPNE3;PNPLA3;DGKH;PLA2G4C;PIGF;CPNE7;PIGA;ABHD3
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.28869186688948323,0.8069583899069963,0.8307849133537207,0.9760944584026477,1.0,16/114,17.93%,TNFSF9;PSMC4;TNFRSF11B;PSMC6;TNFRSF18;CHUK;PSMD8;TNFSF13B;PLVAP;CD27;TNFRSF1B;EDA;BAG4;TRAF3;MAP3K14;ILK
prerank,regulation of AMPA receptor activity (GO:2000311),-0.2504877834241813,-0.8067276893210263,0.7976190476190477,0.8938767817198688,1.0,8/25,17.69%,MEF2C;SHANK3;CACNG4;CACNG8;GSG1L;SHISA9;MINK1;ADRB2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.36486997955346345,0.806362176790685,0.7336956521739131,0.9765839428707657,1.0,4/16,13.22%,INPP5F;PARP14;PIBF1;BCL3
prerank,negative regulation of cellular metabolic process (GO:0031324),0.31933241739645174,0.8062471408674764,0.7666277712952159,0.9763381025502714,1.0,6/37,13.20%,ITGB3;DLG4;ATXN2;SIRT2;ITGAV;NCOR1
prerank,response to UV-B (GO:0010224),0.3814899858087053,0.8058819240508431,0.709366391184573,0.976498452413185,1.0,2/12,13.16%,CRIP1;CDKN1A
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.28506378527509574,-0.8055185103406391,0.7489711934156379,0.8946295091397813,1.0,2/16,3.32%,ETS1;NFAT5
prerank,steroid metabolic process (GO:0008202),0.2966395494340712,0.8054219704382122,0.8008474576271186,0.976786726330737,1.0,7/72,11.50%,DHRS9;DHRS4;CYP27B1;VDR;SCP2;SRD5A1;GBA2
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.2873801006064148,0.8049775695154415,0.8237113402061855,0.9770373486865912,1.0,20/107,19.15%,CCL8;NPTN;ANK2;TNNI3;SLC39A13;SLC39A14;ATP2B4;SLC39A7;ATP13A1;SLC30A9;CCL13;ATP2A2;SLC8A2;STC1;TMEM165;SLC30A5;CHRNA7;ATP2B1;HTR2C;STIM1
prerank,positive regulation of protein modification process (GO:0031401),0.27997851615752906,0.8048850787538664,0.889,0.9767713793550605,1.0,37/203,19.33%,FGF18;NIBAN1;FGF7;EGFR;EFNA5;TMEM119;NPTN;ITGB3;VEGFA;PDE8A;FGF2;AXIN1;GAS6;FLCN;UBE2N;MUSK;HDAC3;CAMKK2;KRAS;AKT1;GPNMB;CALM2;PIN1;CCND1;NSMF;WDFY2;HSP90AA1;CHP1;HGF;FXR2;CHRNA7;PPIA;PLAUR;ILK;SMPD1;THPO;CLIP3
prerank,kinetochore organization (GO:0051383),0.3740060349404003,0.8041709166522473,0.739247311827957,0.9774964246588158,1.0,3/13,18.82%,CENPT;CENPC;CENPE
prerank,negative regulation of reproductive process (GO:2000242),0.357404858666084,0.8038746130254275,0.7317708333333334,0.9775621294259845,1.0,9/17,33.45%,SULF1;WDR77;PAEP;CALR;DUSP1;NPPC;ACVR1C;ARHGDIB;TIMP1
prerank,regulation of aerobic respiration (GO:1903715),-0.2886730884129398,-0.8036400473329106,0.7046413502109705,0.8964759274906193,1.0,4/15,15.34%,CBFA2T3;PINK1;UQCC2;AK4
prerank,regulation of ATP biosynthetic process (GO:2001169),0.35870323434456064,0.803586727065854,0.714095744680851,0.9775937566005961,1.0,4/16,14.82%,PID1;FLCN;ANTKMT;IL4
prerank,regulation of amyloid-beta clearance (GO:1900221),0.3668724927825856,0.8033948890839425,0.7294429708222812,0.9774785467095629,1.0,1/16,1.37%,LRP1
prerank,regulation of innate immune response (GO:0045088),-0.20964152301097752,-0.8026448088531155,0.875,0.8967891233513936,1.0,17/57,17.35%,XIAP;PLSCR1;POLR3C;ERAP1;USP18;PTPN1;POLR3B;APPL2;RNF135;GBP5;RNASEL;TRIM21;N4BP1;NMI;LRP8;DHX58;PARP9
prerank,negative regulation of protein depolymerization (GO:1901880),0.34053624679161953,0.8026113575684939,0.7448107448107448,0.9782704495686908,1.0,5/24,20.62%,FGF13;PIK3CA;CAMSAP1;NAV3;CLASP2
prerank,negative regulation of cellular catabolic process (GO:0031330),0.30310420015486284,0.8024905740685504,0.7978835978835979,0.9780406847818148,1.0,17/63,23.84%,TIMP2;FOXK2;MTOR;IL10RA;SIRT2;AKT1;BMF;NUPR1;HGF;DAP;MCL1;GPLD1;PTPN3;TAB2;KLHL22;EIF4G3;LEPR
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3243170485649471,0.8022606094950787,0.7399309551208285,0.9779859028437219,1.0,9/33,20.35%,TRIAP1;FLCN;GPX1;AKT1;MAPT;GHITM;HGF;IAPP;PRELID1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.2702575754543537,-0.8020998922217994,0.7543859649122807,0.8963035766585087,1.0,5/17,12.25%,IGF1;APOE;GGA3;SORL1;NTRK2
prerank,regulation of protein autophosphorylation (GO:0031952),0.31749213058778186,0.8020499726376529,0.7485779294653014,0.977894320816479,1.0,10/36,17.41%,VEGFA;RASSF2;GPNMB;CALM2;TAOK2;NBN;TNKS1BP1;CHP1;PPP2R5B;RAD50
prerank,maintenance of protein location in nucleus (GO:0051457),0.34681764700478646,0.8019895949513002,0.7368421052631579,0.9775776918111619,1.0,6/20,16.87%,TAF8;SYNE1;TAF3;BCL3;BBS4;PML
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.25713361129564716,-0.8019406554589837,0.7947368421052632,0.8951133780415046,1.0,3/24,6.54%,ABCG2;PGRMC1;FECH
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.34472549849931383,0.8018946097214411,0.7264516129032258,0.9773109716278356,1.0,12/20,33.76%,ADAM9;PSEN1;SPPL2B;RELA;MBTPS1;NFKB1;HM13;ADAM17;TRAF6;PSENEN;SPPL2A;NCSTN
prerank,cellular response to alcohol (GO:0097306),0.3132995656568054,0.8014075110056426,0.7806236080178174,0.9776345149899849,1.0,10/42,19.54%,LRP6;GRAMD1A;JUP;LARP1;ADCY8;ADAM15;GNB1;SPIDR;BLM;GPLD1
prerank,actin filament organization (GO:0007015),0.28185904981729687,0.8012831855433075,0.850956696878147,0.977403955326947,1.0,32/151,20.71%,DBN1;GSN;SCIN;TLE6;CDC42EP2;COBL;SVIL;SPTA1;MARCKS;MYO1A;GAS2L1;MYO5A;ABI1;MCU;EFS;AVIL;RHOA;FHOD3;TRIOBP;TMOD2;RND3;PLS1;RAC3;CORO7;PPP1R9B;TPM4;ALDOA;RFLNA;FLNA;SAMD14;SHROOM3;CORO1C
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.31202035058804434,0.8011283112299579,0.7660753880266076,0.9772202755097321,1.0,7/45,11.15%,GAS1;ZFP36L1;ZW10;ZFP36L2;ZWINT;AURKAIP1;BCL6
prerank,regulation of nervous system process (GO:0031644),0.3534769009324507,0.8010441506099799,0.7289836888331243,0.9769421860582314,1.0,9/18,25.88%,DLGAP4;DLGAP3;SLC8A2;DLGAP1;CHRNA7;AKAP9;HTR2C;NPTX1;BEGAIN
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.2819329639405038,0.8010292078772269,0.8488843813387424,0.9765512325598146,1.0,45/149,29.06%,AR;RAB7B;IRAK3;S100A8;S100A9;MID2;CARD16;DHX33;UBE2N;PRKD2;CHUK;TIRAP;TLR4;NPM1;IRAK1;UBA52;FER;EDA;TRIM68;RBCK1;IL6;FLOT2;PPIA;IL18;CARD11;PYCARD;TAB2;TERF2IP;ROR1;FLOT1;MAP3K7;TRAF5;TRIM8;RELA;PRKCZ;TICAM1;RNF31;RHEBL1;BCL10;NFKB1;EDA2R;PRKCI;RPS6KA5;ZBTB7A;MYD88
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2997378817963776,0.8010173151896222,0.7803030303030303,0.9761548352354579,1.0,14/63,16.87%,TRIAP1;RFWD3;MUC1;MDM4;FBXO31;SFN;RPS27L;CDKN1A;CCND1;CNOT3;CNOT10;PLAGL1;TNKS1BP1;PML
prerank,protein tetramerization (GO:0051262),0.2986129633479936,0.8006032988075544,0.7985153764581124,0.9763774130021364,1.0,12/67,15.11%,PKD1;KRT10;TK1;KCNJ2;OSBPL2;PKD2;CPSF6;SAMHD1;ALDH1A3;GLS;CRYZ;HSD17B8
prerank,regulation of myoblast differentiation (GO:0045661),0.32345084014228315,0.8003762431207957,0.7529411764705882,0.9762922630307722,1.0,6/32,8.12%,MAPK14;ZFP36L1;AKIRIN1;TRIP4;BOC;SOX8
prerank,protein localization to membrane (GO:0072657),0.2786909112814703,0.8002492346596564,0.8872104733131924,0.9760732610482461,1.0,50/187,24.39%,LRP6;TTC7A;TSPAN17;PKP3;PRAM1;RAB32;ANK2;FGF13;S100A10;RFTN1;DLG4;PLEKHF1;DLG2;MYADM;AP3D1;MYO5A;GAS6;PACS2;CD81;EHD2;INPP5K;FYB2;RAB3D;MAGI2;JUP;ZDHHC2;HPS6;PIGW;FRMPD1;ANK1;SPTBN1;AP4M1;FLOT2;SYNJ2BP;RAB40C;TMED2;FLNA;CLASP2;RAB10;ABHD17A;SMURF1;SPTBN4;KCNIP4;FLOT1;SYNE3;PICK1;TTC7B;DVL1;RAB12;MRAP2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.2905027281102988,-0.7999671400572311,0.7366412213740458,0.8970050879819819,1.0,3/13,9.43%,PTPN1;DNAJB9;PPP1R15B
prerank,amyloid fibril formation (GO:1990000),0.29954949513044193,0.7998563418486452,0.765033407572383,0.9762819972163085,1.0,10/51,14.77%,GSN;TGFBI;SIAH1;GGA1;CALCA;MAPT;NAT8;UBA52;HSPG2;GGA2
prerank,cellular response to nutrient levels (GO:0031669),0.29635164165511574,0.7998112637389666,0.7843347639484979,0.9759400796863712,1.0,12/62,14.37%,MTOR;FOXO1;GAS2L1;FLCN;WIPI2;USP33;WDR45B;RRAGD;ULK1;EHMT2;FADS1;STK24
prerank,lipoxygenase pathway (GO:0019372),0.36870197605899113,0.7997580847257945,0.7312252964426877,0.9756054486435279,1.0,2/14,10.96%,PON3;GPX1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.20236350273606626,-0.7990916047617178,0.8977272727272727,0.8971156316906383,1.0,14/55,14.88%,BCL2L1;BCL2;DAB2IP;TPD52L1;CAV1;ING5;TNFSF12;FAS;WWOX;BCL2L11;RIPK1;TNFSF10;DEDD2;GPER1
prerank,cellular response to amyloid-beta (GO:1904646),0.3169517406280304,0.7990160553268906,0.7730414746543779,0.9763628931113413,1.0,9/35,17.99%,LRP1;FYN;ATP1A3;PSEN1;TLR4;ABCC1;CACNB1;GRIN2A;SNX6
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.3386558034316703,0.798966076593523,0.7671068427370948,0.9760275441371011,1.0,6/26,12.35%,WDTC1;PRKAB2;MLXIPL;ACADVL;ELOVL5;EIF6
prerank,photoreceptor cell development (GO:0042461),0.37249802109218394,0.7986936582164093,0.7393048128342246,0.9760311658468618,1.0,6/14,31.50%,VEGFA;AHI1;DCX;TOPORS;TULP1;RORB
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.36171178796572206,0.7983594270947334,0.7306122448979592,0.9761013427076106,1.0,3/15,12.14%,IRS1;AKT1;IRS2
prerank,cellular metal ion homeostasis (GO:0006875),0.2848591147043392,0.7979580557408735,0.827300930713547,0.9763127338123657,1.0,10/102,5.51%,CCL8;KCNMA1;NPTN;ANK2;TNNI3;ATP1A3;ATP1A4;ATP1A1;ATP2B4;KCNJ2
prerank,vitamin transport (GO:0051180),-0.2405904121627751,-0.7978549021041409,0.7988826815642458,0.8977704954402711,1.0,5/29,9.01%,ABCG2;PDPN;SLC35F3;TCN2;CUBN
prerank,ncRNA processing (GO:0034470),0.27806100879953743,0.7971701145872901,0.9038076152304609,0.9770863384861305,1.0,48/200,23.67%,C1D;TARBP2;INTS3;DDX49;RPP21;DGCR8;FCF1;INTS10;AGO2;ESF1;HELQ;EXOSC7;INTS6;RRP36;RPL10A;WDR46;UBA52;SBDS;MPHOSPH10;RCL1;SNU13;NOLC1;DCAF13;RRP7A;EXOSC1;ZCCHC8;RPL6;NOP53;DDX52;POP4;INTS2;AGO4;PWP2;TRPT1;EBNA1BP2;INTS12;AGO3;TBL3;RPL23;RPL17;PDCD11;KRR1;RPS25;RPP30;WDR18;NOC4L;TEX10;RRP1B
prerank,regulation of adaptive immune response (GO:0002819),-0.2679394173168956,-0.7969926813311212,0.8388625592417062,0.8978166738530685,1.0,8/18,35.10%,AHR;SIRT1;FCGR2B;IRF7;SKAP1;FADD;IL4I1;SASH3
prerank,regulation of TORC1 signaling (GO:1903432),0.32031517734862053,0.7968012883509588,0.7445838084378563,0.9772437909480448,1.0,10/33,22.86%,DGKQ;FLCN;SESN3;SMCR8;RRAGD;PIP4P1;GPR137B;CASTOR2;SESN2;KLHL22
prerank,central nervous system myelination (GO:0022010),0.3871907079561533,0.7967067786365329,0.7248603351955307,0.9769683932363377,1.0,6/11,28.07%,SOX10;PLP1;PTEN;CNTNAP1;B4GALT5;MYRF
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3569825488408673,0.7965635585851402,0.7474093264248705,0.9767621057937783,1.0,5/17,25.59%,WASF1;ARF1;GMFB;PICK1;CYFIP1
prerank,regulation of G0 to G1 transition (GO:0070316),0.31413856146707725,0.7964476695126721,0.7607934655775963,0.9765080446792994,1.0,12/38,22.14%,RNF2;RHNO1;RYBP;PHC3;PHC1;EHMT2;UXT;APAF1;RING1;PCGF6;FOXO4;EZH2
prerank,secondary alcohol biosynthetic process (GO:1902653),0.32844671253692337,0.7963259524168577,0.7781731909845789,0.9762689451362294,1.0,4/30,9.30%,ACLY;MVK;INSIG2;GGPS1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.38004828165537724,0.796281570926259,0.7136812411847673,0.9759268620756482,1.0,7/12,34.09%,SGTA;SEC63;SEC61A1;SEC61B;CHMP4A;CHMP4B;HSPA5
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.25505717421157614,-0.7957205617676046,0.7843137254901961,0.8984397147582972,1.0,3/22,9.01%,ALDH1A2;RBP1;CUBN
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.23421426120025748,-0.7952369567243261,0.8104575163398693,0.8978334530436389,1.0,7/29,13.17%,WNT5A;MAVS;CNOT7;USP18;PTPN1;PTPN2;RNASEL
prerank,myotube cell development (GO:0014904),0.38551533709867075,0.7951280253666131,0.7372881355932204,0.9772259233347921,1.0,4/10,23.89%,SKI;SIX1;SELENON;MYORG
prerank,lymphocyte proliferation (GO:0046651),0.34034573513761807,0.794952126006791,0.7213740458015268,0.9770882854004914,1.0,6/22,21.27%,ELF4;FLT3;CR2;LMBR1L;PPP3CB;PIK3CG
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.35628961910976653,0.7949463191597745,0.7367741935483871,0.9766882189681878,1.0,6/16,23.07%,SIRPA;ZC3H12A;PDCD4;PYCARD;CUEDC2;CHID1
prerank,DNA methylation (GO:0006306),0.32953603731700126,0.7948230468866302,0.7350427350427351,0.9764577228013026,1.0,11/23,29.85%,SPOCD1;EHMT2;DMAP1;N6AMT1;BAZ2A;GATAD2A;PICK1;MTRR;ATF7IP;ATRX;FOS
prerank,T cell receptor signaling pathway (GO:0050852),0.2836553381249114,0.7948055994528292,0.875882946518668,0.9760733773457234,1.0,40/138,28.72%,PRAM1;PSMC4;FYN;RFTN1;PIK3R2;PTPRJ;CSK;PSMC6;RC3H1;UBE2N;PRKD2;CHUK;PIK3CA;PSMD8;FYB2;PDE4D;ZC3H12A;MOG;BTN3A3;RBCK1;NCK1;VTCN1;CARD11;EIF2B1;TAB2;RC3H2;FBXW11;MAP3K7;RELA;PSMD3;PSMD4;EIF2B2;PSMB3;RNF31;PAK3;BCL10;PSMB2;NFKB1;PSMD5;CUL1
prerank,sensory organ development (GO:0007423),0.3027255883465943,0.7946446024242623,0.7906976744186046,0.9759037819986598,1.0,7/51,9.83%,SIX4;ZDHHC16;TGFB2;PBX1;MEIS2;ECE1;ADAMTS18
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.30977545201054835,0.794472087600516,0.7549889135254989,0.975760866271772,1.0,11/40,21.65%,PID1;PIP5KL1;AKT1;MAPT;NDUFS1;BAK1;TUSC2;SLC25A36;PYCR1;PRELID1;SLC25A33
prerank,transcription by RNA polymerase I (GO:0006360),0.31980650971435,0.7944040670102283,0.7491248541423571,0.9754523871960349,1.0,10/34,23.85%,POLR2H;GTF2H3;POLR1G;UBTF;ERCC3;CCNH;POLR1C;RRN3;TBP;POLR1B
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3492528253816445,0.7941472211685698,0.7438231469440832,0.9754203267434,1.0,3/19,15.94%,CARD16;ZC3H12A;NLRP2B
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.2789253997890567,0.7941198084757968,0.8318042813455657,0.9750461955208689,1.0,20/118,13.54%,PHLDB1;ARHGAP44;EFNA5;SPARC;FGF2;PPFIA2;ZRANB1;RC3H1;PID1;LARP4;SRCIN1;HECW2;EPHB3;CAMSAP1;BCL6;MAPT;GPNMB;TANC2;GDNF;NSMF
prerank,oligosaccharide metabolic process (GO:0009311),0.3072699689124758,0.7937162494113398,0.7797956867196367,0.9752446115833234,1.0,7/46,12.06%,ST3GAL2;B4GALT1;FUT2;GAL3ST3;FUT9;ST3GAL4;GLA
prerank,response to amino acid starvation (GO:1990928),0.29314911085059914,0.7935596031029984,0.7957446808510639,0.9750847545289648,1.0,19/72,23.20%,EIF2AK3;MTOR;FLCN;CEBPB;ATP6V1E1;SESN3;LARP1;CDKN1A;RRAGD;EIF2S1;ATP6V1D;ATP6V1B2;DAP;CASTOR2;MAPK1;SESN2;ATF4;SLC38A9;ATP6V0B
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3131397134196977,-0.7934020362957386,0.7509025270758123,0.8995852791082549,1.0,4/11,17.69%,GRK3;GTF2H2;ADM;ADRB2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3077531842061116,0.7933375956756301,0.7779043280182233,0.9749930392844617,1.0,9/43,17.38%,IRS1;GRB10;TNS2;PID1;INPP5K;KANK1;NCK1;OGT;PIP4K2C
prerank,response to muramyl dipeptide (GO:0032495),-0.3087914956340122,-0.7932968116598291,0.7426470588235294,0.8983673603154855,1.0,4/12,24.87%,NOD1;NOD2;ERBIN;RIPK2
prerank,positive regulation of myelination (GO:0031643),-0.3080067328696128,-0.7927027018041795,0.75,0.8979599304535226,1.0,2/11,7.90%,TENM4;TPPP
prerank,nucleotide catabolic process (GO:0009166),0.36381633827528603,0.7922565211207881,0.7371879106438897,0.9762096924385315,1.0,3/16,10.96%,SAMHD1;GDA;GPX1
prerank,heterocycle biosynthetic process (GO:0018130),0.36885948883860564,0.7920579092798209,0.7369146005509641,0.9760927620108858,1.0,8/14,35.05%,NFS1;PYCR1;MOCS1;NOXRED1;PYCR3;MOCS2;LIAS;MOCS3
prerank,embryonic heart tube development (GO:0035050),0.36742580634244204,0.7920093091701355,0.7269180754226268,0.9757542678749727,1.0,2/14,8.17%,ACVR1;NDRG4
prerank,regulation of protein targeting to membrane (GO:0090313),0.32432603084060063,0.791888352604146,0.7425860023724793,0.9755233862425374,1.0,12/28,30.42%,FYN;MIEF2;INPP5K;GDI1;CHP1;ITGAM;FIS1;DMTN;MTCL1;PRNP;MYO1C;AKT2
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2915505156055249,0.7917255833422394,0.8004223864836325,0.9753560930356107,1.0,6/69,5.07%,TGFB3;SIX4;F2R;ZPR1;CLCF1;NFATC4
prerank,mismatch repair (GO:0006298),-0.2404547512561649,-0.791606198900234,0.8074534161490683,0.898384100272976,1.0,12/27,25.85%,MCM9;MSH3;XPC;PCNA;ABL1;TDG;MSH2;POLD2;RPA2;MLH3;MUTYH;POLD4
prerank,intracellular sterol transport (GO:0032366),0.37609519338269126,0.7911465725920944,0.7533692722371967,0.9757612868405348,1.0,2/13,7.00%,OSBPL2;ABCA1
prerank,DNA conformation change (GO:0071103),-0.2701246864572731,-0.7911410956342166,0.7626262626262627,0.8977222733211885,1.0,7/17,25.52%,HMGB1;ABL1;HHEX;TOP1MT;NAA10;TOP2A;TOP3B
prerank,prostaglandin biosynthetic process (GO:0001516),-0.2758487611037934,-0.7910156050198273,0.7725321888412017,0.8965094783927724,1.0,9/18,23.96%,PTGDS;PTGS2;PTGIS;PTGES3;EDN1;CD74;TBXAS1;CBR1;PTGS1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.312045486357808,-0.79093085489038,0.7508771929824561,0.8952491153036298,1.0,2/11,5.24%,SCARB1;NR1H3
prerank,lipid catabolic process (GO:0016042),0.34902778709669113,0.7908298591441999,0.7360931435963778,0.9758331903958767,1.0,4/18,18.64%,CEL;SIRT2;LIPC;LIPH
prerank,regulation of interleukin-13 production (GO:0032656),0.3764959188722803,0.7908262789919646,0.7479224376731302,0.9754305741412265,1.0,5/13,24.85%,IRF4;IL4;IL18;PRKCZ;RARA
prerank,ear morphogenesis (GO:0042471),0.33896901709752075,0.7904803999852972,0.7392996108949417,0.9755378516110468,1.0,1/20,0.46%,EPHB2
prerank,regulation of cellular component size (GO:0032535),-0.22250103437093538,-0.7904778046463685,0.8473282442748091,0.8946376110310185,1.0,5/30,8.03%,EPS8;RAB22A;RPTOR;RIN3;LAMTOR5
prerank,UV-damage excision repair (GO:0070914),0.36881231712670265,0.7900019515020875,0.7250673854447439,0.9758194166823055,1.0,4/12,22.85%,ACTR5;DDB1;INO80;ERCC1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.29843767319393194,0.789889343529923,0.8002159827213823,0.9755790492213267,1.0,6/65,9.40%,FHL1;PSMC4;INTS3;PSMC6;PSMD8;AVEN
prerank,neuromuscular process controlling balance (GO:0050885),0.37437684988301206,0.7896396668607519,0.7394270122783083,0.9755682200028989,1.0,5/12,33.82%,TPP1;PAFAH1B1;NRXN1;PCDH15;SHANK1
prerank,response to ethanol (GO:0045471),0.364657520159834,0.7893360234957082,0.7290836653386454,0.9756043822209397,1.0,4/14,30.12%,GRIN3A;GRIN2A;GOT2;GLRA2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.28767290964088343,0.7891741579826568,0.8100208768267223,0.9754162264718579,1.0,11/76,18.41%,ESR1;PLCE1;F2R;LPAR1;GPR20;CALCA;LHCGR;GRM1;CXCR2;TRHR;HTR2C
prerank,positive regulation of insulin secretion (GO:0032024),0.31616825988297065,0.788413130380247,0.7632794457274826,0.976094248676581,1.0,13/36,26.38%,TCF7L2;MCU;STX4;IRS2;ADCY8;TRH;GLUD1;CAPN10;PPP3CB;GPLD1;TM7SF3;BAIAP3;CFTR
prerank,positive regulation of chromosome organization (GO:2001252),0.35923752481915144,0.7883246941398822,0.7536041939711664,0.9758166479941275,1.0,4/15,17.41%,DDX11;NBN;PML;RAD50
prerank,neuron maturation (GO:0042551),-0.263925137115123,-0.7880248358938328,0.7887323943661971,0.8972901745928733,1.0,9/18,23.13%,APP;EPHA8;ANKS1A;CX3CL1;C1QA;C3;CLN5;SCARF1;ACTL6B
prerank,response to hexose (GO:0009746),0.32749565876821096,0.7875978597241974,0.7617283950617284,0.9764931293423447,1.0,6/25,19.82%,TCF7L2;IRS2;SELENOS;VAMP2;GPLD1;EIF2B1
prerank,respiratory chain complex IV assembly (GO:0008535),0.33300764045178105,0.787258439608907,0.7645569620253164,0.9765631858748326,1.0,8/21,27.02%,COX19;SURF1;BCS1L;COX16;COX14;COX18;SCO1;COX15
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.38757079031220676,0.7871385254037637,0.7391304347826086,0.97633381375131,1.0,1/10,3.40%,SRI
prerank,cellular response to type I interferon (GO:0071357),-0.21823895343739838,-0.7870801672943559,0.8389830508474576,0.8960419063978391,1.0,12/41,18.30%,SP100;IFNAR1;IFITM3;IFIT1;IFIT2;OAS2;STAT1;IFIT3;RNASEL;ADAR;RSAD2;PSMB8
prerank,type I interferon signaling pathway (GO:0060337),-0.21823895343739838,-0.7870801672943559,0.8389830508474576,0.8960419063978391,1.0,12/41,18.30%,SP100;IFNAR1;IFITM3;IFIT1;IFIT2;OAS2;STAT1;IFIT3;RNASEL;ADAR;RSAD2;PSMB8
prerank,positive regulation of cell motility (GO:2000147),0.27412003020218767,0.7869999270041174,0.9158316633266533,0.9761333052737361,1.0,28/205,14.82%,SEMA3C;HAS2;MYOC;EPHB2;DUOX1;COL1A1;PRKCA;EGFR;VEGFA;F2R;ADAM9;ACVR1;MYADM;RET;NTN1;SEMA3A;STX4;MAPRE1;GPNMB;SEMA3D;CCDC25;EGF;MGAT5;TWIST1;PDGFRA;FER;PPP3CA;IL4
prerank,regulation of anoikis (GO:2000209),0.3429501501149133,0.7868172909547264,0.7587064676616916,0.9760023953046879,1.0,6/19,19.35%,ITGA5;SRC;PIK3CA;SNAI2;PTRH2;MCL1
prerank,visual system development (GO:0150063),0.30905687751990324,0.7862659318390955,0.7565415244596132,0.9764155180846547,1.0,5/37,9.83%,ZDHHC16;TGFB2;PBX1;MEIS2;ADAMTS18
prerank,positive regulation of cytokinesis (GO:0032467),0.32116757257913375,0.7858689296396169,0.7677725118483413,0.976581052003617,1.0,6/32,15.08%,CDC14B;SVIL;CUL3;KIF20B;RHOA;GIPC1
prerank,establishment of vesicle localization (GO:0051650),0.34739805593868917,0.7857800463531116,0.7384615384615385,0.976306591033803,1.0,4/18,16.18%,SYT11;TOR1A;CCDC186;SNAPIN
prerank,negative regulation of viral process (GO:0048525),0.29438713305692976,0.7854104289031089,0.7913043478260869,0.9764506735881311,1.0,17/57,24.78%,MID2;TRIM11;ZC3HAV1;SLPI;TNIP1;ZFP36;FAM111A;UBP1;PML;PPIA;MBL2;TRIM35;BTBD17;SRPK1;LARP7;TRIM8;HEXIM1
prerank,protein kinase B signaling (GO:0043491),0.3333400412445939,0.7850770849272102,0.7576126674786845,0.976505610145625,1.0,8/23,25.32%,ZFP36L1;GAS6;SIRT2;AKT1;TYRO3;PTEN;TSC2;PAX2
prerank,regulation of type I interferon production (GO:0032479),0.28468784861803714,0.7849897186785562,0.8284823284823285,0.9762190396149827,1.0,28/84,29.06%,POLR2H;ITCH;CGAS;DHX33;POLR3E;TIRAP;POLR3D;IRAK1;XRCC5;PIN1;CD14;RNF216;ILRUN;TRAF3;TAX1BP1;POLR3H;POLR1C;POLR3A;CYLD;RELA;G3BP1;UBA7;UFD1;PRKDC;NPLOC4;NFKB1;XRCC6;MYD88
prerank,nuclear migration (GO:0007097),0.3770386523046885,0.7847266071039916,0.7493112947658402,0.9761870867482672,1.0,8/13,23.24%,DCTN1;DOCK7;DYNC1H1;PAFAH1B1;PCM1;TMEM201;FBXW11;SYNE3
prerank,fatty acid biosynthetic process (GO:0006633),0.28895867589857055,0.7837594813436285,0.8096256684491978,0.9771561644270603,1.0,13/63,19.72%,ACLY;TECR;NDUFAB1;ELOVL5;FADS1;HSD17B8;HACD3;FADS3;LIPC;LIPH;ABCD3;MCAT;SCD5
prerank,lipid homeostasis (GO:0055088),0.29523453277843936,0.7837131741751151,0.7978142076502732,0.9768161925325641,1.0,12/57,18.77%,NR1D2;TLCD2;RCN3;MLXIPL;ABCA1;ORMDL2;PNPLA8;IRS2;THADA;ACOX1;POLD1;ANGPTL3
prerank,ncRNA export from nucleus (GO:0097064),0.3112236638364149,0.7832290101799432,0.7784156142365097,0.9770996014022224,1.0,19/36,34.13%,NUP93;NUP107;NUP98;NPM1;NUP37;NUP50;XPOT;TPR;NUP133;NUP85;NUP188;NUP88;TSC1;SEC13;AAAS;NUP160;NCBP2;NUP54;RANBP2
prerank,pharyngeal system development (GO:0060037),0.35415903300355245,0.7831131603276313,0.7509933774834437,0.9768700367968602,1.0,2/15,2.91%,SIX4;TGFB2
prerank,purine ribonucleotide transport (GO:0015868),0.35123176304462833,0.7829961991810903,0.7516087516087516,0.9766165623216978,1.0,3/16,14.88%,LRRC8D;SLC25A4;SLC25A17
prerank,chloride transport (GO:0006821),0.287063585097942,0.7829740795170439,0.8294736842105264,0.9762396356237513,1.0,12/74,17.36%,SLC4A10;ANO3;SLC4A8;SLC12A8;GABRR3;SLC12A4;SLC26A6;SLC12A5;GABRG3;TTYH3;SLC26A1;ANO5
prerank,phosphorylation (GO:0016310),0.27084616270209316,0.7828156616848472,0.955,0.9760737212014393,1.0,52/385,12.80%,SYK;EPHB2;DCLK1;PRKCA;TNK1;FGFR1;STK25;EIF2AK3;CDKL2;FYN;DGKQ;IRAK3;SGK3;SGK2;TGFB2;LMTK3;CDK14;TGFBR2;TAOK3;ACVR1;CDK4;MTOR;CAMK2D;CSK;RET;TBCK;GAS6;GK5;STRADA;PRKD2;TNNI3K;CHUK;PIK3CA;TESK2;CDK9;CDK20;AGK;AKT3;BMP2K;NRBP2;ERN1;DYRK2;AMHR2;CAMKK2;AKT1;MAP3K6;IRAK1;PASK;STK39;CERK;PXK;TAOK2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.3283691142203512,0.7824984585131483,0.7493670886075949,0.9761197607571657,1.0,3/25,6.20%,ANK2;F2R;CXCL10
prerank,positive regulation of hemostasis (GO:1900048),0.3849914657411102,0.7823940167021594,0.7411598302687411,0.9754573513634293,1.0,2/10,11.72%,F2R;ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),0.3849914657411102,0.7823940167021594,0.7411598302687411,0.9754573513634293,1.0,2/10,11.72%,F2R;ST3GAL4
prerank,negative regulation of transmembrane transport (GO:0034763),0.3829668649003949,0.7820265495836222,0.7525179856115108,0.9756021535200493,1.0,3/10,12.14%,INPP5K;AKT1;IRS2
prerank,piRNA metabolic process (GO:0034587),-0.26381130054531166,-0.7815521353571682,0.8075117370892019,0.9032742142647502,1.0,17/19,50.43%,TDRKH;EXD1;MYBL1;PIWIL2;TDRD9;TDRD12;PIWIL4;FKBP6;MAEL;MOV10L1;HENMT1;ASZ1;GPAT2;BTBD18;TDRD1;PIWIL1;PLD6
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.31191870905274044,0.7814555876420772,0.7726218097447796,0.9759955500433687,1.0,4/34,6.77%,TNS2;PTPRS;PTPRJ;PTPRF
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3595828202011425,0.7804448349659424,0.748,0.9770299669201934,1.0,6/14,27.78%,PPP5C;PPP3CA;NCK1;PPP2R2A;DUSP1;PPP2R2D
prerank,adherens junction organization (GO:0034332),0.3019469812132334,0.7802022950856997,0.8093645484949833,0.9769670505770048,1.0,7/48,12.08%,CADM3;ANG;NECTIN3;CSK;JAM3;CDH22;JUP
prerank,negative regulation of GTPase activity (GO:0034260),-0.2516278427716131,-0.7801162930996688,0.7891891891891892,0.9041788569402464,1.0,5/22,10.29%,F11R;DAB2IP;LRCH1;CPEB2;ARL2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2813878736664443,0.7800109447097217,0.8272632674297606,0.9768405845228979,1.0,12/86,9.59%,TGFB3;TGFB2;SMAD4;ACVR1;BMP15;NUP93;SH2B1;RNF111;INHA;SULF1;FLCN;BMP8A
prerank,stem cell differentiation (GO:0048863),0.31014124215864325,0.7799203012616025,0.7972665148063781,0.9765622815583114,1.0,8/39,18.29%,LRP6;TGFB2;EEF1AKMT4-ECE2;PUM1;SETD2;LMBR1L;UFL1;GPM6A
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3346854847029293,0.7798623459518398,0.7571964956195244,0.9762430408481099,1.0,7/22,27.44%,SCAF8;TCERG1;THOC1;ELL;KAT7;ALYREF;THOC5
prerank,heart looping (GO:0001947),0.30321672962158513,0.779369223161312,0.7857142857142857,0.9765241358667851,1.0,9/40,18.90%,TGFBR2;TBX6;PKD2;NDRG4;MICAL2;VANGL2;BBS4;AHI1;BBS5
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.3068944984605519,-0.7793262507097858,0.7426470588235294,0.9040477655464636,1.0,3/10,16.20%,ABCA3;PHB2;MTMR3
prerank,ribosomal large subunit biogenesis (GO:0042273),0.29642684478215525,0.7788080729002168,0.8087912087912088,0.9769423762983989,1.0,16/54,24.19%,SDAD1;NOC2L;NPM1;RPL10A;EIF6;SNU13;RSL1D1;RPL6;NOP53;RPF2;EBNA1BP2;MAK16;NOP2;RSL24D1;BRIX1;LTO1
prerank,histone mRNA metabolic process (GO:0008334),-0.23579836883810867,-0.7780114354938327,0.8431372549019608,0.9045796080828636,1.0,11/27,21.24%,SSB;TUT1;TUT4;TUT7;SNRPB;ATM;MTPAP;LSM11;SNRPE;SNRPF;LSM10
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.2861726061446921,-0.7778275889680231,0.7175572519083969,0.9034621318649214,1.0,9/13,46.22%,NECTIN2;CYRIB;FADD;IL12A;IL12RB1;IL23A;IL23R;IL12B;XCL1
prerank,positive regulation of calcium ion transport (GO:0051928),0.31026910514194106,0.7776742461205544,0.793465577596266,0.9781865895917411,1.0,3/36,4.28%,ANK2;F2R;P2RX3
prerank,acyl-CoA metabolic process (GO:0006637),0.3074824790239926,0.7776054176808372,0.7746806039488966,0.9778887532308231,1.0,4/35,14.25%,GPAT4;ACOT6;ACOT9;ACOT1
prerank,protein localization to synapse (GO:0035418),0.3686946068807273,0.7774701179493776,0.751660026560425,0.9776825004485621,1.0,7/12,33.82%,DLG4;NLGN1;ZDHHC15;NRXN1;NLGN2;NRXN2;SHANK1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2840645987123391,0.7772940798925403,0.8369678089304258,0.9775318357875376,1.0,9/86,8.57%,PSMC4;MAPK7;VEGFA;NFE2L2;KLF2;MUC1;PSMC6;EGLN2;PSMD8
prerank,regulation of T cell mediated immunity (GO:0002709),0.3824168550487684,0.7770406770185175,0.7322946175637394,0.977476543831535,1.0,2/10,13.72%,ZBTB1;TNFRSF1B
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2745589849232464,0.7770366029543064,0.8829465186680121,0.97707989650058,1.0,28/151,17.79%,CERS6;ST3GAL2;PCSK5;GPAT4;PLPP3;ALDH3A2;INHA;PLPP1;CHKB;PRKD2;SLC44A1;LCAT;SGMS2;LPCAT1;LARGE1;GSTM2;FA2H;ELOVL5;ST3GAL4;TNIP1;PRKD3;NFS1;CEPT1;HACD3;SLC44A2;SLC25A15;GSTO2;PLPP2
prerank,regulation of response to interferon-gamma (GO:0060330),-0.2772022351980913,-0.7770171753081043,0.8058608058608059,0.9032647641744969,1.0,14/14,72.31%,STAT1;PTPN2;PIAS1;PARP9;SOCS1;IFNGR2;JAK1;IFNG;HSP90AB1;CDC37;SUMO1;SOCS3;JAK2;IFNGR1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.33930160895168016,0.7761581594096445,0.762796504369538,0.9779016801934182,1.0,9/19,29.03%,PTPRJ;STIMATE;BCAP31;FIS1;DMTN;GRM5;PTGFR;FKBP1B;PRNP
prerank,positive regulation of interferon-alpha production (GO:0032727),0.33817563474517287,0.7759048932933068,0.7660377358490567,0.977861032035012,1.0,3/19,11.81%,CHUK;TLR4;SETD2
prerank,protein K63-linked ubiquitination (GO:0070534),0.3015170668949094,0.77585905890143,0.7956371986222732,0.977516836981288,1.0,10/41,18.12%,UBE2B;ITCH;PELI3;STUB1;UBE2N;MAGEL2;TRAF3IP2;TRAF3;UBE2G1;ARIH2
prerank,cognition (GO:0050890),0.2996807223943044,0.7758261536047414,0.7970687711386697,0.9771597996087772,1.0,11/42,18.94%,DGCR2;GPR155;ST3GAL4;SLC8A2;BBS4;LHCGR;SETD5;TTC8;TUSC3;CHRNA7;NIPBL
prerank,regulation of inclusion body assembly (GO:0090083),-0.3072980432018599,-0.7756822467130148,0.7508650519031141,0.9039398004514659,1.0,1/11,0.83%,SNCAIP
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.3814946549153826,0.775673211812562,0.7562326869806094,0.9769827479368448,1.0,5/10,33.73%,CPEB1;PAF1;HSF1;CPEB3;NCBP2
prerank,regulation of synapse maturation (GO:0090128),0.37825796370120807,0.7749549467892665,0.7447405329593267,0.9775867089952872,1.0,1/10,2.53%,NEUROD2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3347283012657219,0.7748091934245254,0.7599009900990099,0.9773774522523089,1.0,6/20,23.47%,AMPD2;PAICS;GART;ATIC;ADSS2;LHPP
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.309770515498642,0.7747655559232597,0.7725225225225225,0.9770397184744067,1.0,2/33,1.34%,EGFR;ANXA1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.37426950584695096,0.7744458177539083,0.7696476964769647,0.9770880481977199,1.0,3/12,17.50%,ZFP36L2;JAG1;YTHDF2
prerank,membrane lipid metabolic process (GO:0006643),0.3276378465139004,0.7738025794320396,0.7490864799025578,0.9775743371408615,1.0,4/22,12.38%,FUT2;TECR;AGK;CERK
prerank,protein localization to mitochondrion (GO:0070585),0.3750568473662387,0.7735815612058935,0.7391891891891892,0.9774792449135623,1.0,5/11,27.79%,AKT1;MTCH2;RALA;COX18;DNAJA1
prerank,axoneme assembly (GO:0035082),0.3112606055723423,0.7733103234312422,0.7810304449648712,0.9774492422605103,1.0,7/31,22.28%,TOGARAM1;RSPH1;TTLL3;DNAAF3;SPAG17;SPAG16;DCX
prerank,macrophage chemotaxis (GO:0048246),-0.31409825754460663,-0.7732589092955897,0.7193548387096774,0.9062060554676672,1.0,5/10,35.46%,EDNRB;TAFA4;CCL2;CXCL17;CCL5
prerank,protein kinase A signaling (GO:0010737),-0.29758929392052036,-0.7720085325504331,0.7333333333333333,0.9067184437668584,1.0,4/12,26.25%,MYOM1;PRKACB;LCP1;TTN
prerank,cholesterol biosynthetic process (GO:0006695),0.3173755890472201,0.7712802503872777,0.8049940546967895,0.9798633452384028,1.0,4/31,9.30%,ACLY;MVK;INSIG2;GGPS1
prerank,neuromuscular synaptic transmission (GO:0007274),-0.2680283997640177,-0.7703837040352776,0.7816593886462883,0.9077524087237211,1.0,4/18,13.16%,DTNA;TBC1D24;FCHSD2;SLC5A7
prerank,plasma membrane tubulation (GO:0097320),-0.2920802663675638,-0.7700415089404058,0.7769784172661871,0.9069256593158125,1.0,2/13,3.88%,FNBP1L;CAVIN2
prerank,Rho protein signal transduction (GO:0007266),0.2884372638621129,0.769770966538207,0.8195991091314031,0.9815668717031174,1.0,6/53,9.72%,COL1A2;CDC42EP2;NTN1;ARHGEF3;MYO9B;RHOJ
prerank,determination of heart left/right asymmetry (GO:0061371),0.29580080290901767,0.769504428404279,0.7895927601809954,0.9815360292255738,1.0,9/43,18.90%,TGFBR2;TBX6;PKD2;NDRG4;MICAL2;VANGL2;BBS4;AHI1;BBS5
prerank,tryptophan metabolic process (GO:0006568),-0.30646578782172,-0.7694242842006203,0.7475083056478405,0.9064537121940592,1.0,11/11,69.38%,KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD;ATP7A;KYAT1;KMO
prerank,intracellular pH reduction (GO:0051452),0.304314108964588,0.7691428605261649,0.7887981330221704,0.9816247334871875,1.0,7/33,16.13%,ATP6V0A2;TMEM9;DMXL2;ATP6V1E1;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,"phagocytosis, engulfment (GO:0006911)",0.30967909503185087,0.7690863965482565,0.7838452787258248,0.981306287451298,1.0,1/36,0.45%,GSN
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.27411072082827903,0.7688040025906573,0.8693877551020408,0.981288638580486,1.0,18/108,18.05%,SYK;GSN;EIF2AK3;F2R;S100A8;S100A9;MTCH1;PDCD2;MAPT;ANP32B;BBC3;DIABLO;RPS27L;GRAMD4;HTRA2;CTSD;BCAP31;DAP
prerank,microtubule depolymerization (GO:0007019),0.3381429996850112,0.768519702172318,0.7678571428571429,0.981270213527488,1.0,4/17,20.38%,KIF2A;CCSAP;CKAP5;STMN4
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.3716431784532897,0.7682039401050725,0.7482993197278912,0.9812913156807646,1.0,7/11,29.45%,MUC1;ING4;RPS27L;TFAP4;KAT5;FOXM1;TP53
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.31510510990072294,0.7680648944893343,0.7821297429620563,0.9810781887293168,1.0,8/26,22.99%,ITCH;UBE2N;IRAK1;UBA52;AAMP;TAB2;CYLD;MAP3K7
prerank,sarcomere organization (GO:0045214),0.3192318541738003,0.7679117367826183,0.7879146919431279,0.9808873440819106,1.0,4/27,14.04%,SIX4;CSRP2;FHOD3;CASQ1
prerank,positive regulation of cell division (GO:0051781),0.303785914147167,0.7666893524088295,0.8057471264367816,0.9821437985442213,1.0,7/38,15.08%,CDC14B;SVIL;CUL3;SIRT2;KIF20B;RHOA;GIPC1
prerank,regulation of mitotic cell cycle (GO:0007346),0.2699207642001179,0.7659514717477385,0.9105527638190954,0.9827645140112469,1.0,53/171,30.16%,PRKCA;PSMC4;GAS1;CKS1B;SMOC2;CCDC8;TTC28;MEIS2;PSMC6;PSMD8;CDK9;IQGAP1;CDC23;ANAPC5;KIF20B;FBXO5;ERCC3;PIN1;DDB1;CDC27;CUL9;USP22;TFAP4;TTL;CDC26;ANAPC4;NEK7;TRIM35;PTPN3;ANAPC10;BTG1;ANAPC15;SDCBP;CYLD;CDC25B;PSMD3;PSMD4;MDM2;BTG3;CKS2;RNF20;PSMB3;ANAPC2;GBF1;CUL7;PSMB2;PSMD5;THAP1;CUL1;BRINP2;SRA1;HSF1;PSMD14
prerank,negative regulation of chemotaxis (GO:0050922),0.31041474999207547,0.7656420859359714,0.7934272300469484,0.9827766851385384,1.0,4/31,12.28%,SEMA3C;SLIT2;SEMA3A;SEMA3D
prerank,iron-sulfur cluster assembly (GO:0016226),-0.23710070264697958,-0.7654910687665833,0.8227848101265823,0.910635561412972,1.0,7/24,16.27%,NUBPL;HSPA9;CIAO1;NFU1;ISCU;GLRX3;NDOR1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.307989758746067,0.7651305995841724,0.7799043062200957,0.9830568742498083,1.0,4/29,14.82%,CXCL10;C1QBP;GAS6;IL4
prerank,cellular senescence (GO:0090398),0.3117715901599798,0.7647819590902104,0.796092796092796,0.9831193485543414,1.0,8/27,24.80%,MAPK14;SMC5;CDKN1A;SMC6;PML;ECRG4;NSMCE2;CALR
prerank,protein autoprocessing (GO:0016540),0.33733025239256176,0.7644407609330215,0.7798165137614679,0.9831841351600796,1.0,6/17,30.31%,KLK6;FAM111A;HTRA2;CTSL;MYRF;SPRTN
prerank,AMP metabolic process (GO:0046033),0.35973609985318206,0.7640041085473049,0.7670299727520435,0.9833827199505585,1.0,1/13,2.31%,AMPD2
prerank,synaptic vesicle localization (GO:0097479),0.3562439180626835,0.7635419346086029,0.7726063829787234,0.9836031806832467,1.0,3/13,16.18%,TOR1A;SYNDIG1;SNAPIN
prerank,smoothened signaling pathway (GO:0007224),0.3089378420034839,0.7630463971234656,0.7963855421686747,0.9838344766803704,1.0,5/32,11.60%,DISP2;GLI2;ARL13B;DYRK2;GLI3
prerank,regulation of cellular catabolic process (GO:0031329),0.28625723837588735,0.7629071867472809,0.8344086021505376,0.9836189099595626,1.0,16/62,17.44%,PIK3R2;USP10;HDAC6;ABL2;WDR91;FBXL2;USP33;MAPT;SMCR8;DRAM1;RRAGD;CISD2;NUPR1;KEAP1;PIP4K2C;GPR137B
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.31749981113606107,0.7626381481026808,0.7936117936117936,0.9835831375216447,1.0,4/24,15.83%,SYVN1;CREB3L1;HERPUD1;SELENOS
prerank,lipid modification (GO:0030258),0.3025664743201121,0.7625956671733825,0.7965909090909091,0.9832370176793622,1.0,6/37,12.78%,DGKQ;PLPP3;PLPP5;PLPP1;MBOAT7;PLPPR3
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.308766045672974,0.7621136508736485,0.7936507936507936,0.9834802617476671,1.0,11/28,27.80%,ITCH;UBE2N;IRAK1;UBA52;AAMP;TAB2;CYLD;MAP3K7;RELA;OTULIN;CASP8
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3114494157853244,0.761705568585694,0.7787182587666264,0.9836208498629475,1.0,3/30,5.51%,ANK2;ATP1A1;KCNJ2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.33029657961592906,0.7615243146208406,0.773989898989899,0.9834685903292343,1.0,3/21,8.08%,FOXP1;PRKD2;CD81
prerank,epithelial to mesenchymal transition (GO:0001837),0.292997987493203,0.761295968580971,0.8209121245828699,0.9833725451142122,1.0,4/47,3.94%,LOXL2;FGFR1;TGFB2;AKNA
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.2562763325368908,-0.7612449402287662,0.8043478260869565,0.9153919421410374,1.0,10/18,37.75%,PLCB1;AGRN;OPRM1;RGS10;CDK5R1;CHRM1;GNA15;GNA11;HRH3;CHRM5
prerank,regulation of embryonic development (GO:0045995),0.30041104856456796,0.7612059350642522,0.7886178861788617,0.9831079799286364,1.0,2/34,1.66%,PHLDB1;TLE6
prerank,phospholipid biosynthetic process (GO:0008654),0.30154645801212265,0.7610810691046906,0.8122866894197952,0.9828828214386843,1.0,13/36,27.23%,FAR1;AGK;SGMS2;AGPAT3;LPCAT1;DHDDS;AGPAT5;FADS1;GPAM;CPNE1;SRD5A3;MVD;NUS1
prerank,histone H4-K5 acetylation (GO:0043981),0.34837678191223276,0.760787887450377,0.7948717948717948,0.9824839594949638,1.0,4/15,16.37%,ING4;WDR5;KANSL3;OGT
prerank,histone H4-K8 acetylation (GO:0043982),0.34837678191223276,0.760787887450377,0.7948717948717948,0.9824839594949638,1.0,4/15,16.37%,ING4;WDR5;KANSL3;OGT
prerank,regulation of neuron projection arborization (GO:0150011),0.34493134510843904,0.7605767457086976,0.7625994694960212,0.9823818506971689,1.0,6/15,26.64%,DLG4;MYO9A;FZD4;NTNG2;DVL1;GRIP1
prerank,actin crosslink formation (GO:0051764),-0.2879896228026899,-0.7605608014110066,0.8045977011494253,0.9149403383113769,1.0,4/12,16.75%,EPS8;GAS2L3;LCP1;BAIAP2L1
prerank,ruffle organization (GO:0031529),-0.27299473273567343,-0.7604448308318468,0.7804878048780488,0.9137553812115754,1.0,2/16,5.86%,TPM1;PIP5K1A
prerank,activation of GTPase activity (GO:0090630),0.27265759059260936,0.7602579643634062,0.8530020703933747,0.982396821978872,1.0,27/89,24.04%,SGSM2;RABGAP1L;RAP1GAP2;RASGRF1;ARHGAP42;DOCK7;TBCK;TBC1D2B;TBC1D17;ARHGEF10;TIAM2;TBC1D10A;NGEF;BCAS3;EVI5;SGSM1;EVI5L;TBC1D13;ADPRH;TBC1D22B;TBC1D15;TIAM1;CORO1C;RUNDC1;TBC1D8B;TBC1D12;BCR
prerank,macroautophagy (GO:0016236),0.27209448536448866,0.7602355129942835,0.8862704918032787,0.9820253359772748,1.0,35/118,25.12%,VPS4B;PRKAB2;MVB12A;VPS37D;SRC;LIX1L;WIPI2;SQSTM1;TMEM74;VPS33A;PGAM5;STX17;EPG5;VPS37C;ULK1;VDAC1;ILRUN;NBR1;VPS37B;ATG13;VPS33B;TOMM5;PIP4K2B;VPS36;ATG16L1;ATG3;VPS39;CSNK2A2;ATG10;UBXN6;ATG14;STAM;DYNLL1;TOMM40;TECPR1
prerank,oligodendrocyte differentiation (GO:0048709),0.32701839560297985,0.7599233601427158,0.7742346938775511,0.9820521683248973,1.0,3/19,8.12%,PRDM8;SOX10;SOX8
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3131474189715202,0.7594845162985333,0.7992874109263658,0.9822325727634165,1.0,1/26,0.56%,UCP1
prerank,mitochondrial gene expression (GO:0140053),0.2940930837016202,0.759215599835603,0.8179775280898877,0.9821936680982071,1.0,16/42,34.40%,MRPS11;MRPS18B;MRPS17;MRPS34;MRPL51;HARS1;QRSL1;SLC25A33;NOA1;MRPL12;MRPL23;LARS2;FOXO3;IARS2;MRPL16;GFM2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.3361099560521228,0.7589398835693086,0.7675033025099075,0.9821821303888104,1.0,4/16,18.66%,ERCC4;TERF1;SMG6;TINF2
prerank,lipid oxidation (GO:0034440),-0.28928266865759156,-0.7582633293890173,0.8131868131868132,0.9154707000855726,1.0,4/12,23.67%,ADIPOR2;ALOX12;ADIPOR1;PPARGC1A
prerank,protein export from nucleus (GO:0006611),0.31122409896845515,0.7582396846202655,0.7983193277310925,0.9827049936841565,1.0,8/27,24.80%,DESI1;PKD1;STRADA;CHP1;SMURF1;TPR;XPO7;CALR
prerank,adenine nucleotide transport (GO:0051503),0.33613774746926794,0.7574527798152795,0.7701149425287356,0.98332108309878,1.0,3/17,14.88%,LRRC8D;SLC25A4;SLC25A17
prerank,indolalkylamine catabolic process (GO:0046218),-0.3064465507501098,-0.7573415263026168,0.7579617834394905,0.9154386055086574,1.0,10/10,69.38%,KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD;KYAT1;KMO
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.2979092140936121,0.7573018774314317,0.8082191780821918,0.9831320287487062,1.0,12/36,23.78%,TCF7L2;NFATC1;AGO2;GNB1;PPP3CA;FZD4;AGO4;PPP3CB;AGO3;GNAO1;MAP3K7;TNRC6A
prerank,detection of calcium ion (GO:0005513),0.36130369660439293,0.7571888098394172,0.7780748663101604,0.9828795757368094,1.0,7/13,31.13%,CALM2;SYT1;STIM1;KCNIP2;KCNMB2;KCNMB3;CALM1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.3700243327091145,0.7570613273489005,0.7631954350927247,0.9826433042865665,1.0,1/10,3.19%,TGFBR2
prerank,regulation of monocyte differentiation (GO:0045655),0.35363817083678095,0.7567985923154409,0.7836021505376344,0.9825829177974292,1.0,2/14,4.40%,FOXP1;ZFP36L1
prerank,SNARE complex assembly (GO:0035493),-0.31407749106888366,-0.7567619227954603,0.768976897689769,0.9148307031887015,1.0,2/10,3.46%,SNCA;UVRAG
prerank,mammary gland epithelium development (GO:0061180),0.3503691891627475,0.7566267060892116,0.7722371967654986,0.982417049235655,1.0,2/14,11.30%,WNT2;AKT1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.3724732146367156,0.7563598489048003,0.7689075630252101,0.9823848283908851,1.0,2/10,9.07%,IL33;TLR4
prerank,cellular response to amino acid starvation (GO:0034198),0.27942027493652394,0.7563526776990986,0.8336886993603412,0.9819989421832164,1.0,18/71,23.20%,EIF2AK3;MTOR;FLCN;CEBPB;ATP6V1E1;SESN3;CDKN1A;RRAGD;EIF2S1;ATP6V1D;ATP6V1B2;DAP;CASTOR2;MAPK1;SESN2;ATF4;SLC38A9;ATP6V0B
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.2743316533293216,0.7562465978890672,0.8764278296988577,0.9817436614088928,1.0,24/87,21.65%,NDUFS5;COX19;TMEM126A;NDUFAF8;NDUFAB1;NDUFAF6;SDHAF1;NDUFS1;NDUFB7;NDUFV2;SURF1;TTC19;NDUFA2;ACAD9;DMAC2;BCS1L;UQCC3;COX16;COX14;SDHAF2;NDUFB2;DMAC1;COX18;SLC25A33
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.27796859179569905,0.7555258647701721,0.8641188959660298,0.9822867656772111,1.0,16/72,16.87%,TRIAP1;USP10;MUC1;MDM4;ING4;SFN;RPS27L;CDKN1A;BCL3;CNOT3;CNOT10;PLAGL1;NBN;TNKS1BP1;TFAP4;PML
prerank,actin filament network formation (GO:0051639),0.36643715819161665,0.7550992979216895,0.7543391188251002,0.9824792777161107,1.0,3/11,15.81%,COBL;FHOD3;PLS1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.3522405946053129,0.7549461272544,0.7737617135207496,0.9822812172443492,1.0,2/14,7.15%,UMPS;NT5M
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.36445962003653987,0.754540783575105,0.7514204545454546,0.9824207657941334,1.0,2/10,17.29%,SIRT2;RCC2
prerank,regulation of chemokine production (GO:0032642),0.2989876208982935,0.7545231304004759,0.8112128146453089,0.9820501538094029,1.0,8/36,20.96%,FOXP1;IL33;TLR4;ACKR1;IL6;SNAI2;IL18;PYCARD
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.30908469683116596,0.7542646996800444,0.8240291262135923,0.9819937382142999,1.0,6/32,14.04%,F2R;CXCL10;PKD2;GSTM2;CALM2;CASQ1
prerank,cellular response to zinc ion (GO:0071294),-0.27370337812382267,-0.7540980234954904,0.7992125984251969,0.9171151934302846,1.0,15/15,72.66%,MT3;HVCN1;MT2A;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;ATP13A2;GLRA1;GLRA2;P2RX4
prerank,endocardial cushion development (GO:0003197),0.32346505054804997,0.7537471519914057,0.7730138713745272,0.9822852733307645,1.0,3/21,6.76%,TGFB2;ACVR1;MDM4
prerank,megakaryocyte differentiation (GO:0030219),-0.2945045024351177,-0.7535011556550605,0.7697368421052632,0.9165509037034048,1.0,3/11,20.80%,KIT;TAL1;UBA5
prerank,mitochondrial fusion (GO:0008053),0.34076275974357995,0.7534786866322154,0.7925736235595391,0.9822249318633749,1.0,7/18,30.71%,GDAP1;MIEF2;SPG7;FIS1;CHCHD3;BAX;MFN2
prerank,synapse organization (GO:0050808),0.2642053436503944,0.7532523819412287,0.8905930470347648,0.982135960302647,1.0,21/125,15.06%,SNCB;GPC6;DCTN1;F2R;PTPRS;PPFIA2;PTPRF;FARP1;CAST;PSEN1;MUSK;DSCAM;L1CAM;MAPT;FLRT3;PIN1;SLC8A2;CTNND2;PPFIA1;LRFN5;CACNB1
prerank,histone acetylation (GO:0016573),0.27572041058213353,0.7531682959124198,0.8545837723919916,0.9818572387342365,1.0,21/69,25.21%,TADA1;MRGBP;MSL3;KAT2B;POLE3;ING4;WDR5;DR1;KAT14;DMAP1;YEATS2;PER1;MORF4L1;NAA50;TAF6L;TRRAP;SGF29;KAT6B;MAP3K7;KAT5;KAT7
prerank,negative regulation of cell aging (GO:0090344),0.3372718673458522,0.7527559018723622,0.7813712807244502,0.9819710090514479,1.0,4/16,13.56%,MIF;AKT3;FBXO5;TWIST1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2783401326334077,0.7518258301629465,0.8634453781512605,0.9828135616627545,1.0,18/78,24.78%,EGFR;PKD1;GTPBP4;PSRC1;MAPRE3;PKD2;AKT1;CDKN1A;CCND1;CCNH;TFAP4;IPO5;BLM;PTEN;CDKN2C;LATS1;CCNYL1;HEXIM1
prerank,cellular response to heat (GO:0034605),0.3010052243227077,0.7513617860032302,0.8200455580865603,0.9830212697913755,1.0,9/35,22.68%,STUB1;YWHAE;MAPT;POLR2D;HSP90AA1;HSBP1;HTRA2;BAG3;TPR
prerank,mucosal immune response (GO:0002385),0.3459971461231084,0.7506292758208305,0.7741514360313316,0.9835842558383653,1.0,2/15,14.82%,OTUD7B;IL4
prerank,protein localization to microtubule organizing center (GO:1905508),0.3399145375263908,0.7504234332271315,0.7851351351351351,0.9834388956628538,1.0,6/15,23.47%,PIBF1;BBS4;CEP83;PCM1;DCTN2;NEDD1
prerank,response to interferon-beta (GO:0035456),-0.23345907277290842,-0.7500941651601564,0.8603351955307262,0.9197855591944739,1.0,4/22,10.42%,AIM2;PLSCR1;IFITM3;STAT1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.31284546326325585,0.7496182399791479,0.8122786304604487,0.9840627144921933,1.0,5/26,15.98%,ASAP3;PFN2;ALMS1;SLC9A1;ACTG1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.3380931611595939,0.749007495274484,0.7848761408083442,0.9844839963220723,1.0,7/16,26.19%,PIGZ;PIGC;PIGW;PIGM;PIGL;DPM2;PIGH
prerank,pancreas development (GO:0031016),0.35730764259298137,0.748154698078517,0.773841961852861,0.9851814305866773,1.0,1/12,5.14%,TCF7L2
prerank,positive regulation of intracellular transport (GO:0032388),0.2948349033733769,0.7478237023432565,0.828505214368482,0.9852271234850976,1.0,15/38,27.71%,B3GAT3;EHD2;KIF20B;BCAS3;PLA2G4E;DYNC1H1;VAMP2;CAPN10;NUMA1;PCM1;ICE1;TPR;RAB29;OAZ1;EIPR1
prerank,negative regulation of hippo signaling (GO:0035331),0.3485628575890952,0.747785988152441,0.7816411682892906,0.9848811432868713,1.0,2/12,4.92%,MAPK14;MAP2K3
prerank,diol metabolic process (GO:0034311),0.33305234714809884,0.7476564423150478,0.78562421185372,0.9846449757700295,1.0,5/19,17.79%,PLPP3;PLPP1;AKT1;HSP90AA1;PLPP2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.3197608615474661,0.7476426739865955,0.804374240583232,0.9842736706403415,1.0,4/23,11.60%,GPC3;GLIS2;GPR161;GLI3
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.30758796456907633,0.7473737729435446,0.8085106382978723,0.98382857691344,1.0,4/29,15.93%,CENPT;HJURP;NPM1;CENPC
prerank,CENP-A containing chromatin organization (GO:0061641),0.30758796456907633,0.7473737729435446,0.8085106382978723,0.98382857691344,1.0,4/29,15.93%,CENPT;HJURP;NPM1;CENPC
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.3057913011555783,0.7471728889365096,0.8209134615384616,0.9836987150439174,1.0,8/30,24.18%,MGAT1;LMAN1;MGAT5;MGAT2;TUSC3;DDOST;UGGT1;DPM2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.2860902788493959,0.7466410217487077,0.8360302049622438,0.9840116261103722,1.0,9/46,23.29%,ANXA2;MIF;RAP1B;ARF1;PDCD4;PPIA;RALA;SNRPA1;MTAP
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.27344233743508767,0.7465458641408125,0.8569915254237288,0.9837475072612434,1.0,10/73,10.96%,POLR2H;GLMN;CREBZF;HDAC6;POLR1G;PHF1;KAT2B;MPHOSPH8;DDX21;GPX1
prerank,chloride transmembrane transport (GO:1902476),0.2818588292710566,0.7462631358475785,0.8353591160220994,0.9837328349058925,1.0,10/48,20.50%,ANO3;SLC4A8;SLC12A8;GABRR3;SLC12A4;SLC12A5;GABRG3;ANO5;GABRG2;SLC12A6
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.2895019930225787,0.7460648738888749,0.8372352285395763,0.9836016789784362,1.0,10/46,20.02%,GPAT4;DGKQ;AGPAT3;LPCAT1;AGPAT5;GPAT3;GPAM;LIPH;DDHD1;PLD2
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3155345765640143,0.7456553890942145,0.7864450127877238,0.9837427257436279,1.0,11/20,34.78%,AGO2;EIF6;AGO4;AGO3;TNRC6A;AGO1;CELF1;CNOT8;LIMD1;TNRC6C;NRDE2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.3490599404357558,0.7456415199562918,0.7951153324287653,0.9833692597236681,1.0,5/13,28.27%,EGF;MGAT5;IL6;HES1;JAK2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.31478674931647543,0.7455414777376703,0.8192918192918193,0.9831089901049179,1.0,11/25,33.72%,TCERG1;EAF2;EAF1;LARP7;LDB1;ELL;HEXIM1;NELFA;WDR43;NELFB;HNRNPU
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.31280178464358765,0.7454621251614602,0.801920768307323,0.9828186012185033,1.0,7/26,25.79%,IRAK3;TLR5;NLRP2B;FLOT2;TYRO3;FLOT1;OTUD4
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.2805101216783005,0.744822583774348,0.8433079434167573,0.9832390770435631,1.0,22/52,29.92%,SAMD4B;RC3H1;LSM4;EDC4;EXOSC7;ZFP36;POLR2D;CNOT3;CNOT10;EXOSC1;TNKS1BP1;LSM7;RC3H2;EDC3;DCP1A;DCP1B;LSM5;HBS1L;LSM1;PDE12;PATL1;EXOSC3
prerank,neuron projection regeneration (GO:0031102),0.3691507772038558,0.7447981078622082,0.7814661134163209,0.9828825104060173,1.0,3/10,13.45%,GAP43;MTR;RTN4RL1
prerank,regulation of viral genome replication (GO:0045069),0.2791497669262066,0.7447031649902839,0.8281417830290011,0.9826075083174147,1.0,12/56,21.08%,TARBP2;ADARB1;ZC3HAV1;SLPI;TNIP1;LARP1;DDB1;FAM111A;HACD3;PPIA;BTBD17;SRPK1
prerank,positive regulation of binding (GO:0051099),0.2708852175757323,0.7444922880302322,0.8792924037460979,0.9824933083754793,1.0,18/84,17.83%,LRP1;SKI;PKD1;DACT1;TCF7L2;GPSM1;PSEN1;SIRT2;USP33;EGF;PIN1;DDX11;STK3;AMFR;GMNN;IDE;NME1;PLAUR
prerank,canonical glycolysis (GO:0061621),0.31252638773865804,0.744252349682443,0.8169364881693649,0.9820223856814325,1.0,2/24,4.84%,PFKP;FOXK2
prerank,glucose catabolic process to pyruvate (GO:0061718),0.31252638773865804,0.744252349682443,0.8169364881693649,0.9820223856814325,1.0,2/24,4.84%,PFKP;FOXK2
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.3277127312638347,0.7434229618987424,0.8045685279187818,0.9826569329572687,1.0,4/20,17.82%,HOPX;PSMG2;HSP90AA1;PFDN6
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.2773804931840282,0.7428112506208329,0.8476605005440696,0.9830564135428852,1.0,9/59,13.54%,CADM3;NPTN;NECTIN3;PKD1;TENM3;DSCAM;L1CAM;IGSF9;PALLD
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3025291757626667,0.7424033075308365,0.8110709987966306,0.98319356538873,1.0,9/28,24.04%,DBN1;PFN2;GBA2;FCHSD1;COTL1;RASA1;ABITRAM;CTTN;LATS1
prerank,ribosome biogenesis (GO:0042254),0.26032795471000286,0.7411647362583685,0.9388164493480441,0.9843216628296662,1.0,65/187,31.08%,C1D;SDAD1;DDX49;RIOK1;ABCE1;FCF1;NOC2L;ESF1;HELQ;EXOSC7;RRP36;NPM1;RPL10A;WDR46;UBA52;EIF6;SBDS;MPHOSPH10;RCL1;SNU13;MRPL36;NOLC1;DCAF13;RRP7A;EXOSC1;RPL6;NOP53;DDX52;POP4;PWP2;DDX31;RPF2;EBNA1BP2;TBL3;RPL23;RPL17;PDCD11;RIOK2;KRR1;RPS25;EIF2A;RBIS;WDR18;NOC4L;TEX10;RRP1B;LTO1;RPL22;EXOSC10;NOP16;DHX29;TSC1;RPL34;NOP56;WDR43;UTP18;NOP58;RPS15;EXOSC3;NIP7;RPL31;RPLP2;DDX27;RPS28;RPS6
prerank,cell junction organization (GO:0034330),0.2722764661834888,0.740583251903083,0.868675995694295,0.9846779732588379,1.0,17/71,17.93%,SNCB;TGFB3;TGFB2;PPFIA2;MYO9A;PSEN1;L1CAM;MAPT;PIN1;RHOA;SLC8A2;CTNND2;PPFIA1;LIMS2;ACTG1;CHRNA7;ILK
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.2704155896772183,0.7404701603764181,0.86875,0.9844261618046279,1.0,11/76,16.35%,GPSM2;CDC42EP2;BIN1;SORBS3;PFN2;FCHSD1;FER;BCAS3;ARF6;DYNC1H1;NCK1
prerank,purine-containing compound catabolic process (GO:0072523),-0.2710771366967314,-0.7400871788037282,0.8254545454545454,0.9316623665648535,1.0,4/13,17.94%,DPYD;NT5E;NT5C2;NT5C1A
prerank,monocarboxylic acid catabolic process (GO:0072329),0.31775236289230113,0.7393389730317413,0.7987341772151899,0.9854367260621503,1.0,4/21,20.27%,CEL;ACOX1;NUDT19;LPIN3
prerank,transcription by RNA polymerase III (GO:0006383),0.3034845797022672,0.7389051194631194,0.816884661117717,0.9855948127148446,1.0,8/27,23.54%,ZC3H8;GTF3C2;BRF1;POLR3H;ICE1;ELL;TBP;GTF3C5
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.3484370806090416,0.738888658180413,0.7952127659574468,0.9852311292865609,1.0,3/13,14.08%,RC3H1;ZC3HAV1;ZC3H12A
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.29254338335578034,-0.7387718349985436,0.7968253968253968,0.931940692872039,1.0,6/10,24.42%,RAPGEF3;SMARCB1;HDAC5;SPHK2;BRCA1;CHEK1
prerank,regulation of neuron apoptotic process (GO:0043523),0.26463808869770217,0.7386726936780841,0.8802889576883385,0.9851069003112042,1.0,21/96,22.18%,TGFB3;SIX4;TGFB2;F2R;CLCF1;NFATC4;EGLN2;NRBP2;GDNF;NSMF;SIX1;NUPR1;FAIM2;SET;SNX6;RASA1;BACE1;TYRO3;KDM2B;NF1;ATF4
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.2476870293721756,-0.7385016557060468,0.8377192982456141,0.9308886221958602,1.0,5/17,21.25%,COX4I1;COX6C;NDUFA4;CYCS;COX5A
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.2739935779831286,0.7374063844273542,0.8493449781659389,0.9862833795632916,1.0,7/57,13.71%,GNAI3;LPAR1;HTR1F;AKAP12;GPR37L1;ADCY8;GPR37
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.33385955570167264,0.7370891187189355,0.8085381630012937,0.9862655564988614,1.0,1/16,0.89%,PARP3
prerank,regulation of response to oxidative stress (GO:1902882),0.3535033677342906,0.7370040735600096,0.7893258426966292,0.9859882868597615,1.0,3/11,19.01%,AIFM2;GGT7;SELENON
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.3168481236641358,0.7367993732201882,0.8165605095541402,0.9858433898200261,1.0,1/20,1.05%,PSTPIP1
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.2548535390351507,-0.7367043462194244,0.8204081632653061,0.9318843457309465,1.0,7/17,25.85%,OSR1;CAV1;CEACAM1;APOLD1;MAFG;DSPP;DLL1
prerank,platelet degranulation (GO:0002576),0.26385686795842167,0.7365219419478659,0.9039433771486349,0.9858021570010165,1.0,8/118,3.06%,CD9;TGFB3;CLEC3B;SPARC;ITGB3;VEGFA;TGFB2;ECM1
prerank,DNA alkylation (GO:0006305),0.3182769837662007,0.7361666953496997,0.8038709677419354,0.9854656800253679,1.0,9/19,29.85%,SPOCD1;EHMT2;DMAP1;BAZ2A;GATAD2A;MTRR;ATF7IP;ATRX;FOS
prerank,DNA methylation or demethylation (GO:0044728),0.3182769837662007,0.7361666953496997,0.8038709677419354,0.9854656800253679,1.0,9/19,29.85%,SPOCD1;EHMT2;DMAP1;BAZ2A;GATAD2A;MTRR;ATF7IP;ATRX;FOS
prerank,regulation of protein kinase C signaling (GO:0090036),0.3411803459681374,0.7357047883131332,0.8071625344352618,0.9856463310327079,1.0,2/14,6.59%,VEGFA;MYADM
prerank,phospholipid catabolic process (GO:0009395),-0.23088883665474294,-0.7356170747596297,0.9022988505747126,0.9317879038836393,1.0,1/24,0.63%,GPCPD1
prerank,cortical cytoskeleton organization (GO:0030865),0.2864546436345413,0.7356170408986191,0.8321917808219178,0.9853589329199893,1.0,9/41,16.20%,LLGL1;FMNL1;RHOQ;RHOA;FMNL3;FHOD3;ARF6;RND3;RAC3
prerank,regulation of astrocyte differentiation (GO:0048710),0.34858698505584784,0.7344906258434256,0.8022130013831259,0.9863271303641461,1.0,2/12,5.01%,BIN1;CLCF1
prerank,peptidyl-asparagine modification (GO:0018196),0.2982980213109429,0.734202478951638,0.8333333333333334,0.9862861848124751,1.0,8/31,24.18%,MGAT1;LMAN1;MGAT5;MGAT2;TUSC3;DDOST;UGGT1;DPM2
prerank,regulation of protein modification process (GO:0031399),0.280958992772034,0.7341531595854435,0.8576158940397351,0.985961667305661,1.0,16/50,23.64%,CCDC88C;FLCN;CDK9;KAT2B;PARG;PIN1;FER;NOP53;PML;CORO1C;SESN2;CCDC88A;STAT2;ATG10;ATG14;RABL3
prerank,negative regulation of neuron differentiation (GO:0045665),-0.24527275217443748,-0.7338814101695015,0.8936170212765957,0.932568585264075,1.0,2/22,6.86%,BMP7;B2M
prerank,positive regulation of defense response to virus by host (GO:0002230),0.30691875033041205,0.73377012005622,0.8280871670702179,0.9860377854759617,1.0,5/24,14.82%,CGAS;TRAF3IP2;ZC3H12A;HSP90AA1;IL4
prerank,regulation of ERAD pathway (GO:1904292),0.35476312987237424,0.7337022486098623,0.8036211699164345,0.9857367599220382,1.0,4/11,22.66%,TMEM259;HERPUD1;USP13;USP19
prerank,positive regulation of immune response (GO:0050778),0.27415798861336316,0.7335845547683426,0.8650371944739639,0.9854958852314294,1.0,10/64,20.96%,CD177;TGFB2;CD81;STX4;POLR3D;AKIRIN2;SLC15A4;IFI35;ITGAM;PYCARD
prerank,purine nucleotide catabolic process (GO:0006195),0.3444724105795005,0.7334008596071007,0.7948717948717948,0.9853355603356357,1.0,2/13,10.96%,GDA;GPX1
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.3565660908298169,0.7332445026007576,0.8098591549295775,0.9851287540519499,1.0,4/10,32.41%,RC3H1;PRNP;LGALS9;CD274
prerank,histone H2B ubiquitination (GO:0033523),-0.3009899480065885,-0.7330278774326309,0.7871621621621622,0.932252532927788,1.0,2/10,8.79%,DTX3L;CTR9
prerank,inorganic anion transmembrane transport (GO:0098661),0.26997285716828,0.7329453190356335,0.8547008547008547,0.9851130082589737,1.0,14/63,21.28%,ANO3;SLC4A8;SLC12A8;GABRR3;SLC37A3;SLC12A4;SLC12A5;GABRG3;SLC25A3;SLC20A1;ANO5;GABRG2;SLC12A6;SLC37A4
prerank,regulation of cilium assembly (GO:1902017),0.2762414491079064,0.7319616443762598,0.8733905579399142,0.9859291028746229,1.0,29/62,31.25%,SAXO1;TBC1D2B;TBC1D17;TBC1D10A;CEP97;BBS4;EVI5;DYNC2LI1;EVI5L;CCP110;TBC1D13;ODF2L;TBC1D22B;TBC1D15;TBC1D19;ENTR1;ATG3;CROCC;CCDC88A;CYLD;CDKL1;FUZ;KCTD17;TBC1D5;TCHP;SDCCAG8;RABGAP1;TBC1D9B;IFT20
prerank,regulation of neurotransmitter secretion (GO:0046928),0.2969116556049794,0.7318180684350699,0.8235981308411215,0.9857230640217362,1.0,7/32,18.84%,SYT11;DTNBP1;STX1B;HCRT;SNAPIN;PREPL;RIMS2
prerank,positive regulation by host of viral transcription (GO:0043923),0.3331721085039627,0.7316464795688844,0.8052980132450331,0.9855455602346367,1.0,7/15,23.67%,HPN;CTDP1;SMARCA4;CHD1;TFAP4;JUN;RRP1B
prerank,microglial cell activation (GO:0001774),-0.23697057011059275,-0.7314068144072718,0.8656716417910447,0.9329730717676725,1.0,3/21,9.16%,APP;SNCA;CX3CL1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.30761024512234264,0.7311130881281301,0.815136476426799,0.9857891060300786,1.0,3/24,7.57%,MAPK7;NFE2L2;GAS6
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.289226404442304,0.7307509099131227,0.8292397660818713,0.9858336183365035,1.0,11/36,22.14%,RNF2;RYBP;PHC3;PHC1;EHMT2;UXT;APAF1;RING1;PCGF6;FOXO4;EZH2
prerank,response to cytokine (GO:0034097),0.25585683680452276,0.7307088958917577,0.9219066937119675,0.9854934115634489,1.0,17/141,14.50%,COL3A1;TIMP2;AFF3;PRKCA;ANXA1;IRAK3;ADAM9;SRC;PID1;CYP27B1;CDK9;IRAK1;SETD2;FLT3;RHOA;HDAC4;GGT7
prerank,positive regulation of transmembrane transport (GO:0034764),-0.28006265294666616,-0.7302826677714633,0.7875,0.9330199744777719,1.0,1/13,0.82%,ACSL1
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.28965334255867664,-0.7298579521100305,0.8109965635738832,0.9321397244853956,1.0,2/12,3.96%,APOE;PFDN5
prerank,regulation of protein ubiquitination (GO:0031396),0.2601839479307335,0.7295215859276254,0.9109730848861284,0.9865552456821803,1.0,36/108,30.46%,AXIN1;GTPBP4;GNL3L;USP4;STUB1;MYCBP2;UBE2N;CUL3;SQSTM1;HDAC3;AKT1;DNAJB2;NDFIP1;HSP90AA1;CHP1;OGT;UFL1;TGFBR1;U2AF2;ARRB1;NSMCE3;DERL1;UBE3A;FKBP1A;BAG5;FBXW7;PRKCG;DCUN1D1;BCL10;DNAJA1;HDAC8;LAPTM5;SENP2;SPRTN;SIRT7;TRAF6
prerank,phosphatidic acid metabolic process (GO:0046473),0.2813855615718081,0.7294483478072832,0.8552338530066815,0.9862705283505069,1.0,10/48,20.02%,GPAT4;DGKQ;AGPAT3;LPCAT1;AGPAT5;GPAT3;GPAM;LIPH;DDHD1;PLD2
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.2922087982237943,0.7290803111625684,0.8473193473193473,0.9863347884477263,1.0,15/34,33.00%,MPP2;GRIN2D;AKT1;GABRG3;GRIN2A;GABRG2;GABRA3;GRID2;NPAS4;NLGN3;GABRA1;DRD2;GSK3A;RAB3GAP1;GABRA5
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.30688051637347513,0.728779148030625,0.8436724565756824,0.9863122207988627,1.0,12/22,37.16%,PPP1R1B;MGAT5;FKBP1A;TIPRL;CRY2;PTPA;FKBP1B;BOD1;PPP4R4;NCKAP1L;ROCK2;GSK3B
prerank,protein localization to Golgi apparatus (GO:0034067),-0.22233448245991377,-0.7286417121919404,0.8758169934640523,0.9322714041833428,1.0,7/27,13.91%,OPTN;PAQR3;VPS13A;GBP5;SORL1;GCC2;RIPOR1
prerank,organophosphate catabolic process (GO:0046434),0.35725047080979283,0.7280150154368044,0.811373092926491,0.986842946676102,1.0,11/11,64.30%,ANGPTL3;ENPP2;PNLIPRP2;APOA2;LIPG;PLBD2;PON1;PDXP;ABHD12;NUDT15;PLBD1
prerank,cellular response to hypoxia (GO:0071456),0.2589732864764161,0.7278485777521475,0.9154786150712831,0.9866482864678724,1.0,14/126,9.05%,ANGPT4;PSMC4;VEGFA;LMNA;ZFP36L1;MTOR;CARD16;PSMC6;MDM4;EGLN2;STUB1;TIGAR;PSMD8;SIRT2
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.26560348439529513,0.7271123061304227,0.8928199791883454,0.9871272171479134,1.0,21/78,25.85%,NFE2L2;COP1;STUB1;SIRT2;HERPUD1;DNAJB2;USP5;SGTA;NOP53;RNF14;ZER1;KEAP1;BCAP31;ARIH2;RNF19A;ARIH1;ZYG11B;DVL1;MDM2;FBXO22;CSNK1E
prerank,sphingosine metabolic process (GO:0006670),0.3258784178751467,0.7264010748037641,0.8210116731517509,0.9876340289812021,1.0,2/17,7.04%,PLPP3;PLPP1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.2940902646732944,0.7262025650277169,0.8281622911694511,0.9874957727171754,1.0,9/29,28.30%,CHUK;TLR4;UBA52;CD14;TRAF3;UBE2D3;TICAM1;CASP8;CD300LF
prerank,regulation of cellular senescence (GO:2000772),0.2959996814973915,0.7259890231961804,0.8133971291866029,0.9873557416725757,1.0,8/28,17.49%,CGAS;YPEL3;AKT3;FBXO5;TWIST1;RSL1D1;EEF1E1;NEK4
prerank,regulation of RNA export from nucleus (GO:0046831),0.3514895308732958,0.7254281853196215,0.8093883357041252,0.987633855385504,1.0,4/11,22.68%,CPSF6;SETD2;AKAP8L;TPR
prerank,regulation of smoothened signaling pathway (GO:0008589),0.28312095606620774,0.7253885330275777,0.8614525139664805,0.9872967902916682,1.0,7/50,12.43%,GPC3;GAS1;GLIS2;TEDC1;UCHL5;GLI3;TUBD1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.3041468125599131,0.7247004709144839,0.8383594692400482,0.9877243506868911,1.0,10/25,32.92%,MPP2;GRIN2D;AKT1;GRIN2A;GRID2;NPAS4;NLGN3;DRD2;GSK3A;RAB3GAP1
prerank,myelin maintenance (GO:0043217),0.35827027457530486,0.7246192019449229,0.799721835883171,0.9874359941494911,1.0,7/10,37.95%,CXCR4;PTEN;MYRF;EPB41L3;DEGS1;CLU;ABCD1
prerank,regulation of double-strand break repair (GO:2000779),-0.20034603353127395,-0.7245523301204436,0.9236641221374046,0.9358692589142783,1.0,6/39,9.45%,TRIP12;SPIRE1;UBR5;SLF2;MGMT;MRNIP
prerank,L-glutamate transmembrane transport (GO:0015813),0.35973830943008867,0.7241214039029349,0.8166666666666667,0.9876321218031845,1.0,2/10,9.92%,SLC1A6;PRAF2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.28855963442063,0.7239815751052111,0.8454545454545455,0.9874210103089973,1.0,9/37,14.96%,DGKQ;AXIN1;S1PR2;SIRT2;INPP5K;PPEF2;EGF;CALM2;TNKS1BP1
prerank,endocrine system development (GO:0035270),0.3127906348020563,0.7238713315605216,0.8227215980024969,0.9871657654333308,1.0,6/21,21.96%,WT1;GLI2;SIX1;DKK3;TGFBR1;NF1
prerank,regulation of chromosome segregation (GO:0051983),0.321743154742885,0.7229705041979598,0.8081841432225064,0.9878522233591776,1.0,5/16,22.88%,SMC5;PUM1;SMC6;NUMA1;CSNK2A2
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.2524178292020032,0.7226836303742559,0.9305835010060363,0.9877991913355203,1.0,31/168,19.51%,RPSA;DIS3L2;ZFP36L1;CTIF;SAMD4B;RC3H1;EXOSC7;HELZ2;PNRC2;GSPT2;RPL10A;UBA52;ZFP36;POLR2D;POLR2G;RPS5;CNOT3;CNOT10;ZC3H12A;SMG7;EIF3E;GSPT1;TNKS1BP1;SMG6;RPL6;DDX5;TENT2;TENT4B;PPP2R2A;RPL23;RPL17
prerank,cytosolic calcium ion transport (GO:0060401),0.29971326246545693,0.7218808481338974,0.8283671036948749,0.988351762516736,1.0,8/28,24.49%,MCU;SLC35G1;MCUB;ATP2A2;SLC8A2;ATP2B1;JPH4;CACNA2D1
prerank,apoptotic process (GO:0006915),0.2544360427768576,0.7215934690894971,0.9599198396793587,0.9883000777197177,1.0,42/203,19.41%,EFNA5;FAP;MAGI3;TGFBR2;DPF2;KREMEN1;MTOR;FOXO1;DPF1;AIFM2;PIK3CA;SIAH1;PAEP;ING4;AKT1;BMF;ERCC3;NDUFS1;BAK1;BBC3;TAOK2;ADAM15;DIABLO;NSG1;PLAGL1;DCC;STK3;ATCAY;THOC1;CD14;VDAC1;PDCD4;PRUNE2;OGT;CXCR4;PPIA;IAPP;DAP;AKAP1;SFRP5;APAF1;CIT
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.30146985524203884,0.7214138757392939,0.8362282878411911,0.988127039295735,1.0,2/25,4.84%,PFKP;FOXK2
prerank,regulation of dendrite extension (GO:1903859),0.3180239188469539,0.7212365924560779,0.80970625798212,0.9879597523941626,1.0,5/18,24.12%,SYT2;SYT1;RIMS2;SMURF1;RNF157
prerank,positive regulation of dendrite extension (GO:1903861),0.3220643133236187,0.7210563581751244,0.8221092757306226,0.9877873532702905,1.0,5/17,24.12%,SYT2;SYT1;RIMS2;SMURF1;RNF157
prerank,tRNA modification (GO:0006400),0.2681399142010431,0.720923302019223,0.8648936170212767,0.9875615711630819,1.0,13/62,20.75%,ANKRD16;TRMT6;TYW3;TRMT61A;FTSJ1;THADA;TRMT1;DTWD1;QTRT1;TYW5;DUS2;TRUB1;METTL1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.2806515308106289,0.7201367409112095,0.8588888888888889,0.9881122071897503,1.0,8/44,20.33%,KCNMA1;ANK2;KCNJ2;KCNJ3;GNB1;AKAP9;KCNH2;FLNA
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3359682668569983,0.7196880967917495,0.8034076015727392,0.9882510744707254,1.0,5/14,23.47%,PAICS;GART;ATIC;ADSS2;LHPP
prerank,regulation of cellular amide metabolic process (GO:0034248),0.2868330097322741,0.7192716605383328,0.8329355608591885,0.9883296520927211,1.0,11/32,27.19%,PKP3;ATXN2;TIGAR;NOLC1;RBM3;PCIF1;METAP1;EIF2A;GRM5;CYFIP1;TSC1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.24936122054861415,-0.7191844926683576,0.8547008547008547,0.9405948647861896,1.0,5/16,20.58%,SCARB1;NR1H3;CTDNEP1;PNPLA2;ABHD5
prerank,regulation of intracellular signal transduction (GO:1902531),0.24652439432543333,0.7191838579267338,0.993,0.9880487071259154,1.0,80/420,18.32%,MYOC;TRIP10;ARHGAP21;ARHGAP10;EGFR;ARHGAP44;AKAP13;VEGFA;PIK3R2;TAOK3;MAPK14;TRIO;MTOR;PRKAB2;RCN3;SRGAP1;RASSF2;TBCK;MDM4;RIT2;ARHGEF3;MYO9B;NOC2L;FLCN;PRKD2;MYO9A;RHNO1;OCRL;ARHGAP9;FBXL2;TAGAP;RHOJ;MAPK11;ITGAV;TIAM2;RHOQ;BRD7;DYRK2;SQSTM1;AKAP12;TAF3;RMI1;AKT1;MAPT;NGEF;RAD1;TAOK2;PIN1;BCL3;RHOA;DNA2;TMEM127;BRIP1;EHMT2;NBN;STK3;SLC15A4;USP7;GPAT3;NOP53;RFC4;TRAF3;RAC3;SOS1;PEX5L;CHD3;UFL1;PML;PIP4P1;PPP2R5B;SRGAP2;SRGAP3;PIP4K2C;ARAP1;RAD50;TCP11;TMBIM4;RPF2;DIPK2A;BLM
prerank,sphingolipid biosynthetic process (GO:0030148),0.2658560823350001,0.7191300350394766,0.8922914466737064,0.9877186742374388,1.0,11/71,12.42%,CERS6;PLPP3;ALDH3A2;PLPP1;PRKD2;AGK;SGMS2;LARGE1;FA2H;ELOVL5;PRKD3
prerank,estrogen metabolic process (GO:0008210),0.3323055821311161,0.7190610076223372,0.8192771084337349,0.9874135380683745,1.0,4/15,22.29%,HSD17B8;HSD17B4;HSD17B11;CYP1B1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.2885530914539828,0.7188441599303995,0.8410672853828306,0.9872743507687601,1.0,10/31,28.12%,CDC14B;AXIN1;UBE2N;PIN1;PTEN;RAB1A;FBXW7;GORASP1;DCUN1D1;TOPORS
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.22682692111764063,-0.7183988439206652,0.9108910891089109,0.9401203466092664,1.0,5/22,13.90%,RPS7;RPL37;ATM;SPRED3;SPRED2
prerank,mitotic chromosome condensation (GO:0007076),0.2997058469117695,0.7177523770641663,0.8432304038004751,0.9881153682797195,1.0,7/26,26.78%,TENT4A;NCAPG;SMC2;SET;AKAP8L;CSNK2A2;KMT5A
prerank,retinoic acid metabolic process (GO:0042573),0.3306348193372043,0.7177401305378484,0.8023715415019763,0.9877515065655627,1.0,3/14,19.31%,CYP2S1;ALDH1A3;SCPEP1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.33313131838405846,0.717661179817526,0.8040268456375839,0.9874792604181268,1.0,7/13,32.05%,IRAK4;IRAK1;EPG5;TNIP2;MYD88;TRAF6;PIK3R4
prerank,aerobic respiration (GO:0009060),0.3085189389142284,0.7176055777723768,0.821831869510665,0.9871662312537366,1.0,7/20,25.53%,SURF1;MDH2;MTFR1L;UQCRH;UQCR10;ME3;SDHC
prerank,I-kappaB phosphorylation (GO:0007252),0.35766147794215264,0.7175307082230067,0.7994350282485876,0.9868735582247646,1.0,2/10,9.07%,CHUK;TLR4
prerank,positive regulation of catalytic activity (GO:0043085),0.2834233205443103,0.7170641497793071,0.8617511520737328,0.9870268370454633,1.0,7/37,14.55%,MAPK14;ABL2;B3GAT3;PSEN1;STX4;XRCC5;BCAS3
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.28541984975959234,0.7169169188693417,0.8466042154566745,0.9868222877700328,1.0,10/36,23.83%,UCHL5;RYBP;FHIT;USP7;GIPC1;NOP53;OGT;MAP1A;SDCBP;BAG5
prerank,T cell activation (GO:0042110),0.26470592606151055,0.7167964789968042,0.8724760892667375,0.9865866403157993,1.0,15/69,25.66%,IRF4;DPP4;CD44;PPP3CA;IL4;LMBR1L;NCK1;PPP3CB;DDOST;PIK3CG;FKBP1A;LEPR;NCK2;RAB29;KIF13B
prerank,regulation of stem cell population maintenance (GO:2000036),0.31985590983053,0.7166568423765334,0.8124191461836999,0.9863734900853725,1.0,2/18,6.23%,LOXL2;NCOA3
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.24213252465308813,-0.7166472447108782,0.8828828828828829,0.9407588540479899,1.0,7/18,28.98%,SHANK3;CACNG4;CACNG8;CACNG3;TSHZ3;CCR2;CCL2
prerank,calcium ion homeostasis (GO:0055074),0.25700166353428944,0.7166289740760703,0.9110651499482937,0.9860277708955847,1.0,27/95,27.55%,CCL8;NPTN;ANK2;TNNI3;ATP2B4;CYP27B1;ATP13A1;CCL13;ATP2A2;SLC8A2;STC1;TMEM165;CHRNA7;ATP2B1;HTR2C;SELENON;STIM1;SLC8B1;HTR2A;RMDN3;CALR;TMCO1;SLC24A4;SLC24A2;TMEM203;SLC10A7;FAM20A
prerank,peptidyl-lysine methylation (GO:0018022),0.29967364428677584,0.7165249457470646,0.8321342925659473,0.9857718859287498,1.0,9/26,28.06%,SETD7;SETD2;ANTKMT;EHMT2;EEF2KMT;N6AMT1;EEF1AKMT3;KMT5A;SUV39H1
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.29833787511237136,0.7164073389552151,0.8455284552845529,0.9855332866351936,1.0,4/28,12.37%,EGFR;BEND6;AKT1;EGF
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.2474352839926218,-0.7162932650913948,0.8605769230769231,0.9398069017952893,1.0,5/19,13.27%,IL34;THBS1;MDK;MAPK3;PTK2
prerank,GPI anchor metabolic process (GO:0006505),0.3005814050231517,0.7161967837755069,0.8422330097087378,0.9853862276188885,1.0,9/26,26.19%,PIGZ;PIGC;MPPE1;PIGW;PIGM;GPLD1;PIGL;DPM2;PIGH
prerank,cilium-dependent cell motility (GO:0060285),-0.2226605980288023,-0.7161649884910358,0.8923076923076924,0.9385806084890423,1.0,12/22,34.87%,CFAP44;EFHC2;DNAH2;GAS8;RSPH9;DNAH3;DRC1;CCDC65;DNAAF2;TEKT2;DNAH17;CFAP54
prerank,cardiolipin metabolic process (GO:0032048),0.33432545454134727,0.7158145165696955,0.8087431693989071,0.985425267473205,1.0,8/13,35.64%,PNPLA8;TAMM41;SLC27A1;PGS1;PLSCR3;CRLS1;PTPMT1;HADHB
prerank,negative regulation of centrosome duplication (GO:0010826),0.35470538750602165,0.7153103067094646,0.8160762942779292,0.9856242164485179,1.0,4/11,19.74%,KAT2B;NPM1;CDK5RAP2;MDM1
prerank,respiratory electron transport chain (GO:0022904),0.3302217835575608,0.7148098064585706,0.8232876712328767,0.9858122558230941,1.0,3/14,15.90%,ETFA;ETFDH;ETFB
prerank,copper ion homeostasis (GO:0055070),-0.25147558187311436,-0.714739352439292,0.8391304347826087,0.9389170150337859,1.0,3/17,9.41%,APP;XIAP;CUTC
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2878931771468065,0.7146889044381621,0.8327402135231317,0.9855711307005126,1.0,9/30,28.30%,CHUK;TLR4;UBA52;CD14;TRAF3;UBE2D3;TICAM1;CASP8;CD300LF
prerank,regulation of protein binding (GO:0043393),0.25722487631880686,0.7146364040634774,0.9248971193415638,0.985250497362973,1.0,21/114,16.88%,LRP1;PKD1;DACT1;GNL3L;TCF7L2;CARD16;TFIP11;PSEN1;USP33;AKT1;SLPI;DNAJB2;CDKN1A;PIN1;DDX11;HDAC4;STK3;AMFR;GTF2F1;SNAPIN;IDE
prerank,phosphatidylcholine catabolic process (GO:0034638),0.358093237054561,0.7140047802687597,0.8175182481751825,0.9855770389267834,1.0,3/10,26.89%,PNPLA8;LIPC;PLA2G7
prerank,positive regulation of type I interferon production (GO:0032481),0.2669671869938862,0.7138751264042773,0.9114194236926361,0.9853459096908005,1.0,12/73,14.87%,POLR2H;CGAS;DHX33;POLR3E;CHUK;TLR4;POLR3D;IRAK1;SETD2;XRCC5;HSP90AA1;CD14
prerank,regulation of establishment of planar polarity (GO:0090175),0.25959093197351596,0.7134294012710171,0.8958762886597939,0.985474828541797,1.0,21/88,25.96%,PSMC4;SMURF2;DACT1;AP2A2;PSMC6;CLTC;FZD7;PARD6A;PSMD8;VANGL2;RHOA;FZD4;DAAM1;TIAM1;SMURF1;AP2M1;PSMD3;DVL1;PSMD4;RAC1;PSMB3
prerank,brain development (GO:0007420),0.2524975976638736,0.7132879399853824,0.9283551967709385,0.9852472455433469,1.0,36/136,24.29%,AFF2;UGP2;PBX1;TGFBR2;MEIS2;NFIB;GRIN2D;ZFHX3;NDRG4;EEF1AKMT4-ECE2;SLC6A4;TBC1D23;HSPG2;SLC23A1;BBS4;MDGA1;UFC1;CHD8;CDK5RAP2;GRIN2A;CXCR4;QARS1;CNTN4;UFM1;EML1;NIPBL;PAFAH1B1;PITPNM1;PTEN;NF1;UBE3A;FBXW11;MAP1S;NCOA6;NKX2-2;RAB18
prerank,amide biosynthetic process (GO:0043604),0.27335788487896573,0.7130051010041636,0.8796909492273731,0.9851988948034315,1.0,5/47,11.28%,CERS6;PCSK5;AGK;SGMS2;FA2H
prerank,cytoskeleton organization (GO:0007010),0.25280782559110454,0.7125340139516675,0.9109518935516888,0.9853484318875432,1.0,35/114,26.31%,ARHGAP10;PLCE1;DIAPH3;BIN1;ZRANB1;DST;MAST4;LARP4;CAMSAP1;MICAL2;PRPF40A;CCL13;RHOA;PALLD;FMNL3;DIAPH1;RND3;ANK1;RAC3;MICAL1;RANBP10;SH3D19;PLD2;ZMYM3;PACSIN2;PACSIN3;CNTNAP1;SYNE3;DMTN;RAC1;RHOBTB2;STRIP1;ZMYM6;MAST2;RND2
prerank,epithelial cell development (GO:0002064),0.30946534938875825,0.7125135754194868,0.820577164366374,0.9849980558312149,1.0,2/20,5.33%,DACT2;PDZD7
prerank,cellular copper ion homeostasis (GO:0006878),0.32865458499068223,0.7117760352551767,0.8241610738255034,0.9854357913179653,1.0,2/14,9.95%,COX19;ARF1
prerank,regulation of DNA repair (GO:0006282),0.27591660737875806,0.7116838805141491,0.872,0.9851580497542594,1.0,7/44,13.31%,EGFR;EYA2;UBE2N;TIGAR;CDK9;PARG;ABRAXAS1
prerank,sulfur amino acid catabolic process (GO:0000098),0.3474246810874704,0.7112535457206017,0.8246844319775596,0.985257525704363,1.0,4/10,25.43%,MPST;TXN2;MTRR;CTH
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.3233516644914317,0.7111458494818512,0.8059895833333334,0.9849951969068949,1.0,10/14,38.29%,NME2;CMPK2;AK8;AK3;AK5;ME1;NMNAT2;CMPK1;AK7;PNP
prerank,rRNA processing (GO:0006364),0.24976925171658101,0.7102485852873073,0.9577464788732394,0.9856093734872955,1.0,60/172,31.08%,C1D;DDX49;RIOK1;FCF1;ESF1;HELQ;EXOSC7;RRP36;RPL10A;WDR46;UBA52;EIF6;SBDS;MPHOSPH10;RCL1;SNU13;NOLC1;DCAF13;RRP7A;EXOSC1;RSL1D1;RPL6;NOP53;DDX52;POP4;PWP2;EBNA1BP2;SRFBP1;TBL3;RPL23;RPL17;PDCD11;RIOK2;KRR1;RPS25;MAK16;NOP2;WDR18;NOC4L;TSR3;TEX10;RRP1B;RPL22;EXOSC10;RIOK3;PRKDC;RPL34;NOP56;NHP2;WDR43;UTP18;NOP58;RPS15;EXOSC3;NAT10;RPL31;RPLP2;DDX27;RPS28;RPS6
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.2191373609219377,-0.7100221318478048,0.9116022099447514,0.9428096332181014,1.0,6/22,16.27%,NUBPL;HSPA9;CIAO1;NFU1;ISCU;NDOR1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.26805485757526437,0.7099790827349641,0.8827361563517915,0.9855241490731129,1.0,22/58,30.16%,CYREN;UBE2N;POLB;SMC5;ERCC4;XRCC5;ABRAXAS1;NBN;IFFO1;RAD50;DCLRE1A;SMARCAL1;ERCC1;NSMCE2;KAT5;PRPF19;PRKDC;XRCC6;KDM2A;ZBTB7A;SUMO1;PSMD14
prerank,oxoacid metabolic process (GO:0043436),0.2916258909934248,0.7098916156057369,0.8407494145199064,0.985249851274275,1.0,6/27,21.08%,LIPT2;MIF;BPNT2;SULT4A1;ABHD14B;TPST2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.33631112960844783,0.7096015321359203,0.8223140495867769,0.9851755161758287,1.0,6/13,22.68%,RAB23;MDFIC;CABP1;CHP1;UFM1;TPR
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.2639923021451822,0.7095096307627451,0.9039487726787621,0.9849000854984654,1.0,25/75,26.99%,MAP1B;LLGL1;DOCK7;FARP1;S100A6;UNK;TAOK2;MAP6;DCC;SDC2;SHTN1;CNTN4;SLITRK4;RAB10;MAP1A;ABITRAM;SPTBN4;MAP1S;NTNG2;DVL1;PAX2;ATL1;NRCAM;SLITRK5;PAK3
prerank,regulation of Rac protein signal transduction (GO:0035020),0.32215553576701694,0.709337683016604,0.8370273794002607,0.9847051469180585,1.0,7/16,24.31%,ARHGAP44;RASGRF1;ARF6;OGT;PIK3CG;ARHGAP17;ALS2
prerank,mRNA modification (GO:0016556),0.3096152370834192,0.7093146448946376,0.825925925925926,0.9843594227087485,1.0,4/22,20.09%,TRMT6;TRMT61A;PCIF1;TRUB1
prerank,C-terminal protein amino acid modification (GO:0018410),0.34756462092342877,0.7090962103780893,0.8105117565698479,0.9842251876729848,1.0,4/11,25.31%,TTL;GPLD1;ICMT;AGBL1
prerank,dephosphorylation (GO:0016311),0.2509219169874953,0.7081424642728227,0.9584599797365755,0.9848815673257157,1.0,41/147,23.47%,TIMM50;CDC14B;PTPRS;PLPP3;ACP2;PTPRJ;PLPP5;ILKAP;PTPRF;PLPP1;PPP5C;CTDSP2;DUSP11;PPM1G;INPP5K;PPP3CC;SSH1;PPEF2;PLPPR3;CTDP1;PPP3CA;PPP2R1B;MTMR6;PPP1CC;PPP2R5B;PDP2;PTPN5;PLPP2;SDHAF2;PPP3CB;PPP2R2A;ACP3;PTPN3;PPM1A;PTEN;PPP6C;FBXW11;ACP6;CTDSP1;PTPN18;LHPP
prerank,positive regulation of neuron death (GO:1901216),0.27176389915193777,0.7077493525790711,0.8801331853496115,0.9849237379168224,1.0,11/46,22.18%,FYN;TGFB2;TLR4;MAPT;EIF2S1;NUPR1;SARM1;ITGAM;BACE1;NF1;ATF4
prerank,regulation of cellular biosynthetic process (GO:0031326),0.2901440556976748,0.7074930543695667,0.848780487804878,0.9848287719231532,1.0,7/28,13.72%,PRKAB2;CD47;SIRPA;MITF;AVIL;EIF6;TNFRSF1B
prerank,regulation of cellular protein metabolic process (GO:0032268),0.27194830869200753,0.7063519172644109,0.8866666666666667,0.985701330251968,1.0,17/47,28.22%,PKP3;ATXN2;WDR91;SSH1;AKT1;NOLC1;RBM3;KLF4;PCIF1;METAP1;EIF2A;CSF1;GRM5;CYFIP1;EIF4G1;TSC1;NFKB1
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.2812817286756322,-0.7062815194263793,0.819078947368421,0.9454122649045256,1.0,5/10,29.91%,TBX1;ACTN4;RXRG;RXRB;RXRA
prerank,lamellipodium organization (GO:0097581),0.2900447132327555,0.7058931263710881,0.847877358490566,0.9858456176687168,1.0,10/29,26.99%,ABLIM1;WASF1;SNX1;CTTN;CCDC88A;DMTN;RAC1;CYFIP1;SPATA13;ARHGEF7
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.304778799090126,0.7049428317215733,0.8303571428571429,0.9864953687651921,1.0,4/18,16.43%,C1QBP;PUM1;NOP53;SEC14L1
prerank,positive regulation of hydrolase activity (GO:0051345),0.24748894814405645,0.7046697808501501,0.951417004048583,0.9864289461547056,1.0,22/137,17.39%,CCL8;SGSM2;MAPK12;S100A10;F2R;RASGRF1;NDEL1;RCN3;ASAP3;ADCYAP1;FLCN;CCL25;CALM2;CCL13;PIN1;RHOA;BCAS3;RAPGEF1;EVI5;EVI5L;SRGAP2;ARAP1
prerank,negative regulation of bone mineralization (GO:0030502),0.3257453403848507,0.7046674177045624,0.8260869565217391,0.9860587991233701,1.0,1/13,3.06%,ECM1
prerank,cilium movement (GO:0003341),0.26702527064487724,0.7045789111070039,0.8737650933040615,0.9857831838758524,1.0,1/48,0.51%,CFAP251
prerank,steroid biosynthetic process (GO:0006694),0.26721122462487523,0.7042537131272606,0.8957654723127035,0.98576439716937,1.0,7/56,9.72%,OSBPL3;OSBPL2;INSIG2;SCP2;SRD5A1;HSD3B7;OSBPL6
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.32642113356874203,0.7039071658302873,0.8371161548731643,0.9857437923485498,1.0,3/13,15.83%,IL33;TLR4;SELENOS
prerank,regulation of mitochondrial translation (GO:0070129),0.30414515441197987,0.7035531048090863,0.8605230386052304,0.9857481130827616,1.0,5/21,21.41%,C1QBP;MRPS27;RCC1L;RMND1;MPV17L2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.3044332644141641,0.7032429715813121,0.8473091364205256,0.9857180091524628,1.0,1/19,2.31%,AMPD2
prerank,presynapse assembly (GO:0099054),0.3190870132871012,0.7030044514277037,0.833117723156533,0.9856169148341424,1.0,8/16,31.31%,CEL;PTEN;LRRTM3;DVL1;IL1RAPL1;NLGN1;NLGN3;NLGN2
prerank,tRNA wobble uridine modification (GO:0002098),0.3287603087211104,0.7020067387566584,0.8493150684931506,0.9862795485952339,1.0,3/14,13.76%,ELP4;TRMU;ELP1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.2545856743526081,0.7011076930985564,0.9072916666666667,0.9868626761192495,1.0,37/94,29.97%,CRIP1;C1QBP;CUL3;GSKIP;ERN1;SELENOK;CEBPB;BAK1;SFN;BBC3;QRICH1;DIABLO;CDKN1A;FHIT;TNFRSF1B;STK24;MLLT11;DDX5;HTRA2;PML;APAF1;MCL1;CUL5;PYCARD;ATF4;CYP1B1;DDIT3;SCN2A;LGALS12;MSH6;PRKDC;HIC1;TOPORS;CUL1;BAX;TP53;AIFM1
prerank,protein homotetramerization (GO:0051289),0.27092225407812615,0.7010627761801219,0.8830022075055187,0.9865400566769703,1.0,10/49,19.05%,TK1;KCNJ2;OSBPL2;PKD2;SAMHD1;ALDH1A3;GLS;CRYZ;ALDOA;HCN1
prerank,ganglioside biosynthetic process (GO:0001574),0.3172284737649208,0.7009872052396118,0.8376184032476319,0.9862469199746767,1.0,1/15,1.20%,ST3GAL2
prerank,negative regulation of cholesterol transport (GO:0032375),-0.2823426024731655,-0.7009209360480527,0.8235294117647058,0.9497758958350966,1.0,10/10,71.79%,ABCA2;APOC1;SHH;ABCG5;APOA2;PLA2G10;ABCG8;APOC3;SREBF2;NFKB1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.34364353591138497,0.7008551428434835,0.8179347826086957,0.9860219606035391,1.0,2/10,11.81%,SETD7;SETD2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.28109752565788204,0.7007722684537544,0.8728121353558926,0.9857445789444772,1.0,8/30,18.16%,RASGRF1;RASGEF1A;SRC;ITGAV;IRS2;SHOC2;RAPGEF1;STK19
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.3255542648268051,0.7006631097840722,0.8388814913448736,0.9854812792165449,1.0,2/13,13.35%,ANK2;KCNJ3
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.28734361769500594,0.7002016164947492,0.8579881656804734,0.985598450533676,1.0,4/29,15.33%,LPCAT1;PNPLA8;MBOAT7;PLA2G4E
prerank,stem cell development (GO:0048864),0.3151348449052464,0.6999346766830664,0.8206451612903226,0.9855097820194595,1.0,3/16,16.59%,SOX8;NOLC1;SNAI2
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.3136825296050443,0.6996743150953205,0.8615782664941786,0.9854109693900042,1.0,4/18,17.60%,ABL2;POR;GDNF;PDP2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.3378686336728612,0.6995400744282742,0.8217270194986073,0.9851875604719432,1.0,1/11,2.47%,FYN
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.29702464800792927,0.6989225302100637,0.8629130966952264,0.9854704666280606,1.0,5/21,22.86%,ZW10;ZWINT;FBXO5;TPR;KLHL22
prerank,regulation of receptor binding (GO:1900120),0.3476421876775818,0.6984578064190639,0.8301886792452831,0.9856052707473842,1.0,3/10,13.33%,PTPRF;ADAM15;ATP2A2
prerank,carboxylic acid transmembrane transport (GO:1905039),0.2746565469734112,0.6976292599197784,0.8677309007981756,0.9861284932001946,1.0,5/40,13.02%,SLC25A21;SLC7A6;ABCC1;SLC23A1;SLC23A2
prerank,regulation of interferon-beta production (GO:0032648),0.2717252040297976,0.6971802711673267,0.8885172798216276,0.9862298264540806,1.0,11/46,22.92%,PTPRS;TIRAP;TLR4;SIRPA;POLR3D;HSP90AA1;RNF216;TRAF3;PYCARD;POLR3A;FLOT1
prerank,myofibril assembly (GO:0030239),0.271676379784527,0.6968128011072022,0.8885135135135135,0.986236118808381,1.0,7/42,15.36%,SIX4;CSRP2;FHOD3;CASQ1;PDGFRA;TMOD2;KLHL41
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.2797989994903694,0.6964534083737186,0.8569780853517878,0.9858771132980203,1.0,16/32,34.13%,NUP93;NUP107;NUP98;NUP37;NUP50;XPOT;TPR;NUP133;NUP85;NUP188;NUP88;SEC13;AAAS;NUP160;NUP54;RANBP2
prerank,tRNA export from nucleus (GO:0006409),0.2797989994903694,0.6964534083737186,0.8569780853517878,0.9858771132980203,1.0,16/32,34.13%,NUP93;NUP107;NUP98;NUP37;NUP50;XPOT;TPR;NUP133;NUP85;NUP188;NUP88;SEC13;AAAS;NUP160;NUP54;RANBP2
prerank,cellular protein-containing complex assembly (GO:0034622),0.24211146095747554,0.6962183136218097,0.9556004036326943,0.9857646854773674,1.0,40/160,25.43%,BIN1;SMAD4;AXIN1;HOPX;NUP93;PSMG2;AHCTF1;CENPT;VAMP1;SRC;SRP19;NUP107;CLTC;ADRM1;NUP98;MAPT;TBCEL;CALY;NSG1;CASQ1;DNAAF3;HSP90AA1;CENPC;NCK1;PFDN6;VAMP2;CENPE;TIAM1;VAMP4;TPR;FKBP1A;AP2M1;NCK2;EIF4H;RAB5IF;RTN4;PSMD4;NDUFAF1;VBP1;FCHO2
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.27962354074413404,0.6962063515449676,0.8558139534883721,0.9854111073366484,1.0,8/32,20.62%,FGF13;MAPRE1;CAMSAP1;TUBB4A;FKBP4;NAV3;CLIP3;CLASP2
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.23150520155629195,-0.6954836119359029,0.8837209302325582,0.9539210323651546,1.0,9/19,32.19%,MTHFS;ALDH1L1;SLC19A1;SHMT2;MTHFR;FPGS;SHMT1;ALDH1L2;MTHFD1L
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.3199598166635271,0.6952801715405894,0.8288043478260869,0.9860321763903513,1.0,14/14,68.03%,ATP6AP1;CSF1;TRAF6;IFNG;POU4F2;IL12B;IL23R;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;TYROBP
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.2528636621555439,-0.694544314646486,0.8507462686567164,0.9535272486868911,1.0,2/14,4.55%,CHKA;ETNK2
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.26200891268208426,0.6945299486620476,0.9034994697773064,0.9860847947288043,1.0,14/56,20.51%,NDUFS5;TMEM126A;NDUFAF8;NDUFAB1;NDUFAF6;NDUFS1;NDUFB7;NDUFV2;NDUFA2;ACAD9;DMAC2;BCS1L;NDUFB2;DMAC1
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.26200891268208426,0.6945299486620476,0.9034994697773064,0.9860847947288043,1.0,14/56,20.51%,NDUFS5;TMEM126A;NDUFAF8;NDUFAB1;NDUFAF6;NDUFS1;NDUFB7;NDUFV2;NDUFA2;ACAD9;DMAC2;BCS1L;NDUFB2;DMAC1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2525035729868559,0.6942680467721744,0.9084210526315789,0.9859939023973204,1.0,26/76,31.82%,AXIN1;PIAS3;STUB1;UBA2;MYCBP2;CUL3;HDAC3;TNIP1;NDFIP1;HDAC4;ZC3H12A;SAE1;NSMCE3;DERL1;UBE3A;FKBP1A;FBXW7;MUL1;DCUN1D1;BCL10;LAPTM5;SENP2;SPRTN;TRAF6;GSK3A;CDK5RAP3
prerank,cristae formation (GO:0042407),0.28806530372708683,0.6937357734322532,0.8543352601156069,0.986195354537434,1.0,13/27,29.81%,ATP5PO;ATP5ME;SPG7;UQCC3;APOOL;IMMT;ATP5MC3;DNAJC11;ATP5F1B;LETM1;CHCHD3;ATP5F1A;CHCHD6
prerank,positive regulation of dephosphorylation (GO:0035306),0.28633796537258555,0.6935206117113691,0.8661137440758294,0.986052290198994,1.0,8/27,22.96%,SRC;CALM2;PIN1;NSMF;PPIA;SMPD1;PTBP1;ANKLE2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.29447151677174643,0.6935074100212603,0.8736059479553904,0.9856991668277375,1.0,3/24,7.85%,FGF2;F2R;PKD2
prerank,clathrin coat assembly (GO:0048268),0.31372851865649787,0.6931597434943545,0.8519515477792732,0.9856918647920758,1.0,3/15,13.64%,CLTC;CALY;NSG1
prerank,phosphate ion transmembrane transport (GO:0035435),0.32751724857126235,0.692635609839068,0.8067114093959732,0.9858500408306217,1.0,4/12,21.28%,SLC37A3;SLC25A3;SLC20A1;SLC37A4
prerank,inner dynein arm assembly (GO:0036159),0.33006905210295034,0.69262568933263,0.8359486447931527,0.9854919589717858,1.0,11/11,67.02%,DNAAF5;CCDC39;CFAP73;CCDC103;ZMYND10;DNAI3;DNAAF1;DNAH1;DNAAF4;CCDC40;CFAP100
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.2514639054742436,-0.692407075568112,0.8669354838709677,0.9542745741497023,1.0,4/14,17.41%,ENPP1;ENPP3;AK4;AK1
prerank,cellular response to interleukin-6 (GO:0071354),0.29010142680250073,0.6923458735162954,0.875,0.9854145504004452,1.0,6/26,16.30%,SMAD4;SRC;PID1;CBL;FER;IL6
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.2978818154995165,0.6916461125657908,0.8628205128205129,0.9857466207450756,1.0,5/20,20.82%,ACLY;FAR1;HSD17B8;SCD5;HSD17B4
prerank,aspartate family amino acid catabolic process (GO:0009068),0.30391879189669624,0.6913028949692136,0.865211810012837,0.9857367838176397,1.0,1/19,0.85%,SLC25A21
prerank,negative regulation of MAP kinase activity (GO:0043407),0.26573417516839226,0.6912340129588671,0.893569844789357,0.9854374648183187,1.0,4/44,5.35%,UCHL1;IRAK3;AIDA;PTPRJ
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.28960880831931113,0.691182805397324,0.8645962732919255,0.985120666281479,1.0,7/26,22.79%,FGF2;F2R;PKD2;HTR2C;IBTK;SLC8B1;HTR2A
prerank,DNA integrity checkpoint signaling (GO:0031570),0.27380096057678593,0.6907061669588863,0.8677309007981756,0.9852613079918111,1.0,9/36,23.62%,TIPIN;RHNO1;RAD1;DNA2;BRIP1;NBN;DONSON;CLSPN;TIPRL
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.32087747778171105,0.6903464894587639,0.8375499334221038,0.9852516663232006,1.0,5/13,17.32%,FUT9;IRAK1;RHOA;IL6;ZDHHC21
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.25205706134535855,0.6902130343637033,0.9255429162357808,0.985027673755047,1.0,29/85,31.72%,PSMC4;SMURF2;AP2A2;PSMC6;CLTC;FZD7;PARD6A;PSMD8;MAGI2;VANGL2;RHOA;FZD4;DAAM1;TIAM1;SMURF1;AP2M1;PSMD3;DVL1;PSMD4;RAC1;PSMB3;PSMB2;PSMD5;PSMD14;WNT11;PSMC3;PSMC5;AP2A1;PSME4
prerank,regulation of protein localization to cell surface (GO:2000008),0.27613692524754324,0.6901562329794397,0.8737980769230769,0.9847248461696728,1.0,12/33,28.93%,RAB11FIP5;TOR1A;STX4;EGF;GOPC;STX3;MAP1A;LEPROT;GBF1;SNX33;RANGRF;TM9SF4
prerank,protein alkylation (GO:0008213),0.2973545076300207,0.6899676454386231,0.8609756097560975,0.9845437672394454,1.0,9/22,35.24%,PRMT2;GSPT1;SNRPD3;EEF2KMT;CAMKMT;PRMT8;ETF1;EEF1AKMT1;FAM98A
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.2780184218351359,0.6895876342991054,0.8704156479217604,0.9845531509803113,1.0,3/32,6.20%,F2R;P2RX3;CXCL10
prerank,rRNA catabolic process (GO:0016075),-0.24095433306355343,-0.6894976669163521,0.8893280632411067,0.9557906784833191,1.0,6/16,24.23%,EXOSC9;DIS3L;DEDD2;DIS3;PELO;EXOSC4
prerank,histone H3-K4 trimethylation (GO:0080182),0.3280815544643556,0.6886124376958425,0.8453188602442334,0.9851887916536711,1.0,6/11,31.06%,OGT;PRDM9;SETD1B;KMT2A;SETD1A;TET3
prerank,cardiac conduction system development (GO:0003161),0.2911031092945832,0.6885362370138185,0.8721804511278195,0.9848986009128882,1.0,3/24,10.04%,SMAD4;SMAD5;HCN4
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.28038674274110154,0.6864995803959028,0.8744075829383886,0.9865652375817572,1.0,7/32,23.74%,HNRNPA1;ACD;CCT7;XRCC5;NEK7;MAPK1;CCT4
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.2977450594444805,0.6856226237502169,0.8591022443890274,0.9870979224506342,1.0,5/19,20.96%,DYRK2;RPS27L;BCL3;PML;PYCARD
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.33678403198710793,0.6855983637537424,0.8418918918918918,0.9867562546975301,1.0,4/11,21.20%,UQCRQ;UQCC3;UQCRH;UQCR10
prerank,positive regulation of ion transport (GO:0043270),0.2620461298328907,0.6850697729840367,0.8947951273532669,0.9869151384067764,1.0,3/48,3.19%,FHL1;ANK2;F2R
prerank,cellular amino acid catabolic process (GO:0009063),0.24801572564982427,0.6849614018054685,0.9207188160676533,0.9866593609167708,1.0,11/87,15.42%,AMDHD1;SLC25A21;HAL;BCAT1;AUH;HIBADH;GLS2;GLS;CRYM;ALDH5A1;GLUD1
prerank,negative regulation of dephosphorylation (GO:0035305),0.2966816494143729,0.6848274734821057,0.8554838709677419,0.9864339626804404,1.0,8/18,28.88%,INPP5K;URI1;CHP1;SH2D4A;YWHAB;PPP1R26;PTPA;GPATCH2
prerank,phagosome acidification (GO:0090383),0.27837546436799787,0.6847089660252619,0.8759036144578313,0.9861875345760016,1.0,5/26,16.13%,ATP6V0A2;ATP6V1E1;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,modulation of chemical synaptic transmission (GO:0050804),0.24557778372812086,0.6846965733467728,0.9396110542476971,0.9858335483569073,1.0,33/107,26.07%,CEL;SLC4A8;DLG4;DLGAP4;STX1B;NRG3;DLGAP3;HCRT;LGI1;PXK;BTBD9;SLC8A2;DLGAP1;CNTNAP4;GRID1;GRM1;CHRNA7;SYT1;AKAP9;RIMS2;CLSTN3;PTEN;NMU;GRIK5;GRIK2;NPTX1;DGKI;BCR;GRIK4;BAIAP3;GRM5;BEGAIN;EIF4EBP2
prerank,phosphate ion transport (GO:0006817),0.30516303795178495,0.6839998473245442,0.8365508365508365,0.986155466622514,1.0,4/16,21.28%,SLC37A3;SLC25A3;SLC20A1;SLC37A4
prerank,peptidyl-lysine trimethylation (GO:0018023),0.2847188023622861,0.6839991459462219,0.8768115942028986,0.9857909881015338,1.0,8/26,20.13%,SETD2;ANTKMT;SETD5;OGT;EEF2KMT;PRDM9;SETD1B;KMT2A
prerank,regulation of primary metabolic process (GO:0080090),0.2429229220260532,0.683972972550779,0.9411167512690355,0.9854536844281923,1.0,21/126,16.32%,PSMC4;NR1D2;MVK;PRKAB2;NR1D1;PSMC6;PLPP1;SIN3B;CHD9;PSMD8;GGPS1;ODC1;HELZ2;HDAC3;IRS2;TGS1;NCOR2;NCOR1;BBS4;PMVK;OPA3
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.2754414519647922,-0.6839280159044513,0.840625,0.9598772368846711,1.0,2/10,9.07%,ALDH7A1;SARDH
prerank,regulation of amyloid fibril formation (GO:1905906),0.31438294218116103,0.6821793704085009,0.8590785907859079,0.9869010447424013,1.0,8/15,26.38%,PSEN1;CHRNA7;PFDN6;IAPP;LDLR;CRYAB;VBP1;PFDN2
prerank,stress-activated MAPK cascade (GO:0051403),0.255250204473236,0.6815887590645692,0.9094827586206896,0.9870912504876145,1.0,17/61,24.27%,MAPK14;ZFP36L1;MAP2K3;UBE2N;CHUK;MAPK11;IRAK1;UBA52;ZFP36;TAOK2;MAP2K4;MAPK1;TAB2;FBXW11;MAP3K7;TNIP2;GPS1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.3068661800353521,0.6810260284168346,0.8578811369509044,0.9872884824894842,1.0,2/16,13.94%,CLDN10;CLDN12
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.32972994260352,0.6805527672761524,0.8373071528751753,0.9874056886759559,1.0,6/10,33.35%,DBF4;INO80;E2F7;ATRX;WIZ;CDC7
prerank,"transcription, DNA-templated (GO:0006351)",0.2360210313346388,0.6805133517802003,0.9709418837675351,0.9870730664847707,1.0,48/207,23.87%,NFIX;POLR2H;GTF2H3;ABT1;PAX1;BRF2;PPP5C;CDK9;SOX5;TAF3;DDX21;UBTF;ERCC3;GTF3C2;POLR2D;POLR2G;BCL3;GTF2A2;CCNH;EAF2;CTDP1;BRF1;GTF2F1;BTF3;NFE2L3;EAF1;DDX5;POLR3H;TCEA2;HIPK3;GTF2E2;POLR1C;MBD1;PAF1;SLC25A33;LHX1;ATF4;RNMT;POLR3A;BAZ2A;SMN1;ELL;TBP;TAF13;GTF3C5;NCOA6;TRIM24;RTF1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.20271778692726317,-0.6804558010085777,0.9503105590062112,0.9617326354016944,1.0,3/29,4.69%,KCNIP3;DLG1;CACNA1D
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.2460578747930225,-0.6796856257993311,0.8541666666666666,0.9610740875136075,1.0,5/13,19.99%,PHYH;OGDH;ADHFE1;DLST;IDH2
prerank,positive regulation of defense response (GO:0031349),0.24488529107163673,0.6796640823368757,0.9431230610134437,0.98750024394256,1.0,16/89,19.46%,IL16;S100A8;S100A9;IL33;IL17RA;TLR4;CD47;POLR3D;TNIP1;AKIRIN2;ABCC1;SLC15A4;PDCD4;IL18;IFI35;LRSAM1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.21785182313012214,-0.6793507963558343,0.8979591836734694,0.9600341563642332,1.0,8/23,27.14%,NR1H3;STAT1;PTPN2;PIAS1;PARP9;IRGM;TXK;SOCS1
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.25846667776895926,-0.6792714305194576,0.8957528957528957,0.9587284723623424,1.0,3/12,14.28%,AXIN2;WAPL;CTNNB1
prerank,acylglycerol homeostasis (GO:0055090),0.29702886014135715,0.67903745079291,0.85375,0.9877625134014981,1.0,6/20,22.60%,MLXIPL;PNPLA8;IL18;LIPC;ANGPTL3;RORA
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.26178125942629477,0.6787084728975292,0.9132882882882883,0.9877259278000549,1.0,12/48,23.66%,PAPSS2;AMPD2;SLC25A16;ADCY8;PANK1;SLC26A1;PANK3;DCAKD;ACAT1;NPR2;ADSS2;ADCY2
prerank,regulation of lipid metabolic process (GO:0019216),0.24599644087491784,0.6779630613905975,0.928944618599791,0.9880958998575717,1.0,17/88,16.32%,NR1D2;MVK;NR1D1;PLPP1;SIN3B;CHD9;GGPS1;HELZ2;HDAC3;IRS2;MBOAT7;TGS1;NCOR2;NCOR1;BBS4;PMVK;OPA3
prerank,calcium ion transmembrane transport (GO:0070588),0.24556491078589296,0.6776950538862224,0.9318658280922432,0.9879827315591386,1.0,26/86,26.25%,PKD1;TRPV3;ATP2B4;GRIN2D;GAS6;PKD2;MCU;ITGAV;SLC35G1;MCUB;ATP2A2;SLC8A2;TRPC4AP;TMEM165;GRIN2A;SPG7;ATP2B1;SLC8B1;FKBP1A;PARL;TRPC1;CACNA2D1;TRPV2;TMCO1;SLC24A4;SLC24A2
prerank,cellular response to catecholamine stimulus (GO:0071870),0.28602361931142833,0.6772659667360833,0.8920245398773006,0.9880136318334596,1.0,7/23,22.18%,ATP2B4;SIRT2;SLC9A1;GNB1;MAPK1;GABPA;ATF4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.2895558457960087,0.6771482743898436,0.8599033816425121,0.9873920271086066,1.0,5/23,15.08%,SMAD4;RNF111;FLCN;SLC2A10;GIPC1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.2895558457960087,0.6771482743898436,0.8599033816425121,0.9873920271086066,1.0,5/23,15.08%,SMAD4;RNF111;FLCN;SLC2A10;GIPC1
prerank,regulation of potassium ion transport (GO:0043266),0.27790873137125616,0.6771086564871363,0.8862275449101796,0.9870697904567978,1.0,2/31,2.71%,FHL1;ANK2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.24864327632515362,0.6757205729549354,0.9343065693430657,0.9880488864667887,1.0,21/76,25.85%,AXIN1;COP1;STUB1;SIRT2;DNAJB2;USP5;NOP53;RNF14;ZER1;KEAP1;ARIH2;RNF19A;ARIH1;PTEN;SMURF1;ZYG11B;DVL1;MDM2;FBXO22;FBXW7;CSNK1E
prerank,positive regulation of phagocytosis (GO:0050766),0.25858762709232314,0.6754330929574904,0.912751677852349,0.9879559561794985,1.0,5/47,10.21%,PTPRJ;GAS6;CD47;SIRPA;C4B
prerank,response to glucose (GO:0009749),0.25908513013967793,0.6754269122241108,0.8981900452488688,0.9875975050075724,1.0,10/46,19.82%,SLC39A14;TCF7L2;GAS6;ERN1;IRS2;ADCY8;SELENOS;VAMP2;GPLD1;EIF2B1
prerank,sensory perception of taste (GO:0050909),0.3403959071426325,0.6753189672020345,0.8546195652173914,0.9873341101898697,1.0,2/10,20.32%,ASIC2;ASIC1
prerank,negative regulation of DNA metabolic process (GO:0051053),0.280346361302427,0.6748332403674102,0.8879415347137637,0.9874274987827532,1.0,10/24,27.51%,ERCC4;XRCC5;CDKN1A;BLM;KMT2A;TERF2IP;ERCC1;H1-0;MSH6;DFFA
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.24775497517176806,0.6742214959824506,0.9266247379454927,0.9876472353526635,1.0,11/73,12.87%,EIF2AK3;F2R;S100A8;S100A9;MTCH1;PDCD2;MAPT;ANP32B;BBC3;DIABLO;RPS27L
prerank,microtubule nucleation (GO:0007020),0.2896268120830468,0.6739491924727826,0.8716981132075472,0.9875510632519496,1.0,6/20,23.10%,NDEL1;SLAIN2;AKAP9;CLASP2;TUBGCP5;TUBG2
prerank,sterol transport (GO:0015918),0.2964527038040788,0.6736923402786359,0.8737244897959183,0.9874375254681709,1.0,2/19,8.68%,OSBPL2;LCAT
prerank,response to interferon-gamma (GO:0034341),0.24958862762756676,0.6730788936274895,0.9331175836030206,0.9876516809590237,1.0,8/67,12.90%,CCL8;CYP27B1;CCL25;TLR4;CD47;SIRPA;SLC26A6;CCL13
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.33412409494914214,0.6720800732113602,0.8563134978229318,0.9882020588779173,1.0,3/10,27.82%,CCT7;CCT4;CCT6A
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.28545043754542027,0.6715517991383263,0.8788968824940048,0.9883215828869707,1.0,4/24,10.96%,PKD1;RHBDF1;UCHL5;GPX1
prerank,regulation of feeding behavior (GO:0060259),-0.2577238773559181,-0.6693263860271068,0.8583333333333333,0.9663920903189166,1.0,3/11,21.72%,SGIP1;CFAP20;NR4A3
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2454986716697672,0.6690058134709556,0.9497907949790795,0.9903867532833677,1.0,23/85,25.85%,TMEM259;COP1;PSMC6;STUB1;SIRT2;DNAJB2;USP5;NUPR1;NOP53;RNF14;ZER1;KEAP1;ARIH2;RNF19A;ARIH1;TMTC3;USP13;ZYG11B;DVL1;MDM2;FBXO22;FBXW7;CSNK1E
prerank,regulation of transposition (GO:0010528),0.31468992872204904,0.6689766182512645,0.8432203389830508,0.990056074207529,1.0,3/13,22.64%,SPOCD1;DDX4;UBR2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2425885576099727,0.6684647930657109,0.9558067831449126,0.9901779838799647,1.0,14/104,15.60%,LRP6;GTPBP4;ETAA1;SRC;SYAP1;AKT1;PPEF2;CALM2;CDKN1A;CCND1;RHOA;SLC8A2;CCNH;MAP2K2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.2455061846955637,0.6677234159334723,0.938090241343127,0.9905106329164558,1.0,5/75,5.35%,LRP6;UCHL1;HEG1;IRAK3;PTPRJ
prerank,negative regulation of histone modification (GO:0031057),0.30468581750350426,0.6676335184427314,0.8609986504723347,0.9902249762377019,1.0,4/14,20.02%,NOC2L;TWIST1;SET;CTBP1
prerank,folic acid metabolic process (GO:0046655),-0.22334925376756473,-0.6672787589328438,0.9130434782608695,0.9667651236111012,1.0,9/18,32.19%,MTHFS;ALDH1L1;SLC19A1;SHMT2;MTHFR;FPGS;SHMT1;ALDH1L2;MTHFD1L
prerank,negative regulation of blood pressure (GO:0045776),0.3055619709022445,0.6661405786441601,0.879286694101509,0.991213860337444,1.0,3/13,19.31%,PRCP;GPR37L1;SCPEP1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.24416788583619142,-0.6655236873466462,0.8969465648854962,0.9669587172204092,1.0,4/13,14.83%,YAE1;CIAO1;NFU1;GLRX3
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.2708181589593222,0.6652908738242311,0.9004629629629629,0.991630501337069,1.0,6/34,13.53%,BTC;CUL3;CDC23;ANAPC5;EGF;CDC27
prerank,liver development (GO:0001889),0.2667963197683638,0.6651396519055043,0.8988235294117647,0.9914174029726286,1.0,4/32,11.24%,ANXA1;COBL;PKD2;CEBPB
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.26291200711624496,-0.6648331703591918,0.8885245901639345,0.9662044412333671,1.0,4/11,17.97%,CAV1;PTPRT;NF2;ADIPOR1
prerank,response to light stimulus (GO:0009416),0.25204332353613135,0.664679560996124,0.9325481798715204,0.991473360388385,1.0,19/55,31.28%,UBE2B;DTL;ERCC3;UBE2A;ERCC4;PCLAF;UVSSA;ERCC5;TYR;POLD1;OPN3;REV1;CRY2;MSH6;MEN1;SPRTN;DRD2;COPS3;CIRBP
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.28855754910900544,0.664516394471446,0.8859649122807017,0.991251975332366,1.0,5/19,17.16%,BIN1;PIN1;RTN3;FLOT2;CHRNA7
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.27862600482494876,0.6633159579712937,0.8874841972187105,0.9919958199551385,1.0,5/23,24.99%,CNGB1;SAG;METAP2;METAP1;CAMKMT
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.253707153683626,0.6627229364958208,0.9224806201550387,0.9921700597091356,1.0,9/53,17.25%,EGFR;EYA2;UBE2N;TIGAR;ABRAXAS1;NACC2;DDX5;FXR2;EEF1E1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2665488870694244,0.6616856658938631,0.9093050647820966,0.9927418045545546,1.0,7/35,23.74%,HNRNPA1;ACD;CCT7;XRCC5;NEK7;MAPK1;CCT4
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.30873270619652116,0.6612536297079582,0.8778220451527224,0.9927611062361571,1.0,4/13,21.08%,BPNT2;SULT4A1;ABHD14B;TPST2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.29175799350457954,0.6607682617338655,0.8970398970398971,0.9928415506364483,1.0,10/18,38.06%,CCT7;CCT4;EXOSC10;CCT6A;NHP2;RUVBL1;RUVBL2;TCP1;PARN;CCT8
prerank,cellular response to unfolded protein (GO:0034620),0.2753532399592213,0.6605782357216482,0.8966346153846154,0.9926431206649216,1.0,10/26,29.97%,HSPA13;ERN1;BAK1;HSPA14;ABCB10;BAG3;TM7SF3;BAX;HSPA8;HSF1
prerank,protein acetylation (GO:0006473),0.26869050797493155,0.6605187527857737,0.9021479713603818,0.9923307354765527,1.0,6/30,18.79%,FOXO1;KAT2B;ING4;MAPT;NAA15;NAA50
prerank,regulation of p38MAPK cascade (GO:1900744),0.2634971433107306,0.6603463375783003,0.9242937853107345,0.9921160392246084,1.0,5/35,16.19%,GADD45G;VEGFA;EMC10;ZC3H12A;PER1
prerank,macrophage migration (GO:1905517),-0.24930280401772054,-0.6598735884347285,0.8671586715867159,0.9689629405322654,1.0,6/13,35.46%,EDNRB;TAFA4;CCR2;CCL2;CXCL17;CCL5
prerank,organic cation transport (GO:0015695),0.287361312795985,0.659824682801607,0.8853503184713376,0.9922439023151285,1.0,4/20,17.46%,SLC47A1;SLC44A1;SEC14L1;SLC44A2
prerank,negative regulation of secretion (GO:0051048),0.32173143051538333,0.65960496915359,0.8558823529411764,0.9920897336733279,1.0,2/10,12.37%,SPX;EGF
prerank,meiosis I (GO:0007127),0.275220324797909,0.6591847587076082,0.8780487804878049,0.9920862954902998,1.0,3/23,18.64%,SLC25A31;DDX4;FOXJ2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.24170308918205938,0.6590542301587757,0.9541666666666667,0.9918395603357747,1.0,22/84,28.25%,PSMC4;PSMC6;PSMD8;CUL3;CDC23;ANAPC5;FBXO5;FBXO31;UBA52;CDC27;CDC26;ANAPC4;SKP2;ANAPC10;ANAPC15;ECRG4;PSMD3;PSMD4;PSMB3;ANAPC2;PSMB2;PSMD5
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2352074627277102,0.6588158630588775,0.9499489274770173,0.9916976909955533,1.0,22/117,20.06%,CYP2S1;ACOT6;CPT1C;ALKBH7;SLC6A8;SCP2;HAGH;PTGR1;PDHX;FA2H;PNPLA8;GBA2;GAMT;ALDH1A3;ACOT1;VDAC1;PDHA1;BTD;GPAM;ANGPTL3;SCPEP1;LDHA
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.2761569298746131,0.6586339925789407,0.8883553421368547,0.9915030719556346,1.0,12/26,31.31%,DLG4;STX1B;SLC8A2;CHRNA7;RIMS2;PTEN;PRKCZ;NLGN1;NLGN3;NRXN1;CBLN1;NLGN2
prerank,negative regulation of binding (GO:0051100),0.24229114611390956,0.6580044289332335,0.9571129707112971,0.9916974493536271,1.0,15/81,16.80%,DACT1;GTPBP4;GNL3L;CARD16;TFIP11;USP33;AKT1;SLPI;DNAJB2;CDKN1A;PIN1;DDX11;GTF2F1;ILRUN;TFAP4
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.3146954672927925,0.6576634883605791,0.8737864077669902,0.991647331035684,1.0,1/12,8.30%,ZBTB1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.2683991677496991,0.657644775629507,0.8870392390011891,0.9913044115294385,1.0,5/27,15.33%,PLAAT1;CHKB;PNPLA8;CEPT1;PLA2G4E
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.2592266244629388,0.6570361336234163,0.9026345933562429,0.9914771872005685,1.0,5/39,12.02%,FHL1;ANK2;FXYD5;YWHAE;STK39
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.3203428692622663,0.6568538696959708,0.8661202185792349,0.9912668221403445,1.0,2/10,17.23%,ZNHIT6;NUFIP1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.30665588982877245,0.6563292917713426,0.8643835616438356,0.9913628405501544,1.0,3/13,26.15%,ALG1;SRD5A3;MPDU1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.26989077024643887,0.6562009202748585,0.9054842473745625,0.9911161177137786,1.0,11/28,31.82%,AXIN1;PSMC6;NUPR1;PTEN;TMTC3;SMURF1;FBXW7;LAPTM5;PSMC3;PSMC5;CDK5RAP3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.24929819297114464,0.6560718805916127,0.9262114537444934,0.9908716815822745,1.0,10/54,16.87%,TRIAP1;MUC1;MDM4;SFN;CDKN1A;CNOT3;CNOT10;PLAGL1;TNKS1BP1;PML
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.31891101143714495,0.6558552212799686,0.8675034867503487,0.9907022288223225,1.0,3/10,16.54%,FLCN;SETD5;DIP2A
prerank,regulation of histone acetylation (GO:0035065),0.25847433911674295,0.6547516855261429,0.9094076655052264,0.9912803406229024,1.0,9/33,21.51%,NOC2L;FLCN;BRD7;SETD5;SET;GLYR1;CTBP1;KMT2A;ARRB1
prerank,negative regulation of cell cycle process (GO:0010948),0.2448361772777801,0.6538992114110955,0.9289617486338798,0.9916758913185848,1.0,15/61,22.14%,RNF2;AURKAIP1;RYBP;PHC3;PHC1;FBXO5;TERF1;EHMT2;CCP110;UXT;APAF1;RING1;PCGF6;FOXO4;EZH2
prerank,nucleic acid-templated transcription (GO:0097659),0.25384380457316075,0.6535598594826552,0.9222857142857143,0.9915919322676058,1.0,5/42,13.22%,POLR2H;PPP5C;POLR2D;POLR2G;BCL3
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.23586602771032947,0.6535307360247524,0.9600409836065574,0.9912569357757047,1.0,37/109,31.13%,SYK;PSMC4;PIK3R2;NFATC1;PSMC6;CHUK;PIK3CA;PSMD8;FER;PPP3CA;SOS1;MAP2K4;CARD11;PPP3CB;MAPK1;GAB2;TAB2;JUN;FBXW11;MAP3K7;VAV2;RELA;PSMD3;PSMD4;RAC1;PSMB3;BCL10;PSMB2;NFKB1;PSMD5;CUL1;FOS;PSMD14;TRAF6;PSMC3;PSMC5;CALM1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2374635061976669,0.6534854608048105,0.9528301886792453,0.9909341007666462,1.0,9/80,13.17%,SPSB4;AXIN1;STUB1;MYCBP2;UBE2N;CUL3;HDAC3;NDFIP1;PIN1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.24562202415021786,0.6534766201000655,0.926006528835691,0.9905852158439479,1.0,10/54,19.21%,GTPBP4;GNL3L;PIAS3;USP4;SQSTM1;AKT1;CHP1;OGT;UFL1;U2AF2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.2552977049390956,0.6532030647319668,0.9277522935779816,0.9904537787023586,1.0,12/36,30.32%,AXL;GAS6;PARP14;CXCR4;CPNE1;CSF1;TRIM44;UBE2K;LAPTM5;CD300LF;AGPAT2;ADAM17
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.22822708589286178,0.6530855879264171,0.967644084934277,0.9901974188744338,1.0,37/148,24.94%,MAPK14;MTOR;PRKAB2;MDM4;NOC2L;RHNO1;MAPK11;BRD7;DYRK2;TAF3;RMI1;AKT1;RAD1;PIN1;DNA2;BRIP1;EHMT2;NBN;USP7;NOP53;RFC4;CHD3;PML;PIP4P1;RAD50;RPF2;BLM;TTC5;RPL23;PIP4K2B;NOP2;CSNK2A2;TBP;TAF13;HEXIM1;MDM2;KAT5
prerank,histone H4 acetylation (GO:0043967),0.2491835417651938,0.6527336201931951,0.9287305122494433,0.9901554825977172,1.0,12/47,20.88%,MSL2;MSL3;ING4;MSL1;WDR5;KANSL3;DMAP1;PER1;OGT;MORF4L1;KMT2A;TRRAP
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.31858971604135433,0.6513955457361054,0.8904109589041096,0.9909082827259161,1.0,2/11,15.11%,SLC25A4;NUPR1
prerank,receptor clustering (GO:0043113),0.2674026604028339,0.651373254970384,0.8923821039903265,0.9905691312606255,1.0,11/27,28.16%,DLG4;DLG2;MUSK;MAGI2;DNAJA3;SYNJ2BP;FLNA;PICK1;DVL1;LRRC7;NLGN1
prerank,rRNA metabolic process (GO:0016072),0.22922887400834138,0.6511850469828918,0.9778894472361809,0.9903690490076213,1.0,35/160,23.67%,C1D;DDX49;FCF1;ESF1;HELQ;EXOSC7;RRP36;RPL10A;WDR46;MAPT;UBA52;SBDS;MPHOSPH10;RCL1;SNU13;NOLC1;DCAF13;RRP7A;EXOSC1;RPL6;NOP53;DDX52;POP4;PWP2;EBNA1BP2;TBL3;RPL23;RPL17;PDCD11;KRR1;RPS25;WDR18;NOC4L;TEX10;RRP1B
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.2387120463840036,0.6511696965400862,0.9464469618949537,0.9900268407108059,1.0,30/88,31.72%,PSMC4;PSMC6;FBXO2;PSMD8;FBXO17;FBXL2;FBXW4;FBXL20;FBXO31;FBXL3;DMAC2;FBXL5;SKP2;CUL5;FBXW11;FBXO38;PSMD3;FBXL12;PSMD4;FBXW7;PSMB3;PSMB2;PSMD5;CUL1;FBXL8;PSMD14;PSMC3;PSMC5;FBXL13;PSME4
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.2531053612826842,0.6510891452551024,0.9223085460599334,0.989740089284972,1.0,8/44,15.71%,OSBPL3;OSBPL2;INSIG2;SCP2;HSD3B7;OSBPL6;PSAT1;PMVK
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.2658790674953152,0.6505076434531474,0.908256880733945,0.9898688699188724,1.0,6/31,12.73%,YWHAG;YWHAE;PPP3CC;BAK1;SFN;BBC3
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.2761135200287219,0.6502874875704471,0.9062119366626066,0.9897052934631648,1.0,6/22,24.13%,INHA;INPP5K;CDKN1A;CDKN2C;ANKLE2;DYNLL1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.2993063321424679,0.6498426503563651,0.9,0.9897181076089203,1.0,7/15,33.06%,CNTNAP4;BAIAP3;NPAS4;NLGN1;DRD2;NLGN2;ZDHHC3
prerank,action potential (GO:0001508),0.24921600431281896,0.649154232982544,0.9186991869918699,0.9899367810263897,1.0,5/44,10.51%,SRI;SLC4A3;KCNJ2;MYH14;KCNA2
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.2459495436377161,-0.6486550776518961,0.914396887159533,0.9763965036306069,1.0,5/12,25.85%,MFNG;GPR183;DOCK10;FCGR2B;DLL1
prerank,chromatin remodeling at centromere (GO:0031055),0.26415828325790186,0.6478570869152337,0.9058823529411765,0.9906404837899999,1.0,4/31,15.93%,CENPT;HJURP;NPM1;CENPC
prerank,inositol phosphate biosynthetic process (GO:0032958),0.3159657226330024,0.6472911480298529,0.9001367989056087,0.9907585976353843,1.0,3/11,20.19%,FGF2;IPPK;IP6K1
prerank,glycogen catabolic process (GO:0005980),0.2977953649639493,0.6462182015641348,0.9010554089709762,0.99128060011424,1.0,8/15,31.13%,PHKA2;PGM2L1;GAA;PYGB;PHKA1;RB1CC1;PHKG1;CALM1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.24628461575990554,0.6457199072747594,0.92880978865406,0.9913349852285983,1.0,16/50,29.16%,GTPBP4;GNL3L;USP4;SQSTM1;AKT1;FBXO5;CHP1;OGT;UFL1;U2AF2;ARRB1;BAG5;PRKCG;DNAJA1;HDAC8;SENP2
prerank,peptidyl-arginine modification (GO:0018195),0.29207601312153497,0.6454714131053181,0.890038809831824,0.991193584888622,1.0,5/15,31.65%,ART4;PADI2;KRTCAP2;PRMT8;PRMT7
prerank,leukotriene metabolic process (GO:0006691),0.28178283696139594,0.6450429255570548,0.892059553349876,0.9912065289907235,1.0,3/19,12.70%,DPEP1;PTGR1;ABCC1
prerank,protein targeting to ER (GO:0045047),0.23202803490537943,0.6450404189412912,0.9658385093167702,0.9908519195699298,1.0,12/99,15.51%,RPSA;EDEM1;SPCS1;SRP19;SRP9;RPL10A;UBA52;RPS5;SGTA;SEC63;SEC61A1;RPL6
prerank,phasic smooth muscle contraction (GO:0014821),-0.2627570380618757,-0.6445111820121019,0.8928571428571429,0.9781427710106255,1.0,3/10,15.58%,EDNRB;EDN1;EDN3
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.3063269372544598,0.6436342637411971,0.8778409090909091,0.9916432927928871,1.0,1/10,7.10%,HDAC6
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.2841039933866714,0.6435309018163703,0.8878627968337731,0.9913666890815042,1.0,2/15,11.61%,MLXIPL;ELOVL5
prerank,L-serine metabolic process (GO:0006563),-0.24989873719839817,-0.6429641077171275,0.8972602739726028,0.9779421827684296,1.0,1/10,2.06%,SERINC3
prerank,regulation of blood circulation (GO:1903522),0.2572626879653692,0.642884559842006,0.92,0.9915189718606674,1.0,4/34,11.25%,SRI;CAMK2D;ECE1;CELF2
prerank,ceramide catabolic process (GO:0046514),-0.23571091529972632,-0.6428189621673034,0.9186046511627907,0.9766809021456749,1.0,1/14,2.35%,ACER2
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.2592670928120733,0.6427781216270492,0.9094117647058824,0.9912554704178748,1.0,7/32,20.96%,DYRK2;RPS27L;BCL3;FHIT;DDX5;PML;PYCARD
prerank,negative regulation of chemokine production (GO:0032682),0.30034982172328323,0.6426727363086712,0.9037940379403794,0.9909831245510663,1.0,3/14,16.30%,SIRPA;KLF4;IL6
prerank,tRNA transport (GO:0051031),0.25661076079718353,0.6423118499821697,0.9243119266055045,0.9909217881759911,1.0,11/35,27.02%,NUP93;NUP107;NUP98;NUP37;NUP50;XPOT;TPR;NUP133;NUP85;NUP188;NUP88
prerank,protein-DNA complex assembly (GO:0065004),0.23086525720911716,0.6420529538255746,0.9543610547667343,0.9907612018691474,1.0,19/116,17.52%,PSMC4;GTF2H3;CHAF1B;RAD23B;PSMC6;SPTY2D1;PSMD8;MCM3;NPM1;ERCC3;UBA52;ANP32B;DDB1;CCNH;ORC6;GMNN;GRWD1;NAP1L2;ERCC5
prerank,regulation of neurogenesis (GO:0050767),0.24344070572499857,0.641867166671889,0.9449244060475162,0.9905583895137277,1.0,4/55,8.12%,NUMBL;BHLHE40;DOCK7;SERPINF1
prerank,regulation of mitotic nuclear division (GO:0007088),0.2461954113570541,0.6417827935369029,0.9360780065005417,0.9902686420714173,1.0,9/55,15.78%,BTC;CCDC8;AURKAIP1;KIF20B;FBXO5;EGF;PIN1;CUL9;CDK5RAP2
prerank,regulation of telomerase activity (GO:0051972),0.2511789561892663,0.6412401708885328,0.9368191721132898,0.9903432511283958,1.0,10/45,21.04%,SRC;ACD;ERCC4;XRCC5;TERF1;KLF4;HSP90AA1;SMG6;NEK7;MAPK1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.28585713561955006,0.640788320188807,0.9094437257438551,0.9903436162816963,1.0,3/17,12.62%,MTOR;MAGI2;CALM2
prerank,membrane lipid catabolic process (GO:0046466),0.31609256885358245,0.6405511722723858,0.8842975206611571,0.9901914943067308,1.0,3/10,27.12%,PDXDC1;CYP1B1;PPT1
prerank,mitotic cytokinesis (GO:0000281),0.24566938065848032,0.6399062961510283,0.9230769230769231,0.9903367241854384,1.0,15/47,29.89%,SON;BBS4;TTC19;SPTBN1;RAB35;CIT;RASA1;PDCD6IP;TRIM36;SNX18;SNX33;CUL7;MYH10;INCENP;CKAP2
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.27191413904010997,0.6398971085790265,0.9106699751861043,0.9899911239845505,1.0,5/24,25.86%,LPCAT1;PNPLA8;GPAM;SLC27A1;PGS1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.25646608243684493,-0.6398625781491191,0.8477508650519031,0.9774977368607003,1.0,2/10,9.96%,ERLEC1;SVIP
prerank,negative regulation of innate immune response (GO:0045824),0.25671221857622584,0.6394726885839075,0.9173553719008265,0.9899888447664116,1.0,7/34,22.59%,IRAK3;SAMHD1;SERPING1;YTHDF2;TYRO3;YTHDF3;STAT2
prerank,tyrosine metabolic process (GO:0006570),0.30364092906465784,0.6386494824921843,0.8767908309455588,0.990288337166736,1.0,11/11,69.66%,TYR;GSTZ1;THAP4;PAH;TH;TAT;IYD;DCT;IL4I1;HGD;FAH
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.24247098159800076,0.6385746881135793,0.9462129527991219,0.9899957073290414,1.0,19/56,29.89%,SON;RHOA;BBS4;TTC19;SPTBN1;RAB35;CIT;RASA1;PDCD6IP;SEPTIN9;TRIM36;IST1;BIN3;SNX18;SNX33;CUL7;MYH10;INCENP;CKAP2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.1944088986205103,-0.6384558479414758,0.9717514124293786,0.977173827859976,1.0,10/25,29.30%,HSPA9;ERO1A;PTGES3;DNAJC18;HSPE1;HSPA1A;ST13;HSPA1B;HSPA2;SDF2L1
prerank,negative regulation of nuclear division (GO:0051784),0.3146793848724505,0.638420353598855,0.8901408450704226,0.9897655336959854,1.0,2/11,11.79%,AURKAIP1;FBXO5
prerank,Fc receptor signaling pathway (GO:0038093),0.23055700285016884,0.6383773432217102,0.9703476482617587,0.9894463344209901,1.0,37/110,31.13%,SYK;PSMC4;PIK3R2;NFATC1;PSMC6;CHUK;PIK3CA;PSMD8;FER;PPP3CA;SOS1;MAP2K4;CARD11;PPP3CB;MAPK1;GAB2;TAB2;JUN;FBXW11;MAP3K7;VAV2;RELA;PSMD3;PSMD4;RAC1;PSMB3;BCL10;PSMB2;NFKB1;PSMD5;CUL1;FOS;PSMD14;TRAF6;PSMC3;PSMC5;CALM1
prerank,early endosome to late endosome transport (GO:0045022),0.2772205772241797,0.6380044400138881,0.9106487148102815,0.9894065858493205,1.0,6/20,28.35%,HOOK2;WDR91;ANKRD27;SNX16;STX8;PTPN23
prerank,necroptotic process (GO:0070266),0.2874616258983017,0.637620203470325,0.901595744680851,0.9893540839278872,1.0,5/16,25.36%,TLR4;PGAM5;CD14;CYLD;TICAM1
prerank,embryonic hemopoiesis (GO:0035162),0.30508240419587807,0.6374989429260782,0.9030054644808743,0.9890968402930139,1.0,2/12,7.86%,TGFBR2;FLT3LG
prerank,cellular response to dsRNA (GO:0071359),0.2929709455464978,0.6369992492009742,0.8951507208387942,0.9891363103442681,1.0,6/15,28.67%,CGAS;NPM1;FLOT1;RIOK3;MUL1;PDE12
prerank,regulation of chromosome organization (GO:0033044),0.27298007046385125,0.6362955490050186,0.9033457249070632,0.9893479480376327,1.0,8/22,27.95%,HNRNPD;MAPT;XRCC5;SMG6;TERF2IP;UPF1;SMG5;HDAC8
prerank,heterochromatin assembly (GO:0031507),0.27131273447232673,0.6361326682291673,0.898989898989899,0.9891120235193976,1.0,7/20,28.06%,SIRT2;POLE3;EZH1;BAHD1;BAZ2A;MBD2;SUV39H1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.23489278540144926,0.6361191723596182,0.9523809523809523,0.9887717813516439,1.0,7/74,9.05%,PSMC4;VEGFA;NFE2L2;PSMC6;EGLN2;PSMD8;SIRT2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.24899090982045646,0.6354480172172039,0.9321266968325792,0.9889171379251156,1.0,5/38,15.93%,CENPT;HJURP;NPM1;UBN1;CENPC
prerank,polyol biosynthetic process (GO:0046173),0.28737017646608665,0.6354414403167341,0.9019867549668874,0.9885699703070092,1.0,4/16,20.19%,FGF2;CYP27B1;IPPK;IP6K1
prerank,DNA damage checkpoint signaling (GO:0000077),0.26297185140081913,0.6353891124953758,0.9130952380952381,0.9882602518976521,1.0,13/28,33.83%,RHNO1;RAD1;BRIP1;NBN;DONSON;CLSPN;TIPRL;PRPF19;RAD17;RAD9A;USP28;CHEK2;E2F1
prerank,regulation of lipid catabolic process (GO:0050994),-0.20963324265234956,-0.6349332640355903,0.9369369369369369,0.9781862339953568,1.0,2/19,8.97%,LONP2;ADRA2A
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.27333134843158746,0.6345866836788391,0.900516795865633,0.9885151374817948,1.0,3/18,15.70%,POLE3;MCM3;RFC4
prerank,negative regulation of double-strand break repair (GO:2000780),0.26069385135127354,0.6343290719665269,0.9224343675417661,0.9883574613136609,1.0,5/30,13.56%,CGAS;CYREN;TFIP11;NUDT16L1;TWIST1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.309878071395304,0.6339671294422572,0.899581589958159,0.9882821374644479,1.0,1/11,4.40%,ZFP36L1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.30241596108475177,0.633946662845424,0.904635761589404,0.9879481938596105,1.0,2/12,12.25%,TLR4;DUOXA1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.28580365486760984,0.6327019217782058,0.8976377952755905,0.9885404975540849,1.0,3/17,19.54%,AKT1;PDE3B;GPLD1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.2079464438840588,-0.6325498086835708,0.9423076923076923,0.9784410948695048,1.0,8/18,28.20%,MPV17L;HIP1R;SLC35F6;CHCHD10;HSPA1A;ZNF205;BOK;BID
prerank,regulation of steroid metabolic process (GO:0019218),0.27091347558398216,0.6322365265171863,0.8975609756097561,0.9885191555504229,1.0,3/23,9.89%,DGKQ;STUB1;ACADVL
prerank,covalent chromatin modification (GO:0016569),0.2890176890454066,0.6319111328856417,0.9028871391076115,0.9884263568007842,1.0,5/14,30.38%,SETD5;CHD1;UFL1;MBD2;SIRT7
prerank,axonemal dynein complex assembly (GO:0070286),0.25899687316469333,0.6315942626336255,0.9261992619926199,0.9883216015153965,1.0,5/28,22.56%,DNAH8;DNAAF3;DNAAF5;DNAH5;DNAL1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.2622164194890878,0.631573640027165,0.9130966952264382,0.9879844579054017,1.0,9/24,34.63%,POLB;UBA52;RFC4;POLD1;XRCC1;RFC3;RPA3;LIG1;POLD3
prerank,chromosome condensation (GO:0030261),0.25263172569224696,0.6309755778709043,0.936145952109464,0.9880628853594277,1.0,11/36,29.97%,TENT4A;NCAPG;SMC2;SET;AKAP8L;CSNK2A2;DFFB;H1-0;KMT5A;INCENP;AIFM1
prerank,cellular response to interferon-beta (GO:0035458),0.2881622786347322,0.6304776929827138,0.9059278350515464,0.988085327375101,1.0,5/14,27.23%,UBE2G2;CDC34;HTRA2;UBE2K;NDUFA13
prerank,synaptic vesicle transport (GO:0048489),0.3013544790421351,0.6281988968661006,0.906721536351166,0.9893960886309132,1.0,2/11,16.18%,TOR1A;SNAPIN
prerank,regulation of mRNA processing (GO:0050684),0.2549144900850924,0.6276585484552387,0.9248554913294798,0.9894633044660316,1.0,10/32,26.61%,ZFP36L1;SRSF3;SON;CPSF4;PTCD2;RBM39;SRPK1;LARP7;PABPN1;SAFB
prerank,regulation of ruffle assembly (GO:1900027),0.2649197457880487,0.6275553136810536,0.9089805825242718,0.9891887362829843,1.0,4/23,16.27%,NDEL1;PFN2;KANK1;EPS8L2
prerank,cellular response to mechanical stimulus (GO:0071260),0.24322250221789862,0.6274616892358909,0.9366812227074236,0.9889102503476975,1.0,5/46,12.13%,PIEZO2;TLR5;TLR4;SLC9A1;BAK1
prerank,autophagosome maturation (GO:0097352),0.25390745517758906,0.6273461999071493,0.929171668667467,0.9886487446977593,1.0,6/32,13.33%,LIX1L;WIPI2;VPS33A;STX17;EPG5;ATP2A2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.24065463684977187,0.6266672695829818,0.944994499449945,0.9887900882257107,1.0,17/48,29.45%,CRIP1;DYRK2;BAK1;SFN;RPS27L;BCL3;TNFRSF1B;HTRA2;PML;MCL1;PYCARD;MSH6;PRKDC;HIC1;TOPORS;BAX;TP53
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.2690060248698289,0.6265176602589432,0.918444165621079,0.9885404470794643,1.0,6/21,27.10%,CDC14B;FBXO5;RPL23;PTEN;RAB1A;GORASP1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.2990445931045257,0.6262995521797836,0.8844566712517193,0.9883703632334307,1.0,4/12,25.00%,KLF2;EZH2;CALR;ASXL1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.2720109075160533,0.6257632579694022,0.9098873591989988,0.9884121218695289,1.0,3/21,12.43%,TEDC1;UCHL5;TUBD1
prerank,positive regulation of cell development (GO:0010720),0.25428739842714776,0.6257374984828952,0.9426229508196722,0.9880862880624744,1.0,3/31,12.57%,NUMBL;SERPINF1;ATP6AP1
prerank,neurotransmitter secretion (GO:0007269),0.24384298312429992,0.6255392156057626,0.9308390022675737,0.9878823641774196,1.0,8/44,18.84%,STX1A;SNAP25;GAD2;SNAPIN;SNPH;SYT1;VAMP2;RIMS2
prerank,steroid catabolic process (GO:0006706),-0.26201258350307216,-0.6251187267490159,0.8865030674846626,0.9818775382465219,1.0,2/10,10.29%,YWHAH;SPP1
prerank,regulation of protein dephosphorylation (GO:0035304),0.24639239721778208,0.6246074774981414,0.9367816091954023,0.9881914429311986,1.0,13/37,28.87%,PPP6R2;CALM2;PIN1;NSMF;PPIA;SMPD1;PTBP1;YWHAB;ANKLE2;TIPRL;HSP90B1;TSC1;PTPA
prerank,regulation of erythrocyte differentiation (GO:0045646),0.24845601093346661,0.6245189191647025,0.9179019384264538,0.9879172647024211,1.0,10/35,24.70%,MAPK14;ZFP36L1;HOXA5;MAPK11;ZFP36;STAT5B;ABCB10;ACVR2A;LDB1;ACVR1B
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.23249764739434564,0.6244169927659731,0.9563365282215123,0.9876507911176222,1.0,17/59,27.46%,CHUK;TLR4;AKT1;UBA52;NKIRAS1;BCL3;CD14;RBCK1;MAP3K14;CARD11;TAB2;AZI2;MAP3K7;RELA;TICAM1;RNF31;BCL10
prerank,exit from mitosis (GO:0010458),0.2910234180331391,0.624047668089065,0.9032258064516129,0.9875647207127043,1.0,6/12,31.64%,CHMP7;CTDP1;CLASP2;PPP2R2D;SIRT7;CHMP4B
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.2841883711706846,0.6237463989525858,0.9037940379403794,0.9874425439247524,1.0,6/15,30.17%,SAMHD1;YTHDF2;YTHDF3;STAT2;MUL1;CACTIN
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.23749102690089788,0.6236053526829219,0.9467969598262758,0.9871986883879055,1.0,13/57,22.19%,SDAD1;RIOK1;NOC2L;RRP36;NPM1;TGS1;MRPL36;DDX31;RPF2;EBNA1BP2;RIOK2;RPS25;RBIS
prerank,branched-chain amino acid catabolic process (GO:0009083),0.27015411728704086,0.6234512346651276,0.9188144329896907,0.986619465206593,1.0,5/20,21.00%,BCAT1;AUH;HIBADH;BCKDHA;ACAT1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.27015411728704086,0.6234512346651276,0.9188144329896907,0.986619465206593,1.0,5/20,21.00%,BCAT1;AUH;HIBADH;BCKDHA;ACAT1
prerank,DNA biosynthetic process (GO:0071897),-0.21234461020901563,-0.6225932136980127,0.9282700421940928,0.9821648081605623,1.0,7/16,29.02%,SIRT1;TERT;WRN;POLD2;POLE;POLD4;POLL
prerank,nerve growth factor signaling pathway (GO:0038180),0.30403541585561944,0.6224146644186753,0.9131693198263386,0.987016705750437,1.0,3/10,14.99%,MAGI2;KIDINS220;RAPGEF1
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.2002883255781476,-0.6211206159395543,0.9567307692307693,0.981769778596328,1.0,11/20,37.75%,PLCB1;AGRN;LYPD1;RGS10;CDK5R1;CHRM1;LY6H;LY6G6D;CHRNB2;GNA11;CHRM5
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.27721301180500607,0.6208550608473542,0.9205548549810845,0.9878029713725625,1.0,5/16,23.22%,KAT2B;NAA15;NAA50;NAA20;NAA30
prerank,cellular response to ionizing radiation (GO:0071479),0.24124985916054706,0.6206153983548787,0.9425414364640884,0.9876258106797896,1.0,18/47,30.64%,MAPK14;RHNO1;RAD1;XRCC5;CDKN1A;INO80;TNKS1BP1;SPIDR;BLM;NIPBL;CRYAB;MDM2;EEF1D;XRCC6;TP53;HSF1;TLK2;RAD9A
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.29366421506626755,0.6205105924139617,0.9094707520891365,0.9873704916383855,1.0,5/13,31.00%,NT5M;OGG1;DUT;SMUG1;UPP2
prerank,RNA polyadenylation (GO:0043631),0.2587578919494873,0.6204000737898242,0.9184177997527813,0.9867471304786932,1.0,8/26,24.47%,SCAF8;CPSF2;PAPOLB;TENT2;TENT4B;PAF1;CPSF1;WDR33
prerank,mRNA polyadenylation (GO:0006378),0.2587578919494873,0.6204000737898242,0.9184177997527813,0.9867471304786932,1.0,8/26,24.47%,SCAF8;CPSF2;PAPOLB;TENT2;TENT4B;PAF1;CPSF1;WDR33
prerank,pseudouridine synthesis (GO:0001522),0.29150846430128496,0.620191205674315,0.890520694259012,0.9865420281220489,1.0,4/13,29.72%,GAR1;TRUB1;NHP2;PUS10
prerank,regulation of histone methylation (GO:0031060),-0.23244389079505806,-0.6198811179895933,0.9283018867924528,0.9811309765499621,1.0,2/13,8.79%,TET1;CTR9
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.2781336347651342,0.6194754868755764,0.9215938303341902,0.9867038026211568,1.0,17/17,72.22%,LPCAT1;CRLS1;PLA2G12A;LPGAT1;PLA2G4D;PLA2G1B;PLA2G2F;PLA2G2E;PLA2G10;PLA2G2D;PLA2G3;SERAC1;LPCAT4;PLA2G5;PLA2G4B;PLA2G4A;PLA2G4F
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.26227098622905026,0.6190823610024782,0.9156626506024096,0.9866408802074883,1.0,8/22,27.43%,CAMK2N1;CDKN1A;TFAP4;IPO5;PTEN;LATS1;HEXIM1;MEN1
prerank,magnesium ion transport (GO:0015693),0.2965436692079698,0.6187958777804751,0.8970588235294118,0.9865124504874901,1.0,3/12,16.08%,NIPAL2;CNNM4;TUSC3
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.24812051900919949,0.617904966943173,0.934052757793765,0.9867884855680857,1.0,4/30,11.89%,INPP5F;SRCIN1;PARP14;PIBF1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.2624884539142649,0.6178549520835513,0.9230769230769231,0.9857890055354488,1.0,2/20,8.28%,ZW10;ZWINT
prerank,spindle assembly checkpoint signaling (GO:0071173),0.2624884539142649,0.6178549520835513,0.9230769230769231,0.9857890055354488,1.0,2/20,8.28%,ZW10;ZWINT
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.2624884539142649,0.6178549520835513,0.9230769230769231,0.9857890055354488,1.0,2/20,8.28%,ZW10;ZWINT
prerank,RNA destabilization (GO:0050779),0.2720547867544743,0.6175538021991168,0.9174311926605505,0.985654995103755,1.0,6/18,27.88%,PUM1;YTHDF1;YTHDF2;YTHDF3;RBM24;CELF1
prerank,regulation of neuron differentiation (GO:0045664),0.22563150869957005,0.6173298184713004,0.9664570230607966,0.9854698995338722,1.0,27/76,31.82%,FGFR1;NEUROD2;BIN1;BEND6;ZFHX3;YWHAG;RHOA;SIX1;CDK5RAP2;ZEB1;CNTN4;NBL1;KCTD11;TIAM1;CPNE1;PCP4;CALR;NRCAM;HES1;IMPACT;NLGN1;BRINP2;MMD;DISP3;ALK;NGF;CDK5RAP3
prerank,regulation of vacuole organization (GO:0044088),0.2701599877960972,0.6164859733712259,0.912826899128269,0.9856999803862869,1.0,8/20,31.25%,ANXA2;RAB1B;ADPRH;TBC1D12;MTM1;PIKFYVE;LAPTM4B;IFT20
prerank,protein localization to cilium (GO:0061512),0.2499542414946698,0.6157656068041722,0.9440559440559441,0.985839468822511,1.0,10/32,32.00%,BBS9;BBS4;ATP6V1D;TCTN2;TCTN1;RAB29;TULP1;ZNF423;IFT20;ARL6
prerank,regulation of interleukin-17 production (GO:0032660),0.2507936845102896,0.6150232527223657,0.9376470588235294,0.9859896943632178,1.0,4/31,17.74%,RFTN1;TLR4;IL6;IL18
prerank,sensory perception (GO:0007600),0.23671400242226878,0.6146119191728738,0.9510567296996663,0.9859198165126069,1.0,5/45,17.16%,GNAS;KCNA2;BBS4;TTC8;CHRNA7
prerank,melanosome transport (GO:0032402),0.26876482755000053,0.6134804578904202,0.9050131926121372,0.986002757928136,1.0,4/18,18.90%,MYO5A;BBS4;RAB27B;BBS5
prerank,pigment granule transport (GO:0051904),0.26876482755000053,0.6134804578904202,0.9050131926121372,0.986002757928136,1.0,4/18,18.90%,MYO5A;BBS4;RAB27B;BBS5
prerank,regulation of macrophage chemotaxis (GO:0010758),0.2638735159384492,0.6134059526759318,0.9334186939820742,0.9857148706051012,1.0,2/21,5.85%,MIF;AKIRIN1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.2275353758620809,-0.6128517977119162,0.9277566539923955,0.9825844426296136,1.0,2/13,5.53%,PLCB1;SHC1
prerank,cellular response to interleukin-15 (GO:0071350),-0.2275353758620809,-0.6128517977119162,0.9277566539923955,0.9825844426296136,1.0,2/13,5.53%,PLCB1;SHC1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.3050220518908168,0.6127993501215637,0.9035087719298246,0.985780380942766,1.0,3/10,18.68%,NAGK;ST3GAL1;GNE
prerank,RNA stabilization (GO:0043489),0.24606132923476537,0.6125839528192576,0.9345579793340988,0.985586361580033,1.0,7/33,24.84%,TENT5B;LARP1;GDNF;TENT2;ZCCHC17;THRAP3;RBM24
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.2539901640742679,0.6123649804739559,0.9297820823244553,0.9854019343907987,1.0,7/25,24.48%,DOK1;AKT1;CBL;ARAP1;PLAUR;CCDC88A;RTN4
prerank,regulation of cholesterol metabolic process (GO:0090181),0.26474695141501475,0.6118426766141241,0.9208899876390606,0.9854026593883695,1.0,9/20,28.82%,DGKQ;ACADVL;SREBF1;FMO5;ARV1;LPCAT3;KPNB1;MBTPS1;SREBF2
prerank,regulation of chromatin binding (GO:0035561),0.3017464709588825,0.6114506550774638,0.8971830985915493,0.9853287925817427,1.0,3/10,19.09%,DDX11;GMNN;BTAF1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.2454807625021178,0.6113862012637258,0.9385863267670915,0.9850306062965014,1.0,2/32,3.64%,CDK14;ZPR1
prerank,retinal metabolic process (GO:0042574),0.290353529800578,0.6111462658141915,0.9005524861878453,0.9848530372184936,1.0,3/12,22.29%,ALDH1A3;RDH13;CYP1B1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.22266942430979778,0.6103182531356561,0.964509394572025,0.985052542326049,1.0,22/76,24.58%,EGFR;HDAC7;RASSF2;TLR4;IRAK1;LRRC19;CD27;BCL3;RHOA;ZC3H12A;CD14;PDCD4;ILK;IFI35;PPM1A;TSPAN6;CPNE1;TERF2IP;CYLD;CCN3;RELA;TRIM44
prerank,microtubule-based transport (GO:0099111),0.2883593683173928,0.6100023917087449,0.9124487004103967,0.984919242323867,1.0,2/13,14.28%,DYNC1I1;SPAG17
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.2901860646119335,0.6098386735092458,0.9016172506738545,0.9846913573060397,1.0,3/13,16.79%,TBC1D10A;BAK1;GRIN2A
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.2441715113948431,0.609589790378148,0.947429906542056,0.9845070795518619,1.0,15/35,32.28%,PPP1R1B;MTOR;PPP6R2;MAGI2;CALM2;FKBP1A;TIPRL;HSP90B1;CRY2;TSC1;PTPA;FKBP1B;BOD1;CALM1;PPP4R4
prerank,DNA-dependent DNA replication (GO:0006261),0.21712491301721032,0.6094779142284883,0.9888097660223805,0.9842401022315318,1.0,20/128,19.01%,REV3L;PSMC4;PSMC6;PSMD8;POLG2;POLB;POLE3;MCM3;DDX21;UBA52;CDC34;DNA2;ORC6;DBF4;GMNN;RFC4;RECQL;BLM;POLD1;NOC3L
prerank,DNA replication checkpoint signaling (GO:0000076),0.2760622061221565,0.6090825088926395,0.9207397622192867,0.9841459758752885,1.0,2/16,13.51%,TIPIN;DNA2
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.22146355084999914,0.6084504806943041,0.975991649269311,0.9842090432941314,1.0,11/94,12.07%,PSMC4;IRAK3;PSMC6;PELI3;UBE2N;CHUK;PSMD8;SQSTM1;IRAK4;IRAK1;UBA52
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.24399010393416737,-0.6072498494659967,0.9119718309859155,0.9843429513642221,1.0,4/10,28.33%,SORL1;NAB2;RB1;EGR1
prerank,sphingolipid catabolic process (GO:0030149),0.27649298585320714,0.6051655375416988,0.9348109517601043,0.9860271250167467,1.0,3/15,18.57%,PDXDC1;GLA;SMPD1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.29349998514348596,0.605142500996059,0.9153225806451613,0.9856998057532255,1.0,4/12,22.83%,ERN1;BAK1;ATF6;TMEM33
prerank,sterol biosynthetic process (GO:0016126),0.24616673656509536,0.6036655030860116,0.9458186101295641,0.986324587590217,1.0,4/33,9.30%,ACLY;MVK;INSIG2;GGPS1
prerank,calcium ion transport into cytosol (GO:0060402),0.2600862158370876,0.6030448814118439,0.9308176100628931,0.9863723651125762,1.0,2/21,6.14%,ATP2B4;GRIN2D
prerank,cellular response to starvation (GO:0009267),0.21242765482561665,0.602908606423961,0.9888324873096447,0.9861205036697619,1.0,32/147,23.55%,EIF2AK3;HNRNPA1;MTOR;FOXO1;GAS2L1;FLCN;WIPI2;USP33;WDR45B;CEBPB;ATP6V1E1;SESN3;CDKN1A;RRAGD;EIF2S1;ZC3H12A;EHMT2;FADS1;STK24;ATP6V1D;ATP6V1B2;DAP;SREBF1;CASTOR2;STK26;MAPK1;SESN2;ATF4;SLC38A9;ATP6V0B;ATG14;PICK1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.28911519496025917,0.6027925737035047,0.9209431345353676,0.9858490064645802,1.0,5/12,27.89%,MPHOSPH8;SETDB1;SETDB2;TASOR;ATF7IP
prerank,glial cell differentiation (GO:0010001),0.24718950390847927,0.6022691214785824,0.9477434679334917,0.9858391673950799,1.0,3/28,8.12%,SOX10;NFIB;SOX8
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.29044555894493007,0.6018440978093319,0.9274755927475593,0.9857484718034806,1.0,6/12,33.72%,TCERG1;LARP7;HEXIM1;NELFA;NELFB;HNRNPU
prerank,protein localization to vacuole (GO:0072665),0.28086732714451057,0.6017188420982401,0.9101876675603218,0.9854884536194294,1.0,2/13,14.69%,CD81;RNF128
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.27122789194294195,0.6017083497331406,0.9203655352480418,0.9851551843776272,1.0,2/16,7.10%,IRAK3;HDAC6
prerank,DNA catabolic process (GO:0006308),0.29176210358999,0.6011769425486412,0.93646408839779,0.9851301801579432,1.0,3/11,24.95%,DNASE1L2;DFFB;DNASE1L1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.21222204847342116,-0.6006012038998786,0.9836065573770492,0.9865773036380088,1.0,9/17,40.02%,AKAP6;KCNE4;ANK3;NOS1AP;KCNAB1;KCNS2;RNF207;KCNG1;KCNE5
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.26813025331219165,0.6003427362260504,0.9255050505050505,0.9852857953396527,1.0,4/18,21.04%,SRC;MAP2K2;VPS11;MAPK1
prerank,DNA strand elongation (GO:0022616),0.25821105568521674,0.5996857789977994,0.9180537772087067,0.9853635939142578,1.0,4/18,17.41%,MCM3;NBN;RFC4;RAD50
prerank,histone lysine demethylation (GO:0070076),0.25215560567658424,0.5993627980076012,0.9301204819277108,0.9852263730652243,1.0,10/25,28.64%,KDM3B;KDM5C;KDM5B;KDM1B;JMJD1C;KDM2B;KDM4C;KDM3A;KDM4B;KDM2A
prerank,positive regulation of protein deacetylation (GO:0090312),0.279918239465286,0.5992246772771614,0.9306666666666666,0.9849680775454526,1.0,6/14,29.82%,AKAP8;NIPBL;CTBP1;AKAP8L;NNMT;BRMS1
prerank,histone H2A acetylation (GO:0043968),0.2697591183656757,0.5980150119296272,0.9251612903225807,0.9853396897649921,1.0,8/16,32.78%,MSL3;DMAP1;MORF4L1;TRRAP;BRD8;YEATS4;RUVBL1;RUVBL2
prerank,neurotransmitter biosynthetic process (GO:0042136),0.27746814869623254,0.597242663208385,0.9251700680272109,0.9854718845087669,1.0,4/14,22.34%,DAGLA;SLC6A4;DAGLB;ALDH9A1
prerank,regulation of presynapse assembly (GO:1905606),0.2656670677810073,0.5965241966260394,0.9134253450439147,0.9852182309280304,1.0,3/18,15.06%,GPC6;LRFN5;MDGA1
prerank,regulation of presynapse organization (GO:0099174),0.2656670677810073,0.5965241966260394,0.9134253450439147,0.9852182309280304,1.0,3/18,15.06%,GPC6;LRFN5;MDGA1
prerank,nucleotide biosynthetic process (GO:0009165),0.25995045649905374,0.5964181151630179,0.9338422391857506,0.9849440099599294,1.0,4/18,16.62%,GART;PRPSAP1;PRPS1;PRPS1L1
prerank,synaptonemal complex organization (GO:0070193),0.27391521003655095,0.5962654469476899,0.9417989417989417,0.9843557306302121,1.0,1/15,8.81%,SYCP2
prerank,synaptonemal complex assembly (GO:0007130),0.27391521003655095,0.5962654469476899,0.9417989417989417,0.9843557306302121,1.0,1/15,8.81%,SYCP2
prerank,icosanoid biosynthetic process (GO:0046456),-0.24118052036469909,-0.5953821900021474,0.9328621908127208,0.9879069801558783,1.0,6/10,33.13%,MGST3;PLA2G4A;PLA2G5;ALOX5AP;MGST2;ALOX5
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.27701908299767614,0.5952034182440664,0.9347536617842876,0.9846321928678197,1.0,4/14,22.83%,COPS5;BAK1;UFL1;TMEM33
prerank,regulation of microtubule-based movement (GO:0060632),0.29463549648684484,0.5947837351234159,0.9246088193456614,0.9845460821996931,1.0,1/11,7.10%,HDAC6
prerank,detection of visible light (GO:0009584),-0.20759404773838908,-0.5930576213458592,0.9699570815450643,0.9876907664836418,1.0,2/16,10.26%,ABCA4;RP1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.24337005574868714,0.592982089713008,0.9495192307692307,0.985263603248279,1.0,10/31,35.05%,SCP2;SRD5A1;NFS1;PYCR1;MOCS1;NOXRED1;PYCR3;MOCS2;LIAS;MOCS3
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.2529697458241299,0.5928999779296311,0.9407313997477932,0.9849705918152537,1.0,10/21,32.28%,PPP1R1B;YWHAE;YWHAB;FKBP1A;TIPRL;CRY2;PTPA;FKBP1B;BOD1;PPP4R4
prerank,lipoprotein biosynthetic process (GO:0042158),0.2903191931826309,0.5920358617277656,0.9357541899441341,0.9851341265829957,1.0,2/11,10.46%,WIPI2;WDR45B
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.15325893746781305,-0.5913083637975396,1.0,0.9871948443347679,1.0,19/45,32.25%,APP;WNT5A;AIM2;GBP5;HSPB1;LPL;CCL19;NOD2;GSDMD;RIPK2;CASP1;FZD5;AGER;EGR1;MALT1;NLRC4;TYROBP;CD36;TLR6
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.24769378064925632,0.5902318121610108,0.9415347137637028,0.9858270470335567,1.0,10/24,32.22%,FYN;MIEF2;CHP1;ITGAM;FIS1;MTCL1;PRNP;MYO1C;AKT2;TCAF1
prerank,negative regulation of leukocyte activation (GO:0002695),0.26807401999807523,0.5893149188954344,0.9162234042553191,0.9860098290250665,1.0,6/15,28.30%,ZC3H12A;IL4;LRFN5;IL31RA;HAVCR2;CD300LF
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.2324504199919536,0.5874835725441532,0.9552572706935123,0.9867166250440544,1.0,11/38,27.23%,NDUFS5;NDUFAB1;NDUFS1;NDUFB7;NDUFV2;NDUFA2;NDUFB2;NDUFB3;NDUFAF1;NDUFB9;NDUFA13
prerank,natural killer cell mediated immunity (GO:0002228),-0.21103855330905438,-0.5867361478872613,0.95703125,0.987926895832896,1.0,15/15,78.92%,ULBP1;RAET1E;KIF5B;TUBB4B;SLAMF7;KLRD1;KLRK1;TUBB;KLRC2;KIR3DL1;GZMB;CEBPG;ARL8B;PLEKHM2;LYST
prerank,regulation of mitochondrial fusion (GO:0010635),0.28011968103734136,0.5857475515777684,0.9268635724331927,0.9873387162694524,1.0,3/11,27.42%,PID1;MUL1;VAT1
prerank,protein neddylation (GO:0045116),0.2728556590925641,0.584624975199962,0.9263301500682128,0.987592669876054,1.0,5/13,29.05%,RNF7;NEDD8;UBE2F;DCUN1D1;UBE2M
prerank,protein-containing complex subunit organization (GO:0043933),0.2069101195818773,0.5840766360223463,0.9866803278688525,0.9875513835781549,1.0,27/109,27.25%,WIPF1;LLGL1;DLG4;GPAA1;ZW10;WASF1;MDM4;NUP98;MITF;TFAP4;PML;SPG7;NAPG;EPRS1;VAMP2;LAMC1;KMT2A;TPR;DMTN;NDUFAF1;NUP133;MDM2;PPIH;KIFAP3;HES1;VAMP3;WASL
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.20979153217408744,0.5836056610475423,0.9917184265010351,0.9874509331483001,1.0,13/110,15.51%,RPSA;CTIF;HELZ2;PNRC2;GSPT2;RPL10A;UBA52;RPS5;SMG7;EIF3E;GSPT1;SMG6;RPL6
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.1840364115892008,-0.5835929557980615,0.9479166666666666,0.9880601781368412,1.0,13/23,39.72%,ABHD4;PLAAT3;PLA2G4C;PLA2G6;PLA2G4F;PLA2G4A;PLA2G4B;PLA2G5;MBOAT2;LPCAT4;PLBD1;MBOAT1;PLA2G3
prerank,neuron fate commitment (GO:0048663),0.26621151469344584,0.5820190809048191,0.934228187919463,0.9879472595252153,1.0,3/14,25.68%,POU3F2;TGFBR1;MYT1L
prerank,receptor recycling (GO:0001881),0.29163099391013514,0.5810327494619235,0.9429824561403509,0.9881049502374628,1.0,3/10,16.29%,NSG1;REP15;PHETA2
prerank,centromere complex assembly (GO:0034508),0.2295549622281216,0.5807350013443374,0.9594594594594594,0.9879230243978311,1.0,5/36,18.82%,CENPT;HJURP;NPM1;CENPC;CENPE
prerank,glutamate receptor signaling pathway (GO:0007215),0.22935070293290657,0.5802445586680572,0.9633867276887872,0.9878302222810191,1.0,11/37,27.38%,GRIN3A;DAGLA;GRIA2;DAGLB;GRIN2A;GRM1;GRIA3;GRIK2;GRIK4;GRM5;GRID2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.24689106696801805,0.5800725346533336,0.94625,0.9875967272323564,1.0,9/20,32.78%,BRD7;DIP2A;GLYR1;ARRB1;RPS6KA5;TADA2A;PRKAA1;TADA2B;RUVBL2
prerank,ribosomal large subunit assembly (GO:0000027),0.24383477878410967,0.5800457610338232,0.9473684210526315,0.9872727943887412,1.0,6/24,24.03%,RPL6;NOP53;RPF2;NOP2;RSL24D1;BRIX1
prerank,regulation of membrane repolarization (GO:0060306),0.2699511537910919,0.5786423404816976,0.9336099585062241,0.9876603458840832,1.0,4/13,18.73%,KCNJ2;YWHAE;AKAP9;KCNH2
prerank,pinocytosis (GO:0006907),0.2875747846163171,0.5779315775871089,0.953083109919571,0.9876831685134927,1.0,5/10,31.86%,PYCARD;SNX33;PPT1;MAPKAPK3;SNX5
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.25230957282230454,0.5775690417814487,0.9513381995133819,0.9875309335436844,1.0,7/20,30.79%,MCU;MCUB;SPG7;SLC8B1;PARL;LETM1;MICU1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.2581796379953213,0.5750090170002033,0.9399744572158365,0.9885383910545555,1.0,4/17,21.01%,ACVR1;JAG1;SNAI2;BMPR1A
prerank,ncRNA 3'-end processing (GO:0043628),0.2667705936732986,0.5742695965670449,0.9482993197278912,0.9885655285161791,1.0,4/14,19.29%,INTS6;INTS2;INTS12;PTCD1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.23394443320832586,0.5741284404732828,0.9638273045507585,0.9883025343080548,1.0,4/29,13.17%,AXIN1;UBE2N;FBXO5;PIN1
prerank,signal release from synapse (GO:0099643),0.22353047835582368,0.5731899113815889,0.9600456621004566,0.9884214391226538,1.0,7/43,18.56%,STX1A;SNAP25;GAD2;SNAPIN;SNPH;SYT1;VAMP2
prerank,aerobic electron transport chain (GO:0019646),0.21347551541170912,0.5731230790025978,0.985200845665962,0.988123923425088,1.0,20/68,27.23%,NDUFS5;NDUFAB1;NDUFS1;NDUFB7;NDUFV2;NDUFA2;UQCRQ;UQCC3;UQCRH;SDHAF2;COX7B;NDUFB2;UQCR10;AFG1L;NDUFB3;NDUFAF1;SDHC;NDUFB9;COX15;NDUFA13
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.21205672296758551,0.5725536416842459,0.9841269841269841,0.9880793728308339,1.0,6/73,9.29%,PSMC4;RUNX1;ITCH;PSMC6;PSMD8;PDCD2
prerank,cytoplasmic translation (GO:0002181),0.2068379430580438,0.5720867507838558,0.9792315680166147,0.9879806132687861,1.0,14/91,20.91%,RPSA;EIF4A1;FTSJ1;GSPT2;RPL10A;UBA52;RPS5;GSPT1;RPL6;RPL22L1;RPL23;RPL17;RWDD1;RPS25
prerank,positive regulation of interleukin-1 production (GO:0032732),0.21754526119958972,0.5709264808395169,0.9759825327510917,0.9882042706534924,1.0,4/51,11.69%,IL16;TMEM106A;TLR4;USP50
prerank,regulation of store-operated calcium entry (GO:2001256),0.28036251469850104,0.5702528358112537,0.9261838440111421,0.9882089830718748,1.0,3/10,21.65%,CASQ1;STIM1;SLC8B1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.2571883110070929,0.570161787045857,0.943078913324709,0.9879166718621565,1.0,9/17,33.73%,CPSF6;CDK9;CPEB1;CPSF7;RNF20;HSF1;VIRMA;CPEB3;NCBP2
prerank,cell differentiation in hindbrain (GO:0021533),-0.21947818831885518,-0.569034906638463,0.9611307420494699,0.9928978800370442,1.0,2/11,9.17%,OPHN1;KNDC1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.2092186870828271,-0.568921488620667,0.9682539682539683,0.991589427698573,1.0,6/13,28.95%,SOX11;MAD2L2;TAF1;HEY1;HEY2;SIN3A
prerank,glucose metabolic process (GO:0006006),0.21208283017611168,0.5674101330171243,0.9824175824175824,0.9888948061800963,1.0,12/58,23.16%,CRTC2;SLC39A14;IRS2;GAA;MDH2;G6PC3;ALDOA;GALM;GOT1;SLC37A4;ATF4;KCNJ11
prerank,ether lipid metabolic process (GO:0046485),-0.19878444449323435,-0.5672160497661273,0.9653679653679653,0.9909085796946628,1.0,5/14,18.91%,AGPS;LIPE;PLAAT3;DHRS7B;TMEM86B
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.15236356330958462,-0.5661036463803488,1.0,0.9900109351083229,1.0,16/48,31.74%,IL1R1;SLC7A5;TLR3;SCRIB;CYRIB;TXK;SLC11A1;IL27;CD276;FZD5;CCR2;IL12RB2;TLR7;RASGRP1;LILRB1;FADD
prerank,autophagy of peroxisome (GO:0030242),0.26874581373431616,0.5648128653251872,0.9511533242876526,0.9897672822162242,1.0,3/12,17.80%,SQSTM1;NBR1;PEX5
prerank,negative regulation of cellular protein localization (GO:1903828),0.22221302996638564,0.5628858616169751,0.9619500594530321,0.9902965699935081,1.0,10/34,27.79%,FLCN;OTUD7B;MAPT;ILRUN;GOPC;MAP1A;LEPROT;LATS1;SNX33;DNAJA1
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.2116156927301847,-0.5624386562031221,0.967032967032967,0.9900453231658597,1.0,1/12,2.06%,SERINC3
prerank,motile cilium assembly (GO:0044458),-0.2184020268828146,-0.5616012913348434,0.9644128113879004,0.9889737365966735,1.0,2/12,8.49%,BBOF1;SPATA6
prerank,positive regulation of interleukin-17 production (GO:0032740),0.23903911956279503,0.5611749458311046,0.9618226600985221,0.9907387234183539,1.0,3/22,17.74%,RFTN1;IL6;IL18
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.20812454088577234,0.5589851041966164,0.9883597883597883,0.99141673307334,1.0,20/69,27.23%,NDUFS5;NDUFAB1;NDUFS1;NDUFB7;NDUFV2;NDUFA2;UQCRQ;UQCC3;UQCRH;SDHAF2;COX7B;NDUFB2;UQCR10;AFG1L;NDUFB3;NDUFAF1;SDHC;NDUFB9;COX15;NDUFA13
prerank,snRNA 3'-end processing (GO:0034472),0.24253902371299543,0.558820557250758,0.9577464788732394,0.9911549209839741,1.0,4/19,18.59%,EXOSC7;INTS6;INTS2;INTS12
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.2630711926471919,0.5587550535331902,0.9547325102880658,0.9908474718680281,1.0,6/13,33.72%,TCERG1;LARP7;HEXIM1;NELFA;NELFB;HNRNPU
prerank,ether lipid biosynthetic process (GO:0008611),0.2774749418732647,0.5572599577651527,0.9511854951185496,0.9911616535065345,1.0,2/10,20.92%,FAR1;PEDS1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.257006522875877,0.5572516244167975,0.937584803256445,0.9908287192501802,1.0,2/14,11.73%,TIRAP;IRAK1
prerank,endothelial tube morphogenesis (GO:0061154),0.2771555434063912,0.5572235310564712,0.9438040345821326,0.9905065476040525,1.0,2/10,13.49%,PRKD2;RHOA
prerank,endocytic recycling (GO:0032456),0.21164951426389353,0.5570779934907037,0.9856670341786108,0.9902385762792755,1.0,17/50,31.07%,VPS52;EHD2;CMTM6;DENND1A;ARF6;ANKRD27;RAB35;ENTR1;VPS39;RAB11FIP3;MICALL1;EIPR1;PTPN23;ACAP2;SNX27;CCDC93;RAB14
prerank,establishment of epithelial cell polarity (GO:0090162),0.24414126287936097,0.556640526350254,0.9568527918781726,0.9900836491594854,1.0,8/19,35.19%,MYO9A;RHOA;FBF1;SIPA1L3;PARD3;GOLPH3;CYTH1;CLASP1
prerank,cotranslational protein targeting to membrane (GO:0006613),0.20175119210665043,0.5560886775574476,0.9947753396029259,0.9899758645779438,1.0,10/91,15.51%,RPSA;SRP19;SRP9;RPL10A;UBA52;RPS5;TRAM1;SEC63;SEC61A1;RPL6
prerank,primary miRNA processing (GO:0031053),0.2673118930654192,0.5558785417656599,0.9373259052924791,0.9897270885035194,1.0,1/10,6.56%,DGCR8
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.2529042019016037,0.5555504296059435,0.9506008010680908,0.9895330469613565,1.0,8/15,38.06%,CCT7;CCT4;CCT6A;NHP2;RUVBL1;RUVBL2;TCP1;CCT8
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.273491262605048,0.5550168093925513,0.9405940594059405,0.9894212866476245,1.0,3/10,20.02%,NOC2L;SET;CTBP1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.21005712850775315,-0.5543121177541069,0.9675090252707581,0.9902211452755062,1.0,12/12,79.02%,ACSL3;APOC1;MTTP;P4HB;APOC4;DGAT1;APOB;APOC3;MFSD2A;SOAT2;LPCAT3;SOAT1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.2334286478791609,0.5533255577140987,0.9594272076372315,0.9897865662825114,1.0,6/25,20.96%,BMF;BBC3;MLLT11;HRK;PLAUR;PYCARD
prerank,positive regulation of ruffle assembly (GO:1900029),0.25961627312207736,0.5519672175554767,0.9451697127937336,0.9899989034965098,1.0,2/13,16.27%,NDEL1;EPS8L2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.23394690524228462,0.551760692916845,0.9657282741738066,0.9897410208682705,1.0,5/23,26.30%,GSTM2;FADS1;GSTM1;ELOVL6;ACOT7
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.20564386836248533,0.551351255624663,0.9839228295819936,0.9895696173286207,1.0,5/70,8.57%,PSMC4;RUNX1;ITCH;PSMC6;PSMD8
prerank,presynapse organization (GO:0099172),0.2715946582420396,0.5511979911870835,0.948016415868673,0.9892979484310769,1.0,5/10,31.31%,LRRTM3;DVL1;NLGN1;NLGN3;NLGN2
prerank,hydrogen peroxide catabolic process (GO:0042744),0.26377599170936605,0.5491523044757342,0.9587912087912088,0.9897616879418127,1.0,2/11,17.99%,GPX1;PXDN
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.2523621850250811,0.5477747167491872,0.9455782312925171,0.9899622010050225,1.0,2/14,11.71%,TLR5;PUM1
prerank,negative regulation of viral genome replication (GO:0045071),0.2147249922471603,0.5466315919496721,0.9783845278725825,0.9900786845831483,1.0,9/40,23.06%,INPP5K;MPHOSPH8;ZC3HAV1;SLPI;TNIP1;FAM111A;BTBD17;SRPK1;SETDB1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.2615064216034783,0.5461225158022515,0.9546061415220294,0.9896053480473509,1.0,3/12,19.99%,STIMATE;SLC9A1;PTBP1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.2615064216034783,0.5461225158022515,0.9546061415220294,0.9896053480473509,1.0,3/12,19.99%,STIMATE;SLC9A1;PTBP1
prerank,negative regulation of cell division (GO:0051782),0.2633253923803256,0.5452576202752412,0.9527027027027027,0.9895869539150738,1.0,4/11,29.73%,ORC6;BLM;E2F7;CHMP4C
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.25548353999291784,0.5432882777662323,0.9502688172043011,0.9900090758584151,1.0,2/12,18.71%,TLR4;STRAP
prerank,regulation of oxidative phosphorylation (GO:0002082),0.24422502881228972,0.5406189504907375,0.96,0.9907011458358989,1.0,3/16,21.65%,MLXIPL;NUPR1;SLC25A33
prerank,negative regulation of histone acetylation (GO:0035067),0.2603132303415523,0.539451803569301,0.9624478442280946,0.9907870562203991,1.0,3/11,20.02%,NOC2L;SET;CTBP1
prerank,gluconeogenesis (GO:0006094),0.2104703025516159,0.5393940556975182,0.9791183294663574,0.9904730637812253,1.0,8/39,22.18%,CRTC2;SLC39A14;MDH2;G6PC3;ALDOA;GOT1;SLC37A4;ATF4
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.22760102489504977,0.5390410624442553,0.9739130434782609,0.9902638677696226,1.0,7/25,27.22%,MAPK14;MAPK11;STAT5B;ABCB10;ACVR2A;ACVR1B;PRKDC
prerank,regulation of cell projection organization (GO:0031344),0.24959295463512593,0.5380596146601258,0.9506008010680908,0.9902809012244409,1.0,1/13,8.00%,MYO9A
prerank,glycerophospholipid catabolic process (GO:0046475),0.22381440263893587,0.5374306965036363,0.972939729397294,0.9901738123412656,1.0,5/27,20.38%,INPP5F;PNPLA8;PLA2G4E;LIPC;GDPD3
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.2342670518779046,0.5371248447129563,0.9723618090452262,0.989956112856194,1.0,19/19,76.60%,SPAG17;SPEF2;NPHP3;CCDC39;NEK10;CCDC103;RFX3;DNAAF1;DNAAF4;CCDC40;OFD1;AQP4;ODAD4;DNAAF2;SPA17;ADCY10;ROPN1L;CFAP53;CABYR
prerank,NIK/NF-kappaB signaling (GO:0038061),0.1989194190625374,0.536419830146122,0.9936238044633369,0.9898782538313261,1.0,22/72,31.72%,PSMC4;PSMC6;CHUK;PSMD8;TIRAP;AKT1;IRAK1;MAP3K14;FBXW11;MAP3K7;RELA;PSMD3;PSMD4;PSMB3;PSMB2;PSMD5;CUL1;PSMD14;TRAF6;PSMC3;PSMC5;PSME4
prerank,positive regulation of telomere maintenance (GO:0032206),0.2134425220098082,0.5359408476843438,0.972318339100346,0.9897022375140744,1.0,7/31,22.85%,HNRNPD;NBN;PML;RAD50;NEK7;MAPK1;ERCC1
prerank,tRNA metabolic process (GO:0006399),0.23767089563671812,0.5359160237055538,0.953185955786736,0.9893785853439497,1.0,5/17,31.03%,RPP21;TRPT1;RPP30;SARS1;AARS1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.24236196329090554,0.5334889735998493,0.9587096774193549,0.9898901868968424,1.0,3/15,16.84%,DAGLA;DAGLB;GRM1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.20511221718941658,0.5325654206624464,0.9890948745910578,0.989850590714171,1.0,4/50,9.78%,PSMC4;PSMC6;PSMD8;ODC1
prerank,positive regulation of DNA repair (GO:0045739),0.20582657412906644,0.5324865765416762,0.9784824462061155,0.989541551804873,1.0,7/46,16.66%,EGFR;EYA2;UBE2N;TIGAR;ABRAXAS1;DDX11;SPIDR
prerank,endoderm development (GO:0007492),-0.19971120040180815,-0.5321719232120627,0.9633699633699634,0.9956452189306203,1.0,13/13,80.05%,SOX17;SOX7;DUSP4;TBX20;DUSP5;DUSP2;GATA4;KIF16B;EOMES;APELA;DUSP1;LHX1;LAMC1
prerank,lipid droplet organization (GO:0034389),-0.17230981845593316,-0.5299120172773285,1.0,0.9948573752176668,1.0,22/22,82.80%,ZFYVE1;PNPLA3;PLA2G4C;FITM2;CDS2;HILPDA;PPID;PLIN5;CIDEA;SMIM22;FAF2;HSD17B13;TSPO2;SQLE;CIDEC;FITM1;BSCL2;CDS1;RAB3GAP1;RAB18;AUP1;PPIA
prerank,response to histamine (GO:0034776),0.2589740481366732,0.5284271225522781,0.9674681753889675,0.9905310808566055,1.0,2/10,19.26%,DIAPH1;GABRG2
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.2406040173721918,0.5273106962478883,0.9735799207397622,0.9905404781552862,1.0,6/16,32.88%,VAMP2;LYST;VAMP7;PLEKHM2;ARL8B;CEBPG
prerank,establishment of skin barrier (GO:0061436),0.2441483123323545,0.5266377379700986,0.9672774869109948,0.9900864442199913,1.0,2/15,12.48%,FA2H;SFN
prerank,regulation of water loss via skin (GO:0033561),0.2441483123323545,0.5266377379700986,0.9672774869109948,0.9900864442199913,1.0,2/15,12.48%,FA2H;SFN
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.2114976887548553,-0.5256489158685687,0.9833333333333333,0.9945952747560556,1.0,1/10,4.21%,MTHFS
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.2027638812098933,0.5221019690595676,0.9834983498349835,0.9911684729520484,1.0,5/50,14.13%,CAMK2N1;GTPBP4;CDKN1A;CCND1;CCNH
prerank,DNA replication initiation (GO:0006270),0.20345505589688703,0.5175998505767879,0.9841269841269841,0.9921343358362772,1.0,6/37,14.84%,POLE3;MCM3;CDC34;ORC6;DBF4;GMNN
prerank,pre-replicative complex assembly (GO:0036388),0.19307311431994154,0.5168766826704914,0.9893390191897654,0.992007623744313,1.0,7/64,14.84%,PSMC4;PSMC6;PSMD8;MCM3;UBA52;ORC6;GMNN
prerank,response to gamma radiation (GO:0010332),0.21719667360535302,0.5166618577695711,0.9831730769230769,0.9917360615806554,1.0,10/24,30.05%,FANCD2;XRCC5;CRYAB;MDM2;MEN1;XRCC6;TP53;HSF1;PRKAA1;TLK2
prerank,glycine metabolic process (GO:0006544),-0.19379747630108607,-0.5161995680143923,0.9755102040816327,0.9955266517405137,1.0,12/12,80.64%,DLD;GCSH;SHMT2;SHMT1;AMT;GLYAT;RIDA;BAAT;SDS;SDSL;GCAT;GLDC
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.19758398405296884,-0.5147180106228553,0.9656488549618321,0.9944996051033678,1.0,1/12,2.45%,APOE
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.19757956030552287,0.5144244272857602,0.9900221729490022,0.9920315575968284,1.0,14/48,27.02%,NUP93;NUP107;TIGAR;NUP98;EIF6;NUP37;OGT;NUP50;TPR;NOA1;NUP133;NUP85;NUP188;NUP88
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.19534943774646896,0.5122461096188125,0.9946178686759957,0.9922787929484036,1.0,4/53,9.78%,PSMC4;PSMC6;PSMD8;ODC1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.20815058809454584,0.5102782233298307,0.986904761904762,0.9924602855281834,1.0,5/27,17.92%,AK2;NME2;NME1;AK8;AK9
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.22561336481526395,0.5085766555298941,0.974293059125964,0.9925926524232799,1.0,2/17,15.33%,MBOAT7;PLA2G4E
prerank,regulation of mRNA metabolic process (GO:1903311),0.24832748844400154,0.5078676385811518,0.967605633802817,0.9924572819021565,1.0,4/11,29.70%,PTCD2;SRPK1;SAFB;SLTM
prerank,neuronal action potential (GO:0019228),0.2150271239666864,0.5063670053751873,0.9861460957178841,0.9925214552643576,1.0,11/22,35.52%,MYH14;KCNA2;SCN9A;SCN2A;CACNA1H;KCNMB2;KCNMB3;CACNA1I;CACNA1G;SCN8A;SCN1A
prerank,regulation of stem cell proliferation (GO:0072091),0.22671694915559398,0.5057169339338801,0.9747155499367889,0.9923476185109672,1.0,1/17,4.40%,ZFP36L1
prerank,regulation of stem cell differentiation (GO:2000736),0.18288214139207792,0.5039891850451392,0.9969072164948454,0.9924782256591113,1.0,7/89,8.92%,PSMC4;RUNX1;ITCH;PSMC6;ZFP36L2;PSMD8;JAG1
prerank,B cell mediated immunity (GO:0019724),0.24597497973245486,0.5004772295254165,0.9631728045325779,0.9929994768379016,1.0,1/10,12.21%,CD27
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.1980928961396478,0.49675707288891197,0.9847417840375586,0.9935294486114183,1.0,11/35,28.61%,ACLY;FAR1;GGT7;HSD17B8;BDH2;SCD5;ACAT1;BDH1;PPT1;PAM;HMGCL
prerank,peptidyl-glutamic acid modification (GO:0018200),0.21138859233313137,0.4949868053095321,0.9816625916870416,0.9935960709676771,1.0,5/24,25.85%,GGCX;TTLL3;TTLL11;VKORC1;TPGS1
prerank,fibrinolysis (GO:0042730),-0.17842792566549473,-0.4900134211360461,0.9961089494163424,0.9977860947729712,1.0,13/13,82.18%,SERPINE1;PLAT;HRG;PLG;SERPINB2;CPB2;GP1BA;F2;KRT1;FGG;SERPINF2;PLAU;PLAUR
prerank,tryptophan catabolic process (GO:0006569),0.23308223477715012,0.484714399013681,0.9815078236130867,0.9953340556275408,1.0,11/11,76.71%,AFMID;KMO;KYAT1;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KYNU
prerank,mitotic DNA replication (GO:1902969),0.23733369362316056,0.48360750025205296,0.9714693295292439,0.9952133391118793,1.0,1/10,10.20%,MCM3
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.2272336789666326,0.4795379943323764,0.9840425531914894,0.9956448310343586,1.0,6/12,33.72%,CDYL;LRIF1;PCGF3;RBM15;RLIM;HNRNPU
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.1625687166173258,-0.46561931027355125,0.9904306220095693,0.9994166263152763,1.0,6/17,27.11%,GJA1;TERT;SOX11;HMGA2;PTPRC;N4BP2L2
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.20209648822433468,0.46369556404208634,0.9861286254728878,0.9979074413872581,1.0,3/19,17.91%,CHRNA7;CHRFAM7A;CHRNA5
prerank,positive regulation of telomerase activity (GO:0051973),0.18460160012285437,0.44958505586480896,0.997709049255441,0.9994710054542825,1.0,7/33,23.74%,ACD;XRCC5;KLF4;HSP90AA1;NEK7;MAPK1;CCT4
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.18310610095155702,0.44478417890553046,0.9952774498229043,0.9996776909187123,1.0,1/29,3.89%,CD160
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.2217208520828552,0.44445206531644665,0.9857752489331437,0.9993767767415449,1.0,5/10,33.00%,GABRG3;GABRG2;GABRA3;GABRA1;GABRA5
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.21421261872169634,0.442043001783286,0.9931787175989086,0.9992982256217952,1.0,3/11,28.35%,VPS11;EIPR1;PTPN23
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.1844830832967171,-0.44113300009884365,0.9964788732394366,0.9998010284414174,1.0,10/10,81.57%,QDPR;KYNU;IL4I1;PCBD1;IYD;PAH;ATP7A;KYAT1;THAP4;ASRGL1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.17892748972087394,0.4406081086960555,1.0,0.9991280505982032,1.0,5/30,21.23%,HSPA13;HSPA14;SELENOF;UGGT1;DNAJB1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.2052591013970418,0.43831542948015567,0.9973404255319149,0.9990212372296313,1.0,1/12,10.20%,MCM3
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.16311923149368998,-0.43678438231437505,0.9960629921259843,0.9986769498854432,1.0,14/14,83.71%,PTGS2;ADAM8;PARK7;TNF;CREB3L3;OSM;FFAR2;IL1B;C2CD4B;C2CD4A;IL6ST;PTGER3;OSMR;IL6
prerank,innate immune response in mucosa (GO:0002227),0.21589201437991348,0.4341737033152325,0.9930843706777317,0.9990751441086153,1.0,1/10,14.82%,IL4
prerank,negative regulation of transposition (GO:0010529),0.19649707259731547,0.4334203008010352,0.9972862957937585,0.9988178204781971,1.0,3/16,22.64%,SPOCD1;DDX4;UBR2
prerank,sensory perception of pain (GO:0019233),0.1830402010050251,0.4321971778774319,0.9926017262638718,0.998591938195509,1.0,21/21,81.72%,KCNA2;SCN9A;P2RX4;RETREG1;TRPA1;PTGES;NIPSNAP1;MME;P2RX7;MRGPRX2;PRDM12;PROK2;ALOXE3;CHRNB2;OPRL1;KCNK4;CCL2;CCR2;CHRNA4;OPRM1;OPRK1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.2008692413893465,0.43033150090658756,0.997275204359673,0.9984364602605266,1.0,5/13,32.96%,CBL;SNX6;CBLB;SOCS4;TSG101
prerank,negative regulation of inclusion body assembly (GO:0090084),0.21202577708525383,0.42769784362436614,0.9885550786838341,0.9983277988302774,1.0,2/10,21.23%,DNAJB2;DNAJB1
prerank,glutathione derivative metabolic process (GO:1901685),0.18336916514817603,0.42336379460401274,0.992583436341162,0.9980285960306067,1.0,8/20,33.91%,GSTM2;GSTO2;GSTM1;ESD;GSTM5;GSTT1;GSTZ1;HPGDS
prerank,glutathione derivative biosynthetic process (GO:1901687),0.18336916514817603,0.42336379460401274,0.992583436341162,0.9980285960306067,1.0,8/20,33.91%,GSTM2;GSTO2;GSTM1;ESD;GSTM5;GSTT1;GSTZ1;HPGDS
prerank,positive regulation of telomere capping (GO:1904355),0.18564099893535757,0.41693872535070414,0.9961587708066582,0.9981692818943739,1.0,3/17,21.04%,HNRNPD;NEK7;MAPK1
prerank,dendritic cell chemotaxis (GO:0002407),0.1907057142800564,0.4102362056749478,0.9947575360419397,0.9983082657701504,1.0,3/14,21.27%,CXCR4;CXCR2;PIK3CG
prerank,positive regulation of lipid storage (GO:0010884),0.16669334454854523,0.39449695521257205,0.9973992197659298,0.9988327872133701,1.0,2/21,14.08%,PLIN2;ZC3H12A
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.16172888713064018,0.38080500436577547,0.9987623762376238,0.999011327454456,1.0,4/23,23.60%,SRCIN1;CBL;SNX6;CBLB
